Citrus Sinensis ID: 005599
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 688 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZT07 | 833 | G-type lectin S-receptor- | yes | no | 0.979 | 0.809 | 0.538 | 0.0 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.982 | 0.8 | 0.532 | 0.0 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.922 | 0.747 | 0.502 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.970 | 0.792 | 0.469 | 1e-174 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.957 | 0.778 | 0.469 | 1e-171 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.933 | 0.749 | 0.461 | 1e-169 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.952 | 0.771 | 0.426 | 1e-160 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.954 | 0.780 | 0.434 | 1e-160 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.895 | 0.786 | 0.452 | 1e-159 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.940 | 0.793 | 0.450 | 1e-159 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function desciption |
|---|
Score = 756 bits (1952), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/693 (53%), Positives = 498/693 (71%), Gaps = 19/693 (2%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
MRLG+ ++ G +R LT+WKS DPGSG+ +M+ GF Q+ LYK WWR GSWTG R
Sbjct: 155 MRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYKGVTPWWRMGSWTGHR 214
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWI 120
SGVPEM +IFN ++++N+DEV Y + + S+++R +VNETG RFTW ++D+RW
Sbjct: 215 WSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNETGTMHRFTWIARDKRWN 274
Query: 121 GFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKRKLG 180
FW+ PKEQCD Y HCGPN C + FECTCLPGFEPK+P+ W LRD SGGC +K
Sbjct: 275 DFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPRHWFLRDSSGGCTKKKR 334
Query: 181 TSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETN-GG 239
S C + +GF+KL +K+PDTS A+ VDMN+ LK C+++CL NCSCVAYASAY E+ G
Sbjct: 335 ASICSEKDGFVKLKRMKIPDTSDAS-VDMNITLKECKQRCLKNCSCVAYASAYHESKRGA 393
Query: 240 IGCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVAIVLG 299
IGCL +HG + D RTY N+GQD ++R D ELA + +++ + KRR+ LI+++++
Sbjct: 394 IGCLKWHGGMLDARTYLNSGQDFYIRVDKEELA----RWNRNGLSGKRRVLLILISLIAA 449
Query: 300 VLLLGLCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVT 359
V+LL + F + R ER++ R N + D + S +++K N ++
Sbjct: 450 VMLLTVILFCVVR-------ERRKSNRHRSSSANFAPVPFDFDESFRFEQDK-ARNRELP 501
Query: 360 FFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVL 419
F+L+T++AAT+NFS+ NKLG GGFGPVYKG L N EIAVKRLS SGQG+EEFKNEV
Sbjct: 502 LFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVK 561
Query: 420 LIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 479
LI+KLQHRNLV++LGCC+E +EKML+YE++PNKSLDYFIF E ++ LDW KR +I+ GI
Sbjct: 562 LISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGI 621
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
ARG+LYLHQDSRLRIIHRDLKASNILLD EM P+ISDFG AR+FGG ++ T+RVVGT+
Sbjct: 622 ARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVVGTF 681
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL 599
GYM+PEYA+ G FS KSDV+SFGVL+LEIITGKKN+ F+++SSNL+ ++W+LW + +A
Sbjct: 682 GYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSA-FHEESSNLVGHIWDLWENGEAT 740
Query: 600 EIVDSSM-ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML-SNETSVPSPKQPTF 657
EI+D+ M ++ E ++CIQ+GLLCVQ+ +DR MS+VV ML N T++P+PK P F
Sbjct: 741 EIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNATNLPNPKHPAF 800
Query: 658 -SVRKIEIDTDYSSTG-TKSSANEVTLTTFIGR 688
S R+ + G T S N+VT + GR
Sbjct: 801 TSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 747 bits (1929), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/700 (53%), Positives = 504/700 (72%), Gaps = 24/700 (3%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
M+ G+ +++G +R +T+W+SP DPGSGN +++++ GF Q+ +YK WWR GSWTGQR
Sbjct: 158 MKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQMMMYKGLTLWWRTGSWTGQR 217
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWI 120
SGVPEMT FIFNI++++N DEV + Y + + S+ +RMV+NETG QRF W+ +D++WI
Sbjct: 218 WSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVLNETGTLQRFRWNGRDKKWI 277
Query: 121 GFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKRKLG 180
GFW+AP+++CD Y HCG N C ++FEC+CLPG+EPK P++W LRD S GC R
Sbjct: 278 GFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPKTPRDWFLRDASDGCTRIKA 337
Query: 181 TSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAET-NGG 239
S C EGF KL VK+P+TS A +VDMN+ LK CE++CL NCSCVAYASAY E+ +G
Sbjct: 338 DSICNGKEGFAKLKRVKIPNTS-AVNVDMNITLKECEQRCLKNCSCVAYASAYHESQDGA 396
Query: 240 IGCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVAIVLG 299
GCL +HG++ DTRTY ++GQD ++R D +ELA + + + + K+RL LI+++++
Sbjct: 397 KGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELA----RWNGNGASGKKRLVLILISLIAV 452
Query: 300 VLLLGLCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDR---EASTSAKRNKDTGNV 356
V+LL + + R+ R + R R+ F SS L D E R+++
Sbjct: 453 VMLLLISFHCYLRKRRQRT-QSNRLRKAPSSFAPSSFDLEDSFILEELEDKSRSRE---- 507
Query: 357 DVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKN 416
+ FELST+ AT+NF+ NKLG GGFGPVYKG L NG EIAVKRLS +SGQG+EEFKN
Sbjct: 508 -LPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKSSGQGMEEFKN 566
Query: 417 EVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII 476
EV LI+KLQHRNLV++LGCC+E +EKML+YE++PNKSLDYFIF E ++ LDW KR II
Sbjct: 567 EVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMGII 626
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
GI RG+LYLHQDSRLRIIHRDLKASN+LLD EM P+I+DFG AR+FGG +I +TNRVV
Sbjct: 627 RGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGNQIEGSTNRVV 686
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD 596
GTYGYMSPEYA+ G FS KSDV+SFGVL+LEIITGK+N+ F ++S NL++++W+ W +
Sbjct: 687 GTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSA-FYEESLNLVKHIWDRWENG 745
Query: 597 KALEIVDSSMA-DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML-SNETSVPSPKQ 654
+A+EI+D M ++ E ++C+ +GLLCVQ+ ++DRP MS+VVFML N +PSPK
Sbjct: 746 EAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVVFMLGHNAIDLPSPKH 805
Query: 655 PTFSV-RKIEIDT-----DYSSTGTKSSANEVTLTTFIGR 688
P F+ R+ T ++ S T S+ N+VTLT GR
Sbjct: 806 PAFTAGRRRNTKTGGSSDNWPSGETSSTINDVTLTDVQGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 645 bits (1663), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/679 (50%), Positives = 450/679 (66%), Gaps = 44/679 (6%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
M+LGWD +TGFNR++ +WKSPDDP SG+ SFK++ GF ++ L+ + + +R+G W G R
Sbjct: 167 MKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIR 226
Query: 61 LSGVPEMT--RNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRR 118
SGVPEM +FN T +++EV + + + SR+ ++ +G QRFTW +
Sbjct: 227 FSGVPEMQPFEYMVFNFT--TSKEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQN 284
Query: 119 WIGFWTAPKEQCDYYGHCGP----NSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGG 174
W FW APK+QCD Y CG +SN SP C C+ GF+P+ P+ W LRDGS G
Sbjct: 285 WNQFWYAPKDQCDEYKECGVYGYCDSNTSPV------CNCIKGFKPRNPQVWGLRDGSDG 338
Query: 175 CKRKLGTSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYA 234
C RK S C G+GF++L +K+PDT+ A+ VD +G+K CE+KCL +C+C A+A+
Sbjct: 339 CVRKTLLS-CGGGDGFVRLKKMKLPDTTTAS-VDRGIGVKECEQKCLRDCNCTAFANTDI 396
Query: 235 ETNGGIGCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIV 294
+G GC+ + G+L D R Y GQDL+VR A +L K NR+ K + I V
Sbjct: 397 RGSGS-GCVTWTGELFDIRNYAKGGQDLYVRLAATDL------EDKRNRSAKIIGSSIGV 449
Query: 295 AIVLGVLLLGLCYFFLWRR-------LDTRIGERQRQRRRELLFLNSSTRLSDREASTSA 347
+++L LL FFLW+R ++T I + Q R R+LL +N S R S
Sbjct: 450 SVLL---LLSFIIFFLWKRKQKRSILIETPIVDHQ-LRSRDLL-MNEVVISSRRHIS--- 501
Query: 348 KRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTS 407
R +T ++++ E V AT+NFS +NKLGQGGFG VYKGKL +GQE+AVKRLS TS
Sbjct: 502 -RENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTS 560
Query: 408 GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLL 467
QG +EFKNEV LIA+LQH NLV+LL CC++ EKMLIYE++ N SLD +FD+SR L
Sbjct: 561 VQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKL 620
Query: 468 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527
+W+ RFDII GIARG+LYLHQDSR RIIHRDLKASNILLD+ M P+ISDFG AR+FG +E
Sbjct: 621 NWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDE 680
Query: 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSS-NLI 586
NT +VVGTYGYMSPEYA+ G+FS KSDVFSFGVLLLEII+ K+N G +N D NL+
Sbjct: 681 TEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLL 740
Query: 587 RYVWELWSDDKALEIVDSSMADSCPA---PEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643
VW W + K LEI+D + DS E LRCIQ+GLLCVQ+R DRP+MS V+ ML
Sbjct: 741 GCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILML 800
Query: 644 SNE-TSVPSPKQPTFSVRK 661
+E T++P PK P + + +
Sbjct: 801 GSESTTIPQPKAPGYCLER 819
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 612 bits (1577), Expect = e-174, Method: Compositional matrix adjust.
Identities = 330/703 (46%), Positives = 439/703 (62%), Gaps = 35/703 (4%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
M+LGWD++TGFNR L +WK+ DDP SG S K++ + F + + + +R+G W G R
Sbjct: 161 MKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESILYRSGPWNGMR 220
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWI 120
S VP + + +++EV Y +N ++ SR+ +N G QR TW + W
Sbjct: 221 FSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRLYLNSAGLLQRLTWFETTQSWK 280
Query: 121 GFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKRKLG 180
W +PK+ CD Y CG C C C+ GF+P + W LRDGS GC RK
Sbjct: 281 QLWYSPKDLCDNYKVCGNFGYCDSNSLPN--CYCIKGFKPVNEQAWDLRDGSAGCMRKTR 338
Query: 181 TSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETNGGI 240
S C +GF +L +K+PDT+ A VD +GLK C+E+CL +C+C A+A+A NGG
Sbjct: 339 LS-CDGRDGFTRLKRMKLPDTT-ATIVDREIGLKVCKERCLEDCNCTAFANADIR-NGGS 395
Query: 241 GCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVAIVLGV 300
GC+I+ ++ D R Y GQDL+VR AAEL + KN K I+ +GV
Sbjct: 396 GCVIWTREILDMRNYAKGGQDLYVRLAAAELEDKRIKNEK------------IIGSSIGV 443
Query: 301 ---LLLGLCYFFLWRRLDTR---IGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTG 354
LLL F W+R R I + R L + +S R ++ K+++
Sbjct: 444 SILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLE 503
Query: 355 NVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEF 414
+ L+T AT+NFS NKLGQGGFG VYKG+L +G+EIAVKRLS S QG +EF
Sbjct: 504 LPLLELEALAT---ATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEF 560
Query: 415 KNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD 474
NEV LIAKLQH NLV+LLGCC++K EKMLIYE++ N SLD +FD++R L+W+KRFD
Sbjct: 561 MNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFD 620
Query: 475 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR 534
II GIARG+LYLHQDSR RIIHRDLKASN+LLD+ M P+ISDFG AR+FG EE NT R
Sbjct: 621 IINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRR 680
Query: 535 VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSS-NLIRYVWELW 593
VVGTYGYMSPEYA+ G+FS KSDVFSFGVLLLEII+GK+N G +N + NL+ +VW W
Sbjct: 681 VVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHW 740
Query: 594 SDDKALEIVD----SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETS- 648
+ LEIVD S++ P E LRCIQ+GLLCVQ+R DRP MS+V+ ML +ET+
Sbjct: 741 KEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTA 800
Query: 649 VPSPKQPTFSVRKIEIDTDYSSTGTKS---SANEVTLTTFIGR 688
+P PK+P F + + ++ D SS+ + + N++TL+ R
Sbjct: 801 IPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 601 bits (1550), Expect = e-171, Method: Compositional matrix adjust.
Identities = 334/712 (46%), Positives = 448/712 (62%), Gaps = 53/712 (7%)
Query: 1 MRLGWDKRTG-FNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQ 59
M++GWD ++G FNR L +WK+ DDP SG+ S K+ +GF + +Y + +R+G W G
Sbjct: 165 MKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGN 224
Query: 60 RLSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRW 119
R S VP M + ++ +N +V Y +N +I S + ++ TG QR TW + W
Sbjct: 225 RFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGLLQRLTWMEAAQSW 284
Query: 120 IGFWTAPKEQCDYYGHCGP----NSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGC 175
W +PK+ CD Y CG ++N SP C C+ GFEP ++ +LRD S GC
Sbjct: 285 KQLWYSPKDLCDNYKECGNYGYCDANTSPI------CNCIKGFEP-MNEQAALRDDSVGC 337
Query: 176 KRKLGTSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAE 235
RK S C +GF++L +++PDT+ + VD +GLK CEE+CL C+C A+A+
Sbjct: 338 VRKTKLS-CDGRDGFVRLKKMRLPDTTETS-VDKGIGLKECEERCLKGCNCTAFANTDIR 395
Query: 236 TNGGIGCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVA 295
NGG GC+I+ G L D R Y GQDL+VR A +L + K+ K I+
Sbjct: 396 -NGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLEDKRIKSKK------------IIG 442
Query: 296 IVLGV---LLLGLCYFFLWRR-------LDTRIGERQRQRRRELLFLNSSTRLSDREAST 345
+GV LLL F W+R + T I + R + + L ++R S
Sbjct: 443 SSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASR------SY 496
Query: 346 SAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLST 405
++K NK T +++ E + AT+NFST NKLGQGGFG VYKG L +G+EIAVKRLS
Sbjct: 497 TSKENK-TDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSK 555
Query: 406 TSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQ 465
S QG +EF NEV LIAKLQH NLV+LLGCC++K EKMLIYE++ N SLD +FD++R
Sbjct: 556 MSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSS 615
Query: 466 LLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525
L+W+KRFDII GIARG+LYLHQDSR RIIHRDLKASN+LLD+ M P+ISDFG AR+FG
Sbjct: 616 NLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGR 675
Query: 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSS-N 584
EE NT RVVGTYGYMSPEYA+ G+FS KSDVFSFGVLLLEII+GK+N G +N + N
Sbjct: 676 EETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLN 735
Query: 585 LIRYVWELWSDDKALEIVD----SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV 640
L+ +VW W + K LEIVD +++ P E LRCIQ+GLLCVQ+R DRP MS+V+
Sbjct: 736 LLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVM 795
Query: 641 FMLSNETS-VPSPKQPTFSVRKIEIDTDYSSTGTKS---SANEVTLTTFIGR 688
ML +ET+ +P PK+P F V + ++ D SS+ + + N+VTL+ R
Sbjct: 796 VMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 595 bits (1535), Expect = e-169, Method: Compositional matrix adjust.
Identities = 321/696 (46%), Positives = 447/696 (64%), Gaps = 54/696 (7%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
M+LG++ +TG NR+LT+W+S DDP SGN S+K++ + L + + R+G W G R
Sbjct: 169 MKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIR 228
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWI 120
SG+PE + +++N +EV + + N S SR+ + G+ QR TW R W
Sbjct: 229 FSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWN 288
Query: 121 GFWTAPKE-QCDYYGHCGPNSNC----SPYHADEFECTCLPGFEPKYPKEWSLRDGSGGC 175
FW++P + QCD Y CGP + C SP C C+ GF P+ ++W R +GGC
Sbjct: 289 RFWSSPVDPQCDTYIMCGPYAYCDVNTSPV------CNCIQGFNPRNIQQWDQRVWAGGC 342
Query: 176 KRKLGTSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAE 235
R+ T G+GF ++ +K+P+T++A VD ++G+K C+++C+ +C+C A+A+A
Sbjct: 343 IRR--TQLSCSGDGFTRMKKMKLPETTMAT-VDRSIGVKECKKRCISDCNCTAFANADIR 399
Query: 236 TNGGIGCLIYHGDLNDTRTY-TNA--GQDLFVRADAAELAAEAQKNSKSNRARKRRLALI 292
NGG GC+I+ L D R Y T+A GQDL+VR AA++A +KR +
Sbjct: 400 -NGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAADIA------------KKRNASGK 446
Query: 293 IVAIVLGV-LLLGLCYFFLWRRLDTR-------IGERQRQRRRELLFLNSSTRLSDREAS 344
I+++ +GV +LL L F LW+R R I QR + L +N S RE S
Sbjct: 447 IISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIANTQRNQN---LPMNEMVLSSKREFS 503
Query: 345 TSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLS 404
K + +++ E+ TV+ AT+NFS+ NKLGQGGFG VYKG+L +G+EIAVKRLS
Sbjct: 504 GEYKFEE----LELPLIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAVKRLS 559
Query: 405 TTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRK 464
TS QG +EF NEV LIA+LQH NLV++LGCC+E DEKMLIYE++ N SLD ++F ++R+
Sbjct: 560 KTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFGKTRR 619
Query: 465 QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524
L+W +RFDI G+ARG+LYLHQDSR RIIHRDLK SNILLD+ M P+ISDFG AR+F
Sbjct: 620 SKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMARIFE 679
Query: 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSN 584
+E NT +VVGTYGYMSPEYA+ G+FS KSDVFSFGV++LEI++GKKN G +N D N
Sbjct: 680 RDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGFYNLDYEN 739
Query: 585 -LIRYVWELWSDDKALEIVDSSMADSCPA-------PEALRCIQVGLLCVQDRTTDRPSM 636
L+ YVW W + +ALEIVD + DS + E L+CIQ+GLLCVQ+ RP+M
Sbjct: 740 DLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQEVLKCIQIGLLCVQELAEHRPAM 799
Query: 637 STVVFMLSNE-TSVPSPKQPTFSVRKIEIDTDYSST 671
S+VV+M +E T +P PK P + VR+ + D SS+
Sbjct: 800 SSVVWMFGSEATEIPQPKPPGYCVRRSPYELDPSSS 835
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 566 bits (1458), Expect = e-160, Method: Compositional matrix adjust.
Identities = 307/719 (42%), Positives = 443/719 (61%), Gaps = 64/719 (8%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSD-VKWWRAGSWTGQ 59
MR+ + +TG N +W+S DP GN S +D +G ++ L++ + + WR+G W
Sbjct: 164 MRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSA 223
Query: 60 RLSGVPEMT--RNFIFNITYMDNQDE---VFVYYSLNNPSILSRMVVNETGFEQRFTWSS 114
+G+P M+ N+++ DE V+ Y ++PS+L R V G E+ W+
Sbjct: 224 IFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNE 283
Query: 115 QDRRWIGFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGG 174
++W F + P +CD Y CG C ++ C+C+ G+E WS G
Sbjct: 284 TLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSNGI-CSCIHGYEQVSVGNWSR-----G 337
Query: 175 CKRKLGTSTCQKG-----EGFIKLTLVKVPDTSVAAH--VDMNLGLKACEEKCLGNCSCV 227
C+R+ C++ + F+ L VK+PD + H VD + C E+CL NCSC
Sbjct: 338 CRRRTPLK-CERNISVGEDEFLTLKSVKLPDFEIPEHNLVDP----EDCRERCLRNCSCN 392
Query: 228 AYASAYAETNGGIGCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKR 287
AY+ GGIGC+I++ DL D + + G L +R +E+ RK
Sbjct: 393 AYSLV-----GGIGCMIWNQDLVDLQQFEAGGSSLHIRLADSEVGEN----------RKT 437
Query: 288 RLALIIVAIVLGVLLLGLCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSA 347
++A +IVA+++GV+L+G+ LWR +R++ N+ T + + + S
Sbjct: 438 KIA-VIVAVLVGVILIGIFALLLWRF------KRKKDVSGAYCGKNTDTSVVVADLTKSK 490
Query: 348 KRNKD-TGNVDVTF------------FELSTVLAATDNFSTSNKLGQGGFGPVYKGKLAN 394
+ +G+VD+ F L+ + AT++F N+LG+GGFGPVYKG L +
Sbjct: 491 ETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLED 550
Query: 395 GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL 454
G+EIAVKRLS SGQG++EFKNE++LIAKLQHRNLV+LLGCC E +EKML+YE+MPNKSL
Sbjct: 551 GREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSL 610
Query: 455 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRI 514
D+F+FDE+++ L+DWK RF II GIARG+LYLH+DSRLRIIHRDLK SN+LLD EMNP+I
Sbjct: 611 DFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKI 670
Query: 515 SDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKN 574
SDFG AR+FGG + NT RVVGTYGYMSPEYA+ GLFS KSDV+SFGVLLLEI++GK+N
Sbjct: 671 SDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRN 730
Query: 575 TGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRP 634
T + + + +LI Y W L++ ++ E+VD + +C EALRCI V +LCVQD +RP
Sbjct: 731 TSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERP 790
Query: 635 SMSTVVFMLSNET-SVPSPKQPTF-SVRKIEIDTDY---SSTGTKSSANEVTLTTFIGR 688
+M++V+ ML ++T ++ +P+QPTF S R+ ID ++ SS S+NE+T T +GR
Sbjct: 791 NMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 566 bits (1458), Expect = e-160, Method: Compositional matrix adjust.
Identities = 306/705 (43%), Positives = 429/705 (60%), Gaps = 48/705 (6%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
M LG D RTG N LT+W S DDP +GN + + F ++ ++K++V WR+G W GQ
Sbjct: 169 MTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIAPFTFPELLIWKNNVPTWRSGPWNGQV 228
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWI 120
G+P M + +++ ++ + S N S + ++ G + WS+ R W
Sbjct: 229 FIGLPNMDSLLFLDGFNLNSDNQGTISMSYANDSFMYHFNLDPEGIIYQKDWSTSMRTWR 288
Query: 121 GFWTAPKEQCDYYGHCGPNSNCSPYHADEFE-CTCLPGFEPKYPKEWSLRDGSGGCKRKL 179
P CD YG CG +C HA E C C+ GF PK EW+ + S GC RK
Sbjct: 289 IGVKFPYTDCDAYGRCGRFGSC---HAGENPPCKCVKGFVPKNNTEWNGGNWSNGCMRK- 344
Query: 180 GTSTCQ------------KGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCV 227
C+ K +GF+KL +KVP ++ + + C + CL NCSC
Sbjct: 345 APLQCERQRNVSNGGGGGKADGFLKLQKMKVPISAERSEASE----QVCPKVCLDNCSCT 400
Query: 228 AYASAYAETNGGIGCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKR 287
AYA + GIGC+++ GDL D +++ +G DLF+R +EL +
Sbjct: 401 AYA-----YDRGIGCMLWSGDLVDMQSFLGSGIDLFIRVAHSELKTHSN----------- 444
Query: 288 RLALIIVAIVLGVLLLG-LCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREASTS 346
LA++I A V+GV+L+ +C R+ R + R EL+F SD E++++
Sbjct: 445 -LAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAP-AKDRSAELMFKRMEALTSDNESASN 502
Query: 347 AKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTT 406
+ K+ + FE + +TD+FS NKLGQGGFGPVYKGKL GQEIAVKRLS
Sbjct: 503 QIKLKE-----LPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRK 557
Query: 407 SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQL 466
SGQG+EE NEV++I+KLQHRNLVKLLGCC+E +E+ML+YE+MP KSLD ++FD ++++
Sbjct: 558 SGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKI 617
Query: 467 LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526
LDWK RF+I+ GI RG+LYLH+DSRL+IIHRDLKASNILLDE +NP+ISDFG AR+F
Sbjct: 618 LDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRAN 677
Query: 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSS-NL 585
E NT RVVGTYGYMSPEYA+ G FS KSDVFS GV+ LEII+G++N+ ++++ NL
Sbjct: 678 EDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNL 737
Query: 586 IRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
+ Y W+LW+D +A + D ++ D C E +C+ +GLLCVQ+ DRP++S V++ML+
Sbjct: 738 LAYAWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTT 797
Query: 646 ET-SVPSPKQPTFSVRKIEIDTDYS-STGTKSSANEVTLTTFIGR 688
E S+ PKQP F VR+ + + S + K S N+V+LT GR
Sbjct: 798 ENMSLADPKQPAFIVRRGASEAESSDQSSQKVSINDVSLTAVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 562 bits (1449), Expect = e-159, Method: Compositional matrix adjust.
Identities = 312/689 (45%), Positives = 419/689 (60%), Gaps = 73/689 (10%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
M+ G + TG NR+LT+W++ DDP +GN + KMD G Q L K+ V +R G W G R
Sbjct: 162 MKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLR 221
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWI 120
+G+P + N I+ Y+ ++EV+ Y L NPS+L+RM +N G QR+TW + W
Sbjct: 222 FTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWN 281
Query: 121 GFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKRKLG 180
+ +A + CD Y CG +C+ + C CL GF K P+ W D S GC R++
Sbjct: 282 FYLSAMMDSCDQYTLCGSYGSCNINESP--ACRCLKGFVAKTPQAWVAGDWSEGCVRRVK 339
Query: 181 TSTCQKGE-GFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETNGG 239
C KGE GF+K++ +K+PDT + + D N+ L C++ CL NC+C AY S + +GG
Sbjct: 340 LD-CGKGEDGFLKISKLKLPDTRTSWY-DKNMDLNECKKVCLRNCTCSAY-SPFDIRDGG 396
Query: 240 IGCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVAIVLG 299
GC+++ GDL D R Y GQDL+VR ++E+ +++S
Sbjct: 397 KGCILWFGDLIDIREYNENGQDLYVRLASSEIETLQRESS-------------------- 436
Query: 300 VLLLGLCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVT 359
R+ +R +Q + EL FL+
Sbjct: 437 -------------RVSSR---KQEEEDLELPFLD-------------------------- 454
Query: 360 FFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVL 419
L TV AT FS NKLGQGGFGPVYKG LA GQE+AVKRLS TS QG+EEFKNE+
Sbjct: 455 ---LDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIK 511
Query: 420 LIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 479
LIAKLQHRNLVK+LG C++++E+MLIYE+ PNKSLD FIFD+ R++ LDW KR +II GI
Sbjct: 512 LIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGI 571
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
ARG+LYLH+DSRLRIIHRDLKASN+LLD +MN +ISDFG AR GG+E NT RVVGTY
Sbjct: 572 ARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTY 631
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSS-NLIRYVWELWSDDKA 598
GYMSPEY + G FS KSDVFSFGVL+LEI++G++N G N++ NL+ + W + +DKA
Sbjct: 632 GYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKA 691
Query: 599 LEIVDSSMADSCP-APEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSPKQPTF 657
EI+D ++ +SC E LR I +GLLCVQ DRP+MS VV MLS+E + P+QP F
Sbjct: 692 YEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDPRQPGF 751
Query: 658 SVRKIEIDTDYSSTGTKSSANEVTLTTFI 686
+ + +D S + +N + I
Sbjct: 752 FNERNLLFSDTVSINLEIPSNNFQTMSVI 780
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 561 bits (1446), Expect = e-159, Method: Compositional matrix adjust.
Identities = 313/695 (45%), Positives = 444/695 (63%), Gaps = 48/695 (6%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKS-DVKW-WRAGSWTG 58
M+LG + +T L++WK+ DP G+ + +D G Q+ L K+ D + +R GSW G
Sbjct: 162 MKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNG 221
Query: 59 QRLSGVPEMTR-NFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDR 117
+G P M R N +F+ + + EV ++ + I+SR+V+N TG RF S Q++
Sbjct: 222 LSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTPRH-RIVSRLVLNNTGKLHRFIQSKQNQ 280
Query: 118 RWIGFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKR 177
WI TAP+++CDYY CG + C + C+CL GF+PK ++W++ G+ GC
Sbjct: 281 -WILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVH 339
Query: 178 KLGTSTCQKGEGFIKLTLVKVPDTSVAAHVDMN-LGLKACEEKCLGNCSCVAYASAYAET 236
++ T+ C+K + F+K +K+PDTS + + N + L+ C+ KC NCSC AYA+
Sbjct: 340 EIPTN-CEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIR- 397
Query: 237 NGGIGCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVAI 296
GG GCL++ GDL D R Y++ GQD+++R A++ + R + +VAI
Sbjct: 398 EGGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKIEFKG-------REVVGMVVGSVVAI 450
Query: 297 VLGVLLLGLCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNV 356
+ ++++ C+ R++++ R + ++ + ++
Sbjct: 451 AVVLVVVFACF------------------RKKIM---------KRYRGENFRKGIEEEDL 483
Query: 357 DVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKN 416
D+ F+ T+ ATD+FS N LG+GGFGPVYKGKL +GQEIAVKRLS SGQG+EEFKN
Sbjct: 484 DLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKN 543
Query: 417 EVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII 476
EV LIAKLQHRNLV+LLGCC++ +E MLIYE+MPNKSLD+FIFDE R LDWKKR +II
Sbjct: 544 EVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNII 603
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
G+ARG+LYLHQDSRLRIIHRDLKA N+LLD +MNP+ISDFG A+ FGG++ ++TNRVV
Sbjct: 604 NGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVV 663
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSS-NLIRYVWELWSD 595
GTYGYM PEYA+ G FS KSDVFSFGVL+LEIITGK N G + D NL+ +VW++W +
Sbjct: 664 GTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVE 723
Query: 596 DKALEIVDSSMADSCPA-PEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSPKQ 654
D+ +E+ + + PE LRCI V LLCVQ + DRP+M++VV M +++S+P P Q
Sbjct: 724 DREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSSLPHPTQ 783
Query: 655 PT-FSVRKIEIDTDYSSTGTKSSANEVTLTTFIGR 688
P F+ R + D SS+ + S NEV++T GR
Sbjct: 784 PGFFTNRNV---PDISSSLSLRSQNEVSITMLQGR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 688 | ||||||
| 356527947 | 838 | PREDICTED: G-type lectin S-receptor-like | 0.976 | 0.801 | 0.567 | 0.0 | |
| 255555113 | 1480 | Negative regulator of the PHO system, pu | 0.981 | 0.456 | 0.582 | 0.0 | |
| 359496850 | 2807 | PREDICTED: uncharacterized protein LOC10 | 0.981 | 0.240 | 0.550 | 0.0 | |
| 224076623 | 793 | predicted protein [Populus trichocarpa] | 0.915 | 0.794 | 0.558 | 0.0 | |
| 297843970 | 842 | hypothetical protein ARALYDRAFT_471279 [ | 0.982 | 0.802 | 0.538 | 0.0 | |
| 147804673 | 950 | hypothetical protein VITISV_035828 [Viti | 0.984 | 0.712 | 0.544 | 0.0 | |
| 359496273 | 1576 | PREDICTED: G-type lectin S-receptor-like | 0.979 | 0.427 | 0.540 | 0.0 | |
| 322510108 | 833 | RecName: Full=G-type lectin S-receptor-l | 0.979 | 0.809 | 0.538 | 0.0 | |
| 334182463 | 901 | putative S-locus lectin protein kinase [ | 0.979 | 0.748 | 0.538 | 0.0 | |
| 4008008 | 829 | receptor-like protein kinase [Arabidopsi | 0.973 | 0.808 | 0.536 | 0.0 |
| >gi|356527947|ref|XP_003532567.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 822 bits (2122), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/691 (56%), Positives = 510/691 (73%), Gaps = 19/691 (2%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
M+LG +++TG +R+L +WKSP+DPG+GN ++K+D GF Q+ LYK + WR GSWTGQR
Sbjct: 164 MKLGLNRKTGLDRFLVSWKSPNDPGTGNMTYKIDPTGFPQLFLYKDKIPLWRVGSWTGQR 223
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWI 120
SGVPEMT NFIF + Y++N+ EV + Y + +PS+ SRMV++E+G R TW + + RW
Sbjct: 224 WSGVPEMTPNFIFTVNYVNNESEVSIMYGVKDPSVFSRMVLDESGHVARSTWQAHEHRWF 283
Query: 121 GFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKRKLG 180
W APKE+CD + CG N+NC PYHAD+FEC CLPGFEPK+ +EW LRDGSGGC RK
Sbjct: 284 QIWDAPKEECDNFRRCGSNANCDPYHADKFECECLPGFEPKFEREWFLRDGSGGCVRKSN 343
Query: 181 TSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETNGGI 240
STC+ GEGF+++T VKVPDTS A V +G++ C+E+CL +CSCVAY SA + G
Sbjct: 344 VSTCRSGEGFVEVTRVKVPDTS-KARVAATIGMRECKERCLRDCSCVAYTSA--NESSGS 400
Query: 241 GCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVAIVLGV 300
GC+ +HG++ DTRTY GQ LFVR D ELA A K+ + +K +A++ AI L +
Sbjct: 401 GCVTWHGNMEDTRTYMQVGQSLFVRVDKLELAKYA-KHPYGSLGKKGMVAVLTAAIFLFL 459
Query: 301 LL-LGLCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVT 359
LL + Y+F+ R R G R+ ++ L + ST L + + T N D+
Sbjct: 460 LLAITFVYWFVKTR---RQGIRRDRKYSFRLTFDDSTDLQEFDT---------TKNSDLP 507
Query: 360 FFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVL 419
FFELS++ AATDNFS +NKLGQGGFG VYKG L NG EIAVKRLS SGQGIEEFKNEV+
Sbjct: 508 FFELSSIAAATDNFSDANKLGQGGFGSVYKGLLINGMEIAVKRLSKYSGQGIEEFKNEVV 567
Query: 420 LIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 479
LI+KLQHRNLV++LGCC++ +EKMLIYE++PNKSLD IFDES++ LDWKKRFDII G+
Sbjct: 568 LISKLQHRNLVRILGCCIQGEEKMLIYEYLPNKSLDSLIFDESKRSQLDWKKRFDIICGV 627
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
ARG+LYLHQDSRLRIIHRDLKASN+L+D +NP+I+DFG AR+FGG++I+ NTNRVVGTY
Sbjct: 628 ARGMLYLHQDSRLRIIHRDLKASNVLMDSSLNPKIADFGMARIFGGDQIAANTNRVVGTY 687
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFND-DSSNLIRYVWELWSDDKA 598
GYMSPEYA+ G FS KSDV+SFGVLLLEI+TG+KN+G++ D ++NL+ ++W+LW + K
Sbjct: 688 GYMSPEYAMEGQFSVKSDVYSFGVLLLEIVTGRKNSGLYEDITATNLVGHIWDLWREGKT 747
Query: 599 LEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSPKQPTFS 658
+EIVD S+ +SC E RCIQ+GLLCVQD DRPSMS VVFML N++++P PKQP F
Sbjct: 748 MEIVDQSLGESCSDHEVQRCIQIGLLCVQDYAADRPSMSAVVFMLGNDSTLPDPKQPAFV 807
Query: 659 VRKIEIDTDYSSTGTK-SSANEVTLTTFIGR 688
+K ++ ST S N+V++T R
Sbjct: 808 FKKTNYESSNPSTSEGIYSVNDVSITMIEAR 838
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555113|ref|XP_002518594.1| Negative regulator of the PHO system, putative [Ricinus communis] gi|223542439|gb|EEF43981.1| Negative regulator of the PHO system, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 809 bits (2090), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/692 (58%), Positives = 502/692 (72%), Gaps = 17/692 (2%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
M+LG D++TG N +L++WKS DDPG+GN +++D G+ Q+ LYK ++WWR G WTGQR
Sbjct: 802 MKLGLDRKTGKNWFLSSWKSKDDPGTGNIFYRIDPTGYPQLFLYKGSLRWWRGGPWTGQR 861
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLN-NPSILSRMVVNETGFEQRFTWSSQDRRW 119
SGVPEMTRN+IFN ++++ +DEVF+ Y L N +I SRM+VNE+G QR TW+ +D RW
Sbjct: 862 WSGVPEMTRNYIFNASFVNTEDEVFITYGLTTNATIFSRMMVNESGTVQRATWNDRDGRW 921
Query: 120 IGFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKRKL 179
IGFW+APKE CD YG CG NSNC PY +D F C CLPGF PK P W LRDGS GC RK
Sbjct: 922 IGFWSAPKEPCDNYGECGANSNCDPYDSDNFICKCLPGFYPKSPGSWYLRDGSDGCNRKA 981
Query: 180 GTSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETNGG 239
G STC+ GEGF++L LVKVPDT+ A V+M+L LKACE++CL NCSC AY SAY G
Sbjct: 982 GVSTCRDGEGFVRLALVKVPDTA-TARVNMSLSLKACEQECLRNCSCTAYTSAY---ESG 1037
Query: 240 IGCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVAIVLG 299
IGCL ++GDL D RTY++ GQD++VR DA ELA + S R K A++I ++ +
Sbjct: 1038 IGCLTWYGDLVDIRTYSSVGQDIYVRVDAVELAKYGKSKS---RLTKGVQAILIASVSVA 1094
Query: 300 VLLLGLCYFFLWRRLDTRIGERQRQRRRELL-FLNSSTRLSDREASTSAKRNKDTGNVDV 358
L F ++ + R R R+R + L F S T L D S K N + G D+
Sbjct: 1095 SFL---AVFVVYCLVKKRRKARDRRRSKSLFSFTQSPTDLGD---SHGGKGNDEDGIPDL 1148
Query: 359 TFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEV 418
FF+LS + AT NFS NKLG+GGFG VYKG L G+EIAVKRLS SGQG EEFKNEV
Sbjct: 1149 PFFDLSAIATATSNFSDDNKLGEGGFGSVYKGLLHGGKEIAVKRLSRYSGQGTEEFKNEV 1208
Query: 419 LLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG 478
LIAKLQHRNLV+++G C+++ EKMLIYE++PNKSLD FIFDE+++ LLDW R II G
Sbjct: 1209 ALIAKLQHRNLVRMIGYCVQEPEKMLIYEYLPNKSLDSFIFDEAKRSLLDWSIRHSIICG 1268
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT 538
IARG+LYLHQDSRLRIIHRDLKASN+LLD MNP+ISDFG AR+ G ++I NTNRVVGT
Sbjct: 1269 IARGILYLHQDSRLRIIHRDLKASNVLLDASMNPKISDFGMARIVGVDQIEANTNRVVGT 1328
Query: 539 YGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDD-SSNLIRYVWELWSDDK 597
YGYMSPEYA+ GLFS KSDV+SFGVLL+EIITG+KN+ + + SSNL+ YVW+LW + +
Sbjct: 1329 YGYMSPEYAMQGLFSVKSDVYSFGVLLIEIITGRKNSSFYEESTSSNLVGYVWDLWREGR 1388
Query: 598 ALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSPKQPTF 657
ALEIVD S+ D+ P E LRCIQ+GLLCVQ+ DRP+M+TVVFMLSN T +PSP QP F
Sbjct: 1389 ALEIVDISLGDAYPEHEVLRCIQIGLLCVQESAVDRPAMTTVVFMLSNHTILPSPNQPAF 1448
Query: 658 SV-RKIEIDTDYSSTGTKSSANEVTLTTFIGR 688
+ R S++ +S NEVT+T R
Sbjct: 1449 IMKRSYNSGEPVSASDGGNSVNEVTMTVLEAR 1480
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496850|ref|XP_003635354.1| PREDICTED: uncharacterized protein LOC100854728 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 779 bits (2011), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/690 (55%), Positives = 498/690 (72%), Gaps = 15/690 (2%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
M+LG ++RTGFNR+LT+WKSP DPG+G SF ++ +G Q+ LY+ + WR G W G R
Sbjct: 2131 MKLGLNRRTGFNRFLTSWKSPTDPGTGENSFGINASGSPQLCLYQGSERLWRTGHWNGLR 2190
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWI 120
SGVP M N I N ++++NQDE+ + + N S+LSRM V G+ QR+TW + +W
Sbjct: 2191 WSGVPRMMHNMIINTSFLNNQDEISYMFVMANASVLSRMTVELDGYLQRYTWQETEGKWF 2250
Query: 121 GFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKRKLG 180
F+T P++QCD YG CG N NC A EFECTCL GFEPK P++WSL+DGS GC RK G
Sbjct: 2251 SFYTVPRDQCDRYGRCGLNGNCDNSRA-EFECTCLAGFEPKSPRDWSLKDGSAGCLRKEG 2309
Query: 181 TSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETNGGI 240
C GEGF+K+ VK PDTSVA V+MN+ L+AC E CL CSC YA+A +G
Sbjct: 2310 AKVCGNGEGFVKVEGVKPPDTSVA-RVNMNMSLEACREGCLKECSCSGYAAANVSGSGS- 2367
Query: 241 GCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVAIVLGV 300
GCL +HGDL DTR + GQDL+VR DA L SK A+K +A+++V + +
Sbjct: 2368 GCLSWHGDLVDTRVFPEGGQDLYVRVDAITLG---MLQSKGFLAKKGMMAVLVVGATVIM 2424
Query: 301 LLLGLCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVTF 360
+LL Y+FL +++ G +++ F +T L D + + + ++ T N ++ F
Sbjct: 2425 VLLISTYWFLRKKMK---GNQKKNSYGS--FKPGATWLQD--SPGAKEHDESTTNSELQF 2477
Query: 361 FELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLL 420
F+L+T+ AAT+NFS+ N+LG+GGFG VYKG+L NGQEIAVK+LS SGQG EEFKNEV L
Sbjct: 2478 FDLNTIAAATNNFSSENELGRGGFGSVYKGQLYNGQEIAVKKLSKDSGQGKEEFKNEVTL 2537
Query: 421 IAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIA 480
IAKLQH NLV+LLGCC++++EKML+YE++PNKSLD FIFDE+++ LLDW+KRF+II+GIA
Sbjct: 2538 IAKLQHVNLVRLLGCCIQEEEKMLVYEYLPNKSLDSFIFDETKRSLLDWRKRFEIIVGIA 2597
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
RG+LYLH+DSRLRIIHRDLKASN+LLD EM P+ISDFG AR+FGG ++ NTNRVVGTYG
Sbjct: 2598 RGILYLHEDSRLRIIHRDLKASNVLLDAEMLPKISDFGLARIFGGNQMEGNTNRVVGTYG 2657
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSS-NLIRYVWELWSDDKAL 599
YMSPEYA+ GLFSTKSDV+SFGVLLLEIITG+KN+ + D+ S NL+ VW LW +DKAL
Sbjct: 2658 YMSPEYAMEGLFSTKSDVYSFGVLLLEIITGRKNSTHYRDNPSMNLVGNVWNLWEEDKAL 2717
Query: 600 EIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSPKQPTFSV 659
+I+DSS+ S P E LRCIQ+GLLCVQ+ D+P+M T++FML N +++P PK+PTF
Sbjct: 2718 DIIDSSLEKSYPTDEVLRCIQIGLLCVQESAIDQPTMLTIIFMLGNNSALPFPKRPTFIS 2777
Query: 660 RKIEIDTDYSSTGTK-SSANEVTLTTFIGR 688
+ D SS+G + S N VTLT+ R
Sbjct: 2778 KTTHKGEDLSSSGERLLSVNNVTLTSLQPR 2807
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076623|ref|XP_002304971.1| predicted protein [Populus trichocarpa] gi|222847935|gb|EEE85482.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 772 bits (1993), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/686 (55%), Positives = 477/686 (69%), Gaps = 56/686 (8%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
M+LG D + G NR L++WKS DDPG+G +D +GF Q+ LYKS + WR G WTG R
Sbjct: 160 MKLGLDLKIGLNRSLSSWKSKDDPGTGTIVLGIDPSGFPQLFLYKSQTRRWRVGPWTGLR 219
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWI 120
SGVP+M +IF T++ + DEV YS+NNPS++SRMVVNE+G QR TW+ D++W
Sbjct: 220 WSGVPQMATTYIFGNTFVSSVDEVSYSYSINNPSLISRMVVNESGVVQRLTWNDPDKQWF 279
Query: 121 GFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKRKLG 180
G W APKE CD YG CGPNSNC PY + F C CLPGFEPK P+EW LR+GS GC RK
Sbjct: 280 GIWYAPKEPCDTYGQCGPNSNCDPYQTNNFMCKCLPGFEPKSPQEWYLREGSRGCVRKPN 339
Query: 181 TSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETNGGI 240
STC GEGF+KL VKVPDTS+A+ +M+L LK C +CL NCSC AYASA G+
Sbjct: 340 VSTCHGGEGFVKLARVKVPDTSMAS-ANMSLRLKECARECLRNCSCTAYASADER---GL 395
Query: 241 GCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVAIVLGV 300
GCL ++GDL DTRT+++ GQ++++R D AEL A N
Sbjct: 396 GCLRWYGDLVDTRTFSDVGQEIYIRVDRAELEAMNWFNK--------------------- 434
Query: 301 LLLGLCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVTF 360
+L+ C F WR L + E E +TS+ D+
Sbjct: 435 VLIVFCRCFGWRDLPIKEFE---------------------EGTTSS---------DLPL 464
Query: 361 FELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLL 420
F+LS V AAT+NFS +NKLG+GGFG VYKG L +G+EIAVKRL+ SGQGI EF+NEV L
Sbjct: 465 FDLSVVAAATNNFSGANKLGEGGFGSVYKGLLHDGKEIAVKRLAKYSGQGINEFRNEVEL 524
Query: 421 IAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIA 480
IAKLQHRNLV++LGCC++ EKMLIYE++PNKSLD FIF+E R+ LDW R +II GIA
Sbjct: 525 IAKLQHRNLVRILGCCIQGREKMLIYEYLPNKSLDSFIFNEPRRSQLDWSTRHNIICGIA 584
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
RG+LYLH+DSRLRIIHRDLKASN+LLD MNP+ISDFG AR+FG ++I NTNRVVGTYG
Sbjct: 585 RGILYLHEDSRLRIIHRDLKASNVLLDASMNPKISDFGMARIFGVDQIEANTNRVVGTYG 644
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFN-DDSSNLIRYVWELWSDDKAL 599
YMSPEYA+ GLFS KSDV+SFGVLLLE+ITG+KN ++ +SSNL+ YVW+LW + +AL
Sbjct: 645 YMSPEYAMQGLFSVKSDVYSFGVLLLEVITGRKNINFYDKSNSSNLVGYVWDLWREGRAL 704
Query: 600 EIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSPKQPTFSV 659
E+VD+ M DS P + LRCIQ+GLLCVQ+ DRPSMS VVFMLSN+T++PSPKQP F +
Sbjct: 705 ELVDTLMGDSYPEDQVLRCIQIGLLCVQESAMDRPSMSNVVFMLSNDTTLPSPKQPAFIL 764
Query: 660 RKIEIDTDYSSTGTKSSANEVTLTTF 685
+K D S++ S NEVT+T
Sbjct: 765 KKSYNSGDPSTSEGSHSINEVTITML 790
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297843970|ref|XP_002889866.1| hypothetical protein ARALYDRAFT_471279 [Arabidopsis lyrata subsp. lyrata] gi|297335708|gb|EFH66125.1| hypothetical protein ARALYDRAFT_471279 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 770 bits (1988), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/697 (53%), Positives = 499/697 (71%), Gaps = 21/697 (3%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
M+LG+ ++ G +R +T+W+SP DPGSGN +++++ GF Q+ +YK WWR GSWTGQR
Sbjct: 158 MKLGFTRQNGVDRIMTSWRSPGDPGSGNITYRIERRGFPQMMMYKGLTLWWRTGSWTGQR 217
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWI 120
SGVPEMT FIFNI+++ N DEV + Y + + S+++RMV+NETG QRF W+ +D++WI
Sbjct: 218 WSGVPEMTNKFIFNISFVSNPDEVSITYGVFDASVITRMVLNETGTLQRFRWNGRDKKWI 277
Query: 121 GFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKRKLG 180
GFW+AP+++CD Y HCG N C P D+FEC+CLPG+EPK P++W LRD S GC R
Sbjct: 278 GFWSAPEDKCDIYNHCGFNGYCDPTSTDKFECSCLPGYEPKTPRDWFLRDASDGCTRIKA 337
Query: 181 TSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAET-NGG 239
S C EGF KL VK+P+TS A +VDMN+ LK CE++CL NCSCVAYASAY E+ NG
Sbjct: 338 ASICNGKEGFAKLKRVKIPNTS-AVNVDMNITLKECEQRCLKNCSCVAYASAYHESENGA 396
Query: 240 IGCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVAIVLG 299
GCL +HG++ DTRTY ++GQD ++R D +EL S K RL LI+++++
Sbjct: 397 KGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELVRWNGNGSSG----KMRLFLILISLLAV 452
Query: 300 VLLLGLCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVT 359
V+LL + F R+ RQ +R R+ + ++ + + ++
Sbjct: 453 VMLLMISLFCFIRK------RRQFKRLRKAPSSFAPCSFDLEDSFILEELEDKSRTRELP 506
Query: 360 FFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVL 419
FELST+ AAT+NF+ NKLG GGFGPVYKG L NG EIAVKRLS +SGQG+EEFKNEV
Sbjct: 507 LFELSTIAAATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKSSGQGMEEFKNEVK 566
Query: 420 LIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 479
LI+KLQHRNLV++LGCC+E +EKML+YE++PNKSLDYFIF++ + LDW KR II GI
Sbjct: 567 LISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFNDEHRVELDWPKRMGIIRGI 626
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
ARG+LYLHQDSRLRIIHRDLKASN+LLD EM P+I+DFG AR+FGG +I +TNRVVGTY
Sbjct: 627 ARGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGNQIEGSTNRVVGTY 686
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL 599
GYMSPEYA+ G FS KSDV+SFGVL+LEIITGKKN+ F ++S NL++++W+ W +A+
Sbjct: 687 GYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKKNSA-FYEESLNLVKHIWDRWEKGEAI 745
Query: 600 EIVDSSMA-DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML-SNETSVPSPKQPTF 657
EI+D M+ D+ E ++C+ +GLLCVQ+ +DRP MS+VVFML N +PSPK P F
Sbjct: 746 EIIDKLMSEDTYDVSEVMKCLHIGLLCVQENASDRPDMSSVVFMLGHNAIDLPSPKHPAF 805
Query: 658 SV-RKIEIDT-----DYSSTGTKSSANEVTLTTFIGR 688
+ R+ + T ++ S T S+ N+VTLT GR
Sbjct: 806 TAGRRRNVKTGGSSDNWPSGETGSTINDVTLTDVQGR 842
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147804673|emb|CAN66867.1| hypothetical protein VITISV_035828 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1970), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/691 (54%), Positives = 498/691 (72%), Gaps = 14/691 (2%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
M+LG ++RTGFNR+LT+WKSP DPG+G S +++G Q+ LY+ WR G+W G R
Sbjct: 271 MKLGLNRRTGFNRFLTSWKSPTDPGTGKXSLGFNVSGSPQIFLYQGSEPLWRTGNWNGLR 330
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWI 120
SG+P M I +++NQDE+ +++ N S L R+ V+ G+ QR W ++ +W
Sbjct: 331 WSGLPVMKYIIQHKIIFLNNQDEISEMFTMANASFLXRVTVDHDGYLQRNMWQEREDKWF 390
Query: 121 GFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKRKLG 180
F+TAP+++CD YG CGPNSNC A EFECTCL GFEPK P++W L+DGS GC RK G
Sbjct: 391 SFYTAPRDRCDRYGLCGPNSNCDDSQA-EFECTCLAGFEPKSPRDWFLKDGSAGCLRKEG 449
Query: 181 TSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETNGGI 240
C GEGF+K+ K PDTSVA V+MN+ ++AC E+CL CSC YA+A +G
Sbjct: 450 AKVCGNGEGFVKVGRAKPPDTSVA-RVNMNISMEACREECLKECSCSGYAAANVSGSGS- 507
Query: 241 GCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVAIVLGV 300
GCL +HGDL DTR + GQDL+VR DA LA E QK SK A+K +A+++V + +
Sbjct: 508 GCLSWHGDLVDTRVFPEGGQDLYVRVDAITLA-ENQKQSKGFLAKKGMMAVLVVGAAVIM 566
Query: 301 LLLGLCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSAK-RNKDTGNVDVT 359
+LL ++FL +++ + R R+ ++L+ NS + + S AK ++ T N ++
Sbjct: 567 VLLVSSFWFLRKKM------KGRGRQNKMLY-NSRPGATWLQDSLGAKEHDESTTNSELQ 619
Query: 360 FFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVL 419
FF+L+T++AAT+NFS N+LG+GGFG VYKG+L NGQEIAVK+LS SGQG EEFKN V
Sbjct: 620 FFDLNTIVAATNNFSFENELGRGGFGSVYKGQLYNGQEIAVKKLSKDSGQGKEEFKNXVT 679
Query: 420 LIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 479
LIAKLQH NLV+LL CC++++EKML+YE++PNKSLD FIFDE+++ LLDW+KRF+II+GI
Sbjct: 680 LIAKLQHVNLVRLLXCCIQEEEKMLVYEYLPNKSLDSFIFDETKRSLLDWRKRFEIIVGI 739
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
AR +LYLH+DSRLRIIHRDLKASN+LLD EM P+ISDFG AR+FGG ++ NTNRVVGTY
Sbjct: 740 ARXILYLHEDSRLRIIHRDLKASNVLLDAEMLPKISDFGLARIFGGNQMEXNTNRVVGTY 799
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSS-NLIRYVWELWSDDKA 598
GYMSPEYA+ GLFSTKSDV+SFGVLLLEIITG+KN+ + D+ S NL+ VW LW +DKA
Sbjct: 800 GYMSPEYAMEGLFSTKSDVYSFGVLLLEIITGRKNSTHYRDNPSMNLVGNVWNLWEEDKA 859
Query: 599 LEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSPKQPTFS 658
L+I+DSS+ S P E LRCIQ+GLLCVQ+ DRP+M T++FML N +++P PK+PTF
Sbjct: 860 LDIIDSSLEKSYPIDEVLRCIQIGLLCVQESAIDRPTMLTIIFMLGNNSALPFPKRPTFI 919
Query: 659 VRKIEIDTDYSSTGTK-SSANEVTLTTFIGR 688
+ D SS+G + S N VTLT R
Sbjct: 920 SKTTHKGEDLSSSGERLLSVNNVTLTLLQPR 950
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496273|ref|XP_002270694.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RKS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 759 bits (1961), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/690 (54%), Positives = 491/690 (71%), Gaps = 16/690 (2%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
M+LG ++RTGFNR+LT+WKSP DPG+G S +++G Q+ LY+ WR G+W G R
Sbjct: 901 MKLGLNRRTGFNRFLTSWKSPTDPGTGKYSLGFNVSGSPQIFLYQGSEPLWRTGNWNGLR 960
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWI 120
SG+P M I +++NQDE+ +++ N S L R+ V+ G+ QR W ++ +W
Sbjct: 961 WSGLPVMKYIIQHKIIFLNNQDEISEMFTMANASFLERVTVDHDGYLQRNMWQEREDKWF 1020
Query: 121 GFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKRKLG 180
F+TAP+++CD YG CGPNSNC A EFECTCL GFEPK P++W L+DGS GC RK G
Sbjct: 1021 SFYTAPRDRCDRYGLCGPNSNCDDSQA-EFECTCLAGFEPKSPRDWFLKDGSAGCLRKEG 1079
Query: 181 TSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETNGGI 240
C GEGF+K+ K PDTSVA V+MN+ ++AC E+CL CSC YA+A +G
Sbjct: 1080 AKVCGNGEGFVKVGRAKPPDTSVA-RVNMNISMEACREECLKECSCSGYAAANVSGSGS- 1137
Query: 241 GCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVAIVLGV 300
GCL +HGDL DTR + GQDL+VR DA L A SK A+K +A+++V + +
Sbjct: 1138 GCLSWHGDLVDTRVFPEGGQDLYVRVDAITLGMLA---SKGFLAKKGMMAVLVVGAAVIM 1194
Query: 301 LLLGLCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVTF 360
+LL ++FL +++ R + R +L S + + ST+ N ++ F
Sbjct: 1195 VLLVSSFWFLRKKMKGRQNKMLYNSRPGATWLQDSLGAKEHDESTT--------NSELQF 1246
Query: 361 FELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLL 420
F+L+T++AAT+NFS N+LG+GGFG VYKG+L NGQEIAVK+LS SGQG EEFKNEV L
Sbjct: 1247 FDLNTIVAATNNFSFENELGRGGFGSVYKGQLYNGQEIAVKKLSKDSGQGKEEFKNEVTL 1306
Query: 421 IAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIA 480
IAKLQH NLV+LLGCC++++EKML+YE++PNKSLD FIFDE+++ LLDW+KRF+II+GIA
Sbjct: 1307 IAKLQHVNLVRLLGCCIQEEEKMLVYEYLPNKSLDSFIFDETKRSLLDWRKRFEIIVGIA 1366
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
RG+LYLH+DSRLRIIHRDLKASN+LLD EM P+ISDFG AR+FGG ++ NTNRVVGTYG
Sbjct: 1367 RGILYLHEDSRLRIIHRDLKASNVLLDAEMLPKISDFGLARIFGGNQMEGNTNRVVGTYG 1426
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSS-NLIRYVWELWSDDKAL 599
YMSPEYA+ GLFSTKSDV+SFGVLLLEIITG+KN+ + D+ S NL+ VW LW +DKAL
Sbjct: 1427 YMSPEYAMEGLFSTKSDVYSFGVLLLEIITGRKNSTHYRDNPSMNLVGNVWNLWEEDKAL 1486
Query: 600 EIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSPKQPTFSV 659
+I+DSS+ S P E LRCIQ+GLLCVQ+ DRP+M T++FML N +++P PK+PTF
Sbjct: 1487 DIIDSSLEKSYPTDEVLRCIQIGLLCVQESAIDRPTMLTIIFMLGNNSALPFPKRPTFIS 1546
Query: 660 RKIEIDTDYSSTGTK-SSANEVTLTTFIGR 688
+ D SS+G + S N VTLT R
Sbjct: 1547 KTTHKSQDLSSSGERLLSGNNVTLTLLQPR 1576
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|322510108|sp|Q9ZT07.3|RKS1_ARATH RecName: Full=G-type lectin S-receptor-like serine/threonine-protein kinase RKS1; AltName: Full=Receptor-like protein kinase 1; Flags: Precursor | Back alignment and taxonomy information |
|---|
Score = 756 bits (1952), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/693 (53%), Positives = 498/693 (71%), Gaps = 19/693 (2%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
MRLG+ ++ G +R LT+WKS DPGSG+ +M+ GF Q+ LYK WWR GSWTG R
Sbjct: 155 MRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYKGVTPWWRMGSWTGHR 214
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWI 120
SGVPEM +IFN ++++N+DEV Y + + S+++R +VNETG RFTW ++D+RW
Sbjct: 215 WSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNETGTMHRFTWIARDKRWN 274
Query: 121 GFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKRKLG 180
FW+ PKEQCD Y HCGPN C + FECTCLPGFEPK+P+ W LRD SGGC +K
Sbjct: 275 DFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPRHWFLRDSSGGCTKKKR 334
Query: 181 TSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETN-GG 239
S C + +GF+KL +K+PDTS A+ VDMN+ LK C+++CL NCSCVAYASAY E+ G
Sbjct: 335 ASICSEKDGFVKLKRMKIPDTSDAS-VDMNITLKECKQRCLKNCSCVAYASAYHESKRGA 393
Query: 240 IGCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVAIVLG 299
IGCL +HG + D RTY N+GQD ++R D ELA + +++ + KRR+ LI+++++
Sbjct: 394 IGCLKWHGGMLDARTYLNSGQDFYIRVDKEELA----RWNRNGLSGKRRVLLILISLIAA 449
Query: 300 VLLLGLCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVT 359
V+LL + F + R ER++ R N + D + S +++K N ++
Sbjct: 450 VMLLTVILFCVVR-------ERRKSNRHRSSSANFAPVPFDFDESFRFEQDK-ARNRELP 501
Query: 360 FFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVL 419
F+L+T++AAT+NFS+ NKLG GGFGPVYKG L N EIAVKRLS SGQG+EEFKNEV
Sbjct: 502 LFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVK 561
Query: 420 LIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 479
LI+KLQHRNLV++LGCC+E +EKML+YE++PNKSLDYFIF E ++ LDW KR +I+ GI
Sbjct: 562 LISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGI 621
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
ARG+LYLHQDSRLRIIHRDLKASNILLD EM P+ISDFG AR+FGG ++ T+RVVGT+
Sbjct: 622 ARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVVGTF 681
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL 599
GYM+PEYA+ G FS KSDV+SFGVL+LEIITGKKN+ F+++SSNL+ ++W+LW + +A
Sbjct: 682 GYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSA-FHEESSNLVGHIWDLWENGEAT 740
Query: 600 EIVDSSM-ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML-SNETSVPSPKQPTF 657
EI+D+ M ++ E ++CIQ+GLLCVQ+ +DR MS+VV ML N T++P+PK P F
Sbjct: 741 EIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNATNLPNPKHPAF 800
Query: 658 -SVRKIEIDTDYSSTG-TKSSANEVTLTTFIGR 688
S R+ + G T S N+VT + GR
Sbjct: 801 TSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334182463|ref|NP_172601.2| putative S-locus lectin protein kinase [Arabidopsis thaliana] gi|332190599|gb|AEE28720.1| putative S-locus lectin protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1952), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/693 (53%), Positives = 498/693 (71%), Gaps = 19/693 (2%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
MRLG+ ++ G +R LT+WKS DPGSG+ +M+ GF Q+ LYK WWR GSWTG R
Sbjct: 223 MRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYKGVTPWWRMGSWTGHR 282
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWI 120
SGVPEM +IFN ++++N+DEV Y + + S+++R +VNETG RFTW ++D+RW
Sbjct: 283 WSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNETGTMHRFTWIARDKRWN 342
Query: 121 GFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKRKLG 180
FW+ PKEQCD Y HCGPN C + FECTCLPGFEPK+P+ W LRD SGGC +K
Sbjct: 343 DFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPRHWFLRDSSGGCTKKKR 402
Query: 181 TSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETN-GG 239
S C + +GF+KL +K+PDTS A+ VDMN+ LK C+++CL NCSCVAYASAY E+ G
Sbjct: 403 ASICSEKDGFVKLKRMKIPDTSDAS-VDMNITLKECKQRCLKNCSCVAYASAYHESKRGA 461
Query: 240 IGCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVAIVLG 299
IGCL +HG + D RTY N+GQD ++R D ELA + +++ + KRR+ LI+++++
Sbjct: 462 IGCLKWHGGMLDARTYLNSGQDFYIRVDKEELA----RWNRNGLSGKRRVLLILISLIAA 517
Query: 300 VLLLGLCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVT 359
V+LL + F + R ER++ R N + D + S +++K N ++
Sbjct: 518 VMLLTVILFCVVR-------ERRKSNRHRSSSANFAPVPFDFDESFRFEQDK-ARNRELP 569
Query: 360 FFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVL 419
F+L+T++AAT+NFS+ NKLG GGFGPVYKG L N EIAVKRLS SGQG+EEFKNEV
Sbjct: 570 LFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVK 629
Query: 420 LIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 479
LI+KLQHRNLV++LGCC+E +EKML+YE++PNKSLDYFIF E ++ LDW KR +I+ GI
Sbjct: 630 LISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGI 689
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
ARG+LYLHQDSRLRIIHRDLKASNILLD EM P+ISDFG AR+FGG ++ T+RVVGT+
Sbjct: 690 ARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVVGTF 749
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL 599
GYM+PEYA+ G FS KSDV+SFGVL+LEIITGKKN+ F+++SSNL+ ++W+LW + +A
Sbjct: 750 GYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSA-FHEESSNLVGHIWDLWENGEAT 808
Query: 600 EIVDSSM-ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML-SNETSVPSPKQPTF 657
EI+D+ M ++ E ++CIQ+GLLCVQ+ +DR MS+VV ML N T++P+PK P F
Sbjct: 809 EIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNATNLPNPKHPAF 868
Query: 658 -SVRKIEIDTDYSSTG-TKSSANEVTLTTFIGR 688
S R+ + G T S N+VT + GR
Sbjct: 869 TSARRRGGENGACLKGQTGISVNDVTFSDIQGR 901
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|4008008|gb|AAC95352.1| receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 752 bits (1942), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/693 (53%), Positives = 496/693 (71%), Gaps = 23/693 (3%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
MRLG+ ++ G +R LT+WKS DPGSG+ +M+ GF Q+ LYK WWR GSWTG R
Sbjct: 155 MRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYKGVTPWWRMGSWTGHR 214
Query: 61 LSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWI 120
SGVPEM +IFN ++++N+DEV Y + + S+++R +VNETG RFTW ++D+RW
Sbjct: 215 WSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNETGTMHRFTWIARDKRWN 274
Query: 121 GFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKRKLG 180
FW+ PKEQCD Y HCGPN C + FECTCLPGFEPK+P+ W LRD SGGC +K
Sbjct: 275 DFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPRHWFLRDSSGGCTKKKR 334
Query: 181 TSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETN-GG 239
S C + +GF+KL +K+PDTS A+ VDMN+ LK C+++CL NCSCVAYASAY E+ G
Sbjct: 335 ASICSEKDGFVKLKRMKIPDTSDAS-VDMNITLKECKQRCLKNCSCVAYASAYHESKRGA 393
Query: 240 IGCLIYHGDLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALIIVAIVLG 299
IGCL +HG + D RTY N+GQD ++R D ELA + +++ + KRR+ LI+++++
Sbjct: 394 IGCLKWHGGMLDARTYLNSGQDFYIRVDKEELA----RWNRNGLSGKRRVLLILISLIAA 449
Query: 300 VLLLGLCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVT 359
V+LL + F + R+RR +F D + S +++K N ++
Sbjct: 450 VMLLTVILFCV-----------VRERRSIEVFGKLRPVPFDFDESFRFEQDK-ARNRELP 497
Query: 360 FFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVL 419
F+L+T++AAT+NFS+ NKLG GGFGPVYKG L N EIAVKRLS SGQG+EEFKNEV
Sbjct: 498 LFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVK 557
Query: 420 LIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 479
LI+KLQHRNLV++LGCC+E +EKML+YE++PNKSLDYFIF E ++ LDW KR +I+ GI
Sbjct: 558 LISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGI 617
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
ARG+LYLHQDSRLRIIHRDLKASNILLD EM P+ISDFG AR+FGG ++ T+RVVGT+
Sbjct: 618 ARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVVGTF 677
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL 599
GYM+PEYA+ G FS KSDV+SFGVL+LEIITGKKN+ F+++SSNL+ ++W+LW + +A
Sbjct: 678 GYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSA-FHEESSNLVGHIWDLWENGEAT 736
Query: 600 EIVDSSM-ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML-SNETSVPSPKQPTF 657
EI+D+ M ++ E ++CIQ+GLLCVQ+ +DR MS+VV ML N T++P+PK P F
Sbjct: 737 EIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNATNLPNPKHPAF 796
Query: 658 -SVRKIEIDTDYSSTG-TKSSANEVTLTTFIGR 688
S R+ + G T S N+VT + GR
Sbjct: 797 TSARRRGGENGACLKGQTGISVNDVTFSDIQGR 829
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 688 | ||||||
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.973 | 0.788 | 0.468 | 3.7e-167 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.502 | 0.410 | 0.577 | 9.6e-161 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.5 | 0.406 | 0.590 | 5.3e-160 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.472 | 0.415 | 0.602 | 4.2e-158 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.508 | 0.429 | 0.579 | 1e-154 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.491 | 0.398 | 0.583 | 8.8e-145 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.481 | 0.393 | 0.588 | 1.1e-142 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.491 | 0.398 | 0.583 | 7.1e-141 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.482 | 0.4 | 0.579 | 8.2e-138 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.507 | 0.433 | 0.560 | 1.1e-137 |
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1626 (577.4 bits), Expect = 3.7e-167, P = 3.7e-167
Identities = 329/702 (46%), Positives = 439/702 (62%)
Query: 1 MRLGWDKRTGFNRYLTAWKSPDDPGSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQR 60
M+LGWD +TGFNR++ +WKSPDDP SG+ SFK++ GF ++ L+ + + +R+G W G R
Sbjct: 167 MKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIR 226
Query: 61 LSGVPEMT--RNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRR 118
SGVPEM +FN T +++EV + + + SR+ ++ +G QRFTW +
Sbjct: 227 FSGVPEMQPFEYMVFNFT--TSKEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQN 284
Query: 119 WIGFWTAPKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPKYPKEWSLRDGSGGCKRK 178
W FW APK+QCD Y CG C + C C+ GF+P+ P+ W LRDGS GC RK
Sbjct: 285 WNQFWYAPKDQCDEYKECGVYGYCDSNTSPV--CNCIKGFKPRNPQVWGLRDGSDGCVRK 342
Query: 179 LGTSTCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETNG 238
S C G+GF++L +K+PDT+ A+ VD +G+K CE+KCL +C+C A+A+ +G
Sbjct: 343 TLLS-CGGGDGFVRLKKMKLPDTTTAS-VDRGIGVKECEQKCLRDCNCTAFANTDIRGSG 400
Query: 239 GIGCLIYHGDLNDTRTYTNAGQDLFVRXXXXXXXXXXQKXXXXXXXXXXXXXXXXXXXXX 298
GC+ + G+L D R Y GQDL+VR +
Sbjct: 401 S-GCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLLSFII 459
Query: 299 XXXXXXXCYFFLWRRLDTRIGXXXXXXXXXXXFLNSSTRLSDREASTSAK---RNKDTGN 355
FFLW+R R L S L + +S + R +T +
Sbjct: 460 ---------FFLWKRKQKR--SILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDD 508
Query: 356 VDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFK 415
+++ E V AT+NFS +NKLGQGGFG VYKGKL +GQE+AVKRLS TS QG +EFK
Sbjct: 509 LELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFK 568
Query: 416 NEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDI 475
NEV LIA+LQH NLV+LL CC++ EKMLIYE++ N SLD +FD+SR L+W+ RFDI
Sbjct: 569 NEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDI 628
Query: 476 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV 535
I GIARG+LYLHQDSR RIIHRDLKASNILLD+ M P+ISDFG AR+FG +E NT +V
Sbjct: 629 INGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKV 688
Query: 536 VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSS-NLIRYVWELWS 594
VGTYGYMSPEYA+ G+FS KSDVFSFGVLLLEII+ K+N G +N D NL+ VW W
Sbjct: 689 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWK 748
Query: 595 DDKALEIVDSSMADSCPA---PEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE-TSVP 650
+ K LEI+D + DS E LRCIQ+GLLCVQ+R DRP+MS V+ ML +E T++P
Sbjct: 749 EGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIP 808
Query: 651 SPKQPTFSVRKIEIDTDYSSTGTKS----SANEVTLTTFIGR 688
PK P + + + +DTD SS+ + + N++T++ R
Sbjct: 809 QPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1038 (370.5 bits), Expect = 9.6e-161, Sum P(2) = 9.6e-161
Identities = 206/357 (57%), Positives = 261/357 (73%)
Query: 341 REASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAV 400
R TS + K + +++ EL + AT+NFS NKLGQGGFG VYKG+L +G+EIAV
Sbjct: 489 RRGYTS--KEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAV 546
Query: 401 KRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFD 460
KRLS S QG +EF NEV LIAKLQH NLV+LLGCC++K EKMLIYE++ N SLD +FD
Sbjct: 547 KRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFD 606
Query: 461 ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA 520
++R L+W+KRFDII GIARG+LYLHQDSR RIIHRDLKASN+LLD+ M P+ISDFG A
Sbjct: 607 QTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMA 666
Query: 521 RVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFND 580
R+FG EE NT RVVGTYGYMSPEYA+ G+FS KSDVFSFGVLLLEII+GK+N G +N
Sbjct: 667 RIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNS 726
Query: 581 DSS-NLIRYVWELWSDDKALEIVD----SSMADSCPAPEALRCIQVGLLCVQDRTTDRPS 635
+ NL+ +VW W + LEIVD S++ P E LRCIQ+GLLCVQ+R DRP
Sbjct: 727 NRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPV 786
Query: 636 MSTVVFMLSNETS-VPSPKQPTFSVRKIEIDTDYSSTGTKS---SANEVTLTTFIGR 688
MS+V+ ML +ET+ +P PK+P F + + ++ D SS+ + + N++TL+ R
Sbjct: 787 MSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1047 (373.6 bits), Expect = 5.3e-160, Sum P(2) = 5.3e-160
Identities = 209/354 (59%), Positives = 262/354 (74%)
Query: 344 STSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRL 403
S ++K NK T +++ E + AT+NFST NKLGQGGFG VYKG L +G+EIAVKRL
Sbjct: 495 SYTSKENK-TDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRL 553
Query: 404 STTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESR 463
S S QG +EF NEV LIAKLQH NLV+LLGCC++K EKMLIYE++ N SLD +FD++R
Sbjct: 554 SKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTR 613
Query: 464 KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523
L+W+KRFDII GIARG+LYLHQDSR RIIHRDLKASN+LLD+ M P+ISDFG AR+F
Sbjct: 614 SSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIF 673
Query: 524 GGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSS 583
G EE NT RVVGTYGYMSPEYA+ G+FS KSDVFSFGVLLLEII+GK+N G +N +
Sbjct: 674 GREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRD 733
Query: 584 -NLIRYVWELWSDDKALEIVD----SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMST 638
NL+ +VW W + K LEIVD +++ P E LRCIQ+GLLCVQ+R DRP MS+
Sbjct: 734 LNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSS 793
Query: 639 VVFMLSNETS-VPSPKQPTFSVRKIEIDTDYSSTGTKS---SANEVTLTTFIGR 688
V+ ML +ET+ +P PK+P F V + ++ D SS+ + + N+VTL+ R
Sbjct: 794 VMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1024 (365.5 bits), Expect = 4.2e-158, Sum P(2) = 4.2e-158
Identities = 197/327 (60%), Positives = 248/327 (75%)
Query: 333 NSSTRLSDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKL 392
+S RE+S + R ++ ++++ F +L TV AT FS NKLGQGGFGPVYKG L
Sbjct: 425 SSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTL 484
Query: 393 ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNK 452
A GQE+AVKRLS TS QG+EEFKNE+ LIAKLQHRNLVK+LG C++++E+MLIYE+ PNK
Sbjct: 485 ACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNK 544
Query: 453 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP 512
SLD FIFD+ R++ LDW KR +II GIARG+LYLH+DSRLRIIHRDLKASN+LLD +MN
Sbjct: 545 SLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNA 604
Query: 513 RISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+ISDFG AR GG+E NT RVVGTYGYMSPEY + G FS KSDVFSFGVL+LEI++G+
Sbjct: 605 KISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGR 664
Query: 573 KNTGIFNDDSS-NLIRYVWELWSDDKALEIVDSSMADSCP-APEALRCIQVGLLCVQDRT 630
+N G N++ NL+ + W + +DKA EI+D ++ +SC E LR I +GLLCVQ
Sbjct: 665 RNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDP 724
Query: 631 TDRPSMSTVVFMLSNETSVPSPKQPTF 657
DRP+MS VV MLS+E + P+QP F
Sbjct: 725 KDRPNMSVVVLMLSSEMLLLDPRQPGF 751
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1063 (379.3 bits), Expect = 1.0e-154, Sum P(2) = 1.0e-154
Identities = 205/354 (57%), Positives = 266/354 (75%)
Query: 337 RLSDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQ 396
++ R + ++ + ++D+ F+ T+ ATD+FS N LG+GGFGPVYKGKL +GQ
Sbjct: 464 KIMKRYRGENFRKGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQ 523
Query: 397 EIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDY 456
EIAVKRLS SGQG+EEFKNEV LIAKLQHRNLV+LLGCC++ +E MLIYE+MPNKSLD+
Sbjct: 524 EIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDF 583
Query: 457 FIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISD 516
FIFDE R LDWKKR +II G+ARG+LYLHQDSRLRIIHRDLKA N+LLD +MNP+ISD
Sbjct: 584 FIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISD 643
Query: 517 FGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTG 576
FG A+ FGG++ ++TNRVVGTYGYM PEYA+ G FS KSDVFSFGVL+LEIITGK N G
Sbjct: 644 FGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRG 703
Query: 577 IFNDDSS-NLIRYVWELWSDDKALEIVDSS-MADSCPAPEALRCIQVGLLCVQDRTTDRP 634
+ D NL+ +VW++W +D+ +E+ + + ++ PE LRCI V LLCVQ + DRP
Sbjct: 704 FRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRP 763
Query: 635 SMSTVVFMLSNETSVPSPKQPTFSVRKIEIDTDYSSTGTKSSANEVTLTTFIGR 688
+M++VV M +++S+P P QP F + + D SS+ + S NEV++T GR
Sbjct: 764 TMASVVLMFGSDSSLPHPTQPGFFTNR-NVP-DISSSLSLRSQNEVSITMLQGR 815
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1068 (381.0 bits), Expect = 8.8e-145, Sum P(2) = 8.8e-145
Identities = 200/343 (58%), Positives = 267/343 (77%)
Query: 351 KDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQG 410
K ++ F L+ + AT++F N+LG+GGFGPVYKG L +G+EIAVKRLS SGQG
Sbjct: 507 KAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQG 566
Query: 411 IEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWK 470
++EFKNE++LIAKLQHRNLV+LLGCC E +EKML+YE+MPNKSLD+F+FDE+++ L+DWK
Sbjct: 567 VDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWK 626
Query: 471 KRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530
RF II GIARG+LYLH+DSRLRIIHRDLK SN+LLD EMNP+ISDFG AR+FGG +
Sbjct: 627 LRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEA 686
Query: 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVW 590
NT RVVGTYGYMSPEYA+ GLFS KSDV+SFGVLLLEI++GK+NT + + + +LI Y W
Sbjct: 687 NTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAW 746
Query: 591 ELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETS-V 649
L++ ++ E+VD + +C EALRCI V +LCVQD +RP+M++V+ ML ++T+ +
Sbjct: 747 YLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATL 806
Query: 650 PSPKQPTF-SVRKIEIDTDYSSTGTKS---SANEVTLTTFIGR 688
+P+QPTF S R+ ID +++ ++ S+NE+T T +GR
Sbjct: 807 AAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1040 (371.2 bits), Expect = 1.1e-142, Sum P(2) = 1.1e-142
Identities = 197/335 (58%), Positives = 254/335 (75%)
Query: 357 DVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKN 416
D+ F +V +AT +F+ NKLGQGGFG VYKG + G+EIAVKRLS S QG+EEFKN
Sbjct: 509 DLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKN 568
Query: 417 EVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII 476
E+LLIAKLQHRNLV+LLGCC+E +EKML+YE+MPNKSLD F+FDES++ LDW+KR+++I
Sbjct: 569 EILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVI 628
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
GIARG+LYLH+DSRL+IIHRDLKASNILLD EMNP+ISDFG AR+F + NT RVV
Sbjct: 629 GGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVV 688
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD 596
GTYGYM+PEYA+ G+FS KSDV+SFGVL+LEI++G+KN D +LI Y W LWS
Sbjct: 689 GTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQG 748
Query: 597 KALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETS-VPSPKQP 655
K E++D + D+ EA+RCI VG+LC QD RP+M +V+ ML ++TS +P P+QP
Sbjct: 749 KTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQP 808
Query: 656 TFS--VRKIEIDTDYSSTGTKSSANEVTLTTFIGR 688
TF + +I+ ++ +S N+VT TT +GR
Sbjct: 809 TFHSFLNSGDIELNFDGHDV-ASVNDVTFTTIVGR 842
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 7.1e-141, Sum P(2) = 7.1e-141
Identities = 199/341 (58%), Positives = 260/341 (76%)
Query: 351 KDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQG 410
+D + ++ + L + AT NFS SNKLG+GGFGPVY G L G+E+AVKRL SGQG
Sbjct: 508 EDGKSHELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQG 567
Query: 411 IEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWK 470
+EEFKNEV+LIAKLQHRNLV+LLGCC+ ++EK+L+YE+MPNKSLD F+F+ +++LLDWK
Sbjct: 568 LEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWK 627
Query: 471 KRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530
KRFDII GIARG+LYLH+DSRLR++HRDLKASNILLD +M P+ISDFG AR+FGG++
Sbjct: 628 KRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQF 687
Query: 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIF-NDDSSNLIRYV 589
NTNRVVGT+GYMSPEYA+ G+FS KSDV+ FGVL+LEIITGK+ ++DS N+ Y
Sbjct: 688 NTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYA 747
Query: 590 WELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETS- 648
W W++D A E++D + SC + LRCI + LLCVQD +RP + TV+ MLSN++S
Sbjct: 748 WRQWNEDNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSS 807
Query: 649 VPSPKQPTFSVRKIEIDTDYSSTGTKS-SANEVTLTTFIGR 688
+P+P+ PT +R EI++ SS +S S VT+T GR
Sbjct: 808 LPNPRPPTLMLRGREIESSKSSEKDRSHSIGTVTMTQLHGR 848
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1026 (366.2 bits), Expect = 8.2e-138, Sum P(2) = 8.2e-138
Identities = 194/335 (57%), Positives = 255/335 (76%)
Query: 357 DVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKN 416
++ FE + AT+NFS +NKLGQGGFG VYKG+L G +IAVKRLS TSGQG+EEF N
Sbjct: 496 ELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVN 555
Query: 417 EVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII 476
EV++I+KLQHRNLV+LLG C+E +E+ML+YEFMP LD ++FD +++LLDWK RF+II
Sbjct: 556 EVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNII 615
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
GI RG++YLH+DSRL+IIHRDLKASNILLDE +NP+ISDFG AR+F G E +T RVV
Sbjct: 616 DGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVV 675
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSS-NLIRYVWELWSD 595
GTYGYM+PEYA+GGLFS KSDVFS GV+LLEI++G++N+ +ND + NL Y W+LW+
Sbjct: 676 GTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNT 735
Query: 596 DKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETS-VPSPKQ 654
+ + +VD + + C E RC+ VGLLCVQD DRPS++TV++MLS+E S +P PKQ
Sbjct: 736 GEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPKQ 795
Query: 655 PTFSVRKIEIDTDYSS-TGTKSSANEVTLTTFIGR 688
P F R+ + + S + ++S N V+LT GR
Sbjct: 796 PAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1016 (362.7 bits), Expect = 1.1e-137, Sum P(2) = 1.1e-137
Identities = 199/355 (56%), Positives = 254/355 (71%)
Query: 337 RLSDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQ 396
R +A + +D V+ FFE+ T+ AT+NFS SNKLGQGGFGPVYKGKL +G+
Sbjct: 454 RAKQNDAWKNGFERQDVSGVN--FFEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGK 511
Query: 397 EIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDY 456
EI VKRL+++SGQG EEF NE+ LI+KLQHRNLV+LLG C++ +EK+LIYEFM NKSLD
Sbjct: 512 EIGVKRLASSSGQGTEEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDI 571
Query: 457 FIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISD 516
FIFD K LDW KRF+II GIARG+LYLH+DSRLR+IHRDLK SNILLD+ MNP+ISD
Sbjct: 572 FIFDPCLKFELDWPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISD 631
Query: 517 FGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKK-NT 575
FG AR+F G + NT RVVGT GYMSPEYA GLFS KSD++SFGVL+LEII+GK+ +
Sbjct: 632 FGLARMFQGTQYQDNTRRVVGTLGYMSPEYAWAGLFSEKSDIYSFGVLMLEIISGKRISR 691
Query: 576 GIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPS 635
I+ D+S L+ Y W+ W + ++D + D+C A E RC+Q+GLLCVQ DRP+
Sbjct: 692 FIYGDESKGLLAYTWDSWCETGGSNLLDRDLTDTCQAFEVARCVQIGLLCVQHEAVDRPN 751
Query: 636 MSTVVFMLSNETSVPSPKQPTFSVRKIEIDTDYSSTGTKS--SANEVTLTTFIGR 688
V+ ML++ T +P PKQP F+V + D ++ S NE+T + GR
Sbjct: 752 TLQVLSMLTSATDLPVPKQPIFAVHTLN-DMPMLQANSQDFLSVNEMTESMIQGR 805
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9ZT07 | RKS1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5382 | 0.9796 | 0.8091 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00010713001 | SubName- Full=Chromosome undetermined scaffold_278, whole genome shotgun sequence; (815 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 688 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-53 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-41 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 7e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-32 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-30 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-29 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-29 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-27 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-25 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-24 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-24 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 1e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-23 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-23 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-21 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-20 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 5e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-07 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 7e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-05 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 4e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| TIGR03503 | 374 | TIGR03503, TIGR03503, TIGR03503 family protein | 0.002 | |
| TIGR00606 | 1311 | TIGR00606, rad50, rad50 | 0.002 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 1e-53
Identities = 94/281 (33%), Positives = 140/281 (49%), Gaps = 34/281 (12%)
Query: 377 NKLGQGGFGPVYKGKL----ANGQEIAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVK 431
KLG+G FG VYKGKL E+AVK L S + ++F E ++ KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFI------FDESRKQLLDWKKRFDIILGIARGVLY 485
LLG C E++ L+ E+M L ++ F K L K + IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR-VFGGEEISTNTNRVVGTYGYMSP 544
L + +HRDL A N L+ E++ +ISDFG +R V+ + T + +M+P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIIT-GKK-NTGIFNDDSSNLIRYVWELWSDDKALEIV 602
E G+F++KSDV+SFGVLL EI T G G+ N++ ++ Y+ L
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYL----RKGYRLP-- 227
Query: 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643
+ C P+ L ++ L C Q DRP+ S +V L
Sbjct: 228 ---KPEYC--PDELY--ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 3e-53
Identities = 96/276 (34%), Positives = 137/276 (49%), Gaps = 33/276 (11%)
Query: 378 KLGQGGFGPVYKGKL-----ANGQEIAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVK 431
KLG+G FG VYKG L E+AVK L S Q IEEF E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 491
LLG C E++ M++ E+MP L ++ +R + L L IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 492 LRIIHRDLKASNILLDEEMNPRISDFGTAR-VFGGEEISTNTNRVVGTYGYMSPEYALGG 550
IHRDL A N L+ E + +ISDFG +R ++ + ++ +M+PE G
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEG 179
Query: 551 LFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609
F++KSDV+SFGVLL EI T G++ + S+ + LE +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEP---------------YPGMSNAEVLEYLKKGYRLP 224
Query: 610 CPA--PEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643
P P L ++ L C + DRP+ S +V +L
Sbjct: 225 KPPNCPPELY--KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 1e-52
Identities = 93/279 (33%), Positives = 129/279 (46%), Gaps = 40/279 (14%)
Query: 378 KLGQGGFGPVYKGKL-----ANGQEIAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVK 431
KLG+G FG VYKGKL E+AVK L S Q IEEF E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 491
LLG C E++ ++ E+M L ++ + L L IARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 492 LRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGL 551
IHRDL A N L+ E + +ISDFG +R ++ + +M+PE G
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKEGK 179
Query: 552 FSTKSDVFSFGVLLLEIIT-------GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS 604
F++KSDV+SFGVLL EI T G N ++ Y+ + L
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSN--------EEVLEYL----KNGYRLPQP-- 225
Query: 605 SMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643
+CP + L C + DRP+ S +V +L
Sbjct: 226 ---PNCPP----ELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 1e-50
Identities = 69/194 (35%), Positives = 106/194 (54%), Gaps = 11/194 (5%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLST-TSGQGIEEFKNEVLLIAKLQHRNLVKLLGCC 436
LG+GGFG VY + G+++A+K + S +EE E+ ++ KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 437 LEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 496
+++ L+ E+ SL + + + L + I+L I G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 497 RDLKASNILLDE-EMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG-GLFST 554
RDLK NILLD +++DFG +++ + +VGT YM+PE LG G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 555 KSDVFSFGVLLLEI 568
KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 75/203 (36%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 378 KLGQGGFGPVYKGKL-----ANGQEIAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVK 431
KLG+G FG VYKG L ++AVK L S + EEF E ++ KL H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 491
LLG C + + ++ E+MP L F+ + L K + L IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 492 LRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG---YMSPEYAL 548
+HRDL A N L+ E + +ISDFG +R ++ G +M+PE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMAPESLK 177
Query: 549 GGLFSTKSDVFSFGVLLLEIITG 571
G F++KSDV+SFGVLL EI T
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 4e-48
Identities = 77/199 (38%), Positives = 108/199 (54%), Gaps = 12/199 (6%)
Query: 378 KLGQGGFGPVYKGKLAN-GQEIAVKRL--STTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
KLG G FG VYK K G+ +AVK L + + + + E+ ++ +L H N+V+L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 494
+KD L+ E+ L ++ SR L + I L I RG+ YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 495 IHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGL-FS 553
IHRDLK NILLDE +I+DFG A+ S++ VGT YM+PE LGG +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 554 TKSDVFSFGVLLLEIITGK 572
K DV+S GV+L E++TGK
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 6e-48
Identities = 66/202 (32%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 373 FSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEE-FKNEVLLIAKLQHRNLV 430
+ KLG+G FG VY + G+ +A+K + + E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
+L ++D+ L+ E+ L + + R +L + + RF + I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS-- 115
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG 550
I+HRDLK NILLDE+ + +++DFG AR VGT YM+PE LG
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDP---GEKLTTFVGTPEYMAPEVLLGK 171
Query: 551 LFSTKSDVFSFGVLLLEIITGK 572
+ D++S GV+L E++TGK
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 31/211 (14%)
Query: 377 NKLGQGGFGPVYKGK-LANGQEIAVK--RLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
LG+G FG VY G+ +AVK LS S + +E + E+ +++ LQH N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 434 GCCLEKDEKML-IY-EFMPNKSLDYFI-----FDESR-----KQLLDWKKRFDIILGIAR 481
G ++++ L I+ E++ SL + E +Q+L
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-------------E 112
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGY 541
G+ YLH I+HRD+K +NIL+D + +++DFG A+ G E T V GT +
Sbjct: 113 GLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
M+PE G + +D++S G ++E+ TGK
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 8e-41
Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 23/208 (11%)
Query: 373 FSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVK 431
F K+G+GGFG VYK + G+E+A+K + S + E+ NE+ ++ K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLD-WKKRFD------IILGIARGVL 484
G L+KDE ++ EF SL K LL + + + +G+
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSL---------KDLLKSTNQTLTESQIAYVCKELLKGLE 112
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
YLH IIHRD+KA+NILL + ++ DFG + + N +VGT +M+P
Sbjct: 113 YLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAP 166
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITGK 572
E G + K+D++S G+ +E+ GK
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 7e-38
Identities = 48/115 (41%), Positives = 66/115 (57%), Gaps = 10/115 (8%)
Query: 51 WRAGSWTGQRLSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRF 110
WR+G W G R SG+PEM + + + +N +EV+ Y + N SI SR+ ++ G +RF
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60
Query: 111 TWSSQDRRWIGFWTAPKEQCDYYGHCGPNSNC----SPYHADEFECTCLPGFEPK 161
TW + W FW+APK+QCD YG CGP C SP +C C+ GF PK
Sbjct: 61 TWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSP------KCNCIKGFVPK 109
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 372 NFSTSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRN 428
N+ + +G+G FG VYKG L G +A+K++S + ++ E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD---------IILGI 479
+VK +G D +I E+ N SL +Q++ K+F + +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSL---------RQII---KKFGPFPESLVAVYVYQV 108
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
+G+ YLH+ +IHRD+KA+NIL ++ +++DFG A + VVGT
Sbjct: 109 LQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTP 163
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+M+PE ST SD++S G ++E++TG
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 74/199 (37%), Positives = 104/199 (52%), Gaps = 18/199 (9%)
Query: 378 KLGQGGFGPVYKGKLANGQEIAVKRL--STTSGQGIEEFKNEVLLIAKLQHRNLVKLLGC 435
KLG G FG V+ G ++AVK L T S E F E ++ KL+H LV+L
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 436 CLEKDEKMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 494
C E++ ++ E+M SL D+ E +K L + D+ IA G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLE---SRNY 124
Query: 495 IHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT---YGYMSPEYALGGL 551
IHRDL A NIL+ E + +I+DFG AR+ +E + G + +PE A G
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGR 180
Query: 552 FSTKSDVFSFGVLLLEIIT 570
F+ KSDV+SFG+LL EI+T
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 68/198 (34%), Positives = 108/198 (54%), Gaps = 6/198 (3%)
Query: 373 FSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
F+ KLG G FG V++G N +A+K L + ++F+ EV + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 492
C + +I E M SL F+ Q+L D+ +A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 493 RIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLF 552
IHRDL A NIL+ E++ +++DFG AR+ + ++ ++ Y + +PE A G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 553 STKSDVFSFGVLLLEIIT 570
STKSDV+SFG+LL E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 79/324 (24%), Positives = 139/324 (42%), Gaps = 24/324 (7%)
Query: 372 NFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLS---TTSGQGIEEFKNEVLLIAKLQH-R 427
++ KLG+G FG VY + + + +A+K L+ + + +E F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 487
N+VKL ++ L+ E++ SL+ + RK L + I+ I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 488 QDSRLRIIHRDLKASNILLDEEMN-PRISDFGTARVFGGEEISTN----TNRVVGTYGYM 542
IIHRD+K NILLD + ++ DFG A++ +++ + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 543 SPEYALGGLF---STKSDVFSFGVLLLEIITGKKNTGIFNDDSSN--LIRYVWELWSDDK 597
+PE LG S+ SD++S G+ L E++TG + S+ ++ + EL +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 598 ALEIVDSSMADSCPAPEALRCIQVGLLCV--QDRTTDRPSMSTVVFMLSNETSVPSPKQP 655
A + S+ +A + LL ++R + +S +
Sbjct: 236 ASPLSPSN---PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
Query: 656 TFSVRKIEIDTDYSSTGTKSSANE 679
+ S S+
Sbjct: 293 KPDDSAPLRLSLPPSLEALISSLN 316
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 377 NKLGQGGFGPVYKGK-LANGQEIAVKR--LSTTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
++G+G FG VY + ++G+ +K LS S + E+ NEV ++ KL H N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFI---------FDESRKQLLDWKKRFDIILGIARGVL 484
EK + ++ E+ L I F E +Q+LDW + + +
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE--EQILDW------FVQLCLALK 117
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
YLH SR +I+HRD+K NI L ++ DFG ++V T VVGT Y+SP
Sbjct: 118 YLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSP 172
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITGKK 573
E ++ KSD++S G +L E+ T K
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 76/232 (32%), Positives = 120/232 (51%), Gaps = 27/232 (11%)
Query: 379 LGQGGFGPVYKGKLA--NGQE----IAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVK 431
LG+G FG VYKG+L N + +A+K L + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFIF-------------DESRKQLLDWKKRFDIILG 478
LLG C ++ +++E++ + L F+ DE+ K LD I +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR-VFGGEEISTNTNRVVG 537
IA G+ YL S +HRDL A N L+ E + +ISDFG +R ++ + + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT--GKKNTGIFNDDSSNLIR 587
+M PE L G F+T+SD++SFGV+L EI + + G N + +IR
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 70/218 (32%), Positives = 110/218 (50%), Gaps = 30/218 (13%)
Query: 379 LGQGGFGPVYKGKLANGQE------IAVKRLS-TTSGQGIEEFKNEVLLIAKLQHRNLVK 431
LG+G FG V+ G+ + + +AVK L T S ++F+ E L+ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYF-----------IFDESRKQLLDWKKRFDIILGIA 480
G C E D ++++E+M + L+ F +S L + I + IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT-- 538
G++YL + +HRDL N L+ ++ +I DFG +R + +T+ RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 539 --YGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKK 573
+M PE + F+T+SDV+SFGV+L EI T GK+
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 67/202 (33%), Positives = 103/202 (50%), Gaps = 20/202 (9%)
Query: 379 LGQGGFGPVYK-GKLANGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLG 434
LG+G FG V K G+ A+K L + +E E +++++ H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 435 CCLEKDEKM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYLHQDS 490
+ +EK+ L+ E+ P L + + + + RF +I+L + YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLALE----YLH--- 110
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG 550
L II+RDLK NILLD + + +++DFG A+ E TNT GT Y++PE LG
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGK 168
Query: 551 LFSTKSDVFSFGVLLLEIITGK 572
+ D +S GVLL E++TGK
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRN 428
+ LGQG G VYK + G+ A+K++ + ++ E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL---- 484
+VK G ++ E ++ E+M SL + K++ + ++ IAR +L
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEP--VLAYIARQILKGLD 113
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
YLH IIHRD+K SN+L++ + +I+DFG ++V E N VGT YMSP
Sbjct: 114 YLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSP 169
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITGK 572
E G +S +D++S G+ LLE GK
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 379 LGQGGFGPVYKG-----KLANGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKL 432
LG G FG VYKG +A+K L + + +E +E ++A + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDES----RKQLLDWKKRFDIILGIARGVLYLHQ 488
LG CL + LI + MP L ++ + + LL+W + IA+G+ YL +
Sbjct: 75 LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL 548
R++HRDL A N+L+ + +I+DFG A++ +E + +M+ E L
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 549 GGLFSTKSDVFSFGVLLLEIIT-GKK 573
+++ KSDV+S+GV + E++T G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 81/289 (28%), Positives = 128/289 (44%), Gaps = 34/289 (11%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLAN-----GQEIAVKRLSTTSG-QGIEEFKNEVLLIAKL 424
+ +LG+G FG V + G+++AVK L+ + Q +F+ E+ ++ L
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 425 QHRNLVKLLGCCLEKDEK--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 482
H N+VK G C + + LI E++P+ SL ++ + L F I +G
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICKG 121
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF--GGEEISTNTNRVVGTYG 540
+ YL R IHRDL A NIL++ E +ISDFG A+V + +
Sbjct: 122 MDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKN--------TGIFNDDSSNLIRYVWE 591
Y +PE FS+ SDV+SFGV L E+ T G + I ++ + E
Sbjct: 179 Y-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237
Query: 592 LWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV 640
L + + L SCP E ++ LC + DRPS + ++
Sbjct: 238 LLKEGERL-----PRPPSCPD-EVYDLMK---LCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 84/270 (31%), Positives = 128/270 (47%), Gaps = 28/270 (10%)
Query: 378 KLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCL 437
KLG G FG V++G N +AVK L + ++F E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 438 EKDEKMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 496
++ ++ E M SL +Y R L + D+ +A G+ YL + IH
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 497 RDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKS 556
RDL A N+L+ E +++DFG ARV E+I + +PE AL FS KS
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIK-EDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 557 DVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPA--P 613
DV+SFG+LL EI+T G R + ++ + L+ VD CP P
Sbjct: 186 DVWSFGILLTEIVTYG---------------RMPYPGMTNAEVLQQVDQGYRMPCPPGCP 230
Query: 614 EALRCIQVGLLCVQDRTTDRPSMSTVVFML 643
+ L + L C ++ DRP+ T+ + L
Sbjct: 231 KEL--YDIMLDCWKEDPDDRPTFETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 66/194 (34%), Positives = 102/194 (52%), Gaps = 19/194 (9%)
Query: 379 LGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLE 438
+G+G FG V G GQ++AVK L S + F E ++ L+H NLV+LLG L+
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 439 KDEKMLIYEFMPNKSL-DYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 496
+ ++ E+M SL DY SR + ++ ++ L + G+ YL + +H
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVH 125
Query: 497 RDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY--GYMSPEYALGGLFST 554
RDL A N+L+ E++ ++SDFG A+ + + G + +PE FST
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFST 178
Query: 555 KSDVFSFGVLLLEI 568
KSDV+SFG+LL EI
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 24/265 (9%)
Query: 378 KLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGI-EEFKNEVLLIAKLQHRNLVKLLGCC 436
K+G+G FG VYKG L E+AVK +T + +F E ++ + H N+VKL+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 437 LEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 496
++K ++ E +P SL F+ +K L KK + L A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 497 RDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKS 556
RDL A N L+ E +ISDFG +R G + + + +PE G ++++S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 557 DVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP--APE 614
DV+S+G+LL E + + S+ + E ++S P PE
Sbjct: 177 DVWSYGILLWETFSLGDTP--------------YPGMSNQQTRERIESGYRMPAPQLCPE 222
Query: 615 ALRCIQVGLLCVQDRTTDRPSMSTV 639
+ ++ L C +RPS S +
Sbjct: 223 EIY--RLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN 428
+ + K+G+G G VYK A G+E+A+K++ Q E NE+L++ +H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL---- 484
+V L DE ++ E+M SL I ++ ++ + I + R VL
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNE-----PQIAYVCREVLQGLE 130
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
YLH +IHRD+K+ NILL ++ + +++DFG A E+ N+ VVGT +M+P
Sbjct: 131 YLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAP 185
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITG 571
E + K D++S G++ +E+ G
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 73/203 (35%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
+ KLG G FG V+ G ++A+K L S E F E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
+L + ++ +I E+M N SL D+ E K L K D+ IA G+ ++
Sbjct: 65 RLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE-- 119
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY--GYMSPEYA 547
R IHRDL+A+NIL+ E + +I+DFG AR+ E + T R + + +PE
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAI 175
Query: 548 LGGLFSTKSDVFSFGVLLLEIIT 570
G F+ KSDV+SFG+LL EI+T
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 80/216 (37%), Positives = 110/216 (50%), Gaps = 34/216 (15%)
Query: 379 LGQGGFGPVYKGK----LANG---QEIAVKRLSTTSGQGIEEFKN---EVLLIAKLQHRN 428
LG G FG VY+G L G +AVK L G +E K E L++ H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR--KGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQ-----LLDWKKRFDIILGIARGV 483
+VKLLG CL + + +I E M L ++ D +R + LL K+ DI L +A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRD-ARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNPR-----ISDFGTARVFGGEEISTNTNRVVGT 538
+YL Q + IHRDL A N L+ E+ I DFG AR + ++ R G
Sbjct: 120 VYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDYYRKEGE 172
Query: 539 ----YGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M+PE L G F+T+SDV+SFGVL+ EI+T
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 84/293 (28%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 369 ATDNFSTSNKLGQGGFGPVYKGKL------ANGQEIAVKRL-STTSGQGIEEFKNEVLLI 421
D+ + LG G FG VY+G A ++AVK L + S Q +F E L++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 422 AKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIIL 477
+K H+N+V+L+G E+ + ++ E M L F+ + R L K
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPR---ISDFGTARVFGGEEISTNTNR 534
+A+G YL ++ IHRD+ A N LL + R I+DFG AR R
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 535 VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEII-------TGKKNTGIFNDDSSNLIR 587
+ +M PE L G+F++K+DV+SFGVLL EI G+ N +
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN------------Q 228
Query: 588 YVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV 640
V E + L+ CP P ++ C Q DRP+ +T++
Sbjct: 229 EVMEFVTGGGRLD-----PPKGCPGP----VYRIMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 73/277 (26%), Positives = 131/277 (47%), Gaps = 27/277 (9%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
+ ++G G FG V+ G +++A+K + E+F E ++ KL H LV
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLV 62
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
+L G C E+ L++EFM + L ++ +++ + + L + G+ YL +
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT---YGYMSPEYA 547
+IHRDL A N L+ E ++SDFG R ++ +++T GT + SPE
Sbjct: 121 ---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVF 173
Query: 548 LGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607
+S+KSDV+SFGVL+ E+ + K +E S+ + +E +++
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTP--------------YENRSNSEVVETINAGFR 219
Query: 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644
P + ++ C ++R DRPS S ++ L+
Sbjct: 220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 80/284 (28%), Positives = 124/284 (43%), Gaps = 45/284 (15%)
Query: 377 NKLGQGGFGPVYKG--KLANGQEI--AVKRLS-TTSGQGIEEFKNEVLLIAKLQHRNLVK 431
+LG G FG V KG + +G+E+ AVK L G +EF E ++A+L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 491
L+G C + ML+ E P L ++ + D K ++ +A G+ YL
Sbjct: 61 LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLESK-- 114
Query: 492 LRIIHRDLKASNILLDEEMNPRISDFGTARVFG-GEEISTNTNRVVGTYG-----YMSPE 545
+HRDL A N+LL +ISDFG +R G G + T T G + +PE
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT-----TAGRWPLKWYAPE 168
Query: 546 YALGGLFSTKSDVFSFGVLLLEIIT--GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603
G FS+KSDV+S+GV L E + K + + + +++
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE----------------VIAMLE 212
Query: 604 SSMADSCPA--PEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
S P P+ + + L C + R DRP+ S +
Sbjct: 213 SGERLPRPEECPQEI--YSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 3e-28
Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 37/214 (17%)
Query: 377 NKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEF----KNEVLLIAKLQHRNLVK 431
++G+G +G VYK + G+ +A+K++ + + E F E+ L+ KL+H N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62
Query: 432 LLGCCLEKDEK--MLIYEFMPN--KSLDY---FIFDESR-----KQLLDWKKRFDIILGI 479
L K + +++E+M + L F ES+ KQLL
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL------------ 110
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
G+ YLH + I+HRD+K SNIL++ + +++DFG AR + + TNRV+ T
Sbjct: 111 -EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TL 165
Query: 540 GYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
Y PE LG + + D++S G +L E+ GK
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 66/207 (31%), Positives = 111/207 (53%), Gaps = 15/207 (7%)
Query: 372 NFSTSNKLGQGGFGPVYKG-KLANGQEIAVKR--LSTTSGQGIEEFKNEVLLIAKLQHRN 428
+F NK+G+G FG V+K + A+ + A+K+ LS + + EE +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLD---WKKRFDIILGIARGVLY 485
+++ L+K + ++ E+ N L + + + L + W+ I+LG+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE 545
LH +I+HRD+K+ N+ LD N +I D G A++ NT +VGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 546 YALGGLFSTKSDVFSFGVLLLEIITGK 572
++ KSDV++ GV+L E TGK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 373 FSTSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVK 431
F KLG+G +G VYK GQ +A+K + ++E E+ ++ + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVK 62
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFIFD--ESRKQLLDWKKRFDIILGIARGVLYLHQD 489
G + + ++ E+ S + D + + L ++ I+ +G+ YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGS----VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS- 117
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG 549
+ IHRD+KA NILL+EE +++DFG + NT V+GT +M+PE
Sbjct: 118 --NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQE 173
Query: 550 GLFSTKSDVFSFGVLLLEIITGK 572
++ K+D++S G+ +E+ GK
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 75/196 (38%), Positives = 105/196 (53%), Gaps = 12/196 (6%)
Query: 378 KLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCL 437
KLG G FG V+ G N ++AVK L + ++ F E L+ LQH LV+L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 438 EKDEKMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 496
+++ +I E+M SL D+ DE K LL K D IA G+ Y+ R IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 497 RDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY--GYMSPEYALGGLFST 554
RDL+A+N+L+ E + +I+DFG ARV E T R + + +PE G F+
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTI 183
Query: 555 KSDVFSFGVLLLEIIT 570
KSDV+SFG+LL EI+T
Sbjct: 184 KSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 41/231 (17%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLST---TSGQGIEEFKNEVLLIAKL-Q 425
D+F +G+G F V K +E A+K L + ++ K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 426 HRNLVKLLGCCLEKDEKM-LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGI 479
H ++KL + +E + + E+ PN L +I DE + I
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--------YAAEI 111
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV---- 535
+ YLH IIHRDLK NILLD++M+ +I+DFGTA+V +
Sbjct: 112 LLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 536 --------------VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
VGT Y+SPE SD+++ G ++ +++TGK
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 78/274 (28%), Positives = 131/274 (47%), Gaps = 28/274 (10%)
Query: 379 LGQGGFGPVYKG--KLANGQEI--AVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
+G G FG V +G KL +EI A+K L + +S + +F E ++ + H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493
G + M+I E+M N SLD F+ + ++ GIA G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFS 553
+HRDL A NIL++ + ++SDFG +R E + T + +PE F+
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186
Query: 554 TKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP-- 611
+ SDV+SFG+++ E+++ + + R W+ S+ ++ V+ P
Sbjct: 187 SASDVWSFGIVMWEVMS-------YGE------RPYWD-MSNQDVIKAVEDGYRLPPPMD 232
Query: 612 APEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
P AL Q+ L C Q +RP+ S +V L
Sbjct: 233 CPSALY--QLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFK----NEVLLIAKLQHRNLVKL 432
KLG+G +G VYK + G+ +A+K++ E E+ L+ +L+H N+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 492
L + + L++E+ + L ++ + R L I+ + RG+ Y H
Sbjct: 64 LDVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYCHSH--- 117
Query: 493 RIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLF 552
RI+HRDLK NIL++ + +++DFG AR F G + T T+ VV T Y +PE LG
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEILLGSKH 175
Query: 553 -STKSDVFSFGVLLLEIITGK 572
ST D++S G + E+ITGK
Sbjct: 176 YSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 379 LGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLE 438
LG G FG V+ GK ++A+K + + ++F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 439 KDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRD 498
+ ++ E+M N L ++ RK L + D+ + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 499 LKASNILLDEEMNPRISDFGTAR-VFGGEEISTNTNRVVGT---YGYMSPEYALGGLFST 554
L A N L+ E+ ++SDFG AR V + S+ GT + PE FS+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS-----QGTKFPVKWAPPEVFDYSRFSS 180
Query: 555 KSDVFSFGVLLLEIITGKK 573
KSDV+SFGVL+ E+ + K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 70/203 (34%), Positives = 112/203 (55%), Gaps = 19/203 (9%)
Query: 379 LGQGGFGPVYKGKL--ANGQEI--AVKRLS-TTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
+G+G FG VY G L ++GQ+I AVK L+ T + +E+F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 434 GCCLEKD-EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII---LGIARGVLYLHQD 489
G CL + +++ +M + L FI E+ + D+I L +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK-----DLIGFGLQVAKGMEYLASK 117
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTAR-VFGGEEISTNTNRVVG-TYGYMSPEYA 547
+ +HRDL A N +LDE +++DFG AR ++ E S + + +M+ E
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 548 LGGLFSTKSDVFSFGVLLLEIIT 570
F+TKSDV+SFGVLL E++T
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 85/275 (30%), Positives = 129/275 (46%), Gaps = 31/275 (11%)
Query: 377 NKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGC 435
+KLG G +G VY+G +AVK L + +EEF E ++ +++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 436 CLEKDEKMLIYEFMPNKS-LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 494
C + +I EFM + LDY E +Q ++ + I+ + YL + +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 495 IHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY--GYMSPEYALGGLF 552
IHRDL A N L+ E +++DFG +R+ G+ T T + + +PE F
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 553 STKSDVFSFGVLLLEIITGKKN--TGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSC 610
S KSDV++FGVLL EI T + GI D S V+EL +E + C
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQ----VYELLEKGYRME-----RPEGC 230
Query: 611 PAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
P P+ + C Q +DRPS + +
Sbjct: 231 P-PKVYELM---RACWQWNPSDRPSFAEIHQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQGIE-EFKNEVLLIAKLQHRN 428
+ ++LG+G G V K +L N I A+K ++T ++ + E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 429 LVKLLGCCLEKDEKML--IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL-- 484
+VK G L++ + E+ SLD I+ + +K+ ++ ++ IA VL
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEK--VLGKIAESVLKG 117
Query: 485 --YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
YLH +IIHRD+K SNILL + ++ DFG + GE +++ GT YM
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYM 170
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+PE G +S SDV+S G+ LLE+ +
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 79/288 (27%), Positives = 128/288 (44%), Gaps = 32/288 (11%)
Query: 372 NFSTSNKLGQGGFGPVYKGKLANGQE------IAVKRLSTTSGQGIE-EFKNEVLLIAKL 424
N LG+G FG V+ K +E + VK L T + ++ EF+ E+ + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 425 QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI------FDESRKQLLDWKKRFDIILG 478
H+N+V+LLG C E + +I E+ L F+ ++ + L K++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT 538
IA G+ +L S R +HRDL A N L+ + ++S ++ E N ++
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-P 181
Query: 539 YGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDK 597
+++PE FSTKSDV+SFGVL+ E+ T G+ +D+ + L +
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-----VLNRLQAGKL 236
Query: 598 ALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
L + + C P L + C DRPS S +V L
Sbjct: 237 ELPV-----PEGC--PSRLYKLM--TRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 68/203 (33%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 379 LGQGGFGPVYKG-KLANGQEIAVKR-----LSTTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
LGQG FG VY + G+E+AVK+ S + + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 433 LGCCLEKDEKMLIY-EFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
GC L DE + I+ E+MP S+ D + + + K I+ GV YLH +
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHSN- 123
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR-VVGTYGYMSPEYALG 549
I+HRD+K +NIL D N ++ DFG ++ S + V GT +MSPE G
Sbjct: 124 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 550 GLFSTKSDVFSFGVLLLEIITGK 572
+ K+DV+S G ++E++T K
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 67/213 (31%), Positives = 114/213 (53%), Gaps = 30/213 (14%)
Query: 379 LGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQG---------IEEFKNEVLLIAKLQHRN 428
+G G FG VY G A +G+ +AVK++ S ++ E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDIILGIARGV 483
+V+ LG L+ D + E++P S+ +Y F+E+ + + + I +G+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKGL 119
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST--NTNR--VVGTY 539
YLH IIHRD+K +NIL+D + +ISDFG ++ +ST N R + G+
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+M+PE ++ K+D++S G L++E++TGK
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 85/288 (29%), Positives = 116/288 (40%), Gaps = 54/288 (18%)
Query: 378 KLGQGGFGPVYKG--KLANGQEI--AVKRLSTTSGQGI-EEFKNEVLLIAKLQHRNLVKL 432
KLG G FG V +G + G+ I AVK L + I ++F E ++ L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQ---------LLDWKKRFDIILGIARGV 483
G L M++ E P SL D RK L D+ + IA G+
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYA------VQIANGM 110
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF--GGEEISTNTNRVVGTYGY 541
YL R IHRDL A NILL + +I DFG R + + V + +
Sbjct: 111 RYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAW 166
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELW---SDDKA 598
+PE FS SDV+ FGV L E+ T Y E W S +
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFT-----------------YGEEPWAGLSGSQI 209
Query: 599 LEIVDSSMADSCPAPEA--LRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644
L+ +D + PEA V L C DRP+ + + L
Sbjct: 210 LKKIDKE-GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 72/211 (34%), Positives = 116/211 (54%), Gaps = 22/211 (10%)
Query: 379 LGQGGFGPVYKGKLANGQE-----IAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKL 432
LG G FG VYKG E +A+K L+ T+G + EF +E L++A + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDES----RKQLLDWKKRFDIILGIARGVLYLHQ 488
LG CL + L+ + MP+ L ++ + + LL+W + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL 548
R++HRDL A N+L+ + +I+DFG AR+ G+E N + +M+ E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 549 GGLFSTKSDVFSFGVLLLEIIT--GKKNTGI 577
F+ +SDV+S+GV + E++T GK GI
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 70/219 (31%), Positives = 110/219 (50%), Gaps = 30/219 (13%)
Query: 378 KLGQGGFGPVYKGKLAN---GQE---IAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVK 431
+LG+G FG V+ + N Q+ +AVK L S ++F+ E L+ LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYF---------IFDESRKQL---LDWKKRFDIILGI 479
G C E ++++E+M + L+ F I L + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVG-- 537
A G++YL + L +HRDL N L+ + + +I DFG +R + ST+ RV G
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRT 184
Query: 538 --TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKK 573
+M PE L F+T+SD++SFGV+L EI T GK+
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 379 LGQGGFGPVYKGKLANG----QEIAVK--RLSTTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
LG+G FG V +G+L+ ++AVK +L + IEEF +E + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 433 LGCCLEKDEK------MLIYEFMPNKSLDYFIFD---ESRKQLLDWKKRFDIILGIARGV 483
+G C E M+I FM + L F+ + L + ++ IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMS 543
YL S IHRDL A N +L E+M ++DFG ++ + +++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 544 PEYALGGLFSTKSDVFSFGVLLLEIITGKKN--TGIFNDDSSNLIRYVWELWSDDKALEI 601
E ++++KSDV++FGV + EI T + G+ N + + +R+ L + L+
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDE 243
Query: 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
+ M C + DRP+ + + +L N
Sbjct: 244 LYDLMYS----------------CWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN--EVLLIAKLQHRNLVKLLG 434
K+G+G +G VYK + G+ +A+K++ E+ L+ +L H N++KLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 494
K + L++EFM + L I D R L + + +G+ + H I
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQR--GLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 495 IHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG-GLFS 553
+HRDLK N+L++ E +++DFG AR FG T+ VV T Y +PE LG +S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGYS 177
Query: 554 TKSDVFSFGVLLLEIITGK 572
T D++S G + E+++ +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 57/302 (18%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLAN------GQEIAVKRLSTTSGQG-IEEFKNEVLLIAK 423
+ + +LGQG FG VY+G +A+K ++ + EF NE ++ +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFM-------------PNKSLDYFIFDESRKQLLDWK 470
++V+LLG +++ E M P + + + ++ +
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM- 124
Query: 471 KRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530
IA G+ YL + +HRDL A N ++ E++ +I DFG R +
Sbjct: 125 -----AAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-------GKKNTGIFNDDSS 583
+ + +M+PE G+F+TKSDV+SFGV+L E+ T G N
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------E 228
Query: 584 NLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643
++++V D L+ + ++CP +++ +C Q RP+ +V L
Sbjct: 229 EVLKFV----IDGGHLD-----LPENCPDK----LLELMRMCWQYNPKMRPTFLEIVSSL 275
Query: 644 SN 645
+
Sbjct: 276 KD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 84/272 (30%), Positives = 130/272 (47%), Gaps = 29/272 (10%)
Query: 378 KLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCL 437
KLGQG FG V+ G ++A+K L + E F E ++ KL+H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 438 EKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHR 497
E + ++ EFM SL F+ E + L + D+ IA G+ Y+ R+ IHR
Sbjct: 72 E-EPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 498 DLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSD 557
DL+A+NIL+ + + +I+DFG AR+ E + + +PE AL G F+ KSD
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 185
Query: 558 VFSFGVLLLEIITGKK--NTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP--AP 613
V+SFG+LL E++T + G+ N + LE V+ CP P
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNRE----------------VLEQVERGYRMPCPQGCP 229
Query: 614 EALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
E+L ++ LC + +RP+ + L +
Sbjct: 230 ESLH--ELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 71/217 (32%), Positives = 121/217 (55%), Gaps = 17/217 (7%)
Query: 372 NFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTS-GQGIEEFK-NEVLLIAKLQHRN 428
+++ K+G+G +G VYKG+ GQ +A+K++ S +G+ E+ L+ +LQH N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDES--RKQLLDWKKRFDIILGIARGVLYL 486
+V L +++ LI+EF+ S+D + +S + Q +D + + I +G+L+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
H R++HRDLK N+L+D + +++DFG AR F G + T+ VV T Y +PE
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEV 172
Query: 547 ALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDS 582
LG +ST D++S G + E+ T K +F+ DS
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKP---LFHGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN---EVLLIAKLQH 426
D+ +LG G G V K G+ +AVK + + K E+ ++ K
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNS 58
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL-- 484
+V G + + E+M SLD I E + ++ + I+ IA VL
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPE-----RILGKIAVAVLKG 112
Query: 485 --YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
YLH + +IIHRD+K SNIL++ ++ DFG + G+ +++ VGT YM
Sbjct: 113 LTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYM 166
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+PE G +S KSD++S G+ L+E+ TG+
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 68/193 (35%), Positives = 102/193 (52%), Gaps = 7/193 (3%)
Query: 378 KLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCL 437
KLGQG FG V+ G +A+K L + E F E ++ KL+H LV+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 438 EKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHR 497
E + ++ E+M SL F+ E K L + D+ IA G+ Y+ R+ +HR
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 498 DLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSD 557
DL+A+NIL+ E + +++DFG AR+ E + + +PE AL G F+ KSD
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 185
Query: 558 VFSFGVLLLEIIT 570
V+SFG+LL E+ T
Sbjct: 186 VWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCL 437
LG+G +G VY + L+ IA+K + + ++ E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 438 EKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVLYLHQDSRLRII 495
E + E +P SL + S+ L ++ I I G+ YLH +I+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIV 130
Query: 496 HRDLKASNILLDEEMNP-RISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGL--F 552
HRD+K N+L++ +ISDFGT++ G I+ T GT YM+PE G +
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGY 188
Query: 553 STKSDVFSFGVLLLEIITGK 572
+D++S G ++E+ TGK
Sbjct: 189 GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-23
Identities = 37/69 (53%), Positives = 50/69 (72%), Gaps = 3/69 (4%)
Query: 184 CQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETNGGIGCL 243
C G+GF++L +K+PDT+ A VD ++GLK CE++CL NCSC AY AYA+ GG GCL
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAI-VDRSIGLKECEQRCLSNCSCTAY--AYADIRGGSGCL 57
Query: 244 IYHGDLNDT 252
I+ G+L D
Sbjct: 58 IWTGELVDM 66
|
Length = 66 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 67/203 (33%), Positives = 106/203 (52%), Gaps = 9/203 (4%)
Query: 369 ATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN 428
++ KLG G FG V+ G ++AVK L + E F E ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFD-ESRKQLLDWKKRFDIILGIARGVLYLH 487
LV+L + ++ ++ E+M SL F+ D E R L D+ +A G+ Y+
Sbjct: 63 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRA--LKLPNLVDMAAQVAAGMAYIE 119
Query: 488 QDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYA 547
R+ IHRDL+++NIL+ + + +I+DFG AR+ E + + +PE A
Sbjct: 120 ---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 175
Query: 548 LGGLFSTKSDVFSFGVLLLEIIT 570
L G F+ KSDV+SFG+LL E++T
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 33/213 (15%)
Query: 373 FSTSNKLGQGGFGPVYKG-KLANGQEIAVKRLS-TTSGQGIEEFKNEVLLIAKLQHRNLV 430
F+ +G+G FG VYK Q +A+K + + IE+ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 431 KLLGCCLEKDEKM-LIYEFMPNKS----LDYFIFDESRKQLLDWKKRFDIILGIARGVL- 484
K G L K K+ +I E+ S L DE I I R VL
Sbjct: 63 KYYGSFL-KGSKLWIIMEYCGGGSCLDLLKPGKLDE------------TYIAFILREVLL 109
Query: 485 ---YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR--VVGTY 539
YLH++ IHRD+KA+NILL EE + +++DFG + G+ ST + R VGT
Sbjct: 110 GLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTP 162
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+M+PE + K+D++S G+ +E+ G+
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 75/276 (27%), Positives = 130/276 (47%), Gaps = 47/276 (17%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLS----TTSGQG--IEEFKNEVLLIAKLQHRNLVK 431
LG G F Y+ + + G +AVK+++ T+S Q +E + E+ L+A+L H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 432 LLGCCLEKDEKMLIYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
+LG E L E+M S+ Y F E+ + + RG+ YL
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI--------INYTEQLLRGLSYL 119
Query: 487 HQDSRLRIIHRDLKASNILLDEE-MNPRISDFGTA-----RVFGGEEISTNTNRVVGTYG 540
H++ +IIHRD+K +N+L+D RI+DFG A + G E +++GT
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ---GQLLGTIA 173
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALE 600
+M+PE G + DV+S G +++E+ T K + SN + ++++
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN--AEKHSNHLALIFKI-------- 223
Query: 601 IVDSSMADSCPAPEALR--CIQVGLLCVQDRTTDRP 634
+S + PE L V L C++ + DRP
Sbjct: 224 ---ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 68/199 (34%), Positives = 106/199 (53%), Gaps = 25/199 (12%)
Query: 378 KLGQGGFGPVYKGKLANGQEIAVKRLST-TSGQGIEEFKNEVLLIAKLQHRNLVKLLGCC 436
+G+G FG V +G+ GQ++AVK + + Q F E ++ KL H+NLV+LLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 437 LEKDEKMLIYEFMPNKSLDYFIFDESRK-----QLLDWKKRFDIILGIARGVLYLHQDSR 491
L ++ E M +L F+ R QLL +F L +A G+ YL
Sbjct: 69 LHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLL----QFS--LDVAEGMEYLESK-- 119
Query: 492 LRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGL 551
+++HRDL A NIL+ E+ ++SDFG ARV + + +++ + +PE
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKK 173
Query: 552 FSTKSDVFSFGVLLLEIIT 570
FS+KSDV+S+GVLL E+ +
Sbjct: 174 FSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 73/194 (37%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 378 KLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCL 437
KLG G FG V+ ++AVK + S +E F E ++ LQH LVKL +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 70
Query: 438 EKDEKMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 496
K+ +I EFM SL D+ DE KQ L K D IA G+ ++ Q + IH
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIH 125
Query: 497 RDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKS 556
RDL+A+NIL+ + +I+DFG ARV E + + +PE G F+ KS
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 184
Query: 557 DVFSFGVLLLEIIT 570
DV+SFG+LL+EI+T
Sbjct: 185 DVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 25/214 (11%)
Query: 378 KLGQGGFGPVYKGKL-----ANGQEIAVKRLST-TSGQGIEEFKNEVLLIAKLQHRNLVK 431
+LG+ FG +YKG L + Q +A+K L + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFIF--------------DESRKQLLDWKKRFDIIL 477
LLG ++ +++E++ L F+ D + K LD I +
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR-VFGGEEISTNTNRVV 536
IA G+ YL S +H+DL A NIL+ E+++ +ISD G +R ++ + ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M PE + G FS+ SD++SFGV+L EI +
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 70/216 (32%), Positives = 118/216 (54%), Gaps = 16/216 (7%)
Query: 372 NFSTSNKLGQGGFGPVYKGK-LANGQEIAVK--RLSTTSGQGIEEFK-NEVLLIAKLQHR 427
NF K+G+G +G VYK + G+ +A+K RL T + +G+ E+ L+ +L H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHP 59
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 487
N+VKLL +++ L++EF+ ++ L F+ D S + + + +G+ + H
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 488 QDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYA 547
R++HRDLK N+L++ E +++DFG AR F G + T T+ VV T Y +PE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 172
Query: 548 LGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDS 582
LG +ST D++S G + E++T + +F DS
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 4e-23
Identities = 77/206 (37%), Positives = 105/206 (50%), Gaps = 26/206 (12%)
Query: 379 LGQGGFGPV--YKGKLAN---GQEIAVKRLSTTSGQGIEE-FKNEVLLIAKLQHRNLVKL 432
LG+G FG V Y AN G+ +AVK L GQ +K E+ ++ L H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 433 LGCCLEKDEK--MLIYEFMPNKSL-DYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQ 488
GCC E+ K LI E++P SL DY + + QLL + ++ I G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAYLHS 125
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTAR-VFGGEE---ISTNTNRVVGTYGYMSP 544
IHRDL A N+LLD + +I DFG A+ V G E + + + V Y +
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY---AV 179
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIIT 570
E FS SDV+SFGV L E++T
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 5e-23
Identities = 68/219 (31%), Positives = 121/219 (55%), Gaps = 10/219 (4%)
Query: 372 NFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFK-NEVLLIAKLQHRNL 429
NF KLG+G + VYKG+ G+ +A+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
V+L +++ ML++E+M +K L ++ + LD + +G+ + H++
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG 549
R++HRDLK N+L+++ +++DFG AR F G ++T +N VV T Y +P+ LG
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNEVV-TLWYRAPDVLLG 174
Query: 550 G-LFSTKSDVFSFGVLLLEIITGKK-NTGIFNDDSSNLI 586
+ST D++S G ++ E+ITG+ G N+D I
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-23
Identities = 72/233 (30%), Positives = 120/233 (51%), Gaps = 27/233 (11%)
Query: 378 KLGQGGFGPVYKGKL---ANG---QEIAVKRLSTTSGQGI-EEFKNEVLLIAKLQHRNLV 430
+LG+ FG VYKG L A G Q +A+K L + + EEFK+E ++ ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIF-------------DESRKQLLDWKKRFDIIL 477
LLG ++ +I+ + + L F+ D++ K L+ I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR-VFGGEEISTNTNRVV 536
IA G+ +L S ++H+DL N+L+ +++N +ISD G R V+ + N ++
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITG--KKNTGIFNDDSSNLIR 587
+MSPE + G FS SD++S+GV+L E+ + + G N D +IR
Sbjct: 189 PIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 6e-23
Identities = 66/271 (24%), Positives = 123/271 (45%), Gaps = 30/271 (11%)
Query: 379 LGQGGFGP--VYKGKLANGQ----EIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
LG+G FG +Y+ + E+ + RLS + + NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAY 64
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 492
++ + ++ E+ +L Y + QL + + + I V Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 493 RIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLF 552
I+HRD+K NI L + ++ DFG +++ G E T VVGT YMSPE G +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 553 STKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPA 612
+ KSD+++ G +L E++T K+ F D++N + V ++ + +
Sbjct: 179 NFKSDIWALGCVLYELLTLKR---TF--DATNPLNLVVKIVQGNYTPV----------VS 223
Query: 613 PEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643
+ I + +Q RP+ V+
Sbjct: 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 65/201 (32%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 379 LGQGGFGPVYKGKL-----ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
LG+G FG V + G+ +AVK+L ++ + + +F+ E+ ++ LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 434 GCCLE--KDEKMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
G C + L+ E++P SL DY R LD +K I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL---G 125
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVF-GGEEISTNTNRVVGTYGYMSPEYALG 549
R +HRDL NIL++ E +I DFG +V +E + +PE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 550 GLFSTKSDVFSFGVLLLEIIT 570
FS SDV+SFGV+L E+ T
Sbjct: 186 SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 66/203 (32%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 379 LGQGGFGPVY------KGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
LG+GGFG V GK+ +++ KRL G+ + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYLHQD 489
KD+ L+ M L Y I++ + + F II G+ +LHQ
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGL----EHLHQ- 113
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG 549
RI++RDLK N+LLD+ N RISD G A G GT GYM+PE G
Sbjct: 114 --RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRAGTPGYMAPEVLQG 168
Query: 550 GLFSTKSDVFSFGVLLLEIITGK 572
++ D F+ G L E+I G+
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 67/217 (30%), Positives = 99/217 (45%), Gaps = 36/217 (16%)
Query: 376 SNKLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQG--IEEFKNEVLLIAKLQHRNLVKL 432
NK+G G FG VY L G+ +AVK + I+E +E+ ++ L+H NLVK
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 433 LGCCLEKDEKMLIY-EFMPNKSLDYF-----IFDES-----RKQLLDWKKRFDIILGIAR 481
G + EK+ I+ E+ +L+ I DE QLL
Sbjct: 65 YGVEVH-REKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL-------------E 110
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF--GGEEISTNTNRVVGTY 539
G+ YLH I+HRD+K +NI LD ++ DFG A + + GT
Sbjct: 111 GLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167
Query: 540 GYMSPEYALGGLFSTK---SDVFSFGVLLLEIITGKK 573
YM+PE GG +D++S G ++LE+ TGK+
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK---LANGQE---IAVKRLST-TSGQGIEEFKNEVLLIAK 423
+N +GQG FG V++ + L + +AVK L S +F+ E L+A+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQL----------------- 466
H N+VKLLG C L++E+M L+ F+ S +
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 467 --LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR-VF 523
L ++ I +A G+ YL S + +HRDL N L+ E M +I+DFG +R ++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 524 GGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+ + N + +M PE ++T+SDV+++GV+L EI +
Sbjct: 182 SADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 78/274 (28%), Positives = 123/274 (44%), Gaps = 50/274 (18%)
Query: 379 LGQGGFGPVYKG-KLANGQEIAVKRLS-----TTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
LG G FG VY+G L +G AVK +S T + +++ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 433 LGCCLEKDEKMLIYEFMPNKSL-----DYFIFDES-----RKQLLDWKKRFDIILGIARG 482
LG E+D + E +P SL Y F E +Q+L G
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------------G 114
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
+ YLH +HRD+K +NIL+D +++DFG A+ E S G+ +M
Sbjct: 115 LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV--VEFSF-AKSFKGSPYWM 168
Query: 543 SPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601
+PE G + +D++S G +LE+ TGK + V+++ + I
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----VAAVFKIGRSKELPPI 223
Query: 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPS 635
D + EA I L C+Q + RP+
Sbjct: 224 PDHL------SDEAKDFI---LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 68/218 (31%), Positives = 112/218 (51%), Gaps = 32/218 (14%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVK--RLSTTSGQGIEEFK-NEVLLIAKLQHRNLVKLL 433
K+G+G +G VYK + G+ +A+K RL T +G+ E+ L+ +L H N+V+LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLL 64
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF----DIILG----IARGVLY 485
+++ L++EF+ D K+ +D +I + +G+ Y
Sbjct: 65 DVVHSENKLYLVFEFL----------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE 545
H R++HRDLK N+L+D E +++DFG AR F G + T T+ VV T Y +PE
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPE 169
Query: 546 YALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDS 582
LG +ST D++S G + E++ + +F DS
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRRP---LFPGDS 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 65/243 (26%), Positives = 98/243 (40%), Gaps = 33/243 (13%)
Query: 372 NFSTSNKLGQGGFGPVYK-GKLANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHR 427
+F +G+G FG V K + A+K ++ + NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 428 NLVKLLGCCLEKDEKM-LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIAR 481
LV L + +E M L+ + + L Y + F E + + I I
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--------WICEIVL 111
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGY 541
+ YLH IIHRD+K NILLDE+ + I+DF A + T T GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTSGTPGY 165
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYV--------WELW 593
M+PE +S D +S GV E + GK+ + + IR W
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW 225
Query: 594 SDD 596
S +
Sbjct: 226 STE 228
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 66/210 (31%), Positives = 108/210 (51%), Gaps = 21/210 (10%)
Query: 372 NFSTSNKLGQGGFGPVYKGK-LANGQEIAVKR--LSTTSGQGIEEFKNEVLLIAKLQHRN 428
+F KLG+G +G VYK K L++ Q A+K L + S + E+ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 429 LVK-----LLGCCLEKDEKMLIYEFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARG 482
++ L G L ++ E+ P L I + ++L+ ++ + I + + RG
Sbjct: 61 IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
+ LH+ +I+HRDLK++NILL +I D G ++V +GT YM
Sbjct: 116 LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYM 168
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+PE G +S KSD++S G LL E+ T
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 4e-22
Identities = 71/223 (31%), Positives = 110/223 (49%), Gaps = 28/223 (12%)
Query: 372 NFSTSNKLGQGGFGPVYKGKLAN---GQE---IAVKRLSTTSGQGIEEFKNEVLLIAKLQ 425
N +LG+G FG V+ + N Q+ +AVK L S ++F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQL----------LDWKKRFDI 475
H ++VK G C+E D ++++E+M + L+ F+ + L + I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 476 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV 535
IA G++YL + +HRDL N L+ E + +I DFG +R + ST+ RV
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRV 178
Query: 536 VG----TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKK 573
G +M PE + F+T+SDV+S GV+L EI T GK+
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 56/199 (28%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 379 LGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEE---FKNEVLLIAKLQHRNLVKLLGC 435
+G+G FG V+ + Q++ + + +E +NE ++ L H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 436 CLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 495
LE M++ E+ P +L +I LLD + I + ++H I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---IL 123
Query: 496 HRDLKASNILLDE-EMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFST 554
HRDLK NILLD+ +M +I DFG +++ + + VVGT Y+SPE G ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSK---SKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 555 KSDVFSFGVLLLEIITGKK 573
KSD+++ G +L E+ + K+
Sbjct: 181 KSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 67/224 (29%), Positives = 116/224 (51%), Gaps = 21/224 (9%)
Query: 373 FSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN---EVLLIAKLQHRN 428
FS ++G G FG VY + + N + +A+K++S + Q E++++ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
++ GC L + L+ E+ + D E K+ L + + G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL 548
+ +IHRD+KA NILL E ++ DFG+A I N VGT +M+PE L
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVIL 184
Query: 549 G---GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYV 589
G + K DV+S G+ +E+ ++ +FN ++ + + ++
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 7/193 (3%)
Query: 379 LGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIE-EFKNEVLLIAKLQHRNLVKLLGCCL 437
LG+G FG V+KG L + +AVK Q ++ +F +E ++ + H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 438 EKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHR 497
++ ++ E +P D+ F +K L K+ L A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 498 DLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSD 557
DL A N L+ E +ISDFG +R S++ + + + +PE G +S++SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSESD 176
Query: 558 VFSFGVLLLEIIT 570
V+S+G+LL E +
Sbjct: 177 VWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 56/204 (27%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLST---TSGQGIEEFKNEVLLIAKLQ 425
NF K+G+G F VYK L +G+ +A+K++ + ++ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI-FDESRKQLLDWKKRFDIILGIARGVL 484
H N++K L +E +E ++ E L I + +K+L+ + + + + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
++H RI+HRD+K +N+ + ++ D G R F + +T + +VGT YMSP
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSP 175
Query: 545 EYALGGLFSTKSDVFSFGVLLLEI 568
E ++ KSD++S G LL E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 378 KLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCL 437
+LG G FG V+ GK ++A+K ++ + E+F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 438 EKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHR 497
++ ++ EFM N L ++ R+ L + + G+ YL ++S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 498 DLKASNILLDEEMNPRISDFGTAR-VFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKS 556
DL A N L+ ++SDFG R V E S++ + + PE +S+KS
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF--PVKWSPPEVFNFSKYSSKS 182
Query: 557 DVFSFGVLLLEIITGKK 573
DV+SFGVL+ E+ T K
Sbjct: 183 DVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 65/224 (29%), Positives = 117/224 (52%), Gaps = 21/224 (9%)
Query: 373 FSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQGIEEFKN---EVLLIAKLQHRN 428
F+ ++G G FG VY + E+ A+K++S + Q E++++ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
++ GC L + L+ E+ + D E K+ L + I G +G+ YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL 548
+ +IHRD+KA NILL E +++DFG+A I++ N VGT +M+PE L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVIL 194
Query: 549 G---GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYV 589
G + K DV+S G+ +E+ ++ +FN ++ + + ++
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 377 NKLGQGGFGPVYKGKLANGQEIAVKRLS------TTSGQGIEEFKNEVLLIAKLQHRNLV 430
LG+G +G VY G GQ IAVK++ + + E+ + EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 431 KLLGCCLEKDEKMLIYEFMPNKS----LDYF------IFDESRKQLLDWKKRFDIILGIA 480
+ LG CL+ + + EF+P S L+ F +F + KQ+LD
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------------ 113
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV---- 536
GV YLH + ++HRD+K +N++L ++ DFG AR + + ++
Sbjct: 114 -GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
GT +M+PE + KSD++S G + E+ TGK
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 377 NKLGQGGFGPVYKGK-LANGQEIAVKRLS--TTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
+G+G FG V K + ++G+ + K + + + ++ +EV ++ +L+H N+V+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 434 GCCLEKD-EKMLIY-EFMPNKSLDYFIFDESRKQLLDWKKRF--DIILGIARGVL----Y 485
+++ + + I E+ L I + +K+ +K + I I +L
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLI-QKCKKE----RKYIEEEFIWRILTQLLLALYE 120
Query: 486 LH--QDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMS 543
H D ++HRDLK +NI LD N ++ DFG A++ G + T VGT YMS
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMS 178
Query: 544 PEYALGGLFSTKSDVFSFGVLLLEIITGK 572
PE + KSD++S G L+ E+
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 78/282 (27%), Positives = 138/282 (48%), Gaps = 47/282 (16%)
Query: 379 LGQGGFGPVYKG--KLANGQEIAVKRLSTTSG---QGIEEFKNEVLLIAKLQHRNLVKLL 433
+G G FG V++G K+ +E+AV + G + ++F +E ++ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIILGIARGVLYLHQD 489
G + M+I E+M N +LD ++ D S QL+ ++ GIA G+ YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG------MLRGIAAGMKYL--- 123
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG------YMS 543
S + +HRDL A NIL++ + ++SDFG +RV + T T T G + +
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT-----TSGGKIPIRWTA 178
Query: 544 PEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603
PE F++ SDV+SFG+++ E+++ F + R W++ S+ + ++ ++
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMS-------FGE------RPYWDM-SNHEVMKAIN 224
Query: 604 SSMADSCP--APEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643
P P A+ Q+ L C Q RP +V +L
Sbjct: 225 DGFRLPAPMDCPSAVY--QLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 67/237 (28%), Positives = 110/237 (46%), Gaps = 51/237 (21%)
Query: 369 ATDNFSTSNKLGQGGFGPVYKG-KLANGQEIAVKRL---STTSGQGIEEFKNEVLLIAKL 424
++ KLG+G FG VYK ++ G+ +A+K++ + G I + E+ ++ KL
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64
Query: 425 QHRNLVKLLGCCLEK-----DEKMLIYEFMPNKSLDY--------FIFDESR-----KQL 466
+H N+V L+ +E+ ++ +Y P D ES+ QL
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 467 LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF--- 523
L+ G+ YLH++ I+HRD+KA+NIL+D + +I+DFG AR +
Sbjct: 125 LE-------------GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
Query: 524 -------GGEEISTNTNRVVGTYGYMSPEYALGGL-FSTKSDVFSFGVLLLEIITGK 572
GG TN VV T Y PE LG ++T D++ G + E+ T +
Sbjct: 169 PPNPKGGGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 81/291 (27%), Positives = 138/291 (47%), Gaps = 39/291 (13%)
Query: 372 NFSTSNKLGQGGFGPVYK-GKLANGQEI-AVKRLSTT----------SGQGIEEFKNEVL 419
++ LG G FG VYK K NGQ + A+K ++ + I + +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 420 LIAK-LQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIIL 477
+I + L+H N+V+ LE D ++ + + L ++F + +KQ ++ ++I +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVG 537
+ + YLH++ R I+HRDL +NI+L E+ I+DFG A+ E T+ VVG
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS---VVG 175
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK 597
T Y PE + K+DV++FG +L ++ T + F S+N++
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQP---PFY--STNMLSL--------- 221
Query: 598 ALEIVDSSMADSCPAPEALRCIQVGLL---CVQDRTTDRPSMSTVVFMLSN 645
A +IV+ A P PE + V + C+ RP + V M+S+
Sbjct: 222 ATKIVE---AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 62/215 (28%), Positives = 112/215 (52%), Gaps = 21/215 (9%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL-----ANGQEIAVKRLSTTSGQ-GIEEFKNEVLLIAKL 424
D + S+ L +G FG ++ G L +E+ VK + + + + E L+ L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 425 QHRNLVKLLGCCLEKDEK-MLIYEFMPNKSLDYF-----IFDESRKQLLDWKKRFDIILG 478
H+N++ +L C+E E ++Y +M +L F + + + Q L ++ + +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR-VFGGEE--ISTNTNRV 535
IA G+ YLH + +IH+D+ A N ++DEE+ +I+D +R +F + + N NR
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 536 VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
V +M+ E + +S+ SDV+SFGVLL E++T
Sbjct: 183 VK---WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRL-STTSGQGI-EEFKNEVLLIAKLQHRNLVKLLG 434
++G+G G V+K K G+ +A+K++ GI + E+ + QH +VKLL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 494
+L+ E+MP+ L + DE R K + +L +GV Y+H I
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHA---NGI 120
Query: 495 IHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFST 554
+HRDLK +N+L+ + +I+DFG AR+F EE +++ V T Y +PE G
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLYGARKYD 179
Query: 555 KS-DVFSFGVLLLEIITG 571
D+++ G + E++ G
Sbjct: 180 PGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 8e-21
Identities = 67/224 (29%), Positives = 118/224 (52%), Gaps = 21/224 (9%)
Query: 373 FSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQGIEEFKN---EVLLIAKLQHRN 428
F +++G G FG VY ++ E+ AVK++S + Q E++++ EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
++ GC L++ L+ E+ + D E K+ L + I G +G+ YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL 548
+ +IHRD+KA NILL E +++DFG+A S+ N VGT +M+PE L
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVIL 190
Query: 549 G---GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYV 589
G + K DV+S G+ +E+ ++ +FN ++ + + ++
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 64/193 (33%), Positives = 99/193 (51%), Gaps = 17/193 (8%)
Query: 379 LGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLE 438
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 439 KDEKMLIY-EFMPNKSL-DYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRII 495
+ + I E+M SL DY SR + +L L + + YL ++ +
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124
Query: 496 HRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTK 555
HRDL A N+L+ E+ ++SDFG + E S+ + + +PE FSTK
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 556 SDVFSFGVLLLEI 568
SDV+SFG+LL EI
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 69/220 (31%), Positives = 109/220 (49%), Gaps = 31/220 (14%)
Query: 378 KLGQGGFGPVYKGKLAN------GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVK 431
+LG+G FG V+ + N +AVK L + ++F+ E L+ LQH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYF----------IFDESRKQL---LDWKKRFDIILG 478
G C + D ++++E+M + L+ F + D +Q L + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVG- 537
IA G++YL + +HRDL N L+ + +I DFG +R + ST+ RV G
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 184
Query: 538 ---TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKK 573
+M PE + F+T+SDV+SFGV+L EI T GK+
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 373 FSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN---EVLLIAKLQHRN 428
F+ ++G G FG VY + + + +A+K++S + Q E++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL---- 484
++ GC L + L+ E+ + D I + +K L + I I G L
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPL-----QEVEIAAICHGALQGLA 129
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
YLH R IHRD+KA NILL E +++DFG+A + + N VGT +M+P
Sbjct: 130 YLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAP 180
Query: 545 EYALG---GLFSTKSDVFSFGVLLLEI 568
E L G + K DV+S G+ +E+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 33/221 (14%)
Query: 379 LGQGGFGPVYKGK------LANGQEIAVKRLSTTSGQG-IEEFKNEVLLIAKLQHRNLVK 431
LG+G FG V K A +AVK L + + + +E L+ ++ H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRK----------------------QLLDW 469
L G C + +LI E+ SL F+ ESRK + L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFL-RESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 470 KKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529
I+RG+ YL + ++++HRDL A N+L+ E +ISDFG +R E+
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
++ +M+ E +++T+SDV+SFGVLL EI+T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 13/205 (6%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN 428
D + +LG G FG VYK + G A K + S + +E+F E+ ++++ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
+V L +++ ++ EF +LD I E + L + + R+ + + + +LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHS 121
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL 548
++IHRDLKA NILL + + +++DFG + +T +GT +M+PE
Sbjct: 122 H---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVA 176
Query: 549 GGLFST-----KSDVFSFGVLLLEI 568
F K+D++S G+ L+E+
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 377 NKLGQGGFGPVYKGK-LANGQEIAVKRLS-TTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
+G G VY L N +++A+KR+ ++E + EV +++ H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL----YLHQDS 490
+ DE L+ ++ SL + + LD II + + VL YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEA----IIATVLKEVLKGLEYLHSNG 122
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVF--GGEEISTNTNRVVGTYGYMSPE--Y 546
+ IHRD+KA NILL E+ + +I+DFG + GG+ VGT +M+PE
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 547 ALGGLFSTKSDVFSFGVLLLEIITGK 572
+ G + K+D++SFG+ +E+ TG
Sbjct: 180 QVHG-YDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 29/206 (14%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLS-TTSGQGIEEFKNEVLLIAKLQH---RNLVKLL 433
+G+G +G VY+GK + G+ +A+K ++ T + + + EV L+++L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL----YLHQD 489
G L+ +I E+ S+ + + K I I R VL Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTL----MKAGPIAEK----YISVIIREVLVALKYIHKV 120
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR---VVGTYGYMSPEY 546
+IHRD+KA+NIL+ N ++ DFG A ++ N+++ VGT +M+PE
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVA-----ALLNQNSSKRSTFVGTPYWMAPEV 172
Query: 547 ALGG-LFSTKSDVFSFGVLLLEIITG 571
G + TK+D++S G+ + E+ TG
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 43/229 (18%)
Query: 378 KLGQGGFGPVYKGKLANGQE-----------------IAVKRLSTTSGQGIE-EFKNEVL 419
KLG+G FG V+ ++ N Q+ +AVK L + + +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 420 LIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLD----------- 468
++++L+ N+++LLG C+++D +I E+M N L+ F+ S L D
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128
Query: 469 --------WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA 520
+ + L IA G+ YL S L +HRDL N L+ E + +I+DFG +
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 521 RVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEII 569
R + R V +M+ E L G F+T SDV++FGV L EI+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 373 FSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLS-TTSGQGIEEFK-NEVLLIAKLQ---H 426
+ ++G+G +G VYK + L G+ +A+K++ S +GI E+ L+ +L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 427 RNLVKLLGCCLEKDEK-----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 481
N+V+LL C L++E + ++ L ++ + L + D++ + R
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLR 118
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGY 541
GV +LH RI+HRDLK NIL+ + +I+DFG AR++ E T+ VV T Y
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS---VVVTLWY 172
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEI 568
+PE L ++T D++S G + E+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 70/212 (33%), Positives = 109/212 (51%), Gaps = 24/212 (11%)
Query: 378 KLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCL 437
+LG G FG V GK ++A+K + S +EF E ++ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 438 EKDEKMLIYEFMPNKSLDYFIFDESRK----QLLDWKKRFDIILGIARGVLYLHQDSRLR 493
++ ++ E+M N L ++ + ++ QLL+ K + G+ YL +
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK------DVCEGMAYLESK---Q 120
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTAR-VFGGEEISTNTNRVVGT---YGYMSPEYALG 549
IHRDL A N L+D++ ++SDFG +R V E S+ VG+ + PE L
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS-----VGSKFPVRWSPPEVLLY 175
Query: 550 GLFSTKSDVFSFGVLLLEIIT-GKKNTGIFND 580
FS+KSDV++FGVL+ E+ + GK FN+
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-20
Identities = 34/88 (38%), Positives = 48/88 (54%), Gaps = 10/88 (11%)
Query: 181 TSTCQKGE---GFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETN 237
C GF+KL VK+PD + A + L+ C E CL NCSC AYA N
Sbjct: 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI---TAISLEECREACLSNCSCTAYAY----NN 54
Query: 238 GGIGCLIYHGDLNDTRTYTNAGQDLFVR 265
G GCL+++G LN+ R+ ++ G L++R
Sbjct: 55 GSGGCLLWNGLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 6e-20
Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 20/208 (9%)
Query: 373 FSTSNKLGQGGFGPVYKGK-LANGQEI----AVKRL-STTSGQGIEEFKNEVLLIAKLQH 426
F LG G FG VYKG + G+++ A+K L TS + +E +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSL-DYFIFDESR---KQLLDWKKRFDIILGIARG 482
++ +LLG CL + LI + MP L DY + + LL+W + IA+G
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
+ YL + R++HRDL A N+L+ + +I+DFG A++ G +E + +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+ E L +++ +SDV+S+GV + E++T
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 8e-20
Identities = 71/236 (30%), Positives = 114/236 (48%), Gaps = 39/236 (16%)
Query: 373 FSTSNKLGQGGFGPVYKGKL----ANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQH 426
F+ LG+G FG V + +L + Q++AVK L S IEEF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 427 RNLVKLLGCCLEKDEK------MLIYEFMPNKSLDYFI---------FDESRKQLLDWKK 471
N++KL+G L K M+I FM + L F+ F + L+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV---- 116
Query: 472 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR-VFGGEEIST 530
RF ++ IA G+ YL S IHRDL A N +L+E M ++DFG ++ ++ G+
Sbjct: 117 RF--MIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171
Query: 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-------GKKNTGIFN 579
+ +++ E +++T SDV++FGV + EI+T G +N+ I+N
Sbjct: 172 GCASKLPV-KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 9e-20
Identities = 58/215 (26%), Positives = 115/215 (53%), Gaps = 13/215 (6%)
Query: 362 ELSTVLAATD---NFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNE 417
+L T+++ D ++ K+GQG G V+ +A GQE+A+K+++ E NE
Sbjct: 7 KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINE 66
Query: 418 VLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL 477
+L++ +L++ N+V L L DE ++ E++ SL D + +D + +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCR 122
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVG 537
+ + +LH + ++IHRD+K+ N+LL + + +++DFG E+ +T +VG
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
T +M+PE + K D++S G++ +E++ G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 47/219 (21%)
Query: 377 NKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN-----------EVLLIAKL 424
KLG+G + VYK + G+ +A+K++ + E K E+ L+ +L
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIKLLQEL 59
Query: 425 QHRNLVKLLGCCLEKDEKMLIYEFMP--------NKSLDYFIFDESRKQLLDWKKRFDII 476
+H N++ LL K L++EFM +KS+ D K +
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVL--------TPADIKS---YM 108
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG--GEEISTNTNR 534
L RG+ YLH I+HRDLK +N+L+ + +++DFG AR FG +++
Sbjct: 109 LMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ--- 162
Query: 535 VVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
VV T Y +PE G + D++S G + E++
Sbjct: 163 VV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 57/215 (26%), Positives = 110/215 (51%), Gaps = 33/215 (15%)
Query: 379 LGQGGFGPVYKG-KLANGQEIAVKRL---STTSGQG-------IEEFKNEVLLIAKLQHR 427
+G+G +G VY + G+ +AVK++ +T +G+ ++ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDIILGIARG 482
N+V+ LG ++ + E++P S+ Y F+E + + + G
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLEG 120
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN--TNRVVGTYG 540
+ YLH I+HRDLKA N+L+D + +ISDFG ++ ++I N + G+
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVF 175
Query: 541 YMSPE--YALGGLFSTKSDVFSFGVLLLEIITGKK 573
+M+PE ++ +S K D++S G ++LE+ G++
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 38/289 (13%)
Query: 378 KLGQGGFGPVYKGKLANGQE---------------IAVKRL-STTSGQGIEEFKNEVLLI 421
KLG+G FG V+ + E +AVK L + + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 422 AKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFD-ESRKQL--------LDWKKR 472
++L++ N+++LLG C+ D +I E+M N L+ F+ E +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 473 FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT 532
+ + IA G+ YL + L +HRDL N L+ +I+DFG +R +
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 533 NRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNT--GIFNDDSSNLIRYVW 590
R V +M+ E L G F+T SDV++FGV L E+ T K + +D+ +I
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE--QVIENTG 246
Query: 591 ELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTV 639
E + ++ +I S CP+P ++ + C DRP+ + +
Sbjct: 247 EFFR-NQGRQIY-LSQTPLCPSP----VFKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 61/219 (27%), Positives = 113/219 (51%), Gaps = 21/219 (9%)
Query: 362 ELSTVLAATD---NFSTSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQGIEEFKNE 417
+L T+++ D ++ K+GQG G VY +A GQE+A+K+++ E NE
Sbjct: 7 KLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINE 66
Query: 418 VLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL 477
+L++ + +H N+V L L DE ++ E++ SL + + + I
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE--------GQIA 118
Query: 478 GIARGVL----YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTN 533
+ R L +LH + ++IHRD+K+ NILL + + +++DFG E+ +T
Sbjct: 119 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST- 174
Query: 534 RVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+VGT +M+PE + K D++S G++ +E++ G+
Sbjct: 175 -MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 372 NFSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRL-----STTSGQGIEEFKNEVLLIAKLQ 425
N+ LGQG FG VY A+ G+E+AVK++ S + + + + E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 426 HRNLVKLLGCCLEKDEKML--IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL-----G 478
H +V+ GC + E+ L E MP S+ + QL + + +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSI--------KDQLKSYGALTENVTRKYTRQ 114
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS-TNTNRVVG 537
I GV YLH + I+HRD+K +NIL D N ++ DFG ++ +S T V G
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
T +MSPE G + K+D++S G ++E++T K
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 35/226 (15%)
Query: 374 STSNKLGQGGFGPVYKGKLANGQEI-----------------AVKRL-STTSGQGIEEFK 415
+ KLG+G FG V+ + Q+ AVK L S E+F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 416 NEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD- 474
EV ++++L N+ +LLG C +I E+M N L+ F+ + +
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL---QKHVAETSGLACNS 124
Query: 475 ----------IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524
+ IA G+ YL L +HRDL N L+ + +I+DFG +R
Sbjct: 125 KSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+ R +M+ E L G F+TKSDV++FGV L EI+T
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 84/287 (29%), Positives = 136/287 (47%), Gaps = 57/287 (19%)
Query: 379 LGQGGFGPVYKG--KLANGQEIAVKRLSTTSG---QGIEEFKNEVLLIAKLQHRNLVKLL 433
+G G FG V G KL +EI V + +G + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL------GIARGVLYLH 487
G + M++ E+M N SLD F+ RK +F +I GIA G+ YL
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL----RKH----DGQFTVIQLVGMLRGIASGMKYL- 122
Query: 488 QDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG------Y 541
S + +HRDL A NIL++ + ++SDFG +RV + + T R G +
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRW 175
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD--KAL 599
+PE F++ SDV+S+G+++ E+++ + R WE+ + D KA+
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE-------------RPYWEMSNQDVIKAI 222
Query: 600 E---IVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643
E + + M CPA AL Q+ L C Q +RP +V +L
Sbjct: 223 EEGYRLPAPM--DCPA--ALH--QLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 15/206 (7%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGI-EEFKNEVLLIAKLQHRN 428
++ T + LG G G V K K + G +A K + + + ++ E+ ++ + +
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLD--YFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
+V G L ++ + EFM SLD Y ++L I + + G+ YL
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL 119
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
+ + RI+HRD+K SNIL++ ++ DFG + GE I++ + VGT YMSPE
Sbjct: 120 Y--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPER 173
Query: 547 ALGGLFSTKSDVFSFGVLLLEIITGK 572
GG ++ KSDV+S G+ ++E+ GK
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 60/218 (27%), Positives = 112/218 (51%), Gaps = 21/218 (9%)
Query: 363 LSTVLAATD---NFSTSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQGIEEFKNEV 418
L V+ D K+G+G G V + G+++AVK++ Q E NEV
Sbjct: 8 LQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEV 67
Query: 419 LLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIIL 477
+++ QH N+V++ L DE ++ EF+ +L D I +R ++ ++ + L
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD--IVTHTR---MNEEQIATVCL 122
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR--- 534
+ + + +LH +IHRD+K+ +ILL + ++SDFG F ++S R
Sbjct: 123 AVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCA-QVSKEVPRRKS 174
Query: 535 VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+VGT +M+PE + T+ D++S G++++E++ G+
Sbjct: 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 25/204 (12%)
Query: 379 LGQGGFGPVYKGKLANGQEI-AVKRLSTTS--GQGIEE-FKNEVLLIAKLQHRNLVKLLG 434
LG GGFG V K+ + A+K + G +E +E ++ + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 435 CCLEKDEK---MLIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYLHQ 488
KD+K ML+ E+ L + D R ++ RF ++L YLH
Sbjct: 60 -RTFKDKKYIYMLM-EYCLGGELWTILRD--RGLFDEYTARFYIACVVLAFE----YLH- 110
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL 548
II+RDLK N+LLD ++ DFG A+ + T GT Y++PE L
Sbjct: 111 --NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIIL 165
Query: 549 GGLFSTKSDVFSFGVLLLEIITGK 572
+ D +S G+LL E++TG+
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 379 LGQGGFGPVYKG-KLANGQEIAVKRL-----STTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
LGQG FG VY + G+E+A K++ S + + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 433 LGCCLEKDEKML--IYEFMPNKSLD-----YFIFDESRKQLLDWKKRFDIILGIARGVLY 485
GC ++ EK L E+MP S+ Y ES + + I G+ Y
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ--------ILEGMSY 121
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS-TNTNRVVGTYGYMSP 544
LH + I+HRD+K +NIL D N ++ DFG ++ +S T V GT +MSP
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITGK 572
E G + K+DV+S G ++E++T K
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 30/223 (13%)
Query: 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QH 426
T F +G+G +G VYK + GQ +A+K + EE K E ++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNH 62
Query: 427 RNLVKLLGCCLEK------DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------ 474
N+ G ++K D+ L+ E S+ + K L KR
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAY 117
Query: 475 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR 534
I+ RG+ YLH++ ++IHRD+K NILL + ++ DFG + NT
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT-- 172
Query: 535 VVGTYGYMSPE-----YALGGLFSTKSDVFSFGVLLLEIITGK 572
+GT +M+PE + +SDV+S G+ +E+ GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 5e-19
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 372 NFSTSNKLGQGGFGPVY--KGKLANGQEIAVKRLSTTSG--QGIEEFKNEVLLIAKLQHR 427
+ K+G+G FG +Y K K + + +K + T + E K EV+L+AK++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE-----SRKQLLDWKKRFDIILGIARG 482
N+V E ++ E+ L I + S Q+L W + I+ G
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLG 113
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEE-MNPRISDFGTARVFGGEEISTNTNRVVGTYGY 541
+ ++H +I+HRD+K+ NI L + M ++ DFG AR T VGT Y
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYY 168
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+SPE ++ K+D++S G +L E+ T K
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 371 DNFSTSNKLGQGGFGPVYKG------KLANGQEIAVKRL-STTSGQGIEEFKNEVLLIAK 423
D + LG+G FG V K +AVK L + + + + +E+ ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 424 L-QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG---- 478
+ +H+N++ LLG C ++ ++ E+ + +L F+ R
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLT 130
Query: 479 ----------IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528
+ARG+ +L + IHRDL A N+L+ E+ +I+DFG AR +
Sbjct: 131 QKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187
Query: 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
T +M+PE +++ +SDV+SFGVLL EI T
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 80/289 (27%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 369 ATDNFSTSNKLGQGGFGPVYKGKLANG-------QEIAVKRLS-TTSGQGIEEFKNEVLL 420
A + + S +LGQG FG VY+G +A G +A+K ++ S + EF NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62
Query: 421 IAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIF-------DESRKQLLDWKKRF 473
+ + ++V+LLG + ++I E M L ++ + + KK
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 474 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTN 533
+ IA G+ YL+ + + +HRDL A N ++ E+ +I DFG R +
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 534 RVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKN--TGIFNDDSSNLIRYVWE 591
+ + +MSPE G+F+T SDV+SFGV+L EI T + G+ N+ ++R+V E
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRFVME 236
Query: 592 LWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV 640
DK D+CP ++ +C Q RPS ++
Sbjct: 237 GGLLDK---------PDNCPD----MLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-19
Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 14/201 (6%)
Query: 379 LGQGGFGPV----YKGKLAN-GQEIAVKRLSTTSGQG-IEEFKNEVLLIAKLQHRNLVKL 432
LG+G FG V Y + N G+++AVK L SG I + K E+ ++ L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 433 LGCCLEKDEK--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
G C E LI EF+P+ SL ++ K ++ K++ + I +G+ YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--GS 127
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFG-TARVFGGEEISTNTNRVVGTYGYMSPEYALG 549
R + +HRDL A N+L++ E +I DFG T + +E T + + + +PE +
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 550 GLFSTKSDVFSFGVLLLEIIT 570
F SDV+SFGV L E++T
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 8e-19
Identities = 71/231 (30%), Positives = 110/231 (47%), Gaps = 43/231 (18%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQE-IAVKRLS-TTSGQGIEEFK-NEVLLIAKLQHR 427
D + K+G+G +G VYK + E IA+K++ +G+ E+ L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------------- 474
N+V+L + L++E+ LD LD KK D
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LD-----------LDLKKHMDSSPDFAKNPRLIK 105
Query: 475 -IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP-RISDFGTARVFGGEEISTNT 532
+ I RG+ Y H R++HRDLK N+L+D N +++DFG AR F G + T T
Sbjct: 106 TYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFT 161
Query: 533 NRVVGTYGYMSPEYALGGL-FSTKSDVFSFGVLLLEIITGKKNTGIFNDDS 582
+ VV T Y +PE LG +ST D++S G + E++ K +F DS
Sbjct: 162 HEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKP---LFPGDS 208
|
Length = 294 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 68/215 (31%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 372 NFSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRL-----STTSGQGIEEFKNEVLLIAKLQ 425
N+ LG+G FG VY A+ G+E+AVK++ S + + + + E+ L+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 426 HRNLVKLLGCCLEKDEKML--IYEFMPNKSLDYFIFDESRKQL-----LDWKKRFDIILG 478
H +V+ GC + +EK L E+MP S+ + QL L
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI--------KDQLKAYGALTENVTRRYTRQ 114
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS-TNTNRVVG 537
I +GV YLH + I+HRD+K +NIL D N ++ DFG ++ +S T V G
Sbjct: 115 ILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
T +MSPE G + K+DV+S ++E++T K
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 373 FSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQG-IEEFKNEVLLIAKLQHRNLV 430
F+ ++G+G FG VYKG +E+ A+K + + IE+ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
+ G L+ + +I E++ S D + L+ I+ I +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG 550
R IHRD+KA+N+LL E+ + +++DFG A +I NT VGT +M+PE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176
Query: 551 LFSTKSDVFSFGVLLLEIITGK 572
+ K+D++S G+ +E+ G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 68/203 (33%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 379 LGQGGFGPVYKGKL-ANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
LG+GGFG V ++ A G+ A K+L+ +G E E ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFIF--DESRKQLLDWKKRF---DIILGIARGVLYLHQD 489
K + L+ M L Y I+ DE + + F II G+ +LHQ
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLE----HLHQR 116
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG 549
RII+RDLK N+LLD + N RISD G A ++ + T GT G+M+PE G
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELLQG 171
Query: 550 GLFSTKSDVFSFGVLLLEIITGK 572
+ D F+ GV L E+I +
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 25/203 (12%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCC 436
+LG G FG VYK K G A K + T S + +E++ E+ ++A H +VKLLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 437 LEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL----YLHQDSRL 492
+ ++ EF P ++D + + LD I I R +L YLH +
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVICRQMLEALQYLHS---M 129
Query: 493 RIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR--VVGTYGYMSPEYAL-- 548
+IIHRDLKA N+LL + + +++DFG + + + T R +GT +M+PE +
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 549 ---GGLFSTKSDVFSFGVLLLEI 568
+ K+D++S G+ L+E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 1e-18
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN--EVLLIAKLQ-HRNLVKLL 433
+LG G FG VY + G+ +A+K++ EE N EV + KL H N+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493
E DE ++E+M +L Y + + + + II I +G+ ++H +
Sbjct: 65 EVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHG 119
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN---TNRVVGTYGYMSPEYAL-G 549
HRDLK N+L+ +I+DFG AR EI + T+ V T Y +PE L
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVSTRWYRAPEILLRS 173
Query: 550 GLFSTKSDVFSFGVLLLEIITGK 572
+S+ D+++ G ++ E+ T +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 10/202 (4%)
Query: 372 NFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLS---TTSGQGIEEFKNEVLLIAKLQHR 427
NF K+G+G F VY+ L + + +A+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI-FDESRKQLLDWKKRFDIILGIARGVLYL 486
N++K L +E +E ++ E L I + + +K+L+ + + + + V ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
H SR R++HRD+K +N+ + ++ D G R F + +T + +VGT YMSPE
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPER 177
Query: 547 ALGGLFSTKSDVFSFGVLLLEI 568
++ KSD++S G LL E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 27/209 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
+++ ++G G +G VYK + +A G+ +A+K + G E + E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR----GVLY 485
V G L +D+ ++ E+ SL I+ +R L + I + R G+ Y
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSE-----LQIAYVCRETLKGLAY 116
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT----NRVVGTYGY 541
LH+ IHRD+K +NILL E+ + +++DFG + T T +GT +
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGTPYW 167
Query: 542 MSPEYA---LGGLFSTKSDVFSFGVLLLE 567
M+PE A G + K D+++ G+ +E
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 57/202 (28%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 373 FSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQG-IEEFKNEVLLIAKLQHRNLV 430
F+ ++G+G FG V+KG Q++ A+K + + IE+ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
K G L+ + +I E++ S D R D + ++ I +G+ YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG 550
+ IHRD+KA+N+LL E+ + +++DFG A +I NT VGT +M+PE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176
Query: 551 LFSTKSDVFSFGVLLLEIITGK 572
+ +K+D++S G+ +E+ G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 58/215 (26%), Positives = 114/215 (53%), Gaps = 13/215 (6%)
Query: 362 ELSTVLAATD---NFSTSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQGIEEFKNE 417
+L ++++ D ++ K+GQG G VY +A GQE+A+K+++ E NE
Sbjct: 7 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINE 66
Query: 418 VLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL 477
+L++ + ++ N+V L L DE ++ E++ SL D + +D + +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVG 537
+ + +LH + ++IHRD+K+ NILL + + +++DFG E+ +T +VG
Sbjct: 123 ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
T +M+PE + K D++S G++ +E++ G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 69/225 (30%), Positives = 116/225 (51%), Gaps = 30/225 (13%)
Query: 379 LGQGGFGPVYKGKLANGQEI---AVK--RLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
LG+G FG V +G+L I AVK +++ + +E+F +E + + + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 434 GCCLEKDEK------MLIYEFMPNKSLDYFIFDESR----KQLLDWKKRFDIILGIARGV 483
G CL+ E ++I FM + L F+ SR Q L + + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG-TARVFGGEEISTNTNRVVGT-YGY 541
YL S IHRDL A N +L+E MN ++DFG + +++ G+ R+ +
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD--YYRQGRIAKMPVKW 180
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEIIT-------GKKNTGIFN 579
++ E +++TKSDV+SFGV + EI T G +N+ I++
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD 225
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 65/202 (32%), Positives = 107/202 (52%), Gaps = 20/202 (9%)
Query: 379 LGQGGFGPVYKGKLANGQE-----IAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
LG G FG VYKG E +A+K L TS + +E +E ++A + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 433 LGCCLEKDEKMLIYEFMPNKSL-DYFIFDESR---KQLLDWKKRFDIILGIARGVLYLHQ 488
LG CL + L+ + MP L DY ++ R + LL+W + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLEE 127
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL 548
+R++HRDL A N+L+ + +I+DFG AR+ +E + + +M+ E L
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 549 GGLFSTKSDVFSFGVLLLEIIT 570
F+ +SDV+S+GV + E++T
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 37/210 (17%)
Query: 378 KLGQGGFGPVY--KGKLANGQEIAVKRLSTTSGQGIEEFK-NEVL-------LIAKLQHR 427
+LG+G FG VY K K A +E RL + E NE + L++KL H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEE----RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRK--------QLLDWKKRFDIILGI 479
+VK LE+D +I E+ + LD +E + Q+ +W + +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLD-CKLEELKHTGKTLSENQVCEW------FIQL 115
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE-EISTNTNRVVGT 538
GV Y+HQ RI+HRDLKA NI L + +I DFG +R+ G +++T GT
Sbjct: 116 LLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT---FTGT 168
Query: 539 YGYMSPEYALGGLFSTKSDVFSFGVLLLEI 568
YMSPE + +KSD++S G +L E+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 373 FSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQG-IEEFKNEVLLIAKLQHRNLV 430
F+ K+G+G FG V+KG Q++ A+K + + IE+ + E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
K G L+ + +I E++ S D LD + I+ I +G+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG 550
+ IHRD+KA+N+LL E +++DFG A +I N VGT +M+PE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQS 176
Query: 551 LFSTKSDVFSFGVLLLEIITGK 572
+ +K+D++S G+ +E+ G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.2 bits (210), Expect = 4e-18
Identities = 57/215 (26%), Positives = 114/215 (53%), Gaps = 13/215 (6%)
Query: 362 ELSTVLAATD---NFSTSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQGIEEFKNE 417
+L ++++ D ++ K+GQG G VY +A GQE+A+++++ E NE
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 418 VLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL 477
+L++ + ++ N+V L L DE ++ E++ SL D + +D + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 123
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVG 537
+ + +LH + ++IHRD+K+ NILL + + +++DFG E+ + + +VG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVG 178
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
T +M+PE + K D++S G++ +E+I G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 378 KLGQGGFGPVYKGKLAN---GQEIAVKRL--STTSGQGIEEFK-NEVLLIAKLQHRNLVK 431
+G+G +G VYK K N G+E A+K+ GI + E+ L+ +L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFIFD---------ESRKQLLDWKKRFDIILGIARG 482
L+ LE +K + F DY D ++++ + ++ I G
Sbjct: 67 LVEVFLEHADKSVYLLF------DYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPR----ISDFGTARVFGGE-EISTNTNRVVG 537
V YLH + ++HRDLK +NIL+ E R I D G AR+F + + + VV
Sbjct: 121 VHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 538 TYGYMSPEYALGGLFSTKS-DVFSFGVLLLEIIT 570
T Y +PE LG TK+ D+++ G + E++T
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 43/281 (15%)
Query: 379 LGQGGFGPVYKG--KLANGQEI--AVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
+G G FG V +G KL +EI A+K L S + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRK----QLLDWKKRFDIILGIARGVLYLHQD 489
G + M+I EFM N +LD F+ + QL+ ++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG------MLRGIAAGMKYL--- 122
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG-----YMSP 544
S + +HRDL A NIL++ + ++SDFG +R E+ +++ G + +P
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD--KALEIV 602
E F++ SDV+S+G+++ E+++ + + R W++ + D A+E
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS-------YGE------RPYWDMSNQDVINAIE-Q 226
Query: 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643
D + P AL Q+ L C Q RP +V L
Sbjct: 227 DYRLPPPMDCPTALH--QLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 379 LGQGGFGPVYKGKLANG---QEIAVKRLSTTSGQGIE-EFKNEVLLIAKL-QHRNLVKLL 433
+G+G FG V K ++ + A+KR+ + + +F E+ ++ KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 434 GCCLEKDEKMLIYEFMPNKSL-DY------------FIFDESRKQLLDWKKRFDIILGIA 480
G C + L E+ P+ +L D+ F S L ++ +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
RG+ YL Q + IHRDL A NIL+ E +I+DFG +R G+E+
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 188
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M+ E +++T SDV+S+GVLL EI++
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 9e-18
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 29/226 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQE-----------------IAVKRLSTTSGQGIE- 412
+ KLG+G FG V+ + ++ +AVK L + +
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 413 EFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFD-ESRKQLLDWKK 471
+F E+ ++++L+ N+++LL C+ D +I E+M N L+ F+ E ++
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 472 RF-------DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524
+ IA G+ YL S L +HRDL N L+ + +I+DFG +R
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+ R V +MS E L G F+T SDV++FGV L EI+T
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN----EVLLIAKLQ 425
+ + +G+G +G V K + A G+ +A+K+ + E+ K EV ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLR 58
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
H N+V L K L++E++ L+ E+ L I + + + Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE 545
H IIHRD+K NIL+ E ++ DFG AR S T+ V T Y +PE
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPE 171
Query: 546 YALGGLFSTKS-DVFSFGVLLLEIITG 571
+G K DV++ G ++ E++ G
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 61/193 (31%), Positives = 101/193 (52%), Gaps = 9/193 (4%)
Query: 378 KLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIE-EFKNEVLLIAKLQHRNLVKLLGC 435
++G+G FG V+ G+L A+ +AVK T ++ +F E ++ + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 436 CLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 495
C +K ++ E + + D+ F + L K+ ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 496 HRDLKASNILLDEEMNPRISDFGTARV-FGGEEISTNTNRVVGTYGYMSPEYALGGLFST 554
HRDL A N L+ E+ +ISDFG +R G ST + + + +PE G +S+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI-PVKWTAPEALNYGRYSS 175
Query: 555 KSDVFSFGVLLLE 567
+SDV+SFG+LL E
Sbjct: 176 ESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 68/231 (29%), Positives = 110/231 (47%), Gaps = 51/231 (22%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFK----NEVLLIAKLQ 425
D F ++G+G +G VYK + G+ +A+K++ + + E F E+ ++ +L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLN 64
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFD----------ESR------------ 463
HRN+V L +K + + +F +K Y +F+ ES
Sbjct: 65 HRNIVNLKEIVTDKQDAL---DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121
Query: 464 -KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522
KQLL+ G+ Y H+ + L HRD+K SNILL+ + +++DFG AR+
Sbjct: 122 MKQLLE-------------GLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARL 165
Query: 523 FGGEEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
+ EE TN+V+ T Y PE LG + DV+S G +L E+ T K
Sbjct: 166 YNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 71/278 (25%), Positives = 132/278 (47%), Gaps = 20/278 (7%)
Query: 377 NKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGC 435
N + +G G YKGK + NG + VK ++ + I +E+ + KLQH N+VKL+G
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPS--SEIADMGKLQHPNIVKLIGL 751
Query: 436 CLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 495
C + LI+E++ K+L + + L W++R I +GIA+ + +LH ++
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 496 HRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTK 555
+L I++D + P + R+ + T+T + + Y++PE + K
Sbjct: 806 VGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS-AYVAPETRETKDITEK 858
Query: 556 SDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD--SCPAP 613
SD++ FG++L+E++TGK +++ + +SD +D S+ S
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918
Query: 614 EALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPS 651
E + + + L C T RP + V+ L + + S
Sbjct: 919 EIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956
|
Length = 968 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 69/228 (30%), Positives = 116/228 (50%), Gaps = 36/228 (15%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQE---------IAVKRLS-TTSGQGIEEFKNEVLL 420
D LG+G FG V + + A G + +AVK L + + + + +E+ L
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMEL 70
Query: 421 IAKL-QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI-----------FD--ESRKQL 466
+ + +H+N++ LLG C ++ +I E+ +L F+ FD + ++
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 467 LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526
L +K +ARG+ YL +SR R IHRDL A N+L+ E+ +I+DFG AR G
Sbjct: 131 LSFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR--GVH 185
Query: 527 EI----STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+I T+ R+ +M+PE +++ +SDV+SFG+L+ EI T
Sbjct: 186 DIDYYKKTSNGRL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 60/198 (30%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 379 LGQGGFGPVYKGK-LANGQEI----AVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKL 432
LG G FG V+KG + G I A+K + SG Q +E + +L + L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 492
LG C L+ + P SL + + LD ++ + + IA+G+ YL +
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 493 RIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLF 552
R++HR+L A NILL + +I+DFG A + ++ + +M+ E L G +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 553 STKSDVFSFGVLLLEIIT 570
+ +SDV+S+GV + E+++
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 371 DNFSTSNKLGQGGFGPVYK------GKLANGQEIAVKRL-STTSGQGIEEFKNEVLLIAK 423
+N S LG G FG V + K ++AVK L T E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 424 L-QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 482
L H N+V LLG C ++I E+ L F+ R+ L + +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVG----- 537
+ +L + IHRDL A N+LL +I DFG AR +I ++N VV
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARL 205
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M+PE +++ +SDV+S+G+LL EI +
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 78/276 (28%), Positives = 120/276 (43%), Gaps = 42/276 (15%)
Query: 317 RIGERQRQRRRELLFLNSSTRLSDREAS---------TSAKRNKDTGNVDVTFFELSTVL 367
R + R RRR L L L R+ S S+ + + + +
Sbjct: 17 RHTTKSRPRRRPDLTLP----LPQRDPSLAVPLPLPPPSSSSSSSSSSSASG-----SAP 67
Query: 368 AATDNFST---SNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIE-EFKNEVLLIA 422
+A + S N++G G G VYK G+ A+K + + + E+ ++
Sbjct: 68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR 127
Query: 423 KLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLD-YFIFDESRKQLLDWKKRFDIILGIAR 481
+ H N+VK E ++ EFM SL+ I DE + L D ++ I+ GIA
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE--QFLADVARQ--ILSGIA- 182
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGY 541
YLH R I+HRD+K SN+L++ N +I+DFG +R+ + N VGT Y
Sbjct: 183 ---YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAY 234
Query: 542 MSPEYALGGLFSTK-----SDVFSFGVLLLEIITGK 572
MSPE L D++S GV +LE G+
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 70/231 (30%), Positives = 104/231 (45%), Gaps = 60/231 (25%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTS-GQG-----IEEFKNEVLLIAK 423
D + N++ +G +G VY+ + G+ +A+K+L +G + E +LL K
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI--NILL--K 60
Query: 424 LQHRNLVKL----LGC----------CLEKDEKMLIYEFMPN-------KSLDYFIFDES 462
LQH N+V + +G +E D K L+ E M K L
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQPFLQSEVKCL-------- 111
Query: 463 RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522
QLL GV +LH + I+HRDLK SN+LL+ +I DFG AR
Sbjct: 112 MLQLL-------------SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLARE 155
Query: 523 FGGEEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGK 572
+ G + T VV T Y +PE LG +ST D++S G + E++T K
Sbjct: 156 Y-GSPLKPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 73/273 (26%), Positives = 127/273 (46%), Gaps = 22/273 (8%)
Query: 372 NFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLST---TSGQGIEEFKNEVLLIAKLQHR 427
NF K+G+G F VY+ L +G +A+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFD-ESRKQLLDWKKRFDIILGIARGVLYL 486
N++K +E +E ++ E L I + +K+L+ K + + + + ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
H SR R++HRD+K +N+ + ++ D G R F + +T + +VGT YMSPE
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPER 177
Query: 547 ALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606
++ KSD++S G LL E+ + F D N L+S K +E D
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMN-------LYSLCKKIEQCDYPP 227
Query: 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTV 639
S E LR Q+ +C+ RP ++ V
Sbjct: 228 LPSDHYSEELR--QLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 378 KLGQGGFGPVYKGKLAN-GQEIAVKR-LSTTSGQGIEEFK-NEVLLIAKLQHRNLVKLLG 434
+G+G +G V K K GQ +A+K+ L + + +++ E+ ++ +L+H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 494
K L++EF+ + LD E LD + + I RG+ + H + I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHN---I 121
Query: 495 IHRDLKASNILLDEEMNPRISDFGTAR-VFGGEEISTNTNRVVGTYGYMSPEYALGGLFS 553
IHRD+K NIL+ + ++ DFG AR + E+ T+ V T Y +PE +G
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPELLVGDTKY 178
Query: 554 TKS-DVFSFGVLLLEIITG 571
++ D+++ G L+ E++TG
Sbjct: 179 GRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 379 LGQGGFGPV------YKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
LG+GGFG V GK+ +++ KRL SG+ + + E+L K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 492
K L+ M L Y I++ + L + ++ I G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---M 114
Query: 493 RIIHRDLKASNILLDEEMNPRISDFGTA-RVFGGEEISTNTNRVVGTYGYMSPEYALGGL 551
I++RD+K N+LLD++ N R+SD G A + G+ I+ GT GYM+PE
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA----GTNGYMAPEILKEEP 170
Query: 552 FSTKSDVFSFGVLLLEIITGK 572
+S D F+ G + E++ G+
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 50/224 (22%)
Query: 376 SNKLGQGGFGPVYKGK-LANGQEIAVKRL---STTSGQGIEEFKNEVLLIAKLQHRNLVK 431
K+GQG FG V+K + Q +A+K++ + G I + E+ ++ L+H N+V
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN 75
Query: 432 LLGCCLEKDEK--------MLIYEF--------MPNKSLDYFIFDESR-----KQLLDWK 470
L+ C K L++EF + NK++ F S K LL+
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIKKVMKMLLN-- 130
Query: 471 KRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530
G+ Y+H R +I+HRD+KA+NIL+ ++ +++DFG AR F + S
Sbjct: 131 -----------GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
Query: 531 N---TNRVVGTYGYMSPEYALGGL-FSTKSDVFSFGVLLLEIIT 570
TNRVV T Y PE LG + D++ G ++ E+ T
Sbjct: 177 PNRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 67/219 (30%), Positives = 112/219 (51%), Gaps = 38/219 (17%)
Query: 372 NFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHR 427
F N++G+G +G VY+ + +G+ +A+K++ + G I + E+ L+ L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 428 NLVKLLGCCLEK--DEKMLIYEF-----------MPNKSLDYFIFDESRKQLLDWKKRFD 474
N+V+L + K D L+ E+ MP F ES+ +
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP------FSESQVKC-------- 112
Query: 475 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR 534
++L + RG+ YLH++ IIHRDLK SN+LL ++ +I+DFG AR +G T +
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TPK 168
Query: 535 VVGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLEIITGK 572
VV T Y +PE LG T + D+++ G +L E++ K
Sbjct: 169 VV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 55/195 (28%), Positives = 99/195 (50%), Gaps = 12/195 (6%)
Query: 378 KLGQGGFGPVYKGKLANGQEI-AVKRLSTTS-GQGIEEFK-NEVLLIAKLQHRNLVKLLG 434
K+G+G +G V+K K EI A+KR+ +G+ E+ L+ +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 494
+ L++E+ YF +S +D + + + +G+ + H +
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 495 IHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG-LFS 553
+HRDLK N+L+++ +++DFG AR F G + + VV T Y P+ G L+S
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 178
Query: 554 TKSDVFSFGVLLLEI 568
T D++S G + E+
Sbjct: 179 TSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 39/228 (17%)
Query: 379 LGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQG---IEEFKNEVLLIAKLQHRNLVKLLG 434
+ +G +G V+ K + G A+K + +++ E ++++ Q +VKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 435 CCLEKDEKM-LIYEFMPN---KSL--DYFIFDESRKQLLDWKKRF--DIILGIARGVLYL 486
+ + + L+ E++P SL + DE D + + +I+L + YL
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVARIYIAEIVLALE----YL 109
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFG------TARVFGGEEISTNTNRVVGTYG 540
H IIHRDLK NIL+D + +++DFG R + R+VGT
Sbjct: 110 HS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGI--FNDDSSNLI 586
Y++PE LG S D +S G +L E + GI F+ ++ I
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFL-----VGIPPFHGETPEEI 209
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 51/221 (23%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN---------EVLLIAKLQHRN 428
+G G +G V G+++A+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLRHLRHEN 60
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLD----YFIFD----------ESRKQLLDWKKRFD 474
++ LL I P D Y + + +S + L D ++
Sbjct: 61 IIGLL----------DI--LRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY- 107
Query: 475 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN--T 532
+ I RG+ YLH +IHRDLK SNIL++ + +I DFG AR +E T
Sbjct: 108 FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 533 NRVVGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLEIITGK 572
VV T Y +PE L TK+ D++S G + E++T K
Sbjct: 165 EYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 57/197 (28%), Positives = 105/197 (53%), Gaps = 12/197 (6%)
Query: 378 KLGQGGFGPV-YKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCC 436
K+G+G G V + G+++AVK++ Q E NEV+++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 437 LEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 496
L DE ++ EF+ +L D ++ ++ + L + R + YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 497 RDLKASNILLDEEMNPRISDFG-TARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTK 555
RD+K+ +ILL + ++SDFG A+V +E+ + +VGT +M+PE + T+
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRKS-LVGTPYWMAPEVISRLPYGTE 198
Query: 556 SDVFSFGVLLLEIITGK 572
D++S G++++E+I G+
Sbjct: 199 VDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 70/229 (30%), Positives = 108/229 (47%), Gaps = 22/229 (9%)
Query: 379 LGQGGFGPV------YKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
LG+GGFG V GK+ +++ KR+ G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 492
KD L+ M L + I+ + + F I G+ LHQ+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDLHQE--- 121
Query: 493 RIIHRDLKASNILLDEEMNPRISDFGTA-RVFGGEEISTNTNRVVGTYGYMSPEYALGGL 551
RI++RDLK NILLD+ + RISD G A V G+ I VGT GYM+PE
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER 177
Query: 552 FSTKSDVFSFGVLLLEIITG-----KKNTGIFNDDSSNLIRYVWELWSD 595
++ D ++ G LL E+I G ++ I ++ L++ V E +S+
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 56/196 (28%), Positives = 103/196 (52%), Gaps = 13/196 (6%)
Query: 378 KLGQGGFGPVYKG--KLANGQ-EIAVKRLSTTSGQGI-EEFKNEVLLIAKLQHRNLVKLL 433
+LG G FG V KG K+ Q ++A+K L + + + +E E ++ +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493
G C E + ML+ E L+ F+ +K + +++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY--GYMSPEYALGGL 551
+HRDL A N+LL + +ISDFG ++ G ++ S R G + + +PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRK 174
Query: 552 FSTKSDVFSFGVLLLE 567
FS++SDV+S+G+ + E
Sbjct: 175 FSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 26/225 (11%)
Query: 369 ATDNFSTSNKLGQGGFGPVY--------KGKLANGQEIAVKRL-STTSGQGIEEFKNEVL 419
D LG+G FG V K K ++AVK L S + + + + +E+
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 420 LIAKL-QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIF-------------DESRKQ 465
++ + +H+N++ LLG C + +I E+ +L ++ + ++
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 466 LLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525
L +K +ARG+ YL + + IHRDL A N+L+ E+ +I+DFG AR
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 192
Query: 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+ T +M+PE +++ +SDV+SFGVLL EI T
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 48/221 (21%)
Query: 377 NKLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQGIEEFKN---------EVLLIAKL-Q 425
KLG+G +G V+K + +A+K++ + F+N E++ + +L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGD 65
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFD--ES------RKQLL-DWKKRFDII 476
H N+VKLL + + +K + Y +F+ E+ R +L D KR+ I+
Sbjct: 66 HPNIVKLLN----------VIKAENDKDI-YLVFEYMETDLHAVIRANILEDVHKRY-IM 113
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV- 535
+ + + Y+H S +IHRDLK SNILL+ + +++DFG AR E + N V
Sbjct: 114 YQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN-PENPVL 169
Query: 536 ---VGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLEIITGK 572
V T Y +PE LG TK D++S G +L E++ GK
Sbjct: 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 379 LGQGGFGPVYKG---KLANGQEIAVKRLST-TSGQGIEEFKNEVLLIAKL-QHRNLVKLL 433
+G+G FG V + K A+K L S +F E+ ++ KL H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 434 GCCLEKDEKMLIYEFMPNKSL-DY------------FIFDESRKQLLDWKKRFDIILGIA 480
G C + + E+ P +L D+ F + L ++ +A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
G+ YL S + IHRDL A N+L+ E + +I+DFG +R GEE+
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLPVR 183
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M+ E +++TKSDV+SFGVLL EI++
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 378 KLGQGGFGPVYKG--KLANGQEI--AVKRLSTTSGQGI-EEFKNEVLLIAKLQHRNLVKL 432
+G+G FG VY+G ++I AVK + + E+F E ++ + H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 492
+G ++ ++ E P L ++ + K LD ++ + YL
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 493 RIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLF 552
R +HRD+ A N+L+ ++ DFG +R E + + +M+PE F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS-KGKLPIKWMAPESINFRRF 185
Query: 553 STKSDVFSFGVLLLEIIT-GKK 573
++ SDV+ FGV + EI+ G K
Sbjct: 186 TSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-16
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 373 FSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLVK 431
F +G G +G VYKG+ ++A ++ +G EE K E+ ++ K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 432 LLGCCLEK------DEKMLIYEFMPNKSLDYFIFDESRKQLL-DWKKRFDIILGIARGVL 484
G ++K D+ L+ EF S+ I + L +W I I RG+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLS 125
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
+LHQ ++IHRD+K N+LL E ++ DFG + + N +GT +M+P
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAP 180
Query: 545 EYAL-----GGLFSTKSDVFSFGVLLLEIITG 571
E + KSD++S G+ +E+ G
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 68/208 (32%), Positives = 95/208 (45%), Gaps = 31/208 (14%)
Query: 379 LGQGGFGPV------YKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
LG+GGFG V GK+ +++ KR+ G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFI-------FDESRKQLLDWKKRFDIILGIARGVLY 485
KD L+ M L + I FDE R + I G+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE--------ITCGLED 117
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA-RVFGGEEISTNTNRVVGTYGYMSP 544
LH R RI++RDLK NILLD+ + RISD G A + GE I VGT GYM+P
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAP 170
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITGK 572
E ++ D + G L+ E+I GK
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 377 NKLGQGGFGPVYKGKLA-NGQEIAVK--RLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
+KLG+G + VYKG+ +A+K RL G + EV L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493
+ L++E++ +K L ++ D + K F + + RG+ Y H R +
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRK 124
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT--NRVVGTYGYMSPEYALGGL 551
++HRDLK N+L++E +++DFG AR + I T T N VV T Y P+ LG
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVV-TLWYRPPDILLGST 180
Query: 552 -FSTKSDVFSFGVLLLEIITGK 572
+ST+ D++ G + E+ TG+
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 41/218 (18%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLSTT----SGQGIEEFKNEVLLIAKLQ 425
D+F LG G FG V + + A+K LS Q +E NE ++ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 426 HRNLVKLLGCCLEKDEKML--IYEFMPNKSLDYFIFDESRKQLLDWKKRFD--------- 474
H LV L G +D+ L + E++P L F RK RF
Sbjct: 60 HPFLVNLYGS--FQDDSNLYLVMEYVPGGEL----FSHLRK-----SGRFPEPVARFYAA 108
Query: 475 -IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTN 533
++L + YLH L I++RDLK N+LLD + +I+DFG A+ + T
Sbjct: 109 QVVLALE----YLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKR-----VKGRTY 156
Query: 534 RVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITG 571
+ GT Y++PE L + D ++ G+L+ E++ G
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 76/279 (27%), Positives = 127/279 (45%), Gaps = 41/279 (14%)
Query: 379 LGQGGFGPVYKG--KLANGQE--IAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
LG G FG + +G KL + +E +A+ L + S + F E L + + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQ--LLDWKKRFDIILGIARGVLYLHQDSR 491
G + M++ E+M N +LD F+ RK L + ++ G+A G+ YL S
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQLMGMLPGLASGMKYL---SE 125
Query: 492 LRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGL 551
+ +H+ L A +L++ ++ +IS F + E I T T + +PE
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT-TMSGKSPVLWAAPEAIQYHH 184
Query: 552 FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD--KALEIVDSSMADS 609
FS+ SDV+SFG+++ E+++ + R W++ D KA+E D
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGE-------------RPYWDMSGQDVIKAVE-------DG 224
Query: 610 CPAPEALRCI----QVGLLCVQDRTTDRPSMSTVVFMLS 644
P C Q+ L C Q +RP S + +LS
Sbjct: 225 FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 371 DNFSTSNKLGQGGFGPVY--------KGKLANGQEIAVKRLS-TTSGQGIEEFKNEVLLI 421
D + LG+G FG V K K +AVK L + + + + +E+ ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 422 AKL-QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI-----------FDESR--KQLL 467
+ +H+N++ LLG C + +I E+ +L ++ +D +R + +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 468 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527
+K +ARG+ YL + + IHRDL A N+L+ E +I+DFG AR +
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
T +M+PE +++ +SDV+SFGVL+ EI T
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 19/208 (9%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVK--RLSTTSGQGIEEFKNEVLLIAKLQHR 427
D++ KLG+G + VYKGK NG+ +A+K RL G + E L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLL-DWKKRFDIILGIARGVLYL 486
N+V L K+ L++E++ Y D+ L + K F + + RG+ Y+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLF--LFQLLRGLSYI 119
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT--NRVVGTYGYMSP 544
HQ I+HRDLK N+L+ + +++DFG AR + + ++T N VV T Y P
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVV-TLWYRPP 172
Query: 545 EYALGGL-FSTKSDVFSFGVLLLEIITG 571
+ LG +ST D++ G + +E+I G
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 55/199 (27%), Positives = 108/199 (54%), Gaps = 16/199 (8%)
Query: 378 KLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCC 436
K+G+G G V + +G+++AVK + Q E NEV+++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 437 LEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 496
L +E ++ EF+ +L I ++R L+ ++ + + + + YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALTD-IVSQTR---LNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 497 RDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR---VVGTYGYMSPEYALGGLFS 553
RD+K+ +ILL + ++SDFG +IS + + +VGT +M+PE +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFC-----AQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 554 TKSDVFSFGVLLLEIITGK 572
T+ D++S G++++E++ G+
Sbjct: 196 TEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 379 LGQGGFGPVYKGKLAN-GQEIAVKRL-STTSGQGIEEFKNEVLLIAKLQH-RNLVKLLGC 435
+G+G FG V K G +AVKR+ ST + + ++ ++ + +VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 436 CLEKDEKMLIYEFMPNKSLD--YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493
+ + + E M + SLD Y E K ++ + I + + + YL ++ L+
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LK 128
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGL-- 551
IIHRD+K SNILLD N ++ DFG + G S R G YM+PE
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPERIDPSARD 185
Query: 552 -FSTKSDVFSFGVLLLEIITGK 572
+ +SDV+S G+ L E+ TGK
Sbjct: 186 GYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKR-LSTTSGQGIEEFK-NEVLLIAKLQHR 427
D + K+G+G +G VYK + G+ +A+K+ +GI E+ L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 428 N-LVKLLGC--CLEKDEKMLIY---EFMPNKSLDYFIFDESRK--QLLDWKKRFDIILGI 479
+V+LL EK+ K +Y E++ + L F+ R + L K + +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP-RISDFGTARVFGGEEISTNTNRVVGT 538
+GV + H + ++HRDLK N+L+D++ +I+D G R F + + T+ +V T
Sbjct: 120 LKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-T 174
Query: 539 YGYMSPEYALGGL-FSTKSDVFSFGVLLLEIITGKKNTGIFNDDS 582
Y +PE LG +ST D++S G + E+ +F DS
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK---QPLFPGDS 216
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 56/206 (27%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
DNF K+G+G G V + ++G+ +AVK++ Q E NEV+++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
V++ L DE ++ EF+ +L D ++ ++ + L + + + LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR---VVGTYGYMSPEY 546
+IHRD+K+ +ILL + ++SDFG ++S R +VGT +M+PE
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMAPEL 187
Query: 547 ALGGLFSTKSDVFSFGVLLLEIITGK 572
+ + D++S G++++E++ G+
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 379 LGQGGFGPVY--------KGKLANGQEIAVKRLST-TSGQGIEEFKNEVLLIAKL-QHRN 428
LG+G FG V K K +AVK L + + + + +E+ ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFI-----------FDESR--KQLLDWKKRFDI 475
++ LLG C + ++ E+ +L ++ FD + ++ L +K
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 476 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV 535
+ARG+ YL + + IHRDL A N+L+ E+ +I+DFG AR + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 536 VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M+PE +++ +SDV+SFGVLL EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 42/224 (18%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHR-- 427
D+ +LG+G +G V K + + G +AVKR+ T +E K +L+ + R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQK-RLLMDLDISMRSV 57
Query: 428 ---NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILG 478
V G + + + E M + SLD F K++ D I +
Sbjct: 58 DCPYTVTFYGALFREGDVWICMEVM-DTSLDKFY-----KKVYDKGLTIPEDILGKIAVS 111
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN-TNRVV- 536
I + + YLH S+L +IHRD+K SN+L++ ++ DFG IS + V
Sbjct: 112 IVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFG---------ISGYLVDSVAK 160
Query: 537 ----GTYGYMSPEYALGGL----FSTKSDVFSFGVLLLEIITGK 572
G YM+PE L + KSDV+S G+ ++E+ TG+
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 373 FSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQGIEEFK---NEVLLIAKLQHRN 428
F ++GQGG+G V+ K + EI A+KR+ + + E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
LVKLL + + L E++P D+ + L + RF + V LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH- 118
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL 548
L IHRDLK N L+D + +++DFG ++ I T N VVG+ YM+PE
Sbjct: 119 --ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLR 171
Query: 549 GGLFSTKSDVFSFGVLLLEIITG 571
G + D +S G +L E + G
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 46/132 (34%), Positives = 71/132 (53%), Gaps = 21/132 (15%)
Query: 447 EFMPNKSLDYFIFDESRKQLLDWKKRF-DIILG-----IARGVLYLHQDSRLRIIHRDLK 500
E M SLD Q+L R + ILG + RG+ YL + + +I+HRD+K
Sbjct: 79 EHMDGGSLD---------QVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVK 127
Query: 501 ASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFS 560
SNIL++ ++ DFG + G+ I + N VGT YMSPE G ++ +SD++S
Sbjct: 128 PSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWS 183
Query: 561 FGVLLLEIITGK 572
G+ L+E+ G+
Sbjct: 184 LGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 47/214 (21%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCC 436
+LG G FG VYK + G A K + T S + +E++ E+ ++A H N+VKLL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 437 LEKDEKMLIYEFMPNKSLDYFIFDESR-----------KQLLDWKKRFDIILGIARGVLY 485
++ ++ EF ++D + + R KQ L+ + Y
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE-------------ALNY 118
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV------VGTY 539
LH++ +IIHRDLKA NIL + + +++DFG + + NT + +GT
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTP 167
Query: 540 GYMSPEYALGGL-----FSTKSDVFSFGVLLLEI 568
+M+PE + + K+DV+S G+ L+E+
Sbjct: 168 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 41/213 (19%)
Query: 379 LGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKN---EVLLIAKLQHRNLVKLLG 434
+G G +G V G+++A+K+LS Q K E+ L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 435 CCLEKDEKMLIYEFMPNKSLDYF--------IFDES------RKQLLDWKKRFDIILGIA 480
F P SL+ F + ++L D +F ++ I
Sbjct: 82 V------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQIL 128
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
RG+ Y+H IIHRDLK SNI ++E+ +I DFG AR V T
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRW 180
Query: 541 YMSPEYALGGLFSTKS-DVFSFGVLLLEIITGK 572
Y +PE L + ++ D++S G ++ E++TGK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 39/211 (18%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVK--RLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
KLG+G + VYKG+ GQ +A+K RL G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKR-----------FDIILGIARGV 483
K L++E++ D KQ +D F ++ RG+
Sbjct: 71 IIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLL----RGL 116
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT--NRVVGTYGY 541
Y HQ R++HRDLK N+L+ E +++DFG AR + + + T N VV T Y
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVV-TLWY 169
Query: 542 MSPEYALGGL-FSTKSDVFSFGVLLLEIITG 571
P+ LG +ST D++ G + E+ TG
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 74/298 (24%), Positives = 136/298 (45%), Gaps = 40/298 (13%)
Query: 378 KLGQGGFGPVYKG---KLANGQ---EIAVKRLS-TTSGQGIEEFKNEVLLIAKLQHRNLV 430
+LGQG FG VY+G + G+ +AVK ++ + S + EF NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIF-------DESRKQLLDWKKRFDIILGIARGV 483
+LLG + +++ E M + L ++ + + ++ + IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMS 543
YL+ + +HRDL A N ++ + +I DFG R + + + +M+
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 544 PEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIV- 602
PE G+F+T SD++SFGV+L EI ++L ++ S+++ L+ V
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEI--------------TSLAEQPYQGLSNEQVLKFVM 235
Query: 603 DSSMAD---SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSPKQPTF 657
D D +CP R + +C Q RP+ +V +L ++ PS + +F
Sbjct: 236 DGGYLDQPDNCPE----RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH-PSFPEVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 25/200 (12%)
Query: 381 QGGFGPVYKG-KLANGQEIAVKRLSTTSGQGIEEFKN----EVLLIAKLQHRNLVKLLGC 435
+G FG VY K + G A+K L + + N +++ + + + KL
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 436 CLEKDEKMLIYEFMPNKSLDYFIFDESRKQL----LDWKKRFDIILGIARGVLYLHQDSR 491
KD L+ E++ I K L DW K++ I + GV LHQ
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG- 117
Query: 492 LRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGL 551
IIHRD+K N+L+D+ + +++DFG +R G E + VGT Y++PE LG
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDYLAPETILGVG 169
Query: 552 FSTKSDVFSFGVLLLEIITG 571
SD +S G ++ E + G
Sbjct: 170 DDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 379 LGQGGFGPVYKGKLANG---QEIAVKRLSTTSGQGI-EEFKNEVLLIAKL-QHRNLVKLL 433
+G+G FG V K ++ + A+KR+ + + +F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 434 GCCLEKDEKMLIYEFMPNKSL-DY------------FIFDESRKQLLDWKKRFDIILGIA 480
G C + L E+ P+ +L D+ F S L ++ +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
RG+ YL S+ + IHRDL A NIL+ E +I+DFG +R G+E+
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M+ E +++T SDV+S+GVLL EI++
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 9e-15
Identities = 43/173 (24%), Positives = 80/173 (46%), Gaps = 11/173 (6%)
Query: 417 EVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII 476
E +L+ + H +++++ + ++ +P+ S D + + R + L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
I G+ YLH RIIHRD+K NI +++ I D G A+ ++ +
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYV 589
GT +PE +++K+D++S G++L E++ IF D S YV
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST--IFEDPPSTPEEYV 268
|
Length = 357 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHR--- 427
D+F ++LG G G V K + I ++L + +N+++ ++ H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62
Query: 428 -NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF-DIILG-----IA 480
+V G E + E M SLD Q+L KR + ILG +
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLD---------QVLKEAKRIPEEILGKVSIAVL 113
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
RG+ YL + + +I+HRD+K SNIL++ ++ DFG + G+ I + N VGT
Sbjct: 114 RGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRS 167
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
YMSPE G +S +SD++S G+ L+E+ G+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 379 LGQGGFGPV------YKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
LG+GGFG V GK+ + + KR+ G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 492
KD L+ M L + I++ + + F I G+ LH+++
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF-YAAEILCGLEDLHREN-- 122
Query: 493 RIIHRDLKASNILLDEEMNPRISDFGTA-RVFGGEEISTNTNRVVGTYGYMSPEYALGGL 551
++RDLK NILLD+ + RISD G A ++ GE I VGT GYM+PE
Sbjct: 123 -TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNNQR 177
Query: 552 FSTKSDVFSFGVLLLEIITGK 572
++ D + G L+ E+I G+
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 50/211 (23%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQH 426
D+ +G G FG V+ + + A+K ++ + + NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 427 RNLVKLLGCCLEKDEKML--IYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIAR 481
+++L E D++ L + E++P L F + + + + F +I+ +
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASEIVCALE- 115
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGY 541
YLH I++RDLK NILLD+E + +++DFG A+ ++ T + GT Y
Sbjct: 116 ---YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEY 164
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
++PE + D ++ G+L+ E++ G
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 378 KLGQGGFGPVYKGK-LANGQE-IAVKRLST-TSGQGIE-EFKNEVLLIAKLQ---HRNLV 430
++G+G +G V+K + L NG +A+KR+ T +G+ EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 431 KLLGCCL----EKDEKM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
+L C +++ K+ L++E + Y D+ + + + D++ + RG+ +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE 545
LH R++HRDLK NIL+ +++DFG AR++ + T+ VV T Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVVTLWYRAPE 179
Query: 546 YALGGLFSTKSDVFSFGVLLLEI 568
L ++T D++S G + E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQ-GIE-EFKNEVLLIAKLQ---HRNLVK 431
++G G +G VYK + +G +A+K + + + G+ EV L+ +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 432 LLGCC--LEKDEKM---LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
L+ C D + L++E + Y D+ L + D++ RG+ +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
H + I+HRDLK NIL+ +++DFG AR++ + T VV T Y +PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP---VVVTLWYRAPEV 178
Query: 547 ALGGLFSTKSDVFSFGVLLLEIITGK 572
L ++T D++S G + E+ K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 378 KLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQGIEEFK--NEVLLIAKLQHRNLVKLLG 434
KLG+G + VYKG NGQ +A+K +S + +G+ F E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 494
K+ ++E+M Y I + L + R + + RG+ Y+H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMI--QHPGGLHPYNVRL-FMFQLLRGLAYIH---GQHI 124
Query: 495 IHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT-NRVVGTYGYMSPEYALGGL-F 552
+HRDLK N+L+ +++DFG AR + I + T + V T Y P+ LG +
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181
Query: 553 STKSDVFSFGVLLLEIITGK 572
S+ D++ G + +E++ G+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 377 NKLGQGGFGPVYKGKLANGQE-IAVK--RLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
KLG+G + V+KG+ + +A+K RL G + EV L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493
L++E++ +K L ++ D + K F + I RG+ Y H R +
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRK 124
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT--NRVVGTYGYMSPEYALGGL 551
++HRDLK N+L++E +++DFG AR + + T T N VV T Y P+ LG
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180
Query: 552 -FSTKSDVFSFGVLLLEIITGK 572
+ST+ D++ G + E+ +G+
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 65/208 (31%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 379 LGQGGFGPV------YKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
LG+GGFG V GK+ +++ KR+ G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFI-------FDESRKQLLDWKKRFDIILGIARGVLY 485
KD L+ M L + I FDE R I A
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA-----------IFYAAELCCG 114
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA-RVFGGEEISTNTNRVVGTYGYMSP 544
L R RI++RDLK NILLD+ + RISD G A ++ GE + VGT GYM+P
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAP 170
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITGK 572
E ++ D + G L+ E+I G+
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 62/201 (30%), Positives = 103/201 (51%), Gaps = 23/201 (11%)
Query: 378 KLGQGGFGPVYKG--KLANGQE-IAVKRLSTTSGQGIEEFKNEVLLIAK----LQHRNLV 430
+LG G FG V KG K+ ++ +AVK L + K+E+L A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
+++G C E + ML+ E L+ F+ + K + + K +++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL--QKNKHVTE-KNITELVHQVSMGMKYLEETN 115
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT----YGYMSPEY 546
+HRDL A N+LL + +ISDFG ++ G +E N + + +PE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPEC 169
Query: 547 ALGGLFSTKSDVFSFGVLLLE 567
FS+KSDV+SFGVL+ E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 51/208 (24%), Positives = 101/208 (48%), Gaps = 32/208 (15%)
Query: 377 NKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN--EVLLIAKLQ-HRNLVKL 432
K+G+G F V K + G+ A+K + + +E+ N E+ + +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 433 LGCCLEKDEK--MLIYEFMPNKSLDYFIFD--ESRKQLLDWKKRFDIILGIARGVLYLHQ 488
+ ++ L++E M D +++ + RK+ L K+ + + + + ++H+
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG-----EEISTNTNRVVGTYGYMS 543
+ I HRD+K NIL+ ++ +++DFG+ R E IST Y +
Sbjct: 119 NG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRW--------YRA 166
Query: 544 PEYAL-GGLFSTKSDVFSFGVLLLEIIT 570
PE L G + K D+++ G + EI++
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHR--- 427
D+F ++LG G G V+K I ++L + +N+++ ++ H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62
Query: 428 -NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESR--KQLLDWKKRFDIILGIARGVL 484
+V G E + E M SLD + R +Q+L + + + +G+
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLT 117
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
YL + + +I+HRD+K SNIL++ ++ DFG + G+ I + N VGT YMSP
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 171
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITGK 572
E G +S +SD++S G+ L+E+ G+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 50/207 (24%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
++F ++G G +G VYK + + G+ A+K + G+ + E++++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLD--YFIFDESRKQLLDWKKRFDIILGIARGVLYLH 487
V G L +D+ + EF SL Y + + + + R + +G+ YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 488 QDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR---VVGTYGYMSP 544
+ +HRD+K +NILL + + +++DFG + +I+ + +GT +M+P
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVS-----AQITATIAKRKSFIGTPYWMAP 175
Query: 545 EYAL---GGLFSTKSDVFSFGVLLLEI 568
E A G ++ D+++ G+ +E+
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 49/231 (21%)
Query: 377 NKLGQGGFGPVYKGK-LANGQEIAVKRL--------STTSGQGIEE----FK--NEVLLI 421
LG+G +G V K G+ +A+K++ T Q + F E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 422 AKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------I 475
+++H N++ L+ +E D L+ + M K+++D K R I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTESQVKCI 124
Query: 476 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN---- 531
+L I G+ LH+ +HRDL +NI ++ + +I+DFG AR +G S
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 532 ---------TNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
T++VV T Y +PE +G + D++S G + E++TGK
Sbjct: 182 ETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 377 NKLGQGGFGPVYKGKLA-NGQEIAVK--RLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
+KLG+G + V+KG+ +A+K RL G + EV L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493
+ L++E++ + Y ++ L+ + + RG+ Y H + +
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT--NRVVGTYGYMSPEYALGGL 551
I+HRDLK N+L++E+ +++DFG AR + + T T N VV T Y P+ LG
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVV-TLWYRPPDVLLGST 179
Query: 552 -FSTKSDVFSFGVLLLEIITGK 572
+ST D++ G +L E+ TG+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 373 FSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLV 430
F +G G +G VYKG+ + GQ A+K + T + EE K E+ ++ K HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76
Query: 431 KLLGCCLEK------DEKMLIYEFMPNKSLDYFIFDESRKQLL-DWKKRFDIILGIARGV 483
G ++K D+ L+ EF S+ + + L DW I I RG+
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMS 543
+LH ++IHRD+K N+LL E ++ DFG + + N +GT +M+
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMA 189
Query: 544 PEYAL-----GGLFSTKSDVFSFGVLLLEIITG 571
PE + +SD++S G+ +E+ G
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 378 KLGQGGFG-PVYKGKLANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
K+G+G FG + +G++ +K ++ + S + EE + EV +++ ++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFIFDE-----SRKQLLDWKKRFDIILGIARGVLYLHQD 489
E ++ ++ L I + Q+LDW + I + ++H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHVHDR 120
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG 549
+I+HRD+K+ NI L ++ ++ DFG ARV T +GT Y+SPE
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICEN 175
Query: 550 GLFSTKSDVFSFGVLLLEIITGK 572
++ KSD+++ G +L E+ T K
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 31/208 (14%)
Query: 379 LGQGGFGPVYKGKLANGQEI-AVKRLS---TTSGQGIEEFKNE--VLLIAKLQHRNLVKL 432
LG+G FG V +L E+ AVK L +E E VL +A +H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQL 61
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVL 484
C KD + E++ L + I FDE R RF +I+LG+
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA-------RFYAAEIVLGL----Q 110
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
+LH+ II+RDLK N+LLD E + +I+DFG + ++T+T GT Y++P
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST--FCGTPDYIAP 165
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITGK 572
E + D ++ GVLL E++ G+
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 20/198 (10%)
Query: 379 LGQGGFGPVYKG-KLANGQEIAVKRLS---TTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
LG G G VYK L + +AVK + T Q ++ +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYIIGFYG 66
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 494
++ + EFM SLD ++ + + +L I + + +G+ YL L+I
Sbjct: 67 AFFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKI 116
Query: 495 IHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFST 554
+HRD+K SN+L++ ++ DFG + + +++ VGT YM+PE G +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 555 KSDVFSFGVLLLEIITGK 572
SDV+S G+ +E+ G+
Sbjct: 173 HSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-14
Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 49/230 (21%)
Query: 378 KLGQGGFGPVYKG-KLANGQEIAVKRL-STTSGQGI--EEFKNEVLLIAKLQHRNLVKLL 433
+G+GG G VY + +A+K++ S + + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLD--WKKR---------------FDII 476
C + D +Y MP +I + K LL W+K I
Sbjct: 69 SICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE-----IS-- 529
I + Y+H S+ ++HRDLK NILL I D+G A EE I
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 530 ---------TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
T ++VGT YM+PE LG S +D+++ GV+L +++T
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 40/212 (18%)
Query: 379 LGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGC-- 435
+G+GGFG VY + A+ G+ A+K L + I+ + E L + + +LV C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 436 --CLE-----KDEKMLIYEFMPNKSLDYF-----IFDESRKQLLDWKKRF---DIILGIA 480
C+ D+ I + M L Y +F E+ + RF +IILG+
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-------EMRFYAAEIILGLE 111
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
H +R +++RDLK +NILLDE + RISD G A F ++ + VGT+G
Sbjct: 112 ------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHG 160
Query: 541 YMSPE-YALGGLFSTKSDVFSFGVLLLEIITG 571
YM+PE G + + +D FS G +L +++ G
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 32/222 (14%)
Query: 363 LSTVLAATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRL----STT--SGQGIEEFK 415
TV T+ + +G G FG V + GQ +A+K++ ST + + E K
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 416 NEVLLIAKLQHRNLVKLLGCCLEKDEKM-LIYEFMPNKSLDYFIFDESR---KQLLDWKK 471
L+ L+H N++ L + E + + E + D SR KQ + +
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQY-- 112
Query: 472 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531
+ I RG+ Y+H ++HRDLK SNIL++E + +I DFG AR+ +
Sbjct: 113 ---FLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQM 162
Query: 532 TNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGK 572
T V Y Y +PE L + + D++S G + E++ GK
Sbjct: 163 TGYVSTRY-YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 51/228 (22%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLS-----TTSGQGIEEFKNEVLLIAKL 424
+ + +G+G +G V G ++A+K++S T + + E K ++ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 425 QHRNLVKLLGCCLEKD-EKM----LIYEFMP-------------NKSLDYFIFDESRKQL 466
+H N++ +L E ++ E M N + YF++ Q+
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY-----QI 115
Query: 467 LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526
L RG+ Y+H + ++HRDLK SN+LL+ + +I DFG AR+ E
Sbjct: 116 L-------------RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159
Query: 527 EISTNT-NRVVGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLEIITGK 572
T V T Y +PE L TK+ D++S G +L E+++ +
Sbjct: 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 41/213 (19%)
Query: 379 LGQGGFGPVYKGKLANGQEI-AVKRLST--------TSGQGIEEFKNEVLLIAKLQHRNL 429
LG+G FG V +L E A+K L +E VL +A +H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVER---RVLALAW-EHPFL 58
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIAR 481
L K+ + E++ L + I FDE+R RF +II G+
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARA-------RFYAAEIICGLQ- 110
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI--STNTNRVVGTY 539
+LH+ II+RDLK N+LLD++ + +I+DFG + E + + GT
Sbjct: 111 ---FLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK----ENMNGEGKASTFCGTP 160
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
Y++PE G ++ D +SFGVLL E++ G+
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 32/208 (15%)
Query: 379 LGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGC-- 435
+G+GGFG VY + A+ G+ A+K L + I+ + E L + + +LV C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 436 --CLE-----KDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKK-RF---DIILGIARGVL 484
C+ D+ I + M L Y + S+ + K+ RF +IILG+
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLE---- 111
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
H +R +++RDLK +NILLDE + RISD G A F ++ + VGT+GYM+P
Sbjct: 112 --HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAP 164
Query: 545 E-YALGGLFSTKSDVFSFGVLLLEIITG 571
E G + + +D FS G +L +++ G
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 40/196 (20%)
Query: 395 GQEIAVKRLS------TTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448
GQ +A+K+LS T + + E L+ + H+N++ LL F
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNIIGLLNV------------F 84
Query: 449 MPNKSLDYF--------IFDESRKQ----LLDWKKRFDIILGIARGVLYLHQDSRLRIIH 496
P KSL+ F + D + Q LD ++ ++ + G+ +LH IIH
Sbjct: 85 TPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIH 141
Query: 497 RDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKS 556
RDLK SNI++ + +I DFG AR G T VV Y Y +PE LG +
Sbjct: 142 RDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVILGMGYKENV 198
Query: 557 DVFSFGVLLLEIITGK 572
D++S G ++ E+I G
Sbjct: 199 DIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN-------EVLLIAKLQHRNL 429
K+G+G +G V+K + GQ +A+K+ + E+ E+ ++ +L+H NL
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRK--QLLDWKKRFDIILGIARGVLYLH 487
V L+ K + L++E+ D+ + +E K + + II + V + H
Sbjct: 63 VNLIEVFRRKRKLHLVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 488 QDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF-GGEEISTNTNRVVGTYGYMSPEY 546
+ IHRD+K NIL+ ++ ++ DFG AR+ G + T+ V T Y +PE
Sbjct: 118 K---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD---YVATRWYRAPEL 171
Query: 547 ALGGL-FSTKSDVFSFGVLLLEIITG 571
+G + DV++ G + E++TG
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 379 LGQGGFGPVYKGKL-ANGQEIAVKRLS---TTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
LG+G FG V +L G+ AVK L +E E ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 435 CCLE-KDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYLHQDS 490
C + K+ + EF+ L + I D+ R L ++ F +I+ G+ +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCGLQ----FLHSKG 116
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTAR--VFGGEEISTNTNRVVGTYGYMSPEYAL 548
II+RDLK N++LD + + +I+DFG + VFG ST GT Y++PE
Sbjct: 117 ---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST----FCGTPDYIAPEILQ 169
Query: 549 GGLFSTKSDVFSFGVLLLEIITGK 572
G ++ D +SFGVLL E++ G+
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 370 TDNFSTSNKLGQGGFGPVYK-GKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHR 427
TD + +G+G +G VYK +G AVK L S EE + E ++ L H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHP 79
Query: 428 NLVKLLGCCLEKDEKM-----LIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------II 476
N+VK G + D+ + L+ E S+ + K LL +R D I+
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDEAMISYIL 134
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
G G+ +LH + RIIHRD+K +NILL E ++ DFG + + NT+ V
Sbjct: 135 YGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--V 189
Query: 537 GTYGYMSPEY-----ALGGLFSTKSDVFSFGVLLLEIITG 571
GT +M+PE + + DV+S G+ +E+ G
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 378 KLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFK-NEVLLIAKLQHRNLVKLLGCC 436
K+G+G +G VYK K +G++ L G GI E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 437 L-EKDEKM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY-----LHQD 489
L D K+ L++++ + F + K KK + G+ + +LY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 490 SRLRIIHRDLKASNILL----DEEMNPRISDFGTARVFGGE-EISTNTNRVVGTYGYMSP 544
++HRDLK +NIL+ E +I+D G AR+F + + + VV T+ Y +P
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 545 EYALGGLFSTKS-DVFSFGVLLLEIITGK 572
E LG TK+ D+++ G + E++T +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 63/241 (26%), Positives = 99/241 (41%), Gaps = 55/241 (22%)
Query: 371 DNFSTSNKLGQGGFGPVY--KGKLANGQEIAVKRLSTT----SGQGIEEFKNEVLLIAKL 424
D+F +G+G FG V+ + K GQ A+K L + Q I + E ++A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADA 58
Query: 425 QHRNLVKLLGCCLEKDEKML--IYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDIIL 477
+VKL +DE+ L + E+MP L +F E + + +
Sbjct: 59 DSPWIVKLY--YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFY---- 106
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA----------------- 520
IA VL L +L IHRD+K NIL+D + + +++DFG
Sbjct: 107 -IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 521 ----RVFGGEEISTNTNR------VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
R + R VGT Y++PE G + + D +S GV+L E++
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225
Query: 571 G 571
G
Sbjct: 226 G 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 379 LGQGGFGPVYKGKL-ANGQEIAVKRLS---TTSGQGIE--EFKNEVLLIAKLQHRNLVKL 432
LG+G FG V+ +L Q A+K L +E + VL +A +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL 61
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIARGVLYLH 487
K+ + E++ L + I FD R +II G+ +LH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY----AAEIICGLQ----FLH 113
Query: 488 QDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI--STNTNRVVGTYGYMSPE 545
I++RDLK NILLD + + +I+DFG + E + T GT Y++PE
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGMCK----ENMLGDAKTCTFCGTPDYIAPE 166
Query: 546 YALGGLFSTKSDVFSFGVLLLEIITGK 572
LG ++T D +SFGVLL E++ G+
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 377 NKLGQGGFGPVYKGKLANGQEIA---VKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
+++G G FG V G+ G A VK L ++ + F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVLYLHQDS 490
LG C+E +L+ EF P L ++ +K + +A G+L+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYA--- 547
IH DL N L +++ +I D+G A E+ + +++PE
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 548 ----LGGLFSTKSDVFSFGVLLLEIIT 570
L + KS+++S GV + E+ T
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 13/214 (6%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLS--TTSGQGIEEFKNEVLLIAKLQHRNLVKLLGC 435
+G+G +G V + +G++ +K+L+ S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 436 CLEKDEKM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 494
+D + ++ F L Y E + +LL + + + IA + YLH+ I
Sbjct: 68 WEGEDGLLYIVMGFCEGGDL-YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HI 123
Query: 495 IHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFST 554
+HRDLK N+ L ++ D G ARV + +T ++GT YMSPE ++
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNY 181
Query: 555 KSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRY 588
KSDV++ G + E+ T K FN N + Y
Sbjct: 182 KSDVWALGCCVYEMATLKH---AFNAKDMNSLVY 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 66/202 (32%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 379 LGQGGFGPVY-----KGKLANGQEIAVKRL--STTSGQGIEEFKNEVLLIAKLQHRNLVK 431
LGQG FG V+ G A GQ A+K L +T + K E ++A++ H +VK
Sbjct: 4 LGQGSFGKVFLVRKITGPDA-GQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 491
L + + LI +F+ L F K+++ ++ D+ +A L L
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEE--DVKFYLAELALALDHLHS 116
Query: 492 LRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI--STNTNRVVGTYGYMSPEYALG 549
L II+RDLK NILLDEE + +++DFG ++ E I GT YM+PE
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 550 GLFSTKSDVFSFGVLLLEIITG 571
+ +D +SFGVL+ E++TG
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 63/192 (32%), Positives = 93/192 (48%), Gaps = 34/192 (17%)
Query: 395 GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL 454
G +AVK+LS F+N+ AK +R LV LL C K+ L+ F P KSL
Sbjct: 46 GINVAVKKLS-------RPFQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSL 95
Query: 455 DYF--------IFDESRKQL----LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKAS 502
+ F + D + Q+ LD ++ ++ + G+ +LH IIHRDLK S
Sbjct: 96 EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 152
Query: 503 NILLDEEMNPRISDFGTARVFGGEEISTN---TNRVVGTYGYMSPEYALGGLFSTKSDVF 559
NI++ + +I DFG AR TN T VV Y Y +PE LG + D++
Sbjct: 153 NIVVKSDCTLKILDFGLART-----ACTNFMMTPYVVTRY-YRAPEVILGMGYKENVDIW 206
Query: 560 SFGVLLLEIITG 571
S G ++ E++ G
Sbjct: 207 SVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 378 KLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFK-NEVLLIAKLQHRNLVKLLGCC 436
K+G+G +G VYK K +G++ L G GI E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 437 LEKDEKM--LIYEFMPNKSLDYFIF---DESRKQLLDWKKRF--DIILGIARGVLYLHQD 489
L ++ L++++ + F ++ K+ + + ++ I G+ YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 490 SRLRIIHRDLKASNILL----DEEMNPRISDFGTARVFGGE-EISTNTNRVVGTYGYMSP 544
++HRDLK +NIL+ E +I+D G AR+F + + + VV T+ Y +P
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 545 EYALGGLFSTKS-DVFSFGVLLLEIITGK 572
E LG TK+ D+++ G + E++T +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 379 LGQGGFGPVYKGKL-ANGQEIAVKRLSTT---SGQGIEEFKNE--VLLIAKLQHRNLVKL 432
LG+G FG V +L +G+ AVK L +E E +L +A+ H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 433 LGCCLEKDEKML-IYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIARGVLYL 486
CC + +++ + EF+ L + I FDE+R + + I +++L
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALMFL 112
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR--VFGGEEISTNTNRVVGTYGYMSP 544
H II+RDLK N+LLD E + +++DFG + +F G+ ST GT Y++P
Sbjct: 113 HDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST----FCGTPDYIAP 165
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITG 571
E L+ D ++ GVLL E++ G
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 42/115 (36%), Positives = 56/115 (48%), Gaps = 14/115 (12%)
Query: 459 FDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG 518
F ES ++ IA VL L +L II+RD+K NILLD E + ++DFG
Sbjct: 102 FTESEVRVY-----------IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFG 150
Query: 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALGGL--FSTKSDVFSFGVLLLEIITG 571
++ F EE GT YM+PE GG D +S GVL E++TG
Sbjct: 151 LSKEFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 379 LGQGGFGP--VYKGKLANGQEIAVKRLS-TTSGQGIEEFKNEVLLIAKLQHRNLVKLLGC 435
+G+G FG + + ++ Q+ A+K + S +E+ + E +L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 436 CLEKDEKMLIYEFMPNKSLDYFIFDESRK-----QLLDWKKRFDIILGIARGVLYLHQDS 490
++ E+ L I + K +L W + + GV ++H+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHEK- 119
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG 550
R++HRD+K+ NI L + ++ DFG+AR+ T VGT Y+ PE
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENM 175
Query: 551 LFSTKSDVFSFGVLLLEIITGK 572
++ KSD++S G +L E+ T K
Sbjct: 176 PYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 71/228 (31%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 357 DVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKN 416
D TF TVL N QG Y L + +A+K+LS F+N
Sbjct: 17 DSTF----TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLS-------RPFQN 63
Query: 417 EVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYF--------IFDESRKQL-- 466
+ AK +R LV L+ C K+ L+ F P KSL+ F + D + Q+
Sbjct: 64 QTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ 120
Query: 467 --LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524
LD ++ ++ + G+ +LH IIHRDLK SNI++ + +I DFG AR G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177
Query: 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+ T VV Y Y +PE LG + D++S G ++ E+I G
Sbjct: 178 TSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 90/345 (26%), Positives = 137/345 (39%), Gaps = 105/345 (30%)
Query: 379 LGQGGFGPVYK------GKLANGQEIAVKRL---STTSGQG--IEEFKNEVLLIAKLQHR 427
LG+G FG V + K A+ + +AVK L +T S + E K +LI H
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK---ILIHIGHHL 71
Query: 428 NLVKLLGCCLEKDEK-MLIYE-----------------FMPNK----SLDYFIFDESRKQ 465
N+V LLG C + M+I E F P + E +KQ
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ 131
Query: 466 LLD-------------------------------WKKRF---DII---LGIARGVLYLHQ 488
LD +K+ D+I +ARG+ +L
Sbjct: 132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL-- 189
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVG-----TYGYMS 543
SR + IHRDL A NILL E +I DFG AR +I + + V +M+
Sbjct: 190 ASR-KCIHRDLAARNILLSENNVVKICDFGLAR-----DIYKDPDYVRKGDARLPLKWMA 243
Query: 544 PEYALGGLFSTKSDVFSFGVLLLEIIT--GKKNTGI-FNDDSSNLIRYVWELWSDDKALE 600
PE +++T+SDV+SFGVLL EI + G+ +++ ++ + + + A
Sbjct: 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATP 303
Query: 601 IVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
+ S M D C + DRP+ S +V +L +
Sbjct: 304 EIYSIMLD----------------CWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 365 TVLAATDNFSTSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQGIEEFKN---EVLL 420
T+ + + + +G G +G V G +AVK+LS Q I K E+ L
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRL 69
Query: 421 IAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYF--------IFDESRKQLLDWKKR 472
+ ++H N++ LL F P +SL+ F + ++ +K
Sbjct: 70 LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 117
Query: 473 FD-----IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527
D +I I RG+ Y+H IIHRDLK SN+ ++E+ +I DFG AR +E
Sbjct: 118 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDE 173
Query: 528 ISTNTNRVVGTYGYMSPEYALGGL-FSTKSDVFSFGVLLLEIITGK 572
++ V T Y +PE L + ++ D++S G ++ E++TG+
Sbjct: 174 MTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 51/205 (24%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 372 NFSTSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
++ ++G G +G VYK L G+ AVK + G + E+ ++ + +H N+V
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLD--YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
G L +++ + E+ SL Y + + + + R + +G+ YLH
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHS 124
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR--VVGTYGYMSPEY 546
++ HRD+K +NILL + + +++DFG A + +T R +GT +M+PE
Sbjct: 125 KGKM---HRDIKGANILLTDNGDVKLADFGVA----AKITATIAKRKSFIGTPYWMAPEV 177
Query: 547 AL---GGLFSTKSDVFSFGVLLLEI 568
A G ++ D+++ G+ +E+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 7e-12
Identities = 74/295 (25%), Positives = 135/295 (45%), Gaps = 35/295 (11%)
Query: 331 FLNSSTRLSDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKG 390
F + +L + E S + +D + +++ + ++ N +G G FG VY+
Sbjct: 28 FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINR--SPNKSYKLGNIIGNGSFGVVYEA 85
Query: 391 K-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAK-LQHRNLVKLLGC----CLEKDEKML 444
+ +++A+K++ ++KN LLI K L H N++ L C +K+EK +
Sbjct: 86 ICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140
Query: 445 ----IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLK 500
+ EF+P Y L + R + Y+H I HRDLK
Sbjct: 141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLK 197
Query: 501 ASNILLDEEMNP-RISDFGTAR-VFGGEE-ISTNTNRVVGTYGYMSPEYALGGL-FSTKS 556
N+L+D + ++ DFG+A+ + G+ +S +R Y +PE LG ++T
Sbjct: 198 PQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHI 252
Query: 557 DVFSFGVLLLEIITGKKNTGIFNDDSS--NLIRYVWELWS-DDKALEIVDSSMAD 608
D++S G ++ E+I G IF+ SS L+R + L + + L+ ++ + AD
Sbjct: 253 DLWSLGCIIAEMILGYP---IFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD 304
|
Length = 440 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 31/209 (14%)
Query: 379 LGQGGFGPVYKGKLAN---------GQEIAVKRLSTTSGQGI-EEFKNEVLLIAKLQHRN 428
LGQG F +YKG L GQE++V S F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
LVKL G C+ +DE +++ E++ LD F+ E L WK D+ +A + YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119
Query: 489 DSRLRIIHRDLKASNILL-----DEEMNP--RISDFGTARVFGGEEISTNTNRVVGTYGY 541
+++H ++ NIL+ +E P ++SD G E V +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VERIPW 170
Query: 542 MSPEYALGGLFSTKS--DVFSFGVLLLEI 568
++PE G S D +SFG LLEI
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 41/227 (18%)
Query: 365 TVLAATDNFSTSNKLGQGGFGPV---YKGKLANGQEIAVKRLSTTSGQGIEEFKN--EVL 419
TV + + +G G +G V Y +L Q++AVK+LS I + E+
Sbjct: 9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELR 66
Query: 420 LIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYF--------IFDESRKQLLDWKK 471
L+ ++H N++ LL F P S++ F + ++ +K
Sbjct: 67 LLKHMKHENVIGLLDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQK 114
Query: 472 RFD-----IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526
D +I + RG+ Y+H IIHRDLK SN+ ++E+ RI DFG AR
Sbjct: 115 LSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR----- 166
Query: 527 EISTNTNRVVGTYGYMSPEYALGGL-FSTKSDVFSFGVLLLEIITGK 572
+ V T Y +PE L + ++ D++S G ++ E++ GK
Sbjct: 167 QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 1e-11
Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 357 DVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKN 416
D TF TVL N QG Y L + +A+K+LS F+N
Sbjct: 10 DSTF----TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQN 56
Query: 417 EVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYF--------IFDESRKQL-- 466
+ AK +R LV L+ C K+ L+ F P KSL+ F + D + Q+
Sbjct: 57 QTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ 113
Query: 467 --LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524
LD ++ ++ + G+ +LH IIHRDLK SNI++ + +I DFG AR G
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170
Query: 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+ T VV Y Y +PE LG + D++S G ++ E++ K
Sbjct: 171 TSFMMTPY--VVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 48/205 (23%)
Query: 395 GQEIAVKRLSTTSGQGIEE---FKNEVLLIAKLQHRNLVKLL--GCCLEKDEKMLIYEFM 449
G E+A+K L T + + + F+ E L A+L H N+V LL G ++E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR--------------II 495
P ++L +++L A G L + RL I+
Sbjct: 62 PGRTL---------REVLA-----------ADGALPAGETGRLMLQVLDALACAHNQGIV 101
Query: 496 HRDLKASNILL---DEEMNPRISDFGTARVFGG-----EEISTNTNRVVGTYGYMSPEYA 547
HRDLK NI++ + ++ DFG + G T T V+GT Y +PE
Sbjct: 102 HRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161
Query: 548 LGGLFSTKSDVFSFGVLLLEIITGK 572
G + SD++++G++ LE +TG+
Sbjct: 162 RGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQ--EIAVKRLSTTS---GQGIEEFKNEVLLIAKLQ 425
++F+ LG G FG V N +A+KR + + ++ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI---ARG 482
H V L G ++ L+ EF+ ++F F L KRF +G A+
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGG--EFFTF-------LRRNKRFPNDVGCFYAAQI 140
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
VL L I++RDLK N+LLD++ +++DFG A+V + T T + GT Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYI 195
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIITG 571
+PE L +D ++ G+ + EI+ G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 378 KLGQGGFGPVYKGKLANG---QEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLL 433
++G G FG V G++ +G ++ VK L ++ Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLL--DWKKRFDIILGIARGVLYLHQDSR 491
G C E +L+ EF P L ++ + +L+ D + IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 492 LRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY---AL 548
IH DL N LL ++ +I D+G + E+ +++ +++PE
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 549 GGLF----STKSDVFSFGVLLLEI 568
G L + +S+V+S GV + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQGIEEFKN----EVLLIAKLQ 425
+ F +G+G +G V K + +EI A+K+ + EE K E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLK 58
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
N+V+L + + L++E++ L+ + +E + K R I + + + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVR-SYIYQLIKAIHW 115
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE 545
H++ I+HRD+K N+L+ ++ DFG AR E + N V T Y SPE
Sbjct: 116 CHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPE 171
Query: 546 YALGGLFSTKSDVFSFGVLLLEIITGK 572
LG + D++S G +L E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 30/207 (14%)
Query: 379 LGQGGFGPV----YKGKLANGQEIAVKRLS---TTSGQGIEEFKNE--VLLIA-KLQHRN 428
LG+G FG V YK G+ A+K L + +E E + A +H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFI----FDESRKQLLDWKKRFDIILGIARGVL 484
LV L C +D + E+ L I F E R ++LG+
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY----AACVVLGLQ---- 115
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
YLH++ +I++RDLK N+LLD E +I+DFG + G T+T GT +++P
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FCGTPEFLAP 170
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITG 571
E ++ D + GVL+ E++ G
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 365 TVLAATDNFSTSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQGI--EEFKNEVLLI 421
TV + +++ ++G G +G V G+++A+K+LS I + E+ L+
Sbjct: 9 TVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLL 68
Query: 422 AKLQHRNLVKLLGCCLEK---DEKMLIYEFMPNKSLDY-----FIFDESRKQLLDWKKRF 473
+QH N++ LL DE Y MP D E + Q L
Sbjct: 69 KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL------ 122
Query: 474 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTN 533
+ + G+ Y+H IIHRDLK N+ ++E+ +I DFG AR E T
Sbjct: 123 --VYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TG 173
Query: 534 RVVGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLEIITGK 572
VV T Y +PE L + ++ D++S G ++ E++TGK
Sbjct: 174 YVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 53/220 (24%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLL---IAKLQHR--NLVKL 432
+G G G VYK + G +AVK++ T + EE K +L+ + H +VK
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENK-RILMDLDVVLKSHDCPYIVKC 79
Query: 433 LGC----------------CLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII 476
G CL+K K I +P L +
Sbjct: 80 YGYFITDSDVFICMELMSTCLDKLLK-RIQGPIPEDILG------------------KMT 120
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
+ I + + YL + +IHRD+K SNILLD N ++ DFG + G S R
Sbjct: 121 VAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKAKTRSA 175
Query: 537 GTYGYMSPEY----ALGGLFSTKSDVFSFGVLLLEIITGK 572
G YM+PE + ++DV+S G+ L+E+ TG+
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 365 TVLAATDNFSTSNKLGQGGFGPV-YKGKLANGQEIAVKRLST--TSGQGIEEFKNEVLLI 421
T+ D + ++G G +G V G ++A+K+L S + E+ L+
Sbjct: 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68
Query: 422 AKLQHRNLVKLLGCCLEKDEKM-------LIYEFMPN---KSLDYFIFDESRKQLLDWKK 471
++H N++ LL D + L+ FM K + + E R Q L ++
Sbjct: 69 KHMKHENVIGLLDV-FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQ- 126
Query: 472 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531
+ +G+ Y+H IIHRDLK N+ ++E+ +I DFG AR + S
Sbjct: 127 -------MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEM 172
Query: 532 TNRVVGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLEIITGK 572
T VV T Y +PE L + T++ D++S G ++ E++TGK
Sbjct: 173 TGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 36/96 (37%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR--VFGGEEISTNTNRVV 536
IA G+ +LH II+RDLK N++LD E + +I+DFG + +FGG T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFC 162
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
GT Y++PE + D ++FGVLL E++ G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-11
Identities = 54/183 (29%), Positives = 92/183 (50%), Gaps = 30/183 (16%)
Query: 401 KRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE---FMPNKSLDY- 456
KR+ S I+ +NE+L + +L H N++K+ E++L E +M + D+
Sbjct: 198 KRVKAGSRAAIQ-LENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFD 248
Query: 457 ---FIFDESRKQLLDWKKR------FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 507
F++DE+ DWK R I+ + V Y+H ++IHRD+K NI L+
Sbjct: 249 LYSFMYDEA----FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301
Query: 508 EEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLE 567
+ + DFGTA F E + + VGT SPE G + +D++S G++LL+
Sbjct: 302 CDGKIVLGDFGTAMPFEKEREAFDYGW-VGTVATNSPEILAGDGYCEITDIWSCGLILLD 360
Query: 568 IIT 570
+++
Sbjct: 361 MLS 363
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 87/361 (24%), Positives = 139/361 (38%), Gaps = 111/361 (30%)
Query: 371 DNFSTSNKLGQGGFGPVYK------GKLANGQEIAVKRL-STTSGQGIEEFKNEVLLIAK 423
DN LG G FG V + GK N +AVK L ++ E +E+ +++
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 424 L-QHRNLVKLLG--------------CCL--------EKDEKMLIY----EFMPNKSLDY 456
L QH+N+V LLG CC +K E L + + S DY
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDY 157
Query: 457 --------FIFDES-------------------------RKQLLD----WKKRFDIILG- 478
+I +S K D W D +L
Sbjct: 158 KNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRF 217
Query: 479 ---IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV 535
+A+G+ +L + IHRD+ A N+LL + +I DFG AR +I ++N V
Sbjct: 218 SSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYV 269
Query: 536 VGTYG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKN--TGIFNDDSSNLIRY 588
V +M+PE +++ +SDV+S+G+LL EI + K+ GI
Sbjct: 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL---------- 319
Query: 589 VWELWSDDKALEIVDSSMADSCP---APEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
+ K ++V S P PE ++ +C T+RP+ S + ++
Sbjct: 320 -----VNSKFYKMVKRGYQMSRPDFAPPEIYSIMK---MCWNLEPTERPTFSQISQLIQR 371
Query: 646 E 646
+
Sbjct: 372 Q 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT 538
I RG+ YLH I+HRD+K N+L++ +I DFG ARV +E T VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 539 YGYMSPEYALGGL-FSTKSDVFSFGVLLLEIITGK 572
Y Y +PE +G +++ D++S G + E++ +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 72/230 (31%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN---------EVLLIAKLQHRN 428
+G+G +G V K +++A+K+++ F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 429 LVKLLGCCLEKDEKM-----------LIYEFM---------PNKSL-----DYFIFDESR 463
++ + KD ++YE M +++L YF++
Sbjct: 66 VIAI------KDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY---- 115
Query: 464 KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523
QLL RG+ Y+H + ++HRDLK SN+LL+ + +I DFG AR
Sbjct: 116 -QLL-------------RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART- 157
Query: 524 GGEEISTNTNRVVGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLEIITGK 572
E+ T VV T Y +PE L T + DV+S G + E++ K
Sbjct: 158 TSEKGDFMTEYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 370 TDNFSTSNKLGQGGFGPVYK-GKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-HR 427
+D + +G+G +G V+K NG + AVK L EE + E ++ L H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHP 75
Query: 428 NLVKLLGCCLEKDEK-----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------II 476
N+VK G +KD K L+ E S+ + K L +R + I+
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEEPIIAYIL 130
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
G+ +LH + + IHRD+K +NILL E ++ DFG + + NT+ V
Sbjct: 131 HEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--V 185
Query: 537 GTYGYMSPEY-----ALGGLFSTKSDVFSFGVLLLEIITG 571
GT +M+PE L + + DV+S G+ +E+ G
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 379 LGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLL---- 433
LG G G V+ ++ + +AVK++ T Q ++ E+ +I +L H N+VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 434 --GCCLEKDEKML-----IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
G L +D L +Y D E + + F L RG+ Y+
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQL--LRGLKYI 130
Query: 487 HQDSRLRIIHRDLKASNILLD-EEMNPRISDFGTARVFGGE-EISTNTNRVVGTYGYMSP 544
H + ++HRDLK +N+ ++ E++ +I DFG AR+ + + T Y SP
Sbjct: 131 HSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187
Query: 545 EYALGGLFSTKS-DVFSFGVLLLEIITGK 572
L TK+ D+++ G + E++TGK
Sbjct: 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 379 LGQGGFGPVYKGKLANGQEI----AVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
+G+G FG V + + + Q I +++ S + E ++A++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
++ L+ F+ L + + FD SR + A + L
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFY-----------TAELLCALENL 109
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG 549
+ +I+RDLK NILLD + + + DFG ++ ++ TNT GT Y++PE LG
Sbjct: 110 HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLG 167
Query: 550 GLFSTKSDVFSFGVLLLEIITG 571
++ D ++ GVLL E++TG
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 38/92 (41%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT 538
+ARG+ +L SR + IHRDL A NILL E +I DFG AR +
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 539 YGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M+PE +++T+SDV+SFGVLL EI +
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 372 NFSTSNKLGQGGFGPVYKGKLANGQE----IAVKRLSTTS----GQGIEEFKNEVLLIAK 423
NF LG G +G V+ + +G + A+K L + + E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 424 LQHRNLVKLLGCCLEKDEKM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 482
++ + L + D K+ LI +++ L F R++ K ++ +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERF----KEQEVQIYSGEI 114
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
VL L +L II+RD+K NILLD + ++DFG ++ F +E+ + GT YM
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYM 173
Query: 543 SPEYALGGL--FSTKSDVFSFGVLLLEIITG 571
+P+ GG D +S GVL+ E++TG
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 35/209 (16%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEV----LLIAKLQHRNLVKLL 433
+G+G FG V K A+G+ AVK L + +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFD-----------ESRKQLLDWKKRFDIILGIARG 482
Y F L YF+ D + + + + RF IA
Sbjct: 63 ------------YSFQTADKL-YFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASA 108
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
+ YLH L II+RDLK NILLD + + ++DFG + G E S T+ GT Y+
Sbjct: 109 LGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYL 163
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIITG 571
+PE + D + G +L E++ G
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 372 NFSTSNKLGQGGFGPVYKGKLANGQE----IAVKRLSTTS----GQGIEEFKNEVLLIAK 423
NF LG G +G V+ + G + A+K L + + +E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 424 LQHRNLVKLLGCCLEKDEKM-LIYEFMPNKSL-------DYFIFDESRKQLLDWKKRFDI 475
++ + L + + K+ LI +++ + D F DE R +I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS------GEI 114
Query: 476 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV 535
IL + +LH +L I++RD+K NILLD E + ++DFG ++ F EE T
Sbjct: 115 ILALE----HLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSF 166
Query: 536 VGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLEIITG 571
GT YM+PE G K+ D +S G+L+ E++TG
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 371 DNFSTSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
+ +G G +G V +G+++A+K++ +V +AK R L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------DVPTLAKRTLREL 55
Query: 430 VKLLGCCLEKDEKMLIYE-FMPNKSLD---YFIFD----------ESRKQLLDWKKRFDI 475
K+L + D + I + P + Y + D S + L + R+
Sbjct: 56 -KILRH-FKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRY-F 112
Query: 476 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG--EEISTNTN 533
+ + RG+ Y+H + +IHRDLK SN+L++E+ RI DFG AR E
Sbjct: 113 LYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169
Query: 534 RVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEII 569
V T Y +PE L ++T D++S G + E++
Sbjct: 170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 372 NFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQGIEEFKNEVLLIAK----LQH 426
+F+ LG+G FG V + E+ A+K L I++ E ++ K LQ
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQD 58
Query: 427 RN--LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARG 482
+ L +L C D + E++ L Y I +Q+ +K+ + I+ G
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPQAVFYAAEISVG 113
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
+ +LH+ II+RDLK N++LD E + +I+DFG + + ++T T GT Y+
Sbjct: 114 LFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--FCGTPDYI 168
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+PE + D +++GVLL E++ G+
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 12/146 (8%)
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVLYL 486
L +L C D + E++ L Y I +Q+ +K+ + IA G+ +L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQI-----QQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
H II+RDLK N++LD E + +I+DFG + + ++T T GT Y++PE
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--FCGTPDYIAPEI 172
Query: 547 ALGGLFSTKSDVFSFGVLLLEIITGK 572
+ D ++FGVLL E++ G+
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 417 EVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII 476
E+ ++ + HR ++ L+ K ++ MP D F + + R L ++ I
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVD-RSGPLPLEQAITIQ 191
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
+ + YLH IIHRD+K NI LDE N + DFG A +T +
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD---AHPDTPQCY 245
Query: 537 GTYGYM---SPEYALGGLFSTKSDVFSFGVLLLEIITGKKNT-GIFNDDSSNLIR 587
G G + SPE + K+D++S G++L E+ G SS+ +R
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLR 300
|
Length = 392 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 379 LGQGGFGPVYKGKLANGQEI-AVKRL---STTSGQGIEEFKNE--VLLIAKLQHRNLVKL 432
LG+G FG V +L E+ A+K L ++ E +L +A +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIARGVLYLH 487
C KD + E++ L + I FDE R RF + +++LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS-------RF-YAAEVTLALMFLH 113
Query: 488 QDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYA 547
+ +I+RDLK NILLD E + +++DFG + ++T T GT Y++PE
Sbjct: 114 RHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT--FCGTPDYIAPEIL 168
Query: 548 LGGLFSTKSDVFSFGVLLLEIITGK 572
+ D ++ GVL+ E++ G+
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 13/97 (13%)
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT 538
+A+G+ +L + IHRDL A NILL +I DFG AR +I ++N VV
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKG 274
Query: 539 YG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M+PE +++ +SDV+S+G+LL EI +
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 34/214 (15%)
Query: 377 NKLGQGGFGPVYK------GKLANGQEIAVKRLSTTSGQGIEEFK-NEVLLIAKLQHR-- 427
++LG+G +G VYK G +EI RL ++E K N++++ + H+
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE------LDESKFNQIIMELDILHKAV 57
Query: 428 --NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
+V G + + E+M SLD + + I + +G+ +
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS-TNTNRVVGTYGYMSP 544
L ++ IIHRD+K +N+L++ ++ DFG V G S TN +G YM+P
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFG---VSGNLVASLAKTN--IGCQSYMAP 170
Query: 545 EYALGG------LFSTKSDVFSFGVLLLEIITGK 572
E G ++ +SDV+S G+ +LE+ G+
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT 538
+A+G+ +L SR + IHRDL A NILL E +I DFG AR +
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 539 YGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M+PE +++ +SDV+SFGVLL EI +
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 65/254 (25%), Positives = 105/254 (41%), Gaps = 45/254 (17%)
Query: 372 NFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHR 427
+F LG G FG V K G+ A+K L + ++ E ++ +L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF----------DIIL 477
+V ++ +++ + EF+ L F RK RF +++L
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGEL----FTHLRK-----AGRFPNDVAKFYHAELVL 129
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVG 537
YLH II+RDLK N+LLD + + +++DFG A+ ++ T + G
Sbjct: 130 AFE----YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCG 177
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLI-------RYVW 590
T Y++PE D ++ GVLL E I G F DD+ I R +
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP---FFDDTPFRIYEKILAGRLKF 234
Query: 591 ELWSDDKALEIVDS 604
W D +A ++V
Sbjct: 235 PNWFDGRARDLVKG 248
|
Length = 329 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 57/275 (20%), Positives = 115/275 (41%), Gaps = 50/275 (18%)
Query: 387 VYKGKLANGQEIAVKRL---STTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKM 443
+YKG N +E+ ++ I+ +NE+ + ++ N++K+ G ++ + +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 444 ----LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRD 498
LI E+ L + E + L +K + D+ + +G+ L++ ++ +++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKN 148
Query: 499 LKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFST---K 555
L + + L+ E +I G ++ N N +V Y S + L +FS K
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPP-FKNVNFMV----YFSYKM-LNDIFSEYTIK 202
Query: 556 SDVFSFGVLLLEIITGK---KN---TGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609
D++S GV+L EI TGK +N I++ +I L
Sbjct: 203 DDIYSLGVVLWEIFTGKIPFENLTTKEIYD----LIINKNNSLKLPLD------------ 246
Query: 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644
P ++CI C + RP++ +++ LS
Sbjct: 247 --CPLEIKCIVEA--CTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 379 LGQGGFGPVYKGKLANGQE----IAVKRLS----TTSGQGIEEFKNEVLLIAKLQHRNLV 430
LG+GG+G V++ + G + A+K L + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 431 KLLGCCLEKDEKM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARGVLYL 486
L+ + K+ LI E++ L F+ E ++ F +I L + +L
Sbjct: 64 DLI-YAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALE----HL 116
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN--TNRVVGTYGYMSP 544
HQ II+RDLK NILLD + + +++DFG + E I T+ GT YM+P
Sbjct: 117 HQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAP 169
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITG 571
E + D +S G L+ +++TG
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 372 NFSTSNKLGQGGFGPVYKGKLA---NGQEIAVKRLSTTSGQGI------EEFKNEVLLIA 422
+ +LGQG +G V + A + +A+K+++ + I E K LL
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELK---LLRH 57
Query: 423 KLQHRNLVKLLGCCLEKD-------EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDI 475
H+N+ C + D ++ +YE + L I S + L D +
Sbjct: 58 FRGHKNIT----CLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTDAHFQS-F 110
Query: 476 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF--GGEEISTNTN 533
I I G+ Y+H + ++HRDLK N+L++ + +I DFG AR F E +
Sbjct: 111 IYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 534 RVVGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLEIITGK 572
V T Y +PE L TK+ DV+S G +L E++ K
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 33/92 (35%), Positives = 55/92 (59%), Gaps = 2/92 (2%)
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV-VGTYGY 541
+L +H +IHRD+K++NILL ++ DFG ++++ +S + R GT Y
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT-VSDDVGRTFCGTPYY 211
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEIITGKK 573
++PE +S K+D+FS GVLL E++T K+
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 37/232 (15%)
Query: 371 DNFSTSNKLGQGGFGPVY--KGKLANGQEIAVKRLS---TTSGQGIEEFKNEVLLIAKLQ 425
+F + +G+G FG V + K A G A+K + + + + F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMP--------NKSLDYFIFDESRKQLLDWKKRFDIIL 477
+ +L +KD L+ E+ P N+ D FDE Q
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFDEDMAQFY---------- 107
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVG 537
+A VL +H ++ +HRD+K N+L+D + +++DFG+A + N+ VG
Sbjct: 108 -LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVG 165
Query: 538 TYGYMSPEY------ALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSS 583
T Y++PE G + + D +S GV+ E+I G F++ +S
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG---RSPFHEGTS 214
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 379 LGQGGFGPVYKGKLANGQEI----AVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLVKLL 433
+G+G + V +L + I VK+ + I+ + E + + H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493
C + + E++ L + + + +++L + RF I+ + YLH+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARF-YSAEISLALNYLHERG--- 116
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFS 553
II+RDLK N+LLD E + +++D+G + G T+ GT Y++PE G +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 554 TKSDVFSFGVLLLEIITGK 572
D ++ GVL+ E++ G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 378 KLGQGGFGPVYKGKLANGQEIA---VKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLL 433
++G G FG V ++ +A VK L + + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL-------GIARGVLYL 486
G C+E +L++E+ L ++ E W +R +L IA GV ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
H + +H DL N L ++ ++ D+G E+ + +++PE
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL 172
Query: 547 AL---GGLFSTK----SDVFSFGVLLLEI 568
GGL + + S+V++ GV L E+
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 36/97 (37%), Positives = 55/97 (56%), Gaps = 13/97 (13%)
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV-- 536
+A G+ +L + +HRDL A N+L+ E +I DFG AR +I ++N +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLAR-----DIMRDSNYISKG 299
Query: 537 GTY---GYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
T+ +M+PE L++T SDV+SFG+LL EI T
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLSTTS--GQGIEEFKNEVLLIAKLQHR 427
+++ +G+G FG V + + Q++ A+K LS + F E I +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 428 NLVKLLGCCLEKDEKM-LIYEFMPNKSLDYFI--FDESRKQLLDWKKRFDIILGIARGVL 484
V L C + D+ + ++ E+MP L + +D K W K + A VL
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TAEVVL 153
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
L + +IHRD+K N+LLD+ + +++DFGT E + VGT Y+SP
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISP 212
Query: 545 EYALG----GLFSTKSDVFSFGVLLLEIITG 571
E G + + D +S GV L E++ G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 48/208 (23%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 379 LGQGGFGPVYKGKLANGQEI----AVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
+G+G + V +L +I VK+ + I+ + E + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 435 CCLEKDEKM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493
C + ++ L+ E++ L + + + +++L + RF I + +LH+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARF-YAAEICIALNFLHERG--- 116
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFS 553
II+RDLK N+LLD + + +++D+G + G T+ GT Y++PE G +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 554 TKSDVFSFGVLLLEIITGKKNTGIFNDD 581
D ++ GVL+ E++ G+ I D+
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 36/97 (37%), Positives = 56/97 (57%), Gaps = 13/97 (13%)
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV-- 536
+ARG+ +L + +HRDL A N+LL + +I DFG AR +I ++N V
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLAR-----DIMHDSNYVSKG 297
Query: 537 GTY---GYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
T+ +M+PE L++T SDV+S+G+LL EI +
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 379 LGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEV----LLIAKLQHRNLVKLL 433
+G+G FG V K +G+ AVK L +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493
++ + +F+ L F + + + + RF IA + YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARF-YAAEIASALGYLHS---IN 116
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFS 553
I++RDLK NILLD + + ++DFG + G S T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 554 TKSDVFSFGVLLLEIITG 571
D + G +L E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 379 LGQGGFGPVYKGKL--------ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
LGQG F ++KG + E+ +K L + E F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY-LHQD 489
G C+ DE +++ E++ SLD ++ + WK L +A+ + + LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALHFL 116
Query: 490 SRLRIIHRDLKASNILLDEEM-----NP---RISDFGTARVFGGEEISTNTNRVVGTYGY 541
+ H ++ A N+LL E NP ++SD G + +EI V
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEIITG 571
+P+ S +D +SFG L EI +G
Sbjct: 177 ENPQN-----LSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 379 LGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQGIEEFKNEVLLIAKLQH----RNLVKLL 433
+G+G FG VY+ + + + I A+K LS K E++ ++ H RN+ L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS----------KKEIVAKKEVAHTIGERNI---L 47
Query: 434 GCCLEKDEKMLI---YEFMPNKSLDYFIFDESRKQLLDW----KKRFD---IILGIARGV 483
L + ++ + F + L Y + D L W + RF IA V
Sbjct: 48 VRTLLDESPFIVGLKFSFQTDSDL-YLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELV 106
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMS 543
L L + I++RDLK NILLD + + DFG ++ + +TNT GT Y++
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLA 164
Query: 544 PEYALGGLFSTKS-DVFSFGVLLLEIITG 571
PE L TK D +S GVL+ E+ G
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 35/209 (16%)
Query: 379 LGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEV----LLIAKLQHRNLVKLL 433
+G+G FG V K ++G AVK L + +E + + +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFD-----------ESRKQLLDWKKRFDIILGIARG 482
Y F + L YF+ D + + L+ + RF +A
Sbjct: 63 ------------YSFQTAEKL-YFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASA 108
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
+ YLH L II+RDLK NILLD + + ++DFG + G E T+ GT Y+
Sbjct: 109 IGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYL 163
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIITG 571
+PE + D + G +L E++ G
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 51/216 (23%), Positives = 86/216 (39%), Gaps = 42/216 (19%)
Query: 379 LGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFK---NEVLLIAKLQHRNLVKLLGC 435
+ K K +AVK+++ S E+ K E++ +LQH N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 436 CLEKDEKMLIYEFMPNKSLDYFI---FDESRKQLLDWKKRFDIILGIARGVL----YLHQ 488
+ E ++ M S + + F E +L I I + VL Y+H
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA--------IAFILKDVLNALDYIHS 119
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF--GGEEISTNTNRVVGTYG------ 540
IHR +KAS+ILL + +S + G+ RVV +
Sbjct: 120 ---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR-----QRVVHDFPKSSVKN 171
Query: 541 --YMSPEY---ALGGLFSTKSDVFSFGVLLLEIITG 571
++SPE L G ++ KSD++S G+ E+ G
Sbjct: 172 LPWLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 33/100 (33%), Positives = 57/100 (57%), Gaps = 8/100 (8%)
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA-RVFGGEEISTNTNRVVG 537
+A VL + +L +HRD+K N+LLD+ + R++DFG+ R+ + + +N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL--ADGTVQSNVAVG 165
Query: 538 TYGYMSPEY--ALG---GLFSTKSDVFSFGVLLLEIITGK 572
T Y+SPE A+ G + + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 42/150 (28%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF---DIILGIARG 482
H LV L C + + EF+ L + + + +++L + RF +I L +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLALN-- 110
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
+LH+ II+RDLK N+LLD E + +++D+G + G T+ GT Y+
Sbjct: 111 --FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYI 163
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+PE G + D ++ GVL+ E++ G+
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 26/165 (15%)
Query: 417 EVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDI- 475
E ++ + H ++++L G LI +P D + + L K+ I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCY-------LAAKRNIAIC 182
Query: 476 -ILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530
IL I R VL YLH++ RIIHRD+KA NI ++ + + DFG A +
Sbjct: 183 DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF----PVDI 235
Query: 531 NTNRV---VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
N N+ GT +PE + D++S G++L E+ T
Sbjct: 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 379 LGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQGIEEFKNEV----LLIAKLQHRNLVKLL 433
+G+G FG V + ++ AVK L + +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493
D+ + +++ L Y + + + L+ + RF IA + YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARF-YAAEIASALGYLHS---LN 116
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN--TNRVVGTYGYMSPEYALGGL 551
I++RDLK NILLD + + ++DFG + E I N T+ GT Y++PE
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 552 FSTKSDVFSFGVLLLEIITG-----KKNTGIFNDDSSN 584
+ D + G +L E++ G +NT D+ N
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQGIEEFKNEVLLIAKL----Q 425
D+F +G+G FG V K+ + + I A+K L+ K E+L A+ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN----------KWEMLKRAETACFRE 50
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSL----DYFIFDESRKQLLDWKKRFDIILG--- 478
RN V + G C + L Y F L DY++ + L ++ R +
Sbjct: 51 ERN-VLVNGDC--QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT 538
IA VL +H +L +HRD+K N+LLD + R++DFG+ ++ + ++ VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM-NQDGTVQSSVAVGT 166
Query: 539 YGYMSPEYALG-----GLFSTKSDVFSFGVLLLEIITGK 572
Y+SPE G + + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 10/97 (10%)
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV-FGGEEISTNTNRVVGTY 539
R + Y+H + + HRDLK NIL + + +I DFG ARV F + V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 540 GYMSPEYALGGLFSTKS----DVFSFGVLLLEIITGK 572
Y +PE L G F +K D++S G + E++TGK
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQGIEE---FKNEVLLIAKLQH 426
++F +G+G FG V + + +++ A+K LS + F E ++A
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102
Query: 427 RNLVKLLGCCLEKDEKML--IYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDIILGI 479
+V+L +D+K L + E+MP L +Y I + W + +
Sbjct: 103 EWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-------KWARFY-----T 148
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
A VL L + IHRD+K N+LLD+ + +++DFGT + + VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTP 207
Query: 540 GYMSPEYALG----GLFSTKSDVFSFGVLLLEIITG 571
Y+SPE G + + D +S GV L E++ G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 42/156 (26%), Positives = 81/156 (51%), Gaps = 2/156 (1%)
Query: 415 KNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD 474
++E+ +A H +VK D+ +LI E+ L+ I + K+ L +++ ++
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-KQRLKEHLPFQE-YE 170
Query: 475 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR 534
+ L + VL L + +++HRDLK++NI L ++ DFG ++ + +
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 535 VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
GT Y++PE +S K+D++S GV+L E++T
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 64/260 (24%), Positives = 93/260 (35%), Gaps = 75/260 (28%)
Query: 371 DNFSTSNKLGQGGFGPV-YKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
++F T +G+G FG V K G+ A+K L + E FK + L K + L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAERDVL 55
Query: 430 --------VKLLGCCLEKDEKMLIYEFMPNKSL-----DYFIFDESRKQLLDWKKRFDII 476
V L + LI EF+P L Y F E RF
Sbjct: 56 AESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-------VTRF--- 105
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF------------- 523
+A VL + +L IHRD+K NIL+D + ++SDFG + F
Sbjct: 106 -YMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164
Query: 524 -GGEEISTNTNR-------------------------------VVGTYGYMSPEYALGGL 551
G + NR VGT Y++PE L
Sbjct: 165 QGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG 224
Query: 552 FSTKSDVFSFGVLLLEIITG 571
+ + D +S G ++ E + G
Sbjct: 225 YGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 6e-07
Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 46/238 (19%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKN-----EVLLIAKLQ 425
+ + K+G G FG V+ K QE + S +G++E + EV ++ +L+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELK 70
Query: 426 HRNLVKLLGCCLEKDEKML--IYEFMPNKSLD------YFIFDESRKQLLDWKKRFDIIL 477
H+N+V+ + L K + L + EF L Y +F + + + DI
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI-----VDITR 125
Query: 478 GIARGVLYLHQ----DSRLRIIHRDLKASNILLD-------------EEMNPR----ISD 516
+ + Y H + R++HRDLK NI L +N R I D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 517 FGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGL--FSTKSDVFSFGVLLLEIITGK 572
FG ++ G E ++ + VGT Y SPE L + KSD+++ G ++ E+ +GK
Sbjct: 186 FGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-07
Identities = 16/88 (18%), Positives = 27/88 (30%), Gaps = 15/88 (17%)
Query: 182 STCQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCL---GNCSCVAYASAYAETNG 238
C+ + +K+ T C +C SC A+ A A
Sbjct: 3 EFCKSAGTTLIKIALKIKTTKANT-------ADECANRCEKNGLPFSCKAFVFAKARK-- 53
Query: 239 GIGCLIYH-GDLNDTRTYTNAGQDLFVR 265
CL + ++ R + G DL+
Sbjct: 54 --QCLWFPFNSMSGVRKEFSHGFDLYEN 79
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 58/233 (24%), Positives = 102/233 (43%), Gaps = 22/233 (9%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN---EVLLIAKLQHRNLVKLLG 434
LG+G FG V + A+G+ A+K L +E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 494
KD + E++ L F SR+++ + I + YLH +I
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116
Query: 495 IHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFST 554
++RDLK N++LD++ + +I+DFG + G + GT Y++PE +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 555 KSDVFSFGVLLLEIITGKKNTGIFNDDSSNL--------IRYVWELWSDDKAL 599
D + GV++ E++ G+ +N D L I++ L +D K+L
Sbjct: 175 AVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEDIKFPRTLSADAKSL 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 45/226 (19%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
++F +G+G FG V KL N ++ A+K L+ K E+L A+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN----------KWEMLKRAET----- 45
Query: 430 VKLLGCCLEKDEKMLI-----------YEFMPNKSL----DYFIFDESRKQLLDWKKRFD 474
C ++ +L+ Y F +L DY++ + L ++ R
Sbjct: 46 -----ACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP 100
Query: 475 IILG---IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531
+ +A V+ + +L +HRD+K NIL+D + R++DFG+ E+ +
Sbjct: 101 EDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQ 159
Query: 532 TNRVVGTYGYMSPEYALG-----GLFSTKSDVFSFGVLLLEIITGK 572
++ VGT Y+SPE G + + D +S GV + E++ G+
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-06
Identities = 26/79 (32%), Positives = 39/79 (49%), Gaps = 8/79 (10%)
Query: 189 GFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCL-GNCSCVAYASAYAETNGGIGCLIYH- 246
F++L K+P S +L + C KCL NCSC ++ Y NG GCL++
Sbjct: 5 CFVRLPNTKLPGFSRIVISVASL--EECASKCLNSNCSCRSFT--Y--NNGTKGCLLWSE 58
Query: 247 GDLNDTRTYTNAGQDLFVR 265
L D R + + G DL+ +
Sbjct: 59 SSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 16/134 (11%)
Query: 444 LIYEFMPNKSLDYFI--FDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKA 501
++ E+MP L + +D K W + + A VL L + IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIHSMGFIHRDVKP 170
Query: 502 SNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG----GLFSTKSD 557
N+LLD+ + +++DFGT E + + VGT Y+SPE G + + D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229
Query: 558 VFSFGVLLLEIITG 571
+S GV L E++ G
Sbjct: 230 WWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 32/149 (21%), Positives = 59/149 (39%), Gaps = 19/149 (12%)
Query: 378 KLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV--KLLGC 435
L G VY + + +K + + + EV ++ L + L K+L
Sbjct: 5 LLKGGLTNRVYLLGTKDE-DYVLKINPSREKG--ADREREVAILQLLARKGLPVPKVLAS 61
Query: 436 CLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--IARGVLYLHQDSRLR 493
L+ E++ ++LD + +E ++ + + L +A+ LHQ L
Sbjct: 62 GESDGWSYLLMEWIEGETLD-EVSEEEKEDIAE-------QLAELLAK----LHQLPLLV 109
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARV 522
+ H DL NIL+D+ I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 34/114 (29%), Positives = 47/114 (41%), Gaps = 30/114 (26%)
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDF---------GTARVFGG---------- 525
YLH L I++RDLK NILL E + +SDF
Sbjct: 118 YLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 526 --------EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITG 571
EE S +N VGT Y++PE G + D ++ G+LL E++ G
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 45/181 (24%), Positives = 70/181 (38%), Gaps = 40/181 (22%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLAN-----GQEIAVKRLSTTSGQGIEEFKNEVLL----- 420
D+F KLG+G FG VYK L N + +K+ +T G +E + NE +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPN 189
Query: 421 -IAKLQHRNLVKLLGCCLEKDEKML-----------IYEFMPNKSLDY----FIFDESRK 464
A + L K E + + M +K Y ++ + +
Sbjct: 190 SCADFVY----GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQD 245
Query: 465 QLLDWKKRFDIILGIARGVLY----LHQDSRLRIIHRDLKASNILLDEEMNP-RISDFGT 519
++ II I R +L+ LH I+HRD+K NI+ E +I D G
Sbjct: 246 LPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGA 302
Query: 520 A 520
A
Sbjct: 303 A 303
|
Length = 566 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 9e-06
Identities = 40/154 (25%), Positives = 64/154 (41%), Gaps = 25/154 (16%)
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------IILGI 479
+ N +KL +LI +++ + L FD LL + + II +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FD-----LLKKEGKLSEAEVKKIIRQL 118
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP-RISDFGTARVFGGEEISTNTNRVVGT 538
+ LH + IIH D+K N+L D + + D+G ++ G GT
Sbjct: 119 VEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GT 169
Query: 539 YGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
Y SPE G + D ++ GVL E++TGK
Sbjct: 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 9/90 (10%)
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS--TNTNRVVGTYGYM 542
YLH +++RDLK N++LD++ + +I+DFG + E IS GT Y+
Sbjct: 110 YLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYL 162
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+PE + D + GV++ E++ G+
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 60/249 (24%), Positives = 102/249 (40%), Gaps = 62/249 (24%)
Query: 371 DNFSTSNKLGQGGFGPV-YKGKLANGQEIAVKRLSTTS----GQGIEEFKNEVLLIAKLQ 425
D+F + +G+G FG V K G A+K+L + Q + + E ++A+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSL-------DYFIFDESRKQLLDWKKRFDIILG 478
+ +VKL +++ LI E++P + D F +E+R
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR-------------FY 106
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGT------------ARVFGGE 526
IA +L + +L IHRD+K N+LLD + + ++SDFG R+
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 527 EISTNT------------------NR------VVGTYGYMSPEYALGGLFSTKSDVFSFG 562
S NR VGT Y++PE L ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 563 VLLLEIITG 571
V++ E++ G
Sbjct: 227 VIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 29/111 (26%), Positives = 54/111 (48%), Gaps = 6/111 (5%)
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT 538
I + YLH + +++RDLK N++LD++ + +I+DFG + G + GT
Sbjct: 104 IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159
Query: 539 YGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYV 589
Y++PE + D + GV++ E++ G+ +N D L +
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-05
Identities = 17/48 (35%), Positives = 28/48 (58%), Gaps = 4/48 (8%)
Query: 645 NETS-VPSPKQPTFSVRKIEIDTDYSSTGTK---SSANEVTLTTFIGR 688
+ET+ +P PKQP F V + +TD SS+ + + N+VT++ R
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 43/238 (18%)
Query: 371 DNFSTSNKLGQGGFGPV-YKGKLANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQH 426
D+F + +G+G FG V K G A+K L + + + E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
+VK+ +K LI EF+P D + L + +F IA VL +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQF----YIAETVLAI 114
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA--------------------RVFGGE 526
+L IHRD+K N+LLD + + ++SDFG F +
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 527 EIST-------NTNR------VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITG 571
+++ NR VGT Y++PE + ++ D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 55/238 (23%), Positives = 96/238 (40%), Gaps = 43/238 (18%)
Query: 371 DNFSTSNKLGQGGFGPV-YKGKLANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQH 426
++F + +G+G FG V K G A+K L + + + E ++ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
+VK+ +K LI EF+P + + + L + + +F IA VL +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQF----YIAETVLAI 114
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA---RVFGGEEISTNTNR--------- 534
+L IHRD+K N+LLD + + ++SDFG + E N N
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 535 ---------------------VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITG 571
VGT Y++PE + ++ D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 41/134 (30%), Positives = 59/134 (44%), Gaps = 36/134 (26%)
Query: 466 LLDW---------KKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEEMNP- 512
LLDW + II + Y H + L ++H DLK NIL+ D ++P
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPV 275
Query: 513 ------------RISDFGTARVFGGEEISTNTNRVVGTYGYMSPE--YALGGLFSTKSDV 558
RI D G +E + T +V T Y SPE LG ++ST D+
Sbjct: 276 TNRALPPDPCRVRICDLGGC----CDERHSRT-AIVSTRHYRSPEVVLGLGWMYST--DM 328
Query: 559 FSFGVLLLEIITGK 572
+S G ++ E+ TGK
Sbjct: 329 WSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 33/129 (25%), Positives = 61/129 (47%), Gaps = 15/129 (11%)
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT 538
I + YLH +++RD+K N++LD++ + +I+DFG + + + T GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 158
Query: 539 YGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNL--------IRYVW 590
Y++PE + D + GV++ E++ G+ +N D L IR+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEIRFPR 216
Query: 591 ELWSDDKAL 599
L + K+L
Sbjct: 217 TLSPEAKSL 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 44/223 (19%)
Query: 379 LGQGGFGPVYKGKL-----------------------ANGQEIAV--KRLSTTSGQGIEE 413
LGQG +Y G+L NG+E+ V K L +
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 414 FKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF 473
F L++++ H +L + G C+ E +++ EF+ + LD + E + + WK
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--I 120
Query: 474 DIILGIARGVLYLHQDSRLRIIHRDLKASNIL-----LDEEMNP--RISDFGTARVFGGE 526
+ +A + YL + ++H ++ A NIL L E +P ++SD G + F
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175
Query: 527 EISTNTNRVVGTYGYMSPEYALGGL-FSTKSDVFSFGVLLLEI 568
R+ +++PE GG ST +D +SFG LLEI
Sbjct: 176 SREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 27/96 (28%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 476 ILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531
+ +AR +L Y+H + IIHRD+K N+L++ + + DFG A G +
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLE 567
+ GT +PE G ++ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 18/101 (17%)
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT------------ 532
YLH I+HRDLK N+L+ + +++DFG +++ G ++TN
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI-GLMSLTTNLYEGHIEKDTREF 171
Query: 533 --NRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITG 571
+V GT Y++PE L + D ++ G++L E + G
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 49/195 (25%), Positives = 88/195 (45%), Gaps = 29/195 (14%)
Query: 395 GQEIAVK--RLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNK 452
G + V+ L + + ++ +NEV+L +H N++ +I FM
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 453 SLDYFI---FDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE 509
S + + F E + L +I+ G RG+ YLHQ+ IHR++KAS+IL+ +
Sbjct: 85 SANSLLKTYFPEGMSEALIG----NILFGALRGLNYLHQNG---YIHRNIKASHILISGD 137
Query: 510 MNPRISDFGT--ARVFGGEEISTNTNRVVGTY--------GYMSPEYALGGL--FSTKSD 557
+S + V G++ +VV + ++SPE L ++ KSD
Sbjct: 138 GLVSLSGLSHLYSLVRNGQK-----AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSD 192
Query: 558 VFSFGVLLLEIITGK 572
++S G+ E+ TG+
Sbjct: 193 IYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 17/38 (44%), Positives = 26/38 (68%), Gaps = 3/38 (7%)
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522
YLH+ IIHRDLK N+L+ E + +++DFG ++V
Sbjct: 119 YLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 34/212 (16%)
Query: 379 LGQGGFGPVYKGKL-----------ANGQEIAV--KRLSTTSGQGIEEFKNEVLLIAKLQ 425
LG+G +Y G L + +EI V K L + F ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
H+++V L G C+ E +++ EF+ LD F+ +S WK F + +A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--FKVAKQLASALSY 120
Query: 486 LHQDSRLRIIHRDLKASNILL-----DEEMNP--RISDFGTA-RVFGGEEISTNTNRVVG 537
L +D L +H ++ NILL D E P ++SD G V +E V
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQE-------CVE 170
Query: 538 TYGYMSPEYAL-GGLFSTKSDVFSFGVLLLEI 568
+++PE S +D +SFG L EI
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 57/252 (22%), Positives = 96/252 (38%), Gaps = 61/252 (24%)
Query: 373 FSTSNKLGQGGFGPV-YKGKLANGQEIAVKRL---STTSGQGIEEFKNEVLLIAKLQHRN 428
F LG G FG V K+ A+K L + + K E ++A+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG---IARGVLY 485
+VKL +KD + +++P + LL + F +L IA L
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDM---------MSLLIRMEVFPEVLARFYIAELTLA 113
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG--------------------- 524
+ ++ IHRD+K NIL+D + + +++DFG F
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 525 ------------GEEISTNTNR------------VVGTYGYMSPEYALGGLFSTKSDVFS 560
G+ + T R +VGT Y++PE L ++ D +S
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233
Query: 561 FGVLLLEIITGK 572
GV+L E++ G+
Sbjct: 234 VGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|234235 TIGR03503, TIGR03503, TIGR03503 family protein | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 15/54 (27%), Positives = 26/54 (48%), Gaps = 1/54 (1%)
Query: 261 DLFVRADAAELAAEAQKNSKSNRARKRRLA-LIIVAIVLGVLLLGLCYFFLWRR 313
+ +A + AE ++ R K +II+ + +LLLG FF+WR+
Sbjct: 318 EEAATEEALKAKAEQEQALLVEREAKDSKFWIIIIVGNVVILLLGGIGFFVWRK 371
|
This set of conserved hypothetical protein has a phylogenetic range that closely matches that of TIGR03501, a putative C-terminal protein targeting signal. Length = 374 |
| >gnl|CDD|129694 TIGR00606, rad50, rad50 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 30/114 (26%), Positives = 49/114 (42%), Gaps = 10/114 (8%)
Query: 394 NGQEIAV-KRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNK 452
NG+E AV + + T EFK +I + +H V L C E D +M+ + +
Sbjct: 89 NGEECAVVRSMVCTQKTKKTEFKTLEGVITRYKHGEKVSLSSKCAEIDREMISHLGVSKA 148
Query: 453 SLDYFIF---DESRKQLLD---WKKRFDIILGIARGVLYLHQDSRLRIIHRDLK 500
L+ IF ++S L + K++FD I R Y+ LR + +
Sbjct: 149 VLNNVIFCHQEDSNWPLSEGKALKQKFDEIFSATR---YIKALETLRQVRQTQG 199
|
All proteins in this family for which functions are known are involvedin recombination, recombinational repair, and/or non-homologous end joining.They are components of an exonuclease complex with MRE11 homologs. This family is distantly related to the SbcC family of bacterial proteins.This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University). Length = 1311 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 33/135 (24%), Positives = 53/135 (39%), Gaps = 41/135 (30%)
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF-----------GG-- 525
IA + ++ IHRD+K NIL+D + + +++DFG F G
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 526 --------EEISTNTNR--------------------VVGTYGYMSPEYALGGLFSTKSD 557
EE S +VGT Y++PE L ++ D
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226
Query: 558 VFSFGVLLLEIITGK 572
+S GV+L E++ G+
Sbjct: 227 WWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 688 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.98 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.91 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.51 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.48 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.43 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.38 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.38 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.37 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.31 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.18 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.12 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.05 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.97 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.95 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.86 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.77 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.76 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.75 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.63 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.62 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.59 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.58 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.57 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.53 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.53 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.46 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.23 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.18 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.12 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.9 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.88 | |
| PLN02236 | 344 | choline kinase | 96.82 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.64 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.5 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.32 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.93 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.75 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.7 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.61 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.49 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.24 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.06 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.0 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.86 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.83 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.79 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-56 Score=473.07 Aligned_cols=290 Identities=45% Similarity=0.757 Sum_probs=257.2
Q ss_pred ceeeeehHHHHHHhcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEE
Q 005599 357 DVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCC 436 (688)
Q Consensus 357 ~~~~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 436 (688)
....|++.++..||++|...++||+|+||.||+|.+.+|..||||++.....+...+|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999988765443156699999999999999999999999
Q ss_pred EeCC-ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceec
Q 005599 437 LEKD-EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRIS 515 (688)
Q Consensus 437 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 515 (688)
.+.+ +++||||||++|+|.++|+..... .++|..|++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 499999999999999999876544 88999999999999999999999998899999999999999999999999
Q ss_pred ccccceecCCCccccccccc-cccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-CCCccHHHHHHHHh
Q 005599 516 DFGTARVFGGEEISTNTNRV-VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFN-DDSSNLIRYVWELW 593 (688)
Q Consensus 516 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~-~~~~~l~~~~~~~~ 593 (688)
|||+|+......... ... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+... .....+..|++..+
T Consensus 220 DFGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCccccce--eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999997654311111 112 89999999999999999999999999999999999999887544 34456899999999
Q ss_pred cccccccccccccc-CCCCH-HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCC
Q 005599 594 SDDKALEIVDSSMA-DSCPA-PEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSV 649 (688)
Q Consensus 594 ~~~~~~~~~d~~l~-~~~~~-~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 649 (688)
..+.+.+++|+.+. +..+. .+...+..++.+|++.+|++||+|.||+++|+.+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999999999987 66664 7899999999999999999999999999999665433
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=397.55 Aligned_cols=256 Identities=33% Similarity=0.522 Sum_probs=211.7
Q ss_pred CCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCCccceEEEEEeCC-ceeEEEecc
Q 005599 373 FSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSG--QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD-EKMLIYEFM 449 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~ 449 (688)
+.+.+.||+|+||+||+|.+.+...||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344567999999999999997555599999976432 22569999999999999999999999999988 799999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC-CceecccccceecCCCcc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM-NPRISDFGTARVFGGEEI 528 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 528 (688)
++|+|..+++.. .+..+++..+++++.|||+||.|||+.+. ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999765 46679999999999999999999999874 99999999999999997 99999999998765432
Q ss_pred ccccccccccCCccCceeec--CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYAL--GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
.......||+.|||||++. ...|+.|+||||||++||||+||+.||..... ...+... +....
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~v---------~~~~~ 263 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASAV---------VVGGL 263 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHH---------HhcCC
Confidence 2222268999999999999 56999999999999999999999999864332 1111111 11222
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
+...|..+...+..|+.+||+.||+.||++.+++.+|+.+.
T Consensus 264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 23334446667999999999999999999999999998654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=398.68 Aligned_cols=254 Identities=33% Similarity=0.516 Sum_probs=222.3
Q ss_pred CCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005599 374 STSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKS 453 (688)
Q Consensus 374 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 453 (688)
...+.||+|-||+||.|.++....||||.++.. ....+.|.+|+++|++|+|+|||+++|+|..++..+||||||+.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 345799999999999999988889999999765 3456789999999999999999999999999999999999999999
Q ss_pred hhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccccc
Q 005599 454 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTN 533 (688)
Q Consensus 454 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 533 (688)
|.++|.. .....+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+...++.+... .
T Consensus 288 Ll~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~-~ 362 (468)
T KOG0197|consen 288 LLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS-E 362 (468)
T ss_pred HHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeec-C
Confidence 9999976 23456889999999999999999999998 99999999999999999999999999996655554333 2
Q ss_pred cccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCH
Q 005599 534 RVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPA 612 (688)
Q Consensus 534 ~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 612 (688)
...-+..|.|||.+....|+.|||||||||+||||+| |+.|+.. +...++.+.++...+...|.
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~---------------msn~ev~~~le~GyRlp~P~ 427 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG---------------MSNEEVLELLERGYRLPRPE 427 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC---------------CCHHHHHHHHhccCcCCCCC
Confidence 3455788999999999999999999999999999999 7877642 23344556677777888899
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 005599 613 PEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETS 648 (688)
Q Consensus 613 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 648 (688)
.++..+.+||..||+.+|++|||++.+...|+....
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 999999999999999999999999999999987543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=414.45 Aligned_cols=259 Identities=31% Similarity=0.493 Sum_probs=223.9
Q ss_pred cCCCCCCccccCCcEeEEEEEeC------CCcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCCccceEEEEEeCCcee
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTSGQ-GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKM 443 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 443 (688)
.+....+.||+|+||+||+|+.. +.+.||||.++..... ...+|++|+++++.++|||||+|+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 44556689999999999999743 3567999999876554 7889999999999999999999999999999999
Q ss_pred EEEeccCCCChhhHhhccC-------C----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCc
Q 005599 444 LIYEFMPNKSLDYFIFDES-------R----KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP 512 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 512 (688)
+|+|||..|+|.+||.... . +.+|+..+.+.||.|||.||+||-++. +|||||..+|+||.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 9999999999999996421 1 234889999999999999999999987 9999999999999999999
Q ss_pred eecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHH
Q 005599 513 RISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWE 591 (688)
Q Consensus 513 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~ 591 (688)
||+||||++.+...++........-+.+|||||.+..++||++||||||||+|||++| |+.|+...
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl------------- 709 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL------------- 709 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc-------------
Confidence 9999999999988888877666677889999999999999999999999999999999 88886432
Q ss_pred HhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 592 LWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 592 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
.++++.+.+..+-..++|+.++.+++.|+..||+.+|.+||+++||-..|+...
T Consensus 710 --Sn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 710 --SNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred --chHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 223333333333335678888899999999999999999999999999997754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=366.79 Aligned_cols=251 Identities=26% Similarity=0.378 Sum_probs=208.9
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCc-eeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE-KMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~e~ 448 (688)
+++..+.||+|..|+|||+.++ +++.+|+|.+... .....+++.+|++++.+.+||+||.++|.|..... ..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4455789999999999999876 5778999999543 44557889999999999999999999999999995 9999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
|++|+|+.++... +.+++...-+|+.+|++||.|||+.. .||||||||+||||+..|++||+|||.++.+.+.
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999998543 45889999999999999999999632 3999999999999999999999999999876543
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
..++.+||..|||||.+.+..|+.++||||||++++|+.+|+.|+....+........+.....++. .
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp----------P 300 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP----------P 300 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC----------C
Confidence 4456899999999999999999999999999999999999999986543333333333322222111 1
Q ss_pred CCCHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 609 SCPAP-EALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 609 ~~~~~-~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..|.. .+.++.+++..||++||.+||++.|+++
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22333 6778999999999999999999999885
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=360.80 Aligned_cols=198 Identities=30% Similarity=0.541 Sum_probs=178.5
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
..+|.+.+.||+|+||+||+|+++ ++..||||.+... .....+-+..|+.+|+.++|||||+|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 367888899999999999999865 5789999999765 4556677889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCC------CCceecccccc
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE------MNPRISDFGTA 520 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~------~~~kl~DFGla 520 (688)
|||.+|+|..|++.. ..+++.....++.|||.||++||+++ ||||||||.||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999543 36899999999999999999999998 9999999999999865 46899999999
Q ss_pred eecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 005599 521 RVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTG 576 (688)
Q Consensus 521 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~ 576 (688)
+.+...... .+.+|++-|||||++....|+.|+|+||+|+|||++++|+.||.
T Consensus 163 R~L~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 163 RFLQPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred hhCCchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 998754332 34899999999999999999999999999999999999999985
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=376.76 Aligned_cols=247 Identities=24% Similarity=0.365 Sum_probs=211.1
Q ss_pred cCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
..|...+.||+|||+.+|+++. ..|+.||+|++.+. .....+...+||++.+.|+|||||+++++|++.+..|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688889999999999999987 78999999999763 3345678899999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
|+|++++|..++. +++.+++.+...++.||+.||.|||+.+ |||||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999884 5678999999999999999999999998 999999999999999999999999999988754
Q ss_pred ccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
+.. ..+.+|||.|+|||++.....+..+||||+|||||-||.|++||+.. .+.+-... +.. -+
T Consensus 172 ~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~vkety~~-Ik~------~~--- 234 (592)
T KOG0575|consen 172 GER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TVKETYNK-IKL------NE--- 234 (592)
T ss_pred ccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hHHHHHHH-HHh------cC---
Confidence 322 23489999999999999999999999999999999999999999531 11111111 100 01
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
...|...+.++.+|+.++|+.+|.+|||+.+|+.
T Consensus 235 -Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 -YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1234455667899999999999999999999994
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=357.70 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=199.5
Q ss_pred hcCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCCCcc-------cHHHHHHHHHHHhhcCCCCccceEEEEEeCCc
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQ-------GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE 441 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 441 (688)
.+.|.+.+.||+|+||.|-+|. -++|+.||||++++.... ......+|+++|++|+|||||++.+++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3567788999999999999996 457999999999754211 12234699999999999999999999999999
Q ss_pred eeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCC---CCceecccc
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE---MNPRISDFG 518 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFG 518 (688)
.|+|||||++|+|.+++.. ++.+.+..-..++.|++.|+.|||+.+ |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999854 345667777889999999999999999 9999999999999766 679999999
Q ss_pred cceecCCCccccccccccccCCccCceeecCCC---CCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcc
Q 005599 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALGGL---FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSD 595 (688)
Q Consensus 519 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 595 (688)
+|+..+.. ....+.+|||.|.|||++.+.. +..++|+||+||+||-+++|.+||....... .+. +....
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~----eQI~~ 396 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLK----EQILK 396 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHH----HHHhc
Confidence 99987633 3344589999999999998764 3448899999999999999999985321111 011 11111
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 596 DKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 596 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+... + ....-...+++..+|+.++|..||++|||+.|+++
T Consensus 397 G~y~--f----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRYA--F----GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred Cccc--c----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1100 0 00112345678999999999999999999999884
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=346.78 Aligned_cols=260 Identities=25% Similarity=0.394 Sum_probs=210.9
Q ss_pred cCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEE-EEEeCCc-eeEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLG-CCLEKDE-KMLI 445 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV 445 (688)
.+|.++++||+|+||+|||+. +.+|..||.|.+.-. +.+..+....|+.+|++|+|||||++++ .+.+..+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457788999999999999997 668999999998743 3455667889999999999999999999 4545555 8999
Q ss_pred EeccCCCChhhHhhc-cCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 446 YEFMPNKSLDYFIFD-ESRKQLLDWKKRFDIILGIARGVLYLHQDS-RLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
|||+..|+|...+.. ...++.++++.+++++.|++.||.++|+.- +..|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999864 345677999999999999999999999942 124999999999999999999999999999988
Q ss_pred CCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 524 GGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 524 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
..... .....+|||.||+||.+.+..|+.|+||||+||++|||..-++||... ++... ......++.
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L-~~KI~qgd~----- 245 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSL-CKKIEQGDY----- 245 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHH-HHHHHcCCC-----
Confidence 65443 334589999999999999999999999999999999999999998532 23222 111222211
Q ss_pred ccccCCCC-HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 604 SSMADSCP-APEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 604 ~~l~~~~~-~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
.+.| ...+..+..|+..|+..||+.||+...++..+....
T Consensus 246 ----~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l 286 (375)
T KOG0591|consen 246 ----PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSEL 286 (375)
T ss_pred ----CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHh
Confidence 1133 455778999999999999999999766666665543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=387.40 Aligned_cols=256 Identities=25% Similarity=0.435 Sum_probs=223.5
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC----CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN----GQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 445 (688)
....+.++||.|.||+|++|+++- ...||||.|+... .....+|+.|+.||.++.||||++|.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345677999999999999998753 3579999998763 45577899999999999999999999999999999999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
.|||+||+|+.||.... ..+.+.+...++.+||.||.||-+.+ +|||||.++||||+.+..+|++||||++.+.+
T Consensus 709 TEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999997654 34899999999999999999999988 99999999999999999999999999998765
Q ss_pred Cccccccccc--cccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccc
Q 005599 526 EEISTNTNRV--VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 526 ~~~~~~~~~~--~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 602 (688)
+. ....+.. .-+.+|.|||.+...+++.++||||||++|||+++ |++|+- + +.++++.+.+
T Consensus 784 d~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW--------------d-mSNQdVIkaI 847 (996)
T KOG0196|consen 784 DP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW--------------D-MSNQDVIKAI 847 (996)
T ss_pred CC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc--------------c-cchHHHHHHH
Confidence 54 2222222 22578999999999999999999999999999998 999962 1 4456677777
Q ss_pred cccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 603 d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
+...+.+.|++++..+.+||+.|||+|-.+||.+.+|+.+|.+..
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 888888889999999999999999999999999999999987754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.22 Aligned_cols=243 Identities=25% Similarity=0.365 Sum_probs=200.8
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
..++|+++++||+|+||+||.++.+ +++.+|+|++++.. ....+..++|..+|.+++||+||++.-.|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3478999999999999999999754 58899999997653 3346678899999999999999999999999999999
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
|+||+.+|.|..+|.. +..+++....-++.+|+.||.|||+.+ ||||||||+|||||++|+++|+||||++..-
T Consensus 103 Vld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999943 445788878889999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccc
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS 604 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 604 (688)
... ..+.+.+||+.|||||++.+..|+..+|+||+|+++|||++|.+||... +...+..... .++
T Consensus 177 ~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~~~I~-~~k------- 241 (357)
T KOG0598|consen 177 KDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMYDKIL-KGK------- 241 (357)
T ss_pred cCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHHHHHh-cCc-------
Confidence 332 3344589999999999999999999999999999999999999998532 1222211111 111
Q ss_pred cccCCCCHHHHHHHHHHHhhcccCCCCCCC
Q 005599 605 SMADSCPAPEALRCIQVGLLCVQDRTTDRP 634 (688)
Q Consensus 605 ~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RP 634 (688)
+ ...|.-.+.+..+++...++.+|++|-
T Consensus 242 -~-~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 -L-PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -C-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 0 111222455788999999999999996
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=354.29 Aligned_cols=266 Identities=27% Similarity=0.444 Sum_probs=221.1
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
......+.++||+|-||.|.++....+..||||.++.... ....+|..|+++|.+|+|||||+|+|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 3455677899999999999999998889999999987643 446899999999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
||++|+|..|+...... .+.-...++|+.|||.||+||.+.+ +|||||.++|+|+|.++++||+|||+++-+...+
T Consensus 616 YmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999654322 2455667789999999999999987 9999999999999999999999999999888888
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh--CCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT--GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
+.....+.+-+.+|||||.+..++++.++|||+||++|||+++ .++|++...+ ++.++-.-..+..+....+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e~vven~~~~~~~~~~~~~---- 765 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--EQVVENAGEFFRDQGRQVV---- 765 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--HHHHHhhhhhcCCCCccee----
Confidence 8877777888999999999999999999999999999999877 5677643322 1222222222222221111
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
...|..++..+.+++++||..+-++||+++++...|...
T Consensus 766 --l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 --LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 223556677899999999999999999999999988653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=329.70 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=203.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc-c-cHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG-Q-GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
+.|+.+-++|+|+||+|||++.+ +|+.||||++..... . -.+-.++|+++|++|+|+|+|.|+.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777889999999999999876 599999999965432 2 33456899999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|++..-|+++-. ....++.....+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+...
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 999888776643 2345788899999999999999999998 999999999999999999999999999988632
Q ss_pred cccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHH----------HHh-cc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVW----------ELW-SD 595 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~----------~~~-~~ 595 (688)
....+..+.|.+|.|||.+.+ ..|+..+|||++||++.||++|.+-|....+- +++..... ..+ ..
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi-DQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI-DQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH-HHHHHHHHHHcccCHHHHHHhccC
Confidence 122334789999999999988 67999999999999999999999987543321 11211110 011 11
Q ss_pred ccccccccccccCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 596 DKALEIVDSSMADSC-----PAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 596 ~~~~~~~d~~l~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+....+.-|.....- -+.....+++++..|++.||.+|++-++++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111111111111 1123446899999999999999999999883
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=350.63 Aligned_cols=270 Identities=24% Similarity=0.344 Sum_probs=216.2
Q ss_pred HhcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCcee
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKM 443 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 443 (688)
..++|...+.||+|+|++|++|+. ..++++|||++.+. .....+-...|-.+|.+| .||.|++|+-.|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 446889999999999999999974 46899999998653 223345567899999999 8999999999999999999
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
+|+||+++|+|.++|... ..+++.....++.+|+.||+|||+.+ ||||||||+|||||+|+++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999544 45888888889999999999999998 999999999999999999999999999988
Q ss_pred CCCccc---------cc--cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH
Q 005599 524 GGEEIS---------TN--TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWEL 592 (688)
Q Consensus 524 ~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~ 592 (688)
...... .. ...++||..|.+||+|.+...+..+|+|+|||+||+|+.|++||...++ ....+.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--yliFqk---- 298 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--YLIFQK---- 298 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--HHHHHH----
Confidence 643322 11 1448999999999999999999999999999999999999999853221 111111
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--h-----cCCCCCCCCCCCCcccc
Q 005599 593 WSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM--L-----SNETSVPSPKQPTFSVR 660 (688)
Q Consensus 593 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L-----~~~~~~~~p~~~~~~~~ 660 (688)
+++ +.-.+|...++.+.+|+.+.|..||.+|+|.++|-+. + +++-...+|+..++...
T Consensus 299 --------I~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p~ 363 (604)
T KOG0592|consen 299 --------IQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPYKPA 363 (604)
T ss_pred --------HHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCCCCc
Confidence 111 1122344444678999999999999999999999863 2 33334555555555333
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=386.42 Aligned_cols=260 Identities=32% Similarity=0.520 Sum_probs=218.0
Q ss_pred hcCCCCCCccccCCcEeEEEEEeCC--Cc----EEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCce
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLAN--GQ----EIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEK 442 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~~--~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 442 (688)
..+....+.||+|+||.||+|...+ +. .||||.+... +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3445667899999999999998653 33 4899999765 556788999999999999999999999999999999
Q ss_pred eEEEeccCCCChhhHhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccc
Q 005599 443 MLIYEFMPNKSLDYFIFDES----RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG 518 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 518 (688)
++++|||++|+|..||.+.. ....+.....+.++.|||+|+.||++++ +|||||..+|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997642 2456889999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccc
Q 005599 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDK 597 (688)
Q Consensus 519 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 597 (688)
||+.+...++........-+..|||||.+..+.|+.|+|||||||+|||++| |..|+.... ..++.. .....+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~--n~~v~~---~~~~gg- 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS--NFEVLL---DVLEGG- 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc--hHHHHH---HHHhCC-
Confidence 9997777777666555556789999999999999999999999999999999 788874321 111111 111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 598 ALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 598 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
+...|..++..+.+||..||+.+|++||++..|++.+..+.
T Consensus 922 ---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 922 ---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred ---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 23456677888999999999999999999999999887764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=360.50 Aligned_cols=262 Identities=28% Similarity=0.428 Sum_probs=205.8
Q ss_pred HhcCCCCCCccccCCcEeEEEEEe------CCCcEEEEEEccCCCc-ccHHHHHHHHHHHhhc-CCCCccceEEEEEeCC
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKL------ANGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKD 440 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 440 (688)
..++|.+.++||+|+||.||+|.. .++..||||++..... ...+.+.+|+.++..+ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346789999999999999999974 2356899999875432 3356789999999999 8999999999987654
Q ss_pred -ceeEEEeccCCCChhhHhhccCC--------------------------------------------------------
Q 005599 441 -EKMLIYEFMPNKSLDYFIFDESR-------------------------------------------------------- 463 (688)
Q Consensus 441 -~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 463 (688)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999864211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccccccccccCC
Q 005599 464 ---KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540 (688)
Q Consensus 464 ---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 540 (688)
...+++...+.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 234788899999999999999999987 99999999999999999999999999987643332222233456788
Q ss_pred ccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHH
Q 005599 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCI 619 (688)
Q Consensus 541 y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 619 (688)
|+|||++.+..++.++|||||||+||||++ |..||...... ..+ ......+.. ...+...+..+.
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~----~~~~~~~~~---------~~~~~~~~~~l~ 307 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEF----CQRLKDGTR---------MRAPENATPEIY 307 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHH----HHHHhcCCC---------CCCCCCCCHHHH
Confidence 999999999999999999999999999997 99998542211 111 111111110 111223345789
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 620 QVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 620 ~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
+|+.+||+.+|++|||+.||+++|+...
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=344.60 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=204.2
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC-CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCC--ceeEEEe
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD--EKMLIYE 447 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e 447 (688)
.++...+.||+|+||.||++...+ |...|||.+...+....+.+.+|+.+|.+++|||||+.+|.....+ ..+++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 446667999999999999998754 8999999987654333677899999999999999999999865555 5889999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECC-CCCceecccccceecCC-
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-EMNPRISDFGTARVFGG- 525 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~- 525 (688)
|+++|+|.+++..... .+++..+..++.||++||+|||+++ ||||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999965432 5899999999999999999999988 999999999999999 79999999999987764
Q ss_pred CccccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS 604 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 604 (688)
...........||+.|||||++.++ ....++|||||||++.||+||++|+... .....++.......
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~-------- 239 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGRED-------- 239 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccC--------
Confidence 1122233347899999999999964 3445999999999999999999998542 11111111111111
Q ss_pred cccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 005599 605 SMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643 (688)
Q Consensus 605 ~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 643 (688)
.....|...+....+++..|++.+|++|||+.++++..
T Consensus 240 -~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 240 -SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11134455666789999999999999999999999754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=346.46 Aligned_cols=264 Identities=29% Similarity=0.453 Sum_probs=205.5
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC-----------------CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccce
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN-----------------GQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKL 432 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 432 (688)
++|.+.++||+|+||.||++...+ +..||||.+.... .....+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568888999999999999997532 3369999987543 3345679999999999999999999
Q ss_pred EEEEEeCCceeEEEeccCCCChhhHhhccC----------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 005599 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDES----------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 496 (688)
Q Consensus 433 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 496 (688)
++++.+.+..++||||+++|+|.+++.... ....+++..+++++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885421 1234788999999999999999999988 999
Q ss_pred cCCCCCceEECCCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhC--CCC
Q 005599 497 RDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITG--KKN 574 (688)
Q Consensus 497 ~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG--~~p 574 (688)
|||||+|||++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999876544333333345568899999999988999999999999999999975 445
Q ss_pred CCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 575 TGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 575 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
+... ........+........... ....+...+..+.+|+.+||+.+|++|||+.+|.+.|++
T Consensus 242 ~~~~--~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGEL--TDEQVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcC--CHHHHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5322 22222222222111111000 011122334578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=358.25 Aligned_cols=261 Identities=30% Similarity=0.444 Sum_probs=210.4
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC--C--cE-EEEEEccC---CCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCce
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN--G--QE-IAVKRLST---TSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEK 442 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~--~--~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 442 (688)
++....++||+|+||.||+|++.. + .. ||||..+. .......+|++|++++.+++|||||+++|++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 445556999999999999998653 2 23 89999874 3456788999999999999999999999999999999
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
++|||+|.+|+|+++|.... ..++..+++.++.+.|.||+|||+.+ +|||||.++|+|++.++.+||+||||++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999999995433 25899999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccccccc
Q 005599 523 FGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 523 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 601 (688)
-. .+........-+..|+|||.+....|+.++|||||||++||+++ |..|+..... ..+..+ +
T Consensus 312 ~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--~~v~~k------------I 375 (474)
T KOG0194|consen 312 GS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--YEVKAK------------I 375 (474)
T ss_pred Cc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--HHHHHH------------H
Confidence 43 12222212345789999999999999999999999999999999 7888643211 111111 1
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCCCCC
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSP 652 (688)
Q Consensus 602 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~p 652 (688)
+....+...|...+..+..++.+||..+|++||+|.+|.+.|+.+.....+
T Consensus 376 ~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 376 VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 122223334445566788999999999999999999999999887654443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=340.98 Aligned_cols=263 Identities=24% Similarity=0.359 Sum_probs=202.1
Q ss_pred HhcCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeC--Ccee
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEKM 443 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 443 (688)
..+.|+.+++||+|.||.||+|+ ..+|+.||+|++.... .....-..+||.+|++|.||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34667788999999999999997 5679999999987654 33445567899999999999999999999987 5799
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
||+|||++ +|.-++... .-.++..++..++.|++.||+|+|+.+ |+|||||.+|||||.+|.+||+|||||+++
T Consensus 195 lVFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 99999976 455555332 234889999999999999999999998 999999999999999999999999999988
Q ss_pred CCCccccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccc---
Q 005599 524 GGEEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL--- 599 (688)
Q Consensus 524 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--- 599 (688)
........ +..+-|.+|.|||.+.|. .|+.++|+||.||||.||+.|++.+....+ -+++.. +..+.......
T Consensus 269 ~~~~~~~~-T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-veQl~k-IfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 269 TPSGSAPY-TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-VEQLHK-IFKLCGSPTEDYWP 345 (560)
T ss_pred cCCCCccc-ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-HHHHHH-HHHHhCCCChhccc
Confidence 76554433 346779999999999886 599999999999999999999998754321 122222 11111111100
Q ss_pred -------ccccc------cccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 600 -------EIVDS------SMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 600 -------~~~d~------~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..+.+ .+++. -...+...++|+..+|..||.+|.|+.+++.
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111 11100 1112445788999999999999999999884
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=346.11 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=210.6
Q ss_pred cCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
..|...++||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||.++..+..+++++.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 356667899999999999996 5578999999997766566667889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++|+|.+.+. ...+++.++..|+.++++||+|||.++ |+|||||.+||||+.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999988883 345899999999999999999999998 99999999999999999999999999988765543
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
....++|||.|||||++....|++|+||||||++++||+-|++||-. ++..+.++.....+. ....
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln-----E~PlrAlyLIa~ng~--------P~lk 490 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN-----ENPLRALYLIATNGT--------PKLK 490 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC-----CChHHHHHHHhhcCC--------CCcC
Confidence 44458999999999999999999999999999999999999999733 112222222212211 1122
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.+...+..+.++..+||+.|+++||++.|+|+
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 34555678999999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=350.61 Aligned_cols=263 Identities=27% Similarity=0.454 Sum_probs=209.1
Q ss_pred HHHhcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 367 LAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 367 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
.+..+.+.+.+.||+|+||+||+|.+. ..||||+++.. ..+..+.|++|+.++++-+|.||+-+.|+|..... .+
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 334455677899999999999999985 46999999764 34567899999999999999999999999998877 99
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
|..+|++.+|..+|+... ..++..+.++|+.|||+||.|||.++ |||||||..||+|.+++.+||+||||+....
T Consensus 465 iTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeee
Confidence 999999999999997654 45888999999999999999999998 9999999999999999999999999997544
Q ss_pred CCccccccccccccCCccCceeecC---CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccc
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALG---GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 601 (688)
.-.-........|...|||||++.. .+|+..+||||||+|+|||++|..|+.+...+ +.+ +..+. ..
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIi------fmVGr--G~ 609 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QII------FMVGR--GY 609 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heE------EEecc--cc
Confidence 3322223334567889999999965 36999999999999999999999998632111 110 00011 00
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETS 648 (688)
Q Consensus 602 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 648 (688)
+-+.+. .....+..++.+|+..||..++++||.+.+|+.+|+.+..
T Consensus 610 l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 610 LMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111110 1123455679999999999999999999999998887654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=343.23 Aligned_cols=261 Identities=25% Similarity=0.361 Sum_probs=205.7
Q ss_pred HhcCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCCCcccHHHH--HHHHHHHhhcC-CCCccceEEEEEeCC-cee
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEF--KNEVLLIAKLQ-HRNLVKLLGCCLEKD-EKM 443 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~--~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~ 443 (688)
..++|.+.++||.|.||.||+|+ ..++..||||+++..-.. +++. .+|++.|++|+ |||||+|..++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 45778889999999999999997 457899999999765433 4444 47999999998 999999999999988 899
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
+|||||+ .+|..++.+. ++.+++..+..|+.||++||+|+|.+| +.||||||+|||+.....+||+||||||.+
T Consensus 87 fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 9999994 5787777544 778999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccccccccccccCCccCceeec-CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccc---
Q 005599 524 GGEEISTNTNRVVGTYGYMSPEYAL-GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL--- 599 (688)
Q Consensus 524 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--- 599 (688)
...... +..+.|.+|.|||++. .+.|+.+.|||++|||++||.+-++-|....+ -+++.. +...+......
T Consensus 161 ~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~K-Ic~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 161 RSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-IDQIYK-ICEVLGTPDKDSWP 235 (538)
T ss_pred ccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-HHHHHH-HHHHhCCCccccch
Confidence 655433 3478899999999875 56799999999999999999999988754322 111111 11111111111
Q ss_pred ---------cccccccc-----CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 600 ---------EIVDSSMA-----DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 600 ---------~~~d~~l~-----~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.+.-+... .-.+ ..+.++++|+.+|+..||.+|||+.|.+++
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111 1112 267789999999999999999999999964
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=347.20 Aligned_cols=241 Identities=28% Similarity=0.432 Sum_probs=202.7
Q ss_pred CCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCChh
Q 005599 376 SNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLD 455 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 455 (688)
++-||+|+.|.||+|++. ++.||||+++... ..+|+-|++|+||||+.+.|+|....-+++|||||+.|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 478999999999999995 7899999885322 35788899999999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccccccc
Q 005599 456 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV 535 (688)
Q Consensus 456 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 535 (688)
..|.. .+.+.-.....+..+||.||.|||.+. |||||||.-||||..+..+||+|||-++..... .....+
T Consensus 201 ~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 201 EVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred HHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 99943 345777888899999999999999987 999999999999999999999999999876543 233348
Q ss_pred cccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHH
Q 005599 536 VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEA 615 (688)
Q Consensus 536 ~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 615 (688)
.||..|||||++.+.+.++|+|||||||||||||||.-|+....... .+..+=...|....|..++
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--------------IIwGVGsNsL~LpvPstcP 337 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--------------IIWGVGSNSLHLPVPSTCP 337 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--------------eEEeccCCcccccCcccCc
Confidence 99999999999999999999999999999999999999974221100 1111122234444566777
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 616 LRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 616 ~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
.-+.-|+.+||+..|.+||++++++..|+-..
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 78999999999999999999999999996544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=310.35 Aligned_cols=276 Identities=24% Similarity=0.385 Sum_probs=210.6
Q ss_pred cCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCCCcc--cHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQ--GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
++|...++||+|.||.||+|+ ..+|+.||||+++..... -.....+|++.|+.++|+||+.|+++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 457778999999999999997 457999999999765322 13457899999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
||+ .+|...+.+ ....+.-..+..++.++++||+|||++. |+||||||.|+|++.+|.+||+|||+|+.+....
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 678888744 3457888999999999999999999998 9999999999999999999999999999987654
Q ss_pred cccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccc------ccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK------ALE 600 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~------~~~ 600 (688)
..... .+.|.+|.|||.+.|. .|+..+||||.|||+.||+.|.+-|....| -+++. .+.+.+.... +.+
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~-~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLS-KIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHH-HHHHHcCCCCcccCccccc
Confidence 33322 3789999999998875 599999999999999999999886643222 12222 2222221111 111
Q ss_pred cccc--------cccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCc
Q 005599 601 IVDS--------SMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSPKQPTF 657 (688)
Q Consensus 601 ~~d~--------~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~p~~~~~ 657 (688)
+-|. ......-..+...+.+|+..++..||.+|++++|++++= -....|.|..|.-
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~~~ 295 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPPSK 295 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCChhh
Confidence 1111 111112234556779999999999999999999998752 2233455444443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=329.36 Aligned_cols=262 Identities=22% Similarity=0.357 Sum_probs=207.9
Q ss_pred hcCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
.+.|++.+.||.|..++||+|. .+.+..||||++... .....+.+.+|+..+..++||||+++...|..+..+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3678888999999999999997 456799999999654 33447889999999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
||.+|++.+++...-. ..+++..+..|+.++++||.|||.++ .||||||+.||||+.+|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999865433 34899999999999999999999998 9999999999999999999999999887655432
Q ss_pred cc-ccc-ccccccCCccCceeecCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 528 IS-TNT-NRVVGTYGYMSPEYALGG--LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 528 ~~-~~~-~~~~gt~~y~aPE~~~~~--~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
.. ... +..+||+.|||||++... .|+.|+||||||++..||.+|..||.-+.. .+.+...+....- ...-
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-----mkvLl~tLqn~pp-~~~t 254 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-----MKVLLLTLQNDPP-TLLT 254 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-----HHHHHHHhcCCCC-Cccc
Confidence 21 111 568999999999996543 599999999999999999999999864332 2222222222110 0000
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..+..+-.......+.+++..||++||.+|||++++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11111112233447899999999999999999999984
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=354.08 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=205.0
Q ss_pred hcCCCCCCccccCCcEeEEEEEe------CCCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCc
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL------ANGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDE 441 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 441 (688)
.++|++.+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35788899999999999999963 235689999986542 33456788999999999 89999999999999999
Q ss_pred eeEEEeccCCCChhhHhhccCC----------------------------------------------------------
Q 005599 442 KMLIYEFMPNKSLDYFIFDESR---------------------------------------------------------- 463 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 463 (688)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998854211
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 464 --------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 464 --------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
...+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124789999999999999999999987 999999999999999999999999999876543322
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ......+ ..+. ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~----~~~~---------~~ 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMI----KEGY---------RM 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHH----HhCc---------cC
Confidence 22222445678999999999999999999999999999998 88887432211 1111111 1111 01
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
..+...+.++.+|+.+||+.||++||++.||+++|++.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11112234689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.86 Aligned_cols=245 Identities=19% Similarity=0.317 Sum_probs=198.8
Q ss_pred CccccCCcEeEEEEEeCCCcEEEEEEccCCCccc---HHHHHHHHHHHhhcCCCCccceEEEEEe----CCceeEEEecc
Q 005599 377 NKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQG---IEEFKNEVLLIAKLQHRNLVKLLGCCLE----KDEKMLIYEFM 449 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~ 449 (688)
..||+|++|.||+|.+ +|+.||||++....... .+.|.+|+.+|.+++|||||+++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6899999999999998 68999999997653332 5678899999999999999999999987 34678999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
++|+|.+++.. ...+++...+.++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999854 34688999999999999999999985 5 7899999999999999999999999998654322
Q ss_pred ccccccccccCCccCceeecC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYALG--GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ...+.. ...... .
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--~~~~~~---~i~~~~---------~ 239 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--TKEIYD---LIINKN---------N 239 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--HHHHHH---HHHhcC---------C
Confidence 12467899999999976 689999999999999999999999985321 111111 111111 1
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
....+...+..+.+++.+||+.||++|||+.||++.|+...
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11122234557999999999999999999999999997643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=384.43 Aligned_cols=262 Identities=25% Similarity=0.447 Sum_probs=217.7
Q ss_pred cCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
..|...+.||+|+||.||+|+. .++..||||++...... ...|++++++++|||||+++|+|.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577788999999999999986 57899999998654322 235688999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++|+|.+++. .++|..+.+++.|||+||+|||.....+|+||||||+||+++.++.+++. ||.......
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 9999999983 27999999999999999999997655679999999999999999888875 665543221
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC-
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD- 608 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~- 608 (688)
.....+|+.|+|||++.+..++.++|||||||++|||+||+.|+.........+..|+...........++|+.+..
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 11246789999999999999999999999999999999999998654444556777777666555566677776643
Q ss_pred -CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCC
Q 005599 609 -SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSV 649 (688)
Q Consensus 609 -~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 649 (688)
..+..+..++.+++.+|++.+|++||+|.||+++|+.....
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 34556778899999999999999999999999999886543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=330.45 Aligned_cols=269 Identities=25% Similarity=0.363 Sum_probs=202.1
Q ss_pred CCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhh--cCCCCccceEEEEEeCC----ceeEEE
Q 005599 373 FSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAK--LQHRNLVKLLGCCLEKD----EKMLIY 446 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~ 446 (688)
....++||+|.||.||||++. ++.||||++... ..+.|.+|-.+... ++|+||+++++.-.... +..||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 345679999999999999995 599999999643 44567777777655 58999999999977666 789999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------CCCeEecCCCCCceEECCCCCceecccccc
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS------RLRIIHRDLKASNILLDEEMNPRISDFGTA 520 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 520 (688)
||.++|+|.++| +...++|....+|+..|++||+|||+.- +++|+|||||++||||.+|+++.|+|||||
T Consensus 288 ~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 288 EFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999 4557899999999999999999999863 468999999999999999999999999999
Q ss_pred eecCCCccccccccccccCCccCceeecCCC-CC-----CcccchhHHHHHHHHHhCCCCCCCCCCCCccH--HHHHHHH
Q 005599 521 RVFGGEEISTNTNRVVGTYGYMSPEYALGGL-FS-----TKSDVFSFGVLLLEIITGKKNTGIFNDDSSNL--IRYVWEL 592 (688)
Q Consensus 521 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~k~DvwSlGvll~elltG~~p~~~~~~~~~~l--~~~~~~~ 592 (688)
..+............+||.+|||||++.+.. +. .+.||||+|.|||||+++..-+........++ ...+...
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 9887655555555589999999999998753 33 26899999999999999875442110000000 0000000
Q ss_pred hccccccc-cccccccCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCC
Q 005599 593 WSDDKALE-IVDSSMADSCPA-----PEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSV 649 (688)
Q Consensus 593 ~~~~~~~~-~~d~~l~~~~~~-----~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 649 (688)
-.-+++.+ ++.++.+...+. ..+..+++.+..||..||+.|.|+.=|.+.+.++.-.
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 00001111 111122222221 3466789999999999999999999999888776533
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=335.67 Aligned_cols=254 Identities=21% Similarity=0.305 Sum_probs=202.9
Q ss_pred HHHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCce
Q 005599 367 LAATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEK 442 (688)
Q Consensus 367 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 442 (688)
....++|+++++||+|+||.||+++-+ +|..+|+|++++.. ....+..+.|-.+|....+|.||+|+..|++.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345688999999999999999999754 68999999998764 34466788999999999999999999999999999
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
||||||+++|++..+|. ....|++.....++.+++.|++.||..+ +|||||||+|+|||..|++||+||||+..
T Consensus 217 YLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999994 4467888888889999999999999998 99999999999999999999999999853
Q ss_pred cCC----------------------Ccccc-----c------------------cccccccCCccCceeecCCCCCCccc
Q 005599 523 FGG----------------------EEIST-----N------------------TNRVVGTYGYMSPEYALGGLFSTKSD 557 (688)
Q Consensus 523 ~~~----------------------~~~~~-----~------------------~~~~~gt~~y~aPE~~~~~~~s~k~D 557 (688)
+.. .+... . ....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 321 00010 0 01258999999999999999999999
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCCCc--cHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCC
Q 005599 558 VFSFGVLLLEIITGKKNTGIFNDDSS--NLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPS 635 (688)
Q Consensus 558 vwSlGvll~elltG~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt 635 (688)
+||||||+||||.|-+||........ .++.|... +.-+.......++.+||.+|+. ||++|-.
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------LKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999999854322110 11111110 1111112233678999999999 9999986
Q ss_pred ---HHHHHH
Q 005599 636 ---MSTVVF 641 (688)
Q Consensus 636 ---~~evl~ 641 (688)
++||-+
T Consensus 436 ~~G~~EIK~ 444 (550)
T KOG0605|consen 436 SKGAEEIKK 444 (550)
T ss_pred cccHHHHhc
Confidence 555553
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.61 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=204.4
Q ss_pred hcCCCCCCccccCCcEeEEEEEe------CCCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCc
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL------ANGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDE 441 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 441 (688)
.++|.+.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+.++..+ +|+|||++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 35788899999999999999873 234579999997543 33356788999999999 89999999999999999
Q ss_pred eeEEEeccCCCChhhHhhccC-----------------------------------------------------------
Q 005599 442 KMLIYEFMPNKSLDYFIFDES----------------------------------------------------------- 462 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 462 (688)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccccccc
Q 005599 463 --------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR 534 (688)
Q Consensus 463 --------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 534 (688)
....+++.+.++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1124788899999999999999999987 99999999999999999999999999986543322222222
Q ss_pred ccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHH
Q 005599 535 VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAP 613 (688)
Q Consensus 535 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 613 (688)
..++..|+|||++.+..++.++|||||||++|||++ |+.||....... .... .... ......+..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~----~~~~---------~~~~~~~~~ 339 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYK----MVKR---------GYQMSRPDF 339 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHH----HHHc---------ccCccCCCC
Confidence 345678999999999999999999999999999997 999985422111 1111 1111 011111112
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 614 EALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 614 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
.+..+.+++.+||+.+|++||++.+|+++|+++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 235789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=333.89 Aligned_cols=257 Identities=31% Similarity=0.524 Sum_probs=208.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeCCC------cEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCcee
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLANG------QEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKM 443 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~~------~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 443 (688)
++|++.+.||+|+||.||+|..... ..||+|.+.... .....+|.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 4678889999999999999986432 579999986543 234567899999999999999999999999999999
Q ss_pred EEEeccCCCChhhHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC
Q 005599 444 LIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM 510 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 510 (688)
++|||+++++|.+++..... ...+++...+.++.|++.||+|||+.+ |+|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999864321 145888999999999999999999988 99999999999999999
Q ss_pred CceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHH
Q 005599 511 NPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYV 589 (688)
Q Consensus 511 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~ 589 (688)
.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ..+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--~~~~~-- 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--QEVIE-- 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH--
Confidence 999999999987654433333344567889999999998999999999999999999998 9988743211 11111
Q ss_pred HHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 590 WELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 590 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
.+..+ .....+...+.++.+|+.+||+.+|++||++.||++.|++
T Consensus 238 --~i~~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 --MIRSR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHcC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111 1111233445679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.74 Aligned_cols=246 Identities=23% Similarity=0.383 Sum_probs=207.7
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
++|.+.+.||+|+||.||||+-+ +.+.||+|.+.+.. ....+.+.+|++++++++|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999754 67899999986543 3456678999999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|+.+ +|..+|.+ ...+++.....|+.++..||.|||+.. |+|||+||.||||+..+++|++|||+|+.+....
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9977 99999954 345899999999999999999999987 9999999999999999999999999999876432
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
.....+.|||.|||||.+.+++|+..+|+||+|||+||+++|++||-. ..+.+.+.....++
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~~d~----------- 216 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSILKDP----------- 216 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHhcCC-----------
Confidence 333458999999999999999999999999999999999999999832 12222222222111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
-..|...+..+..++.-.+++||.+|.+..+++.
T Consensus 217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1134566778999999999999999999999884
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=314.48 Aligned_cols=236 Identities=26% Similarity=0.349 Sum_probs=199.3
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG---QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|+..+.||.|+||.|.+++.+ +|..+|+|++.+... ...+...+|..+|+.+.||+++++.+.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57888899999999999999865 578899999976532 34556788999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|.|..+|... +.++.+...-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||.|+.+...
T Consensus 124 eyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999543 35788888889999999999999998 999999999999999999999999999987543
Q ss_pred ccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
+-+.+|||.|+|||++....+..++|.|||||++|||+.|.+||..... .. ..+.. +...+
T Consensus 198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~----iY~KI--------~~~~v 258 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQ----IYEKI--------LEGKV 258 (355)
T ss_pred -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HH----HHHHH--------HhCcc
Confidence 4458999999999999999999999999999999999999999853221 11 11111 11111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCC
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDR 633 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~R 633 (688)
.+|.-....+.+|+...++.|-.+|
T Consensus 259 --~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 --KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2455556678899999999999988
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=329.90 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=203.8
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC----CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA----NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888899999999999999753 35689999987643 2334678999999999999999999999999999999
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998543 246889999999999999999999988 9999999999999999999999999876543
Q ss_pred CCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
..... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ...... ....
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--~~~~~~----~~~~------- 224 (266)
T cd05064 159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--QDVIKA----VEDG------- 224 (266)
T ss_pred ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHH----HHCC-------
Confidence 22111 1112345678999999999999999999999999999875 9999743211 111111 1111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
.....+...+..+.+++..||+.+|++||++.+|++.|++.
T Consensus 225 --~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 --FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01112333455789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=338.92 Aligned_cols=257 Identities=26% Similarity=0.449 Sum_probs=203.2
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCc----EEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQ----EIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
.+|++.+.||+|+||.||+|++. ++. .||||.+.... ....++|.+|+.++..++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56888999999999999999854 333 38999986543 34467889999999999999999999999764 5789
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998543 345889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..+ .......
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~~~----~~~~~~~------- 227 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEI----SSILEKG------- 227 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHH----HHHHhCC-------
Confidence 4333222222345678999999999999999999999999999998 9998753211 111 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETS 648 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 648 (688)
.....+......+.+++.+||+.+|++||++.+|+..|.....
T Consensus 228 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 228 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 1111122234568899999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.43 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=207.0
Q ss_pred hcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
.++|++.+.||+|++|.||+|...+++.||||.++... ...++|.+|+.++.+++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998888899999986543 34578999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985433 345899999999999999999999988 999999999999999999999999999877532221
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
. ......+..|+|||++.+..++.++||||||++++||++ |+.|+.... ...+. ...... ...
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~----~~~~~~---------~~~ 223 (261)
T cd05068 160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--NAEVL----QQVDQG---------YRM 223 (261)
T ss_pred c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHH----HHHHcC---------CCC
Confidence 1 111233467999999999999999999999999999999 888874321 11111 111110 011
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
..+...+..+.+++.+|++.+|++||++.++++.|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1222344678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=344.27 Aligned_cols=242 Identities=25% Similarity=0.367 Sum_probs=205.0
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCce
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEK 442 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 442 (688)
..-++|..+++||+|+||+|+++.++ +++.+|||.+++. ...+.+..+.|.+++.... ||.++.|+.+|+..++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 44578999999999999999999876 4778999999876 3466788889999988885 99999999999999999
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
++||||+.+|++..+. ..+.+++....-++..|+.||.|||+++ ||+||||.+|||||.+|++||+||||++.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999943333 3456889888899999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccc
Q 005599 523 FGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 523 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 602 (688)
--. ....+.+++|||.|||||++.+..|+..+|+|||||+|||||.|+.||... +++ ++.
T Consensus 518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dEe----------------e~F 577 (694)
T KOG0694|consen 518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD--DEE----------------EVF 577 (694)
T ss_pred cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC--CHH----------------HHH
Confidence 432 223556799999999999999999999999999999999999999998532 222 222
Q ss_pred ccccc--CCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 005599 603 DSSMA--DSCPAPEALRCIQVGLLCVQDRTTDRPSM 636 (688)
Q Consensus 603 d~~l~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~ 636 (688)
|..+. -.+|.-.+.+.+.|+.+.+.++|++|..+
T Consensus 578 dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 22221 12566677889999999999999999988
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.98 Aligned_cols=249 Identities=33% Similarity=0.542 Sum_probs=194.8
Q ss_pred CCccccCCcEeEEEEEeC-----CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 376 SNKLGQGGFGPVYKGKLA-----NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
.+.||.|.||.||+|.+. .+..|+||.++... ....++|.+|++.+.+++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 478999999999999876 25689999996543 334789999999999999999999999999888899999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++|+|.++|... ....+++..++.|+.|||+||+|||+.+ |+|+||+++|||+++++.+||+|||++.........
T Consensus 84 ~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 84 PGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999665 2346899999999999999999999987 999999999999999999999999999887433333
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
...........|+|||.+.+..++.++||||||+++|||++ |+.|+... ......... ..... .
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~~-~~~~~---------~ 224 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNEEIIEKL-KQGQR---------L 224 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHHH-HTTEE---------T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccc-ccccc---------c
Confidence 33333557789999999999999999999999999999999 67776322 111111111 11111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 643 (688)
..+...+..+.+++..||+.+|++||+|.+|++.|
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11222345688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=346.53 Aligned_cols=262 Identities=25% Similarity=0.380 Sum_probs=206.8
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC------CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcC-CCCccceEEEEEeCC
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKD 440 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 440 (688)
..++|.+.++||+|+||.||+|+.. .+..||||++..... ...+.|.+|++++.++. |||||++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4568889999999999999999753 134799999965432 33567899999999996 999999999999999
Q ss_pred ceeEEEeccCCCChhhHhhccC----------------------------------------------------------
Q 005599 441 EKMLIYEFMPNKSLDYFIFDES---------------------------------------------------------- 462 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 462 (688)
..+|||||+++|+|.++|....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999998885421
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEEC
Q 005599 463 -----------------------------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 507 (688)
Q Consensus 463 -----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 507 (688)
....+++..++.++.||++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0124788889999999999999999987 99999999999999
Q ss_pred CCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHH
Q 005599 508 EEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLI 586 (688)
Q Consensus 508 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~ 586 (688)
.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+....... ..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-~~- 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-TF- 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-HH-
Confidence 999999999999987644332222333456788999999999999999999999999999997 888874321110 11
Q ss_pred HHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 587 RYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 587 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
......+ .....+...+..+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 350 ---~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 ---YNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ---HHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1111111 011122234457899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=326.54 Aligned_cols=257 Identities=24% Similarity=0.345 Sum_probs=203.2
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCc--------------ccHHHHHHHHHHHhhcCCCCccce
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSG--------------QGIEEFKNEVLLIAKLQHRNLVKL 432 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l 432 (688)
..-++|++.+.||+|.||.|-+|.. .+++.||||++.+... ...+...+||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457899999999999999999974 4689999999865321 124578999999999999999999
Q ss_pred EEEEEeC--CceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC
Q 005599 433 LGCCLEK--DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM 510 (688)
Q Consensus 433 ~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 510 (688)
+.+..+. +..|||+|||..|.+...- .....++..+..+++.++..||+|||.++ ||||||||+|+||+++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 9998765 5689999999999875442 22223899999999999999999999998 99999999999999999
Q ss_pred CceecccccceecCCC---ccccccccccccCCccCceeecCCC----CCCcccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 005599 511 NPRISDFGTARVFGGE---EISTNTNRVVGTYGYMSPEYALGGL----FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSS 583 (688)
Q Consensus 511 ~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DvwSlGvll~elltG~~p~~~~~~~~~ 583 (688)
++||+|||.+...... .........+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-. +...
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~--~~~~ 325 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD--DFEL 325 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc--chHH
Confidence 9999999999866321 2222333478999999999987743 36688999999999999999999832 1111
Q ss_pred cHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 584 NLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 584 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
.+. .+++...+.-....++.+.+.+|+.++|++||++|.+..+|....=
T Consensus 326 ~l~------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 326 ELF------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHH------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 111 1233333333333356788999999999999999999999887653
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.97 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=207.2
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC------CcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCCccceEEEEEeCCcee
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN------GQEIAVKRLSTTSGQ-GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKM 443 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 443 (688)
++|.+.+.||+|+||.||+|...+ +..||||.+...... ..+.|.+|++++..++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 467888999999999999998643 478999998765443 4578999999999999999999999999999999
Q ss_pred EEEeccCCCChhhHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCc
Q 005599 444 LIYEFMPNKSLDYFIFDES-----------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP 512 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 512 (688)
+||||+++++|.+++.... ....+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986432 2345789999999999999999999988 9999999999999999999
Q ss_pred eecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHH
Q 005599 513 RISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWE 591 (688)
Q Consensus 513 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~ 591 (688)
||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||.... .........
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~--~~~~~~~~~- 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS--NEEVIECIT- 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHH-
Confidence 9999999986544332222233456788999999999999999999999999999999 999874321 111111111
Q ss_pred HhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 592 LWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 592 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
.+.. ...+...+..+.+++.+||+.+|++||++.||++.|+.
T Consensus 239 ---~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 ---QGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ---cCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1110 11122334578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.68 Aligned_cols=259 Identities=27% Similarity=0.437 Sum_probs=204.9
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCc
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE 441 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 441 (688)
.+++|++.+.||+|+||.||+|... .+..||||++.... .....+|.+|+.++..++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 24679999986432 2345578999999999999999999999999999
Q ss_pred eeEEEeccCCCChhhHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCcee
Q 005599 442 KMLIYEFMPNKSLDYFIFDESR-------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRI 514 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 514 (688)
.++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854221 234678899999999999999999987 999999999999999999999
Q ss_pred cccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHh
Q 005599 515 SDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELW 593 (688)
Q Consensus 515 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 593 (688)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+.... .......+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--~~~~~~~~---- 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--NEQVLRFV---- 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHH----
Confidence 99999986654333322223455788999999999999999999999999999999 677874321 11111111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 594 SDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 594 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
...... ..+...+..+.+++.+|++.+|++|||+.|++++|+.
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111100 1122234568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.61 Aligned_cols=248 Identities=24% Similarity=0.355 Sum_probs=203.2
Q ss_pred HhcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCC----Cc-ccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCc
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT----SG-QGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDE 441 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 441 (688)
...+|.+.+.||+|+||+|++|.. .++..||||.+... .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456888999999999999999964 46899999976543 11 23456678999999999 9999999999999999
Q ss_pred eeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCC-CCceecccccc
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE-MNPRISDFGTA 520 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGla 520 (688)
.++||||+.+|+|.+++.. ...+.+.....++.|++.|++|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999965 345777888999999999999999998 9999999999999999 99999999999
Q ss_pred eecCCCccccccccccccCCccCceeecCCC-CC-CcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccc
Q 005599 521 RVFGGEEISTNTNRVVGTYGYMSPEYALGGL-FS-TKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKA 598 (688)
Q Consensus 521 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 598 (688)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.. .+....... ...+.
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~~~~l~~k-i~~~~- 239 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SNVPNLYRK-IRKGE- 239 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----ccHHHHHHH-HhcCC-
Confidence 8874 1122334589999999999999977 75 789999999999999999999854 121111111 11111
Q ss_pred cccccccccCCCCHHH-HHHHHHHHhhcccCCCCCCCCHHHHH
Q 005599 599 LEIVDSSMADSCPAPE-ALRCIQVGLLCVQDRTTDRPSMSTVV 640 (688)
Q Consensus 599 ~~~~d~~l~~~~~~~~-~~~~~~l~~~Cl~~~P~~RPt~~evl 640 (688)
-.+|... +.++..|+.+|++.+|.+|+++.+|+
T Consensus 240 ---------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 ---------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ---------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1122222 66899999999999999999999999
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=328.77 Aligned_cols=257 Identities=30% Similarity=0.476 Sum_probs=204.8
Q ss_pred cCCCCCCccccCCcEeEEEEEe-----CCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-----ANGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
++|++.+.||+|+||.||+|.. .++..||+|.+.... ......|.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577789999999999999974 346789999997533 3345678999999999999999999999999999999
Q ss_pred EEeccCCCChhhHhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC
Q 005599 445 IYEFMPNKSLDYFIFDES--------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM 510 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 510 (688)
||||+++++|.+++.... ....+++.+.+.++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 1245789999999999999999999988 99999999999999999
Q ss_pred CceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHH
Q 005599 511 NPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYV 589 (688)
Q Consensus 511 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~ 589 (688)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.... ......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--~~~~~~-- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--NQEVIE-- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHH--
Confidence 999999999987654433333333456778999999998889999999999999999999 888874321 111111
Q ss_pred HHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 590 WELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 590 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
....... ...+...+..+.+++.+|++.+|++||++.+|.+.|..
T Consensus 238 --~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 --MVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111 11122234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=324.45 Aligned_cols=255 Identities=29% Similarity=0.445 Sum_probs=206.7
Q ss_pred hcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++..++|+||+++++.+...+..++|+||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35788899999999999999998888999999986432 34578999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999986432 345788999999999999999999987 999999999999999999999999999876543221
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
......++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+. ... ..
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~----~~~-----~~---- 223 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--NSDVMSALQ----RGY-----RM---- 223 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--HHHHHHHHH----cCC-----CC----
Confidence 1222445678999999998899999999999999999998 888874321 111111111 110 00
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
..+...+..+.+++.+|++.+|++||++.+++++|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111233468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=324.47 Aligned_cols=257 Identities=28% Similarity=0.446 Sum_probs=206.0
Q ss_pred hcCCCCCCccccCCcEeEEEEEeCC----CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLAN----GQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
.++|++.+.||+|+||.||+|.+.. ...||||.+.... .....+|.+|+.++.+++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578889999999999999998742 4579999986543 3345678999999999999999999999999999999
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999985432 36899999999999999999999987 9999999999999999999999999998775
Q ss_pred CCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
............++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ...+.... ....
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~----~~~~------ 225 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--NQDVIKAV----EDGY------ 225 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--HHHHHHHH----HcCC------
Confidence 2222222222345678999999999999999999999999999998 988874221 11111111 1110
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
....+...+..+.+++.+|++.+|++||++.+|+++|+..
T Consensus 226 ---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ---RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111223345789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.35 Aligned_cols=257 Identities=32% Similarity=0.493 Sum_probs=212.1
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
...+|.+.++||.|+||.||+|...++..+|+|.+.........++.+|+.++..++|+||+++++++.+....++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568889999999999999999888999999999776665677899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999996543 345799999999999999999999988 99999999999999999999999999987643322
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
.. ....++..|+|||.+.+..++.++||||||+++++|++ |+.|+.... ......... ....
T Consensus 160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~~~-------------~~~~ 222 (261)
T cd05148 160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQIT-------------AGYR 222 (261)
T ss_pred cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHH-------------hCCc
Confidence 21 12446778999999998899999999999999999998 788874322 111111111 1111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
...+...+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 122334456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=322.75 Aligned_cols=252 Identities=26% Similarity=0.428 Sum_probs=203.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccC
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
++|++.+.||+|+||.||++...++..+|+|.+... ....+.|.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457778999999999999999988889999988643 2345688999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999885432 35889999999999999999999988 9999999999999999999999999998654332221
Q ss_pred ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+ ..... ..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--~~~~~~~i---~~~~~---~~------- 221 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--NYEVVEMI---SRGFR---LY------- 221 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHH---HCCCC---CC-------
Confidence 122345668999999998899999999999999999999 888874321 11111111 11100 00
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
.+......+.+++.+||+.+|++||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11122346899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=330.51 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=207.6
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
..|+..+.||+|+||.||||... .++.||+|++... .....++..+|+.+|.+++|+||.+++|.+..+..+.++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 44666789999999999999854 5889999999654 445678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+.+|++.+.|.. ...+++....-|+.+++.||.|||+++ .+|||||+.||||..+|.+||+|||++-.+.....
T Consensus 93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999999832 334477777788999999999999998 99999999999999999999999999988765544
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
.. .+++||+.|||||++....|+.|+||||||++.+||.+|.+|+.-.+. .++.-++-+.-..
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP---------------mrvlflIpk~~PP 229 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP---------------MRVLFLIPKSAPP 229 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc---------------ceEEEeccCCCCC
Confidence 33 568999999999999988999999999999999999999999743222 2333333322222
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
......+..+.+++..||.++|+.||++.++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 222244556999999999999999999999984
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=339.47 Aligned_cols=261 Identities=28% Similarity=0.426 Sum_probs=205.1
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCCccceEEEEEeC-C
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEK-D 440 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 440 (688)
.++|++.+.||+|+||.||+|... .++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357899999999999999999642 24789999986543 23345678899999999 899999999988754 5
Q ss_pred ceeEEEeccCCCChhhHhhccCC---------------------------------------------------------
Q 005599 441 EKMLIYEFMPNKSLDYFIFDESR--------------------------------------------------------- 463 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 463 (688)
..++++||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998853211
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccccccccccCCcc
Q 005599 464 -KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542 (688)
Q Consensus 464 -~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 542 (688)
...++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136899999999999999999999987 9999999999999999999999999998765433333333456678899
Q ss_pred CceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHH
Q 005599 543 SPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQV 621 (688)
Q Consensus 543 aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 621 (688)
|||++.+..++.++|||||||+|+||++ |..||...... ..+ ........ ....+......+.++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~----~~~~~~~~---------~~~~~~~~~~~~~~l 308 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEF----CRRLKEGT---------RMRAPEYATPEIYSI 308 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHH----HHHHhccC---------CCCCCccCCHHHHHH
Confidence 9999999999999999999999999998 99887532211 111 11111111 111122334578999
Q ss_pred HhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 622 GLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 622 ~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
+.+||+.+|++||++.||+++|+.+.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.60 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=209.9
Q ss_pred cCCCCCCccccCCcEeEEEEEeC------CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.++.+++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777899999999999999742 355789999876665556789999999999999999999999999999999
Q ss_pred EEeccCCCChhhHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCC
Q 005599 445 IYEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMN 511 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 511 (688)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986432 1234899999999999999999999988 999999999999999999
Q ss_pred ceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHH
Q 005599 512 PRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVW 590 (688)
Q Consensus 512 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~ 590 (688)
++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~----~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--TEV----I 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHH----H
Confidence 99999999986654333333334556788999999999999999999999999999999 9998743221 111 1
Q ss_pred HHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 005599 591 ELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETS 648 (688)
Q Consensus 591 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 648 (688)
.....+... ..+...+..+.+++.+||+.+|++||++.+|+++|+.+..
T Consensus 236 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 236 ECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111111 1112234568899999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=325.40 Aligned_cols=250 Identities=25% Similarity=0.335 Sum_probs=200.1
Q ss_pred CCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 373 FSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
|...+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.++.+++|+||+++.+++.+.+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999985 578999999886432 22344678999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++|+|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999988875432 335889999999999999999999988 99999999999999999999999999987543221
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....... ....+...... . ..
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~--------~--~~ 222 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--KREEVDRRVKE--------D--QE 222 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--hHHHHHHHhhc--------c--cc
Confidence 123578999999999999999999999999999999999999986432211 11111111100 0 01
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 641 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~ 641 (688)
..+...+..+.+|+.+||+.||++||+ +.++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 122233457889999999999999997 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=329.32 Aligned_cols=259 Identities=29% Similarity=0.469 Sum_probs=208.4
Q ss_pred cCCCCCCccccCCcEeEEEEEeC------CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++.+++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888899999999999999742 345689999876665566789999999999999999999999999999999
Q ss_pred EEeccCCCChhhHhhccC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCcee
Q 005599 445 IYEFMPNKSLDYFIFDES----------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRI 514 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 514 (688)
|+||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 2235899999999999999999999987 999999999999999999999
Q ss_pred cccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHh
Q 005599 515 SDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELW 593 (688)
Q Consensus 515 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 593 (688)
+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||..... .... ...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--~~~~----~~i 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVI----ECI 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHH----HHH
Confidence 99999986654333222333456788999999999999999999999999999999 8888743221 1111 111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 594 SDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 594 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
..+.... .+...+..+.+++.+|++.+|.+|||+.+|+..|+++.
T Consensus 236 ~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 236 TQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111100 11122346899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=301.91 Aligned_cols=266 Identities=23% Similarity=0.272 Sum_probs=214.8
Q ss_pred HHhcCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCC-----c
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD-----E 441 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~ 441 (688)
...++|.+.++||+|||.-||+++ +.++..+|+|++.....++.+..++|++..++++||||++++++...+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345789999999999999999997 6678999999998887788899999999999999999999998876544 3
Q ss_pred eeEEEeccCCCChhhHhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccc
Q 005599 442 KMLIYEFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA 520 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 520 (688)
.||+++|...|+|.+.+..... ...+++.+.+.|+.+|++||.+||+.. ++++||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999866443 347999999999999999999999987 47999999999999999999999999998
Q ss_pred eecCCCc-----c--ccccccccccCCccCceeec---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHH
Q 005599 521 RVFGGEE-----I--STNTNRVVGTYGYMSPEYAL---GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVW 590 (688)
Q Consensus 521 ~~~~~~~-----~--~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~ 590 (688)
....-.- . ...-.....|..|.|||.+. +...++++|||||||+||+|+.|..||+..-+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------- 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------- 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------
Confidence 7643211 0 01112246789999999885 446889999999999999999999998642211
Q ss_pred HHhccccc-cccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 591 ELWSDDKA-LEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 591 ~~~~~~~~-~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
.+.+ ..+....+.-.-....++.+.+|+.+|++.||.+||++.+++..++...
T Consensus 248 ----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 ----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 2223333322222236778999999999999999999999999887653
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=327.35 Aligned_cols=267 Identities=27% Similarity=0.392 Sum_probs=204.1
Q ss_pred CCCCCccccCCcEeEEEEEe-----CCCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCCccceEEEEEeCC--ceeE
Q 005599 373 FSTSNKLGQGGFGPVYKGKL-----ANGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD--EKML 444 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~l 444 (688)
|.+.+.||+|+||+||++.. .++..||+|.+..... ...+.|.+|++++.+++||||+++++++.... ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 3577899999865432 34567889999999999999999999987643 5789
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
||||+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999843 24899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCccccc-cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 525 GEEISTN-TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 525 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
....... .....++..|+|||.+.+..++.++||||||++++||++|+.|+......-.................++++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 4322111 122345667999999998899999999999999999999999875322111111111110111111122222
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
.......+...+..+.+++.+|++.+|++|||+.+|+++|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 2222223334456799999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=337.43 Aligned_cols=256 Identities=27% Similarity=0.365 Sum_probs=209.4
Q ss_pred CCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 372 NFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
-|++.+.||.|+-|.|-+|++ .+|+.+|||++.... ......+.+|+.+|+.+.||||+++++++++..++|||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 356779999999999999985 579999999996542 2234567899999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|+++|-|.++|.. +..+++.+..+++.||+.|+.|+|..+ |+||||||+|+|||..+.+||+|||+|.+-..+.
T Consensus 93 yv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred ecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 9999999999853 456889999999999999999999988 9999999999999999999999999997643322
Q ss_pred cccccccccccCCccCceeecCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLF-STKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
...+.+|.|.|.|||++.|.+| +.++||||.|||||.||||+.||+ +++-..+... ...+.
T Consensus 167 ---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--DdNir~LLlK----V~~G~--------- 228 (786)
T KOG0588|consen 167 ---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--DDNIRVLLLK----VQRGV--------- 228 (786)
T ss_pred ---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--CccHHHHHHH----HHcCc---------
Confidence 2334799999999999999987 678999999999999999999985 1211122111 11111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhcCCCCCCCC
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNETSVPSP 652 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~~~~~p 652 (688)
-+.|...+.++.+|+.+|+..||++|.|++||++ .|.+....+.+
T Consensus 229 -f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 229 -FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred -ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 1234455667899999999999999999999998 45555444443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=331.46 Aligned_cols=262 Identities=23% Similarity=0.314 Sum_probs=203.2
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
.++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468899999999999999999865 57889999886542 2345679999999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 99999999998542 35789999999999999999999853 3999999999999999999999999998765332
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccc----------
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK---------- 597 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~---------- 597 (688)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+............
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA--KELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhcccccccccCCccccCcc
Confidence 12235789999999999999999999999999999999999999853221 111110000000000
Q ss_pred --------------------ccccccccc----cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 598 --------------------ALEIVDSSM----ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 598 --------------------~~~~~d~~l----~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
..++++... ..........++.+|+.+||+.||++|||+.||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 000011234578999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=325.61 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=202.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCc----EEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQ----EIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
++|++.+.||+|+||+||+|... +++ .+++|.+..... ....++..|+.++..++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46788899999999999999864 344 478888754332 33467888999999999999999999875 456789
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998543 345899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ..... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--~~~~~----~~~~~~~~~---- 230 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR--PHEVP----DLLEKGERL---- 230 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHH----HHHHCCCcC----
Confidence 4333223334567789999999999999999999999999999998 998874321 11111 111111110
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCC
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSV 649 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 649 (688)
..+......+.+++.+|+..+|++|||+.|+++.|......
T Consensus 231 -----~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 231 -----AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 01111234578899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=322.04 Aligned_cols=255 Identities=29% Similarity=0.435 Sum_probs=205.1
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
.+|.+.+.||+|+||.||+|... .++.||+|.+... ....+++.+|++++..++|+||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34677789999999999999865 5888999998643 334678999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999998543 2345899999999999999999999987 999999999999999999999999999876543221
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ...+ ...... ....
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--~~~~----~~~~~~---------~~~~ 224 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQV----YELLEK---------GYRM 224 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHH----HHHHHC---------CCCC
Confidence 1112334678999999999999999999999999999998 888874321 1111 111111 1111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
..+...+..+.+++.+|++.+|++||++.+++++|+++
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 12223345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.82 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=203.8
Q ss_pred CCCCCCccccCCcEeEEEEEeCC------CcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLAN------GQEIAVKRLSTTSGQ-GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
+|.+.+.||+|+||.||+|...+ ++.||||++...... ..+.|.+|+.++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46667899999999999998642 478999999754332 34678899999999999999999999999999999
Q ss_pred EEeccCCCChhhHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCC
Q 005599 445 IYEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMN 511 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 511 (688)
++||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1235788999999999999999999987 999999999999999999
Q ss_pred ceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHH
Q 005599 512 PRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVW 590 (688)
Q Consensus 512 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~ 590 (688)
+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+.... ..+...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~ 237 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQDVIE 237 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Confidence 99999999987654333333333456789999999988899999999999999999998 777764321 111111
Q ss_pred HHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 591 ELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 591 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
. ...... ...+...+..+.+|+..|++.+|++||++.+|+..|++
T Consensus 238 ~-i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 M-IRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-HHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 111111 11223345568999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.48 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=202.9
Q ss_pred CCCCCccccCCcEeEEEEEeCC----CcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCc-----
Q 005599 373 FSTSNKLGQGGFGPVYKGKLAN----GQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE----- 441 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 441 (688)
|.+.+.||+|+||.||+|.... +..||||+++... ....+++.+|+..+..++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4667899999999999998643 3679999987542 2345688999999999999999999999876654
Q ss_pred -eeEEEeccCCCChhhHhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccc
Q 005599 442 -KMLIYEFMPNKSLDYFIFDES---RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDF 517 (688)
Q Consensus 442 -~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 517 (688)
.++|+||+++++|..++.... ....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999885432 2346899999999999999999999987 999999999999999999999999
Q ss_pred ccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccc
Q 005599 518 GTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDD 596 (688)
Q Consensus 518 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 596 (688)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ...+.+.. . .+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--~~~~~~~~---~-~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--NHEIYDYL---R-HG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH---H-cC
Confidence 99987654433222222345678999999998899999999999999999999 888874321 11111111 1 11
Q ss_pred cccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 597 KALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 597 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
. ....+...+..+.+++.+|++.+|++||++.||++.|+++
T Consensus 232 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 N---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 0112233455789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=331.60 Aligned_cols=244 Identities=23% Similarity=0.275 Sum_probs=198.9
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|.+.+.||+|+||.||+|+.. +++.||||.+... .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56788899999999999999875 5889999998643 2234567889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|+|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999988543 35788888899999999999999988 999999999999999999999999999876432
Q ss_pred ccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....... ...+. +
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~~~~~~-i~~~~--------~ 232 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-----PFRIYEK-ILAGR--------L 232 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC-----HHHHHHH-HhcCC--------c
Confidence 2 23578999999999999999999999999999999999999984311 1111111 11111 0
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 641 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~ 641 (688)
..|......+.+|+.+||+.||++||+ +.+++.
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 112222346889999999999999997 677763
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=299.27 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=206.6
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEE
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 445 (688)
-++|++.+.||+|-||.||.|+.+ ++-.||+|++.+.. .+..+++.+|+++-..|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 367999999999999999999854 57789999986542 33457889999999999999999999999999999999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
+||.++|.|...|.... ...++......++.|+|.||.|+|..+ ||||||||+|+|++.++.+||+|||-+..-.
T Consensus 101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 99999999999996433 345778888889999999999999988 9999999999999999999999999886543
Q ss_pred CccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
.....+.+||..|.|||...+...+.++|+|++|++.||++.|.+||.... .......+.. .++
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~k-------~~~---- 239 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIRK-------VDL---- 239 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHHH-------ccc----
Confidence 233445899999999999999999999999999999999999999985422 1111111111 111
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..|...+..+.+++..|+..+|.+|.+..||+.
T Consensus 240 ---~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 240 ---KFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ---cCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 233445567899999999999999999999885
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=333.27 Aligned_cols=253 Identities=22% Similarity=0.288 Sum_probs=202.6
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999876 58899999986432 234567889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|+|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999843 345788999999999999999999988 99999999999999999999999999976543
Q ss_pred ccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+. ... ..+....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~~~i~---~~~---~~~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--NETWENLK---YWK---ETLQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--HHHHHHHH---hcc---ccccCCC
Confidence 22346789999999999999999999999999999999999999853211 11111111 000 0011100
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
........+..+.+++.+|++.+|++||++.++++.
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000011234578899999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=320.08 Aligned_cols=252 Identities=27% Similarity=0.458 Sum_probs=203.3
Q ss_pred cCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccC
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
++|.+.+.||+|+||.||+|...++..+|||.+.... ...++|.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577789999999999999998777789999986433 345789999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999985432 35899999999999999999999987 9999999999999999999999999998664432221
Q ss_pred ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ....... .... ...
T Consensus 158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~----~~~~---------~~~ 221 (256)
T cd05113 158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SETVEKV----SQGL---------RLY 221 (256)
T ss_pred -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHH----hcCC---------CCC
Confidence 112345678999999998889999999999999999999 8888753221 1111111 1110 001
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
.+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11223457899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.42 Aligned_cols=241 Identities=19% Similarity=0.253 Sum_probs=195.1
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNK 452 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 452 (688)
+.||+|+||.||+++.. +++.||||++... .......+.+|+.++.+++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 6889999998643 2233456788999999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccccc
Q 005599 453 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT 532 (688)
Q Consensus 453 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 532 (688)
+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 99888853 346889999999999999999999988 9999999999999999999999999987532211 122
Q ss_pred ccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCH
Q 005599 533 NRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPA 612 (688)
Q Consensus 533 ~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 612 (688)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+. ..... +. . ..+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~---~~~~~-~~------~----~~p~ 216 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLF---ELILM-EE------I----RFPR 216 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--HHHHH---HHHHc-CC------C----CCCC
Confidence 23679999999999999999999999999999999999999984321 11111 11111 10 0 1222
Q ss_pred HHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005599 613 PEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 641 (688)
Q Consensus 613 ~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~ 641 (688)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 3345688999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=334.70 Aligned_cols=255 Identities=28% Similarity=0.435 Sum_probs=216.6
Q ss_pred hcCCCCCCccccCCcEeEEEEEeCC-CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
..+....++||-|-||.||.|.++. .-.||||.++.. .-..++|+.|+.+|+.++|||+|+|+|+|..+..+|+|.||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3445566899999999999999865 567999999654 34578999999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
|.+|+|.++|..-.+ ..++-...+.++.||+.||+||...+ +|||||..+|+||.++..+||+||||++++..+.+
T Consensus 345 M~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred ccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 999999999976543 45667778899999999999999988 99999999999999999999999999999887655
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
..... ..-+..|.|||-+.-..|+.|+|||+|||+||||.| |..|+... ++ ..+.+++....+
T Consensus 421 TAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dl----------SqVY~LLEkgyR 484 (1157)
T KOG4278|consen 421 TAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DL----------SQVYGLLEKGYR 484 (1157)
T ss_pred ecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cH----------HHHHHHHhcccc
Confidence 43322 344678999999999999999999999999999999 88886421 11 123345566666
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
.+.|..++..+++|+++||+.+|.+||++.|+-+.++.
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 66788888899999999999999999999999887754
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.20 Aligned_cols=264 Identities=25% Similarity=0.410 Sum_probs=203.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC---------------CcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN---------------GQEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLG 434 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~---------------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g 434 (688)
++|++.+.||+|+||.||++...+ ...||||.+... .......|.+|++++.+++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987542 235899998654 2334567999999999999999999999
Q ss_pred EEEeCCceeEEEeccCCCChhhHhhccCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceE
Q 005599 435 CCLEKDEKMLIYEFMPNKSLDYFIFDESR---------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNIL 505 (688)
Q Consensus 435 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL 505 (688)
++......++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854321 124688999999999999999999988 999999999999
Q ss_pred ECCCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh--CCCCCCCCCCCCc
Q 005599 506 LDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT--GKKNTGIFNDDSS 583 (688)
Q Consensus 506 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt--G~~p~~~~~~~~~ 583 (688)
+++++.+||+|||++................++..|+|||++.+..++.++||||||++++||++ |..|+.... ..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~--~~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS--DE 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC--hH
Confidence 99999999999999986544332222233455778999999998999999999999999999998 445553221 12
Q ss_pred cHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 584 NLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 584 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
................ .....+...+..+.+|+.+|++.+|++||+|.+|++.|+.
T Consensus 240 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIENTGEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 2222111111111000 0001111234579999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=346.52 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=217.3
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeCCC-cEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCCccceEEE-EEeC------
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLANG-QEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-HRNLVKLLGC-CLEK------ 439 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~~~------ 439 (688)
...++++.+.|.+|||+.||+|+...+ ..+|+|++-..+..+.+..++||++|++|+ |+|||.+++. ....
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345667889999999999999998766 999999998888888999999999999997 9999999993 3221
Q ss_pred CceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccc
Q 005599 440 DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGT 519 (688)
Q Consensus 440 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 519 (688)
-+.+|.||||++|.|-+++....... |++.++++|+.++++|+++||... ++|||||||-+||||+.+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 25789999999999999997655444 999999999999999999999975 6899999999999999999999999999
Q ss_pred ceecCCCccccc-------cccccccCCccCceee---cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHH
Q 005599 520 ARVFGGEEISTN-------TNRVVGTYGYMSPEYA---LGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYV 589 (688)
Q Consensus 520 a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~ 589 (688)
+.-......... .-...-|+-|+|||++ .+..+++|+|||+|||+||-|+....||+.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~------------ 260 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE------------ 260 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc------------
Confidence 864322211100 0013458999999987 567899999999999999999999999852
Q ss_pred HHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCCCCC
Q 005599 590 WELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSP 652 (688)
Q Consensus 590 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~p 652 (688)
.-...|++....-.........+.+||..||+.+|++||++-+|++.+-.+...+.|
T Consensus 261 ------sg~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 261 ------SGKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred ------CcceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 113456666655555567888999999999999999999999999988776544443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=327.99 Aligned_cols=245 Identities=21% Similarity=0.270 Sum_probs=199.8
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999865 68899999986432 234566889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999853 345888999999999999999999988 999999999999999999999999999865432
Q ss_pred ccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..... .... ... .
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--~~~~~---~~i~-~~~--------~ 215 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--PFGIY---EKIL-AGK--------L 215 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHH---HHHH-hCC--------c
Confidence 223578999999999999999999999999999999999999985321 11111 1111 110 0
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPS-----MSTVVFM 642 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~~ 642 (688)
..+......+.+|+.+||+.||.+||+ +.++++.
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 112223456889999999999999995 7887753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=318.50 Aligned_cols=248 Identities=28% Similarity=0.424 Sum_probs=197.1
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCCh
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL 454 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 454 (688)
+.||+|+||.||+|+.. +++.||+|.+.... ......|.+|++++..++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999864 68899999876432 33456799999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccccccc
Q 005599 455 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR 534 (688)
Q Consensus 455 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 534 (688)
.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998532 235789999999999999999999987 99999999999999999999999999876543221111111
Q ss_pred ccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHH
Q 005599 535 VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAP 613 (688)
Q Consensus 535 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 613 (688)
...+..|+|||.+.+..++.++||||||+++|||++ |..|+..... .... . .+........+..
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--~~~~----~---------~~~~~~~~~~~~~ 220 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--QQTR----E---------AIEQGVRLPCPEL 220 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--HHHH----H---------HHHcCCCCCCccc
Confidence 233467999999999999999999999999999998 8887743211 1111 1 1111111122333
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 614 EALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 614 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
.+..+.+++.+|++.+|++||++.+|+++|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3557899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=321.06 Aligned_cols=274 Identities=23% Similarity=0.351 Sum_probs=202.8
Q ss_pred HHHhcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHH--HHHHHhhcCCCCccceEEEEEeCC----
Q 005599 367 LAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKN--EVLLIAKLQHRNLVKLLGCCLEKD---- 440 (688)
Q Consensus 367 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~g~~~~~~---- 440 (688)
+....+..+.+.||+|.||+||+|.+. |+.||||++...+.. .+.+ |+.-.-.|+|+||+.+++.-..+.
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 344456777899999999999999996 899999999765443 3444 444456679999999998865543
Q ss_pred ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-----CCCCCeEecCCCCCceEECCCCCceec
Q 005599 441 EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-----DSRLRIIHRDLKASNILLDEEMNPRIS 515 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~iiH~Dlkp~NILl~~~~~~kl~ 515 (688)
+++||.+|.++|||.+|| ....++....++++..+|.||++||. ++++.|.|||||+.||||.+++.+.|+
T Consensus 283 QLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 579999999999999999 34678999999999999999999995 477889999999999999999999999
Q ss_pred ccccceecCCC--ccccccccccccCCccCceeecCCC----C-CC-cccchhHHHHHHHHHhCCCCCCCCCCCCccHHH
Q 005599 516 DFGTARVFGGE--EISTNTNRVVGTYGYMSPEYALGGL----F-ST-KSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIR 587 (688)
Q Consensus 516 DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~-s~-k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~ 587 (688)
|+|||...... ......+..+||.+|||||++...- | +. .+||||||+|+||+..+..--+...+....+.+
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999776543 3445556689999999999986542 2 22 589999999999998764322211111111111
Q ss_pred HHHHHhccccccccc-cccccCC-----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 005599 588 YVWELWSDDKALEIV-DSSMADS-----CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETS 648 (688)
Q Consensus 588 ~~~~~~~~~~~~~~~-d~~l~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 648 (688)
++-.-...++..+++ .++++.. ...+++..+.+|+..||..+|.-|-|+--|-+.|.++..
T Consensus 439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 110000011111111 2222222 245678889999999999999999999999988877654
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=326.37 Aligned_cols=258 Identities=27% Similarity=0.424 Sum_probs=204.3
Q ss_pred CCCCCCccccCCcEeEEEEEeC------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
+|.+.+.||+|+||.||+|+.. ....+|+|.+.... ....+.+.+|+.++..++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999753 23578899886543 2345678999999999999999999999999999999
Q ss_pred EEeccCCCChhhHhhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCc
Q 005599 445 IYEFMPNKSLDYFIFDES---------------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 503 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 503 (688)
|+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1235789999999999999999999987 9999999999
Q ss_pred eEECCCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 005599 504 ILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDS 582 (688)
Q Consensus 504 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~ 582 (688)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.|+.... .
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~ 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--P 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC--H
Confidence 9999999999999999986543332222233456778999999988899999999999999999999 988874321 1
Q ss_pred ccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 583 SNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 583 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
..+ ...... ......+......+.+++.+|++.+|++||++.+|++.|++..
T Consensus 236 ~~~----~~~~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 236 ERL----FNLLKT---------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHH----HHHHhC---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 111 111111 1111122233457889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=348.86 Aligned_cols=252 Identities=18% Similarity=0.224 Sum_probs=203.3
Q ss_pred CCCCCCccccCCcEeEEEEEeC-C-CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-N-GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.++..++|||||++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3777899999999999999743 3 5788888876555555567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 450 PNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 450 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
++|+|.+++... .....+++.+...++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999888543 23446889999999999999999999987 99999999999999999999999999987654332
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......... +.. .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----~~~~~~~~~~-~~~---------~ 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----QREIMQQVLY-GKY---------D 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHh-CCC---------C
Confidence 223344679999999999999999999999999999999999999984321 1111111111 110 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..+...+..+.+++.+||+.+|++||++.+++.
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112233456899999999999999999999864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.54 Aligned_cols=263 Identities=20% Similarity=0.277 Sum_probs=200.8
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++..++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999875 57889999986542 2345678899999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|++++.+..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987765542 2345889999999999999999999987 9999999999999999999999999998764322
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHH-----------HHHhccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYV-----------WELWSDD 596 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~-----------~~~~~~~ 596 (688)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.... .......
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI-DQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhhCCCCHHHHHhhhccc
Confidence 1 1222357899999999999989999999999999999999999998643211 1111000 0000000
Q ss_pred cccccccccccC------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 597 KALEIVDSSMAD------SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 597 ~~~~~~d~~l~~------~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.......+.... ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 011123456999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=323.16 Aligned_cols=265 Identities=27% Similarity=0.418 Sum_probs=207.7
Q ss_pred hcCCCCCCccccCCcEeEEEEEeCC-----------------CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccc
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLAN-----------------GQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVK 431 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 431 (688)
..+|++.+.||+|+||.||+|...+ +..||+|.+.... ....+++.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999997543 2458999987543 344678899999999999999999
Q ss_pred eEEEEEeCCceeEEEeccCCCChhhHhhccC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCc
Q 005599 432 LLGCCLEKDEKMLIYEFMPNKSLDYFIFDES--------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 503 (688)
Q Consensus 432 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 503 (688)
+++++..++..++|+||+++++|..++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986532 1236899999999999999999999987 9999999999
Q ss_pred eEECCCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh--CCCCCCCCCCC
Q 005599 504 ILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT--GKKNTGIFNDD 581 (688)
Q Consensus 504 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt--G~~p~~~~~~~ 581 (688)
|+++.++.++|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999987654433333334566789999999998899999999999999999998 556653221
Q ss_pred CccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 582 SSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 582 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
.......+...+...... .....+...+.++.+++.+|++.+|++|||+.||++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQ------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHHhcccccccc------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 122222222211111111 1111122334579999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=327.60 Aligned_cols=262 Identities=26% Similarity=0.418 Sum_probs=208.1
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEeC------CCcEEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeC
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTT-SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEK 439 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 439 (688)
...++|++.+.||+|+||.||++... +...+|+|.+... ......++.+|+.++.++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34467888899999999999999864 2367999998653 233456788999999999 799999999999999
Q ss_pred CceeEEEeccCCCChhhHhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEE
Q 005599 440 DEKMLIYEFMPNKSLDYFIFDE-------------SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 506 (688)
Q Consensus 440 ~~~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 506 (688)
...++||||+++|+|..++... .....+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998542 22346899999999999999999999987 9999999999999
Q ss_pred CCCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccH
Q 005599 507 DEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNL 585 (688)
Q Consensus 507 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l 585 (688)
++++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+.... .
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~ 240 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----V 240 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-----H
Confidence 9999999999999987654433332333445678999999999999999999999999999998 888874221 1
Q ss_pred HHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 586 IRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 586 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
.+. ........ ....+......+.+|+.+|++.+|++|||+.||++.|+++.
T Consensus 241 ~~~-~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 EEL-FKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHH-HHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111 11111111 11122334457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=341.06 Aligned_cols=250 Identities=27% Similarity=0.434 Sum_probs=211.6
Q ss_pred CCCCccccCCcEeEEEEEe-CCCc----EEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 374 STSNKLGQGGFGPVYKGKL-ANGQ----EIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 374 ~~~~~LG~G~fg~Vy~~~~-~~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
...++||+|+||+||+|.+ ..|+ +||+|++... ..+...++..|+.+|.+|+|||+++|+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3458999999999999974 3443 6899998654 4566789999999999999999999999998776 889999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
||+.|+|.+++.. .+..+--+..+.+..|||+||.|||.+. ++||||..+||||.+..++||.|||+++.+..+.
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999965 3456788999999999999999999887 9999999999999999999999999999988766
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
.........-.+.|||-|.+....|+.++|||||||++||++| |..|+.... .+++.+++....
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~---------------~~eI~dlle~ge 917 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP---------------AEEIPDLLEKGE 917 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC---------------HHHhhHHHhccc
Confidence 5555554556788999999999999999999999999999999 888864321 122333444444
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
+...|+.+..++..++.+||..|++.||+++++...+.
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs 955 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFS 955 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence 55677888899999999999999999999999886553
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.63 Aligned_cols=256 Identities=28% Similarity=0.454 Sum_probs=199.6
Q ss_pred CCCCCccccCCcEeEEEEEeCCCc---EEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeC------Cc
Q 005599 373 FSTSNKLGQGGFGPVYKGKLANGQ---EIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK------DE 441 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~~~~---~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 441 (688)
|.+.++||+|+||.||+|+..+.. .+|+|.++.. .....+.|..|+.++..++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 346789999999999999875433 5899988653 234467889999999999999999999987543 24
Q ss_pred eeEEEeccCCCChhhHhhcc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccc
Q 005599 442 KMLIYEFMPNKSLDYFIFDE---SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG 518 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 518 (688)
.++|+||+++|+|..++... .....+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999887432 22345899999999999999999999987 9999999999999999999999999
Q ss_pred cceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccc
Q 005599 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDK 597 (688)
Q Consensus 519 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 597 (688)
+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ....... ...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~----~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--NSEIYDY----LRQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH----HHcCC
Confidence 9987654332222223346778999999999999999999999999999999 788874321 1111111 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 598 ALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 598 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
.. ..+...+..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 10 11122344689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.19 Aligned_cols=252 Identities=27% Similarity=0.448 Sum_probs=202.4
Q ss_pred cCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccC
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
.+|++.+.||+|+||.||+|...++..+|+|.+.... .....|.+|+.++..++||||+++++++......++|+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3477889999999999999998877889999986432 234678899999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999985432 36899999999999999999999988 9999999999999999999999999998664322211
Q ss_pred ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....+ ..... .. ... ....
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~---~~-~~~---------~~~~ 221 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SEVVE---SV-SAG---------YRLY 221 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HHHHH---HH-HcC---------CcCC
Confidence 111234567999999999999999999999999999999 7888753221 11111 11 110 1111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
.+...+..+.+|+.+|++.+|++|||+.||+++|.
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 12234557999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.62 Aligned_cols=259 Identities=29% Similarity=0.458 Sum_probs=204.2
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeCC------CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCc
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLAN------GQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE 441 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 441 (688)
..++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......|.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678889999999999999998753 5678999886443 3344678999999999999999999999999999
Q ss_pred eeEEEeccCCCChhhHhhccCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC---Ccee
Q 005599 442 KMLIYEFMPNKSLDYFIFDESR----KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM---NPRI 514 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl 514 (688)
.++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865321 235899999999999999999999987 99999999999998765 5999
Q ss_pred cccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHh
Q 005599 515 SDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELW 593 (688)
Q Consensus 515 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 593 (688)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||..... ..+...+ .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--~~~~~~~---~ 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEVMEFV---T 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH---H
Confidence 99999987643333222222344568999999999999999999999999999997 8888753211 1111111 1
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 594 SDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 594 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
.. .....+...+..+.+++.+|++.+|++||++.+|++.|..
T Consensus 236 ~~----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 236 GG----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred cC----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11 0111222334578899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.55 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=205.2
Q ss_pred cCCCCCCccccCCcEeEEEEEeC------CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
.+|...++||+|+||.||++... ++..+|+|.+........+.|.+|++++..++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677899999999999999642 356799999877666667789999999999999999999999999999999
Q ss_pred EEeccCCCChhhHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCc
Q 005599 445 IYEFMPNKSLDYFIFDESR------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP 512 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 512 (688)
|+||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 135789999999999999999999988 9999999999999999999
Q ss_pred eecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHH
Q 005599 513 RISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWE 591 (688)
Q Consensus 513 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~ 591 (688)
||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ... ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~---~~~ 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--TEA---IEC 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--HHH---HHH
Confidence 9999999986644332222233445788999999999999999999999999999998 8888742211 111 111
Q ss_pred HhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 592 LWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 592 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
. .... ....+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 237 ~-~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 I-TQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred H-HcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1 1100 001112233468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=324.62 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=197.7
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
.++|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++.+++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 688999999865432 234567889999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|++ ++|.+++... ...++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 6777776432 345788889999999999999999988 9999999999999999999999999997543222
Q ss_pred cccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccc-------
Q 005599 528 ISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL------- 599 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~------- 599 (688)
.......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....+....+.. +..........
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLER-IFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH-HHHHhCCCChhhccchhh
Confidence 11223567899999998865 45889999999999999999999998643322111111 11111100000
Q ss_pred -ccccc-cccCCCCH---------HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 600 -EIVDS-SMADSCPA---------PEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 600 -~~~d~-~l~~~~~~---------~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
...++ ......+. .....+.+|+.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00000000 01245789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.13 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=208.7
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC--------CCcEEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeC
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA--------NGQEIAVKRLSTT-SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEK 439 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 439 (688)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+... .....+++.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467788899999999999999741 2457999988643 234457789999999999 899999999999999
Q ss_pred CceeEEEeccCCCChhhHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEE
Q 005599 440 DEKMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 506 (688)
Q Consensus 440 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 506 (688)
...++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999865321 235788999999999999999999987 9999999999999
Q ss_pred CCCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccH
Q 005599 507 DEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNL 585 (688)
Q Consensus 507 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l 585 (688)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+... ..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~ 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----PV 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----CH
Confidence 9999999999999987754433333333456778999999999899999999999999999998 77776321 11
Q ss_pred HHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCCC
Q 005599 586 IRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVP 650 (688)
Q Consensus 586 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 650 (688)
.+..... .... ....+...+..+.+++.+||+.+|++||+|.||++.|+++....
T Consensus 246 ~~~~~~~-~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 246 EELFKLL-KEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHHHH-HcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 1211111 1111 11112234557889999999999999999999999998866543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=316.36 Aligned_cols=253 Identities=29% Similarity=0.485 Sum_probs=203.7
Q ss_pred cCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccC
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
++|++.++||+|+||.||+|...++..+|+|.+..... ..+.|.+|+.++.+++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 56888999999999999999988888999999865432 4567999999999999999999999875 456899999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..+.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 99999998643 2345799999999999999999999988 9999999999999999999999999998764432211
Q ss_pred ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||.... ....... ... .....
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~----~~~---------~~~~~ 223 (260)
T cd05070 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--NREVLEQ----VER---------GYRMP 223 (260)
T ss_pred -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHHHHH----HHc---------CCCCC
Confidence 112345668999999988899999999999999999999 888874321 1111111 111 11111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
.+...+..+.+|+.+|++.+|++|||+.++++.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 223345579999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.65 Aligned_cols=241 Identities=22% Similarity=0.259 Sum_probs=193.1
Q ss_pred cccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCCh
Q 005599 379 LGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL 454 (688)
Q Consensus 379 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 454 (688)
||+|+||.||++... +++.||+|++... .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999865 5789999998643 234456788999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccccccc
Q 005599 455 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR 534 (688)
Q Consensus 455 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 534 (688)
.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 998854 345889999999999999999999988 9999999999999999999999999997543222 12234
Q ss_pred ccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHH
Q 005599 535 VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPE 614 (688)
Q Consensus 535 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 614 (688)
..||+.|+|||++.+..++.++|||||||++|||++|+.||... ............ . ...+...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~~~~~~~~~~~---------~--~~~~~~~ 216 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NVNEMYRKILQE---------P--LRFPDGF 216 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-----CHHHHHHHHHcC---------C--CCCCCcC
Confidence 67899999999999999999999999999999999999998532 111211111111 0 0122233
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 005599 615 ALRCIQVGLLCVQDRTTDRPSMSTVVFML 643 (688)
Q Consensus 615 ~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 643 (688)
...+.+++.+||+.||++||++..+.+.|
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 45688999999999999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=330.91 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=194.1
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
++|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++..++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667789999999999999865 68999999986543 23356789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|.... ..++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999985432 3567778889999999999999988 99999999999999999999999999987643221
Q ss_pred ccccccccccCCccCceeecC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYALG-----GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||..... .............
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~-------- 291 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCAICMS-------- 291 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHHHhcc--------
Confidence 1223578999999998743 2345689999999999999999999863221 1111111111000
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.....+......+.+|+.+||+.+|++||++.||++.
T Consensus 292 --~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 --QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011122334578999999999999999999999874
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.04 Aligned_cols=264 Identities=26% Similarity=0.443 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-----CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeC--Ccee
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-----NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEKM 443 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 443 (688)
.+|++.+.||+|+||.||++... ++..||||++........+.|.+|++++..++||||+++.+++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 56888899999999999999743 5789999998776666677899999999999999999999987643 4578
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
+|+||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998533 235899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccc-ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccc-----
Q 005599 524 GGEEIST-NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK----- 597 (688)
Q Consensus 524 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~----- 597 (688)
....... ......++..|+|||++.+..++.++||||||++++||++|..++..... ... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~----~~~~~~~~~~~~ 231 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFM----RMMGNDKQGQMI 231 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhh----hhcccccccccc
Confidence 4332211 11112334569999999988999999999999999999998776432110 000 0000000
Q ss_pred ---ccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 598 ---ALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 598 ---~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
..+++........+...+..+.+|+.+||+.+|++|||+.||++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0011111111112223345799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=316.08 Aligned_cols=259 Identities=22% Similarity=0.357 Sum_probs=207.6
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999864 6899999987543 2233456889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 447 EFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
||+++++|.+++.... ....++......++.|+++||+|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885422 2345788999999999999999999987 99999999999999999999999999987654
Q ss_pred CccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.|+..... ......... .... .+
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~-~~~~-----~~- 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQKI-EQCD-----YP- 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHHH-hcCC-----CC-
Confidence 322 11235688899999999988899999999999999999999999743221 111111111 1000 01
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
...+......+.+++.+||+.+|++||++.+|++.|++.
T Consensus 227 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 --PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111223446789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.93 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=208.2
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeCC-----CcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEe-CCc
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLAN-----GQEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLE-KDE 441 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 441 (688)
..++|.+.+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++.+++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678889999999999999998765 688999988654 23345678899999999999999999999876 467
Q ss_pred eeEEEeccCCCChhhHhhccCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecc
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRK-----QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISD 516 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 516 (688)
.++++||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998653222 56899999999999999999999987 99999999999999999999999
Q ss_pred cccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcc
Q 005599 517 FGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSD 595 (688)
Q Consensus 517 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 595 (688)
||+++.+...+.........++..|+|||.+.+..++.++||||||+++||+++ |+.|+.... ...+..+.. .
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~----~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYLK----D 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHHH----c
Confidence 999987654433322233456778999999998899999999999999999999 999874321 111111111 1
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 596 DKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 596 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
+. ....+...+..+.+++.+|++.+|++|||+.+|++.|+.+.
T Consensus 235 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 GY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 10 00111223456899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=323.57 Aligned_cols=241 Identities=24% Similarity=0.315 Sum_probs=193.6
Q ss_pred CccccCCcEeEEEEEe----CCCcEEEEEEccCC----CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 377 NKLGQGGFGPVYKGKL----ANGQEIAVKRLSTT----SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
++||+|+||.||+++. ..++.||||.+... .......+.+|+.++..++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 35789999998643 122345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|..++.. ...+.+.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999988843 345778888889999999999999988 9999999999999999999999999987543222
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... . .
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-----~~~~~~~~~~~-~--------~-- 217 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-----RKKTIDKILKG-K--------L-- 217 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-----HHHHHHHHHcC-C--------C--
Confidence 12233578999999999999889999999999999999999999985321 11111111111 0 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 641 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~ 641 (688)
..+......+.+++.+||+.+|++|| ++.++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11222345688999999999999999 7888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.65 Aligned_cols=260 Identities=26% Similarity=0.414 Sum_probs=204.9
Q ss_pred hcCCCCCCccccCCcEeEEEEEe-CCCc----EEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCcee
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL-ANGQ----EIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKM 443 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~-~~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 443 (688)
.++|++.++||+|+||+||+|+. .+++ .||+|.+... .....+++.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 45788889999999999999974 3444 4899998654 33345678899999999999999999999875 4578
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
+++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998543 345899999999999999999999988 999999999999999999999999999877
Q ss_pred CCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccc
Q 005599 524 GGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 524 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 602 (688)
.............+++.|+|||.+.+..++.++||||||+++|||++ |..|+.... ...+... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~----~~~~~----- 228 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDL----LEKGE----- 228 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH----HHCCC-----
Confidence 54332222222345678999999999999999999999999999998 888874321 1111111 11111
Q ss_pred cccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCCC
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVP 650 (688)
Q Consensus 603 d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 650 (688)
....+...+..+.+++.+||+.||++||++.++++.|+.....|
T Consensus 229 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 229 ----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 01112223456889999999999999999999999998876555
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.92 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=206.7
Q ss_pred hcCCCCCCccccCCcEeEEEEEeCC------CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCce
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLAN------GQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEK 442 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 442 (688)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678888999999999999997642 3689999986543 23456788999999999999999999999999999
Q ss_pred eEEEeccCCCChhhHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceec
Q 005599 443 MLIYEFMPNKSLDYFIFDESR-------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRIS 515 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 515 (688)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864321 234789999999999999999999987 9999999999999999999999
Q ss_pred ccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhc
Q 005599 516 DFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWS 594 (688)
Q Consensus 516 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 594 (688)
|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ........ .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~~~~~~~~----~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--NEEVLKFV----I 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--HHHHHHHH----h
Confidence 9999987654433333333556789999999988889999999999999999998 888874221 11111111 1
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 595 DDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 595 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
.... ...+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 236 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111 11122235578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=316.27 Aligned_cols=254 Identities=28% Similarity=0.457 Sum_probs=203.2
Q ss_pred cCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccC
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
++|++.++||+|+||.||+|+..+...||+|++.... ...++|.+|++++..++|+||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5688899999999999999998777789999986532 34568999999999999999999999874 456899999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+|+|.+++... ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||+++.+.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 99999998543 2345789999999999999999999987 9999999999999999999999999998765433221
Q ss_pred ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..... ...... ....
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~--~~~~~----~~~~~~---------~~~~ 223 (262)
T cd05071 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVL----DQVERG---------YRMP 223 (262)
T ss_pred -ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--hHHHH----HHHhcC---------CCCC
Confidence 122446678999999998899999999999999999999 777764321 11111 111110 0111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
.+...+..+.+|+.+|++.+|++||++.+++++|+..
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 2233456789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=337.86 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=205.6
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC------CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcC-CCCccceEEEEEeCC
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKD 440 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 440 (688)
..++|.+.++||+|+||.||+|++. .+..||||++..... ...+.+.+|+.++.++. |||||++++++....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456778899999999999999853 346899999975432 33457889999999997 999999999999999
Q ss_pred ceeEEEeccCCCChhhHhhccC----------------------------------------------------------
Q 005599 441 EKMLIYEFMPNKSLDYFIFDES---------------------------------------------------------- 462 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 462 (688)
..++|+||+++|+|.++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999986421
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceE
Q 005599 463 -------------------------------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNIL 505 (688)
Q Consensus 463 -------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL 505 (688)
....+++...+.++.||+.||+|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1124678888999999999999999987 999999999999
Q ss_pred ECCCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 005599 506 LDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSN 584 (688)
Q Consensus 506 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~ 584 (688)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--- 348 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--- 348 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch---
Confidence 99999999999999986543322222223456788999999998889999999999999999998 88887432211
Q ss_pred HHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 585 LIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 585 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
.........+ .....+......+.+|+.+||+.+|++||++.+|++.|++..
T Consensus 349 --~~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 --EQFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --HHHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111111 111122233457899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=326.66 Aligned_cols=199 Identities=27% Similarity=0.403 Sum_probs=173.4
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
.++|++.++||+|+||.||++... ++..+|+|.+... .....+.+.+|++++.+++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999876 5788999988654 23345678999999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|+++++|.+++.. ...+++.....++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999853 345788999999999999999999753 3999999999999999999999999998755322
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGI 577 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~ 577 (688)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12235689999999999998999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=320.66 Aligned_cols=261 Identities=21% Similarity=0.350 Sum_probs=194.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeC--CCcEEEEEEccCCC--cccHHHHHHHHHHHhhc---CCCCccceEEEEEe-----
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA--NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKL---QHRNLVKLLGCCLE----- 438 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----- 438 (688)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46789999886432 22334566787777766 69999999999863
Q ss_pred CCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccc
Q 005599 439 KDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG 518 (688)
Q Consensus 439 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 518 (688)
....++|+||++ ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345899999996 68888875432 335789999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccc--
Q 005599 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD-- 596 (688)
Q Consensus 519 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-- 596 (688)
+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|++||....+ ......+.......
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~--~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLPGE 230 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCCh
Confidence 99876433 222346789999999999988999999999999999999999999864321 11111111111000
Q ss_pred -cc---ccccccccc--CC-----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 597 -KA---LEIVDSSMA--DS-----CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 597 -~~---~~~~d~~l~--~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.. ..+....+. .. ........+.+|+.+|++.+|++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 000000000 00 00123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=327.23 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=211.7
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCc-eeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE-KMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 446 (688)
++|..+++||+|+||.+++.+.+ ++..+|+|.+.... ....+...+|+.++++++|||||.+.+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999998754 57789999886543 3344567899999999999999999999999998 99999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
+|+++|+|.+.+.... ...+++..+.+++.|++.|+.|||++. |+|||||+.||+++.+..+||.|||+|+.++..
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999986554 567899999999999999999999876 999999999999999999999999999998766
Q ss_pred ccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
.. ......||+.||.||++.+.+|..|+|+|||||++|||++-+++|... +....+.... +..
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~ki~----------~~~ 222 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILKIN----------RGL 222 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHHHh----------hcc
Confidence 52 233489999999999999999999999999999999999999998432 2222221111 111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
....|...+.++..|+..|++.+|+.||++.+++.+
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 233566677889999999999999999999999864
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.95 Aligned_cols=261 Identities=24% Similarity=0.427 Sum_probs=205.4
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCc
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE 441 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 441 (688)
..++|++.++||+|+||.||+|... .+..||+|.+.... ......+.+|+.++..++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 24579999886443 2334568899999999999999999999999999
Q ss_pred eeEEEeccCCCChhhHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCcee
Q 005599 442 KMLIYEFMPNKSLDYFIFDESR-------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRI 514 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 514 (688)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999864221 234577888999999999999999987 999999999999999999999
Q ss_pred cccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHh
Q 005599 515 SDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELW 593 (688)
Q Consensus 515 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 593 (688)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.... ....... ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--~~~~~~~---~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--NEQVLKF---VM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH---HH
Confidence 99999986654333222233445778999999999999999999999999999999 677764211 1111111 11
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 594 SDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 594 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
. +... ..+......+.+++.+|++.+|++|||+.++++.|++..
T Consensus 236 ~-~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 D-GGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred c-CCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1 1100 111223457999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.94 Aligned_cols=245 Identities=22% Similarity=0.289 Sum_probs=199.5
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC--CcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN--GQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 445 (688)
++|.+.+.||+|+||.||+|...+ +..||+|++... .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 568888999999999999998543 368999988543 223456788999999999999999999999999999999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
|||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999998533 45889999999999999999999988 99999999999999999999999999987543
Q ss_pred CccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... ..... .+.
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--~~~~---~~~i~-~~~-------- 244 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE--PLLI---YQKIL-EGI-------- 244 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC--HHHH---HHHHh-cCC--------
Confidence 2 223678999999999999899999999999999999999999985321 1111 11111 111
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRP-----SMSTVVFM 642 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~ 642 (688)
. ..|......+.+++.+|++.+|++|+ +++++++.
T Consensus 245 ~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 I--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 11222334678999999999999995 89998864
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=326.84 Aligned_cols=242 Identities=19% Similarity=0.253 Sum_probs=195.4
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNK 452 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 452 (688)
+.||+|+||.||++... +++.||||++... .......+.+|+.++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999854 6899999998653 2334567889999999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccccc
Q 005599 453 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT 532 (688)
Q Consensus 453 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 532 (688)
+|..++.. ...+++.+...++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 99888743 345889999999999999999999988 9999999999999999999999999987543221 112
Q ss_pred ccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCH
Q 005599 533 NRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPA 612 (688)
Q Consensus 533 ~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 612 (688)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... +. ..+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-----~~~~~~~~~~~-------~~----~~p~ 216 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILME-------DI----KFPR 216 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-----HHHHHHHhccC-------Cc----cCCC
Confidence 23578999999999999999999999999999999999999985321 11111111100 01 1122
Q ss_pred HHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 005599 613 PEALRCIQVGLLCVQDRTTDRP-----SMSTVVFM 642 (688)
Q Consensus 613 ~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~ 642 (688)
.....+.+++.+||+.||++|| ++.++++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3345688999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=315.64 Aligned_cols=246 Identities=27% Similarity=0.437 Sum_probs=196.1
Q ss_pred ccccCCcEeEEEEEe---CCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCC
Q 005599 378 KLGQGGFGPVYKGKL---ANGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNK 452 (688)
Q Consensus 378 ~LG~G~fg~Vy~~~~---~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 452 (688)
.||+|+||.||+|.+ .++..+|+|++.... ....+++.+|+.++..++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 357889999986543 234568899999999999999999999875 45778999999999
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc-c
Q 005599 453 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST-N 531 (688)
Q Consensus 453 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~ 531 (688)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999843 235889999999999999999999988 9999999999999999999999999998765433221 1
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSC 610 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 610 (688)
.....++..|+|||.+....++.++||||||+++|||++ |+.||..... ..+... ...+. ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~----i~~~~---------~~~~ 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQM----IESGE---------RMEC 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHCCC---------CCCC
Confidence 122334678999999988889999999999999999998 9999853211 111111 11111 1112
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 611 PAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 611 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
+...+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 23344578899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=326.32 Aligned_cols=241 Identities=19% Similarity=0.255 Sum_probs=194.0
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNK 452 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 452 (688)
+.||+|+||.||+++.. +|+.||+|++... .......+.+|+.++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999864 6899999998653 2234556788999999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccccc
Q 005599 453 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT 532 (688)
Q Consensus 453 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 532 (688)
+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 99888743 345889999999999999999999988 99999999999999999999999999875322211 12
Q ss_pred ccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCH
Q 005599 533 NRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPA 612 (688)
Q Consensus 533 ~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 612 (688)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ....... . . ..+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--~~~---~~~~~~~-~------~----~~p~ 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERL---FELILME-E------I----RFPR 216 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--HHH---HHHHhcC-C------C----CCCC
Confidence 235789999999999999999999999999999999999999853211 111 1111111 0 0 1122
Q ss_pred HHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005599 613 PEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 641 (688)
Q Consensus 613 ~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~ 641 (688)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 3345688999999999999998 7888775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=319.99 Aligned_cols=261 Identities=22% Similarity=0.325 Sum_probs=198.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
++|.+.++||+|+||.||+|... +++.||+|++.... ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999865 68899999986442 23345678999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++ +|.+++... ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 974 888887432 345788999999999999999999988 99999999999999999999999999976543221
Q ss_pred ccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcc------------
Q 005599 529 STNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSD------------ 595 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~------------ 595 (688)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... .............
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV--KEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHHhhccccc
Confidence 1223567899999998875 5689999999999999999999999853221 1111111111100
Q ss_pred ccccccccccccCC----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 596 DKALEIVDSSMADS----CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 596 ~~~~~~~d~~l~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
........+..... .......++.+|+.+|++.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00011111111000 00112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.12 Aligned_cols=260 Identities=26% Similarity=0.407 Sum_probs=202.8
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC-Cc--EEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN-GQ--EIAVKRLSTT-SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 445 (688)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.|.+|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 568888999999999999998754 32 4788888643 334456789999999999 799999999999999999999
Q ss_pred EeccCCCChhhHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCc
Q 005599 446 YEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP 512 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 512 (688)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1235889999999999999999999987 9999999999999999999
Q ss_pred eecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHH
Q 005599 513 RISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWE 591 (688)
Q Consensus 513 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~ 591 (688)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.... ...+. ..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~--~~~~~---~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT--CAELY---EK 230 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHH---HH
Confidence 99999998643211 11111233567999999998899999999999999999998 999874321 11111 11
Q ss_pred HhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCCCC
Q 005599 592 LWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPS 651 (688)
Q Consensus 592 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 651 (688)
... ......+...+..+.+|+.+|++.+|.+||++.+|++.|++......
T Consensus 231 -~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 231 -LPQ---------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred -Hhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111 11111122334568899999999999999999999999987664443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=347.05 Aligned_cols=256 Identities=23% Similarity=0.299 Sum_probs=204.7
Q ss_pred HhcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCC-----
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD----- 440 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 440 (688)
..++|.+.++||+|+||+||+|+. .+++.||||++... .......+.+|+.++..++|+||+++...+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 446899999999999999999975 47899999998654 2344567889999999999999999988776433
Q ss_pred ---ceeEEEeccCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecc
Q 005599 441 ---EKMLIYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISD 516 (688)
Q Consensus 441 ---~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 516 (688)
..++||||+++|+|.+++.... ....+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence 2579999999999999986432 2356889999999999999999999987 99999999999999999999999
Q ss_pred cccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccc
Q 005599 517 FGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD 596 (688)
Q Consensus 517 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 596 (688)
||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||... .....+..... +
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~~~~~~~~-~ 260 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEEVMHKTLA-G 260 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHhc-C
Confidence 99998765433333334467999999999999999999999999999999999999998532 11111111111 1
Q ss_pred cccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 597 KALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 597 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
. . ...+...+..+.+++.+||+.+|.+||++.+++..
T Consensus 261 ~----~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 R----Y-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C----C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 0 11223344578999999999999999999999863
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=319.82 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=203.3
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-----------------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccce
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-----------------NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKL 432 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 432 (688)
++|++.++||+|+||.||++... ++..||+|++.... .....+|.+|+.++..++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56889999999999999998532 23468999987543 3345689999999999999999999
Q ss_pred EEEEEeCCceeEEEeccCCCChhhHhhccCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCce
Q 005599 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDESR--------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNI 504 (688)
Q Consensus 433 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 504 (688)
++++...+..++||||+++++|.+++..... ...+++.+...++.|++.||+|||+.+ |+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 134778899999999999999999988 99999999999
Q ss_pred EECCCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh--CCCCCCCCCCCC
Q 005599 505 LLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT--GKKNTGIFNDDS 582 (688)
Q Consensus 505 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt--G~~p~~~~~~~~ 582 (688)
|++.++.++|+|||+++.+.............++..|+|||...++.++.++|||||||++|||++ |..|+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence 999999999999999986644332222223445678999999888899999999999999999998 5667643221
Q ss_pred ccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 583 SNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 583 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
.................. ....+..++..+.+|+.+||+.+|++||++.+|++.|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQVIENTGEFFRDQGRQV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHHhhccccc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111110000 001122334678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=321.05 Aligned_cols=258 Identities=29% Similarity=0.473 Sum_probs=205.0
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCce
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEK 442 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 442 (688)
.++|++.+.||+|+||.||+|... ++..||+|.+.... .....+|.+|+.++.+++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999863 46789999986543 33456799999999999999999999999999999
Q ss_pred eEEEeccCCCChhhHhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCc
Q 005599 443 MLIYEFMPNKSLDYFIFDES-------------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 503 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 503 (688)
++|+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986321 1234788999999999999999999987 9999999999
Q ss_pred eEECCCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 005599 504 ILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDS 582 (688)
Q Consensus 504 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~ 582 (688)
||++.++.++|+|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..|+....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~--- 237 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA--- 237 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence 9999999999999999986543332222222345678999999998899999999999999999998 777763211
Q ss_pred ccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 583 SNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 583 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
..+.... ...+... ..+...+..+.+++.+|++.+|++|||+.||++.|+.
T Consensus 238 --~~~~~~~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 --HEEVIYY-VRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHHHHH-HhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111111 1111111 1122334578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=314.41 Aligned_cols=254 Identities=30% Similarity=0.460 Sum_probs=205.0
Q ss_pred hcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.|.+|+.++..++|+||+++++++. .+..++|+||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 46788899999999999999998889999999986543 34578999999999999999999999864 56789999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999885433 346889999999999999999999987 999999999999999999999999999876533222
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
. .....++..|+|||++....++.++||||||++++||++ |+.||.... ....... +... ...
T Consensus 159 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~----~~~~---------~~~ 222 (260)
T cd05067 159 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--NPEVIQN----LERG---------YRM 222 (260)
T ss_pred c-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--hHHHHHH----HHcC---------CCC
Confidence 1 122345678999999998899999999999999999999 999985321 1111111 1111 111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
..+...+..+.+++.+|++.+|++||++++++..|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1122234579999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=302.66 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=200.4
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcc-c-HHHHHHHHHHHhhcCCCCccceEEEEEeC--Ccee
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQ-G-IEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEKM 443 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 443 (688)
..+.|+.++.|++|.||.||+|+.+ +++.||+|+++..... + .-.-.+||.+|.+++|||||.+..+.... +..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3466888999999999999999864 6889999999754321 1 12347899999999999999999987754 5699
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
+|||||++ +|...+.... +.+...+..-++.|+++|+.|||.+. |+||||||+|+|+.+.|.+||+|||||+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 99999965 7878876544 56788888899999999999999998 999999999999999999999999999988
Q ss_pred CCCccccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccc-----
Q 005599 524 GGEEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK----- 597 (688)
Q Consensus 524 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~----- 597 (688)
+... ...+..+-|.+|.|||.+.+. .|++..|+||+|||+.||+++++-|....+ .+..+.+...+..+.
T Consensus 228 gsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE--~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 228 GSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE--IDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred cCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch--HHHHHHHHHHhCCCccccCC
Confidence 7542 223347889999999999886 599999999999999999999998754322 122222222221110
Q ss_pred ---cccccc---------ccccCCCCHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 598 ---ALEIVD---------SSMADSCPAP-EALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 598 ---~~~~~d---------~~l~~~~~~~-~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
....+. ..++..++.. ..+.-.+|+...+..||.+|.|+.|.++
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 000110 0111122222 3466788999999999999999999875
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=324.14 Aligned_cols=259 Identities=26% Similarity=0.421 Sum_probs=205.2
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCc
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDE 441 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 441 (688)
.++|.+.+.||+|+||.||++... .+..||||+++... ....+.+.+|+.++.++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357888999999999999999742 34579999987543 33456789999999999 79999999999999999
Q ss_pred eeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccce
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 521 (688)
.++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999985432 234899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccc
Q 005599 522 VFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALE 600 (688)
Q Consensus 522 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 600 (688)
...............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ... ......+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~----~~~~~~~---- 260 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKF----YKLIKEG---- 260 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHH----HHHHHcC----
Confidence 6543322222223456788999999999999999999999999999998 88887432211 011 1111111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 601 IVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 601 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
.....+...+..+.+++.+|++.+|++||++.||++.|+..
T Consensus 261 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 -----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111122345789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=325.39 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=204.5
Q ss_pred cCCCCCCccccCCcEeEEEEEeC--------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCCccceEEEEEeCC
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA--------NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKD 440 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 440 (688)
++|.+.+.||+|+||.||+++.. +...+|+|.+.... .....++..|+.++..+ +|+||+++++++....
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888999999999999999742 23579999987542 33456788999999999 7999999999999999
Q ss_pred ceeEEEeccCCCChhhHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEEC
Q 005599 441 EKMLIYEFMPNKSLDYFIFDESR-------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 507 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 507 (688)
..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999865321 235899999999999999999999987 99999999999999
Q ss_pred CCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHH
Q 005599 508 EEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLI 586 (688)
Q Consensus 508 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~ 586 (688)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+... ...
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-----~~~ 249 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-----PVE 249 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-----CHH
Confidence 999999999999976643322222222334578999999999999999999999999999998 78886421 111
Q ss_pred HHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 587 RYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 587 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
..... ..... ....+......+.+++.+|++.+|++||+|.+|++.|+.+.
T Consensus 250 ~~~~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 250 ELFKL-LKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HHHHH-HHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11111 11111 11122333457889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=316.53 Aligned_cols=257 Identities=26% Similarity=0.461 Sum_probs=203.9
Q ss_pred hcCCCCCCccccCCcEeEEEEEeCC-C---cEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLAN-G---QEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
.++|+..+.||+|+||.||+|+... + ..+|+|.+... .....+++.+|++++.+++|+||+++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567788999999999999998753 3 37999998654 23345678999999999999999999999999999999
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
||||+++++|..++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998543 245899999999999999999999987 9999999999999999999999999998665
Q ss_pred CCcccccc-ccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccc
Q 005599 525 GEEISTNT-NRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 525 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 602 (688)
........ .....+..|+|||++.+..++.++||||||+++|||++ |+.|+..... .... .. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~---~~-i~~~------ 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVM---KA-INDG------ 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHH---HH-HhcC------
Confidence 33221111 11223567999999998889999999999999999998 9999743221 1111 11 1111
Q ss_pred cccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 603 d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
.....+...+..+.+++.+|++.+|++||+|.+|++.|+++
T Consensus 227 ---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ---FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111223345689999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=310.80 Aligned_cols=247 Identities=29% Similarity=0.420 Sum_probs=198.5
Q ss_pred CccccCCcEeEEEEEeCCCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCChh
Q 005599 377 NKLGQGGFGPVYKGKLANGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLD 455 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 455 (688)
++||+|+||.||+|...+++.+|+|.+..... .....|.+|+.++..++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999988899999999865533 33456889999999999999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccccccc
Q 005599 456 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV 535 (688)
Q Consensus 456 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 535 (688)
+++... ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 988543 235789999999999999999999987 999999999999999999999999999764432221 11123
Q ss_pred cccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHH
Q 005599 536 VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPE 614 (688)
Q Consensus 536 ~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 614 (688)
.++..|+|||++.+..++.++||||||+++|||++ |..||..... .. ........ .....+...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----~~-~~~~~~~~---------~~~~~~~~~ 219 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----QQ-AREQVEKG---------YRMSCPQKC 219 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----HH-HHHHHHcC---------CCCCCCCCC
Confidence 44678999999998899999999999999999999 8888743211 11 11111111 111122234
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 615 ALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 615 ~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=325.86 Aligned_cols=261 Identities=26% Similarity=0.404 Sum_probs=205.8
Q ss_pred cCCCCCCccccCCcEeEEEEEeC--------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCCccceEEEEEeCC
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA--------NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKD 440 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 440 (688)
.+|.+.+.||+|+||.||++... ....||+|.+.... ....+++.+|+.++.++ +||||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999742 12368999886532 33467899999999999 7999999999999999
Q ss_pred ceeEEEeccCCCChhhHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEEC
Q 005599 441 EKMLIYEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 507 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 507 (688)
..++++||+++|+|.+++.... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986422 2245889999999999999999999987 99999999999999
Q ss_pred CCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHH
Q 005599 508 EEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLI 586 (688)
Q Consensus 508 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~ 586 (688)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~ 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-----PVE 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC-----CHH
Confidence 999999999999987654332222222344578999999999999999999999999999999 77876421 111
Q ss_pred HHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCC
Q 005599 587 RYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSV 649 (688)
Q Consensus 587 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 649 (688)
...... .... ....+...+..+.+++.+|++.+|++||++.|+++.|+.+...
T Consensus 244 ~~~~~~-~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 244 ELFKLL-KEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHHHHH-HcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 111111 1111 1111223345788999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=313.85 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=207.2
Q ss_pred cCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|.+.+.||+|+||.||+|.. .+++.+|||.+.... .....++.+|+.++..++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999985 578999999876432 234467889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 447 EFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 447 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
||+++++|.+++... .....+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988542 23456899999999999999999999988 99999999999999999999999999876543
Q ss_pred CccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
.... .....++..|+|||++.+..++.++||||||+++|||++|..|+...... ........ .....+.
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~------~~~~~~~ 227 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI------EQCDYPP 227 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhh------hcCCCCC
Confidence 3211 12356888999999999989999999999999999999999997432211 11111110 0011111
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
+ .+......+.+++.+|++.+|++||||.+|+++++..
T Consensus 228 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 L---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 1123455789999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=319.43 Aligned_cols=271 Identities=27% Similarity=0.397 Sum_probs=205.7
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-----CCcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCCccceEEEEEe--CCce
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-----NGQEIAVKRLSTTSGQ-GIEEFKNEVLLIAKLQHRNLVKLLGCCLE--KDEK 442 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 442 (688)
+.|.+.+.||+|+||.||+|++. .+..+|||.+...... ..+.|.+|+.++..++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677899999999999999854 3678999999755432 46789999999999999999999999987 5578
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999985432 25899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCcc-ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccc
Q 005599 523 FGGEEI-STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 523 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 601 (688)
...... ........++..|+|||.+.+..++.++||||||++++||++|+.|+........................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 653221 1112223455679999999988999999999999999999999988643211110000000000000001111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 602 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
+........+...+..+.+|+.+|++.+|++||+|.||+++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111122233446799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=320.00 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=202.6
Q ss_pred CCCCCCccccCCcEeEEEEEe-----CCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeC--Ccee
Q 005599 372 NFSTSNKLGQGGFGPVYKGKL-----ANGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEKM 443 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 443 (688)
.|.+.+.||+|+||.||+++. .++..||+|.+.... ....+.+.+|+.+++.++||||+++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999974 357889999986543 34456799999999999999999999999875 5678
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
+||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||+++.+
T Consensus 85 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 999999999999998433 235899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCccc-cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCC---------CCccHHHHHHHHh
Q 005599 524 GGEEIS-TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFND---------DSSNLIRYVWELW 593 (688)
Q Consensus 524 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~---------~~~~l~~~~~~~~ 593 (688)
...... .......++..|+|||++.+..++.++||||||+++|||++++.|...... .............
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 533221 122235567789999999988999999999999999999998776421100 0000001111111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 594 SDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 594 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
..+ .....+...+..+.+|+.+|++.+|++||++.+|++.|+.+
T Consensus 240 ~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111 11111223456799999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=324.86 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=197.1
Q ss_pred CCCCCCccccCCcEeEEEEEe----CCCcEEEEEEccCC----CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCce
Q 005599 372 NFSTSNKLGQGGFGPVYKGKL----ANGQEIAVKRLSTT----SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEK 442 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 442 (688)
+|++.+.||+|+||.||+++. .+++.||+|++... .....+.+..|+.++..+ +|+||+++.+++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999975 35789999998642 123345678899999999 599999999999999999
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
++||||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998854 345889999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccc
Q 005599 523 FGGEEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 523 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 601 (688)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ..........
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~------- 225 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK------- 225 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc-------
Confidence 5432221 22236799999999999875 478999999999999999999999864332111 1111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 641 (688)
Q Consensus 602 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~ 641 (688)
.++. .+......+.+++.+||+.||++|| +++++++
T Consensus 226 ~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111 1222344688999999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=327.55 Aligned_cols=252 Identities=19% Similarity=0.280 Sum_probs=199.8
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|.+.+.||+|+||.||++... +++.||||+++... ....+.+.+|+.++..++|+||+++.+++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999864 68899999986532 234566889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|+|.+++... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 245889999999999999999999988 999999999999999999999999999876543
Q ss_pred ccccccccccccCCccCceeec------CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYAL------GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALE 600 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 600 (688)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.... ................
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~~~~~~~i~~~~~~~~ 229 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-----SAKTYNNIMNFQRFLK 229 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC-----HHHHHHHHHcCCCccC
Confidence 222 222357899999999986 4567899999999999999999999985321 1111112111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 601 IVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 601 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+ ......+..+.+|+..|++ +|++||++.+++.
T Consensus 230 ~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 F-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 0111234568889999997 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=324.35 Aligned_cols=259 Identities=26% Similarity=0.424 Sum_probs=204.5
Q ss_pred cCCCCCCccccCCcEeEEEEEeC--------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCCccceEEEEEeCC
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA--------NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKD 440 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 440 (688)
++|.+.+.||+|+||.||+++.. ....+|+|.+.... .....++.+|+.++.++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56788899999999999999742 24578999987542 34456788999999999 6999999999999999
Q ss_pred ceeEEEeccCCCChhhHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEEC
Q 005599 441 EKMLIYEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 507 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 507 (688)
..++|+||+++|+|.+++.... ....+++.++..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999986532 1245899999999999999999999987 99999999999999
Q ss_pred CCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHH
Q 005599 508 EEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLI 586 (688)
Q Consensus 508 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~ 586 (688)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.... ...+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~--~~~~~ 246 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP--VEELF 246 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC--HHHHH
Confidence 999999999999987654332222222334567999999999999999999999999999999 888874221 11111
Q ss_pred HHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 587 RYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 587 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
.. ...... ...+...+..+.+++.+|++.+|++||++.++++.|++..
T Consensus 247 ~~----~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 247 KL----LREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HH----HHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11 111110 1112233456889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.43 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=209.2
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++.+++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999876 7899999988642 2233567899999999999999999999999999999999
Q ss_pred eccCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 447 EFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 447 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
||+++++|..++... .....+++.++..++.+++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988542 23455899999999999999999999987 99999999999999999999999999876543
Q ss_pred CccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ......... ...+
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~-~~~~--------- 223 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKK-IEKC--------- 223 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhh-hhcC---------
Confidence 2211 122467889999999998899999999999999999999999974322 111111111 1111
Q ss_pred ccCCCCH-HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 606 MADSCPA-PEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 606 l~~~~~~-~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
.....+. .....+.+++.+|++.+|++||++.+|+++|++..
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1111122 34457889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=323.89 Aligned_cols=247 Identities=21% Similarity=0.340 Sum_probs=194.8
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
+.||+|+||.||++... +++.||+|++... .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999865 5789999998653 223445678899888877 799999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
|+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 999888743 345889999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCC---CccHHHHHHHHhccccccccccccccC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDD---SSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......++........ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~ 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------I 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------C
Confidence 23367899999999999999999999999999999999999998643211 1112222222211111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCC------HHHHHH
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPS------MSTVVF 641 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt------~~evl~ 641 (688)
..|......+.+++.+||+.||++||+ +.++++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 123334456889999999999999998 456653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=312.38 Aligned_cols=248 Identities=24% Similarity=0.414 Sum_probs=195.5
Q ss_pred ccccCCcEeEEEEEeC---CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005599 378 KLGQGGFGPVYKGKLA---NGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKS 453 (688)
Q Consensus 378 ~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 453 (688)
.||+|+||.||+|.+. ++..||+|.+..... ...+.|.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999754 355799999865532 33567999999999999999999999875 457899999999999
Q ss_pred hhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc-cc
Q 005599 454 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST-NT 532 (688)
Q Consensus 454 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~ 532 (688)
|.+++... ...+++..+++++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++......... ..
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99988532 346899999999999999999999987 9999999999999999999999999998654332211 11
Q ss_pred ccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 533 NRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 533 ~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
....++..|+|||.+....++.++||||||+++|||++ |..|+..... .... ..... ......+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~----~~~~~---------~~~~~~~ 220 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--PEVM----SFIEQ---------GKRLDCP 220 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--HHHH----HHHHC---------CCCCCCC
Confidence 11234578999999988889999999999999999996 9999743211 1111 11111 1111223
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 612 APEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
......+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 34456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=321.02 Aligned_cols=244 Identities=23% Similarity=0.328 Sum_probs=192.4
Q ss_pred CCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHH---hhcCCCCccceEEEEEeCCceeEE
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLI---AKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 445 (688)
|.+.+.||+|+||.||+|... +++.||||++.... ....+.+..|+.++ ..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999865 58899999986432 23345666676655 566799999999999999999999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
|||+++++|..++. ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988873 245899999999999999999999988 99999999999999999999999999875322
Q ss_pred CccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||.... . .......... . .
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--~---~~~~~~i~~~-~------~- 218 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--E---EEVFDSIVND-E------V- 218 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--H---HHHHHHHHhC-C------C-
Confidence 21 12234678999999999999999999999999999999999999985321 1 1111111111 0 0
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 641 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~ 641 (688)
..+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11222345688999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=329.68 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=202.6
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|.+.+.||+|+||.||+|... +++.||||++... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999865 6899999998643 2234567889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++++|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 46889999999999999999999987 999999999999999999999999999866533
Q ss_pred c---------------------------cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 005599 527 E---------------------------ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFN 579 (688)
Q Consensus 527 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~ 579 (688)
. .........||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0112233578999999999999999999999999999999999999985422
Q ss_pred CCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHH
Q 005599 580 DDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPS-MSTVVFM 642 (688)
Q Consensus 580 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-~~evl~~ 642 (688)
............ ..+........+..+.+++.+|++ +|.+||+ +.++++.
T Consensus 235 -----~~~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 -----LQETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -----HHHHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111111111100 001000011124568899999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=316.01 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=201.5
Q ss_pred CCCCCCccccCCcEeEEEEEeCC-C---cEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLAN-G---QEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
.|.+.+.||+|+||.||+|.... + ..||||.+... .....++|..|+.+++.++||||+++.+++.++...++|+
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999998653 3 36999998654 3444678999999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++++|.+++... ...+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999998543 345889999999999999999999987 999999999999999999999999998766433
Q ss_pred cccccccc-c--cccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccc
Q 005599 527 EISTNTNR-V--VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 527 ~~~~~~~~-~--~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 602 (688)
........ . ..+..|+|||.+.+..++.++||||||+++|||++ |..||.... .......+. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~--~~~~~~~i~----~~------ 227 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVINAIE----QD------ 227 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--HHHHHHHHH----cC------
Confidence 22111111 1 12457999999999999999999999999999987 999874321 111111111 10
Q ss_pred cccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 603 d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
.....+.+.+..+.+++.+|++.+|++||++.+|+.+|++.
T Consensus 228 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ---YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01111223345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=329.26 Aligned_cols=261 Identities=28% Similarity=0.412 Sum_probs=201.8
Q ss_pred hcCCCCCCccccCCcEeEEEEEe------CCCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCCccceEEEEEeC-C
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL------ANGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEK-D 440 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 440 (688)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35789999999999999999963 357789999996543 23356788999999999 689999999988765 4
Q ss_pred ceeEEEeccCCCChhhHhhccCC---------------------------------------------------------
Q 005599 441 EKMLIYEFMPNKSLDYFIFDESR--------------------------------------------------------- 463 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 463 (688)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999998854210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccccccccc
Q 005599 464 -------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536 (688)
Q Consensus 464 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 536 (688)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124688889999999999999999987 9999999999999999999999999998754332222222345
Q ss_pred ccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHH
Q 005599 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEA 615 (688)
Q Consensus 537 gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 615 (688)
++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .... .....+.. ...+....
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~----~~~~~~~~---------~~~~~~~~ 308 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFC----RRLKEGTR---------MRAPDYTT 308 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHH----HHHhccCC---------CCCCCCCC
Confidence 6678999999999999999999999999999997 88887432211 1111 11111110 01111123
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 616 LRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 616 ~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
..+.+++..||+.+|++||++.||++.|+.+.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 46889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.78 Aligned_cols=255 Identities=21% Similarity=0.350 Sum_probs=201.5
Q ss_pred hcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++.+++||||+++++++...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788999999999999999986 46889999998765555566788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998853 245789999999999999999999987 99999999999999999999999999986643221
Q ss_pred ccccccccccCCccCceeec---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYAL---GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
......+++.|+|||.+. ...++.++||||||++++||++|+.|+........ .. .+... .+..+.
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~-----~~~~~---~~~~~~ 230 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LF-----LMSKS---NFQPPK 230 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-he-----eeecC---CCCCCC
Confidence 122356888999999884 34578899999999999999999998742211000 00 00000 000111
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 643 (688)
.. .....+..+.+++.+||+.+|++||++.+|++.|
T Consensus 231 ~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11 0112345789999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=317.93 Aligned_cols=240 Identities=25% Similarity=0.335 Sum_probs=189.9
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
+.||+|+||.||+|+.. +++.||||.++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999865 5788999998643 223345566677777654 899999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
|+|..++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 9999888532 35888999999999999999999987 9999999999999999999999999998653322 22
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... ....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~-----------~~~~~ 216 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILND-----------RPHFP 216 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcC-----------CCCCC
Confidence 2346789999999999999999999999999999999999999853221 1111111110 01112
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 005599 612 APEALRCIQVGLLCVQDRTTDRPSMS-TVV 640 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPt~~-evl 640 (688)
......+.+++.+||+.+|++||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 22345678999999999999999976 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=310.90 Aligned_cols=247 Identities=22% Similarity=0.380 Sum_probs=206.7
Q ss_pred cCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
.+|++.+.||+|.||.|-+|.. ..|+.||||.+++. +.++.-.+++||++|..|+||||+.++.+|++.+..++||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 5688889999999999999974 67999999998764 3455567889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||..+|.|.+++. ..+.|++.+...++.||..|+.|+|.+. ++|||||.+|||||.++++||+||||+-++...
T Consensus 133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999994 4456899999999999999999999987 999999999999999999999999999877654
Q ss_pred ccccccccccccCCccCceeecCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLF-STKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
... .+++|++-|.+||++.+.+| ++.+|-|||||+||-|+.|..||+.. +....+.+ +..+.. ..
T Consensus 207 kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQ-Is~GaY---rE-- 272 (668)
T KOG0611|consen 207 KFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQ-ISRGAY---RE-- 272 (668)
T ss_pred cHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHH-hhcccc---cC--
Confidence 433 34899999999999999988 67899999999999999999999542 12222222 111111 11
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 643 (688)
++.+....-|+.|||..+|++|.|+.+|....
T Consensus 273 ------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 ------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11233577899999999999999999998653
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.23 Aligned_cols=253 Identities=29% Similarity=0.465 Sum_probs=202.5
Q ss_pred cCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccC
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
++|.+.+.||+|++|.||+|...++..+|+|.+.... ...+.+.+|+.++..++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578889999999999999998877789999886433 34567899999999999999999999875 456889999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999998643 2345789999999999999999999987 999999999999999999999999999876433221
Q ss_pred ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ....... .... ....
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~----~~~~---------~~~~ 223 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--NREVLEQ----VERG---------YRMP 223 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH----HHcC---------CCCC
Confidence 1122346678999999998899999999999999999999 888874321 1111111 1111 0011
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
.+...+..+.+++.+|++.+|++||++.+|+++|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 222345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.26 Aligned_cols=250 Identities=34% Similarity=0.510 Sum_probs=204.5
Q ss_pred CccccCCcEeEEEEEeCC----CcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLAN----GQEIAVKRLSTTSGQ-GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
+.||+|+||.||+|.... +..||+|.+...... ..+.+.+|+.++..++|+||+++++++......++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 788999999765433 367899999999999999999999999999999999999999
Q ss_pred CChhhHhhccCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 452 KSLDYFIFDESR------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 452 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
++|.+++..... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 366899999999999999999999987 99999999999999999999999999987765
Q ss_pred CccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS 604 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 604 (688)
...........++..|+|||.+....++.++||||||++++||++ |..|+.... ...+.. . .....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~---~-~~~~~------- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--NEEVLE---Y-LRKGY------- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--HHHHHH---H-HHcCC-------
Confidence 433233334567889999999988899999999999999999999 588875431 111111 1 11111
Q ss_pred cccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 605 SMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 605 ~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
....+...+..+.+++.+|++.+|++||++.++++.|+
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 --RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11122333567999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=330.11 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=197.9
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999865 58899999986432 233456789999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|+|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999998543 35889999999999999999999988 999999999999999999999999998765321
Q ss_pred cccc------------------------------------ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh
Q 005599 527 EIST------------------------------------NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570 (688)
Q Consensus 527 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt 570 (688)
.... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112469999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCC---HHHHHH
Q 005599 571 GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPS---MSTVVF 641 (688)
Q Consensus 571 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt---~~evl~ 641 (688)
|..||.... .............. +........+..+.+++.+|+. +|.+|++ +.|+++
T Consensus 235 G~~Pf~~~~-----~~~~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDN-----PQETYRKIINWKET-------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCC-----HHHHHHHHHcCCCc-------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999985321 11111111111100 0000011123467788888986 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.93 Aligned_cols=258 Identities=20% Similarity=0.232 Sum_probs=195.3
Q ss_pred hcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
.++|.+.+.||+|+||.||++.. .+++.||+|... ...+.+|++++++++|||||++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 36799999999999999999985 468899999753 23568899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+. ++|..++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 85 678777743 245789999999999999999999987 99999999999999999999999999975432211
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCC-----CCccHHHHHHHHhcc-c------
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFND-----DSSNLIRYVWELWSD-D------ 596 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~-----~~~~l~~~~~~~~~~-~------ 596 (688)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ........+...... .
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred -cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 122236799999999999999999999999999999999999987632211 001111111111000 0
Q ss_pred ---cccccc----cccc--cCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 597 ---KALEIV----DSSM--ADSCP-----APEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 597 ---~~~~~~----d~~l--~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
....+. .... ....+ ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 0000 00000 123457889999999999999999999984
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=325.42 Aligned_cols=261 Identities=21% Similarity=0.327 Sum_probs=194.4
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCC-----cee
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD-----EKM 443 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 443 (688)
+|++.++||+|+||.||+|... +++.||||++... .......+.+|+.++..++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777899999999999999854 6899999998643 2233457889999999999999999999886543 479
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
+||||++ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 688887743 345899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcc-ccccccccccCCccCceeecC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhc------
Q 005599 524 GGEEI-STNTNRVVGTYGYMSPEYALG--GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWS------ 594 (688)
Q Consensus 524 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~------ 594 (688)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHH
Confidence 32221 112233578999999999876 6789999999999999999999999853221 111111111100
Q ss_pred -----ccccccccc---ccccCCCC---HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 595 -----DDKALEIVD---SSMADSCP---APEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 595 -----~~~~~~~~d---~~l~~~~~---~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.......+. +....... ......+.+++.+||+.+|++|||+.|+++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000110 00000000 012345789999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=331.53 Aligned_cols=253 Identities=20% Similarity=0.274 Sum_probs=194.8
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
.|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999754 57899999986532 2345678899999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|+++|+|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999998542 45788888899999999999999988 9999999999999999999999999986432100
Q ss_pred c---------------------------------------------ccccccccccCCccCceeecCCCCCCcccchhHH
Q 005599 528 I---------------------------------------------STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFG 562 (688)
Q Consensus 528 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlG 562 (688)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhh--cccCCCCCCCCHHHHH
Q 005599 563 VLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLL--CVQDRTTDRPSMSTVV 640 (688)
Q Consensus 563 vll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~--Cl~~~P~~RPt~~evl 640 (688)
|++|||++|+.||....... . .......... +..........++.+++.+ |+..+|..||++.+|+
T Consensus 236 ~il~elltG~~Pf~~~~~~~--~---~~~i~~~~~~-------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTE--T---QLKVINWENT-------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHH--H---HHHHHccccc-------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999999985422111 1 0111110000 0000111123456677766 5666777799999998
Q ss_pred HH
Q 005599 641 FM 642 (688)
Q Consensus 641 ~~ 642 (688)
..
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 63
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.66 Aligned_cols=246 Identities=26% Similarity=0.349 Sum_probs=195.7
Q ss_pred cccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCCh
Q 005599 379 LGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL 454 (688)
Q Consensus 379 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 454 (688)
||+|+||+||++... +++.||||.+.... ....+.+..|+.++..++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999864 68899999986432 22345678899999999999999999999999999999999999999
Q ss_pred hhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccccc
Q 005599 455 DYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTN 533 (688)
Q Consensus 455 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 533 (688)
..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++..+...... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 88875432 3456899999999999999999999987 999999999999999999999999999866433221 22
Q ss_pred cccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHH
Q 005599 534 RVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAP 613 (688)
Q Consensus 534 ~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 613 (688)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ........ +.... ..+..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~---------~~~~~--~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRI---------LNDSV--TYPDK 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhh---------cccCC--CCccc
Confidence 35789999999999999999999999999999999999999854322111 01111110 11101 12233
Q ss_pred HHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005599 614 EALRCIQVGLLCVQDRTTDRP-----SMSTVVF 641 (688)
Q Consensus 614 ~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~ 641 (688)
.+..+.+++.+||+.+|++|| ++.++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 455788999999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.86 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=205.0
Q ss_pred hcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
.++|++.+.||+|+||.||+|... ++.||||.+..... ..+++.+|+.++..++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888899999999999999875 78999999976543 5678999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999985432 236899999999999999999999988 99999999999999999999999999987632211
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
....+..|+|||.+.+..++.++||||||++++||++ |..|+.... ...+... .... ...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~----~~~~---------~~~ 218 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPH----VEKG---------YRM 218 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHH----HhcC---------CCC
Confidence 2334668999999998899999999999999999998 888874321 1111111 1111 011
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
..+...+..+.+++.+|++.+|++||++.||+++|+++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11223345788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.97 Aligned_cols=248 Identities=30% Similarity=0.443 Sum_probs=199.8
Q ss_pred CccccCCcEeEEEEEeCCCcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCChh
Q 005599 377 NKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQ-GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLD 455 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 455 (688)
++||+|+||.||++...+++.||+|.+...... ..+.|.+|+.++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 5678999999999999999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccccccc
Q 005599 456 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV 535 (688)
Q Consensus 456 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 535 (688)
+++... ...+++..++.++.+++.||+|||+++ ++||||||+|||++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998543 235789999999999999999999988 999999999999999999999999999865432222222223
Q ss_pred cccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHH
Q 005599 536 VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPE 614 (688)
Q Consensus 536 ~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 614 (688)
..+..|+|||.+.+..++.++|+||||++++||++ |..|+..... ...... ... ......+...
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~----~~~---------~~~~~~~~~~ 220 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRER----IES---------GYRMPAPQLC 220 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHH----Hhc---------CCCCCCCccC
Confidence 34667999999998899999999999999999999 7777643211 111111 111 1111122334
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 615 ALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 615 ~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
+..+.+++.+|++.+|++||++.||++.|+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 557999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=308.65 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=194.5
Q ss_pred CccccCCcEeEEEEEeCC---CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCC
Q 005599 377 NKLGQGGFGPVYKGKLAN---GQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNK 452 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 452 (688)
+.||+|+||.||+|...+ +..+|+|.+.... ......|.+|+.++.+++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998653 3579999886543 233457889999999999999999999999999999999999999
Q ss_pred ChhhHhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 453 SLDYFIFDES--RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 453 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+|.+++.... .....++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 2234677888899999999999999987 9999999999999999999999999997654433322
Q ss_pred ccccccccCCccCceeecCC-------CCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccc
Q 005599 531 NTNRVVGTYGYMSPEYALGG-------LFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~-------~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 602 (688)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||...... ...... . .+....+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~~~~---~-~~~~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--QVLTYT---V-REQQLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--HHHHHH---h-hcccCCCC
Confidence 33335678889999988642 35789999999999999996 99998543211 111111 1 11111222
Q ss_pred cccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 603 d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
++.+... ....+.+++..|+ .+|++|||+.||+..|+
T Consensus 232 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222211 2335778999998 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.10 Aligned_cols=256 Identities=30% Similarity=0.468 Sum_probs=207.1
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
..++|.+.++||+|+||.||+|..++++.||||.+.... ...+++.+|+.++.+++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346788899999999999999998888899999986533 3457899999999999999999999999998999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999986532 245899999999999999999999988 99999999999999999999999999987653221
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
.. .....++..|+|||.+.+..++.++||||||++++||++ |+.||.... ........ . . ...
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~~~~~---~-~---------~~~ 222 (261)
T cd05034 159 TA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--NREVLEQV---E-R---------GYR 222 (261)
T ss_pred hh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH---H-c---------CCC
Confidence 11 112334678999999998899999999999999999999 898874221 11111111 0 0 001
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
...+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11122234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.64 Aligned_cols=200 Identities=25% Similarity=0.367 Sum_probs=173.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|++.+.||+|+||+||++... +++.||||++.... ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999764 58899999986532 233456788999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999854 346889999999999999999999988 999999999999999999999999999764321
Q ss_pred ccc---------------------------------cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCC
Q 005599 527 EIS---------------------------------TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKK 573 (688)
Q Consensus 527 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~ 573 (688)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCC
Q 005599 574 NTG 576 (688)
Q Consensus 574 p~~ 576 (688)
||.
T Consensus 235 Pf~ 237 (363)
T cd05628 235 PFC 237 (363)
T ss_pred CCC
Confidence 985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.38 Aligned_cols=250 Identities=27% Similarity=0.400 Sum_probs=203.5
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+|.+.+.||+|++|.||+|+.. +++.|++|.+... .....+++.+|+++++.++||||+++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677789999999999999865 6889999988643 334567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998653 2356889999999999999999999987 99999999999999999999999999987654322
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
. .....+++.|+|||++.+..++.++|+||||++++||++|+.|+.... ..... ... ..+. ..
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~---~~~-~~~~---------~~ 219 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--QGALI---LKI-IRGV---------FP 219 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHH---HHH-HcCC---------CC
Confidence 1 123567889999999999999999999999999999999999985332 11111 111 1100 01
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
..+......+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1122334578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=330.26 Aligned_cols=251 Identities=29% Similarity=0.422 Sum_probs=211.1
Q ss_pred CCCCCccccCCcEeEEEEEeC--CCc--EEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA--NGQ--EIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~--~~~--~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
....++||+|.||.|++|.+. +|+ .||||.++.... .....|.+|+.+|.+|+|+|+++|+|+..+ ....||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 344689999999999999865 344 589999976543 367899999999999999999999999988 78899999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
.++.|+|.+.|+. ..+..+-......++.|||.||.||.++. +|||||..+|+||-....+||+||||.+.+...+
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999987 45667788888999999999999999987 9999999999999999999999999999887543
Q ss_pred -cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 528 -ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 528 -~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
.........-...|.|||.+....|+.++|||+|||+||||+| |+.|+-.. ..-.+++.+|..
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~---------------~g~qIL~~iD~~ 331 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC---------------RGIQILKNIDAG 331 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC---------------CHHHHHHhcccc
Confidence 3333333455778999999999999999999999999999999 77786321 112234455555
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 643 (688)
-+..-|..+++++++++..||..+|++|||+..|++.+
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 45556778899999999999999999999999998443
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=318.46 Aligned_cols=240 Identities=26% Similarity=0.348 Sum_probs=190.4
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
++||+|+||.||+|+.. +++.||||.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999865 57899999986531 23445667788888765 899999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
|+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999988853 245788999999999999999999988 9999999999999999999999999987432111 12
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ... .+. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--~~~~~~~~----~~~------~~~----~~ 216 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--EDELFESI----RVD------TPH----YP 216 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHH----HhC------CCC----CC
Confidence 233678999999999999999999999999999999999999985321 11111111 100 011 12
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 005599 612 APEALRCIQVGLLCVQDRTTDRPSMS-TVV 640 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPt~~-evl 640 (688)
......+.+++.+||+.||++||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 22344688999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.73 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=199.5
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
..++|++.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++..++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567889999999999999999865 5889999998642 22334567899999999999999999999999999999
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
||||+++|+|..++.. ..++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 24678888889999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccCCccCceeecCC----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccc
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALGG----LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALE 600 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 600 (688)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ..............
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~i~~~~~~-- 265 (370)
T cd05596 194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LVGTYSKIMDHKNS-- 265 (370)
T ss_pred CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCCCc--
Confidence 33211 12336799999999998653 47899999999999999999999985321 11111111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 005599 601 IVDSSMADSCPAPEALRCIQVGLLCVQDRTTD--RPSMSTVVF 641 (688)
Q Consensus 601 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPt~~evl~ 641 (688)
+........+..+.+++.+||+.+|++ ||++.|++.
T Consensus 266 -----~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 266 -----LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred -----CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 110111123457889999999999988 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=323.44 Aligned_cols=242 Identities=19% Similarity=0.262 Sum_probs=193.8
Q ss_pred CccccCCcEeEEEEEe-CCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCC
Q 005599 377 NKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNK 452 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 452 (688)
+.||+|+||.||++.. .+++.||+|.+... .......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999985 46889999998653 2234567788999999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 453 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 453 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 99888743 3468999999999999999999997 56 99999999999999999999999999875432211 1
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... ..... . . ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--~~~~~---~i~~~-~------~----~~p 216 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFE---LILME-E------I----RFP 216 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--HHHHH---HHhcC-C------C----CCC
Confidence 2235789999999999999999999999999999999999999843211 11111 11100 0 0 112
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 005599 612 APEALRCIQVGLLCVQDRTTDRP-----SMSTVVFM 642 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~ 642 (688)
......+.+++.+||+.||++|| ++.++++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 22344688999999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.63 Aligned_cols=255 Identities=25% Similarity=0.430 Sum_probs=217.0
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeCC---Cc--EEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCce
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLAN---GQ--EIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEK 442 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~~---~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 442 (688)
..+.....++||.|-||.||+|...+ |. .||||..+.. .....+.|+.|..++++++|||||+|+|+|.+ ...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 34445566899999999999997533 33 5889988764 45567889999999999999999999999975 578
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
++|||.++-|.|..+|.. .+..++......++.||..||+|||+.. +|||||..+|||+.....+||+||||++.
T Consensus 466 WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 999999999999999954 3456888899999999999999999987 99999999999999999999999999999
Q ss_pred cCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccccccc
Q 005599 523 FGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 523 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 601 (688)
+..+.+.... ...-+..|||||.+.-..|+.++|||-|||.+||+++ |..||.. ..+.++...
T Consensus 541 ~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg---------------vkNsDVI~~ 604 (974)
T KOG4257|consen 541 LEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG---------------VKNSDVIGH 604 (974)
T ss_pred ccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc---------------ccccceEEE
Confidence 8877665443 4556789999999999999999999999999999988 9999853 233445555
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 602 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
+...-+.++|+.++..+..|+.+||..+|.+||.+.++...|+.
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 66666677888899999999999999999999999998876643
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=314.03 Aligned_cols=251 Identities=26% Similarity=0.314 Sum_probs=200.4
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
+|++.++||+|+||.||++... +++.||||++.... ......+.+|+.++..++||||+++.+.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777899999999999999864 68899999986432 2223457889999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|+++|+|..++... ....+++.....++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887543 2345899999999999999999999988 9999999999999999999999999998754322
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
. .....|++.|+|||++.+..++.++||||||+++|||++|+.||...... .....+...... ..
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~--~~~~~~~~~~~~----------~~ 221 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK--VKREEVERRVKE----------DQ 221 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh--hHHHHHHHHhhh----------cc
Confidence 1 12357899999999999999999999999999999999999998642211 111111111100 01
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 641 (688)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~ 641 (688)
...+...+..+.+|+.+|++.||++|| ++.++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 112233455788999999999999999 7888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.06 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=195.7
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
++||+|+||.||+++.. +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999865 5889999998753 223345688899999998 699999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 999888743 345899999999999999999999988 9999999999999999999999999987432111 12
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCC---CccHHHHHHHHhccccccccccccccC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDD---SSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~-- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I-- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------C--
Confidence 22367899999999999999999999999999999999999998643211 1112222222221111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCC------HHHHHH
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPS------MSTVVF 641 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt------~~evl~ 641 (688)
..|...+..+.+++.+||+.||++||+ +.++++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 122233456889999999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=309.98 Aligned_cols=256 Identities=24% Similarity=0.348 Sum_probs=191.5
Q ss_pred CCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCc-----eeEEE
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE-----KMLIY 446 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~lV~ 446 (688)
|...+++|.|+||.||+|.+. +++.||||++-...+. -.+|+++|+++.|||||+|+-+|....+ ..|||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 445689999999999999865 4689999998554322 2469999999999999999999876432 35899
Q ss_pred eccCCCChhhHhhc-cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCC-CCceecccccceecC
Q 005599 447 EFMPNKSLDYFIFD-ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE-MNPRISDFGTARVFG 524 (688)
Q Consensus 447 e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGla~~~~ 524 (688)
||||. +|...+.+ ...++.++...+.-+..||++||+|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99975 56666643 223445677777779999999999999987 9999999999999976 899999999999886
Q ss_pred CCccccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccc-----
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKA----- 598 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~----- 598 (688)
..+... ....|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|... +...++...+. .+.....
T Consensus 178 ~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik-~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 178 KGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIK-VLGTPTREDIKS 252 (364)
T ss_pred cCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHH-HhCCCCHHHHhh
Confidence 554332 25678899999999875 6999999999999999999999987542 22233333222 1211110
Q ss_pred -----cccccccccCC-----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 599 -----LEIVDSSMADS-----CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 599 -----~~~~d~~l~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.+...+.+... .......+.++++.++++.+|.+|.++.|++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111222111 22334567899999999999999999999884
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.39 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=199.5
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCc--EEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQ--EIAVKRLSTT-SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 445 (688)
++|++.+.||+|+||.||+|... ++. .+|+|.+... .......|.+|++++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56788899999999999999864 344 4688877543 233456788999999999 899999999999999999999
Q ss_pred EeccCCCChhhHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCc
Q 005599 446 YEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP 512 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 512 (688)
+||+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1235789999999999999999999987 9999999999999999999
Q ss_pred eecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHH
Q 005599 513 RISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWE 591 (688)
Q Consensus 513 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~ 591 (688)
||+|||+++.... ........++..|+|||++.+..++.++||||||++++||+| |..||.... .......
T Consensus 164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~--- 235 (303)
T cd05088 164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEK--- 235 (303)
T ss_pred EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC--hHHHHHH---
Confidence 9999999864221 111111234668999999988889999999999999999998 999874221 1111111
Q ss_pred HhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 592 LWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 592 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
.... .....+...+..+.+|+.+|++.+|++||++.+++++|+.+
T Consensus 236 -~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 236 -LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred -HhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1100 01111222344688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=312.94 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=198.3
Q ss_pred cCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
++|++.++||+|+||.||+|.. .+++.||+|.+... ......+|.+|+.++.+++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577889999999999999975 46889999998654 233456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|..+. .+++.....++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999996553 3678888899999999999999988 999999999999999999999999999765432
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHH-HHHHHHhcccccccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLI-RYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~-~~~~~~~~~~~~~~~~d~~l~ 607 (688)
......+|..|+|||.+.+..++.++||||||+++|||++|+.||........... ........... .+.+.
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 221 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLP 221 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCC
Confidence 12235789999999999999999999999999999999999999854332211110 00011111110 01111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.......+.+++.+|++.+|++||++.|+++.
T Consensus 222 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 ---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11123468899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=317.46 Aligned_cols=241 Identities=24% Similarity=0.315 Sum_probs=193.6
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
+.||+|+||.||++... +++.||||++... .....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 4789999998653 223456678899999888 699999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
|+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 9998887432 35899999999999999999999988 9999999999999999999999999987532221 11
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ........ ... . ..+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--~---~~~~~~i~-~~~--------~--~~~ 216 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--E---DELFQSIL-EDE--------V--RYP 216 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--H---HHHHHHHH-cCC--------C--CCC
Confidence 223568999999999999999999999999999999999999985322 1 11111111 110 0 112
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCH-----HHHHH
Q 005599 612 APEALRCIQVGLLCVQDRTTDRPSM-----STVVF 641 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPt~-----~evl~ 641 (688)
...+..+.+|+.+||+.||++||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 2234568899999999999999999 88875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.19 Aligned_cols=256 Identities=25% Similarity=0.431 Sum_probs=202.9
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-C---CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-N---GQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 445 (688)
.+|.+.+.||+|+||.||+|+.. + +..+|+|.+.... ....+.|.+|+.++.+++||||+++.+++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56788899999999999999863 2 3379999986532 23456789999999999999999999999999999999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998543 235799999999999999999999988 99999999999999999999999999987654
Q ss_pred Ccccc-ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 526 EEIST-NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 526 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
..... ......++..|+|||.+.+..++.++||||||++++|+++ |..|+..... ......+. .+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~----~~~------ 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAIE----EGY------ 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHHh----CCC------
Confidence 32211 1112233568999999999899999999999999999887 9998743211 11111111 110
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
....+...+..+.+++.+|++.+|++||+|.+|++.|+..
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ---RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011222345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=308.50 Aligned_cols=249 Identities=30% Similarity=0.456 Sum_probs=197.1
Q ss_pred CccccCCcEeEEEEEeCC----CcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLAN----GQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+.++..+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997432 26899999875543 24567899999999999999999999875 5568999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc-
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST- 530 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 530 (688)
++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999998543 25899999999999999999999987 9999999999999999999999999998764332211
Q ss_pred ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
......++..|+|||.+.+..++.++||||||+++|||++ |..||.... ...+...+. ... ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~~----~~~---------~~~ 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAMLE----SGE---------RLP 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHH----cCC---------cCC
Confidence 1111234567999999999999999999999999999998 999975322 112222211 111 011
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
.+...+..+.+++.+|++.+|++||++.+|++.|++..
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 22233457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.10 Aligned_cols=241 Identities=23% Similarity=0.335 Sum_probs=193.0
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
++||+|+||.||+|+.. +++.||||++... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 4789999998653 223455678899998876 799999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
|+|...+.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 999888843 245789999999999999999999988 99999999999999999999999999875432221 1
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+ ......... ..|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--~~~~---~~~i~~~~~-----------~~p 216 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--EDDL---FESILHDDV-----------LYP 216 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--HHHH---HHHHHcCCC-----------CCC
Confidence 223578999999999999999999999999999999999999985322 1111 111111110 011
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC-------CHHHHHH
Q 005599 612 APEALRCIQVGLLCVQDRTTDRP-------SMSTVVF 641 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RP-------t~~evl~ 641 (688)
......+.+++..||+.+|++|| ++.++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 22235688999999999999999 7888874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=323.22 Aligned_cols=238 Identities=26% Similarity=0.277 Sum_probs=191.9
Q ss_pred CccccCCcEeEEEEEe----CCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccC
Q 005599 377 NKLGQGGFGPVYKGKL----ANGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
+.||+|+||.||++.. .+|+.||+|++.... ......+..|++++.+++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 357899999986532 2234567789999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999988843 345899999999999999999999988 9999999999999999999999999987654321 1
Q ss_pred ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCC
Q 005599 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSC 610 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 610 (688)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ........... . ...
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-----~~~~~~~i~~~-~----------~~~ 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-----RKETMTMILKA-K----------LGM 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC-----HHHHHHHHHcC-C----------CCC
Confidence 2223678999999999999889999999999999999999999985321 11111111111 0 011
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 005599 611 PAPEALRCIQVGLLCVQDRTTDRPSMST 638 (688)
Q Consensus 611 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~e 638 (688)
+......+.+|+.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2223456889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.83 Aligned_cols=251 Identities=34% Similarity=0.528 Sum_probs=199.3
Q ss_pred CccccCCcEeEEEEEeCC-------CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 377 NKLGQGGFGPVYKGKLAN-------GQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+.||+|+||.||+|+..+ ++.+|||.+.... .....+|.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998643 2578999886543 23466889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC-----Cceeccccc
Q 005599 449 MPNKSLDYFIFDES----RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM-----NPRISDFGT 519 (688)
Q Consensus 449 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-----~~kl~DFGl 519 (688)
+++++|.+++.... ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 2234789999999999999999999987 99999999999999887 899999999
Q ss_pred ceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccc
Q 005599 520 ARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKA 598 (688)
Q Consensus 520 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 598 (688)
++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+.... .......+ ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--~~~~~~~~----~~~-- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--NQEVLQHV----TAG-- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--HHHHHHHH----hcC--
Confidence 986654333222233456788999999999999999999999999999998 998874321 11111111 110
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 599 LEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 599 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
.....+...+..+.+++.+||+.+|++||++.+|+++|++
T Consensus 230 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 -------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0111222345678899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=309.95 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=201.7
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc-----ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG-----QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
++|.+.+.||+|++|.||++... +++.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999854 689999998864321 234578899999999999999999999999999999
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988532 45788999999999999999999988 9999999999999999999999999998654
Q ss_pred CCccccc-cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 525 GEEISTN-TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 525 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.||.... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-------- 222 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE-----AMAAIFKIATQ-------- 222 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc-----hHHHHHHHhcc--------
Confidence 3221111 123567889999999999999999999999999999999999974321 11111111111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
......+......+.+++.+||+.+|++|||+.++++.
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 -PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01111233344568899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=304.70 Aligned_cols=264 Identities=24% Similarity=0.355 Sum_probs=200.6
Q ss_pred cCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCcc--cHHHHHHHHHHHhhcCCCC-ccceEEEEEeCC------
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQ--GIEEFKNEVLLIAKLQHRN-LVKLLGCCLEKD------ 440 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------ 440 (688)
..|...++||+|+||+||+|+. .+|+.||+|++...... ......+|+.+|++|+|+| ||+|.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3455667899999999999974 46899999998765432 3445689999999999999 999999999887
Q ss_pred ceeEEEeccCCCChhhHhhccCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccc
Q 005599 441 EKMLIYEFMPNKSLDYFIFDESRK-QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGT 519 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 519 (688)
..+||+||+ .-+|..++...... ..++-..+..++.||++||+|||+++ |+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 788999998 56788887554322 45666888999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCccccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccc
Q 005599 520 ARVFGGEEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKA 598 (688)
Q Consensus 520 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 598 (688)
|+...-.. ......++|..|.|||++.+. .|+...||||+|||+.||+++++-|....+ .+....+.+.+..+..
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCCc
Confidence 99654221 113346789999999999987 699999999999999999999887754332 2222233333222111
Q ss_pred ------ccccccc--ccCCC-C----HHH---HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 599 ------LEIVDSS--MADSC-P----APE---ALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 599 ------~~~~d~~--l~~~~-~----~~~---~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
..+.+.. ..... + ... .....+++.+|++.+|.+|.|+..++++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111111 11000 1 011 1368899999999999999999999875
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.80 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=195.3
Q ss_pred cCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|.+.++||+|+||.||++.. .+++.||||++... .....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999975 46889999998543 2234567889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999853 345788888899999999999999988 999999999999999999999999999643211
Q ss_pred ccc------------c---------------------------------ccccccccCCccCceeecCCCCCCcccchhH
Q 005599 527 EIS------------T---------------------------------NTNRVVGTYGYMSPEYALGGLFSTKSDVFSF 561 (688)
Q Consensus 527 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSl 561 (688)
... . ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCC---CCHHH
Q 005599 562 GVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDR---PSMST 638 (688)
Q Consensus 562 Gvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~R---Pt~~e 638 (688)
||++|||++|+.||..... ... ............+ .. .......+.+++.+|++ +|.+| |++.|
T Consensus 235 Gvil~elltG~~Pf~~~~~--~~~---~~~i~~~~~~~~~-----p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS--HET---YRKIINWRETLYF-----PD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred chhhhhhhcCCCCCCCCCH--HHH---HHHHHccCCccCC-----CC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 9999999999999853221 111 1111111110110 00 11123467889999997 66665 69999
Q ss_pred HHHH
Q 005599 639 VVFM 642 (688)
Q Consensus 639 vl~~ 642 (688)
++..
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 8864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=308.13 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=199.7
Q ss_pred cCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEe-CCceeEEEecc
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLE-KDEKMLIYEFM 449 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~ 449 (688)
++|.+.+.||+|+||.||++... +..||+|.+.... ..+.|.+|+.++.+++|+|++++++++.. .+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999875 7889999886432 35678999999999999999999998654 45689999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999985432 345889999999999999999999987 9999999999999999999999999987643221
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+... .+....... ..+. ..
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~-~~~~---------~~ 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRV-EKGY---------KM 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHH-hcCC---------CC
Confidence 12344568999999998899999999999999999998 88887422 111111111 1110 11
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
..+...+..+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11223345788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=317.48 Aligned_cols=242 Identities=22% Similarity=0.347 Sum_probs=192.2
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
+.||+|+||.||++... +++.||||++.... ....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999865 57899999997532 23455688999999888 699999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 999888743 245899999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCC-ccHHHHHHHHhccccccccccccccCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDS-SNLIRYVWELWSDDKALEIVDSSMADSC 610 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 610 (688)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||....... ............... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCC
Confidence 233678999999999999999999999999999999999999996433221 122222222211110 012
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCH
Q 005599 611 PAPEALRCIQVGLLCVQDRTTDRPSM 636 (688)
Q Consensus 611 ~~~~~~~~~~l~~~Cl~~~P~~RPt~ 636 (688)
|...+..+.+++.+||+.||++||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 22334568899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.72 Aligned_cols=241 Identities=24% Similarity=0.320 Sum_probs=192.3
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCC-CccceEEEEEeCCceeEEE
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHR-NLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 446 (688)
+|++.+.||+|+||.||+|+.. +++.||||++... .....+.+..|++++..++|+ +|+++.+++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999865 4678999998643 233456788899999999765 5888999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|+|..++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999888532 35789999999999999999999987 999999999999999999999999998753221
Q ss_pred ccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+. ...... .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--~~~~~---~~i~~~-~--------- 217 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--EDELF---QSIMEH-N--------- 217 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHH---HHHHcC-C---------
Confidence 1 11223578999999999999999999999999999999999999985321 11111 111110 0
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSM 636 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~ 636 (688)
...+......+.+++.+||+.+|++||+.
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11122234568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.10 Aligned_cols=236 Identities=25% Similarity=0.358 Sum_probs=189.8
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
+.||+|+||.||+|+.. +++.||||++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999865 5789999998643 233456678888888877 699999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 9999888432 45889999999999999999999988 9999999999999999999999999987543221 12
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~-~~~~----------~~~ 216 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAIL-NDEV----------VYP 216 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHh-cCCC----------CCC
Confidence 2336789999999999999999999999999999999999999853221 11111111 1110 112
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCH
Q 005599 612 APEALRCIQVGLLCVQDRTTDRPSM 636 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPt~ 636 (688)
......+.+++.+|++.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 2234568899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.52 Aligned_cols=249 Identities=29% Similarity=0.440 Sum_probs=199.8
Q ss_pred CccccCCcEeEEEEEeCC--C--cEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLAN--G--QEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
++||+|++|.||+|.+.+ + ..||||.+..... ...+.|.+|+.++.+++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998643 2 3689999977655 556789999999999999999999999988 889999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc-c
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS-T 530 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 530 (688)
++|.+++..... ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865432 46899999999999999999999987 999999999999999999999999999876543211 1
Q ss_pred ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..... ........ ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~---~~~~~~~~---------~~ 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--SQILK---KIDKEGER---------LE 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHH---HHHhcCCc---------CC
Confidence 1223457789999999999999999999999999999999 9999743211 11111 11111000 01
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
.+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 12223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=318.02 Aligned_cols=237 Identities=22% Similarity=0.282 Sum_probs=186.5
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHH-HHhhcCCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVL-LIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
++||+|+||.||+|+.. +++.||+|++.... ......+..|.. ++..++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999865 57899999986432 122344555554 67889999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
++|..++.. ...++......++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 999888743 345778888889999999999999987 9999999999999999999999999987532221 12
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ........... .+ ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~---------~~--~~~ 216 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNILHK---------PL--QLP 216 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHhcC---------CC--CCC
Confidence 234678999999999999999999999999999999999999985321 11111111111 11 122
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHH
Q 005599 612 APEALRCIQVGLLCVQDRTTDRPSMS 637 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPt~~ 637 (688)
......+.+++.+|++.+|.+||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 23445788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.90 Aligned_cols=257 Identities=28% Similarity=0.481 Sum_probs=201.0
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCc----EEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCcee
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQ----EIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKM 443 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 443 (688)
.++|+..+.||+|+||.||+|... ++. .||+|.+..... ....++.+|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999853 343 478898865432 3345788999999999999999999998754 567
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998543 335789999999999999999999987 999999999999999999999999999876
Q ss_pred CCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccc
Q 005599 524 GGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 524 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 602 (688)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ....... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~----~~~~~~---- 229 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDL----LEKGER---- 229 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH----HHCCCC----
Confidence 54332222233455778999999999999999999999999999998 888874321 1111111 111110
Q ss_pred cccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 603 d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
...+......+.+++..|+..+|++||++.+|++.|+.+.
T Consensus 230 -----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 230 -----LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111223456889999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=324.64 Aligned_cols=255 Identities=20% Similarity=0.265 Sum_probs=198.8
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCcee
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKM 443 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 443 (688)
...++|++.+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.++..++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 44578999999999999999999865 5789999998542 2233456789999999999999999999999999999
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
+||||+++|+|.+++.. ..++......++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999998843 24788889999999999999999988 999999999999999999999999999876
Q ss_pred CCCccccccccccccCCccCceeecCC----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccc
Q 005599 524 GGEEISTNTNRVVGTYGYMSPEYALGG----LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL 599 (688)
Q Consensus 524 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 599 (688)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ..............
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-----~~~~~~~i~~~~~~- 265 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-----LVGTYSKIMDHKNS- 265 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCcc-
Confidence 43221 122346799999999998764 37889999999999999999999985321 11111111111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 005599 600 EIVDSSMADSCPAPEALRCIQVGLLCVQDRTTD--RPSMSTVVFM 642 (688)
Q Consensus 600 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPt~~evl~~ 642 (688)
+........+..+.+++..|++.++.+ ||++.|+++.
T Consensus 266 ------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 ------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 100111122456788889999866544 8999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.77 Aligned_cols=241 Identities=24% Similarity=0.333 Sum_probs=192.8
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEEE
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 446 (688)
+|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+..|..++..+ +|++|+++.+++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 57799999986532 23345567788888777 5899999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999998888432 35889999999999999999999987 999999999999999999999999999754322
Q ss_pred ccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.. ... ...
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~~---~i~-~~~--------- 217 (323)
T cd05616 155 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--EDELFQ---SIM-EHN--------- 217 (323)
T ss_pred CC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC--HHHHHH---HHH-hCC---------
Confidence 21 2233678999999999999999999999999999999999999985322 111111 111 110
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSM 636 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~ 636 (688)
...|......+.+++.+|++.+|++|++.
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01222334578899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.97 Aligned_cols=252 Identities=27% Similarity=0.474 Sum_probs=202.1
Q ss_pred cCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccC
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
.+|++.+.||+|+||.||+|...++..+|+|.+.... ....+|.+|++++.+++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4567789999999999999988778899999886432 335679999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999988543 235789999999999999999999987 9999999999999999999999999998664332211
Q ss_pred ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ........ ... .....
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~-~~~--~~~~~------ 222 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----NSEVVETI-NAG--FRLYK------ 222 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----HHHHHHHH-hCC--CCCCC------
Confidence 112335678999999998899999999999999999998 888874321 11111111 110 01111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
+...+..+.+|+.+||+.+|++||++.+|++.|.
T Consensus 223 -~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 -PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1122457999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=307.00 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=190.7
Q ss_pred CccccCCcEeEEEEEeCC---CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCC
Q 005599 377 NKLGQGGFGPVYKGKLAN---GQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNK 452 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 452 (688)
+.||+|+||.||+|...+ ...+|+|.+.... ......|.+|+.+++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3468888876443 333567889999999999999999999999999999999999999
Q ss_pred ChhhHhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 453 SLDYFIFDESR--KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 453 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 234567888899999999999999987 9999999999999999999999999987644332222
Q ss_pred ccccccccCCccCceeecC-------CCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccc
Q 005599 531 NTNRVVGTYGYMSPEYALG-------GLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~-------~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 602 (688)
......++..|+|||++.. ..++.++||||||+++|||++ |..|+....+ ... ....... ....+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~---~~~~~~~-~~~~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQV---LKQVVRE-QDIKLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--HHH---HHHHhhc-cCccCC
Confidence 2233456778999998743 456889999999999999999 6777643211 111 1111111 111222
Q ss_pred cccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 603 d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
++.+.. .....+.+++..|+ .||++|||+.+|+++|.
T Consensus 232 ~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222222 23345677888888 59999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.05 Aligned_cols=251 Identities=21% Similarity=0.280 Sum_probs=192.2
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
.|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++|+|||++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999864 67899999986532 2335678899999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|+++|+|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999988543 35788888889999999999999988 9999999999999999999999999975331100
Q ss_pred ---------------------------------------------cccccccccccCCccCceeecCCCCCCcccchhHH
Q 005599 528 ---------------------------------------------ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFG 562 (688)
Q Consensus 528 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlG 562 (688)
.........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00001235789999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCC---HHHH
Q 005599 563 VLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPS---MSTV 639 (688)
Q Consensus 563 vll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt---~~ev 639 (688)
|+||||++|+.||..... ........... ..+...........+.+++.+++ .+|++|++ +.++
T Consensus 236 vil~elltG~~Pf~~~~~-----~~~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 236 VILYEMLVGQPPFLAQTP-----LETQMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHHhCCCCCCCCCH-----HHHHHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 999999999999853221 11111111100 01111111112345666666665 49999997 7776
Q ss_pred HH
Q 005599 640 VF 641 (688)
Q Consensus 640 l~ 641 (688)
+.
T Consensus 303 ~~ 304 (382)
T cd05625 303 KA 304 (382)
T ss_pred hc
Confidence 64
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=307.48 Aligned_cols=254 Identities=30% Similarity=0.456 Sum_probs=203.7
Q ss_pred hcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
.++|.+.++||+|+||.||+|...++..+|+|.+... ....+.|.+|+.+++.++|+||+++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3578888999999999999999888888999988643 2345678999999999999999999999887 7789999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999986532 345789999999999999999999987 999999999999999999999999999866433221
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
. .....++..|+|||++....++.++|+||||++++|+++ |+.|+.... ...+... ...... .
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~----~~~~~~---------~ 222 (260)
T cd05073 159 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRA----LERGYR---------M 222 (260)
T ss_pred c-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--HHHHHHH----HhCCCC---------C
Confidence 1 112345678999999998889999999999999999999 888874321 1111111 111110 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
..+...+..+.+++.+|++.+|++||++.+|+++|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=310.31 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=194.9
Q ss_pred CccccCCcEeEEEEEeCC-Cc--EEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLAN-GQ--EIAVKRLSTT-SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
+.||+|+||.||+|+..+ +. .+|+|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999998754 33 4688888643 334456789999999999 799999999999999999999999999
Q ss_pred CChhhHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccc
Q 005599 452 KSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG 518 (688)
Q Consensus 452 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 518 (688)
|+|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1234789999999999999999999987 9999999999999999999999999
Q ss_pred cceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccc
Q 005599 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDK 597 (688)
Q Consensus 519 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 597 (688)
++..... .........+..|+|||++....++.++||||||++++||++ |..||.... ....... ....
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~~-~~~~- 227 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEK-LPQG- 227 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----HHHHHHH-HhCC-
Confidence 9863221 111111234567999999988899999999999999999997 999874211 1111111 1111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 598 ALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 598 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
.....+......+.+|+.+|++.+|.+|||+.+++..|+++.
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 011112223346889999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=326.06 Aligned_cols=253 Identities=20% Similarity=0.267 Sum_probs=194.4
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
.+|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999854 58899999986432 233566889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|+|.+++.. ...++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999854 345788888889999999999999988 999999999999999999999999997533100
Q ss_pred c-----------------------------------------cccccccccccCCccCceeecCCCCCCcccchhHHHHH
Q 005599 527 E-----------------------------------------ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLL 565 (688)
Q Consensus 527 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll 565 (688)
. .........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 00001135799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCC---CHHHHHHH
Q 005599 566 LEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRP---SMSTVVFM 642 (688)
Q Consensus 566 ~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RP---t~~evl~~ 642 (688)
|||++|+.||..... ............. +...........+.+++.+|+ .+|.+|| ++.+++..
T Consensus 235 yell~G~~Pf~~~~~-----~~~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 235 YEMLVGQPPFLADTP-----AETQLKVINWETT-------LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eehhhCCCCCCCCCH-----HHHHHHHhccCcc-------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999854221 1111111110000 000011112335667777765 5999999 88888853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=316.16 Aligned_cols=237 Identities=22% Similarity=0.262 Sum_probs=187.2
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHH-HHhhcCCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVL-LIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
+.||+|+||+||+|+.. +++.||||++.... .....++..|.. ++..++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999865 68999999986432 222344555554 56788999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
|+|..++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 999988853 345788999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... .. ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~---------~~--~~~ 216 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNILNK---------PL--RLK 216 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcC---------CC--CCC
Confidence 233578999999999999999999999999999999999999985321 11111111111 00 011
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHH
Q 005599 612 APEALRCIQVGLLCVQDRTTDRPSMS 637 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPt~~ 637 (688)
......+.+++.+|++.+|++||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 12245688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=307.68 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=201.6
Q ss_pred HHHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEE
Q 005599 367 LAATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 367 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 445 (688)
+.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++..++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345666766789999999999999854 5778999998776666677899999999999999999999999999999999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECC-CCCceecccccceecC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-EMNPRISDFGTARVFG 524 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~~ 524 (688)
+||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999865322212278888899999999999999987 999999999999986 6799999999997654
Q ss_pred CCccccccccccccCCccCceeecCCC--CCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccc
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALGGL--FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 602 (688)
.... ......+++.|+|||++.+.. ++.++||||||+++|||++|+.|+......... .+.....
T Consensus 161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~~--------- 227 (268)
T cd06624 161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGMF--------- 227 (268)
T ss_pred cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhhh---------
Confidence 3221 122245789999999986643 788999999999999999999997532211110 0000000
Q ss_pred cccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 603 d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
......+......+.+++.+||+.+|++|||+.||+.
T Consensus 228 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 --KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0011123334456889999999999999999999886
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=313.76 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=202.7
Q ss_pred cCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
.+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++..++|+||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5688889999999999999985 468899999987665555678899999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 99999998842 34789999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||...... ........... +.+ .
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-----~~~~~~~~~~~------~~~--~ 237 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATNGT------PEL--Q 237 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-----HhHHHHhcCCC------CCC--C
Confidence 112346889999999999888999999999999999999999998532211 11111111100 000 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.+......+.+++.+|++.+|++||++.+|+.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 12233456889999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=320.81 Aligned_cols=258 Identities=21% Similarity=0.261 Sum_probs=200.3
Q ss_pred HHHHHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCC
Q 005599 365 TVLAATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD 440 (688)
Q Consensus 365 ~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 440 (688)
++....++|++.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.++..++||||+++++.+.+..
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445688999999999999999999865 5788999998542 2233456788999999999999999999999999
Q ss_pred ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccc
Q 005599 441 EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA 520 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 520 (688)
..++||||+++|+|..++.. ..++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999998843 24788888889999999999999988 999999999999999999999999999
Q ss_pred eecCCCccccccccccccCCccCceeecCC----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccc
Q 005599 521 RVFGGEEISTNTNRVVGTYGYMSPEYALGG----LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD 596 (688)
Q Consensus 521 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 596 (688)
+....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ............
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~ 263 (371)
T cd05622 190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LVGTYSKIMNHK 263 (371)
T ss_pred eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCC
Confidence 87653322 122346799999999998754 37899999999999999999999985321 111122222111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 005599 597 KALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTD--RPSMSTVVFM 642 (688)
Q Consensus 597 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPt~~evl~~ 642 (688)
....+. .+...+..+.+++.+|++..+.+ ||++.++++.
T Consensus 264 ~~~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 264 NSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CcccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111111 11123456888999999854443 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=333.21 Aligned_cols=260 Identities=20% Similarity=0.332 Sum_probs=191.7
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeC--------
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK-------- 439 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 439 (688)
...+|.+.++||+|+||.||+|... +++.||||++.... ....+|+.++..++|||||++.+++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999864 58899999885432 2345799999999999999999887542
Q ss_pred CceeEEEeccCCCChhhHhhc-cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC-Cceeccc
Q 005599 440 DEKMLIYEFMPNKSLDYFIFD-ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM-NPRISDF 517 (688)
Q Consensus 440 ~~~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DF 517 (688)
...++||||+++ +|..++.. ......+++.....++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999985 56565533 233456889999999999999999999988 99999999999999665 6999999
Q ss_pred ccceecCCCccccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccc
Q 005599 518 GTARVFGGEEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD 596 (688)
Q Consensus 518 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 596 (688)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|.+||..... ...+... .......
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i-~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS-VDQLVRI-IQVLGTP 290 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHH-HHHhCCC
Confidence 99986643221 1235689999999998764 689999999999999999999999853221 1111111 1111110
Q ss_pred cc----------ccc-----ccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 597 KA----------LEI-----VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 597 ~~----------~~~-----~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.. ..+ ....+....|...+.++.+|+.+||+.+|.+|||+.|++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00 000 0011111122233457899999999999999999999984
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=307.75 Aligned_cols=240 Identities=21% Similarity=0.343 Sum_probs=188.8
Q ss_pred CccccCCcEeEEEEEeCC-------------CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCcee
Q 005599 377 NKLGQGGFGPVYKGKLAN-------------GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKM 443 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 443 (688)
+.||+|+||.||+|+..+ ...||+|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258999887655555668899999999999999999999999999999
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCC-------ceecc
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMN-------PRISD 516 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-------~kl~D 516 (688)
+||||+++++|+.++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999887532 345899999999999999999999987 999999999999987664 89999
Q ss_pred cccceecCCCccccccccccccCCccCceeec-CCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhc
Q 005599 517 FGTARVFGGEEISTNTNRVVGTYGYMSPEYAL-GGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWS 594 (688)
Q Consensus 517 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 594 (688)
||++...... ....++..|+|||.+. +..++.++|||||||++|||++ |..|+.... .... .....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~~~~-~~~~~ 223 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-----LAEK-ERFYE 223 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-----hhHH-HHHHh
Confidence 9998654321 1245778899999887 4678999999999999999984 777764211 1110 00011
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 595 DDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 595 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
. . .. ........+.+|+.+||+.||++||++.+|++.|+
T Consensus 224 ~-~--------~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 G-Q--------CM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred c-C--------cc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 0 00 01112346889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=309.26 Aligned_cols=247 Identities=24% Similarity=0.315 Sum_probs=193.4
Q ss_pred cccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCCh
Q 005599 379 LGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL 454 (688)
Q Consensus 379 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 454 (688)
||+|+||.||++... +|+.+|+|++.... ......+..|++++.+++||||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 58999999986422 12234566799999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccccccc
Q 005599 455 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR 534 (688)
Q Consensus 455 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 534 (688)
..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 88875432 345889999999999999999999987 99999999999999999999999999987643221 123
Q ss_pred ccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHH
Q 005599 535 VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPE 614 (688)
Q Consensus 535 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 614 (688)
..|+..|+|||++.+..++.++|||||||++|||++|+.||....... ........... .. +.. .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~-~~--------~~~-~~~~~ 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLE-DE--------VKF-EHQNF 222 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhc-cc--------ccc-ccccC
Confidence 568999999999999899999999999999999999999985432211 11111111111 00 000 00122
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 005599 615 ALRCIQVGLLCVQDRTTDRPSMSTVVFML 643 (688)
Q Consensus 615 ~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 643 (688)
...+.+|+.+||+.+|++||+++|+++.+
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 44688999999999999999998766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=316.45 Aligned_cols=241 Identities=25% Similarity=0.364 Sum_probs=191.1
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999865 47899999986531 23345667788888764 899999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
|+|..++.. ...+++.+...++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999998853 245789999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ... .+. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--~~~~~~~i----~~~------~~~----~~ 216 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--EEELFQSI----RMD------NPC----YP 216 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--HHHHHHHH----HhC------CCC----CC
Confidence 233578999999999999999999999999999999999999985321 11111111 100 011 12
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHH-HHHH
Q 005599 612 APEALRCIQVGLLCVQDRTTDRPSMS-TVVF 641 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPt~~-evl~ 641 (688)
......+.+++.+||+.+|++||++. ++..
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 22344688999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.93 Aligned_cols=253 Identities=21% Similarity=0.254 Sum_probs=204.5
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC-CcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|++++.||.|.-|+||++.+.+ +..+|+|++.+.. .....+...|-+||+.+.||.++.|++.++.+...+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456778999999999999999875 4889999997653 334556778999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC-
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG- 525 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~- 525 (688)
|||++|+|..+++.+ ..+.++.....-++.+|+-||+|||-.| ||.|||||+||||.++|++-|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999998887554 4456788888889999999999999998 99999999999999999999999999753210
Q ss_pred --------------------------------C-c--------------------cccccccccccCCccCceeecCCCC
Q 005599 526 --------------------------------E-E--------------------ISTNTNRVVGTYGYMSPEYALGGLF 552 (688)
Q Consensus 526 --------------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~ 552 (688)
. . .....+..+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0011234689999999999999999
Q ss_pred CCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCC
Q 005599 553 STKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTD 632 (688)
Q Consensus 553 s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~ 632 (688)
+.++|+|+|||+||||+.|..||...+.+. ...+++-+.+.-......+..+.+||...|.+||.+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~--------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh--------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 999999999999999999999995433221 122333333322222245667999999999999999
Q ss_pred CCC----HHHHHH
Q 005599 633 RPS----MSTVVF 641 (688)
Q Consensus 633 RPt----~~evl~ 641 (688)
|.. +.||-+
T Consensus 379 Rlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 379 RLGSKRGAAEIKR 391 (459)
T ss_pred hhccccchHHhhc
Confidence 998 778764
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.77 Aligned_cols=256 Identities=26% Similarity=0.436 Sum_probs=203.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC-Cc----EEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN-GQ----EIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
.+|.+.+.||+|+||.||+|...+ +. .+|+|.+.... .....++.+|+.++.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999998643 33 58999886553 3345688999999999999999999999987 78899
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
|+||+++|+|.+++... ...+++...+.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998543 234899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
............++..|+|||.+....++.++|+||||++++||++ |+.|+.... ...+... .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~----~~~~~------ 228 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--AVEIPDL----LEKGE------ 228 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--HHHHHHH----HhCCC------
Confidence 3332222222334678999999988899999999999999999999 999975321 1111111 11111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
....+......+.+++.+||..+|++||++.++++.|+...
T Consensus 229 ---~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 229 ---RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 01112223346889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=325.64 Aligned_cols=261 Identities=21% Similarity=0.314 Sum_probs=196.9
Q ss_pred CCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCC-----cee
Q 005599 372 NFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD-----EKM 443 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 443 (688)
+|++.++||+|+||.||++.. .+++.||||++... .....+.+.+|+.++..++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 47899999998643 2234567889999999999999999999998776 789
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
+|+||+. ++|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 567776632 346899999999999999999999988 999999999999999999999999999865
Q ss_pred CCCccccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccc---
Q 005599 524 GGEEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL--- 599 (688)
Q Consensus 524 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--- 599 (688)
...... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..........
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP--IQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHcCCCCHHHHH
Confidence 433221 12234678999999998874 479999999999999999999999854321 11111111111100000
Q ss_pred -------c-ccccccc-------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 600 -------E-IVDSSMA-------DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 600 -------~-~~d~~l~-------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
. +...... ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 0000000 00111224568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=308.89 Aligned_cols=250 Identities=30% Similarity=0.435 Sum_probs=192.3
Q ss_pred CccccCCcEeEEEEEeCC----CcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEe-CCceeEEEeccC
Q 005599 377 NKLGQGGFGPVYKGKLAN----GQEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLE-KDEKMLIYEFMP 450 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~ 450 (688)
+.||+|+||.||+|...+ ...||+|++... .....+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 357999998543 33446788999999999999999999998764 456789999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc-
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS- 529 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 529 (688)
+++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998543 234678888999999999999999987 999999999999999999999999999865432211
Q ss_pred -cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCC-CCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 530 -TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK-KNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 530 -~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
.......++..|+|||.+.+..++.++||||||+++|||++|. +|+... ....+. ........ .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~---~~~~~~~~------~--- 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--DSFDIT---VYLLQGRR------L--- 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHH---HHHhcCCC------C---
Confidence 1112244577899999998889999999999999999999965 444321 111111 11111100 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
..+...+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 01112234688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=326.37 Aligned_cols=261 Identities=18% Similarity=0.234 Sum_probs=196.1
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
...|.+.+.||+|+||.||++... .++.||||... ...+.+|+++|.+++|+|||++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457888999999999999999865 47889999642 23467899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+. ++|..++... ...+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 7888877432 236899999999999999999999988 99999999999999999999999999987644322
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCC------CccHHHHHHHHhcc-cccccc
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDD------SSNLIRYVWELWSD-DKALEI 601 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~------~~~l~~~~~~~~~~-~~~~~~ 601 (688)
........||+.|+|||++.+..++.++|||||||+||||++|..++-..... ...+...+...... ......
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 22223467999999999999999999999999999999999988764221111 01111111110000 000000
Q ss_pred cc--------c----cccCCC--C-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 602 VD--------S----SMADSC--P-----APEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 602 ~d--------~----~l~~~~--~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.. . ...... + ......+.+|+.+||+.||++|||+.||++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0 000000 0 0112357889999999999999999999874
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=306.93 Aligned_cols=264 Identities=24% Similarity=0.339 Sum_probs=201.2
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccC--CCcccHHHHHHHHHHHhhcCCCCccceEEEEEe-----CC
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLST--TSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLE-----KD 440 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~ 440 (688)
....|...+.||+|+||.|..+... +|+.||||++.. ......++-.+|+++|+.++|+||+.+++.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999754 689999999973 344556778899999999999999999999876 24
Q ss_pred ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccc
Q 005599 441 EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA 520 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 520 (688)
..|+|+|+| ..+|...+. .++.++.....-++.||++||.|+|+.+ |+||||||+|+|++.+..+||+|||||
T Consensus 100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 689999999 678888883 3344778888889999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHH--------
Q 005599 521 RVFGGEEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWE-------- 591 (688)
Q Consensus 521 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~-------- 591 (688)
+...........+..+.|.+|.|||++.. ..|+.+.||||.|||+.||++|++-|...+. ......+..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~--v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY--VHQLQLILELLGTPSEE 250 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch--HHHHHHHHHhcCCCCHH
Confidence 98865422333355788999999998865 5799999999999999999999998754321 111111111
Q ss_pred ---Hhcccccccccccccc-CCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 592 ---LWSDDKALEIVDSSMA-DSCP-----APEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 592 ---~~~~~~~~~~~d~~l~-~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
....+.+...+...-. ...| +......++|+.+||..||.+|+|++|.++
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111111111111000 0001 123456889999999999999999999885
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=317.76 Aligned_cols=238 Identities=21% Similarity=0.273 Sum_probs=187.6
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHH-HHhhcCCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVL-LIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
+.||+|+||.||+|+.. +|+.+|||++... ......++..|.. ++..++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999854 6899999998643 2223345556655 46778999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
|+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 999888743 345889999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... .+. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~~~~~---------~~~--~~ 216 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDNILHK---------PLV--LR 216 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHHHHcC---------Ccc--CC
Confidence 234678999999999999999999999999999999999999985321 11111111111 000 11
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHH
Q 005599 612 APEALRCIQVGLLCVQDRTTDRPSMST 638 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPt~~e 638 (688)
......+.+++.+|++.+|++||++.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 123446789999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=324.77 Aligned_cols=261 Identities=20% Similarity=0.230 Sum_probs=199.0
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC---CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA---NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
..+|.+.+.||+|+||.||++... .+..||||.+... +.+.+|+.++.+++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3578999988543 24568999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
|++. ++|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+++.....
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 67777772 3356899999999999999999999988 999999999999999999999999999876544
Q ss_pred ccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCC-ccHHHHHHHHhcccccc------
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDS-SNLIRYVWELWSDDKAL------ 599 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~------ 599 (688)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+..........
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 33333334679999999999999999999999999999999999999985433211 11111111111100000
Q ss_pred -c------cccccccCCC--C-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 600 -E------IVDSSMADSC--P-----APEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 600 -~------~~d~~l~~~~--~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
. ......+... + ......+.+++.+|++.+|++|||+.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0000000000 0 0123467889999999999999999999864
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=309.94 Aligned_cols=239 Identities=25% Similarity=0.355 Sum_probs=187.2
Q ss_pred ccccCCcEeEEEEEeCC-------------------------CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccce
Q 005599 378 KLGQGGFGPVYKGKLAN-------------------------GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKL 432 (688)
Q Consensus 378 ~LG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l 432 (688)
+||+|+||.||+|.+.. ...||+|.+.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13589998866544455678899999999999999999
Q ss_pred EEEEEeCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC--
Q 005599 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM-- 510 (688)
Q Consensus 433 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-- 510 (688)
++++.+....++||||+++|+|+.++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999888542 345789999999999999999999987 99999999999998654
Q ss_pred -----CceecccccceecCCCccccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHH-hCCCCCCCCCCCCc
Q 005599 511 -----NPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEII-TGKKNTGIFNDDSS 583 (688)
Q Consensus 511 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~ell-tG~~p~~~~~~~~~ 583 (688)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-- 228 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS-- 228 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH--
Confidence 3799999998643221 12356788999998876 56899999999999999995 688887432211
Q ss_pred cHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 584 NLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 584 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
....... ... ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 229 ~~~~~~~-------------~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 EKERFYE-------------KKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHH-------------hcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111110 000 011112236889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=304.34 Aligned_cols=249 Identities=24% Similarity=0.407 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC-CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
++|++.+.||+|+||.||+|...+ ++.+|+|.+..... .+++.+|++++++++|+||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678889999999999999998765 78999999865432 678999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++... ...+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998432 356899999999999999999999987 99999999999999999999999999987643321
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
......++..|+|||++.+..++.++||||||+++|||++|+.|+........ ..... . ...+.+ .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-----~~~~~-~-----~~~~~~--~ 220 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-----IFMIP-N-----KPPPTL--S 220 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-----hhhhc-c-----CCCCCC--C
Confidence 22235578899999999999999999999999999999999999853221110 00000 0 000001 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.+......+.+++.+|++.+|++|||+.||++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 12233457899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=309.47 Aligned_cols=257 Identities=29% Similarity=0.404 Sum_probs=203.2
Q ss_pred cCCCCCCccccCCcEeEEEEEeC------CCcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCCccceEEEEEeCCcee
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTSGQ-GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKM 443 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 443 (688)
++|.+.+.||+|+||.||+|+.. +.+.||+|.+...... ..+++.+|++++.+++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999854 3467999988654433 4578999999999999999999999999999999
Q ss_pred EEEeccCCCChhhHhhccCCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccc
Q 005599 444 LIYEFMPNKSLDYFIFDESRK------QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDF 517 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 517 (688)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654322 25899999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccc
Q 005599 518 GTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDD 596 (688)
Q Consensus 518 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 596 (688)
|+++........ ......++..|+|||.+.+..++.++||||||++++||++ |..||....+ ... +.. ....
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~---~~~-~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEV---LNR-LQAG 234 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHH---HHH-HHcC
Confidence 998754322211 2222456778999999988889999999999999999999 7777642211 111 111 1111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 597 KALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 597 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
.. ....+...+..+.+++.+|++.+|++||++.+++.+|.+
T Consensus 235 ~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 KL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred Cc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11 011112234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.68 Aligned_cols=254 Identities=20% Similarity=0.324 Sum_probs=190.9
Q ss_pred CccccCCcEeEEEEEeCCCc---EEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCC
Q 005599 377 NKLGQGGFGPVYKGKLANGQ---EIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNK 452 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~~~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 452 (688)
+.||+|+||.||+|...++. .+++|.+.... ....+.|.+|+.++..++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999754433 45677665433 334578999999999999999999999999999999999999999
Q ss_pred ChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 453 SLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 453 sL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
+|.+++.... .....++.....++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999986532 2234667778899999999999999987 99999999999999999999999999864332222222
Q ss_pred cccccccCCccCceeecC-------CCCCCcccchhHHHHHHHHHhC-CCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 532 TNRVVGTYGYMSPEYALG-------GLFSTKSDVFSFGVLLLEIITG-KKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~-------~~~s~k~DvwSlGvll~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+....+ ........ .+....+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~-~~~~~~~~~ 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHVI-KDQQVKLFK 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH-hhcccccCC
Confidence 234567889999998753 2457899999999999999975 556532211 11111111 122223344
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
+.+... ....+.+++..|+ .+|++||++.+|++.|.
T Consensus 232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 433322 2345778888999 57999999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.04 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=199.8
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
++|++.+.||+|+||.||++... ++..+|+|.+.... ....+++.+|++++.+++||||+++++++.+.+..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999865 57788999886542 23345688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|.+++... ..+++.....++.|+++||.|||+.. +++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 9999999998543 45789999999999999999999742 39999999999999999999999999987553221
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccc-----------
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK----------- 597 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~----------- 597 (688)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ................
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCC
Confidence 223578899999999988889999999999999999999999974322 1111111000000000
Q ss_pred ---------ccccccccccC---CCC-HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 598 ---------ALEIVDSSMAD---SCP-APEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 598 ---------~~~~~d~~l~~---~~~-~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
..++.+..... ..+ ......+.+++.+||+.+|++||++.+|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 000 1134468899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=309.63 Aligned_cols=263 Identities=26% Similarity=0.369 Sum_probs=197.4
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+|++.+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|+.++..++||||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777899999999999999865 68899999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
++ ++|.+++........+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 688888755444467899999999999999999999987 9999999999999999999999999997654321
Q ss_pred ccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH-------hccc----
Q 005599 529 STNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWEL-------WSDD---- 596 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~-------~~~~---- 596 (688)
.......+++.|+|||++.+. .++.++||||||++++||++|+.||....+. ..+....... +...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-DQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhcchhhH
Confidence 111224568899999988654 5789999999999999999999998532210 0011100000 0000
Q ss_pred ccccccccccc---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 597 KALEIVDSSMA---DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 597 ~~~~~~d~~l~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.....+..... .........++.+++.+||+.||++|||+.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 0001112456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=343.21 Aligned_cols=260 Identities=22% Similarity=0.280 Sum_probs=201.4
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|++.++||+|+||.||+|... +++.||||++.... ....++|.+|++++.+++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999865 58899999986532 223467899999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccc
Q 005599 447 EFMPNKSLDYFIFDES--------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG 518 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 518 (688)
||+++++|.+++.... ....+++...+.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885421 1234567888999999999999999987 9999999999999999999999999
Q ss_pred cceecCCCcc----------------ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCC
Q 005599 519 TARVFGGEEI----------------STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDS 582 (688)
Q Consensus 519 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~ 582 (688)
+++....... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9987621110 01112356999999999999999999999999999999999999998542111
Q ss_pred ccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhcCC
Q 005599 583 SNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRP-SMSTVVFMLSNE 646 (688)
Q Consensus 583 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-t~~evl~~L~~~ 646 (688)
... .... +.++.-. ......+..+.+++.+|++.||++|| +++++++.|+..
T Consensus 238 -ki~--~~~~--------i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 238 -KIS--YRDV--------ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred -hhh--hhhh--------ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 0000 0010000 00112234688999999999999996 566777776554
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=307.10 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=201.8
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
++|++.+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+||+++.+++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999865 58899999986543 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|.+++... .+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999998432 6899999999999999999999987 9999999999999999999999999998775432
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
.......+++.|+|||.+.+..++.++||||||+++|||++|+.|+..... .... .. .... ..+.+..
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--~~~~---~~-~~~~-----~~~~~~~ 220 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--MRVL---FL-IPKN-----NPPSLEG 220 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--HHHH---HH-hhhc-----CCCCCcc
Confidence 122235678899999999998899999999999999999999999853221 1111 10 0011 0111111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
. ..+..+.+++.+||+.+|++||+++++++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1 03446889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=307.69 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=202.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC----CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN----GQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 445 (688)
++|.+.+.||+|+||.||+|...+ ...||||...... ....+.|.+|+.++..++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998643 2468999886554 4456789999999999999999999998875 567899
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999998543 235899999999999999999999987 99999999999999999999999999987654
Q ss_pred CccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS 604 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 604 (688)
..... .....++..|+|||.+....++.++||||||++++||++ |..||..... ...... ...+...
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~~----~~~~~~~----- 227 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--NDVIGR----IENGERL----- 227 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHH----HHcCCcC-----
Confidence 42221 112344568999999988889999999999999999996 9999853221 111111 1111100
Q ss_pred cccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 605 SMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 605 ~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
..+...+..+.+++.+|+..+|++|||+.++++.|+++.
T Consensus 228 ----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 ----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 112233457899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=308.68 Aligned_cols=240 Identities=23% Similarity=0.400 Sum_probs=189.7
Q ss_pred CccccCCcEeEEEEEeCC--------CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 377 NKLGQGGFGPVYKGKLAN--------GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+.||+|+||.||+|.... ...||+|.+........+++.+|+.++..++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997532 234888888655555567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCC--------ceecccccc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMN--------PRISDFGTA 520 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~kl~DFGla 520 (688)
+++|+|..++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999985432 35889999999999999999999987 999999999999987765 589999987
Q ss_pred eecCCCccccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCC-CCCCCCCCCCccHHHHHHHHhccccc
Q 005599 521 RVFGGEEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGK-KNTGIFNDDSSNLIRYVWELWSDDKA 598 (688)
Q Consensus 521 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~ 598 (688)
...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+..... ..... ...
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--~~~~~----~~~---- 219 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--QKKLQ----FYE---- 219 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--HHHHH----HHH----
Confidence 654321 22467889999999987 45899999999999999999995 44422111 00000 000
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 599 LEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 599 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
. ....+......+.+++.+||+.+|++|||++++++.|+
T Consensus 220 -----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 -----D--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----c--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 01122223356899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=306.92 Aligned_cols=255 Identities=26% Similarity=0.425 Sum_probs=200.8
Q ss_pred CCCCCCccccCCcEeEEEEEeCC--CcEEEEEEccCC----------CcccHHHHHHHHHHHhh-cCCCCccceEEEEEe
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLAN--GQEIAVKRLSTT----------SGQGIEEFKNEVLLIAK-LQHRNLVKLLGCCLE 438 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 438 (688)
+|++.+.||+|+||.||+|.... ++.+|||.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999765 678999987532 12234567788888875 799999999999999
Q ss_pred CCceeEEEeccCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccc
Q 005599 439 KDEKMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDF 517 (688)
Q Consensus 439 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 517 (688)
.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+.. +++|+||+|+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887542 23446889999999999999999999632 3999999999999999999999999
Q ss_pred ccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccc
Q 005599 518 GTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK 597 (688)
Q Consensus 518 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 597 (688)
|++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+... .......... ...
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~-~~~ 229 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NMLSLATKIV-EAV 229 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CHHHHHHHHh-hcc
Confidence 9998765433 223356889999999999988999999999999999999999997421 1111111111 111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 598 ALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 598 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
. .+.. .......+.+++.+|++.+|++||++.||..+|+.
T Consensus 230 ~----~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 230 Y----EPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred C----CcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 0 0100 11223568899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.63 Aligned_cols=255 Identities=20% Similarity=0.259 Sum_probs=194.7
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|++.+.||+|+||.||+++.. +++.||||++... .....+.|.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999865 5889999998642 2234556889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998532 345788899999999999999999988 999999999999999999999999998765432
Q ss_pred ccccccccccccCCccCceeecC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALG-----GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 601 (688)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||... ...+.............+
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~-----~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHKEHFQF 229 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC-----CHHHHHHHHHcCCCcccC
Confidence 211 1122468999999999863 45788999999999999999999998432 112211122111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcccC--CCCCCCCHHHHHHH
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQD--RTTDRPSMSTVVFM 642 (688)
Q Consensus 602 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~--~P~~RPt~~evl~~ 642 (688)
.. .....+..+.+++.+|+.. ++..||++.++++.
T Consensus 230 ~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 PP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 0011234567777776654 44448899998865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.32 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=203.2
Q ss_pred cCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++..++|+||+++++++......++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6788899999999999999985 478999999997665555677899999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999998843 35789999999999999999999987 999999999999999999999999999765433221
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||........ +. .....+ .+ ...
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-~~----~~~~~~------~~--~~~ 236 (297)
T cd06656 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY----LIATNG------TP--ELQ 236 (297)
T ss_pred --cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-ee----eeccCC------CC--CCC
Confidence 2235688899999999998899999999999999999999999853221110 00 000000 00 001
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.+......+.+++.+||+.+|++||++.+|++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12233456889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=307.54 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=199.5
Q ss_pred CCCCCccccCCcEeEEEEEeC----CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCC------
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA----NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD------ 440 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 440 (688)
|.+.+.||+|+||.||+|... +++.||||++... .....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999753 3688999998654 2334667899999999999999999999987543
Q ss_pred ceeEEEeccCCCChhhHhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccc
Q 005599 441 EKMLIYEFMPNKSLDYFIFDES---RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDF 517 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 517 (688)
..++++||+++|+|..++.... ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2378899999999988875321 2235788999999999999999999987 999999999999999999999999
Q ss_pred ccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccc
Q 005599 518 GTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDD 596 (688)
Q Consensus 518 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 596 (688)
|+++...............+++.|++||.+.+..++.++||||||+++|||++ |++|+.... ...+..+.. ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~--~~~~~~~~~---~~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE--NSEIYNYLI---KGN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC--HHHHHHHHH---cCC
Confidence 99987654332222223455678999999999999999999999999999999 788864221 111111111 111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 597 KALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 597 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
. + ..+......+.+++.+|++.+|++||++.+|++.|+++
T Consensus 233 ~--------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 R--------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred c--------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 01122345799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.89 Aligned_cols=261 Identities=22% Similarity=0.344 Sum_probs=196.7
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
++|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++.+++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999865 57889999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++ +|..++... ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 777776433 345788999999999999999999988 99999999999999999999999999976543221
Q ss_pred ccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccc---------
Q 005599 529 STNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKA--------- 598 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--------- 598 (688)
......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .+..............
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV--EDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhhcch
Confidence 1122467899999998865 4689999999999999999999999854321 1111111111110000
Q ss_pred cccccccccCC-------CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 599 LEIVDSSMADS-------CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 599 ~~~~d~~l~~~-------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
....+...... ........+.+|+.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 00112446789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=306.05 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=201.4
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
.+.|++.++||.|+||.||+|+.. +++.+|+|.+........+.+.+|+.++..++|+||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367888999999999999999875 4889999999776666678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|..++... ...+++..+..++.|++.+|+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 9999998887543 235899999999999999999999987 9999999999999999999999999987543221
Q ss_pred ccccccccccCCccCceeec-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYAL-----GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
.......+++.|+|||++. ...++.++|||||||++|||++|+.|+..... .......... . .
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~-----~ 232 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKS-E-----P 232 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHHHhcC-C-----C
Confidence 1122356788999999985 34578899999999999999999999753221 1111111111 0 0
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+.+ ..+......+.+++.+||+.+|++||++.+|++
T Consensus 233 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 011 112233456889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.24 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=199.2
Q ss_pred CCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCC
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|++++..++||||+++++++......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567789999999999999876 4678899998766656677899999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
++|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 9998887542 346899999999999999999999987 9999999999999999999999999987653221 12
Q ss_pred cccccccCCccCceeec-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 532 TNRVVGTYGYMSPEYAL-----GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
.....+++.|+|||++. +..++.++|||||||++|||++|++|+..... ...+........ +.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~~------~~~ 228 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSEP------PTL 228 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-----HHHHHHHhhcCC------CCC
Confidence 23356889999999984 44578899999999999999999999753221 111111111100 000
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122234578999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.07 Aligned_cols=238 Identities=26% Similarity=0.448 Sum_probs=189.3
Q ss_pred CccccCCcEeEEEEEeCCCc-----------EEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEE
Q 005599 377 NKLGQGGFGPVYKGKLANGQ-----------EIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 445 (688)
+.||+|+||.||+|...+.. .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999876433 5788877554333 6789999999999999999999999988 788999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC-------Cceecccc
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM-------NPRISDFG 518 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-------~~kl~DFG 518 (688)
+||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999986432 26889999999999999999999987 99999999999999888 79999999
Q ss_pred cceecCCCccccccccccccCCccCceeecCC--CCCCcccchhHHHHHHHHHhC-CCCCCCCCCCCccHHHHHHHHhcc
Q 005599 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALGG--LFSTKSDVFSFGVLLLEIITG-KKNTGIFNDDSSNLIRYVWELWSD 595 (688)
Q Consensus 519 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwSlGvll~elltG-~~p~~~~~~~~~~l~~~~~~~~~~ 595 (688)
++..... .....++..|+|||++.+. .++.++||||||+++|||++| ..|+..... ...... +..
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~~~----~~~ 221 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERF----YQD 221 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--hhHHHH----Hhc
Confidence 9986543 1124566789999999877 789999999999999999995 666533211 111110 000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 596 DKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 596 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
.. ..+......+.+++.+|++.+|.+||++.+|++.|+
T Consensus 222 ~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QH-----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC-----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 001111257889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=309.45 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=198.7
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
.|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++......++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3555688999999999999864 57889999886443 334567899999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999998873 245789999999999999999999987 99999999999999999999999999976543221
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
......++..|+|||.+.+..++.++||||||++++||++|+.|+...... ... .. . .......
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~---~~-~---------~~~~~~~ 220 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--RVL---FL-I---------PKNSPPT 220 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--hHH---hh-h---------hcCCCCC
Confidence 122246788999999999989999999999999999999999997432111 000 00 0 0000111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.+...+..+.+++.+|++.+|++||+|.+|++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 122334568899999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=315.60 Aligned_cols=194 Identities=21% Similarity=0.321 Sum_probs=165.1
Q ss_pred HHHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEE
Q 005599 367 LAATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 367 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 445 (688)
.....+|.+.+.||+|+||.||+|+.. +++.||+|..... ....|+.++.+++|+||+++++++......++|
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 345568999999999999999999865 4678999975332 235699999999999999999999999999999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
+||+. ++|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 136 LPHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 99995 678777743 2346899999999999999999999988 99999999999999999999999999975432
Q ss_pred CccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCC
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNT 575 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~ 575 (688)
.. ......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 AP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred Cc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 21 112356899999999999999999999999999999999965553
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.43 Aligned_cols=249 Identities=27% Similarity=0.461 Sum_probs=199.3
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcc---------cHHHHHHHHHHHhhcCCCCccceEEEEEeCCc
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQ---------GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE 441 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 441 (688)
+|.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++.+++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999864 5789999988654321 23568899999999999999999999999999
Q ss_pred eeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccce
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 521 (688)
.++|+||+++++|..++.. ...+++.....++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 245788999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCCccc----cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccc
Q 005599 522 VFGGEEIS----TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK 597 (688)
Q Consensus 522 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 597 (688)
........ .......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~---- 225 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-----LQAIFKIG---- 225 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-----HHHHHHHh----
Confidence 76532111 111234678899999999998999999999999999999999999853211 11111100
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 598 ALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 598 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
....+ ..+......+.+++.+||+.+|++||++.+|++
T Consensus 226 --~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 --ENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --ccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 01111 122334457889999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.36 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=201.5
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
+|++.+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.++..++|+||+++.+.+...+..++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999864 6889999988543 3344567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++... ....++....+.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998887532 2345788999999999999999999988 99999999999999999999999999976643221
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
......+++.|+|||++.+..++.++||||||+++|+|++|+.||... .......... .+.. ..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~~~~~~~~~-~~~~---------~~ 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SWKNLILKVC-QGSY---------KP 219 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CHHHHHHHHh-cCCC---------CC
Confidence 112356888999999999888999999999999999999999998531 1111111111 1111 01
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.+......+.+++.+||+.+|++||++.+|+..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.05 Aligned_cols=248 Identities=23% Similarity=0.396 Sum_probs=202.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
..|+..+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|+.++..++|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35677789999999999999865 58899999886543 34467789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|.+++.. ..+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998842 35788899999999999999999987 99999999999999999999999999977643321
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
......++..|+|||++.+..++.++||||||+++|||++|+.|+...... ... ..+......
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~-------------~~~~~~~~~ 219 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--RVL-------------FLIPKNNPP 219 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--hHh-------------hhhhcCCCC
Confidence 122246788999999999889999999999999999999999997532110 000 001111111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
..+...+..+.+++.+||+.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2234456678999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.82 Aligned_cols=241 Identities=23% Similarity=0.349 Sum_probs=192.0
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCceeEEE
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 446 (688)
+|+..+.||+|+||.||+|... +++.||||++... .....+.+..|+.++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999864 6889999998643 2234566788999998885 577888999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|+|..++.. ...+++.+...++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999988843 245889999999999999999999988 999999999999999999999999998754322
Q ss_pred ccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...... ..... . .
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--~~~~~~---~i~~~-~--------~ 218 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED--EDELFQ---SIMEH-N--------V 218 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC--HHHHHH---HHHhC-C--------C
Confidence 21 1223568999999999999999999999999999999999999985321 111111 11110 0 0
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSM 636 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~ 636 (688)
..+...+..+.+++.+|++.+|.+|++.
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1122334568899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.22 Aligned_cols=240 Identities=21% Similarity=0.245 Sum_probs=186.7
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHH-HHHhhcCCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEV-LLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|. .++..++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999865 56789999986432 12223444444 456788999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
++|..++.. ...+.......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999998854 234677888889999999999999988 9999999999999999999999999997543221 12
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... .+ ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~---------~~--~~~ 216 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEMYDNILNK---------PL--QLK 216 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC-----HHHHHHHHHhC---------Cc--CCC
Confidence 234679999999999999999999999999999999999999985321 11111111111 00 011
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 005599 612 APEALRCIQVGLLCVQDRTTDRPSMSTVV 640 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 640 (688)
......+.+++.+|++.+|.+||++.+.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 12334688999999999999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.53 Aligned_cols=255 Identities=19% Similarity=0.253 Sum_probs=196.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|.+.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++..++|+||+++.+++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999865 5788999998642 2233456888999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|+|..++... ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 235788889999999999999999988 999999999999999999999999999876543
Q ss_pred ccccccccccccCCccCceeecC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALG-----GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 601 (688)
... ......||+.|+|||++.+ ..++.++||||||++||||++|+.||.... ................
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~~- 228 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHEERFQ- 228 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-----HHHHHHHHHcCCCccc-
Confidence 221 1223579999999999876 568899999999999999999999985321 1111111111111000
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTD--RPSMSTVVFM 642 (688)
Q Consensus 602 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPt~~evl~~ 642 (688)
+... ....+..+.+++.+|+..++++ |+++.++++.
T Consensus 229 ~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0000 1122456888888888865544 5688888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.60 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=194.4
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|++.+.||+|+||.||++... +++.||||++... .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999865 5889999998643 2234567888999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999853 345889999999999999999999988 999999999999999999999999998754321
Q ss_pred ccc---------------------------------cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCC
Q 005599 527 EIS---------------------------------TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKK 573 (688)
Q Consensus 527 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~ 573 (688)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00113579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCC---HHHHHH
Q 005599 574 NTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPS---MSTVVF 641 (688)
Q Consensus 574 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt---~~evl~ 641 (688)
||..... ............... +.+ . ......+.+++.+++. +|++|++ +.|+++
T Consensus 235 Pf~~~~~-----~~~~~~i~~~~~~~~-~p~----~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 235 PFCSETP-----QETYRKVMNWKETLV-FPP----E--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCH-----HHHHHHHHcCCCcee-cCC----C--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 9853211 111111111100000 000 0 1123467778877664 9999996 555554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.09 Aligned_cols=247 Identities=29% Similarity=0.457 Sum_probs=198.1
Q ss_pred cCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccC
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
++|++.+.||+|+||.||++.. .++.||+|.+.... ..+.+.+|+.++..++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999975 67889999986432 346789999999999999999999998654 5799999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999986542 335789999999999999999999987 999999999999999999999999998764321
Q ss_pred ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..... ..... .....
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~-~~~~~---------~~~~~ 217 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVK-ECVEK---------GYRME 217 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHH-HHHhC---------CCCCC
Confidence 112334568999999998899999999999999999998 888874321 11111 11111 11111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
.+...+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122334578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=301.30 Aligned_cols=251 Identities=35% Similarity=0.519 Sum_probs=201.1
Q ss_pred CCCCCccccCCcEeEEEEEeCC-----CcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 373 FSTSNKLGQGGFGPVYKGKLAN-----GQEIAVKRLSTTSGQ-GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
|.+.+.||.|+||.||+++..+ +..||+|.+...... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998754 478999999665433 5678999999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854322 12899999999999999999999987 999999999999999999999999999877654
Q ss_pred ccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
...... ...+++.|+|||.+.+..++.++||||||++++||++ |..|+... ........... ...
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~~-~~~------- 222 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLEYLKK-GYR------- 222 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhc-CCC-------
Confidence 322221 2347789999999988889999999999999999999 77776431 11111111111 110
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 643 (688)
...+...+..+.+++.+|+..+|++|||+.++++.|
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111222345788999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=307.54 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=198.4
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCCccceEEEEEeC------
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEK------ 439 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------ 439 (688)
.+++.|++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888999999999999999865 57889999986543 3456788999999998 699999999998763
Q ss_pred CceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccc
Q 005599 440 DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGT 519 (688)
Q Consensus 440 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 519 (688)
...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 3578999999999999998543 2346889999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCccccccccccccCCccCceeec-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhc
Q 005599 520 ARVFGGEEISTNTNRVVGTYGYMSPEYAL-----GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWS 594 (688)
Q Consensus 520 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 594 (688)
+....... .......|+..|+|||++. +..++.++|||||||++|||++|+.|+..... ..... ....
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----~~~~~-~~~~ 230 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRALF-LIPR 230 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----HHHHH-HHhc
Confidence 98654321 1223367889999999986 34588899999999999999999999843211 11111 1111
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 595 DDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 595 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
. . ...+ .+...+..+.+|+.+||+.+|.+|||+.+|++
T Consensus 231 ~-~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 N-P-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred C-C-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 0 0011 11122346889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=301.21 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=203.7
Q ss_pred CCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+|+..+.||.|+||.||.++. .+++.+++|.+... ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999874 45889999987643 334566789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999985432 345789999999999999999999987 99999999999999999999999999987644332
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
......+++.|+|||.+.+..++.++||||||++++||++|+.|+... ........... +...
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~-~~~~--------- 219 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-----NPLNLVVKIVQ-GNYT--------- 219 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHc-CCCC---------
Confidence 223356899999999999888999999999999999999999997431 11111111111 1110
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 643 (688)
..+...+..+.+++.+|++.+|++||++.++++.+
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11122345688999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=306.26 Aligned_cols=253 Identities=22% Similarity=0.366 Sum_probs=201.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
++|++.+.||+|+||.||++... ++..||+|.+... .......+.+|+.++.+++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999875 6899999988653 333456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|..++........+++..+..++.|++.||.|||+.. +|+|+||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999998865433446899999999999999999999742 39999999999999999999999999987653221
Q ss_pred ccccccccccCCccCceeecCCC------CCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYALGGL------FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~------~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 602 (688)
.....+++.|+|||.+.+.. ++.++|+|||||++|||++|+.||..... ......... +.
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~---------~~ 223 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFAQLSA---------IV 223 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHHHHHH---------Hh
Confidence 12245788999999986543 58899999999999999999999853211 111111111 11
Q ss_pred cccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 603 d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+. .....+......+.+++.+|++.+|++||++.+++.
T Consensus 224 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 224 DG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 10 011123345667899999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.22 Aligned_cols=260 Identities=23% Similarity=0.338 Sum_probs=192.0
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhc---CCCCccceEEEEEeC-----C
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKL---QHRNLVKLLGCCLEK-----D 440 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~-----~ 440 (688)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++..+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999865 68899999886532 22234566777777665 699999999998653 3
Q ss_pred ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccc
Q 005599 441 EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA 520 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 520 (688)
..++|+||++ ++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 4789999998 47877775432 345899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccc-
Q 005599 521 RVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL- 599 (688)
Q Consensus 521 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~- 599 (688)
+...... ......+|..|+|||++.+..++.++|||||||++|||++|++||..... .................
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH--HHHHHHHHHHhCCCChhh
Confidence 8664322 11235678999999999999999999999999999999999999853221 11111111111000000
Q ss_pred -----c----ccccccc---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 600 -----E----IVDSSMA---DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 600 -----~----~~d~~l~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
. ...+... ..........+.+++.+|++.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0000000 0011123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.84 Aligned_cols=257 Identities=27% Similarity=0.458 Sum_probs=208.0
Q ss_pred ccccCCcEeEEEEEeCC-CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCChhh
Q 005599 378 KLGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDY 456 (688)
Q Consensus 378 ~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 456 (688)
+||+|.||+||.|+..+ ...+|||.+........+-+..||.+.+.|+|.|||+++|.+.+++..-+.||.+++|+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999998655 45799999988877777888999999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEEC-CCCCceecccccceecCCCccccccc
Q 005599 457 FIFDESRKQLL--DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EEMNPRISDFGTARVFGGEEISTNTN 533 (688)
Q Consensus 457 ~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~ 533 (688)
+|...= .++ ++.+.--+..||++||.|||++. |||||||-+||||+ -.|.+||+|||-++.+.. ....+.
T Consensus 662 LLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 662 LLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 995432 234 66777788999999999999998 99999999999996 578999999999987653 334445
Q ss_pred cccccCCccCceeecCCC--CCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 534 RVVGTYGYMSPEYALGGL--FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 534 ~~~gt~~y~aPE~~~~~~--~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
++.||.-|||||++..++ |+.++|||||||++.||.||++||-..+....... ..+ + -....+.|
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF-------kVG----m--yKvHP~iP 801 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF-------KVG----M--YKVHPPIP 801 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh-------hhc----c--eecCCCCc
Confidence 588999999999997664 89999999999999999999999854332211111 000 0 01123467
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhcCCCCCCCCCC
Q 005599 612 APEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNETSVPSPKQ 654 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~~~~~p~~ 654 (688)
.+.++++..++++|+.++|.+||++++++. +|.--...+.|+.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~l 846 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKL 846 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCC
Confidence 788899999999999999999999999985 4444333344443
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.67 Aligned_cols=250 Identities=26% Similarity=0.331 Sum_probs=197.8
Q ss_pred CCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG---QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
|+..+.||+|+||.||++... +++.||||.+..... ...+.+.+|+.++.+++|+|++++.+.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999864 688999999865322 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|.+++.... ...+++.++..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999998885432 245889999999999999999999987 99999999999999999999999999876543221
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ........... ...
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~~~~~~~~----------~~~ 222 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKE----------VQE 222 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--hHHHHHhhhhh----------hhh
Confidence 123478999999999999999999999999999999999999985432111 00111111000 000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 641 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~ 641 (688)
..+......+.+|+..||+.||++||| +.|+++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 112223346889999999999999999 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=308.73 Aligned_cols=197 Identities=27% Similarity=0.447 Sum_probs=160.2
Q ss_pred CCccccCCcEeEEEEEeC---CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeC--CceeEEEeccC
Q 005599 376 SNKLGQGGFGPVYKGKLA---NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEKMLIYEFMP 450 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~ 450 (688)
.++||+|+||+||+|+.. +++.||+|.+.... ....+.+|+.++.+++||||+++++++... ...++|+||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46789999986432 234678899999999999999999998653 45789999986
Q ss_pred CCChhhHhhcc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEE----CCCCCceecccccc
Q 005599 451 NKSLDYFIFDE------SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL----DEEMNPRISDFGTA 520 (688)
Q Consensus 451 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFGla 520 (688)
+ +|..++... .....+++.....++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 776666422 12235888999999999999999999988 9999999999999 45678999999999
Q ss_pred eecCCCccc-cccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 005599 521 RVFGGEEIS-TNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIF 578 (688)
Q Consensus 521 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~ 578 (688)
+........ .......+|+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876543211 222346789999999998774 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.58 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=202.6
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|++++..++||||+++++++......++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56788899999999999999854 58899999876543 33457889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|..++.. ...+++.....++.+++.||.|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 999999988743 245899999999999999999999742 3999999999999999999999999998654221
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCC------ccHHHHHHHHhccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDS------SNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~------~~l~~~~~~~~~~~~~~~~~ 602 (688)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||....... ..+...........
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 229 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------ 229 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------
Confidence 1223578999999999988899999999999999999999999986433211 01111111111100
Q ss_pred cccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643 (688)
Q Consensus 603 d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 643 (688)
.+.+ .....+..+.+++.+|++.+|++|||+.||+++.
T Consensus 230 ~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0001 0112345688999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.50 Aligned_cols=253 Identities=21% Similarity=0.363 Sum_probs=199.7
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
++|.+.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.++..++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 56778899999999999999864 58899999987665555667889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++.. ...+++.+...++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 99999998843 345889999999999999999999988 9999999999999999999999999987654321
Q ss_pred cccccccccCCccCceeec---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 530 TNTNRVVGTYGYMSPEYAL---GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
.......|+..|+|||++. ...++.++|||||||++|||++|+.|+....... .+ .... ... ...+..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~----~~~~-~~~---~~~~~~ 231 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-AL----FLMT-KSN---FQPPKL 231 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hH----Hhhh-ccC---CCCCcc
Confidence 1223357899999999874 4568899999999999999999999974322110 00 0000 000 000111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.. ....+..+.+++.+|++.+|++||++.+|++.
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 10 01123468899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=303.43 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=199.6
Q ss_pred CCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCc------ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEE
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSG------QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 445 (688)
+|.+.+.||+|+||.||+|...+++.+|||.+..... ...+.+.+|+++++.++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677899999999999999988899999998864321 2235688999999999999999999999999999999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998532 35788999999999999999999987 99999999999999999999999999876532
Q ss_pred Ccc----ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccc
Q 005599 526 EEI----STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 526 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 601 (688)
... ........++..|+|||.+.+..++.++||||||++++||++|+.||...... ... ....... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~-~~~~~~~---~- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AAM-FYIGAHR---G- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HHH-HHhhhcc---C-
Confidence 111 11122356889999999999989999999999999999999999998532111 000 0000000 0
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 602 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..+. .+......+.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111 12233456899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=305.21 Aligned_cols=250 Identities=25% Similarity=0.320 Sum_probs=197.0
Q ss_pred CCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
|+..+.||+|+||+||+|... +++.+|+|.+.... ......+.+|++++..++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999864 68899999986532 22334578899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999998885432 345899999999999999999999987 99999999999999999999999999976543211
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
.....|+..|+|||++.+..++.++|+||||+++|||++|+.||....+. .....+........ .
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~--~~~~~~~~~~~~~~----------~ 222 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK--VKREEVDRRVLETE----------E 222 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhhhccc----------c
Confidence 12356899999999999999999999999999999999999998532211 01111111111100 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 641 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~ 641 (688)
..+......+.+|+..|++.+|++||+ +.+++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 112223346789999999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=304.67 Aligned_cols=252 Identities=30% Similarity=0.483 Sum_probs=198.2
Q ss_pred CCCCCccccCCcEeEEEEEeCC-CcEEEEEEccCCCcccH--HHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 373 FSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQGI--EEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
|++.+.||+|+||+||+++... ++.+|+|++........ .....|+.++.+++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999998764 56899999977654332 23456999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++. ....+++..+..++.||++||++||+.+ |+|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence 9999999996 3456799999999999999999999998 9999999999999999999999999998652 112
Q ss_pred cccccccccCCccCceeec-CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 530 TNTNRVVGTYGYMSPEYAL-GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
.......++..|+|||++. +..++.++||||+|+++++|++|..|+.... ..+............ +.....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~--~~~~~~~~~~~~~~~-----~~~~~~- 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN--SDDQLEIIEKILKRP-----LPSSSQ- 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS--HHHHHHHHHHHHHTH-----HHHHTT-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--chhhhhhhhhccccc-----cccccc-
Confidence 2333467899999999998 8889999999999999999999999985431 011111111111000 000000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
........+.+++.+||+.+|++||++.++++
T Consensus 225 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 -QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011267999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.81 Aligned_cols=261 Identities=22% Similarity=0.272 Sum_probs=194.9
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCC-----
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD----- 440 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 440 (688)
..++|.+.+.||+|+||.||++... ++..||||++... .......+.+|+.++..++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4478999999999999999999864 5889999998643 2334567889999999999999999999987543
Q ss_pred -ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccc
Q 005599 441 -EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGT 519 (688)
Q Consensus 441 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 519 (688)
..++||||++++ |...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 469999999764 545442 23788888999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHH----------
Q 005599 520 ARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYV---------- 589 (688)
Q Consensus 520 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~---------- 589 (688)
++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+....
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAEF 245 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHHH
Confidence 97543221 122357899999999999999999999999999999999999998643210 0000000
Q ss_pred --------HHHhccc-c-----ccccccccc-c--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 590 --------WELWSDD-K-----ALEIVDSSM-A--DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 590 --------~~~~~~~-~-----~~~~~d~~l-~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
....... . ..++..... . ...+......+.+|+.+||+.||++|||+.|++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 0 000000000 0 00111124568899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=290.00 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=199.3
Q ss_pred hcCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++.|++-+.||+|.|+.||+.. ..+|+.+|+|.+... ...+.+++.+|+.+...|+|||||+|.....+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4677788999999999999985 457899999987532 3457889999999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEEC---CCCCceecccccceec
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EEMNPRISDFGTARVF 523 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFGla~~~ 523 (688)
|+|.+++|-.-+.. +...++...-..+.||+++|.|+|.++ |||||+||+|+||- ...-+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999998655532 244667777789999999999999998 99999999999995 3345999999999988
Q ss_pred CCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 524 GGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 524 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
+..... ....|||+|||||++...+|+..+|||+.||+||-|+.|.+||.. +....+.+. ...+. .|
T Consensus 164 ~~g~~~---~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~--~~~~rlye~----I~~g~----yd 230 (355)
T KOG0033|consen 164 NDGEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--EDQHRLYEQ----IKAGA----YD 230 (355)
T ss_pred CCcccc---ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC--ccHHHHHHH----Hhccc----cC
Confidence 733222 237899999999999999999999999999999999999999842 222222221 11111 11
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV 640 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 640 (688)
+....-....++..+|+.+||..||.+|.|+.|.+
T Consensus 231 --~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 231 --YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred --CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 11111123456788999999999999999999887
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=307.08 Aligned_cols=264 Identities=23% Similarity=0.375 Sum_probs=208.9
Q ss_pred cCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
.+|.+.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3578889999999999999975 578999999987655555678899999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|..++.. ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999998842 35899999999999999999999988 99999999999999999999999999876543322
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .......... . +.+ .
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-----~~~~~~~~~~-~-----~~~--~ 236 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----RALYLIATNG-T-----PEL--Q 236 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcC-C-----ccc--C
Confidence 122356889999999999988999999999999999999999998543211 1111111110 0 000 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhcCCCCCCCCCCCC
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNETSVPSPKQPT 656 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~~~~~p~~~~ 656 (688)
.+......+.+++.+||+.+|++||++.+|+. .++...+...+....
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~~~~~~ 285 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLI 285 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccccCCccc
Confidence 12223346889999999999999999999985 454444444444333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.75 Aligned_cols=255 Identities=18% Similarity=0.247 Sum_probs=195.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|.+.++||+|+||.||+++.. +++.+|+|.+... .......|.+|+.++..++|+||+++.+++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999875 4678999998542 2223445888999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++|+|.+++... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998542 235888899999999999999999988 999999999999999999999999999765432
Q ss_pred ccccccccccccCCccCceeec-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYAL-----GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 601 (688)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||... .................
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-----~~~~~~~~i~~~~~~~~- 228 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHKERFQ- 228 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-----CHHHHHHHHhCCCcccc-
Confidence 21 1222357999999999986 346889999999999999999999998532 12222222211111000
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcccCCCC--CCCCHHHHHHH
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTT--DRPSMSTVVFM 642 (688)
Q Consensus 602 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~--~RPt~~evl~~ 642 (688)
+. ......+..+.+|+.+|+..++. .||++.|+++.
T Consensus 229 ----~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 ----FP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----CC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 00112345677888887765444 47899998865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=299.91 Aligned_cols=253 Identities=21% Similarity=0.362 Sum_probs=203.5
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
++|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|+.++.+++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999864 57889999987665556788999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++... ...++...+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 999999987543 245889999999999999999999987 9999999999999999999999999987654321
Q ss_pred cccccccccCCccCceeecCC---CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 530 TNTNRVVGTYGYMSPEYALGG---LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~---~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... . ..... .. .+....+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-~----~~~~~-~~---~~~~~~~ 226 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-A----LFLIS-KS---NFPPPKL 226 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-H----HHHHH-hc---cCCCccc
Confidence 112235678899999999877 88999999999999999999999975322110 0 00000 00 0000111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..+...+..+.+++.+|++.+|.+|||+.+|+.
T Consensus 227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112334567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=301.92 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=193.9
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-----cccHHHHHHHHHHHhhcCCCCccceEEEEEeC--Cce
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-----GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEK 442 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 442 (688)
.+|...+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++..++||||+++.+++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 58899999886432 12345688999999999999999999998764 457
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
++++||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999998532 34789999999999999999999887 99999999999999999999999999976
Q ss_pred cCCCcc-ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccc
Q 005599 523 FGGEEI-STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 523 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 601 (688)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----~~~~~~~~~~~----- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----MAAIFKIATQP----- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----HHHHHHHhcCC-----
Confidence 543211 1112235678899999999998899999999999999999999999853211 11111111000
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 602 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.. ...+......+.+++ +|+..+|++||+++||++
T Consensus 226 ~~----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TN----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CC----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01 112222334455665 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=301.20 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=203.6
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
++|+..+.||+|+||.||++... +++.||+|++.... ....+++.+|+++++.++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777899999999999999876 58899999986653 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
+++++|.+++.... ..++......++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999985432 568889999999999999999999 76 9999999999999999999999999987653221
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
. ....++..|+|||.+.+..++.++||||||+++++|++|+.|+.............+........ +
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~--- 222 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP------P--- 222 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC------C---
Confidence 1 11567889999999999999999999999999999999999986443222222222222111110 0
Q ss_pred CCCCHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 608 DSCPAP-EALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 608 ~~~~~~-~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..+.. ....+.+++.+|+..+|++|||+.+++.
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 -RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11111 4456889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=304.23 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=202.4
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
.++|++.+.||.|+||.||+|... ++..+|+|.+........+.|..|+.++.+++|+||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888999999999999999864 5889999998766666677899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|..++... ...+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999988543 245899999999999999999999998 99999999999999999999999999876532211
Q ss_pred ccccccccccCCccCceeec-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYAL-----GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
......+++.|+|||.+. ...++.++||||||+++|||++|+.|+..... ........ ....
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~-~~~~----- 225 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----MRVLLKIL-KSEP----- 225 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----HHHHHHHh-cCCC-----
Confidence 122356889999999875 34577899999999999999999999853211 11111111 1000
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
+.+ ..+......+.+++..||+.+|.+||++.+|++.
T Consensus 226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001 1122234568899999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=302.22 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=199.1
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++..++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999876 58899999886432 2234568899999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|++++.|..++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988877632 235899999999999999999999987 9999999999999999999999999998765432
Q ss_pred cccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHH----------Hhccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWE----------LWSDD 596 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~----------~~~~~ 596 (688)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+...... .+...
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-DQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChHHhhhcccc
Confidence 1 1222457889999999876 46889999999999999999999998533211 111111100 00000
Q ss_pred cc-cccccccccCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 597 KA-LEIVDSSMADSCP-----APEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 597 ~~-~~~~d~~l~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.. .....+......+ ......+.+++.+|++.+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 0000000000001 112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=311.47 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=209.0
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeCC-CcEEEEEEccCCCc---ccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCcee
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTSG---QGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEKM 443 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 443 (688)
..+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+... ...+.+.+|+.+|.++. |||||.+.+.+++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34568888999999999999998765 99999999976533 34568999999999998 999999999999999999
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCC----CCceeccccc
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE----MNPRISDFGT 519 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFGl 519 (688)
+|||++.+|.|.+.+... .+++.....++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998655 2899999999999999999999988 9999999999999643 4799999999
Q ss_pred ceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccc
Q 005599 520 ARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL 599 (688)
Q Consensus 520 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 599 (688)
+..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||....+....+ . ...++.
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~-i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----A-ILRGDF- 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----H-HHcCCC-
Confidence 998765 233445899999999999999999999999999999999999999986433222111 0 111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 600 EIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 600 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
......-...+..+.+++..++..||..|+|+.++++.
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 12222223446778999999999999999999999984
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=311.46 Aligned_cols=257 Identities=18% Similarity=0.251 Sum_probs=192.7
Q ss_pred CCCccccC--CcEeEEEEEe-CCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 375 TSNKLGQG--GFGPVYKGKL-ANGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 375 ~~~~LG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
+.++||+| +|++||++.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999976 468999999986542 233456778999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985432 234889999999999999999999988 999999999999999999999999876443211110
Q ss_pred -----cccccccccCCccCceeecC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccc
Q 005599 530 -----TNTNRVVGTYGYMSPEYALG--GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 530 -----~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 602 (688)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..... .. .....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~----~~-~~~~~~~ 231 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEK----LN-GTVPCLL 231 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-HHHHH----hc-CCccccc
Confidence 01112356778999999976 458999999999999999999999985322111 00000 00 0000000
Q ss_pred -------------------cccc-----------------cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 603 -------------------DSSM-----------------ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 603 -------------------d~~l-----------------~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+..+ ...........+.+++.+||+.||++|||+.||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 00011223457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=287.06 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=199.8
Q ss_pred HhcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCC----ccc----HHHHHHHHHHHhhc-CCCCccceEEEEEe
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS----GQG----IEEFKNEVLLIAKL-QHRNLVKLLGCCLE 438 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~----~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 438 (688)
..++|...+.||.|..++|-+... .+|+.+|+|++.... ... .++-..|+.+|+++ -||+|+.+.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345677789999999999988864 468899999885432 111 23446799999999 59999999999999
Q ss_pred CCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccc
Q 005599 439 KDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG 518 (688)
Q Consensus 439 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 518 (688)
....++|+|.|+.|.|.++|. ..-.+++++..+|+.|+..|++|||..+ ||||||||+|||+|++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 999999999999999999994 3456899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccccccccccccCCccCceeecC------CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH
Q 005599 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALG------GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWEL 592 (688)
Q Consensus 519 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~ 592 (688)
++..+...+.. ...+|||+|+|||.+.- ..|+..+|+|+.||++|.|+.|.+||--. .++ .+.+.
T Consensus 169 Fa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR----kQm--lMLR~ 239 (411)
T KOG0599|consen 169 FACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR----KQM--LMLRM 239 (411)
T ss_pred eeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH----HHH--HHHHH
Confidence 99988655433 23899999999998842 35888999999999999999999997210 000 01111
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 593 WSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 593 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..+++. + ...+--.+.+....+|+.+||+.||.+|.|.+|++.
T Consensus 240 ImeGky-q-----F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 IMEGKY-Q-----FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHhccc-c-----cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 111111 0 111112244567889999999999999999999884
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.09 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=199.9
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-----cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEE
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-----GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 445 (688)
+|...+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+.++..++|+||+++.+++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999876 78999999886533 23456789999999999999999999999999999999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
+||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998532 35789999999999999999999988 99999999999999999999999999887643
Q ss_pred CccccccccccccCCccCceeecCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGL-FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS 604 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 604 (688)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.... ..............
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~------ 220 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-----GVAAVFKIGRSKEL------ 220 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-----HHHHHHHHHhcccC------
Confidence 32 123356889999999988776 8999999999999999999999985322 11111111110000
Q ss_pred cccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 605 SMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 605 ~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
...+......+.+++.+|++.+|++||++.+++.
T Consensus 221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1112223456889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=299.39 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=200.0
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCC-ceeEEEe
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD-EKMLIYE 447 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e 447 (688)
+|++.+.||+|++|.||+++.. +++.||+|++... .....+.+.+|++++++++|+|++++.+.+...+ ..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999865 5788999998643 2334567889999999999999999999876544 5789999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|+++++|.+++... ....+++.++..++.+++.||++||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999988643 2345899999999999999999999988 9999999999999999999999999998764322
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
. ......+++.|+|||++.+..++.++||||||++++||++|+.|+.... .......... +..
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~~-~~~--------- 219 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRIIE-GKL--------- 219 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHh-cCC---------
Confidence 1 2223568899999999999999999999999999999999999975321 1111111111 110
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
...+......+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11223344578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=302.81 Aligned_cols=261 Identities=24% Similarity=0.344 Sum_probs=201.5
Q ss_pred hHHHHHHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCCccceEEEEEe--
Q 005599 363 LSTVLAATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLE-- 438 (688)
Q Consensus 363 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-- 438 (688)
++.+..+.++|++.+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++..+ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3455667889999999999999999999864 57899999875432 2346788999999999 69999999998853
Q ss_pred ---CCceeEEEeccCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCcee
Q 005599 439 ---KDEKMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRI 514 (688)
Q Consensus 439 ---~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 514 (688)
+...++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 34689999999999999887532 23356789999999999999999999987 999999999999999999999
Q ss_pred cccccceecCCCccccccccccccCCccCceeecC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHH
Q 005599 515 SDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG-----GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYV 589 (688)
Q Consensus 515 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~ 589 (688)
+|||+++.+..... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+...... ...
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-----~~~ 238 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-----RAL 238 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-----HHH
Confidence 99999987643222 1223568999999998853 45788999999999999999999997532210 000
Q ss_pred HHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 590 WELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 590 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.. ........+. .+......+.+|+.+|++.+|++||++.||++.
T Consensus 239 ~~-~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 239 FK-IPRNPPPTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hh-ccccCCCccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00 0000000011 111123468899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.09 Aligned_cols=262 Identities=22% Similarity=0.260 Sum_probs=196.1
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCC----
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD---- 440 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 440 (688)
...++|.+.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999754 58899999986532 233467788999999999999999999986543
Q ss_pred --ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccc
Q 005599 441 --EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG 518 (688)
Q Consensus 441 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 518 (688)
..++||||+++ +|...+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 46899999975 5555552 24788889999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHH-------
Q 005599 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWE------- 591 (688)
Q Consensus 519 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~------- 591 (688)
+++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+..
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPE 240 (355)
T ss_pred ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence 998654321 122357899999999999999999999999999999999999998532210 000000000
Q ss_pred -----------Hhcc-cccccccccc-----c---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 592 -----------LWSD-DKALEIVDSS-----M---ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 592 -----------~~~~-~~~~~~~d~~-----l---~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.... .....+..+. + ....+......+.+|+.+|++.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 0000000000 0 000111234568899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=303.55 Aligned_cols=266 Identities=24% Similarity=0.343 Sum_probs=201.0
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcc-----cHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEE
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQ-----GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 445 (688)
+|.+.+.||+|+||.||+|... +++.||||++...... ....+..|++++.+++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999864 6899999998754322 234577899999999999999999999999999999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
|||+ +++|.+++.... ..+++..+..++.||++||+|||+.+ |+|+||||+|||++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999985432 36899999999999999999999988 99999999999999999999999999987654
Q ss_pred CccccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccc--------
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD-------- 596 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-------- 596 (688)
.... .....+++.|+|||.+.+ ..++.++||||||++++||++|.+++....+ ..............
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc--HHHHHHHHHHcCCCchhhhhhc
Confidence 3211 122356788999998865 4678999999999999999999777643221 11111111111000
Q ss_pred -cccccccccccCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--hcCCC
Q 005599 597 -KALEIVDSSMADSC-----PAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LSNET 647 (688)
Q Consensus 597 -~~~~~~d~~l~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~ 647 (688)
.............. .......+.+++.+|++.+|++|||+.||++. +++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 00011100000111 12235678999999999999999999999985 55543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=306.95 Aligned_cols=262 Identities=24% Similarity=0.373 Sum_probs=198.4
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG--QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
++|++.++||+|+||.||+|... +++.||+|++..... ...+.+.+|++++..++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999875 588999998865322 235678899999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|+++++|..+... ...+++.++..++.||+.||+|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999877632 234899999999999999999999987 9999999999999999999999999998764332
Q ss_pred cccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHH----------HHhccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVW----------ELWSDD 596 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~----------~~~~~~ 596 (688)
. ......++..|+|||++.+ ..++.++||||||+++|||++|++|+..... ......... ..+...
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHHHhCCCchhhHHHhccc
Confidence 1 1223467889999999876 4578899999999999999999988753211 000001000 000000
Q ss_pred cc-cccccccccCC-----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 597 KA-LEIVDSSMADS-----CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 597 ~~-~~~~d~~l~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.. .....+..... .....+..+.+++.+||+.+|++||++.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 00000000000 01123567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=299.51 Aligned_cols=250 Identities=23% Similarity=0.367 Sum_probs=201.9
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+|++.+.||+|+||.||+++.. +++.||+|++... .....+++.+|+.++++++||||+++.+++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999754 6889999998643 233456889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|.+++... ....+++.+++.++.|++.||+|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999888542 2235789999999999999999999987 99999999999999999999999999987643321
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
. .....+++.|+|||++.+..++.++||||||++++||++|+.|+... .....+...... .. .
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~~-~~---------~ 219 (256)
T cd08218 157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMKNLVLKIIRG-SY---------P 219 (256)
T ss_pred h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHHHHHHHHhcC-CC---------C
Confidence 1 12245788999999999999999999999999999999999997432 111111111111 00 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
..+......+.+++.+|++.+|++||+|.+|++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1122335578999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.13 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=204.8
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
++|++.+.||.|+||.||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999854 67899999986432 33567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|.+++........+++.....++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865443356899999999999999999999988 99999999999999999999999999976654322
Q ss_pred cc--ccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 529 ST--NTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 529 ~~--~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
.. ......++..|+|||.+... .++.++||||||++++||++|+.|+...... .......... .+.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~~------~~~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-----KVLMLTLQND------PPS 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-----hhHHHHhcCC------CCC
Confidence 21 22335688999999998877 7899999999999999999999998532211 1111111110 011
Q ss_pred ccCCC-CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 606 MADSC-PAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 606 l~~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+.... ....+..+.+++.+|++.+|++||++.+|++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11100 1123456889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=314.70 Aligned_cols=260 Identities=23% Similarity=0.288 Sum_probs=195.5
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeC------
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK------ 439 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 439 (688)
..++|.+.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999854 5889999998653 233456788999999999999999999987643
Q ss_pred CceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccc
Q 005599 440 DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGT 519 (688)
Q Consensus 440 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 519 (688)
...++||||+++ +|...+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 346999999975 5666552 23788899999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhc-----
Q 005599 520 ARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWS----- 594 (688)
Q Consensus 520 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~----- 594 (688)
++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQWNKVIEQLGTPCPE 247 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHH
Confidence 98654322 12235789999999999999999999999999999999999999854321 000000000000
Q ss_pred --------------c-cccc-----ccccccc---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 595 --------------D-DKAL-----EIVDSSM---ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 595 --------------~-~~~~-----~~~d~~l---~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
. .... .+....+ ....+......+.+|+.+|++.||.+|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0000 0000000 000111123568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=307.42 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=200.8
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG---QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|.+.+.||+|+||.||++... +++.+|+|.+..... ...+.+..|++++..++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999876 489999999865432 24567889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+.+++|.+++... ....+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988532 2356899999999999999999999987 999999999999999999999999998754321
Q ss_pred ccc---------------------------cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 005599 527 EIS---------------------------TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFN 579 (688)
Q Consensus 527 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~ 579 (688)
... .......||..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 11123468899999999999889999999999999999999999985322
Q ss_pred CCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCC----HHHHHH
Q 005599 580 DDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPS----MSTVVF 641 (688)
Q Consensus 580 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt----~~evl~ 641 (688)
.. ..... +++...........+..+.+++.+|++.+|++||+ +.+++.
T Consensus 237 ~~-----~~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD-----ETFSN---------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH-----HHHHH---------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 10111 11111111111114567999999999999999999 777665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=306.85 Aligned_cols=261 Identities=22% Similarity=0.346 Sum_probs=197.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++..++||||+++++++......++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888899999999999999865 57899999986442 33345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
++ ++|..++... ...+++.....++.||++||+|||+.+ |+|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5888887543 335789999999999999999999987 99999999999999999999999999976432221
Q ss_pred ccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccc---ccccccc-
Q 005599 529 STNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD---KALEIVD- 603 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d- 603 (688)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||..... .............. ....+++
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV--EEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCChhhchhhhcc
Confidence 11224568899999988654 578899999999999999999999853221 11111111111100 0000000
Q ss_pred --------ccccCCC----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 604 --------SSMADSC----PAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 604 --------~~l~~~~----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+.....+ .......+.+|+.+|++.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 1112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.08 Aligned_cols=195 Identities=28% Similarity=0.458 Sum_probs=158.8
Q ss_pred CccccCCcEeEEEEEeC---CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEe--CCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLA---NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLE--KDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~ 451 (688)
.+||+|+||.||+|+.. ++..||+|.+.... ....+.+|+.++.+++||||+++++++.. ....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 68999999999999865 35689999886542 23467899999999999999999999864 4567899999875
Q ss_pred CChhhHhhcc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEE----CCCCCceecccccce
Q 005599 452 KSLDYFIFDE------SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL----DEEMNPRISDFGTAR 521 (688)
Q Consensus 452 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFGla~ 521 (688)
+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 666665321 12235788999999999999999999988 9999999999999 566789999999998
Q ss_pred ecCCCccc-cccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCC
Q 005599 522 VFGGEEIS-TNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGI 577 (688)
Q Consensus 522 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~ 577 (688)
........ .......+|+.|+|||++.+. .++.++|||||||++|||+||++||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 76543221 122335789999999998764 589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=297.76 Aligned_cols=255 Identities=22% Similarity=0.353 Sum_probs=198.0
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc----------ccHHHHHHHHHHHhhcCCCCccceEEEEEeCC
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG----------QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD 440 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 440 (688)
+|.+.+.||+|+||.||+|... +++.||||.+..... ...+.+..|+.++..++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999754 688999998753211 11346788999999999999999999999999
Q ss_pred ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccc
Q 005599 441 EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA 520 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 520 (688)
..++|+||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 45889999999999999999999987 999999999999999999999999999
Q ss_pred eecCCCccccccccccccCCccCceeecCCC--CCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccc
Q 005599 521 RVFGGEEISTNTNRVVGTYGYMSPEYALGGL--FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKA 598 (688)
Q Consensus 521 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 598 (688)
+...............++..|+|||.+.... ++.++||||||++++||++|..|+.... ........... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~-~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE-----AIAAMFKLGNK-RS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc-----hHHHHHHhhcc-cc
Confidence 7654322222223356889999999987654 8899999999999999999999974211 11111111111 11
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 599 LEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 599 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
...+..... ...+..+.+++.+|++.+|++||++.+|++.
T Consensus 230 ~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPPDVS----MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCcccc----ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111111 1234578899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=299.78 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=196.3
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-----cccHHHHHHHHHHHhhcCCCCccceEEEEEeC--Cce
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-----GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEK 442 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 442 (688)
++|++.++||+|+||.||+|... ++..||||.+.... ....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999864 58899999875321 12345788999999999999999999998764 357
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
++|+||+++++|.+++... ..+++....+++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 7999999999999988532 34788889999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccc-cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccc
Q 005599 523 FGGEEIS-TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 523 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 601 (688)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~-~~~~~~~------ 224 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAA-IFKIATQ------ 224 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHH-HHHHhcC------
Confidence 5432111 122235688899999999988899999999999999999999999853211 111 1111100
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 602 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
......+......+.+++.+|+. +|++||++.||++
T Consensus 225 ---~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 ---PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 01122344555678888999985 8999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=297.85 Aligned_cols=252 Identities=27% Similarity=0.369 Sum_probs=206.3
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
++|++.+.||+|++|.||+|+.. +++.||||++..... .....+.+|+..+.+++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888899999999999999876 489999999876543 4467899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
+++++|.+++... ..++...++.++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998543 568999999999999999999999 87 9999999999999999999999999998765433
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ............. .. +
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~-~~-----~--- 221 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDG-PP-----P--- 221 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcC-CC-----C---
Confidence 221 235678899999999999999999999999999999999999854332 1111111111111 00 1
Q ss_pred CCCCHH-HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 608 DSCPAP-EALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 608 ~~~~~~-~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
..+.. .+..+.+++.+|++.+|++||++.++++.
T Consensus 222 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 -SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11122 44579999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=334.88 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=197.0
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeC--Ccee
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEKM 443 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 443 (688)
..++|.+.++||+|+||+||++... .+..||+|.+... .......|..|+.++..|+|||||++++++... ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3467899999999999999999865 4678899988643 233456789999999999999999999988654 4588
Q ss_pred EEEeccCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCC----CCeEecCCCCCceEECC----------
Q 005599 444 LIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSR----LRIIHRDLKASNILLDE---------- 508 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~iiH~Dlkp~NILl~~---------- 508 (688)
|||||+++|+|..+|... .....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999998642 223468999999999999999999998542 34999999999999964
Q ss_pred -------CCCceecccccceecCCCccccccccccccCCccCceeecC--CCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 005599 509 -------EMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG--GLFSTKSDVFSFGVLLLEIITGKKNTGIFN 579 (688)
Q Consensus 509 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGvll~elltG~~p~~~~~ 579 (688)
...+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 23489999999986643221 223578999999999864 458999999999999999999999985322
Q ss_pred CCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 580 DDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 580 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.....+... .... .+. ....+..+.+|+..||+.+|.+||++.+++.
T Consensus 248 ----~~~qli~~l-k~~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 ----NFSQLISEL-KRGP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred ----cHHHHHHHH-hcCC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 111111111 1110 010 0112356889999999999999999999983
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=298.28 Aligned_cols=254 Identities=23% Similarity=0.357 Sum_probs=200.8
Q ss_pred CCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeC--CceeEEE
Q 005599 372 NFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEKMLIY 446 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 446 (688)
+|++.+.||.|+||.||++.. .+++.+|+|.+... .....+.+.+|+++++.++|+||+++++++... ...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477789999999999999975 46789999998643 233456788999999999999999999987653 4578999
Q ss_pred eccCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 447 EFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDS--RLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 447 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
||+++++|.+++... .....+++...+.++.||+.||+|||..+ ..+|+|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998543 22456899999999999999999999332 234999999999999999999999999999876
Q ss_pred CCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 524 GGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 524 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
...... .....+++.|+|||.+.+..++.++||||||+++++|++|+.|+.... ...+.. ......
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~----~~~~~~------ 226 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLAS----KIKEGK------ 226 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHH----HHhcCC------
Confidence 543321 223568899999999999889999999999999999999999985432 111111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
....+...+..+.+++.+|++.+|++||++.+|+++
T Consensus 227 ---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111233445678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=313.79 Aligned_cols=257 Identities=25% Similarity=0.346 Sum_probs=193.7
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeC-----
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK----- 439 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----- 439 (688)
...++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++..++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999985 467899999986532 22345678899999999999999999987643
Q ss_pred -CceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccc
Q 005599 440 -DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG 518 (688)
Q Consensus 440 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 518 (688)
...++++|++ +++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 778887763 245899999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCccccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcc--
Q 005599 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSD-- 595 (688)
Q Consensus 519 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~-- 595 (688)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .............
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~ 236 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY--IDQLKRIMEVVGTPS 236 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCCC
Confidence 99865432 223568999999999877 5689999999999999999999999853211 1111111110000
Q ss_pred ---------ccccccccccccCCCCH--------HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 596 ---------DKALEIVDSSMADSCPA--------PEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 596 ---------~~~~~~~d~~l~~~~~~--------~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
......+. .+. ..+. .....+.+|+.+|++.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 237 PEVLKKISSEHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHHhcchhhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 000 0000 11234789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=300.64 Aligned_cols=263 Identities=26% Similarity=0.363 Sum_probs=203.1
Q ss_pred eehHHHHHHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCCccceEEEEEe
Q 005599 361 FELSTVLAATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLE 438 (688)
Q Consensus 361 ~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 438 (688)
+++.++..++++|.+.+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344555567889999999999999999999864 68899999986432 2346778899999999 79999999999876
Q ss_pred CC-----ceeEEEeccCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCc
Q 005599 439 KD-----EKMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP 512 (688)
Q Consensus 439 ~~-----~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 512 (688)
.+ ..++|+||+++++|.+++... .....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 579999999999999987542 23346889999999999999999999987 9999999999999999999
Q ss_pred eecccccceecCCCccccccccccccCCccCceeecCC-----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHH
Q 005599 513 RISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG-----LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIR 587 (688)
Q Consensus 513 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~ 587 (688)
||+|||++......... .....++..|+|||.+... .++.++|||||||++|||++|+.|+..... ..
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-----~~ 240 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-----VK 240 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-----HH
Confidence 99999998865432221 1235678899999988643 368899999999999999999999753211 11
Q ss_pred HHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 588 YVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 588 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.+.... ......+. .+......+.+++.+|++.+|++||++.|+++.
T Consensus 241 ~~~~~~-~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 TLFKIP-RNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHHh-cCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111111 11111111 122233468999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.07 Aligned_cols=247 Identities=24% Similarity=0.412 Sum_probs=199.2
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
-|.+.+.||+|+||.||+|... ++..||||.+.... ......+.+|+.++.+++||||+++++++.++...++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667789999999999999864 67899999876432 234567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|..++. ...+++.....++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999998884 235789999999999999999999987 99999999999999999999999999876643221
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
......++..|+|||.+.+..++.++||||||++++||++|..|+..... ...... ..... .+.
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~~~~-----~~~---- 220 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFL-IPKNN-----PPT---- 220 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHH-HhcCC-----CCC----
Confidence 12234678899999999988899999999999999999999999743211 111111 11110 011
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.+...+..+.+++.+|++.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 112234568899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=324.32 Aligned_cols=262 Identities=20% Similarity=0.250 Sum_probs=191.3
Q ss_pred HHHHHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCC------CccceEEEEE
Q 005599 365 TVLAATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHR------NLVKLLGCCL 437 (688)
Q Consensus 365 ~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~g~~~ 437 (688)
++...+++|.+.++||+|+||+||+|... .++.||||+++... ....++..|+.++..++|. +++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34456788999999999999999999864 57889999986432 2334566788887777654 5888989887
Q ss_pred eC-CceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCceEECCCC-----
Q 005599 438 EK-DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEEM----- 510 (688)
Q Consensus 438 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~----- 510 (688)
.. .+.++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||+. + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 65 4688999987 6677777743 24589999999999999999999974 6 99999999999998765
Q ss_pred -----------CceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 005599 511 -----------NPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFN 579 (688)
Q Consensus 511 -----------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~ 579 (688)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998754221 2234689999999999999999999999999999999999999986432
Q ss_pred CCCccHHHHHHHHhc-----------cccccccccc------cc--------cCCC---CHHHHHHHHHHHhhcccCCCC
Q 005599 580 DDSSNLIRYVWELWS-----------DDKALEIVDS------SM--------ADSC---PAPEALRCIQVGLLCVQDRTT 631 (688)
Q Consensus 580 ~~~~~l~~~~~~~~~-----------~~~~~~~~d~------~l--------~~~~---~~~~~~~~~~l~~~Cl~~~P~ 631 (688)
. ......+..... .....++++. .. .... .......+++|+.+||+.||+
T Consensus 350 ~--~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 350 N--LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred h--HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 1 111111111000 0000000000 00 0000 001234678999999999999
Q ss_pred CCCCHHHHHH
Q 005599 632 DRPSMSTVVF 641 (688)
Q Consensus 632 ~RPt~~evl~ 641 (688)
+|||+.|+++
T Consensus 428 ~R~ta~e~L~ 437 (467)
T PTZ00284 428 KRLNARQMTT 437 (467)
T ss_pred hCCCHHHHhc
Confidence 9999999996
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.57 Aligned_cols=245 Identities=22% Similarity=0.329 Sum_probs=197.2
Q ss_pred CCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCCh
Q 005599 376 SNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL 454 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 454 (688)
...||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999864 6889999998665555567789999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccccccc
Q 005599 455 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR 534 (688)
Q Consensus 455 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 534 (688)
..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 106 ~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~ 176 (297)
T cd06659 106 TDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKS 176 (297)
T ss_pred HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccc
Confidence 887732 45789999999999999999999988 99999999999999999999999999875543221 1223
Q ss_pred ccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHH
Q 005599 535 VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPE 614 (688)
Q Consensus 535 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 614 (688)
..++..|+|||++.+..++.++||||||++++||++|+.||..... . ...... ...... ... .....
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~---~~~~~~-~~~~~~-----~~~--~~~~~ 243 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--V---QAMKRL-RDSPPP-----KLK--NAHKI 243 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H---HHHHHH-hccCCC-----Ccc--ccCCC
Confidence 5688999999999988999999999999999999999999853211 1 111111 111000 000 01112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 615 ALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 615 ~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
...+.+++.+|++.+|++||++.+|++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 3468899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.20 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=198.4
Q ss_pred CCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCC
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
|.....||+|+||.||++... ++..||||++........+.+.+|+.++..++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 334467999999999999864 5889999998665555567789999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
++|.+++.. ..+++.+...++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++....... ..
T Consensus 104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~ 174 (292)
T cd06658 104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PK 174 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--cc
Confidence 999998732 34789999999999999999999987 9999999999999999999999999987654322 11
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ......+.. .+.+.+.. .
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~---------~~~~~~~~--~ 241 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAMRRIRD---------NLPPRVKD--S 241 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHh---------cCCCcccc--c
Confidence 2235688999999999988999999999999999999999999753211 111111110 11111111 1
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 612 APEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
......+.+++.+|++.+|++|||+.++++.
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1233467889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.49 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=199.9
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+|+..+.||+|+||.||++... +++.+|||.+... .....+.+.+|+.+++.++||||+++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4777899999999999999764 6889999998654 233466789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC-CceecccccceecCCCc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM-NPRISDFGTARVFGGEE 527 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 527 (688)
+++++|.+++.... ...+++..+..++.+++.+|.|||+.+ |+|+||||+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999985432 345789999999999999999999987 99999999999998654 58999999998765332
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
. .....++..|+|||.+.+..++.++||||||+++++|++|+.|+..... ...+...... . .
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~-~---------~ 218 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKIMSG-T---------F 218 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHHHhc-C---------C
Confidence 1 1225678899999999988899999999999999999999999753221 1111111111 0 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
...+......+.+++.+||+.+|++|||+.|++..
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01122234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=298.34 Aligned_cols=260 Identities=25% Similarity=0.306 Sum_probs=200.9
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCCccceEEEEEeCC--ceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD--EKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 446 (688)
++|...+.||.|++|.||++... +++.+|+|.+..... ....++.+|+++++.++||||+++++++.+.. ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777899999999999999874 578899999865432 34567899999999999999999999987543 689999
Q ss_pred eccCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 447 EFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 447 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
||+++++|.+++... .....+++.....++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887532 23455788999999999999999999988 99999999999999999999999999875432
Q ss_pred CccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...........+...... ......+.+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~- 231 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELKDE- 231 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhhccC-
Confidence 21 11245788999999999999999999999999999999999998654321111111111111 1011111111
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.. ........+.+++.+||+.+|++|||+.||++
T Consensus 232 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00 00123467899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.95 Aligned_cols=266 Identities=22% Similarity=0.335 Sum_probs=196.8
Q ss_pred CCCCCCccccCCcEeEEEEEeC---CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeC--Ccee
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA---NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEKM 443 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 443 (688)
+|.+.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999865 47899999987632 33456788999999999999999999999988 7899
Q ss_pred EEEeccCCCChhhHhhccC-C-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECC----CCCceeccc
Q 005599 444 LIYEFMPNKSLDYFIFDES-R-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE----EMNPRISDF 517 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~-~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~DF 517 (688)
+||||+++ +|..++.... . ...++......++.||+.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 5655553222 2 236888999999999999999999988 999999999999999 999999999
Q ss_pred ccceecCCCcc-ccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcc-------HHHH
Q 005599 518 GTARVFGGEEI-STNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSN-------LIRY 588 (688)
Q Consensus 518 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~-------l~~~ 588 (688)
|++........ ........+++.|+|||.+.+. .++.++||||||++++||++|++||......... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1222335678999999988764 5889999999999999999999998654332200 0000
Q ss_pred HHHHhccc------------cccccccccccCCCC---------H--HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 589 VWELWSDD------------KALEIVDSSMADSCP---------A--PEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 589 ~~~~~~~~------------~~~~~~d~~l~~~~~---------~--~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+...+... ......+.......+ . .....+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00111000 000000000000011 0 23356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=302.14 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=200.0
Q ss_pred ehHHHHHHhcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCCccceEEEEEe-
Q 005599 362 ELSTVLAATDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLE- 438 (688)
Q Consensus 362 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 438 (688)
++.++....+.|++.+.||.|+||.||+|.. .+++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3445556678899999999999999999986 457899999885443 3346788999999998 69999999999863
Q ss_pred -----CCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCce
Q 005599 439 -----KDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPR 513 (688)
Q Consensus 439 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 513 (688)
....+++|||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 356799999999999999885432 345788888999999999999999987 99999999999999999999
Q ss_pred ecccccceecCCCccccccccccccCCccCceeec-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHH
Q 005599 514 ISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL-----GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRY 588 (688)
Q Consensus 514 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~ 588 (688)
|+|||++....... .......|++.|+|||.+. ...++.++||||||+++|||++|+.||....... .
T Consensus 162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-~---- 234 (282)
T cd06636 162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-A---- 234 (282)
T ss_pred EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-h----
Confidence 99999987553221 1122356889999999886 3468889999999999999999999984322110 0
Q ss_pred HHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 589 VWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 589 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
...... .....+ .....+..+.+++.+||+.+|.+||++.|+++
T Consensus 235 ~~~~~~------~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 LFLIPR------NPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hhhHhh------CCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000 000111 11123457899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.19 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=202.5
Q ss_pred cCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
++|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++..++||||+++.+++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6788899999999999999975 467899999986555555678899999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 99999999843 34789999999999999999999988 99999999999999999999999999876543322
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||........ +......+ .....
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-----~~~~~~~~--------~~~~~ 236 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIATNG--------TPELQ 236 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-----eeehhcCC--------CCCCC
Confidence 12234688899999999888899999999999999999999999854221110 00000000 00011
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.+......+.+++.+||+.+|++||++.+++.+
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122234568899999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.51 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=192.7
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHH-HhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLL-IAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
++|++.+.||+|+||.||+++.. +|+.||+|++.... .....++..|+.. ++.++||||+++++++......++|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999865 58999999986542 2233455666665 566689999999999999999999999
Q ss_pred ccCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 448 FMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 448 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
|++ |+|..++... .....+++.....++.||+.||+|||++ + ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6887777542 2345689999999999999999999986 5 99999999999999999999999999986543
Q ss_pred CccccccccccccCCccCceeecC----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALG----GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 601 (688)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+....... .........
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~------ 223 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF----QQLKQVVEE------ 223 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH----HHHHHHHhc------
Confidence 21 1122467889999998865 456889999999999999999999985322111 111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 602 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..+.+. ....+..+.+++.+||+.+|++||++.+|++
T Consensus 224 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001110 1112456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.59 Aligned_cols=252 Identities=26% Similarity=0.465 Sum_probs=200.6
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG--QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999864 688999999876544 3567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999998542 35788999999999999999999988 99999999999999999999999999987654332
Q ss_pred ccc--cccccccCCccCceeecCCC---CCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 529 STN--TNRVVGTYGYMSPEYALGGL---FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 529 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
... .....++..|+|||++.+.. .+.++||||||++++||++|+.||....... ........ .. .
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~----~~~~~~~~-~~-----~ 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF----QIMFHVGA-GH-----K 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH----HHHHHHhc-CC-----C
Confidence 211 12356788999999998766 8899999999999999999999985432111 11111110 00 0
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+.+.. .......+.+++.+|++.+|++||++.+++.
T Consensus 225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11110 0112456789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=302.30 Aligned_cols=262 Identities=21% Similarity=0.344 Sum_probs=200.9
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36788899999999999999875 5789999988653 23345788999999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|++++.+..++.. ...+++.....++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777665532 234789999999999999999999988 9999999999999999999999999998765443
Q ss_pred cccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHh-----------c-
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELW-----------S- 594 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~-----------~- 594 (688)
.. ......++..|+|||++.+. .++.++||||||+++|||++|+.|+...... ..+.. ....+ .
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLYL-IQKCLGPLPPSHQELFSS 231 (288)
T ss_pred cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHHHhCCCCHHHhhhccc
Confidence 21 22235678899999999888 8899999999999999999999988532211 00100 00000 0
Q ss_pred ccccc--ccccc---c-ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 595 DDKAL--EIVDS---S-MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 595 ~~~~~--~~~d~---~-l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..... .+.+. . +....+...+..+.+++.+||+.+|++||++++|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 00000 0 001112223677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=298.98 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=200.6
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999864 68899999986543 33456899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+ +++|.+++.... ..+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999885433 56899999999999999999999987 99999999999999999999999999987654321
Q ss_pred ccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccc-----------
Q 005599 529 STNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD----------- 596 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~----------- 596 (688)
.......++..|+|||.+.+. .++.++||||+|++++||++|.+++....+ ..............
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhhccCc
Confidence 112235688999999998654 468999999999999999999777643221 11111111111100
Q ss_pred -ccccccccccc----CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 597 -KALEIVDSSMA----DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 597 -~~~~~~d~~l~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
....+..+... ..........+.+++.+|++.+|++||++++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00011234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=303.44 Aligned_cols=261 Identities=21% Similarity=0.328 Sum_probs=195.1
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+|++.+.||+|+||.||+|+.. +|+.+|+|++.... ......+.+|+.++.+++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777899999999999999865 68899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
++ ++|..++... ...+++.....++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 5777776432 245899999999999999999999988 99999999999999999999999999986543221
Q ss_pred ccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccc------cccc
Q 005599 529 STNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK------ALEI 601 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~------~~~~ 601 (688)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.|+....+.. .............. ...+
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHHHHHHHhCCCChHHhHHhhhc
Confidence 11224578899999998765 47899999999999999999998863322211 11111111110000 0000
Q ss_pred cccc----cc-----CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 602 VDSS----MA-----DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 602 ~d~~----l~-----~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.+.. .. ..........+.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 00 0011123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.68 Aligned_cols=264 Identities=23% Similarity=0.337 Sum_probs=196.1
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++..++|+||+++.+++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578889999999999999999754 688999999865432 33446789999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||++ ++|..++... ...+.+.....++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 6776666432 234778888899999999999999987 999999999999999999999999999764322
Q ss_pred ccccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccc---------
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD--------- 596 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--------- 596 (688)
.. ......+++.|+|||++.+. .++.++||||||+++|||++|+.||....+....+.. .+......
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK-IWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH-HHHHcCCCChhhhhhhh
Confidence 11 11224568899999998764 5788999999999999999999998643321111111 11110000
Q ss_pred ---c-ccccccccccCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 597 ---K-ALEIVDSSMADSC-----PAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 597 ---~-~~~~~d~~l~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
. ..+.......... .......+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 0000000000000 0012356789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=306.03 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=205.7
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccC--CCcccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCceeEE
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLST--TSGQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 445 (688)
....|+++++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+..|.+|+ |.+||+|++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3456888999999999999999998889999998753 46677889999999999995 99999999999999999999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
||| ..-+|..+|..... ...+| .+..+..||+.++.++|.++ |||.||||.|+|+-+ |.+||+|||+|..+..
T Consensus 439 mE~-Gd~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MEC-GDIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eec-ccccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 997 57789888854432 33445 66779999999999999998 999999999999875 5899999999999988
Q ss_pred CccccccccccccCCccCceeecCC-----------CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGG-----------LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWS 594 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 594 (688)
+.........+||+.||+||.+... +.+.++||||+|||||+|+.|++||+.+. + .+.
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----n--~~a----- 580 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----N--QIA----- 580 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH----H--HHH-----
Confidence 8877777789999999999998542 25679999999999999999999985321 0 111
Q ss_pred cccccccccccccCCCCH-HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 595 DDKALEIVDSSMADSCPA-PEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 595 ~~~~~~~~d~~l~~~~~~-~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
++..+.|+...-++|. ....++++|+..||+.||++||+.-|+++
T Consensus 581 --Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 --KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2234455543322222 11223999999999999999999999986
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=297.86 Aligned_cols=247 Identities=24% Similarity=0.413 Sum_probs=198.3
Q ss_pred CCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcC---CCCccceEEEEEeCCceeEEE
Q 005599 372 NFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQ---HRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 446 (688)
.|++.+.||+|+||.||+|.. .+++.||+|.+... .....+++.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467789999999999999986 46889999998654 3345677889999999997 999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++++|.+++.. ..+++...+.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998743 26889999999999999999999988 999999999999999999999999999876543
Q ss_pred ccccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
.. ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.|+..... ...... ... ...+.
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~-~~~-----~~~~~ 221 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMML-IPK-----SKPPR 221 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhc-ccc-----CCCCC
Confidence 31 12235688899999988754 578999999999999999999999853211 111100 000 01111
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+... .....+.+++.+|++.+|++||++.++++
T Consensus 222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111 13456889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=296.83 Aligned_cols=253 Identities=26% Similarity=0.465 Sum_probs=201.0
Q ss_pred CCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCc------ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 372 NFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSG------QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
+|+..+.||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999985 5688999999864321 134678999999999999999999999999999999
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC-Cceecccccceec
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM-NPRISDFGTARVF 523 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla~~~ 523 (688)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999853 235789999999999999999999988 99999999999998776 5999999999776
Q ss_pred CCCccc--cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccc
Q 005599 524 GGEEIS--TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 524 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 601 (688)
...... .......++..|+|||.+.+..++.++||||+|+++++|++|+.|+..... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~------- 225 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH--SNHLALIFKIAS------- 225 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--cchHHHHHHHhc-------
Confidence 543211 112235678899999999888899999999999999999999999853221 111111111100
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 602 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.......+......+.+++.+|++.+|++||++.++++
T Consensus 226 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 --ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00111233344567889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=311.10 Aligned_cols=194 Identities=25% Similarity=0.405 Sum_probs=167.7
Q ss_pred CCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-C-----CCccceEEEEEeCCceeE
Q 005599 372 NFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-H-----RNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 444 (688)
+|++.+.||+|+||.|-++. ..+++.||||+++... .-..+-..|+.+|..|+ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78999999999999999997 4569999999997543 33456678999999997 4 389999999999999999
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC--Cceeccccccee
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM--NPRISDFGTARV 522 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~--~~kl~DFGla~~ 522 (688)
|+|.+ .-+|.++|.... ...++......|+.||+.||..||+.+ |||+||||+||||.+.. .+||+|||.+..
T Consensus 266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99988 578999986543 445899999999999999999999988 99999999999997543 699999999987
Q ss_pred cCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 005599 523 FGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTG 576 (688)
Q Consensus 523 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~ 576 (688)
....-+ ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 654332 3556778999999999999999999999999999999977664
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.92 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=195.6
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
++|++.+.||+|++|.||+|... +++.||||.+..... .....+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999865 688999999865422 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++ +|.+++... ...+++.....++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 984 898887543 236789999999999999999999987 99999999999999999999999999875432211
Q ss_pred ccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccc--------
Q 005599 529 STNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL-------- 599 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~-------- 599 (688)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..........+......
T Consensus 159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-EDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHHHHHHHhcCCCChhhhhhhhhc
Confidence 1 112346788999998875 45899999999999999999999998533211 11111111111100000
Q ss_pred -ccc--------cccccCCC-CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 600 -EIV--------DSSMADSC-PAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 600 -~~~--------d~~l~~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+.. ...+.... .......+.+++.+|++.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 00000000 0011256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.50 Aligned_cols=240 Identities=21% Similarity=0.240 Sum_probs=184.6
Q ss_pred cccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhc---CCCCccceEEEEEeCCceeEEEeccCC
Q 005599 379 LGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKL---QHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 379 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
||+|+||+||+|+.. +++.||||++.... ......+..|..++..+ +||||+++.+.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 58999999985432 12233455666676655 699999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
|+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999888843 345889999999999999999999988 9999999999999999999999999987543222 12
Q ss_pred cccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCC
Q 005599 532 TNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSC 610 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 610 (688)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....... ...+. ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----~~~~~~~-i~~~~------~~~~~-- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----TQQMYRN-IAFGK------VRFPK-- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----HHHHHHH-HHcCC------CCCCC--
Confidence 2346799999999998765 48999999999999999999999984321 1111111 11111 01110
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCC----HHHHHH
Q 005599 611 PAPEALRCIQVGLLCVQDRTTDRPS----MSTVVF 641 (688)
Q Consensus 611 ~~~~~~~~~~l~~~Cl~~~P~~RPt----~~evl~ 641 (688)
......+.+++.+||+.+|++||+ +.++++
T Consensus 219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 112346789999999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.10 Aligned_cols=257 Identities=18% Similarity=0.221 Sum_probs=200.9
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|.+.+.||+|+||.||++... .++.||+|.+.... ....+.+.+|+.++..++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999865 47899999886543 233457889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++++|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999998443 45889999999999999999999987 999999999999999999999999998742111
Q ss_pred cc-------------ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHh
Q 005599 527 EI-------------STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELW 593 (688)
Q Consensus 527 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~ 593 (688)
.. ........++..|+|||.+.+..++.++|+||||+++|||++|+.||... ... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--~~~---~~~~~~~ 229 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--TPE---ELFGQVI 229 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHH---HHHHHHH
Confidence 00 00111245788999999999889999999999999999999999997421 111 1111111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 594 SDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 594 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
.. . ...+.... ..+..+.+++.+|++.+|++||++.++.+.|+..
T Consensus 230 ~~-~---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 230 SD-D---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred hc-c---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 11 0 01111111 2234688999999999999999988787777663
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.30 Aligned_cols=261 Identities=25% Similarity=0.371 Sum_probs=195.8
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+|++.+.||.|++|.||+|+.. +++.||||++.... ......+.+|++++.+++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999865 68899999886432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+. ++|..++.... ...+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 68888875432 346899999999999999999999987 99999999999999999999999999876543221
Q ss_pred ccccccccccCCccCceeecCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccc----------
Q 005599 529 STNTNRVVGTYGYMSPEYALGGL-FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK---------- 597 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~---------- 597 (688)
......+++.|+|||.+.+.. ++.++||||||+++|||+||+.||....+. ..+.......-....
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHH
Confidence 112245688999999887654 688999999999999999999998532211 111111110000000
Q ss_pred -----ccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 598 -----ALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 598 -----~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
........+. .........+.+++.+|++.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 001112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=297.90 Aligned_cols=254 Identities=25% Similarity=0.408 Sum_probs=200.0
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCC------
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKD------ 440 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~------ 440 (688)
++++|++.+.||+|++|.||+|... +++.+++|.+..... ..+.|.+|+.++.++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5688999999999999999999875 578899998865433 456789999999999 6999999999997655
Q ss_pred ceeEEEeccCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccc
Q 005599 441 EKMLIYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGT 519 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 519 (688)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 3899999999999999885432 2456899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCccccccccccccCCccCceeecC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhc
Q 005599 520 ARVFGGEEISTNTNRVVGTYGYMSPEYALG-----GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWS 594 (688)
Q Consensus 520 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 594 (688)
+....... .......++..|+|||.+.. ..++.++||||||++++||++|+.||..... . .......
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~---~~~~~~~- 231 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--M---RALFKIP- 231 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--H---HHHHHhh-
Confidence 87654322 12223568899999998754 3477899999999999999999999853211 0 1111110
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 595 DDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 595 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
... .+.+ ..+......+.+++.+||..||++|||+.+|++
T Consensus 232 ~~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 100 0111 112234567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=299.00 Aligned_cols=259 Identities=23% Similarity=0.343 Sum_probs=212.5
Q ss_pred cCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
.-|.+.+.||+|.|..|-+|++ -.|..||||++.+.. ......+.+|++.|+.++|||||+|+.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3466678999999999999974 479999999997653 3345678899999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEE-CCCCCceecccccceecCCC
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL-DEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DFGla~~~~~~ 526 (688)
.=.+|+|.+|+.... ..+.+....+++.||..|+.|+|..+ +|||||||+||.+ .+-|-+||.|||++-.+...
T Consensus 98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999996543 45888889999999999999999988 9999999999876 56788999999999766543
Q ss_pred ccccccccccccCCccCceeecCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFS-TKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
. ..++.+|...|-|||++.+..|. +++||||||||||.|++|++||+..++.+ .+.-++|-.
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--------------TLTmImDCK 235 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--------------TLTMIMDCK 235 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh--------------hhhhhhccc
Confidence 3 33458999999999999999885 57899999999999999999997554432 122334433
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhcCCCCCCCCC
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNETSVPSPK 653 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~~~~~p~ 653 (688)
. ..|...+.++.+||..||+.||.+|.+.+||+. -|+....-++.+
T Consensus 236 Y--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~ 283 (864)
T KOG4717|consen 236 Y--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTA 283 (864)
T ss_pred c--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcccc
Confidence 2 356777889999999999999999999999985 344443333333
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.17 Aligned_cols=247 Identities=27% Similarity=0.350 Sum_probs=205.7
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
..+.|..-++||+|+||.||-.+.. +|+.+|.|++.+. ..++..-.++|-++|.+++.+.||.+-..++..+.++|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3466888899999999999999754 6899999988553 23445567899999999999999999999999999999
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
|+..|.+|+|..+|.+... ..++++..+-++.+|+.||++||... ||.|||||+|||||+.|+++|+|.|||..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999977654 56899999999999999999999987 9999999999999999999999999999876
Q ss_pred CCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccc
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS 604 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 604 (688)
..+.... .+||.+|||||++.++.|+...|.|||||+||||+-|+.||....+.. ..+-+|.
T Consensus 339 ~g~~~~~---rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---------------k~eEvdr 400 (591)
T KOG0986|consen 339 EGKPIRG---RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---------------KREEVDR 400 (591)
T ss_pred CCCcccc---ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---------------hHHHHHH
Confidence 5543322 489999999999999999999999999999999999999985432211 1111222
Q ss_pred cc---cCCCCHHHHHHHHHHHhhcccCCCCCCCCHH
Q 005599 605 SM---ADSCPAPEALRCIQVGLLCVQDRTTDRPSMS 637 (688)
Q Consensus 605 ~l---~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~ 637 (688)
++ ...++...++++.+|....|++||++|..-.
T Consensus 401 r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 401 RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 22 1235666777888999999999999997543
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=291.61 Aligned_cols=251 Identities=26% Similarity=0.434 Sum_probs=205.8
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCCccceEEEEEeC--CceeEEE
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG--QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEKMLIY 446 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 446 (688)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999876 688999999865542 4567899999999999999999999999988 8899999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999985432 6899999999999999999999987 999999999999999999999999999877654
Q ss_pred ccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
..........++..|+|||.+.+...+.++||||||+++++|++|+.|+.... ........... ...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~---------~~~ 221 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKIGS---------SGE 221 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhccc---------cCC
Confidence 33212233568889999999998889999999999999999999999986433 11111221111 111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
....+......+.+++.+|++.+|++||++.+++.
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11223333567999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.94 Aligned_cols=242 Identities=28% Similarity=0.452 Sum_probs=196.5
Q ss_pred CCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCcc---cHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 373 FSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQ---GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
|.-++.||.|+||.||.|+. .+.+.||||++.-...+ .+.++..|+..|.+++|||+|.+.|++......+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 45568899999999999985 46788999999765544 356788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
|- |+-.+++. ..++++-..++..|..+.+.||+|||+.+ .||||||+.||||++.|.+||+|||.|....
T Consensus 108 Cl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---- 177 (948)
T KOG0577|consen 108 CL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA---- 177 (948)
T ss_pred Hh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC----
Confidence 95 45555552 23467888999999999999999999998 9999999999999999999999999987653
Q ss_pred ccccccccccCCccCceeec---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYAL---GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
..+.++|||.|||||++. .+.|+-|+||||||++..||.-.++|.-. .+.+..+...-.++ .|.
T Consensus 178 --PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn-----MNAMSALYHIAQNe------sPt 244 (948)
T KOG0577|consen 178 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-----MNAMSALYHIAQNE------SPT 244 (948)
T ss_pred --chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC-----chHHHHHHHHHhcC------CCC
Confidence 334589999999999885 46799999999999999999999999532 12222222211111 111
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV 640 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 640 (688)
+. ..+.+..+++++..||++-|.+|||..+++
T Consensus 245 Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 245 LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 11 345677899999999999999999999887
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=290.09 Aligned_cols=250 Identities=29% Similarity=0.480 Sum_probs=203.4
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccC
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
+|...+.||+|++|.||++... +++.+++|++........+.+.+|+.++..++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677899999999999999875 688999999976655566789999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+++|.+++.... ..+++..+..++.|++.||.+||..+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999885432 46899999999999999999999987 99999999999999999999999999987654332
Q ss_pred ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCC
Q 005599 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSC 610 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 610 (688)
.....++..|+|||.+.+..++.++||||||+++++|++|+.|+..... ........ ......+..
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~-~~~~~~~~~------- 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-----MKALFKIA-TNGPPGLRN------- 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-----HHHHHHHH-hcCCCCcCc-------
Confidence 2345688999999999988899999999999999999999999753221 11111100 000001110
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 611 PAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 611 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
+......+.+++.+|++.+|++|||+.++++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11114568999999999999999999998863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=301.25 Aligned_cols=246 Identities=27% Similarity=0.428 Sum_probs=194.9
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG---QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
..|.+.+.||+|+||.||+|+.. +++.||+|.+..... ...+++.+|+.++..++||||+++.+++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999865 688999998864332 23456889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 5666665322 245899999999999999999999987 999999999999999999999999998765322
Q ss_pred ccccccccccccCCccCceeec---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYAL---GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
....+++.|+|||.+. ...++.++||||||+++|||++|+.|+.... ........... ..
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-----~~~~~~~~~~~-~~----- 231 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQN-DS----- 231 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-----HHHHHHHHhcC-CC-----
Confidence 2246788999999884 4568899999999999999999999974321 11111111100 00
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
+.+ .+......+.+++.+||+.+|++||++.+|+..
T Consensus 232 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 001 122345578999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=297.07 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=203.5
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
.++.|++.+.||+|++|.||+|... +++.||+|++..... ..+.+.+|++++..++|+||+++++.+......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999876 688999999876544 56788999999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999986533 36899999999999999999999987 9999999999999999999999999986554322
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... . ....... ...... .
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~--~---~~~~~~~-~~~~~~-----~- 236 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP--L---RALFLIT-TKGIPP-----L- 236 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--H---HHHHHHH-hcCCCC-----C-
Confidence 1 11234578899999999988899999999999999999999999743211 1 1111100 000000 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..+......+.+++.+|++.+|.+||++.+|++
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 -KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 011113456889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=297.06 Aligned_cols=262 Identities=24% Similarity=0.389 Sum_probs=199.1
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
+|++.+.||.|++|.||+|+.. ++..||||++..... ...+.+.+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 588999999875432 33567788999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++ +|.+++........+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 88888765444456899999999999999999999987 99999999999999999999999999976533211
Q ss_pred cccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccc--------cc
Q 005599 530 TNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKA--------LE 600 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--------~~ 600 (688)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ................ ..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN--EDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 11224568899999988664 578999999999999999999999854321 1111111111100000 00
Q ss_pred ccccccc-------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 601 IVDSSMA-------DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 601 ~~d~~l~-------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
....... ..........+.+++.+|++.+|++||++.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0011123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=297.67 Aligned_cols=261 Identities=25% Similarity=0.340 Sum_probs=198.0
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCCccceEEEEEeC--CceeEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG--QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEKMLI 445 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 445 (688)
++|++.+.||+|+||.||+|+.. +++.+|+|.++.... .....+.+|+.++.+++||||+++.+++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 56888899999999999999875 588999999865432 2234577899999999999999999999887 789999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
+||++ ++|.+++... ...+++.....++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 4888887542 236899999999999999999999988 99999999999999999999999999987654
Q ss_pred CccccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhc----------
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWS---------- 594 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~---------- 594 (688)
... ......+++.|+|||.+.+. .++.++|+||||++++||++|+.||..... ......+...+.
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE--IDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchHHHHHh
Confidence 321 11234578899999998764 468999999999999999999999854321 111111111000
Q ss_pred -c------ccccccccccccCCCCHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 595 -D------DKALEIVDSSMADSCPAP-EALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 595 -~------~~~~~~~d~~l~~~~~~~-~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
. ..........+....+.. ....+.+++.+|++.+|++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000001111111122222 3556889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=290.48 Aligned_cols=246 Identities=23% Similarity=0.385 Sum_probs=208.4
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccC
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
-|.++.+||+|+||.||+|.++ .|+.+|||++... .+.++...|+.++.+...|++|+++|.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3566789999999999999754 6999999998543 457889999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
.|++.+++. .+++++.+.++..++...++||+|||... -||||||+.||||+-+|.+||+|||.|-.+.+ ...
T Consensus 112 AGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMA 184 (502)
T KOG0574|consen 112 AGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMA 184 (502)
T ss_pred CCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hHH
Confidence 999999984 35678999999999999999999999876 89999999999999999999999999976643 334
Q ss_pred ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccc--cccccC
Q 005599 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIV--DSSMAD 608 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~--d~~l~~ 608 (688)
..++..|||.|||||++..-.|..++||||||+...||.-|++|+...+.- +..-++ .+.-.-
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---------------RAIFMIPT~PPPTF 249 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---------------RAIFMIPTKPPPTF 249 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---------------ceeEeccCCCCCCC
Confidence 556689999999999999999999999999999999999999997432210 001111 111122
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..|+..+.++-+++.+||-++|++|-|+.++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 346677888999999999999999999998875
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=294.22 Aligned_cols=247 Identities=22% Similarity=0.336 Sum_probs=198.7
Q ss_pred CCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCC
Q 005599 373 FSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
|...+.||+|++|.||++.. .+++.+|+|++........+.+.+|+.++..++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999985 46889999998655555566789999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 999998854 34789999999999999999999988 99999999999999999999999998875543221 1
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
.....|++.|+|||.+.+..++.++||||||++++||++|+.|+.... ........... . .+.+. .+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-----~~~~~~~~~~~-~-----~~~~~--~~ 238 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-----PLQAMKRIRDN-L-----PPKLK--NL 238 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-----HHHHHHHHHhc-C-----CCCCc--cc
Confidence 122568899999999998889999999999999999999999974311 11111111111 0 01111 01
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 612 APEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
......+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 123457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=296.64 Aligned_cols=260 Identities=24% Similarity=0.362 Sum_probs=195.3
Q ss_pred CCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
|++.+.||.|++|.||+|... +|..||+|++.... ....+.+.+|++++..++|||++++++++.+.+..++|+||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999864 78999999986543 223467889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
+ ++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 68988875432 235899999999999999999999987 99999999999999999999999999976532211
Q ss_pred cccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccc--------ccc
Q 005599 530 TNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK--------ALE 600 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--------~~~ 600 (688)
......++..|+|||++.+. .++.++||||||+++|||++|+.||....+. ..+............ ..+
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchh
Confidence 11223568899999988764 5789999999999999999999998532211 111111111000000 000
Q ss_pred cc-------cccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 601 IV-------DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 601 ~~-------d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.. .... ..........+.+++.+|++.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0000 0011122356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=295.98 Aligned_cols=243 Identities=26% Similarity=0.329 Sum_probs=198.5
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++.+++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46788899999999999999865 58999999986432 233567889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++++|.+++... ..++...+..++.|++.||.|||+.+ |+|+||+|+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998543 46889999999999999999999987 999999999999999999999999999876433
Q ss_pred ccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
.....+++.|+|||.+.+...+.++||||||+++++|++|+.|+.... ......... .+.
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~-~~~--------- 214 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQIYEKIL-EGK--------- 214 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHh-cCC---------
Confidence 223568899999999988889999999999999999999999975322 111111111 110
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHH
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRP-----SMSTVV 640 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl 640 (688)
...+......+.+++.+||+.+|.+|| +++|++
T Consensus 215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 011222345788999999999999999 666666
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=290.51 Aligned_cols=265 Identities=25% Similarity=0.317 Sum_probs=222.4
Q ss_pred hHHHHHHhcCCCCCCccccCCcEeEEEEEe------CCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEE
Q 005599 363 LSTVLAATDNFSTSNKLGQGGFGPVYKGKL------ANGQEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGC 435 (688)
Q Consensus 363 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 435 (688)
..++.....+++...++-+|.||.||+|.+ .+.+.|-||.++.. +.-....|..|..++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 445666677888899999999999999954 34567888888654 34456778999999999999999999999
Q ss_pred EEeCC-ceeEEEeccCCCChhhHhh-----ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCC
Q 005599 436 CLEKD-EKMLIYEFMPNKSLDYFIF-----DESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE 509 (688)
Q Consensus 436 ~~~~~-~~~lV~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 509 (688)
+.+.. ..+.+|.++.-|+|..||. +....+.+...+...++.|++.|++|||..+ |||.||..+|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 98764 5788899999999999998 5666778888999999999999999999998 9999999999999999
Q ss_pred CCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHH
Q 005599 510 MNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRY 588 (688)
Q Consensus 510 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~ 588 (688)
.++||+|=.+++.+-..++.........+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-------- 504 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-------- 504 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--------
Confidence 9999999999999888888887777778899999999999999999999999999999999 8888632111
Q ss_pred HHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 589 VWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 589 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
.++...+....+..-|..++.++..++.-||...|++||++++++.-|.+
T Consensus 505 -------fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 505 -------FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -------HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11112222233333456677789999999999999999999999998864
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=297.17 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=194.5
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556689999999999999864 58899999986543 234567889999999996 99999999999999999999999
Q ss_pred cCCCChhhHhhc--cCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 449 MPNKSLDYFIFD--ESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 449 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
++. +|..+... ......+++.....++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 54443211 12235689999999999999999999975 5 99999999999999999999999999976543
Q ss_pred CccccccccccccCCccCceeecCC---CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGG---LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 602 (688)
... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||.... .....+...... .
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~-~----- 227 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKG-D----- 227 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCC-C-----
Confidence 221 1224678899999998776 68999999999999999999999985332 111111111111 0
Q ss_pred cccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 603 d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.+.+....+...+..+.+|+.+|++.+|++|||+.+|+..
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112112222345578999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=325.61 Aligned_cols=262 Identities=28% Similarity=0.415 Sum_probs=212.1
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEeCC--------CcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCCccceEEEEE
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKLAN--------GQEIAVKRLSTTS-GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCL 437 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 437 (688)
...++..+.+.||+|.||.|++|.... ...||||.++... ....+.+..|+++|..+ +|+||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 344555667799999999999997431 4579999997653 34677899999999999 6999999999999
Q ss_pred eCCceeEEEeccCCCChhhHhhccC------C-----C--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCce
Q 005599 438 EKDEKMLIYEFMPNKSLDYFIFDES------R-----K--QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNI 504 (688)
Q Consensus 438 ~~~~~~lV~e~~~~gsL~~~l~~~~------~-----~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 504 (688)
.++..++|.||+..|+|..+|.... . . ..+.....+.++.|||.||+||++.. +|||||..+||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhE
Confidence 9999999999999999999997654 0 1 24888999999999999999999987 99999999999
Q ss_pred EECCCCCceecccccceecCCCcccccc-ccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 005599 505 LLDEEMNPRISDFGTARVFGGEEISTNT-NRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDS 582 (688)
Q Consensus 505 Ll~~~~~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~ 582 (688)
|+.++..+||+|||+|+.....+..... ....-+..|||||.+....|+.|+|||||||+||||+| |..|+.... ..
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~ 528 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-PT 528 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-cH
Confidence 9999999999999999976655544322 21124567999999999999999999999999999999 777863211 01
Q ss_pred ccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 583 SNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 583 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
.++ .+.+.+..+...|..+..++.+++..||+.+|++||++.++++.|+..
T Consensus 529 ~~l-------------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 EEL-------------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHH-------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111 122333334445667778899999999999999999999999999884
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=294.45 Aligned_cols=260 Identities=22% Similarity=0.337 Sum_probs=197.2
Q ss_pred CCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeC--CceeEEEe
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEKMLIYE 447 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e 447 (688)
|++.+.||+|+||.||+|+.. +++.+|+|++.... ......+.+|+.++..++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999866 48899999997653 33456788999999999999999999999988 78999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|+++ +|..++.... ..+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8888874432 46899999999999999999999987 9999999999999999999999999998765433
Q ss_pred cccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccc------c
Q 005599 528 ISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL------E 600 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~------~ 600 (688)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..... ................. .
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE--LEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchhhcccccc
Confidence 11 1222456788999998765 4579999999999999999999999853221 11111111111110000 0
Q ss_pred c-----------ccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 601 I-----------VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 601 ~-----------~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+ ....+.......++..+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 0000000001112567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=290.32 Aligned_cols=242 Identities=24% Similarity=0.313 Sum_probs=195.0
Q ss_pred cccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCCh
Q 005599 379 LGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL 454 (688)
Q Consensus 379 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 454 (688)
||.|++|.||+++.. +++.+|+|.+.... ....+.+.+|+.++..++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999875 48899999986532 23446789999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccccccc
Q 005599 455 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR 534 (688)
Q Consensus 455 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 534 (688)
.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 9998532 35889999999999999999999987 9999999999999999999999999998765432 1223
Q ss_pred ccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHH
Q 005599 535 VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPE 614 (688)
Q Consensus 535 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 614 (688)
..+++.|+|||.+.+..++.++|+||||+++|||++|..|+.....+. ........ +.......+...
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~---------~~~~~~~~~~~~ 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDIL---------KGNGKLEFPNYI 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHHh---------ccCCCCCCCccc
Confidence 567889999999988889999999999999999999999986433211 11111111 101111223333
Q ss_pred HHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005599 615 ALRCIQVGLLCVQDRTTDRPS-----MSTVVF 641 (688)
Q Consensus 615 ~~~~~~l~~~Cl~~~P~~RPt-----~~evl~ 641 (688)
...+.+++.+||+.+|++||+ +.|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 567999999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=283.93 Aligned_cols=288 Identities=21% Similarity=0.290 Sum_probs=218.2
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeE
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG---QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 444 (688)
.-++|..+++||+|.||.|.+++-+ .++.+|+|++++... .....-..|-++|...+||.+..|...|+..+++|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467888999999999999999754 688999999987533 333445678999999999999999999999999999
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
||||..+|.|..+| ++.+.+++....-+-..|+.||.|||+.+ ||.||||.+|+|||++|++||+||||++.--
T Consensus 246 VMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999998888 34566777777778899999999999988 9999999999999999999999999997532
Q ss_pred CCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccc
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS 604 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 604 (688)
.....+...+|||.|+|||++....|+.++|.|.+||++|||++|+.||.. .+...+...+.. +
T Consensus 320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn--~dh~kLFeLIl~----e-------- 383 (516)
T KOG0690|consen 320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN--KDHEKLFELILM----E-------- 383 (516)
T ss_pred --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc--cchhHHHHHHHh----h--------
Confidence 233445569999999999999999999999999999999999999999843 222222222111 0
Q ss_pred cccCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH--HhcCC-------CCCCCCCCCCccccceecccCCCC
Q 005599 605 SMADSCPAPEALRCIQVGLLCVQDRTTDRPS-----MSTVVF--MLSNE-------TSVPSPKQPTFSVRKIEIDTDYSS 670 (688)
Q Consensus 605 ~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~--~L~~~-------~~~~~p~~~~~~~~~~~~~~~~~~ 670 (688)
. -.+|.....+...|..-.|.+||.+|.. +.||.+ .+..+ +.+++|-.| .+.++++.+=
T Consensus 384 d--~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKP-----qVtSetDTry 456 (516)
T KOG0690|consen 384 D--LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKP-----QVTSETDTRY 456 (516)
T ss_pred h--ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCC-----Ccccccchhh
Confidence 0 1244455557788888999999999963 444442 22222 123333333 2334455544
Q ss_pred CCcccCCCeeeEEee
Q 005599 671 TGTKSSANEVTLTTF 685 (688)
Q Consensus 671 ~~~~~~~~~~~~~~~ 685 (688)
...+-+.-.+++||-
T Consensus 457 FD~EFT~q~v~lTPP 471 (516)
T KOG0690|consen 457 FDEEFTSQPVTLTPP 471 (516)
T ss_pred hhhhhhcceeEecCC
Confidence 555556666666653
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=299.75 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=197.8
Q ss_pred CCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG---QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
|...+.||+|+||.||+|+.. ++..||+|++..... .....+.+|+.+++.++|+|++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666789999999999999864 688999999864322 2345788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
++ |+|.+++... ...+++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 107 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred CC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 97 5776766432 345899999999999999999999988 99999999999999999999999999875432
Q ss_pred ccccccccccCCccCceeec---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYAL---GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
.....+++.|+|||++. .+.++.++||||||+++|||++|+.|+.... . ............
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~---~~~~~~~~~~~~-------- 241 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--A---MSALYHIAQNES-------- 241 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--H---HHHHHHHHhccC--------
Confidence 12356788999999874 4568999999999999999999999974321 1 111111111100
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCCCCC
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSP 652 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~p 652 (688)
...........+.+++.+|++.+|.+||++.+|++.+--....+.+
T Consensus 242 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 242 -PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred -CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 0011122345688999999999999999999999866554444433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=291.62 Aligned_cols=247 Identities=24% Similarity=0.301 Sum_probs=201.0
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
+|++.+.||.|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999875 58899999986532 2446789999999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|+++++|..++... ..+++.....++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998433 46889999999999999999999987 9999999999999999999999999988664332
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+...... ........... ..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~----------~~ 218 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET----------AD 218 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc----------cc
Confidence 122356788999999999888999999999999999999999998543321 11111111110 01
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCH--HHHH
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSM--STVV 640 (688)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~--~evl 640 (688)
...+...+..+.+++.+|++.+|.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11222334678899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=289.32 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=199.8
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+|.+.+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677899999999999999865 57899999986532 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCC-ceecccccceecCCCc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMN-PRISDFGTARVFGGEE 527 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kl~DFGla~~~~~~~ 527 (688)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999885432 235799999999999999999999987 999999999999998864 6999999997664322
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
. ......|++.|+|||++.+..++.++||||||++++||++|+.|+... ...+........ . +.
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~-~----~~---- 220 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKICQG-Y----FA---- 220 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcc-c----CC----
Confidence 1 112246888999999998888999999999999999999999997432 122222221111 1 11
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
..+......+.+++.+|++.+|++|||+.+|++.
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112233468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.02 Aligned_cols=260 Identities=18% Similarity=0.198 Sum_probs=183.8
Q ss_pred hcCCCCCCccccCCcEeEEEEEeCCC----cEEEEEEccCCCcccH-----------HHHHHHHHHHhhcCCCCccceEE
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLANG----QEIAVKRLSTTSGQGI-----------EEFKNEVLLIAKLQHRNLVKLLG 434 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~g 434 (688)
.++|.+.++||+|+||.||+|...++ ..+|+|.......... .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35788999999999999999987553 4566665432221110 11223344556678999999999
Q ss_pred EEEeCC----ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC
Q 005599 435 CCLEKD----EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM 510 (688)
Q Consensus 435 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 510 (688)
++.... ..++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876554 24677777643 45555422 123567888899999999999999987 99999999999999999
Q ss_pred CceecccccceecCCCccc-----cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccH
Q 005599 511 NPRISDFGTARVFGGEEIS-----TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNL 585 (688)
Q Consensus 511 ~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l 585 (688)
.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+++||++|+.||....... .+
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-~~ 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-NL 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-HH
Confidence 9999999999876432211 11223579999999999999999999999999999999999999996543222 11
Q ss_pred HHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 005599 586 IRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 586 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 644 (688)
.......+ ...+....+. ....+..+.+++..|++.+|++||++.++++.|+
T Consensus 243 ~~~~~~~~----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDF----IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHH----HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111000 0001111110 1112356889999999999999999999998874
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=301.18 Aligned_cols=259 Identities=24% Similarity=0.307 Sum_probs=196.2
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeC------
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK------ 439 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 439 (688)
..++|++.+.||+|+||.||+|... +++.||||.+... .....+++.+|+.++..++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999854 6899999998643 233445778899999999999999999998644
Q ss_pred CceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccc
Q 005599 440 DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGT 519 (688)
Q Consensus 440 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 519 (688)
...++|+||+. ++|...+.. .++......++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34699999996 477776632 2788899999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHh------
Q 005599 520 ARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELW------ 593 (688)
Q Consensus 520 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~------ 593 (688)
++....... .....++..|+|||.+.+..++.++|||||||++++|++|+.||...+. ......+...+
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH--IDQWNKIIEQLGTPSDE 239 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhcCCCCHH
Confidence 987643221 2234678899999999999999999999999999999999999853221 00000000000
Q ss_pred -------------cccc------ccccccccc----cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 594 -------------SDDK------ALEIVDSSM----ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 594 -------------~~~~------~~~~~d~~l----~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.... ..+++...+ ....+......+.+++.+|++.||++|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 001111100 00112234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=289.62 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=202.6
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+|++.+.||+|+||.||+++.. +++.+|+|.+.... .....++.+|+.+++.++|+||+++.+++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777899999999999999754 67899999986532 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 449 MPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 449 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999885522 2356899999999999999999999988 999999999999999999999999999876543
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
......+++.|+|||.+.+..++.++|+||||++++||++|+.|+.... ....... ... ...
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~~~~~~~-~~~---------~~~ 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----MQDLRYK-VQR---------GKY 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHH-Hhc---------CCC
Confidence 1122457889999999999999999999999999999999999985322 1111111 111 111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
...+......+.+++.+|++.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11233455679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=286.99 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=204.7
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG--QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+|.+.+.||+|+||.||++... +++.+|+|++..... ...+++.+|++++..++|+|++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777899999999999999865 588999999875433 4566789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 449 MPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 449 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
+++++|.+++.... ....+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886532 2356899999999999999999999987 9999999999999999999999999998765433
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
.......+++.|+|||.+.+..++.++||||+|+++++|++|+.|+.... .......... .. .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~-~~---------~ 220 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILK-GQ---------Y 220 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhc-CC---------C
Confidence 12233568889999999998899999999999999999999999974322 1111111111 11 1
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
...+......+.+++.+|+..+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11222334578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.96 Aligned_cols=263 Identities=22% Similarity=0.312 Sum_probs=194.3
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCc-----
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDE----- 441 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 441 (688)
++|++.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++..++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999865 68899999876432 223467889999999995 6999999999987766
Q ss_pred eeEEEeccCCCChhhHhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECC-CCCceecccc
Q 005599 442 KMLIYEFMPNKSLDYFIFDESR--KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-EMNPRISDFG 518 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFG 518 (688)
.++||||+++ +|..++..... ...+++.....++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78887754322 346899999999999999999999987 999999999999998 8899999999
Q ss_pred cceecCCCccccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccc
Q 005599 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK 597 (688)
Q Consensus 519 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 597 (688)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||....+. ..+.... .......
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~-~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-QQLLHIF-KLLGTPT 232 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHH-HHhCCCC
Confidence 9986533211 1112356788999998865 45799999999999999999999998532211 1111111 1110000
Q ss_pred cc------cccc----cccc----CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 598 AL------EIVD----SSMA----DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 598 ~~------~~~d----~~l~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.. +..+ +... ..........+.+++.+|++.+|.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000 0000 0000123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.81 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=193.1
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC-CcEEEEEEccCCC-cccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCceeEEEe
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 447 (688)
++|.+.+.||+|+||.||+|...+ ++.||||.+.... .....++..|+.++.++. |+||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 668888999999999999999865 8899999986543 233456677887777775 9999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|++ ++|..++... ...+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++..+....
T Consensus 95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 985 4676665432 236899999999999999999999742 39999999999999999999999999987654322
Q ss_pred cccccccccccCCccCceeecCCC----CCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGL----FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
.. ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .+......... ..
T Consensus 170 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~-~~---- 237 (296)
T cd06618 170 AK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FEVLTKILQEE-PP---- 237 (296)
T ss_pred cc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HHHHHHHhcCC-CC----
Confidence 11 2245778999999987654 788999999999999999999998532111 11111111111 00
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.+. ........+.+++.+||+.+|++||++.++++.
T Consensus 238 -~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 -SLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 001234568999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=291.14 Aligned_cols=257 Identities=19% Similarity=0.297 Sum_probs=191.7
Q ss_pred CCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcC-CCCccceEEEEEeC--CceeEEEe
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEK--DEKMLIYE 447 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e 447 (688)
|++.+.||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566789999999999999854 68899999986542 222334557888999885 99999999999988 88999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
|++ ++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 5777776432 246899999999999999999999988 999999999999999 999999999998764332
Q ss_pred cccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhc-----------c
Q 005599 528 ISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWS-----------D 595 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~-----------~ 595 (688)
.. ....++..|+|||.+.. ..++.++|||||||++|||++|..||..... ............ .
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhcc
Confidence 11 22457889999997654 5678999999999999999999999854221 111111111110 0
Q ss_pred ccccccccccccC----CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 596 DKALEIVDSSMAD----SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 596 ~~~~~~~d~~l~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
........+.... ......+..+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000110000000 001133578999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=304.98 Aligned_cols=268 Identities=21% Similarity=0.318 Sum_probs=198.7
Q ss_pred hcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCC-----ce
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD-----EK 442 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 442 (688)
.++|.+.++||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.+++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999975 468999999986432 334567889999999999999999999876543 47
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
++|+||+++ +|..++. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999974 7766662 345899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccc-ccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccc---c
Q 005599 523 FGGEEIST-NTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD---K 597 (688)
Q Consensus 523 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---~ 597 (688)
........ ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .............. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHH
Confidence 64322111 1223568899999998755 5689999999999999999999999843211 11111111111110 0
Q ss_pred cccccccc-------cc--CCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--hcCCC
Q 005599 598 ALEIVDSS-------MA--DSCP-----APEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LSNET 647 (688)
Q Consensus 598 ~~~~~d~~-------l~--~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~ 647 (688)
...+.+.. +. ...+ ......+.+++.+||+.+|++|||+.|+++. ++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00011100 00 0000 1124568899999999999999999999986 65543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=305.18 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=204.3
Q ss_pred cCCCCCCccccCCcEeEEEEEeCCCcE-EEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLANGQE-IAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~-vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
+.|+++-.||.|+||.||+|+.++... .|.|++...+....+.|+-||++|....||+||+|++.|.-.+.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 446677889999999999998775444 4678887778888999999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++|-.+.++..- ...|...++.-+++|++.||.|||++. |||||||+.|||++-+|.++|+|||.+..... ..
T Consensus 112 ~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR 184 (1187)
T ss_pred CCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence 999999998654 356889999999999999999999998 99999999999999999999999999854321 12
Q ss_pred cccccccccCCccCceeec-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccc
Q 005599 530 TNTNRVVGTYGYMSPEYAL-----GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS 604 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 604 (688)
.....+.|||.|||||++. +.+|..++||||||++|.||.-+.+|..- .+.+..+...-.. + -+
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-----lnpMRVllKiaKS-e-----PP 253 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-----LNPMRVLLKIAKS-E-----PP 253 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-----cchHHHHHHHhhc-C-----CC
Confidence 2334589999999999874 56899999999999999999999998531 1222222111111 1 01
Q ss_pred cccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 605 SMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 605 ~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.+. -|......+.++..+||.+||..||++.++++
T Consensus 254 TLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 254 TLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 111 24556778999999999999999999999884
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=290.42 Aligned_cols=242 Identities=25% Similarity=0.317 Sum_probs=186.6
Q ss_pred ccccCCcEeEEEEEeC-CCcEEEEEEccCCCc---ccHHHHHHHHHHHh---hcCCCCccceEEEEEeCCceeEEEeccC
Q 005599 378 KLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG---QGIEEFKNEVLLIA---KLQHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 378 ~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~---~l~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..++. ..+||||+.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 588999998865321 12233445544433 3479999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+++|..++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999988853 345899999999999999999999988 9999999999999999999999999987553221
Q ss_pred ccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 531 NTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
.....|+..|+|||.+.+ ..++.++|||||||+++||++|+.||......... ....... .....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~----------~~~~~ 217 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTL----------TVNVE 217 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHhh----------cCCcC
Confidence 122468999999998864 56899999999999999999999998543221111 1111000 01111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRP-----SMSTVVFM 642 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~ 642 (688)
.+...+..+.+++.+|++.||++|| +++|+++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2333455788999999999999999 59998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=300.27 Aligned_cols=264 Identities=24% Similarity=0.353 Sum_probs=197.3
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCC--ce
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKD--EK 442 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~--~~ 442 (688)
..++|++.+.||+|+||.||+|... +++.+|||++... .......+.+|+.++.++ +||||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888999999999999999865 5789999988542 233455678899999999 9999999999987543 57
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
++|+||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 588887743 26789999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc---cccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH------
Q 005599 523 FGGEEIS---TNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWEL------ 592 (688)
Q Consensus 523 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~------ 592 (688)
....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~ 234 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL--NQLEKIIEVIGPPSA 234 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCH
Confidence 6543221 12233568999999998765 45789999999999999999999998532211 111110000
Q ss_pred -----hccccccccccccccC------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 593 -----WSDDKALEIVDSSMAD------SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 593 -----~~~~~~~~~~d~~l~~------~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
+.......+++..... .........+.+++.+|++.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000001111100000 0001134578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=290.98 Aligned_cols=245 Identities=24% Similarity=0.331 Sum_probs=196.9
Q ss_pred cccCCcEeEEEEEeCC-CcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCCh
Q 005599 379 LGQGGFGPVYKGKLAN-GQEIAVKRLSTTSG---QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL 454 (688)
Q Consensus 379 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 454 (688)
||+|+||.||+++... ++.+|+|.+..... ...+.+.+|++++.+++|+||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 89999999865433 3456789999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc------
Q 005599 455 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI------ 528 (688)
Q Consensus 455 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~------ 528 (688)
.+++... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9998543 26899999999999999999999987 99999999999999999999999999876433211
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
........++..|+|||.+.....+.++||||||++++||++|+.|+.... .......... +. .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~-~~--------~-- 218 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----PEEIFQNILN-GK--------I-- 218 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhc-CC--------c--
Confidence 112233567889999999988889999999999999999999999985322 1111111111 00 0
Q ss_pred CCCHH--HHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 609 SCPAP--EALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 609 ~~~~~--~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
..+.. ....+.+++.+|++.+|++|||+.+|.+.|+.
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 01111 24578899999999999999999777777754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=292.17 Aligned_cols=243 Identities=21% Similarity=0.329 Sum_probs=195.5
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCChh
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLD 455 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 455 (688)
.+||+|+||.||++... +++.||||++........+.+.+|+.++..++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 68999999999999864 68899999986555455677899999999999999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccccccc
Q 005599 456 YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV 535 (688)
Q Consensus 456 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 535 (688)
+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ .....
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 88732 34789999999999999999999987 99999999999999999999999999876543221 12235
Q ss_pred cccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHH
Q 005599 536 VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEA 615 (688)
Q Consensus 536 ~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 615 (688)
.+++.|+|||.+.+..++.++|+||||+++|||++|..|+.... ........... +...+. ......
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~--~~~~~~~~~~~---------~~~~~~--~~~~~~ 243 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDN---------LPPKLK--NLHKVS 243 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhh---------CCcccC--CcccCC
Confidence 67899999999988889999999999999999999999975321 11111111110 011110 011123
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 616 LRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 616 ~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..+.+++.+||+.+|.+||++.+|++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 45788999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.87 Aligned_cols=260 Identities=20% Similarity=0.264 Sum_probs=192.2
Q ss_pred CccccC--CcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQG--GFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
..||+| +||+||+++.. +++.||||.+.... ....+.+.+|+.++..++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 89999999864 78999999986432 23356788999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc--
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS-- 529 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 529 (688)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999885432 235889999999999999999999987 999999999999999999999999865433211110
Q ss_pred ---cccccccccCCccCceeecCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHH-------------
Q 005599 530 ---TNTNRVVGTYGYMSPEYALGG--LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWE------------- 591 (688)
Q Consensus 530 ---~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~------------- 591 (688)
.......++..|+|||++.+. .++.++|||||||+++||++|+.||....... .+......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-MLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-HHHHHhcCCCCCCccccccch
Confidence 001112346679999999764 47899999999999999999999985432110 00000000
Q ss_pred ----------Hhcc---------ccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 592 ----------LWSD---------DKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 592 ----------~~~~---------~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.... .....+.+..+....+......+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000 0000111111222223445678999999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=316.46 Aligned_cols=267 Identities=24% Similarity=0.337 Sum_probs=186.3
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeCC--CcEEEEE------------------EccCCCcccHHHHHHHHHHHhhcCCCC
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLAN--GQEIAVK------------------RLSTTSGQGIEEFKNEVLLIAKLQHRN 428 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~n 428 (688)
..++|.+.+.||+|+||+||++..+. +...++| .+. ........+.+|+.+|.+++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999987532 2222222 111 11223456889999999999999
Q ss_pred ccceEEEEEeCCceeEEEeccCCCChhhHhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEE
Q 005599 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESR--KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 506 (688)
Q Consensus 429 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 506 (688)
||++++++...+..++|+|++. ++|..++..... ...........++.||+.||.|||+.+ ||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 566666643221 122335567789999999999999987 9999999999999
Q ss_pred CCCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCC-CCCCCCC-cc
Q 005599 507 DEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNT-GIFNDDS-SN 584 (688)
Q Consensus 507 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~-~~~~~~~-~~ 584 (688)
+.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.++ ....... ..
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999876533221 122367899999999999999999999999999999999987543 2211111 11
Q ss_pred HHHHHHHHhc-cc-------ccccccccc-cc---CCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 585 LIRYVWELWS-DD-------KALEIVDSS-MA---DSCP-----APEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 585 l~~~~~~~~~-~~-------~~~~~~d~~-l~---~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+......... .+ ...+.++.. +. ...+ ......+.+++.+||+.||++|||+.|++.
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111110000 00 000011000 00 0000 011235677899999999999999999986
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=285.25 Aligned_cols=247 Identities=28% Similarity=0.421 Sum_probs=201.6
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG--QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+|++.+.||+|++|.||+++.. +++.||+|.+..... ...+.+.+|++++.+++|+|++++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999765 578999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988433 46899999999999999999999987 99999999999999999999999999987654332
Q ss_pred ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
. .....++..|+|||.+.+...+.++||||+|+++++|++|+.|+.... .... ..... ... . .
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~-~~~~~-~~~-----~----~ 217 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAA-LFRIV-QDD-----H----P 217 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHH-HHHHh-ccC-----C----C
Confidence 1 223567889999999988888999999999999999999999975322 1111 11111 000 0 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..+......+.+++.+|++.+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112223457889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=284.66 Aligned_cols=247 Identities=21% Similarity=0.253 Sum_probs=190.5
Q ss_pred HHHHhcCCCCCCcc--ccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCc
Q 005599 366 VLAATDNFSTSNKL--GQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDE 441 (688)
Q Consensus 366 ~~~~~~~f~~~~~L--G~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 441 (688)
.....++|.+.+.+ |+|+||.||++... ++..+|+|.+........ |+.....+ +||||+++++.+...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34445677777776 99999999999864 578899998864322111 22222222 69999999999999999
Q ss_pred eeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC-Cceecccccc
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM-NPRISDFGTA 520 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla 520 (688)
.++||||+++++|.+++... ..+++.+...++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 99999999999999998433 37899999999999999999999988 99999999999999998 9999999998
Q ss_pred eecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccc
Q 005599 521 RVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALE 600 (688)
Q Consensus 521 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 600 (688)
+...... ...++..|+|||++.+..++.++||||||++++||++|+.|+....+.......+.... .
T Consensus 158 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------ 224 (267)
T PHA03390 158 KIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q------ 224 (267)
T ss_pred eecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c------
Confidence 7654221 24678899999999998999999999999999999999999863322221122221111 0
Q ss_pred cccccccCCCCHHHHHHHHHHHhhcccCCCCCCCC-HHHHHH
Q 005599 601 IVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPS-MSTVVF 641 (688)
Q Consensus 601 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-~~evl~ 641 (688)
.. ...+......+.+++.+||+.+|.+||+ ++++++
T Consensus 225 ---~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 ---KK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---cc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 0112234557899999999999999996 688874
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=287.80 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=196.7
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC-----CcccHHHHHHHHHHHhhcCCCCccceEEEEEeC--Cce
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT-----SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEK 442 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 442 (688)
.+|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.++.+++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999864 5889999987432 123456788999999999999999999998765 357
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
++|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999988532 34788899999999999999999988 99999999999999999999999999986
Q ss_pred cCCCcc-ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccc
Q 005599 523 FGGEEI-STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 523 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 601 (688)
...... ........++..|+|||.+.+..++.++||||||++++||++|+.||.... .. ..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~-~~~~~~~-------- 222 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE----AM-AAIFKIA-------- 222 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC----HH-HHHHHHH--------
Confidence 532111 111123568899999999998889999999999999999999999985321 11 1111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 602 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
........|......+.+++.+|++ +|..||+..+++.
T Consensus 223 -~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 -TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111122344455678999999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=292.96 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=194.6
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCCccceEEEEEeC--CceeE
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG--QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEKML 444 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 444 (688)
.++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367888999999999999999865 589999999864322 2234567899999999999999999998765 45899
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
|+||+.+ +|.+++... ...+++.++..++.||++||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999974 787777432 256899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccc--c---
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK--A--- 598 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~--- 598 (688)
.... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.... .......+........ .
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~--~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--EIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCChhhchh
Confidence 4321 1122345788999999876 458999999999999999999999985322 1111111111111000 0
Q ss_pred ---------cccccccccC--CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 599 ---------LEIVDSSMAD--SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 599 ---------~~~~d~~l~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..+-...... .........+.+++.+|++.||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 000012456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=291.69 Aligned_cols=262 Identities=22% Similarity=0.355 Sum_probs=193.4
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
++|++.+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999865 68899999986532 2334678899999999999999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECC-CCCceecccccceecCCC
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-EMNPRISDFGTARVFGGE 526 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~ 526 (688)
|++ ++|..++.... ...+++.....++.||+.||+|||+.+ |+|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 57777764322 223578888899999999999999987 999999999999985 557999999999765432
Q ss_pred ccccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccc------c
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKA------L 599 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~------~ 599 (688)
. .......+++.|+|||++.+. .++.++||||||+++|+|+||+.||...... ..+.. .......+.. .
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFK-IFRILGTPNEETWPGVT 232 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHHHhCCCChhhccccc
Confidence 1 111224578899999988764 5789999999999999999999998542211 11111 1111110000 0
Q ss_pred cccc-----ccccC----CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 600 EIVD-----SSMAD----SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 600 ~~~d-----~~l~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.+-+ +.... .........+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00000 001122456889999999999999999999986
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=289.87 Aligned_cols=260 Identities=23% Similarity=0.299 Sum_probs=194.6
Q ss_pred CCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCceeEEEecc
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
|.+.+.||+|++|+||+|+.. +++.||||++..... .......+|+..+.+++ |+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999975 478899999865422 22334567999999999 999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
+|+|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889988875432 346899999999999999999999987 99999999999999999999999999986643221
Q ss_pred cccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccc---------ccc
Q 005599 530 TNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD---------KAL 599 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---------~~~ 599 (688)
.....++..|+|||++.. ..++.++|+||||++++||++|+.|+...... ............. ...
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI--DQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH--HHHHHHHHhcCCCChhhhhhHhhhh
Confidence 123567889999998854 45799999999999999999999887433211 0000000000000 000
Q ss_pred ccccccccCC-------CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 600 EIVDSSMADS-------CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 600 ~~~d~~l~~~-------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
..++..+... ........+.+++.+|++.+|++|||+.|++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0011111000 001124678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=292.02 Aligned_cols=261 Identities=19% Similarity=0.207 Sum_probs=193.3
Q ss_pred CCCccccCCcEeEEEEEeCCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCC
Q 005599 375 TSNKLGQGGFGPVYKGKLANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNK 452 (688)
Q Consensus 375 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 452 (688)
+.+.+|.|+++.||+++. +++.||||++... .....+.+.+|+.+++.++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344556666666666655 6899999998654 3445678999999999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc----
Q 005599 453 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI---- 528 (688)
Q Consensus 453 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 528 (688)
+|.+++.... ...+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999986432 235788889999999999999999988 99999999999999999999999999876542211
Q ss_pred -ccccccccccCCccCceeecCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHh----c-------
Q 005599 529 -STNTNRVVGTYGYMSPEYALGG--LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELW----S------- 594 (688)
Q Consensus 529 -~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~----~------- 594 (688)
........++..|+|||++... .++.++||||||+++|||++|+.||....... .+........ .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccccCchhhh
Confidence 1112234577889999998763 58899999999999999999999986432111 1111110000 0
Q ss_pred cccccc----cccccc----cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 595 DDKALE----IVDSSM----ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 595 ~~~~~~----~~d~~l----~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
...... ..++.. ...........+.+++.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000 000100 01112334567889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=287.44 Aligned_cols=244 Identities=28% Similarity=0.371 Sum_probs=191.6
Q ss_pred cccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCCh
Q 005599 379 LGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL 454 (688)
Q Consensus 379 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 454 (688)
||+|+||+||++... +++.+|+|.+.... ......+.+|++++..++||||+++.+.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999754 68899999886432 22345677899999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccccccc
Q 005599 455 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR 534 (688)
Q Consensus 455 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 534 (688)
.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence 999865432 46889999999999999999999988 999999999999999999999999998765431 11223
Q ss_pred ccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHH
Q 005599 535 VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPE 614 (688)
Q Consensus 535 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 614 (688)
..++..|+|||.+.+..++.++||||||+++++|++|+.||........ ...+.... .. .....+...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~--------~~--~~~~~~~~~ 221 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEELKRRT--------LE--MAVEYPDKF 221 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHHHHhcc--------cc--ccccCCccC
Confidence 4678899999999888899999999999999999999999854322110 01111100 00 011122233
Q ss_pred HHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005599 615 ALRCIQVGLLCVQDRTTDRP-----SMSTVVF 641 (688)
Q Consensus 615 ~~~~~~l~~~Cl~~~P~~RP-----t~~evl~ 641 (688)
...+.+++.+||+.+|++|| ++.+++.
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 55788999999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=293.27 Aligned_cols=263 Identities=22% Similarity=0.346 Sum_probs=192.7
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCc------
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE------ 441 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 441 (688)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++++++||||+++++++.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 57888999999999999999865 68899999886432 2223456789999999999999999999876543
Q ss_pred --eeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccc
Q 005599 442 --KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGT 519 (688)
Q Consensus 442 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 519 (688)
.++||||+++ +|...+... ...+++.+...++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4999999974 777776432 235899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCccc--cccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhc--
Q 005599 520 ARVFGGEEIS--TNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWS-- 594 (688)
Q Consensus 520 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~-- 594 (688)
+......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+..... ......+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--~~~~~~~~~~~~~~ 243 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--QHQLTLISQLCGSI 243 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCC
Confidence 9866432211 111234578899999988765 478899999999999999999998753221 111111111110
Q ss_pred ------cccccccccc-cccCCC---------CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 595 ------DDKALEIVDS-SMADSC---------PAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 595 ------~~~~~~~~d~-~l~~~~---------~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
........+. .+.... +......+.+++.+||+.+|++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000000 000000 0012345779999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=290.39 Aligned_cols=256 Identities=23% Similarity=0.302 Sum_probs=200.1
Q ss_pred CCCCCCccccCCcEeEEEEEe----CCCcEEEEEEccCCC----cccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCce
Q 005599 372 NFSTSNKLGQGGFGPVYKGKL----ANGQEIAVKRLSTTS----GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEK 442 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 442 (688)
+|.+.+.||+|++|.||+++. .++..||||.+.... ....+.+.+|+.++.++ +||||+++.+.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999974 357889999986432 22345688999999999 599999999999999999
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
++||||+++++|..++.. ...+++.....++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998853 245789999999999999999999987 99999999999999999999999999876
Q ss_pred cCCCccccccccccccCCccCceeecCCC--CCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccc
Q 005599 523 FGGEEISTNTNRVVGTYGYMSPEYALGGL--FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALE 600 (688)
Q Consensus 523 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 600 (688)
....... ......++..|+|||.+.+.. .+.++||||||++++||++|..|+....... ............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~----- 227 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKS----- 227 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHcc-----
Confidence 5433221 122356889999999987765 7889999999999999999999985322111 111111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 601 IVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 601 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
.. ..+......+.+++.+||+.+|++|||+.+|.+.|+..
T Consensus 228 --~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 --KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 01 11222334688999999999999999999998888653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=288.20 Aligned_cols=259 Identities=23% Similarity=0.345 Sum_probs=198.2
Q ss_pred CCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG--QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
|.+.+.||+|++|.||++... +++.+|+|++..... .....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999865 688999999865432 24567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
++ +|..++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 75 7877775432 46899999999999999999999988 9999999999999999999999999998765443
Q ss_pred cccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccc---ccccccc--
Q 005599 530 TNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD---KALEIVD-- 603 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d-- 603 (688)
.......++..|+|||.+.+. .++.++||||||+++++|++|+.||..... .+............ ....+.+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCchHhcccchhhh
Confidence 111224577889999998877 789999999999999999999998743221 11111111111100 0000000
Q ss_pred ----cccc-------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 604 ----SSMA-------DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 604 ----~~l~-------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.... ..........+.+++.+||+.+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0011234567999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=285.59 Aligned_cols=245 Identities=22% Similarity=0.248 Sum_probs=189.4
Q ss_pred CccccCCcEeEEEEEeC-CCcEEEEEEccCCCc---ccHHHHHHHHHH-HhhcCCCCccceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG---QGIEEFKNEVLL-IAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
+.||+|+||.||+|... +++.||||.+..... .....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999864 588999999865432 122334455544 4455899999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
++|..++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999998532 35789999999999999999999987 99999999999999999999999999875432
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
.....++..|+|||.+.+..++.++||||||+++|||++|..|+..... ...... ...... + ......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~-~~~~~~----~--~~~~~~ 217 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDN-ILSRRI----N--WPEEVK 217 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH-HHhccc----C--CCCccc
Confidence 2235678899999999888899999999999999999999999853211 111111 111000 0 000111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 612 APEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
...+..+.+++.+|++.+|++||++.++.+.|..
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 1234578999999999999999988777766643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=290.36 Aligned_cols=264 Identities=22% Similarity=0.337 Sum_probs=196.5
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCC----
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD---- 440 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 440 (688)
...++|++.+.||+|+||.||+|... +++.||||+++... ......+.+|++++..++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999875 58899999986542 233456788999999999999999999987755
Q ss_pred ------ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCcee
Q 005599 441 ------EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRI 514 (688)
Q Consensus 441 ------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 514 (688)
..++|+||+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 666665332 345899999999999999999999987 999999999999999999999
Q ss_pred cccccceecCCCccccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHh
Q 005599 515 SDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELW 593 (688)
Q Consensus 515 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~ 593 (688)
+|||++......... ......++..|+|||.+.+. .++.++|||||||+++||++|++|+..... ......+....
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--~~~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--LAQLELISRLC 234 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHh
Confidence 999999876433221 11123457789999988654 578999999999999999999999853221 11111111111
Q ss_pred cccccc---cc--------cc------ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 594 SDDKAL---EI--------VD------SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 594 ~~~~~~---~~--------~d------~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
...... .+ .+ ....... ...+..+.+++.+||+.+|.+||++.+|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 110000 00 00 0000000 012456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=298.57 Aligned_cols=263 Identities=20% Similarity=0.339 Sum_probs=197.4
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeC----Cce
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK----DEK 442 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----~~~ 442 (688)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.+++||||+++.+++... ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478889999999999999999854 68999999986542 23456778899999999999999999987643 457
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
++|+||+. ++|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 688888743 345899999999999999999999987 99999999999999999999999999976
Q ss_pred cCCCccc--cccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHh------
Q 005599 523 FGGEEIS--TNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELW------ 593 (688)
Q Consensus 523 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~------ 593 (688)
....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~--~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY--VHQLKLILSVLGSPSEE 234 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh--HHHHHHHHHHhCCChhH
Confidence 5433211 11123578899999998865 4689999999999999999999999843211 11111111100
Q ss_pred -----cccccccccccc-ccCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 594 -----SDDKALEIVDSS-MADSCP-----APEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 594 -----~~~~~~~~~d~~-l~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..+...+.++.. .....+ ...+..+.+++.+|++.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 001111111100 000111 123567999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=287.10 Aligned_cols=259 Identities=25% Similarity=0.350 Sum_probs=193.4
Q ss_pred CCCCCccccCCcEeEEEEEeCC-CcEEEEEEccCCCc--ccHHHHHHHHHHHhhc---CCCCccceEEEEEeCCc-----
Q 005599 373 FSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTSG--QGIEEFKNEVLLIAKL---QHRNLVKLLGCCLEKDE----- 441 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 441 (688)
|++.+.||+|+||.||+|+... ++.||+|++..... .....+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667899999999999999764 89999999864322 2234566788777666 59999999999998876
Q ss_pred eeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccce
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 521 (688)
.+++|||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 47888775432 235899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccc-
Q 005599 522 VFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALE- 600 (688)
Q Consensus 522 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~- 600 (688)
....... .....++..|+|||.+.+..++.++||||||+++|||++|++|+..... ...+... ...........
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKI-FDVIGLPSEEEW 230 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHH-HHHcCCCChHhc
Confidence 7643321 1224578899999999999999999999999999999999988753221 1111111 11110000000
Q ss_pred ---------ccccccc---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 601 ---------IVDSSMA---DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 601 ---------~~d~~l~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
....... ..........+.+++.+||+.+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 0011123466789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=300.06 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=198.0
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCC-----c
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD-----E 441 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~ 441 (688)
.++|.+.+.||+|+||.||+|+.. ++..||||.+... .......+.+|+.++..++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888999999999999999854 6899999998653 2334556788999999999999999999886542 4
Q ss_pred eeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccce
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 521 (688)
.++|+||+. ++|..++.. ...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 678777743 345899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCCccccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhc------
Q 005599 522 VFGGEEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWS------ 594 (688)
Q Consensus 522 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~------ 594 (688)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||..... ............
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQLKLITELLGSPSEED 232 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCChHH
Confidence 764332 11223467889999998865 4689999999999999999999999853211 111111111110
Q ss_pred -----ccccccccc-------ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--hcC
Q 005599 595 -----DDKALEIVD-------SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LSN 645 (688)
Q Consensus 595 -----~~~~~~~~d-------~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~ 645 (688)
.+...+.+. .... ......+..+.+++.+||+.+|++|||+.++++. ++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 000000000 0000 0011234668999999999999999999999975 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=295.02 Aligned_cols=268 Identities=24% Similarity=0.310 Sum_probs=203.5
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCC-----cee
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD-----EKM 443 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 443 (688)
+|.+.+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|+.++..++|+||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999875 48899999987543 344567899999999999999999999998875 789
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
+||||++ ++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 578877743 236899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcc-ccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHh--------
Q 005599 524 GGEEI-STNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELW-------- 593 (688)
Q Consensus 524 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~-------- 593 (688)
..... ........++..|+|||.+.+. .++.++||||||+++++|++|+.||..... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY--IDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHhcCCCChhHh
Confidence 54321 1112335678899999999888 799999999999999999999999854321 11111111110
Q ss_pred ---cccccccccccc-ccCC-----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--hcCCCC
Q 005599 594 ---SDDKALEIVDSS-MADS-----CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LSNETS 648 (688)
Q Consensus 594 ---~~~~~~~~~d~~-l~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~~ 648 (688)
......+.+... .... ........+.+++.+||+.+|++||++.+++.. +++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000111111100 0000 011234568999999999999999999999974 655443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=287.05 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=195.7
Q ss_pred CCCCCCccccCCcEeEEEEEe----CCCcEEEEEEccCCC----cccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCce
Q 005599 372 NFSTSNKLGQGGFGPVYKGKL----ANGQEIAVKRLSTTS----GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEK 442 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 442 (688)
+|++.+.||+|+||.||++.. .+|..||+|++.... ....+.+.+|+.++.++ +|+||+++.+++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467789999999999999975 368899999986532 22346788999999999 599999999999999899
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
++|+||+++++|.+++.. ...+++.....++.|+++||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999853 245788888899999999999999987 99999999999999999999999999987
Q ss_pred cCCCccccccccccccCCccCceeecCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccc
Q 005599 523 FGGEEISTNTNRVVGTYGYMSPEYALGG--LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALE 600 (688)
Q Consensus 523 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 600 (688)
....... ......|+..|+|||.+... .++.++||||||+++|+|++|+.|+...... ..............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~---- 228 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSE---- 228 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhccC----
Confidence 6433221 12235688999999998753 4678999999999999999999998543221 11122222111110
Q ss_pred cccccccCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005599 601 IVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 641 (688)
Q Consensus 601 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~ 641 (688)
...+......+.+++.+|++.+|++|| ++.+++.
T Consensus 229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 112223345688999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=302.47 Aligned_cols=247 Identities=24% Similarity=0.387 Sum_probs=194.0
Q ss_pred CCccccCCcEeEEEEEeC-CCcEEEEEEcc--C--CCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCc--eeEEEec
Q 005599 376 SNKLGQGGFGPVYKGKLA-NGQEIAVKRLS--T--TSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE--KMLIYEF 448 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~--~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~e~ 448 (688)
..+||+|+|-+||||... +|-.||=-.++ . ......+.|..|+.+|+.|+|||||+++.+..+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 478999999999999754 46666532221 1 234556889999999999999999999999988766 7789999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECC-CCCceecccccceecCCCc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-EMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~ 527 (688)
|..|+|..|+... +.++.+....++.||++||.|||++. +||||||||-+||+|+. -|.+||+|+|||.......
T Consensus 125 ~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999998543 44788899999999999999999986 68999999999999974 5899999999999876443
Q ss_pred cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 607 (688)
.. ...|||.|||||+.. ..|...+||||||+.++||+|+..|+.- .....+....+.....+.....+-|+
T Consensus 201 ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-C~n~AQIYKKV~SGiKP~sl~kV~dP--- 271 (632)
T KOG0584|consen 201 AK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-CTNPAQIYKKVTSGIKPAALSKVKDP--- 271 (632)
T ss_pred cc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-hCCHHHHHHHHHcCCCHHHhhccCCH---
Confidence 22 378999999999876 8899999999999999999999999731 12222222222222222222222222
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhcC
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSN 645 (688)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~--~L~~ 645 (688)
++.++|.+||.. .++|||+.|++. +|..
T Consensus 272 ---------evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 272 ---------EVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred ---------HHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 578999999999 999999999995 4544
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.15 Aligned_cols=263 Identities=22% Similarity=0.330 Sum_probs=194.4
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCC------
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD------ 440 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 440 (688)
.++|.+.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++..++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368888999999999999999854 6899999998643 2223456889999999999999999999987543
Q ss_pred ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccc
Q 005599 441 EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA 520 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 520 (688)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999864 666554 235789999999999999999999987 999999999999999999999999998
Q ss_pred eecCCCccccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHh------
Q 005599 521 RVFGGEEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELW------ 593 (688)
Q Consensus 521 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~------ 593 (688)
+..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...........
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPGPE 237 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHH
Confidence 764321 123467889999999876 4689999999999999999999999853211 11111111100
Q ss_pred -----ccccccccccc--cc-cCCC---CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--hcCCCC
Q 005599 594 -----SDDKALEIVDS--SM-ADSC---PAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LSNETS 648 (688)
Q Consensus 594 -----~~~~~~~~~d~--~l-~~~~---~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~~ 648 (688)
........++. .. .... .......+.+++.+||+.||++||++.+++.. ++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000000000 00 0000 01123468899999999999999999999943 665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=271.60 Aligned_cols=270 Identities=21% Similarity=0.306 Sum_probs=209.1
Q ss_pred hHHHHHHhcCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCCccceEEEEEeCC
Q 005599 363 LSTVLAATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKD 440 (688)
Q Consensus 363 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 440 (688)
+.++...|+ +.||+|+|+.|--++ +.+|.++|||++.+..........+|++++...+ |+||+.|+.+|+++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 455555553 789999999999885 7789999999998887788889999999999996 999999999999999
Q ss_pred ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCC---ceeccc
Q 005599 441 EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMN---PRISDF 517 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DF 517 (688)
..|||||-|.+|+|..++.+ +..+++.+.-++..+||.||.+||.++ |.||||||+|||..+... +||+||
T Consensus 150 ~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred eEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 99999999999999999854 456889999999999999999999998 999999999999976654 899999
Q ss_pred ccceecCCC--c---cccccccccccCCccCceeec-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCC-----
Q 005599 518 GTARVFGGE--E---ISTNTNRVVGTYGYMSPEYAL-----GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDS----- 582 (688)
Q Consensus 518 Gla~~~~~~--~---~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~----- 582 (688)
.|..-+... - ......+.+|+..|||||+.. ...|..++|.||||||||-||+|-+||....+..
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 987543221 1 112223478899999999763 2358889999999999999999999996543211
Q ss_pred -c---cHHHHHHHHhccccccccccccccCCCCHH----HHHHHHHHHhhcccCCCCCCCCHHHHHH-----HhcCCCCC
Q 005599 583 -S---NLIRYVWELWSDDKALEIVDSSMADSCPAP----EALRCIQVGLLCVQDRTTDRPSMSTVVF-----MLSNETSV 649 (688)
Q Consensus 583 -~---~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~----~~~~~~~l~~~Cl~~~P~~RPt~~evl~-----~L~~~~~~ 649 (688)
+ .-...+.+.+.++. -++|+. .+.+..+|+...+..++.+|-++.+++. +.+...++
T Consensus 304 Ge~Cr~CQ~~LFesIQEGk----------YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekal 373 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGK----------YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKAL 373 (463)
T ss_pred CCccHHHHHHHHHHHhccC----------CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccC
Confidence 0 11111111111111 123443 3566778888999999999999999886 33344455
Q ss_pred CCCC
Q 005599 650 PSPK 653 (688)
Q Consensus 650 ~~p~ 653 (688)
|.|+
T Consensus 374 ptp~ 377 (463)
T KOG0607|consen 374 PTPQ 377 (463)
T ss_pred CCCc
Confidence 5554
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.00 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=196.9
Q ss_pred CCCCccccCCcEeEEEEE-eCCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCCccceEEEEEeCC------ceeEE
Q 005599 374 STSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD------EKMLI 445 (688)
Q Consensus 374 ~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lV 445 (688)
...+.||+|+||.||+|+ -..|+.||||.++... ....+...+|+++|++++|+|||++++.-.+.. ..++|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 345789999999999998 4579999999997643 345677889999999999999999999866544 56899
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEEC--CCC--Cceecccccce
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD--EEM--NPRISDFGTAR 521 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~--~~kl~DFGla~ 521 (688)
||||.+|+|...|........|+..+.+.++.+++.||.|||+++ |+||||||.||++- ++| .-||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 999999999999988888888999999999999999999999988 99999999999983 444 47999999999
Q ss_pred ecCCCccccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccc--cc
Q 005599 522 VFGGEEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD--KA 598 (688)
Q Consensus 522 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~ 598 (688)
.+.... ......||..|.+||.... +.|+..+|.|||||++||.+||..||....... ...+.++...... .+
T Consensus 173 el~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk-~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 173 ELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK-NNKEIMWHIITKKPSGV 248 (732)
T ss_pred cCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc-ccchhhhhhhccCCCce
Confidence 876544 4455899999999999984 889999999999999999999999997554332 1112222222111 11
Q ss_pred cccccccccC------------CCCHHHHHHHHHHHhhcccCCCCCCC
Q 005599 599 LEIVDSSMAD------------SCPAPEALRCIQVGLLCVQDRTTDRP 634 (688)
Q Consensus 599 ~~~~d~~l~~------------~~~~~~~~~~~~l~~~Cl~~~P~~RP 634 (688)
.-..++...+ .........+.+....++..+|++|-
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1111221111 11234455566667777778888886
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=293.04 Aligned_cols=261 Identities=23% Similarity=0.367 Sum_probs=196.6
Q ss_pred HHHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEe-CCce
Q 005599 367 LAATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLE-KDEK 442 (688)
Q Consensus 367 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 442 (688)
...+++|++.+.||.|+||.||++... +++.||||++... .....+.+.+|+.++..++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 456788999999999999999999854 7899999987543 22335678899999999999999999999876 4578
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
++|+||+ +++|..++. ...+++.....++.|+++||.|||+.+ |+||||+|+|||+++++.++|+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 568887773 234778888899999999999999988 99999999999999999999999999875
Q ss_pred cCCCccccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH---------
Q 005599 523 FGGEEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWEL--------- 592 (688)
Q Consensus 523 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~--------- 592 (688)
.... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||..... ..........
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHH
Confidence 4321 122467889999998866 5689999999999999999999999853221 0000001110
Q ss_pred --hccccccccccc-cccCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 593 --WSDDKALEIVDS-SMADSCPA-----PEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 593 --~~~~~~~~~~d~-~l~~~~~~-----~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
...+...+++.. ......+. .....+.+++.+|++.+|++||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 001111111110 00111111 124578999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=284.52 Aligned_cols=241 Identities=26% Similarity=0.323 Sum_probs=186.1
Q ss_pred ccccCCcEeEEEEEeC-CCcEEEEEEccCCCc---ccHHHHHHHHHH---HhhcCCCCccceEEEEEeCCceeEEEeccC
Q 005599 378 KLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG---QGIEEFKNEVLL---IAKLQHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 378 ~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
.||+|+||.||++... +++.||+|.+..... .....+..|..+ +....||||+++.+++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999998865321 122234445443 444579999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+++|..++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999988743 346899999999999999999999987 9999999999999999999999999987553221
Q ss_pred ccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 531 NTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........... ..... .... .
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~------~~~~----~ 217 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTL------TMAV----E 217 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH---HHHhh------ccCC----C
Confidence 2235689999999998754 689999999999999999999999854321111100 00000 0011 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 641 (688)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~ 641 (688)
.+...+..+.+++.+|++.+|.+|| ++.++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1222345789999999999999999 9999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=296.15 Aligned_cols=246 Identities=25% Similarity=0.368 Sum_probs=205.2
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEE
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 445 (688)
....|.+.+.||+|.|++|.+|+.. .+..||||.+.+.. ......+.+|+++|..|+|||||+++.+......+++|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467888999999999999999854 68999999987653 33445689999999999999999999999999999999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
|||+.+|.+.+++....+ +.......++.|+.+|++|||+++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999965543 344777788999999999999998 99999999999999999999999999988763
Q ss_pred CccccccccccccCCccCceeecCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLF-STKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS 604 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 604 (688)
.. .....+|++.|.|||++.+..| ++++|+||+|++||-|+.|..||+.. .+.++-++
T Consensus 208 ~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~------------------~lk~Lr~r 266 (596)
T KOG0586|consen 208 GL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ------------------NLKELRPR 266 (596)
T ss_pred cc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc------------------ccccccch
Confidence 32 3344899999999999999875 67899999999999999999998521 12222222
Q ss_pred cccCC--CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 605 SMADS--CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 605 ~l~~~--~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.+.+. .|.....++.+|++++|-.+|.+|+++.++.+
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 23222 33444567889999999999999999999985
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=287.46 Aligned_cols=249 Identities=27% Similarity=0.359 Sum_probs=201.4
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCceeEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 445 (688)
++|.+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999865 6899999998653 2233467889999999998 99999999999999999999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999998543 36899999999999999999999988 99999999999999999999999999987654
Q ss_pred Cccc------------------cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHH
Q 005599 526 EEIS------------------TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIR 587 (688)
Q Consensus 526 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~ 587 (688)
.... .......++..|+|||.+.+..++.++||||||++++++++|+.|+..... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~ 229 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-----YL 229 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-----HH
Confidence 3221 222235678999999999888899999999999999999999999853321 11
Q ss_pred HHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCH----HHHHH
Q 005599 588 YVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSM----STVVF 641 (688)
Q Consensus 588 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~----~evl~ 641 (688)
....... .....+......+.+++.+||+.+|.+||++ ++++.
T Consensus 230 ~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 TFQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111110 1111222335578999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=315.65 Aligned_cols=276 Identities=19% Similarity=0.263 Sum_probs=217.0
Q ss_pred ehHHHHHHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccC---CCcccHHHHHHHHHHHhhcCCCCccceEEEEE
Q 005599 362 ELSTVLAATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLST---TSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCL 437 (688)
Q Consensus 362 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 437 (688)
...++....++|.++++||+|+||.|..++.+ .++.+|+|++.+ ........|..|-.+|..-+.+-|+.|.-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 34566777899999999999999999999875 578899999976 23345567999999999999999999999999
Q ss_pred eCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccc
Q 005599 438 EKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDF 517 (688)
Q Consensus 438 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 517 (688)
+..++|||||||+||+|..++..- ..++.....-++..|.-||.-||+.| +|||||||+|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999998432 35777777788999999999999998 999999999999999999999999
Q ss_pred ccceecCCCccccccccccccCCccCceeecC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH
Q 005599 518 GTARVFGGEEISTNTNRVVGTYGYMSPEYALG-----GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWEL 592 (688)
Q Consensus 518 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~ 592 (688)
|.+..+..+. .......+|||.|++||++.. +.|+..+|+||+||++|||+.|..||. .+.++.-....
T Consensus 220 GsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY-----adslveTY~KI 293 (1317)
T KOG0612|consen 220 GSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY-----ADSLVETYGKI 293 (1317)
T ss_pred hhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch-----HHHHHHHHHHH
Confidence 9998776443 233445799999999999852 569999999999999999999999984 23444433333
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCC---HHHHHHH--h-----cCCCCCCCCCCCCc
Q 005599 593 WSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPS---MSTVVFM--L-----SNETSVPSPKQPTF 657 (688)
Q Consensus 593 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt---~~evl~~--L-----~~~~~~~~p~~~~~ 657 (688)
+...+...+-+ ....++.+.+||.+.+. +|+.|.. ++++-.. + .++.+..+|-.|..
T Consensus 294 m~hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPev 360 (1317)
T KOG0612|consen 294 MNHKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEV 360 (1317)
T ss_pred hchhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcC
Confidence 33333322221 12345677888887764 7788887 8887752 2 33445566666654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=291.64 Aligned_cols=249 Identities=28% Similarity=0.427 Sum_probs=194.1
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
+.|...+.||+|+||.||+|+.. +++.+|+|.+... ......++.+|+++++.++|+|++++.+++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666789999999999999864 5788999988642 2233457889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+. |+|.+++... ...+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 6777766432 345789999999999999999999987 999999999999999999999999998765422
Q ss_pred ccccccccccccCCccCceeec---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYAL---GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
....+++.|+|||.+. ...++.++|||||||++|||++|+.|+..... . ....... ....
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~---~~~~~~~-~~~~----- 231 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--M---SALYHIA-QNES----- 231 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH--H---HHHHHHh-hcCC-----
Confidence 2346788999999874 35678899999999999999999999743211 0 1111100 0000
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
+.. .+......+.+|+.+||+.+|++||++.+|++..-.
T Consensus 232 ~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 000 112344568899999999999999999999976433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=290.70 Aligned_cols=264 Identities=23% Similarity=0.354 Sum_probs=192.8
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCCccceEEEEEeCC------
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG--QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD------ 440 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 440 (688)
.++|.+.++||+|+||.||+|+.. +++.+|||++..... .....+.+|++++..++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468889999999999999999865 588999998864322 22346788999999999999999999876543
Q ss_pred --ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccc
Q 005599 441 --EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG 518 (688)
Q Consensus 441 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 518 (688)
..++|+||+.. +|...+... ...+++..+..++.|+++||+|||+.+ |+|+||||+|||+++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999875 566665432 346899999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCcccc---------ccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHH
Q 005599 519 TARVFGGEEIST---------NTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRY 588 (688)
Q Consensus 519 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~ 588 (688)
+++......... ......+++.|+|||.+.+. .++.++||||||+++|||++|++||..... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~--~~~~~~ 238 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD--IDQLHL 238 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence 998654322111 11224568889999987654 589999999999999999999999853221 111111
Q ss_pred HHHHhccc---------cccccccccccCCCC-------HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 589 VWELWSDD---------KALEIVDSSMADSCP-------APEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 589 ~~~~~~~~---------~~~~~~d~~l~~~~~-------~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
........ ......+.......+ ......+.+++.+|++.+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111000 000000000000001 112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.63 Aligned_cols=261 Identities=22% Similarity=0.299 Sum_probs=194.4
Q ss_pred cCCC-CCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCccc--------------HHHHHHHHHHHhhcCCCCccceEE
Q 005599 371 DNFS-TSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQG--------------IEEFKNEVLLIAKLQHRNLVKLLG 434 (688)
Q Consensus 371 ~~f~-~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g 434 (688)
++|. +.+.||+|+||+||+|... +++.||||.+....... ...+.+|++++..++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 3477999999999999854 68999999886432211 125778999999999999999999
Q ss_pred EEEeCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCcee
Q 005599 435 CCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRI 514 (688)
Q Consensus 435 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 514 (688)
++...+..++||||++ ++|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 688888743 345889999999999999999999987 999999999999999999999
Q ss_pred cccccceecCCCcc------------ccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCC
Q 005599 515 SDFGTARVFGGEEI------------STNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDD 581 (688)
Q Consensus 515 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~ 581 (688)
+|||+++....... ........+++.|+|||.+.+. .++.++||||||+++|||++|+.|+....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~- 239 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE- 239 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 99999987652111 1111123467889999998765 478999999999999999999999854322
Q ss_pred CccHHHHHHHHhcccccccc---------------ccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 582 SSNLIRYVWELWSDDKALEI---------------VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 582 ~~~l~~~~~~~~~~~~~~~~---------------~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
......+...........+ ...... .........+.+++.+|++.+|++||++.|++.
T Consensus 240 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 -IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred -HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111212111111100000 000000 001122456889999999999999999999996
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=284.12 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=197.0
Q ss_pred CCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
|+..+.||+|++|.||+|+.. +++.+|+|.+.... ....+.+..|+.++++++|+||+++.+++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456688999999999999876 48999999987653 334567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
+ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58999885432 45899999999999999999999987 99999999999999999999999999987643321
Q ss_pred cccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccc------ccc-
Q 005599 530 TNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKA------LEI- 601 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~------~~~- 601 (688)
......++..|+|||.+.+. .++.++||||||++++||++|+.|+..... ................ ..+
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE--IDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 11223457789999998776 789999999999999999999988753221 1111111111000000 000
Q ss_pred -ccccccC-------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 602 -VDSSMAD-------SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 602 -~d~~l~~-------~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.+..... .........+.+++.+||+.+|++||++.+|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 000112457999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=288.94 Aligned_cols=244 Identities=27% Similarity=0.430 Sum_probs=190.5
Q ss_pred CCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 373 FSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG---QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
|...+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|++++..++|||++++.+++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 688999999864322 2345688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+. ++|.+++... ...+++.++..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 5676666432 345899999999999999999999988 99999999999999999999999999864321
Q ss_pred ccccccccccCCccCceeec---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYAL---GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
.....++..|+|||++. ...++.++||||||+++|||++|..|+.... ........... .. +.
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-----~~~~~~~~~~~-~~-----~~ 239 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQN-DS-----PT 239 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhc-CC-----CC
Confidence 22356888999999984 4568889999999999999999999974321 11111111111 00 00
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
. ........+.+++.+||+.+|++||++.+++..
T Consensus 240 ~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 L---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011122458899999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=323.16 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=201.8
Q ss_pred hcCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
+-++.-...||.|.||.||-|. ..+|...|||.+... .........+|+.+|..|+|||+|+++|+-..++..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3456677899999999999997 567888999987543 3344567789999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
|||.+|+|.+.+... ...++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|++|||.|..+...
T Consensus 1314 EyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999998543 33555555668899999999999998 999999999999999999999999999887654
Q ss_pred c--cccccccccccCCccCceeecCCC---CCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccc
Q 005599 527 E--ISTNTNRVVGTYGYMSPEYALGGL---FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 527 ~--~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 601 (688)
. .....+...||+-|||||++.+.. -..++||||+|||++||+||++|+...+.+ ...+-.+..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~V~~---------- 1456 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYHVAA---------- 1456 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhHHhc----------
Confidence 2 233344589999999999998754 566899999999999999999998543321 111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 602 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.-....|...+.+-.+++.+|++.||+.|-++.|+++.
T Consensus 1457 ---gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 ---GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 01123455566677899999999999999888877654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=282.83 Aligned_cols=249 Identities=27% Similarity=0.369 Sum_probs=194.3
Q ss_pred CCCCCCccccCCcEeEEEEEeCC-CcEEEEEEccCC-----CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEE
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTT-----SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 445 (688)
+|.+.+.||+|+||.||+++... +..+++|.++.. ......++..|+.++..++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998643 444555555432 122344677899999999999999999999999999999
Q ss_pred EeccCCCChhhHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 446 YEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
+||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++. +.++|+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888542 23456899999999999999999999987 999999999999975 569999999998764
Q ss_pred CCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccc
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS 604 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 604 (688)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..|+... ............ . .
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~-~-----~- 222 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----NFLSVVLRIVEG-P-----T- 222 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHcC-C-----C-
Confidence 3321 122356788999999998888999999999999999999999997421 112211111110 0 1
Q ss_pred cccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 605 SMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 605 ~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
...+......+.+++.+|++.+|++||++.|+++
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 ---PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1123344567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=295.23 Aligned_cols=265 Identities=23% Similarity=0.296 Sum_probs=196.6
Q ss_pred hHHHHHHhcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeC
Q 005599 363 LSTVLAATDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK 439 (688)
Q Consensus 363 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 439 (688)
..++...+++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.+++||||+++.+++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345667889999999999999999999975 468899999986532 22346688899999999999999999988653
Q ss_pred ------CceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCce
Q 005599 440 ------DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPR 513 (688)
Q Consensus 440 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 513 (688)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 2367788776 7888877732 34889999999999999999999988 99999999999999999999
Q ss_pred ecccccceecCCCccccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHH-
Q 005599 514 ISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWE- 591 (688)
Q Consensus 514 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~- 591 (688)
|+|||+++..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||..... ...+......
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~ 234 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLV 234 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHh
Confidence 9999998764321 223567889999998876 5688999999999999999999999843221 1111111000
Q ss_pred ---------Hhcccccccc---ccccccCC---CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 592 ---------LWSDDKALEI---VDSSMADS---CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 592 ---------~~~~~~~~~~---~d~~l~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.+........ +....... ........+.+++.+|++.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000000000 00000000 00012446889999999999999999999885
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=295.14 Aligned_cols=265 Identities=22% Similarity=0.323 Sum_probs=196.5
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCC----
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD---- 440 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 440 (688)
...++|.+.+.||+|+||.||+|.. .++..||||++... .....+.+.+|+.++.+++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3467899999999999999999975 46889999998543 2233456889999999999999999999987654
Q ss_pred --ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccc
Q 005599 441 --EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG 518 (688)
Q Consensus 441 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 518 (688)
..++|+||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999998 678887773 245889999999999999999999987 9999999999999999999999999
Q ss_pred cceecCCCccccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHH-------
Q 005599 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVW------- 590 (688)
Q Consensus 519 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~------- 590 (688)
++...... .....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||..... ...+.....
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH-LDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCH
Confidence 99765322 122467889999999876 4588999999999999999999999853221 001111000
Q ss_pred ---HHhccccccccccc--ccc----CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhcCC
Q 005599 591 ---ELWSDDKALEIVDS--SMA----DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNE 646 (688)
Q Consensus 591 ---~~~~~~~~~~~~d~--~l~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~--~L~~~ 646 (688)
..+........+.. ... ..........+.+++.+|++.||++|||+.+++. .++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00000000000000 000 0001122345889999999999999999999993 44443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=271.16 Aligned_cols=203 Identities=28% Similarity=0.424 Sum_probs=167.8
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC-----CcEEEEEEccCCCc-c-cHHHHHHHHHHHhhcCCCCccceEEEEEe-CCce
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN-----GQEIAVKRLSTTSG-Q-GIEEFKNEVLLIAKLQHRNLVKLLGCCLE-KDEK 442 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~-~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 442 (688)
..|+....||+|.||.||+|.-.+ ...+|+|+++.... . ......+|+.+++.++||||+.|..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 568888999999999999995332 23789999975422 1 13456899999999999999999999988 6778
Q ss_pred eEEEeccCCCChhhHhhc--cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCC----CCceecc
Q 005599 443 MLIYEFMPNKSLDYFIFD--ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE----MNPRISD 516 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~D 516 (688)
+|++||.+. +|..+++. ....+.++-.....|+.||+.|+.|||++- |+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999876 45555543 233456888889999999999999999998 9999999999999877 8999999
Q ss_pred cccceecCCCccc-cccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCC
Q 005599 517 FGTARVFGGEEIS-TNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGI 577 (688)
Q Consensus 517 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~ 577 (688)
||+++.+...-.. ......+-|..|.|||.+.+. .|+.+.|||+.|||+.||+|-++-|..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999988754332 244457889999999999886 599999999999999999999987754
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=295.02 Aligned_cols=262 Identities=20% Similarity=0.307 Sum_probs=192.4
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeC----------
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK---------- 439 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------- 439 (688)
.+|.+.+.||.|+||.||+|... +++.||+|++........+.+.+|++++.+++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67888999999999999999864 5889999998766656677889999999999999999999776654
Q ss_pred ----CceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECC-CCCcee
Q 005599 440 ----DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-EMNPRI 514 (688)
Q Consensus 440 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl 514 (688)
...++|+||++ ++|..++. ...+++.....++.||+.||.|||+.+ |+||||||+||+++. ++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 34689999997 58877773 235789999999999999999999987 999999999999984 557899
Q ss_pred cccccceecCCCccc-cccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH
Q 005599 515 SDFGTARVFGGEEIS-TNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWEL 592 (688)
Q Consensus 515 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~ 592 (688)
+|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+.. .........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~~~ 235 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILESV 235 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhc
Confidence 999999866432111 11122457889999998754 568889999999999999999999985332110 000000000
Q ss_pred hc--c---ccccccccc-----cccCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 593 WS--D---DKALEIVDS-----SMADSCP-----APEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 593 ~~--~---~~~~~~~d~-----~l~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.. . ......+.. ......+ .....++.+++.+|++.+|++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00 0 000000000 0000001 112356889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=265.27 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=192.4
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCceeEEEe
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 447 (688)
++.+.+..||.|..|.|++.+.. .|..+|||.+.... ....+++...+.++.+-+ .|.||+.+|+|..+....+.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34455678999999999999865 58899999997654 445666777777776665 8999999999999999999999
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCc
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 527 (688)
.|. ..++.+|.. ..+++++...-++...+.+||.||.+++ +|||||+||+|||+|+.|++||+|||++-.+.+..
T Consensus 172 lMs-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 884 344444432 2345788778889999999999999876 69999999999999999999999999997765443
Q ss_pred cccccccccccCCccCceeecCC---CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccc
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGG---LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS 604 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 604 (688)
.. ++..|-+.|||||.+.-. .|..++||||||+.|+||.||+.|+..-..+-+. +....+++ -+
T Consensus 247 Ah---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~----ltkvln~e------PP 313 (391)
T KOG0983|consen 247 AH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV----LTKVLNEE------PP 313 (391)
T ss_pred cc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH----HHHHHhcC------CC
Confidence 32 236788999999998643 5888999999999999999999998542222111 11111111 12
Q ss_pred cccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 605 SMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 605 ~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.+.+. ...+..+++++..||++|+.+||...++++
T Consensus 314 ~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 314 LLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 22211 124557899999999999999999999875
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=286.32 Aligned_cols=261 Identities=23% Similarity=0.289 Sum_probs=190.4
Q ss_pred CCCCCCccccCCcEeEEEEEeC-C--CcEEEEEEccCC--CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeC----Cc
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-N--GQEIAVKRLSTT--SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEK----DE 441 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~--~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 441 (688)
+|.+.+.||+|+||.||+++.. . +..||||++... .....+.+.+|+.++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999865 3 678999998643 222356788999999999 599999999976543 34
Q ss_pred eeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccce
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 521 (688)
.++++||++ ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 688888742 346889999999999999999999988 9999999999999999999999999998
Q ss_pred ecCCCccc--cccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHh-----
Q 005599 522 VFGGEEIS--TNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELW----- 593 (688)
Q Consensus 522 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~----- 593 (688)
.+...... .......|+..|+|||.+.+ ..++.++|+||||+++++|++|+.||...... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--DQLNQILQVLGTPDE 231 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--HHHHHHHHHhCCCCH
Confidence 66432211 11233578999999998765 46899999999999999999999998543210 1111111000
Q ss_pred ------cccccccccc---ccccC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 594 ------SDDKALEIVD---SSMAD---SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 594 ------~~~~~~~~~d---~~l~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
........+. ..-.. .........+.+++.+|++.+|++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 00000 000112456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=310.05 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=187.7
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCCccceEEEEEeC------
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK------ 439 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 439 (688)
.-.++|+.++.||+||||.|||++.+ ||+.+|||++... +........+|+.+|++|+|||||+++....+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44577888999999999999999865 8999999999655 334455678899999999999999987532110
Q ss_pred --------------------------------------------------------------------------------
Q 005599 440 -------------------------------------------------------------------------------- 439 (688)
Q Consensus 440 -------------------------------------------------------------------------------- 439 (688)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHh
Q 005599 440 ---------------------------------DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486 (688)
Q Consensus 440 ---------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL 486 (688)
.-+|+-||||+...|.+++....... .-...++++.+|++||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 01256688888888877774432211 3566788999999999999
Q ss_pred hcCCCCCeEecCCCCCceEECCCCCceecccccceecC----C------------CccccccccccccCCccCceeecCC
Q 005599 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG----G------------EEISTNTNRVVGTYGYMSPEYALGG 550 (688)
Q Consensus 487 H~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~ 550 (688)
|+.+ ||||||||.||+|+++..+||+|||+|.... . .......+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9998 9999999999999999999999999998621 0 0011123457899999999999775
Q ss_pred C---CCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC--CCCHHHHHHHHHHHhhc
Q 005599 551 L---FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD--SCPAPEALRCIQVGLLC 625 (688)
Q Consensus 551 ~---~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~~~~l~~~C 625 (688)
. |+.|+|+|||||||+||+.- |+... +.+.. +..+-+..+.. .+..++...-.+++.++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsM-------ERa~i------L~~LR~g~iP~~~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLYP---FGTSM-------ERASI------LTNLRKGSIPEPADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhcc---CCchH-------HHHHH------HHhcccCCCCCCcccccccchHHHHHHHHH
Confidence 4 99999999999999999963 43211 11111 11111222211 12334555678999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 005599 626 VQDRTTDRPSMSTVVF 641 (688)
Q Consensus 626 l~~~P~~RPt~~evl~ 641 (688)
++.||.+|||+.|++.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999874
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=291.33 Aligned_cols=258 Identities=25% Similarity=0.347 Sum_probs=195.2
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCc----
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE---- 441 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 441 (688)
..++|.+.+.||+|++|.||+|+.. +++.||||++... .....+.+.+|+.++++++|+||+++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578888999999999999999875 5789999998643 22334567889999999999999999998876654
Q ss_pred --eeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccc
Q 005599 442 --KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGT 519 (688)
Q Consensus 442 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 519 (688)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5689888743 45899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCccccccccccccCCccCceeecC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH------
Q 005599 520 ARVFGGEEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWEL------ 592 (688)
Q Consensus 520 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~------ 592 (688)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ..........
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCH
Confidence 9865432 223467889999998865 3678999999999999999999999853211 1111111110
Q ss_pred -----hcccccccccccccc---CC---CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 593 -----WSDDKALEIVDSSMA---DS---CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 593 -----~~~~~~~~~~d~~l~---~~---~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+.......++..... .. .....+..+.+++.+|++.+|++|||+.+|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000011110000 00 00112567899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=271.36 Aligned_cols=236 Identities=27% Similarity=0.345 Sum_probs=191.7
Q ss_pred cccCCcEeEEEEEeC-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCCh
Q 005599 379 LGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG---QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL 454 (688)
Q Consensus 379 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 454 (688)
||.|+||.||++... +++.+|+|.+..... ...+.+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 488999999865432 2456789999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccccccc
Q 005599 455 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR 534 (688)
Q Consensus 455 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 534 (688)
.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9998533 35899999999999999999999987 9999999999999999999999999998764332 12233
Q ss_pred ccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHH
Q 005599 535 VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPE 614 (688)
Q Consensus 535 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 614 (688)
..++..|+|||.+.+...+.++|+||||+++|||++|+.|+..... ... ...... .. ...+...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~---~~~~~~---------~~--~~~~~~~ 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEI---YEKILK---------DP--LRFPEFL 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHH---HHHHhc---------CC--CCCCCCC
Confidence 5678899999999988899999999999999999999999853221 111 111111 00 1122222
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHH
Q 005599 615 ALRCIQVGLLCVQDRTTDRPSMST 638 (688)
Q Consensus 615 ~~~~~~l~~~Cl~~~P~~RPt~~e 638 (688)
...+.+++.+|+..+|++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 457889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=274.24 Aligned_cols=241 Identities=25% Similarity=0.352 Sum_probs=194.4
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 445 (688)
.+|..+.+||+|+||.|.+|.-+ ..+.+|||++++.. ..+.+--+.|-++|+.. +-|.++++..+|+.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888999999999999999765 35679999997652 23445556788888877 567899999999999999999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
|||+.+|+|..++.+-.+ +.+....-++.+||-||-+||+.+ ||.||||.+|||||.+|++||+|||+++.---
T Consensus 429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999888865432 455667779999999999999998 99999999999999999999999999985322
Q ss_pred CccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
. ...+.+.+|||.|+|||++..++|+..+|+|||||+||||+.|++||+..+ +..+... +.+..
T Consensus 503 ~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD--E~elF~a------------I~ehn 566 (683)
T KOG0696|consen 503 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--EDELFQA------------IMEHN 566 (683)
T ss_pred C--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHH------------HHHcc
Confidence 2 233445899999999999999999999999999999999999999986432 2222221 12222
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCC
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPS 635 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt 635 (688)
. .+|...+.+...+....+.+.|.+|..
T Consensus 567 v--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 V--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred C--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 1 245556677888888889999999863
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=304.98 Aligned_cols=145 Identities=25% Similarity=0.399 Sum_probs=129.7
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
++|.+.++||+|+||.||+|... +++.||||++.... ....+.+..|+.++..++|+||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888899999999999999875 68899999986542 223467889999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccce
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 521 (688)
||+++++|..++... ..+++...+.++.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998532 35788899999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=269.03 Aligned_cols=221 Identities=20% Similarity=0.149 Sum_probs=176.6
Q ss_pred CCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCChhhHhhc
Q 005599 382 GGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFD 460 (688)
Q Consensus 382 G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 460 (688)
|.+|.||++... +++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999864 68899999986542 344556666667899999999999999999999999999999998854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccccccccccCC
Q 005599 461 ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540 (688)
Q Consensus 461 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 540 (688)
. ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++++|||++...... .....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 3 34899999999999999999999987 999999999999999999999999988655422 112345678
Q ss_pred ccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHH
Q 005599 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQ 620 (688)
Q Consensus 541 y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 620 (688)
|+|||.+.+..++.++||||+|++++||++|+.|+...... .... .....+......+.+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------------~~~~----~~~~~~~~~~~~~~~ 207 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------------INTH----TTLNIPEWVSEEARS 207 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------------cccc----cccCCcccCCHHHHH
Confidence 99999998888999999999999999999999875321100 0000 000122233456889
Q ss_pred HHhhcccCCCCCCCCHHH
Q 005599 621 VGLLCVQDRTTDRPSMST 638 (688)
Q Consensus 621 l~~~Cl~~~P~~RPt~~e 638 (688)
++.+|++.||++||++.+
T Consensus 208 li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 208 LLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHccCCHHHhcCCCc
Confidence 999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=261.88 Aligned_cols=250 Identities=22% Similarity=0.241 Sum_probs=196.6
Q ss_pred HHhcCCCCC-CccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCCccceEEEEEeC----C
Q 005599 368 AATDNFSTS-NKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEK----D 440 (688)
Q Consensus 368 ~~~~~f~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~ 440 (688)
..+++|.+. ++||-|-.|.|-....+ +++.+|+|++... ...++|+++.... .|||||.+++++.+. .
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 356677655 68999999999998654 6889999999543 4568899988777 599999999998753 3
Q ss_pred ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEEC---CCCCceeccc
Q 005599 441 EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EEMNPRISDF 517 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DF 517 (688)
.+++|||.|++|.|...+.+. ..+.+++.+.-.|+.||+.|+.|||+.+ |.||||||+|+|.. .+..+||+||
T Consensus 133 cLLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 567899999999999888654 3457899999999999999999999998 99999999999996 4557999999
Q ss_pred ccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccc
Q 005599 518 GTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK 597 (688)
Q Consensus 518 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 597 (688)
|+|+.... .....+.+-||.|.|||++...+|+...|+||+||++|-|++|-+||..... ..+..-+......+
T Consensus 209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~g- 282 (400)
T KOG0604|consen 209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRTG- 282 (400)
T ss_pred ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhcc-
Confidence 99986543 2233347889999999999999999999999999999999999999843221 11111111111111
Q ss_pred ccccccccccCCCCHH----HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 598 ALEIVDSSMADSCPAP----EALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 598 ~~~~~d~~l~~~~~~~----~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.-.+|.+ .++...++++..|..+|.+|.|+.+++.
T Consensus 283 ---------qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 283 ---------QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ---------CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 0123333 3677889999999999999999999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=287.47 Aligned_cols=240 Identities=22% Similarity=0.250 Sum_probs=193.2
Q ss_pred HhcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEEE
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 446 (688)
.++.|.+...+|.|+|+.|-++.. .+++..+||++..... +-.+|+.++... +||||+++.+.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 367788888999999999999874 4688999999976522 234567666655 6999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEE-CCCCCceecccccceecCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL-DEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DFGla~~~~~ 525 (688)
|.+.++-|.+.+.... ....++..|+.+|+.++.|||+++ ||||||||+|||+ +..++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877774322 222777789999999999999988 9999999999999 6999999999999987765
Q ss_pred CccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
. ....+-|..|.|||++....|++++|+||||++||+||+|+.|+.....+ .+ +...+
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~e----i~~~i------------ 526 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IE----IHTRI------------ 526 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HH----HHHhh------------
Confidence 4 22356788999999999999999999999999999999999998643322 11 11111
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..+......+..+.+|+.+||+.||.+||+|.++..
T Consensus 527 ~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 527 QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 112222445567899999999999999999999874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=274.64 Aligned_cols=255 Identities=26% Similarity=0.399 Sum_probs=196.0
Q ss_pred cCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCC-Ccc------cHHHHHHHHHHHhhcCCCCccceEEEEEeC-Cc
Q 005599 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTT-SGQ------GIEEFKNEVLLIAKLQHRNLVKLLGCCLEK-DE 441 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~-~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~ 441 (688)
++|-.+++||+|+|+.||+|. +...+.||||+-... +.. -.+...+|..+.+.|.||.||++++++.-+ +.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 456677899999999999996 556788999975432 111 134567899999999999999999999755 56
Q ss_pred eeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEEC---CCCCceecccc
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EEMNPRISDFG 518 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFG 518 (688)
+|-|+||+++.+|+.+|. ..+.+++++...|+.||+.||.||.+.. ++|||-||||.||||- .-|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 889999999999999994 4567899999999999999999999875 6899999999999995 45789999999
Q ss_pred cceecCCCccc-----cccccccccCCccCceeecCC----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHH
Q 005599 519 TARVFGGEEIS-----TNTNRVVGTYGYMSPEYALGG----LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYV 589 (688)
Q Consensus 519 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~ 589 (688)
|++.+..+.+. ..+....||.+|++||.+.-+ .++.|+||||.|||+|..+.|+.||+..... .++..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-QdILq-- 695 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-QDILQ-- 695 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-HHHHh--
Confidence 99998765443 234457899999999987533 5789999999999999999999999642211 11111
Q ss_pred HHHhcccccccccccc-ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 005599 590 WELWSDDKALEIVDSS-MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV 640 (688)
Q Consensus 590 ~~~~~~~~~~~~~d~~-l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 640 (688)
... ++... +.-+.-+....+...++.+||+..-++|....++.
T Consensus 696 -----eNT---IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 -----ENT---ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -----hhc---hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111 11111 11111122345678899999999999998877754
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-33 Score=265.06 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=192.9
Q ss_pred CCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEEEeccC
Q 005599 374 STSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 374 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
+-+..||.|+||+|+|-.++ .|+..|||+++.... .+.++++.|.+...+- +.||||+++|.+..++..++.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 33568999999999998754 689999999987644 5677888898876665 6999999999999999999999999
Q ss_pred CCChhhHhh--ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 451 NKSLDYFIF--DESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 451 ~gsL~~~l~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
..+|+.+-. ...++..+++.-.-+|.....+||.||.+.- .|||||+||+||||+..|.+||+|||++-.+...-
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si- 222 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI- 222 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH-
Confidence 456654432 1223455788888888889999999998764 69999999999999999999999999987654322
Q ss_pred ccccccccccCCccCceeecCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYALGG--LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
..+...|-..|||||.+... .|..++||||||++|+|+.||+.|+....+ ..+.+......+.- ++..
T Consensus 223 --AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~gdpp--~l~~-- 292 (361)
T KOG1006|consen 223 --AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVIGDPP--ILLF-- 292 (361)
T ss_pred --HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHcCCCC--eecC--
Confidence 22335788899999998643 488999999999999999999999754322 22222222221110 0110
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
..........++.++..|+.+|-.+||...++.++
T Consensus 293 -~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 -DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11112345679999999999999999999998753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=263.35 Aligned_cols=238 Identities=27% Similarity=0.347 Sum_probs=192.4
Q ss_pred CcEeEEEEEeCC-CcEEEEEEccCCCccc-HHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCChhhHhhc
Q 005599 383 GFGPVYKGKLAN-GQEIAVKRLSTTSGQG-IEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFD 460 (688)
Q Consensus 383 ~fg~Vy~~~~~~-~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 460 (688)
+||.||+|+..+ ++.+|+|++....... .+.+.+|++.+.+++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8999999997665444 78999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccccccccccCC
Q 005599 461 ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540 (688)
Q Consensus 461 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 540 (688)
.. .+++..+..++.+++.+|.|||..+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 32 2889999999999999999999987 9999999999999999999999999998765432 2233567889
Q ss_pred ccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHH
Q 005599 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQ 620 (688)
Q Consensus 541 y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 620 (688)
|+|||.+.+..++.++||||||+++++|++|..|+....+ ....... ........ . .........+.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-~~~~~~~----~~~~~~~~----~---~~~~~~~~~~~~ 219 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-LLELFKK----IGKPKPPF----P---PPEWKISPEAKD 219 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHH----HhccCCCC----c---cccccCCHHHHH
Confidence 9999999988899999999999999999999999754211 1111111 11111000 0 000003457899
Q ss_pred HHhhcccCCCCCCCCHHHHHH
Q 005599 621 VGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 621 l~~~Cl~~~P~~RPt~~evl~ 641 (688)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=259.80 Aligned_cols=291 Identities=22% Similarity=0.353 Sum_probs=219.4
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeE
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 444 (688)
-++|.++.+||+|+|..|-++++. +.+.+|+|++++. .....+=...|-.+..+. +||.+|-|..+|+.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 367888999999999999999865 5778999988653 233344456677777666 79999999999999999999
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
|.||+++|+|.-++ .+.+.+++....-+...|.-||.|||+.+ ||.||||..|||||.+|++||+|+|+++.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999996665 34455777777778899999999999998 9999999999999999999999999998532
Q ss_pred CCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCC--CCccHHHHHHHHhccccccccc
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFND--DSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~~ 602 (688)
.. ...+.+.+|||.|+|||++.+..|+..+|.|+|||+++||+.|+.||++.+. ...+..+++.....+.
T Consensus 403 ~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek------ 474 (593)
T KOG0695|consen 403 GP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK------ 474 (593)
T ss_pred CC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh------
Confidence 22 2344568999999999999999999999999999999999999999987652 2334444554433322
Q ss_pred cccccCCCCHHHHHHHHHHHhhcccCCCCCCCC------HHHHH----------HHhcCCCCCCCCCCCCcccc--ceec
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPS------MSTVV----------FMLSNETSVPSPKQPTFSVR--KIEI 664 (688)
Q Consensus 603 d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt------~~evl----------~~L~~~~~~~~p~~~~~~~~--~~~~ 664 (688)
.++ .|...+.+...+...-+.+||.+|.. +.++- ++|++ +.+.+|-+|...-. ....
T Consensus 475 --qir--iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq-k~v~ppf~p~i~~d~~l~~f 549 (593)
T KOG0695|consen 475 --QIR--IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ-KQVLPPFQPQITDDYGLDNF 549 (593)
T ss_pred --ccc--ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh-cccCCCCCCccccccCcccc
Confidence 121 34444556677888889999998853 33332 34443 34445555655432 3367
Q ss_pred ccCCCCCCcccCCCe
Q 005599 665 DTDYSSTGTKSSANE 679 (688)
Q Consensus 665 ~~~~~~~~~~~~~~~ 679 (688)
+++..+-..|.++.+
T Consensus 550 d~qft~e~~qltpdd 564 (593)
T KOG0695|consen 550 DTQFTSEPVQLTPDD 564 (593)
T ss_pred ccccccCCcccCCCC
Confidence 777766666666543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=278.31 Aligned_cols=242 Identities=25% Similarity=0.368 Sum_probs=191.5
Q ss_pred CCccccCCcEeEEEEEe-CCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCC
Q 005599 376 SNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNK 452 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 452 (688)
.+.||+|-||+||-|+. ++|+.||||++.+. ......++++|+.+|.+++||.||.|.-.|+..+..++|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 47999999999999975 47999999998653 33445789999999999999999999999999999999999995 4
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCC---CCceecccccceecCCCccc
Q 005599 453 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE---MNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 453 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFGla~~~~~~~~~ 529 (688)
+..+.+.... +..++.....-++.||+.||.|||.++ |+|+||||+||||... .++||+|||.|+.++.....
T Consensus 648 DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 648 DMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 5445544332 334777777778999999999999998 9999999999999643 47999999999998765543
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 609 (688)
. ..+|||.|+|||++.+..|...-|+||.|||+|--++|..||....+..+++.. + .++-+ .
T Consensus 724 r---sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN-A----------aFMyP----p 785 (888)
T KOG4236|consen 724 R---SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN-A----------AFMYP----P 785 (888)
T ss_pred h---hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhc-c----------ccccC----C
Confidence 3 379999999999999999999999999999999999999998543322211110 0 11111 1
Q ss_pred CCH-HHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 005599 610 CPA-PEALRCIQVGLLCVQDRTTDRPSMSTVV 640 (688)
Q Consensus 610 ~~~-~~~~~~~~l~~~Cl~~~P~~RPt~~evl 640 (688)
.|. +.....++|+...||..-++|-+...-+
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 122 3345678888889998888888877654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=284.76 Aligned_cols=261 Identities=20% Similarity=0.269 Sum_probs=181.0
Q ss_pred HhcCCCCCCccccCCcEeEEEEEe-----------------CCCcEEEEEEccCCCcccHHH--------------HHHH
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKL-----------------ANGQEIAVKRLSTTSGQGIEE--------------FKNE 417 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E 417 (688)
..++|.+.++||+|+||.||+|.. .+++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 235689999986543222223 3457
Q ss_pred HHHHhhcCCCCc-----cceEEEEEe--------CCceeEEEeccCCCChhhHhhccC---------------------C
Q 005599 418 VLLIAKLQHRNL-----VKLLGCCLE--------KDEKMLIYEFMPNKSLDYFIFDES---------------------R 463 (688)
Q Consensus 418 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~---------------------~ 463 (688)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 778888764 356899999999999999886421 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccccccccccCCccC
Q 005599 464 KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMS 543 (688)
Q Consensus 464 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 543 (688)
...++|..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123567888999999999999999987 99999999999999999999999999976543211 11112344789999
Q ss_pred ceeecCCCC----------------------CCcccchhHHHHHHHHHhCCC-CCCCCCCCCccHHH-----HHHHHhcc
Q 005599 544 PEYALGGLF----------------------STKSDVFSFGVLLLEIITGKK-NTGIFNDDSSNLIR-----YVWELWSD 595 (688)
Q Consensus 544 PE~~~~~~~----------------------s~k~DvwSlGvll~elltG~~-p~~~~~~~~~~l~~-----~~~~~~~~ 595 (688)
||.+..... ..+.||||+||+++||++|.. |+.....-...+.. ..+.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998754321 134799999999999999875 54321100000000 01111111
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHhhcccCCC---CCCCCHHHHHH
Q 005599 596 DKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRT---TDRPSMSTVVF 641 (688)
Q Consensus 596 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P---~~RPt~~evl~ 641 (688)
.. .+ -...........+|+.+++..+| .+|+|+.|+++
T Consensus 459 ~~----~~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QK----YD----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cC----CC----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11 01 01112234567889999998766 68999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=292.49 Aligned_cols=259 Identities=20% Similarity=0.260 Sum_probs=167.4
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeCC-----CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEE------EE
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLAN-----GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGC------CL 437 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 437 (688)
..++|.+.++||+|+||.||+|++.+ +..||||++..... .+.+..| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999998754 68999998754321 1222222 1122222233222221 24
Q ss_pred eCCceeEEEeccCCCChhhHhhccCCC-----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCC
Q 005599 438 EKDEKMLIYEFMPNKSLDYFIFDESRK-----------------QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLK 500 (688)
Q Consensus 438 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk 500 (688)
.....+||+||+++++|.+++...... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556789999999999999888543210 01112345578999999999999987 9999999
Q ss_pred CCceEECC-CCCceecccccceecCCCccccccccccccCCccCceeecCC----------------------CCCCccc
Q 005599 501 ASNILLDE-EMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG----------------------LFSTKSD 557 (688)
Q Consensus 501 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~k~D 557 (688)
|+|||++. ++.+||+|||+++.+..... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 57899999999986543221 122346789999999965322 2345679
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccc-c---cccccccccC------CCCHHHHHHHHHHHhhccc
Q 005599 558 VFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK-A---LEIVDSSMAD------SCPAPEALRCIQVGLLCVQ 627 (688)
Q Consensus 558 vwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-~---~~~~d~~l~~------~~~~~~~~~~~~l~~~Cl~ 627 (688)
||||||+||||+++..+... .+..........+. . ...+.+.... ...........+|+.+||+
T Consensus 362 VwSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999997665321 11111111100000 0 0011111000 0000112245589999999
Q ss_pred CCCCCCCCHHHHHH
Q 005599 628 DRTTDRPSMSTVVF 641 (688)
Q Consensus 628 ~~P~~RPt~~evl~ 641 (688)
.||++|||+.++++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999996
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=234.92 Aligned_cols=262 Identities=24% Similarity=0.337 Sum_probs=191.4
Q ss_pred CCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+|...++||+|.||+||+|+.. .++.||+|+++..+ ........+|+-+|+.++|.|||+++++...+...-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3455689999999999999854 57889999986543 22345678999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
|. .+|..+.. +-+..++.+....++.|+++||.++|+.+ +.||||||.|+|++.+|++|++|||+++.++-.-.
T Consensus 83 cd-qdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 95 45555542 23456888889999999999999999998 99999999999999999999999999997753321
Q ss_pred ccccccccccCCccCceeecCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhc--ccc---ccccc
Q 005599 529 STNTNRVVGTYGYMSPEYALGGL-FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWS--DDK---ALEIV 602 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~--~~~---~~~~~ 602 (688)
-....+.|..|.+|.++.+.+ |+...|+||-||++.|+....+|.-...+-..++....+..-. ++. +..+-
T Consensus 157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 112245689999999998865 8999999999999999999655543333333344433332211 111 11222
Q ss_pred cccccCCCCH---------HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 603 DSSMADSCPA---------PEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 603 d~~l~~~~~~---------~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
|......+|. .....=.+|....+.-+|.+|.++++.++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2222111111 11122345666667779999999988764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=282.05 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=209.4
Q ss_pred ehHHHHHHhcCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCCccceEEEEEe-
Q 005599 362 ELSTVLAATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLE- 438 (688)
Q Consensus 362 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 438 (688)
.++.+...++.|++.+.||.|.+|.||+++ .++++.+|||++... ....++...|..+|+.+ .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344444566788999999999999999997 457889999988554 33446788899999888 69999999999875
Q ss_pred ----CCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCcee
Q 005599 439 ----KDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRI 514 (688)
Q Consensus 439 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 514 (688)
+++++||||||.+|+.-+++..-. ...+.|..+.-|+..++.||.+||.+. +||||||-.||||+.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 467999999999999999986654 566899999999999999999999987 999999999999999999999
Q ss_pred cccccceecCCCccccccccccccCCccCceeecCC-----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHH
Q 005599 515 SDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG-----LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYV 589 (688)
Q Consensus 515 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~ 589 (688)
.|||++..+.. .....++..|||.|||||++.-. .|+..+|+||||++..||--|.+|+.-.+. +
T Consensus 165 vDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--------m 234 (953)
T KOG0587|consen 165 VDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--------M 234 (953)
T ss_pred eeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch--------h
Confidence 99999987643 23344568999999999998543 477789999999999999999999632111 1
Q ss_pred HHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 590 WELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 590 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
+.++.- .-.|......|..-..++.+++..||.+|-++||++.++++
T Consensus 235 raLF~I-----pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 RALFLI-----PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hhhccC-----CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111110 01222233346677889999999999999999999999884
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=283.41 Aligned_cols=245 Identities=25% Similarity=0.357 Sum_probs=186.6
Q ss_pred CCCCCccccCCcE-eEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCceeEEEeccC
Q 005599 373 FSTSNKLGQGGFG-PVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 373 f~~~~~LG~G~fg-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
|...+.+|.|+-| .||+|.. +|+.||||++-.. ...-..+|+..|..- +|||||++++.-.+.+..|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 4445788999998 5899998 5899999998532 233457899999988 5999999999999999999999999
Q ss_pred CCChhhHhhccCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECC---C--CCceecccccceecC
Q 005599 451 NKSLDYFIFDESRK-QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---E--MNPRISDFGTARVFG 524 (688)
Q Consensus 451 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~--~~~kl~DFGla~~~~ 524 (688)
..+|.+++...... ....-...+.++.|+++||++||+.+ ||||||||.||||+. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 57899998653111 11111344678899999999999987 999999999999976 2 469999999999887
Q ss_pred CCccc-cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhC-CCCCCCCCCCCccHHHHHHHHhccccccccc
Q 005599 525 GEEIS-TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITG-KKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 525 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 602 (688)
..... .......||-+|+|||++....-+.++||||+|||+|+.++| .+||+-.-... +.- .........+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~------~NI-l~~~~~L~~L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ------ANI-LTGNYTLVHL 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh------hhh-hcCccceeee
Confidence 65433 234557899999999999999989999999999999999995 89986321111 111 1111111111
Q ss_pred cccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV 640 (688)
Q Consensus 603 d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 640 (688)
.+ ..++ +..+||.+|+..+|..||++.+|+
T Consensus 736 ~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 736 EP------LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred cc------CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 11 1111 788999999999999999999998
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=261.34 Aligned_cols=260 Identities=19% Similarity=0.248 Sum_probs=198.2
Q ss_pred hcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCC--C----CccceEEEEEeCCce
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQH--R----NLVKLLGCCLEKDEK 442 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~g~~~~~~~~ 442 (688)
+++|.+...+|+|.||.|-..... .+..||||+++... .-.+..+-|+++|.++.+ | -+|.+.++|.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 789999999999999999998643 47899999986533 334566789999999942 3 378888999999999
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEEC---------------
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD--------------- 507 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--------------- 507 (688)
++|+|.+ +-|+.++|... .-.+++...+..|+.|+++++++||+.. ++|-||||+|||+.
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999987 55888898543 3456788999999999999999999988 99999999999983
Q ss_pred -----CCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCC
Q 005599 508 -----EEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDS 582 (688)
Q Consensus 508 -----~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~ 582 (688)
++..+||+|||.|..-.... ...+.|..|.|||++.+-.++.++||||+||||.||.||..-|..-+ +.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe-n~ 315 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE-NL 315 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC-cH
Confidence 13458999999998754433 34788999999999999999999999999999999999999876533 22
Q ss_pred ccH--HHHHH--------HHh------ccc-----------cccccccccc----cCCCCHHHHHHHHHHHhhcccCCCC
Q 005599 583 SNL--IRYVW--------ELW------SDD-----------KALEIVDSSM----ADSCPAPEALRCIQVGLLCVQDRTT 631 (688)
Q Consensus 583 ~~l--~~~~~--------~~~------~~~-----------~~~~~~d~~l----~~~~~~~~~~~~~~l~~~Cl~~~P~ 631 (688)
+.| ++.+. ... ..+ +...+.++-. .......+...+.+|+..+|..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 211 11110 000 000 0001111100 0112456778899999999999999
Q ss_pred CCCCHHHHHH
Q 005599 632 DRPSMSTVVF 641 (688)
Q Consensus 632 ~RPt~~evl~ 641 (688)
+|+|+.|++.
T Consensus 396 ~RiTl~EAL~ 405 (415)
T KOG0671|consen 396 RRITLREALS 405 (415)
T ss_pred ccccHHHHhc
Confidence 9999999875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=269.22 Aligned_cols=204 Identities=22% Similarity=0.349 Sum_probs=172.3
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCcee
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSG---QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKM 443 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 443 (688)
....-|..++.||-|+||+|-++.. ++...+|+|.|++.+. ......+.|..||.....+-||+|+-.|.+++.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 3345677889999999999999964 4466789999977643 34556788999999999999999999999999999
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
+||+|+++|++..+|... ..+++....-++.++..|+++.|..+ +|||||||+|||||.+|++||+||||+.-+
T Consensus 706 FVMdYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEEeccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 999999999999998543 45777777788999999999999988 999999999999999999999999998532
Q ss_pred ---------CCCccc-------------------------------cccccccccCCccCceeecCCCCCCcccchhHHH
Q 005599 524 ---------GGEEIS-------------------------------TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGV 563 (688)
Q Consensus 524 ---------~~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGv 563 (688)
...+.. ......+||+.|+|||++....++..+|+||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 110000 0112368999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCC
Q 005599 564 LLLEIITGKKNTGI 577 (688)
Q Consensus 564 ll~elltG~~p~~~ 577 (688)
|||||+.|+.||-.
T Consensus 860 il~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLA 873 (1034)
T ss_pred HHHHHhhCCCCccC
Confidence 99999999999854
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=224.25 Aligned_cols=110 Identities=50% Similarity=1.159 Sum_probs=105.8
Q ss_pred EEeccCCCccccCccccceeeeeEEEEeeCCceEEEEEEecCCCceeeEEEcccCceEEEeeecCCcceEEEeecCCCCC
Q 005599 51 WRAGSWTGQRLSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETGFEQRFTWSSQDRRWIGFWTAPKEQC 130 (688)
Q Consensus 51 w~sg~w~g~~~~~~p~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~r~~l~~~G~~~~~~w~~~~~~w~~~~~~~~~~C 130 (688)
||||||||.+|+|+|+|....++.+.|+.+++|.+|+|.+.+.+.++|++||.+|+++++.|.+..+.|..+|.+|.|+|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 89999999999999999988999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCccCCCCCCCCccccccCCCCcCC
Q 005599 131 DYYGHCGPNSNCSPYHADEFECTCLPGFEPKY 162 (688)
Q Consensus 131 ~~~~~Cg~~~~C~~~~~~~~~C~C~~gf~~~~ 162 (688)
|+|+.||+||+|+.+..+ .|.|++||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~--~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSP--KCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCC--ceECCCCcCCCc
Confidence 999999999999877666 899999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-31 Score=251.71 Aligned_cols=263 Identities=23% Similarity=0.397 Sum_probs=188.4
Q ss_pred cCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCC-c-ccHHHHHHHHHHHhhcCCCCccceEEEEEeC--------
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-G-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK-------- 439 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 439 (688)
..|+...+||+|.||+||+|+.. .|+.||+|++.... . .-.....+|+++|..|+|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34555689999999999999865 57788998764321 1 1234557899999999999999999887643
Q ss_pred CceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccc
Q 005599 440 DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGT 519 (688)
Q Consensus 440 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 519 (688)
...+|||.+++. +|.-+|.+ ....++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 247999999964 56666633 2345788899999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCcc--ccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH----
Q 005599 520 ARVFGGEEI--STNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWEL---- 592 (688)
Q Consensus 520 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~---- 592 (688)
++.+...+. ....+..+.|..|.+||.+.+. .|+++.|||.-|||+.||.||.+-+.... .......+..+
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt--eqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT--EQQQLHLISQLCGSI 248 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh--HHHHHHHHHHHhccC
Confidence 987653322 2223345679999999998875 69999999999999999999998764321 11111111111
Q ss_pred ----hcccccccccccc----cc-CCC--------CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 593 ----WSDDKALEIVDSS----MA-DSC--------PAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 593 ----~~~~~~~~~~d~~----l~-~~~--------~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
|.+-+-..+.... +. +.. |--...+.++|+..++..||.+||.+.+++.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1110001111000 10 000 0111236788999999999999999998874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=267.76 Aligned_cols=248 Identities=22% Similarity=0.285 Sum_probs=200.5
Q ss_pred cCCCCCCccccCCcEeEEEEEeCCCc-EEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLANGQ-EIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~~~-~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
.+++++..||-|+||.|=+.+.+... .+|+|.+++. +....+....|-.+|.+.+.|.||+++-.|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556678999999999999876544 3888888654 3344566788999999999999999999999999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
|-|-+|.|...|.+. ..++..+..-++..+.+|++|||+.+ ||.|||||+|+|||.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999543 44677777778999999999999998 999999999999999999999999999987654
Q ss_pred ccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccc
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 606 (688)
..+.+++|||.|.|||++.+.....++|.||||++++||++|.+||...++ +.-....+.. +|.
T Consensus 574 ---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp-----mktYn~ILkG------id~-- 637 (732)
T KOG0614|consen 574 ---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP-----MKTYNLILKG------IDK-- 637 (732)
T ss_pred ---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch-----HHHHHHHHhh------hhh--
Confidence 345568999999999999999999999999999999999999999964321 1111111111 111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 641 (688)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~ 641 (688)
-..|........+|+.+.+..+|.+|.. +.+|-+
T Consensus 638 -i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 638 -IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred -hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 1244555667889999999999999986 556654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=233.15 Aligned_cols=209 Identities=25% Similarity=0.367 Sum_probs=170.0
Q ss_pred HHHHhcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCCccceEEEEEeCCce
Q 005599 366 VLAATDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT-SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEK 442 (688)
Q Consensus 366 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 442 (688)
+....+.......||+|++|.|-+-++ .+|+..|||++... ..+..++...|+.+..+. ..|.+|+++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 444556666678999999999988764 57999999999765 445667788888876665 699999999999999999
Q ss_pred eEEEeccCCCChhhHhhc-cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccce
Q 005599 443 MLIYEFMPNKSLDYFIFD-ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 521 (688)
++.||.| ..||+.+-.+ -.+...+++...-+|+..+.+||.|||++- .+||||+||+|||++.+|++|++|||++-
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 4677666433 234556888888999999999999999964 69999999999999999999999999997
Q ss_pred ecCCCccccccccccccCCccCceeecC----CCCCCcccchhHHHHHHHHHhCCCCCCCCCC
Q 005599 522 VFGGEEISTNTNRVVGTYGYMSPEYALG----GLFSTKSDVFSFGVLLLEIITGKKNTGIFND 580 (688)
Q Consensus 522 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DvwSlGvll~elltG~~p~~~~~~ 580 (688)
.+.+.-... ...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++....
T Consensus 198 ~L~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 198 YLVDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eehhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 765432221 2457788999998854 3689999999999999999999999865443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-29 Score=233.66 Aligned_cols=258 Identities=21% Similarity=0.320 Sum_probs=199.2
Q ss_pred HhcCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCCccceEEEEEeCC--ceeE
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKD--EKML 444 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~l 444 (688)
..++|++.+++|+|-+++||.|. ..+.+.++||.+++. ..+...+|+.+|..|+ ||||++|++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 35788999999999999999996 567889999999754 3467899999999997 999999999988765 4579
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCC-CCceecccccceec
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE-MNPRISDFGTARVF 523 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGla~~~ 523 (688)
|+||+.+.+...+- +.+....+.-++.++++||.|+|+.| |+|||+||.|+++|.. -.++|+|+|||.++
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998876553 34666777789999999999999998 9999999999999965 46999999999887
Q ss_pred CCCccccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcc-------
Q 005599 524 GGEEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSD------- 595 (688)
Q Consensus 524 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~------- 595 (688)
..... .+..+.+..|.-||.+.+- .|...-|+|||||+|..|+..+.||-...++..+++..+.-+-.+
T Consensus 184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 64432 2234567788999998764 588999999999999999999999976667667776554322111
Q ss_pred -------ccccccccccccCC-------CCH-HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 596 -------DKALEIVDSSMADS-------CPA-PEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 596 -------~~~~~~~d~~l~~~-------~~~-~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.+...++..-.+.. ... -...++++++...|..|-.+|||++|.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11111111111000 001 11356889999999999999999999763
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=233.30 Aligned_cols=211 Identities=34% Similarity=0.579 Sum_probs=183.9
Q ss_pred cccCCcEeEEEEEeCC-CcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCChhh
Q 005599 379 LGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQ-GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDY 456 (688)
Q Consensus 379 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 456 (688)
||+|.+|.||+++..+ ++.+++|++...... ..+.+.+|+..+..++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 899999998765432 35679999999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECC-CCCceecccccceecCCCccccccccc
Q 005599 457 FIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-EMNPRISDFGTARVFGGEEISTNTNRV 535 (688)
Q Consensus 457 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 535 (688)
++.... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985432 35889999999999999999999997 999999999999999 89999999999987654321 12225
Q ss_pred cccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHH
Q 005599 536 VGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPE 614 (688)
Q Consensus 536 ~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 614 (688)
.+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577899999999887 888999999999999999
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 005599 615 ALRCIQVGLLCVQDRTTDRPSMSTVVFML 643 (688)
Q Consensus 615 ~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 643 (688)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3688999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-29 Score=238.58 Aligned_cols=260 Identities=21% Similarity=0.335 Sum_probs=189.9
Q ss_pred CCCCccccCCcEeEEEEEe-CCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeC-----CceeEE
Q 005599 374 STSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK-----DEKMLI 445 (688)
Q Consensus 374 ~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV 445 (688)
+..+.||.|+||.||..+. ++|+.||+|++... +-...+.+.+|+++|...+|.|++..++...-. ++.|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457899999999999975 47999999998543 233457789999999999999999998876543 246778
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
.|.| ..+|+.++. ..+.++-....-+++||++||.|||+.+ |.||||||.|+|++.+..+||+|||+++.-..
T Consensus 136 TELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 8887 456777663 3455777777778999999999999998 99999999999999999999999999997654
Q ss_pred CccccccccccccCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccc--------
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD-------- 596 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-------- 596 (688)
++.... +..+-|..|.|||++.+. .|+.+.||||.|||+.||+.++--|...+.. +..+.+.+++...
T Consensus 209 d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi--qQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 209 RDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI--EQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred hhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH--HHHHHHHHHhCCCcHHHHHHH
Confidence 443322 235668899999999886 5999999999999999999888766432211 1111222211111
Q ss_pred ---ccccccccccc---------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 005599 597 ---KALEIVDSSMA---------DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643 (688)
Q Consensus 597 ---~~~~~~d~~l~---------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 643 (688)
-...++....+ ...+.....+.+.+...++..||+.|.+..+.+..+
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111111111 111223344567788888999999999998887654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=229.48 Aligned_cols=198 Identities=31% Similarity=0.471 Sum_probs=171.5
Q ss_pred CCCCCccccCCcEeEEEEEeCC-CcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccC
Q 005599 373 FSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQ-GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999875 889999999765444 57789999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+++|.+++..... .+++.....++.+++.+|.+||..+ ++|+||+|.||+++.++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999999854321 1789999999999999999999987 99999999999999999999999999987654321 1
Q ss_pred ccccccccCCccCceee-cCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 005599 531 NTNRVVGTYGYMSPEYA-LGGLFSTKSDVFSFGVLLLEIITGKKNTG 576 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~-~~~~~s~k~DvwSlGvll~elltG~~p~~ 576 (688)
......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22335677889999998 66778889999999999999999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=248.32 Aligned_cols=195 Identities=26% Similarity=0.404 Sum_probs=165.5
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC-CcEEEEEEccCCCc--------ccHHHHHHHHHHHhhcC---CCCccceEEEEEe
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTSG--------QGIEEFKNEVLLIAKLQ---HRNLVKLLGCCLE 438 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~ 438 (688)
.+|...+.||+|+||.|+++.++. ...|+||.+.+... ...-..-.||++|..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458889999999999999998764 56788898765321 11223456999999997 9999999999999
Q ss_pred CCceeEEEeccC-CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccc
Q 005599 439 KDEKMLIYEFMP-NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDF 517 (688)
Q Consensus 439 ~~~~~lV~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 517 (688)
.+..+|++|-.. +-+|.+++ ..+..+++.+...|+.||+.|+++||+.+ |||||||-+||.|+.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999764 45677777 34556899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCccccccccccccCCccCceeecCCCC-CCcccchhHHHHHHHHHhCCCCC
Q 005599 518 GTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLF-STKSDVFSFGVLLLEIITGKKNT 575 (688)
Q Consensus 518 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwSlGvll~elltG~~p~ 575 (688)
|.+......... ..+||..|.|||++.+.+| +..-|||++|++||.++..+.|+
T Consensus 715 gsaa~~ksgpfd----~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSGPFD----VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCCCcc----eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 999876554433 4789999999999999887 55689999999999999999886
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=233.37 Aligned_cols=132 Identities=25% Similarity=0.368 Sum_probs=107.3
Q ss_pred hcCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-----C---CCccceEEEEEe--
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-----H---RNLVKLLGCCLE-- 438 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~-- 438 (688)
..+|.+.++||-|.|++||++. ..+.+.||+|+.+... .-.+..+.||++|++++ | .+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3678899999999999999996 4567889999986432 33456688999999984 3 369999999975
Q ss_pred --CCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEE
Q 005599 439 --KDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 506 (688)
Q Consensus 439 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 506 (688)
+.+.+||+|++.. +|..++... .-+-++...+.+|+.||+.||.|||..+ +|||-||||+||||
T Consensus 156 pNG~HVCMVfEvLGd-nLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGD-NLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhhhh-HHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4579999999954 454555333 3345889999999999999999999987 69999999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-27 Score=250.89 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=201.6
Q ss_pred hcCCCCCCccccCCcEeEEEEEe-CCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
.++|+..+.+|+|.||.|||++. ..++..|||.++........-..+|+-+++..+|+|||.++|.+...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 36788899999999999999985 46889999999887777777888999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
+.+|+|.+.-+- ..++++.++..++....+||+|||+.+ =+|||||-.|||+++.+.+|++|||.+-.+...
T Consensus 94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-- 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-- 165 (829)
T ss_pred cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--
Confidence 999999887642 356888888899999999999999998 799999999999999999999999998665422
Q ss_pred ccccccccccCCccCceee---cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccccc
Q 005599 529 STNTNRVVGTYGYMSPEYA---LGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~---~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 605 (688)
-.......||+.|||||+. ..+.|..++|||++|+...|+---++|..-.+ ...+..++. ....++.
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh------pmr~l~LmT----kS~~qpp 235 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH------PMRALFLMT----KSGFQPP 235 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc------hHHHHHHhh----ccCCCCC
Confidence 2233447899999999987 35679999999999999999987777632111 011111111 1122221
Q ss_pred ccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV 640 (688)
Q Consensus 606 l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 640 (688)
-. +....-.+.+.+++..|+.++|++||+++.++
T Consensus 236 ~l-kDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 236 TL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cc-cCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 11 12334566788999999999999999998765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=225.45 Aligned_cols=259 Identities=24% Similarity=0.282 Sum_probs=187.7
Q ss_pred cCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCC------c
Q 005599 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD------E 441 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~ 441 (688)
.+|.-++.+|.|.- .|-.+. .-.++.||+|++... .....+...+|..++..++|+||++++.++.-.. +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45556678888888 454443 235889999988543 3344567789999999999999999999987543 5
Q ss_pred eeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccce
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 521 (688)
.++|||+| ..+|...+. -.++-.+...|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 79999999 467777664 23566778889999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCC-------------CCc----c
Q 005599 522 VFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFND-------------DSS----N 584 (688)
Q Consensus 522 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~-------------~~~----~ 584 (688)
.-... -..+..+.|..|.|||++.+-.+.+.+||||+||++.||++|+--|....- ... +
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 64432 233346788999999999998899999999999999999999876642110 000 0
Q ss_pred HHHHHHHHhcc-c-----cccccc-ccccc--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 585 LIRYVWELWSD-D-----KALEIV-DSSMA--DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 585 l~~~~~~~~~~-~-----~~~~~~-d~~l~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
+...+...... + ...+++ |.... .+.+......+.+++.+||-.+|++|-+..++++.
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 11111111110 0 000111 11111 01122334567899999999999999999999863
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=236.90 Aligned_cols=202 Identities=23% Similarity=0.292 Sum_probs=170.7
Q ss_pred HHHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcC------CCCccceEEEEEeC
Q 005599 367 LAATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ------HRNLVKLLGCCLEK 439 (688)
Q Consensus 367 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~ 439 (688)
+....+|.+.-..|+|-|++|-+|... -|+.||||++.... .-.+.=+.|+++|.+|+ ..|+++|+-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 345678999999999999999999754 47899999996542 22334467999999996 34899999999999
Q ss_pred CceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCC-CCceecccc
Q 005599 440 DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE-MNPRISDFG 518 (688)
Q Consensus 440 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFG 518 (688)
+++|||+|-+ .-+|.+.|..-..+-.|....+..++.|+.-||..|...+ |+|.||||.||||++. ..+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999977 5788999977777777888999999999999999999877 9999999999999975 468999999
Q ss_pred cceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 005599 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGI 577 (688)
Q Consensus 519 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~ 577 (688)
.|......+... ...+..|.|||++.|.+|+...|+||.||.||||.||+-.|..
T Consensus 583 SA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 583 SASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred cccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 998776554332 3345679999999999999999999999999999999987643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=219.29 Aligned_cols=254 Identities=20% Similarity=0.334 Sum_probs=185.1
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEeCC-CcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCCccceEEE-EEeCCceeE
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLVKLLGC-CLEKDEKML 444 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~l 444 (688)
...+.|.+.+.||+|.||.+-++.++. .+.+|+|-+... ....++|.+|...--.| .|.||+.-++. |+..+..++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 345778999999999999999998764 668899988543 34567899998876666 58999987754 566677889
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEEC--CCCCceeccccccee
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD--EEMNPRISDFGTARV 522 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DFGla~~ 522 (688)
++||+|.|+|.+-+.. ..+.+....+++.|++.||.|+|+.+ +||||||.+||||- +...+||+|||+.+.
T Consensus 100 ~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 9999999999887733 34667778889999999999999998 99999999999993 344799999999876
Q ss_pred cCCCccccccccccccCCccCceeecCC-----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccc
Q 005599 523 FGGEEISTNTNRVVGTYGYMSPEYALGG-----LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK 597 (688)
Q Consensus 523 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 597 (688)
.+. ......-+..|.|||..... ...+.+|+|.||++++.++||+.|+.-........ |-+..|..+.
T Consensus 173 ~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y--~~~~~w~~rk 245 (378)
T KOG1345|consen 173 VGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY--WEWEQWLKRK 245 (378)
T ss_pred cCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH--HHHHHHhccc
Confidence 542 12223456789999976432 24667999999999999999999997332222222 2233333333
Q ss_pred ccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 598 ALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 598 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.. .+...+ ...++.+.++..+-+..+|++|=-..++-++
T Consensus 246 ~~-----~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 246 NP-----ALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred Cc-----cCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 22 111111 1234467778888899999999555555443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-26 Score=229.55 Aligned_cols=264 Identities=21% Similarity=0.321 Sum_probs=199.3
Q ss_pred HHHhcCCCCCCccccCCcEeEEEEEeC----CCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCc
Q 005599 367 LAATDNFSTSNKLGQGGFGPVYKGKLA----NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDE 441 (688)
Q Consensus 367 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 441 (688)
....+.|..+++||+|.|++||++.+. ..+.||+|.+...+. .....+|+++|..+. +.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 345577889999999999999999754 367899999876543 356889999999995 9999999999999999
Q ss_pred eeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECC-CCCceecccccc
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-EMNPRISDFGTA 520 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla 520 (688)
..+|+||+++....++.. .++..++..++..+.+||.++|.++ ||||||||+|+|.+. -+.-.|.|||||
T Consensus 110 v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 999999999999888873 3668888999999999999999998 999999999999985 456789999999
Q ss_pred eecCCCc-------------cc-----------------------------cccccccccCCccCceeecC-CCCCCccc
Q 005599 521 RVFGGEE-------------IS-----------------------------TNTNRVVGTYGYMSPEYALG-GLFSTKSD 557 (688)
Q Consensus 521 ~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~s~k~D 557 (688)
....... .. .......||++|.|||++.. ...++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7211000 00 00012469999999999876 45789999
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHH---------hcccc--------c---cc------ccc-cccc---
Q 005599 558 VFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWEL---------WSDDK--------A---LE------IVD-SSMA--- 607 (688)
Q Consensus 558 vwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~---------~~~~~--------~---~~------~~d-~~l~--- 607 (688)
|||.|||++-+++++.||-...++...+.+.+... ...+. . .+ -++ ..+.
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 99999999999999999876656555554432110 00111 0 00 000 0000
Q ss_pred ------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 608 ------DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 608 ------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.....-.+..+++|..+|++.||.+|.|+++.++
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0011112346899999999999999999999885
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-26 Score=268.36 Aligned_cols=197 Identities=20% Similarity=0.237 Sum_probs=140.2
Q ss_pred hhcCC-CCccceEEEE-------EeCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 005599 422 AKLQH-RNLVKLLGCC-------LEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493 (688)
Q Consensus 422 ~~l~H-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 493 (688)
+.++| +||++++++| ......++++|++ .++|.++|... ...+++.+++.++.||++||+|||+.+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 34556 5888888887 2334567788887 66999998533 345899999999999999999999988
Q ss_pred eEecCCCCCceEECC-------------------CCCceecccccceecCCCcc--------------ccccccccccCC
Q 005599 494 IIHRDLKASNILLDE-------------------EMNPRISDFGTARVFGGEEI--------------STNTNRVVGTYG 540 (688)
Q Consensus 494 iiH~Dlkp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~ 540 (688)
|+||||||+||||+. ++.+||+|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 45567777777764321000 001112457899
Q ss_pred ccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHH
Q 005599 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQ 620 (688)
Q Consensus 541 y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 620 (688)
|||||++.+..++.++|||||||+||||++|.+|+... ......... ..+.+.. .........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~----~~~~~~~~~--------~~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK----SRTMSSLRH--------RVLPPQI-----LLNWPKEAS 243 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH----HHHHHHHHH--------hhcChhh-----hhcCHHHHH
Confidence 99999999999999999999999999999988875311 001100000 0111111 112334568
Q ss_pred HHhhcccCCCCCCCCHHHHHH
Q 005599 621 VGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 621 l~~~Cl~~~P~~RPt~~evl~ 641 (688)
++.+||+.+|.+||+|.||++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 889999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=207.24 Aligned_cols=166 Identities=19% Similarity=0.173 Sum_probs=124.8
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
|+|.+++... ...+++.+++.++.||++||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6888888532 346899999999999999999999875 999999999999999 99998754321
Q ss_pred cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCC
Q 005599 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 611 (688)
..||+.|||||++.+..++.++|||||||++|||++|+.|+.........+....... ... ++.. ...+
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~------~~~~-~~~~ 132 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM-PAD------DPRD-RSNL 132 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh-ccC------Cccc-cccH
Confidence 3688999999999999999999999999999999999999853322222121111111 110 0000 0011
Q ss_pred HHHHH--HHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 612 APEAL--RCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 612 ~~~~~--~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
..... .+.+++.+|++.+|++||++.|+++.+..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 22222 68999999999999999999999988754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=220.25 Aligned_cols=168 Identities=19% Similarity=0.195 Sum_probs=131.0
Q ss_pred HHHhcCCCCCCccccCCcEeEEEEEeC--CCcEEEEEEccCC-----CcccHHHHHHHHHHHhhcCCCCccceEEEEEeC
Q 005599 367 LAATDNFSTSNKLGQGGFGPVYKGKLA--NGQEIAVKRLSTT-----SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK 439 (688)
Q Consensus 367 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 439 (688)
....++|.+.+.||+|+||+||+|... +++.||||++... .....+.|.+|+++|.+++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345578999999999999999999864 5778899987533 11235568999999999999999864432 2
Q ss_pred CceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC-CCCceEECCCCCceecccc
Q 005599 440 DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDL-KASNILLDEEMNPRISDFG 518 (688)
Q Consensus 440 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~DFG 518 (688)
+..+|||||+++++|.... . . . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~--~--~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR--P--H---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC--c--c---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 5689999999999996321 1 0 1 1467889999999999988 999999 9999999999999999999
Q ss_pred cceecCCCccccc------cccccccCCccCceeecCC
Q 005599 519 TARVFGGEEISTN------TNRVVGTYGYMSPEYALGG 550 (688)
Q Consensus 519 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 550 (688)
+++.+........ .....+++.|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9997754321111 1246788999999998654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-24 Score=203.66 Aligned_cols=249 Identities=22% Similarity=0.354 Sum_probs=192.2
Q ss_pred CCCCccccCCcEeEEEEEeCCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCC
Q 005599 374 STSNKLGQGGFGPVYKGKLANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 374 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 451 (688)
....+|.+...|+.|+|+++ |..+++|++... .....+.|..|.-.|+-..||||++++|.|....+..++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 33467889999999999996 566777877543 233456799999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccc
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 531 (688)
|+|...|++.. .-..+..+..+++.+||+|++|||+..+ -|.---|.+..|++|++.+++|+- +-+++ ...
T Consensus 272 gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kf------sfq 342 (448)
T KOG0195|consen 272 GSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQ 342 (448)
T ss_pred hHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-cccee------eee
Confidence 99999997653 3457788899999999999999999873 234446899999999999988742 11111 111
Q ss_pred cccccccCCccCceeecCCCC---CCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccC
Q 005599 532 TNRVVGTYGYMSPEYALGGLF---STKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 532 ~~~~~gt~~y~aPE~~~~~~~---s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 608 (688)
.....-.|.||+||.+...+- -.++|+|||+++||||.|.+.||.....-+- -.++.-..++-
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec--------------gmkialeglrv 408 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC--------------GMKIALEGLRV 408 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh--------------hhhhhhccccc
Confidence 111334688999999987653 3479999999999999999999854322110 01222334555
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
..|+..+..+.+|+.-|+..||.+||.+..|+-+||..
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 56777788899999999999999999999999988764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=206.70 Aligned_cols=260 Identities=21% Similarity=0.243 Sum_probs=191.1
Q ss_pred CCCCCCccccCCcEeEEEEEeCCC--cEEEEEEccCCCcccHHHHHHHHHHHhhcCC----CCccceEEEE-EeCCceeE
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLANG--QEIAVKRLSTTSGQGIEEFKNEVLLIAKLQH----RNLVKLLGCC-LEKDEKML 444 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 444 (688)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..++... ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999986553 4788888765433333378889999999973 5888899888 46777899
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCC-----CCceeccccc
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE-----MNPRISDFGT 519 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~~kl~DFGl 519 (688)
||+.+ +.+|.++..... .+.++..+.+.|+.|++.+|.+||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99976 778888764433 567899999999999999999999998 9999999999999865 4589999999
Q ss_pred ce--ecCCCcc----ccc--cccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHH
Q 005599 520 AR--VFGGEEI----STN--TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWE 591 (688)
Q Consensus 520 a~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~ 591 (688)
++ .+..... ... .....||..|+++..+.+...+.+.|+||++.++.|++.|..|+........ ...+..
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~~~ 251 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKFEK 251 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHHHH
Confidence 98 3322211 111 2236699999999999999999999999999999999999999854332111 111111
Q ss_pred HhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 005599 592 LWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 592 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 647 (688)
.... ..... ...... ..+.++..-+-..+..++|....+...|+...
T Consensus 252 ~~~~----~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 252 DPRK----LLTDR--FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred Hhhh----hcccc--ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 0000 01111 111222 23445555555589999999999998876643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.7e-21 Score=199.49 Aligned_cols=260 Identities=29% Similarity=0.427 Sum_probs=198.1
Q ss_pred CCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcc---cHHHHHHHHHHHhhcCCC-CccceEEEEEeCCceeEEEec
Q 005599 373 FSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQ---GIEEFKNEVLLIAKLQHR-NLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~e~ 448 (688)
|.+.+.||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +++++...+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566789999999999999876 88999998765332 367899999999999988 799999999777778999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC-CceecccccceecCCCc
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM-NPRISDFGTARVFGGEE 527 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 527 (688)
+.++++..++........+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966633221135788899999999999999999998 99999999999999998 79999999998665443
Q ss_pred ccc----ccccccccCCccCceeecC---CCCCCcccchhHHHHHHHHHhCCCCCCCCCCC--CccHHHHHHHHhccccc
Q 005599 528 IST----NTNRVVGTYGYMSPEYALG---GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDD--SSNLIRYVWELWSDDKA 598 (688)
Q Consensus 528 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwSlGvll~elltG~~p~~~~~~~--~~~l~~~~~~~~~~~~~ 598 (688)
... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..|+...... .......+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 221 2355789999999999988 57899999999999999999999996443321 11222222111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 599 LEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 599 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000001100012223567889999999999999999987753
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=185.14 Aligned_cols=200 Identities=22% Similarity=0.327 Sum_probs=167.7
Q ss_pred cCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCceeEEEec
Q 005599 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
-+|.+.++||+|+||+.+.|+ +-+++.||||.-...+ ..-+++.|.+..+.|. .++|...+-|..++-+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 478999999999999999996 6689999999764433 3346778888888884 78999999998899899999998
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCC-----CCceecccccceec
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE-----MNPRISDFGTARVF 523 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~~kl~DFGla~~~ 523 (688)
+ +-+|.++..- -.+.++.++...+|.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 5677666422 2345889999999999999999999998 9999999999999744 34889999999987
Q ss_pred CCCccc-----cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 005599 524 GGEEIS-----TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIF 578 (688)
Q Consensus 524 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~ 578 (688)
.+.... .......||.+||+-.-..+.+.+.+.|+=|||-++++.|.|..||...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 654332 2334578999999999999999999999999999999999999998653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-20 Score=176.70 Aligned_cols=259 Identities=21% Similarity=0.280 Sum_probs=190.3
Q ss_pred HhcCCCCCCccccCCcEeEEEEE-eCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCC-CCccceEEEEEeCCceeEEE
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQH-RNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 446 (688)
...+|.++++||+|+||.+|.|. +.+|..||||.-+.... ..++.-|..+...|+| ..|..+..+..++..-.|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34678899999999999999996 67899999998765433 2456788999999975 57888888888999999999
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCC---CCceecccccceec
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE---MNPRISDFGTARVF 523 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFGla~~~ 523 (688)
+.+ +.+|.++..-- .+.++.++.+-++-|++.-++|+|..+ +|||||||+|+|+.-+ ..+.|+|||||+.+
T Consensus 91 dLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 988 66776665322 234788899999999999999999998 9999999999999744 45889999999987
Q ss_pred CCCcc-----ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccc
Q 005599 524 GGEEI-----STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKA 598 (688)
Q Consensus 524 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 598 (688)
.+... ........||.+|.+-..+.+...+.+.|+=|+|.+|..+..|..|+........ ....+...+.+.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk---~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK---KQKYEKISEKKM 241 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH---HHHHHHHHHhhc
Confidence 54322 1233447899999999999988999999999999999999999999865432211 111121222111
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 005599 599 LEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643 (688)
Q Consensus 599 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 643 (688)
...+ ..+-..+|. ++.-.+.-|-...-++-|...-+.+++
T Consensus 242 s~~i-e~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 242 STPI-EVLCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred CCCH-HHHhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 1111 112222333 455566667777777777765544433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-21 Score=218.33 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=185.1
Q ss_pred CCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC--CcccH----HHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 374 STSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGI----EEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 374 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~----~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
....++|.|++|.|+..... .....+.|..... ..... ..+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34578999999988877533 3444444433210 11111 12556777888899999988888877777766669
Q ss_pred eccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
||+++ +|..++... ..+...++..++.|+..|+.|||+.+ |.|||||++|+++..++.+||+|||.+......
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 998888433 35677788889999999999999998 999999999999999999999999999876543
Q ss_pred ccc--cccccccccCCccCceeecCCCCCC-cccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhcccccccccc
Q 005599 527 EIS--TNTNRVVGTYGYMSPEYALGGLFST-KSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 527 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~-k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 603 (688)
... ......+|...|+|||.+.+..|.+ ..||||.|+++..|++|+.||............. ....-..+..
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-----~~~~~~~~~~ 548 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-----NYSDQRNIFE 548 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-----cccccccccc
Confidence 332 4445588999999999999999876 5899999999999999999986544322211000 0000000000
Q ss_pred ccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 604 ~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
. ........+.+...++.++|+.+|.+|.||++|++
T Consensus 549 ~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 G--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred C--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 01112334567888999999999999999999985
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.2e-21 Score=185.98 Aligned_cols=172 Identities=15% Similarity=0.171 Sum_probs=134.8
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHH---H------HHHHHHHHhhcCCCCccceEEEEEe
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIE---E------FKNEVLLIAKLQHRNLVKLLGCCLE 438 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~---~------~~~E~~~l~~l~H~niv~l~g~~~~ 438 (688)
...++|.+.++||.|+||.||+... ++..+|||.+......... . |.+|+..+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3568999999999999999999766 5778999999754332222 2 6899999999999999999988664
Q ss_pred C--------CceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC
Q 005599 439 K--------DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM 510 (688)
Q Consensus 439 ~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 510 (688)
. ...+|||||+++.+|.++.. ++. ....+++.+|..||..+ ++||||||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 35789999999999977631 222 24669999999999998 99999999999999988
Q ss_pred CceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHH
Q 005599 511 NPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEII 569 (688)
Q Consensus 511 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ell 569 (688)
++|+|||........... ..++....+..++|+|+||+.+..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988654321111 11344455778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=180.62 Aligned_cols=139 Identities=20% Similarity=0.214 Sum_probs=108.5
Q ss_pred CCccccCCcEeEEEEEeCCCcEEEEEEccCCCcc--c-------HHHH-----------------HHHHHHHhhcCCCCc
Q 005599 376 SNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQ--G-------IEEF-----------------KNEVLLIAKLQHRNL 429 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~-------~~~~-----------------~~E~~~l~~l~H~ni 429 (688)
...||+|+||.||+|...+|+.||||+++..... . ...| ..|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998654211 1 1122 349999999988877
Q ss_pred cceEEEEEeCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEecCCCCCceEECC
Q 005599 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL-HQDSRLRIIHRDLKASNILLDE 508 (688)
Q Consensus 430 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~Dlkp~NILl~~ 508 (688)
.....+.. ...+|||||++++++...+.. ...++......++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44433322 234899999999877654322 24578899999999999999999 6777 99999999999998
Q ss_pred CCCceecccccceec
Q 005599 509 EMNPRISDFGTARVF 523 (688)
Q Consensus 509 ~~~~kl~DFGla~~~ 523 (688)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.4e-21 Score=213.98 Aligned_cols=251 Identities=18% Similarity=0.210 Sum_probs=181.5
Q ss_pred CCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCC-cccHHHHHHHHHH--HhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTS-GQGIEEFKNEVLL--IAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
++...+.||++.|=+|.+|+.+.|. |+||++-+.. ....+.|.++++- ...++|||++++.-.-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566789999999999999998887 9999986554 3445555554433 4556899999998886666777888888
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC--
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE-- 526 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~-- 526 (688)
+.+ +|.+.| +.+..+...+..-|+.|++.||..+|..+ |+|||||.+||||+.-..+.|+||..-+...-.
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 754 565655 45566788888889999999999999998 999999999999999999999999887654321
Q ss_pred ---ccccccccccccCCccCceeecCC----------C-CCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHH
Q 005599 527 ---EISTNTNRVVGTYGYMSPEYALGG----------L-FSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWE 591 (688)
Q Consensus 527 ---~~~~~~~~~~gt~~y~aPE~~~~~----------~-~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~ 591 (688)
++.....+...-..|+|||.+... . .+++.||||+||++.||++ |+++|.. .++..+-..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----SQL~aYr~~ 250 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----SQLLAYRSG 250 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----HHHHhHhcc
Confidence 111111223334579999987431 2 6788999999999999999 6887742 122221111
Q ss_pred -HhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 005599 592 -LWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 592 -~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 646 (688)
....+.+.+.+ . ...+.++++.|++.||++|.++.+.++.-++.
T Consensus 251 ~~~~~e~~Le~I----e-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 251 NADDPEQLLEKI----E-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred CccCHHHHHHhC----c-------CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 00001111111 1 11578999999999999999999999875554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7e-20 Score=196.09 Aligned_cols=218 Identities=22% Similarity=0.332 Sum_probs=165.1
Q ss_pred HhhcCCCCccceEEEEEeCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCC
Q 005599 421 IAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLK 500 (688)
Q Consensus 421 l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk 500 (688)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.-...++.+|++||+|||... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4578999999999999999999999999999999999966 3456899999999999999999999876 12999999
Q ss_pred CCceEECCCCCceecccccceecCCCccccccccccccCCccCceeecCCC-------CCCcccchhHHHHHHHHHhCCC
Q 005599 501 ASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGL-------FSTKSDVFSFGVLLLEIITGKK 573 (688)
Q Consensus 501 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~k~DvwSlGvll~elltG~~ 573 (688)
++|.++|....+||+|||+.................-..-|.|||.+.+.. .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999987764311111111122345799999987642 4667999999999999999999
Q ss_pred CCCCCCCCCc--cHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCC
Q 005599 574 NTGIFNDDSS--NLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSV 649 (688)
Q Consensus 574 p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 649 (688)
||........ .++..+.. .....+.+.+.... +....+..++..||..+|++||++.+|-..++.....
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9976443322 22222221 11122222221110 2233689999999999999999999999999876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=174.55 Aligned_cols=141 Identities=20% Similarity=0.240 Sum_probs=111.6
Q ss_pred CCccccCCcEeEEEEEeCCCcEEEEEEccCCCcc---------------------c-----HHHHHHHHHHHhhcCCCCc
Q 005599 376 SNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQ---------------------G-----IEEFKNEVLLIAKLQHRNL 429 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~ni 429 (688)
...||+|++|.||+|...+|+.||||++...... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4789999999999999878999999998754211 0 1123578999999999987
Q ss_pred cceEEEEEeCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCceEECC
Q 005599 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDE 508 (688)
Q Consensus 430 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~ 508 (688)
.....+... ..+|||||++++++...... ...++......++.|++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 555444333 35899999998865433211 2346778889999999999999999 77 99999999999999
Q ss_pred CCCceecccccceecCC
Q 005599 509 EMNPRISDFGTARVFGG 525 (688)
Q Consensus 509 ~~~~kl~DFGla~~~~~ 525 (688)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=165.61 Aligned_cols=183 Identities=17% Similarity=0.126 Sum_probs=138.4
Q ss_pred CCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcc----cHHHHHHHHHHHhhcC-CCCccceEEEEEeCCceeEEEecc
Q 005599 375 TSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQ----GIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 375 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
+...|++|+||+||.+.- ++.+++.+.+.....- ....|.+|+++|.+|. |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999998766 6888888877654321 1225889999999995 5889999886 4579999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC-CCCceEECCCCCceecccccceecCCCcc
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDL-KASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~DFGla~~~~~~~~ 528 (688)
.+.+|...+.. ....++.|++.+|.++|+.+ |+|||| ||+|||++.++.++|+|||++........
T Consensus 81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99988654310 12357789999999999998 999999 79999999999999999999986543221
Q ss_pred c----c-------ccccccccCCccCceeecCC-CCC-CcccchhHHHHHHHHHhCCCCC
Q 005599 529 S----T-------NTNRVVGTYGYMSPEYALGG-LFS-TKSDVFSFGVLLLEIITGKKNT 575 (688)
Q Consensus 529 ~----~-------~~~~~~gt~~y~aPE~~~~~-~~s-~k~DvwSlGvll~elltG~~p~ 575 (688)
. . .......++.|++|+...-. ..+ ...+.++.|.-+|.++|++-+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0 0 01113367788888754322 222 5679999999999999998875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-19 Score=194.10 Aligned_cols=232 Identities=25% Similarity=0.273 Sum_probs=180.1
Q ss_pred ccccCCcEeEEEEE----eCCCcEEEEEEccCCCcc--cHHHHHHHHHHHhhcC-CCCccceEEEEEeCCceeEEEeccC
Q 005599 378 KLGQGGFGPVYKGK----LANGQEIAVKRLSTTSGQ--GIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 378 ~LG~G~fg~Vy~~~----~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~ 450 (688)
.+|+|+||.|++.. .+.|..+|+|.+++.... .......|..++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999874 334777899988654321 1125567888999997 9999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCcccc
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIST 530 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 530 (688)
+|.|...+.. ...++......+...+|-+++++|..+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 9999777732 334555666667888999999999998 99999999999999999999999999986543322
Q ss_pred ccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCC
Q 005599 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSC 610 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 610 (688)
.+||..|||||++. .....+|.||||++++||+||..||.. +.+.. ++.. .-..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---------~~~~~---------Il~~--~~~~ 206 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---------DTMKR---------ILKA--ELEM 206 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------HHHHH---------Hhhh--ccCC
Confidence 28999999999998 567889999999999999999999853 11111 1111 1124
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCH--HHHHHHh
Q 005599 611 PAPEALRCIQVGLLCVQDRTTDRPSM--STVVFML 643 (688)
Q Consensus 611 ~~~~~~~~~~l~~~Cl~~~P~~RPt~--~evl~~L 643 (688)
|......+.+++..++..+|.+|-.. ..+.+++
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 55666778888888899999999766 3444444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.3e-19 Score=202.54 Aligned_cols=198 Identities=22% Similarity=0.280 Sum_probs=159.7
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC---CCCccceEEEEEeCCceeE
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ---HRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~l 444 (688)
...+.|.|.+.||+|+||+||+|...+|+.||+|+-+.... .+|---.+++.+|+ -+-|+.+...+.-.+..+|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 34567888999999999999999988899999998766543 22322333444444 3455666666666778899
Q ss_pred EEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEEC-------CCCCceeccc
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-------EEMNPRISDF 517 (688)
Q Consensus 445 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-------~~~~~kl~DF 517 (688)
|+||.+.|+|.+++. ..+.++|.....++.|+++-+++||..+ |||+||||+|+||. +...++|+||
T Consensus 772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence 999999999999984 5677999999999999999999999998 99999999999994 2345999999
Q ss_pred ccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCC
Q 005599 518 GTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKN 574 (688)
Q Consensus 518 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p 574 (688)
|.+..+..-.........++|-.+--+|+..|..++...|.|.|+-+++-||.|+..
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 998655432222334446788999999999999999999999999999999999864
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=2e-18 Score=174.18 Aligned_cols=230 Identities=20% Similarity=0.276 Sum_probs=150.2
Q ss_pred CCCccccCCcEeEEEEEeCC-CcEEEEEEccCCC---cccHHHHHHHHHHHhhcCC----------CCccceEEEEE---
Q 005599 375 TSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQH----------RNLVKLLGCCL--- 437 (688)
Q Consensus 375 ~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~~--- 437 (688)
..+.||.|+++.||.++... ++++|||...... ....+++++|......+.+ -.++-.++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 35789999999999999764 8999999875432 3346777887766666433 12222222211
Q ss_pred ------eCC--------ceeEEEeccCCCChhhHhh---ccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC
Q 005599 438 ------EKD--------EKMLIYEFMPNKSLDYFIF---DESR-KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDL 499 (688)
Q Consensus 438 ------~~~--------~~~lV~e~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl 499 (688)
... ..+++|+-+ .++|..++. .... ...+....++.+..|+++.+++||+.+ ++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 111 236777776 678877753 2211 233556777888899999999999998 999999
Q ss_pred CCCceEECCCCCceecccccceecCCCccccccccccccCCccCceeecC--------CCCCCcccchhHHHHHHHHHhC
Q 005599 500 KASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG--------GLFSTKSDVFSFGVLLLEIITG 571 (688)
Q Consensus 500 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DvwSlGvll~elltG 571 (688)
+|+|++++.+|.+.|+||+.....+..-.. ...+..|.+||.... -.++.+.|.|++|+++|.|.+|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999987765432111 234578999997643 2478899999999999999999
Q ss_pred CCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCC
Q 005599 572 KKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDR 633 (688)
Q Consensus 572 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~R 633 (688)
+.|++.......... .-..|. +.++.+..|+..+|+.+|++|
T Consensus 247 ~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG-------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc-------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999865332111100 112355 667789999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.5e-18 Score=164.72 Aligned_cols=135 Identities=20% Similarity=0.267 Sum_probs=105.4
Q ss_pred CCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-----CCCCccceEEEEEeCC---c-eeEE
Q 005599 375 TSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-----QHRNLVKLLGCCLEKD---E-KMLI 445 (688)
Q Consensus 375 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~lV 445 (688)
-.++||+|+||.||. .++....+||++........+.+.+|+.++..+ .||||++++|++.++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 357999999999996 433333479988665444567899999999999 5799999999999874 2 3378
Q ss_pred Eec--cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCCeEecCCCCCceEECC----CCCceecccc
Q 005599 446 YEF--MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV-LYLHQDSRLRIIHRDLKASNILLDE----EMNPRISDFG 518 (688)
Q Consensus 446 ~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~DFG 518 (688)
+|| +++++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 5589999999432 24444 35677888777 9999998 999999999999974 3479999954
Q ss_pred cc
Q 005599 519 TA 520 (688)
Q Consensus 519 la 520 (688)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 43
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5e-17 Score=160.85 Aligned_cols=134 Identities=20% Similarity=0.309 Sum_probs=114.1
Q ss_pred CccccCCcEeEEEEEeCCCcEEEEEEccCCCcc--------cHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 377 NKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQ--------GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
+.||+|++|.||+|.. .|..++||+....... ....+.+|+.++..++|++++....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999987 6788999986543211 124578899999999999998888888888889999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999888432 12 78889999999999999988 99999999999999 78899999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.5e-17 Score=161.62 Aligned_cols=149 Identities=19% Similarity=0.183 Sum_probs=113.5
Q ss_pred HHHHhcCCCCCCccccCCcEeEEEEE--eCCCcEEEEEEccCCCcc------------------------cHHHHHHHHH
Q 005599 366 VLAATDNFSTSNKLGQGGFGPVYKGK--LANGQEIAVKRLSTTSGQ------------------------GIEEFKNEVL 419 (688)
Q Consensus 366 ~~~~~~~f~~~~~LG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~ 419 (688)
+......|.+.+.||+|+||.||+|. ..+|+.||||++...... ....+..|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33344457888999999999999998 568999999998643210 0123568999
Q ss_pred HHhhcCCCC--ccceEEEEEeCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 005599 420 LIAKLQHRN--LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHR 497 (688)
Q Consensus 420 ~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~ 497 (688)
.+.++.+.. +.+++++ ...++||||+++.+|...... ...+...+...++.||+.+|.+||..+ .|+||
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~ 173 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHG 173 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence 999997633 3444442 245899999999888665422 223455667789999999999999876 49999
Q ss_pred CCCCCceEECCCCCceecccccceecC
Q 005599 498 DLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 498 Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
||||+||+++ ++.++|+|||++....
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999 8899999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.2e-17 Score=158.04 Aligned_cols=146 Identities=18% Similarity=0.186 Sum_probs=113.2
Q ss_pred HHHHHHhcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcc----------------------cHHHHHHHHHHH
Q 005599 364 STVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQ----------------------GIEEFKNEVLLI 421 (688)
Q Consensus 364 ~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l 421 (688)
.++......|.+.+.||+|+||.||++...+|+.||||++...... ....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444457888999999999999999888999999986543210 112357789999
Q ss_pred hhcCCCC--ccceEEEEEeCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC
Q 005599 422 AKLQHRN--LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDL 499 (688)
Q Consensus 422 ~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl 499 (688)
..+.|++ ++..++ ....++||||+++++|...... .....++.+++.++.++|+.+ |+||||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 9998874 444443 2456899999999998765410 234568899999999999987 999999
Q ss_pred CCCceEECCCCCceecccccceecCC
Q 005599 500 KASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 500 kp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
||+||++++++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=156.32 Aligned_cols=130 Identities=24% Similarity=0.354 Sum_probs=107.7
Q ss_pred ccccCCcEeEEEEEeCCCcEEEEEEccCCCc--------ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEecc
Q 005599 378 KLGQGGFGPVYKGKLANGQEIAVKRLSTTSG--------QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 378 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 449 (688)
.||+|+||.||+|.. ++..+++|....... ...+++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 578899998654321 11356778999999999988776666667777889999999
Q ss_pred CCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
++++|.+++.... ..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988873321 078999999999999988 99999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=179.43 Aligned_cols=138 Identities=18% Similarity=0.293 Sum_probs=112.8
Q ss_pred hcCCCCCCccccCCcEeEEEEEeCCCcEEEEEE-ccCC-Cc------ccHHHHHHHHHHHhhcCCCCccceEEEEEeCCc
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKR-LSTT-SG------QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE 441 (688)
Q Consensus 370 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~-l~~~-~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 441 (688)
...|...++||+|+||.||+|.+.+.. +++|+ +... .. ...+.+.+|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344566799999999999999876444 44443 2221 11 123568899999999999999998888888888
Q ss_pred eeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccce
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 521 (688)
.++||||+++++|.+++. ....++.+++++|.+||+.+ |+||||||+|||+ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999988873 35679999999999999988 9999999999999 67899999999997
Q ss_pred ec
Q 005599 522 VF 523 (688)
Q Consensus 522 ~~ 523 (688)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 53
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-17 Score=174.98 Aligned_cols=175 Identities=25% Similarity=0.342 Sum_probs=132.8
Q ss_pred ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccc
Q 005599 441 EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA 520 (688)
Q Consensus 441 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 520 (688)
..++.|+++...+|.++|.........++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 467899999999999999766666678899999999999999999 55 999999999999999999999999998
Q ss_pred eecCCCc----cccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHHHhcc
Q 005599 521 RVFGGEE----ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSD 595 (688)
Q Consensus 521 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 595 (688)
....... .....+...||..||+||.+.+..|+.|+||||||+||+||++ -...++- .....
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-------------~~t~~ 470 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-------------IATLT 470 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-------------HHhhh
Confidence 7765443 2334455789999999999999999999999999999999998 2222110 00000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 005599 596 DKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTV 639 (688)
Q Consensus 596 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~ev 639 (688)
+.-...+++....+.|. -..+..+++...|.+||++.++
T Consensus 471 d~r~g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 471 DIRDGIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhhcCCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence 11112223222222232 3578889999999999955443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=160.87 Aligned_cols=197 Identities=19% Similarity=0.261 Sum_probs=135.1
Q ss_pred CCCCccceEEEEEeC---------------------------CceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHH
Q 005599 425 QHRNLVKLLGCCLEK---------------------------DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL 477 (688)
Q Consensus 425 ~H~niv~l~g~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 477 (688)
+|||||++.++|.+. ...||||.-. .-+|..++... ..+...+.-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC----CCchHHHHHHHH
Confidence 599999999887642 2357787665 34677777432 345566667999
Q ss_pred HHHHHHHHhhcCCCCCeEecCCCCCceEEC--CCC--CceecccccceecCCC----ccccccccccccCCccCceeecC
Q 005599 478 GIARGVLYLHQDSRLRIIHRDLKASNILLD--EEM--NPRISDFGTARVFGGE----EISTNTNRVVGTYGYMSPEYALG 549 (688)
Q Consensus 478 ~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~--~~kl~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 549 (688)
|+++|+.|||.++ |.|||+|++||||. +|+ .+.|+|||++-.-... .+....-...|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 99999999999983 443 4789999987532221 11111222457778999999865
Q ss_pred CC------CCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHh
Q 005599 550 GL------FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGL 623 (688)
Q Consensus 550 ~~------~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 623 (688)
.+ --.|+|.|+.|.+.||+++...||...++-..+... +.+.. -+. .|...+..+.+|+.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe~q-----LPa----lp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQESQ-----LPA----LPSRVPPVARQLVF 491 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhhhh-----CCC----CcccCChHHHHHHH
Confidence 43 234899999999999999999998542211111111 11111 112 23344556889999
Q ss_pred hcccCCCCCCCCHHHHHHHh
Q 005599 624 LCVQDRTTDRPSMSTVVFML 643 (688)
Q Consensus 624 ~Cl~~~P~~RPt~~evl~~L 643 (688)
..++.||.+||+..-....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999976655444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=8e-17 Score=180.36 Aligned_cols=216 Identities=22% Similarity=0.296 Sum_probs=142.7
Q ss_pred HhcCCCCCCccccCCcEeEEEEEeCC-CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEe
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 369 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 447 (688)
..++|..+++|..|+||.||..+++. .+.+|+|+-+.... .++ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li-----lRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI-----LRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccchh-----hhc---cccccCCccee-----------------
Confidence 34688889999999999999998763 56788843221110 011 22222233333
Q ss_pred ccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC-
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE- 526 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~- 526 (688)
|+-...+... ..++ .+++.+++|||+.+ |+|||+||+|+||+.-|++|+.|||+.+.....
T Consensus 136 ----gDc~tllk~~---g~lP--------vdmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLLKNI---GPLP--------VDMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhcccC---CCCc--------chhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 3333333221 1222 12378999999998 999999999999999999999999998753211
Q ss_pred -------cc-----ccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhc
Q 005599 527 -------EI-----STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWS 594 (688)
Q Consensus 527 -------~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 594 (688)
.. .......+||+.|+|||++....|+..+|+|++|+|+||.+-|+.||.. +-.+.|...+..
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG--dtpeelfg~vis--- 272 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG--DTPEELFGQVIS--- 272 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC--CCHHHHHhhhhh---
Confidence 00 1122346899999999999999999999999999999999999999843 222233322211
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 005599 595 DDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV 640 (688)
Q Consensus 595 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 640 (688)
++ .+..+. ......++.+++.+.|+.+|..|--....+
T Consensus 273 d~--i~wpE~------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 273 DD--IEWPEE------DEALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred hh--cccccc------CcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 10 011111 122234678888899999999996544443
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-16 Score=124.58 Aligned_cols=66 Identities=50% Similarity=0.978 Sum_probs=56.7
Q ss_pred cCCCCceEEeeecccCCCCcceeeccccCHHHHHHHHhccCCceeecccccccCCceeeEEeeCCcccc
Q 005599 184 CQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETNGGIGCLIYHGDLNDT 252 (688)
Q Consensus 184 C~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nC~C~a~~~~~~~~~~~~~C~~~~~~l~~~ 252 (688)
|+.+|+|++|++|++|++.. ..+..++++++|++.||+||||+||+|. +.. ++++|++|+++|.|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~-~~~~~~~s~~~C~~~Cl~nCsC~Ayay~-~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDN-AIVDSSVSLEECEKACLSNCSCTAYAYS-NLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcc-eeeecCCCHHHHHhhcCCCCCEeeEEee-ccC-CCCEEEEEcCEeecC
Confidence 55679999999999999976 4565779999999999999999999996 333 678999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.6e-15 Score=145.54 Aligned_cols=137 Identities=21% Similarity=0.249 Sum_probs=98.9
Q ss_pred CCccccCCcEeEEEEEeCCCcEEEEEEccCCCcc--cHHH----------------------HHHHHHHHhhcCCCC--c
Q 005599 376 SNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQ--GIEE----------------------FKNEVLLIAKLQHRN--L 429 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i 429 (688)
.+.||+|+||.||+|...+++.||||++...... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4789999999999999888999999987653211 1111 135666666665433 4
Q ss_pred cceEEEEEeCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecCCCCCceEECC
Q 005599 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDE 508 (688)
Q Consensus 430 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~ 508 (688)
.+.+++ ...++||||++++.+......... .. .+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 346899999999654322111100 11 5567899999999999999 76 99999999999999
Q ss_pred CCCceecccccceecC
Q 005599 509 EMNPRISDFGTARVFG 524 (688)
Q Consensus 509 ~~~~kl~DFGla~~~~ 524 (688)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.2e-15 Score=137.42 Aligned_cols=135 Identities=23% Similarity=0.221 Sum_probs=115.4
Q ss_pred CCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCC--CCccceEEEEEeCCceeEEEeccCCC
Q 005599 375 TSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQH--RNLVKLLGCCLEKDEKMLIYEFMPNK 452 (688)
Q Consensus 375 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~g 452 (688)
+.+.||+|.++.||++...+ ..++||....... ...+.+|+.++..++| .++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999854 7899999865433 5678999999999986 58999999988888899999999888
Q ss_pred ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 453 SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 453 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
.+..+ +......++.+++++|++||.....+++|+||+|.||++++.+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77433 5567778899999999999987555699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.5e-14 Score=142.58 Aligned_cols=135 Identities=19% Similarity=0.253 Sum_probs=105.0
Q ss_pred Cccc-cCCcEeEEEEEeCCCcEEEEEEccCCC-------------cccHHHHHHHHHHHhhcCCCCc--cceEEEEEeCC
Q 005599 377 NKLG-QGGFGPVYKGKLANGQEIAVKRLSTTS-------------GQGIEEFKNEVLLIAKLQHRNL--VKLLGCCLEKD 440 (688)
Q Consensus 377 ~~LG-~G~fg~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~ 440 (688)
..|| .|+.|+||+.... +..+|||++.... ......+.+|+.++..|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5787 8999999999875 7789999874321 1223467889999999998875 67777755433
Q ss_pred c----eeEEEeccCC-CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceec
Q 005599 441 E----KMLIYEFMPN-KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRIS 515 (688)
Q Consensus 441 ~----~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 515 (688)
. .++|+|++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 688888743 223332 3678999999999998 9999999999999999999999
Q ss_pred ccccceec
Q 005599 516 DFGTARVF 523 (688)
Q Consensus 516 DFGla~~~ 523 (688)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.2e-15 Score=171.45 Aligned_cols=256 Identities=20% Similarity=0.260 Sum_probs=187.6
Q ss_pred cCCCCCCccccCCcEeEEEEEeC--CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCceeEE
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA--NGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 445 (688)
..|.+.+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-..+. |+|++++++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34666788999999999888653 34567777765543 223334455787877886 99999999999999999999
Q ss_pred EeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCeEecCCCCCceEECCCC-Cceecccccceec
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH-QDSRLRIIHRDLKASNILLDEEM-NPRISDFGTARVF 523 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla~~~ 523 (688)
.+|..++++...+..... ...+....-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999777732211 12334445568899999999999 776 99999999999999999 9999999999887
Q ss_pred CC-Cccccccccccc-cCCccCceeecCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccc
Q 005599 524 GG-EEISTNTNRVVG-TYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALE 600 (688)
Q Consensus 524 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 600 (688)
.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+............|.... ..
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~--- 249 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GR--- 249 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---cc---
Confidence 76 444455555778 9999999999885 457789999999999999999999865443322222221110 00
Q ss_pred cccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 601 IVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 601 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
..............++...++..+|..|.+.+++..
T Consensus 250 -----~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 -----FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -----cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 000111112234667888888899999999888653
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.8e-14 Score=113.28 Aligned_cols=72 Identities=21% Similarity=0.359 Sum_probs=62.6
Q ss_pred cCCCCceEEeeecccCCCCcceeeccccCHHHHHHHHhc---cCCceeecccccccCCceeeEEeeCCc-cccccccCCC
Q 005599 184 CQKGEGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLG---NCSCVAYASAYAETNGGIGCLIYHGDL-NDTRTYTNAG 259 (688)
Q Consensus 184 C~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nC~C~a~~~~~~~~~~~~~C~~~~~~l-~~~~~~~~~~ 259 (688)
|...++|+++.+|++|++.. +++++|++.|++ ||||+||+|. + .+.+|++|+++| .+++.+.+.|
T Consensus 5 ~~~~g~fl~~~~~klpd~~~-------~s~~eC~~~Cl~~~~nCsC~Aya~~-~---~~~gC~~W~~~l~~d~~~~~~~g 73 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA-------NTADECANRCEKNGLPFSCKAFVFA-K---ARKQCLWFPFNSMSGVRKEFSHG 73 (80)
T ss_pred eecCCeEEEeecccCCcccc-------cCHHHHHHHHhcCCCCCCceeeecc-C---CCCCeEEecCcchhhHHhccCCC
Confidence 55568899999999999864 689999999999 9999999986 2 235899999999 9999888889
Q ss_pred CceEEec
Q 005599 260 QDLFVRA 266 (688)
Q Consensus 260 ~~~yvr~ 266 (688)
.++|+|.
T Consensus 74 ~~Ly~r~ 80 (80)
T cd00129 74 FDLYENK 80 (80)
T ss_pred ceeEeEC
Confidence 9999983
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.3e-13 Score=147.27 Aligned_cols=141 Identities=21% Similarity=0.277 Sum_probs=100.7
Q ss_pred CCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccH------------------------------H----------HHH
Q 005599 376 SNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGI------------------------------E----------EFK 415 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~------------------------------~----------~~~ 415 (688)
.+.||+|++|.||+|++.+|+.||||+.+....... + .|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 368999999999999999999999999865421100 0 244
Q ss_pred HHHHHHhhcC----CCCccceEEEEE-eCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHH-HHHHhhcC
Q 005599 416 NEVLLIAKLQ----HRNLVKLLGCCL-EKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR-GVLYLHQD 489 (688)
Q Consensus 416 ~E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~ 489 (688)
+|+..+.+++ |.+-+.+-..+. .....+|||||+++++|.++...... .. .+.+++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 5555555552 333333333332 24567999999999999887642211 11 24456766666 46788987
Q ss_pred CCCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 490 ~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
+ ++|+|++|.||++++++.++++|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 7 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.39 E-value=5e-13 Score=111.28 Aligned_cols=77 Identities=43% Similarity=0.909 Sum_probs=64.5
Q ss_pred cCCC---CceEEeeecccCCCCcceeeccccCHHHHHHHHhccCCceeecccccccCCceeeEEeeCCccccccccCCCC
Q 005599 184 CQKG---EGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETNGGIGCLIYHGDLNDTRTYTNAGQ 260 (688)
Q Consensus 184 C~~~---~~f~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nC~C~a~~~~~~~~~~~~~C~~~~~~l~~~~~~~~~~~ 260 (688)
|... ++|..+.++++|++.+ .. ..+++++|++.||+||+|+||+|. +++++|++|.+++.+.+.....+.
T Consensus 5 C~~~~~~~~f~~~~~~~~~~~~~--~~-~~~s~~~C~~~Cl~nCsC~a~~~~----~~~~~C~~~~~~~~~~~~~~~~~~ 77 (84)
T cd01098 5 CGGDGSTDGFLKLPDVKLPDNAS--AI-TAISLEECREACLSNCSCTAYAYN----NGSGGCLLWNGLLNNLRSLSSGGG 77 (84)
T ss_pred cCCCCCCCEEEEeCCeeCCCchh--hh-ccCCHHHHHHHHhcCCCcceeeec----CCCCeEEEEeceecceEeecCCCc
Confidence 7544 6899999999998876 23 778999999999999999999986 346799999999998876555568
Q ss_pred ceEEech
Q 005599 261 DLFVRAD 267 (688)
Q Consensus 261 ~~yvr~~ 267 (688)
++|||++
T Consensus 78 ~~yiKv~ 84 (84)
T cd01098 78 TLYLRLA 84 (84)
T ss_pred EEEEEeC
Confidence 8999973
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.6e-13 Score=132.54 Aligned_cols=206 Identities=19% Similarity=0.221 Sum_probs=141.5
Q ss_pred HHHHHhhcCCCCccceEEEEEeC-----CceeEEEeccCCCChhhHhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 005599 417 EVLLIAKLQHRNLVKLLGCCLEK-----DEKMLIYEFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARGVLYLHQDS 490 (688)
Q Consensus 417 E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~ 490 (688)
-..-|-++-|.|||++..|..+. .+..++.|||..|+|..+|....+ ...+......+++.||..||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34445667799999999887654 346899999999999999976433 345777788899999999999999975
Q ss_pred CCCeEecCCCCCceEECCCCCceecccc--cceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHH
Q 005599 491 RLRIIHRDLKASNILLDEEMNPRISDFG--TARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEI 568 (688)
Q Consensus 491 ~~~iiH~Dlkp~NILl~~~~~~kl~DFG--la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~el 568 (688)
++|+|+++.-+-|++..++-+|+.--. .....-............+-++|.|||+-.....+.++|||+||+..+||
T Consensus 197 -PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 -PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred -CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 689999999999999999888874211 11110011111222234567899999988888888899999999999999
Q ss_pred HhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 569 ITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 569 ltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
.-+.--... ..+....+.. -.++.-.+... .-..++..|++..|..||+|++++.
T Consensus 276 ailEiq~tn--seS~~~~ee~-----ia~~i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTN--SESKVEVEEN-----IANVIIGLENG-----------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCC--Ccceeehhhh-----hhhheeeccCc-----------cccCcCcccccCCCCCCcchhhhhc
Confidence 887643211 1111000000 00000001111 1235677899999999999999874
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=7.6e-12 Score=119.07 Aligned_cols=131 Identities=21% Similarity=0.152 Sum_probs=98.4
Q ss_pred CCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccc-eEEEEEeCCceeEEEeccCCCCh
Q 005599 376 SNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVK-LLGCCLEKDEKMLIYEFMPNKSL 454 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~e~~~~gsL 454 (688)
.+.|+.|.++.||+++.. +..+++|....... ....+..|+.++..+.+.++++ ++.+ .....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 367899999999999875 77899998754432 2235678999999997666544 4443 33456899999999887
Q ss_pred hhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 455 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS--RLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 455 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
.... .....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5320 011245678999999999986 23469999999999999 66899999999853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.7e-12 Score=137.01 Aligned_cols=249 Identities=21% Similarity=0.262 Sum_probs=177.1
Q ss_pred cCCCCCCcccc--CCcEeEEEEEe---CCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCce
Q 005599 371 DNFSTSNKLGQ--GGFGPVYKGKL---ANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEK 442 (688)
Q Consensus 371 ~~f~~~~~LG~--G~fg~Vy~~~~---~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 442 (688)
..|.+.+.+|+ |.+|.||.+.. .++..+|+|+-+.. .......=.+|+.....++ |+|.++....+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566789999 99999999986 46788999984332 2232233356777777774 99999988888888999
Q ss_pred eEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCCeEecCCCCCceEECCC-CCceeccc
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR----GVLYLHQDSRLRIIHRDLKASNILLDEE-MNPRISDF 517 (688)
Q Consensus 443 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DF 517 (688)
++-+|++. .+|..+.+.. ...++....+.+..+... ||.++|+.. ++|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999886 6776766433 233556666667777777 999999988 9999999999999999 88999999
Q ss_pred ccceecCCCcccccc---ccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhc
Q 005599 518 GTARVFGGEEISTNT---NRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWS 594 (688)
Q Consensus 518 Gla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 594 (688)
|+...+......... .+..|...|++||.+. +.++.++|+|++|.++.|..++.......-... |....
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-------W~~~r 339 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS-------WSQLR 339 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC-------ccccc
Confidence 999988766533222 2336778899999664 567899999999999999999876543211111 00000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 005599 595 DDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 595 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 641 (688)
. .. +..++-..-..++..++..+++.+|..|++.+.+..
T Consensus 340 ~---~~-----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 Q---GY-----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c---cc-----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 00 111111111234555888899999999999887653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.3e-11 Score=133.06 Aligned_cols=146 Identities=17% Similarity=0.209 Sum_probs=93.9
Q ss_pred cCCCCCCccccCCcEeEEEEEeCC-CcEEEEEEccCCCcc------------------------------cH----H---
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQ------------------------------GI----E--- 412 (688)
Q Consensus 371 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~------------------------------~~----~--- 412 (688)
..|.. +.||+|++|.||+|++++ |+.||||++++.... .. +
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 789999999999999987 999999998754210 00 1
Q ss_pred ---HHHHHHHHHhhcC----CCCccceEEEEEe-CCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHH-HH
Q 005599 413 ---EFKNEVLLIAKLQ----HRNLVKLLGCCLE-KDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR-GV 483 (688)
Q Consensus 413 ---~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L 483 (688)
+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||+.++.+.++..-.. ...+.. .++...+. -+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~--~g~d~~---~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA--AGTDMK---LLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh--cCCCHH---HHHHHHHHHHH
Confidence 1334444444442 3344444444433 456789999999999977521111 111111 12221111 12
Q ss_pred HHhhcCCCCCeEecCCCCCceEECCCC----CceecccccceecCC
Q 005599 484 LYLHQDSRLRIIHRDLKASNILLDEEM----NPRISDFGTARVFGG 525 (688)
Q Consensus 484 ~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFGla~~~~~ 525 (688)
..++..+ ++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 2333445 99999999999999988 999999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.5e-11 Score=127.52 Aligned_cols=249 Identities=20% Similarity=0.208 Sum_probs=178.2
Q ss_pred HHHhcCCCCCCccccCCcEeEEEEEe--CCCcEEEEEEccCCCcccHHHH--HHHHHHHhhc-CCCCccceEEEEEeCCc
Q 005599 367 LAATDNFSTSNKLGQGGFGPVYKGKL--ANGQEIAVKRLSTTSGQGIEEF--KNEVLLIAKL-QHRNLVKLLGCCLEKDE 441 (688)
Q Consensus 367 ~~~~~~f~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~--~~E~~~l~~l-~H~niv~l~g~~~~~~~ 441 (688)
.....+|..+..||.|.|+.|++... .++..+++|.+.........+. ..|+.+...+ .|.++++....+....+
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34456788899999999999999864 4678899998876543332222 4566666666 48999998888888888
Q ss_pred eeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCC-CCceecccccc
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE-MNPRISDFGTA 520 (688)
Q Consensus 442 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGla 520 (688)
.++=.||+.++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||++
T Consensus 341 ~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 88999999999987665 23345777888999999999999999887 9999999999999986 78899999998
Q ss_pred eecCCCccccccccccccCCcc--CceeecCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccc
Q 005599 521 RVFGGEEISTNTNRVVGTYGYM--SPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKA 598 (688)
Q Consensus 521 ~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~k~DvwSlGvll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 598 (688)
..+.-... .....-+++ +|+......+..+.|++|||.-+.|.+++..-... .. ..
T Consensus 415 t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------~~----------~~ 472 (524)
T KOG0601|consen 415 TRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------GV----------QS 472 (524)
T ss_pred cccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcc-------cc----------cc
Confidence 64321111 112223344 55666667789999999999999999998764211 00 11
Q ss_pred cccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 005599 599 LEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 599 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 645 (688)
..+....+. ..+. ....+..++..++..++..||.+.++..+.+-
T Consensus 473 ~~i~~~~~p-~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 473 LTIRSGDTP-NLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred eeeeccccc-CCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111111111 1111 12566778888899999999999888766543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.7e-10 Score=111.57 Aligned_cols=142 Identities=17% Similarity=0.243 Sum_probs=110.7
Q ss_pred CccccCCcEeEEEEEeCCCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCC--CCccceEEEEEeCC---ceeEEEeccC
Q 005599 377 NKLGQGGFGPVYKGKLANGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQH--RNLVKLLGCCLEKD---EKMLIYEFMP 450 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~e~~~ 450 (688)
+.|+.|..+.||++...+|+.+++|....... .....+..|++++..+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778999998755432 245678999999999976 44677887776543 5689999999
Q ss_pred CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------------------
Q 005599 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS---------------------------------------- 490 (688)
Q Consensus 451 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------- 490 (688)
+.++...+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888665421 24677777888888888888888531
Q ss_pred -------------CCCeEecCCCCCceEECC--CCCceeccccccee
Q 005599 491 -------------RLRIIHRDLKASNILLDE--EMNPRISDFGTARV 522 (688)
Q Consensus 491 -------------~~~iiH~Dlkp~NILl~~--~~~~kl~DFGla~~ 522 (688)
...++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 56689999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.1e-09 Score=119.15 Aligned_cols=167 Identities=17% Similarity=0.231 Sum_probs=123.1
Q ss_pred EeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCChhhHhhccCCCCCCCHH
Q 005599 391 KLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWK 470 (688)
Q Consensus 391 ~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~ 470 (688)
+..++.+|.|...+.......+...+-++.|+.+|||||++++......+..|||+|-+. .|..++... .-.
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKE 104 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHH
Confidence 345688888888766655445567788999999999999999999999999999999874 333444221 123
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccccccccccCCccCceeecCC
Q 005599 471 KRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG 550 (688)
Q Consensus 471 ~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 550 (688)
..--.+.||+.||.+||..+ .++|++|.-..|+|++.|..||++|.++........ ......--..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 34446789999999999766 599999999999999999999999998864432111 01112222346666654322
Q ss_pred CCCCcccchhHHHHHHHHHhC
Q 005599 551 LFSTKSDVFSFGVLLLEIITG 571 (688)
Q Consensus 551 ~~s~k~DvwSlGvll~elltG 571 (688)
. -..|.|-||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=1e-09 Score=105.49 Aligned_cols=137 Identities=14% Similarity=0.143 Sum_probs=98.9
Q ss_pred CccccCCcEeEEEEEeCC-------CcEEEEEEccCCC------------c----------ccHHHHH----HHHHHHhh
Q 005599 377 NKLGQGGFGPVYKGKLAN-------GQEIAVKRLSTTS------------G----------QGIEEFK----NEVLLIAK 423 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~------------~----------~~~~~~~----~E~~~l~~ 423 (688)
-.||.|--+.||.|.-.+ +..+|||+.+... . ...+.+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999997543 4799999765221 0 0022233 79999999
Q ss_pred cCC--CCccceEEEEEeCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEecCCC
Q 005599 424 LQH--RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL-HQDSRLRIIHRDLK 500 (688)
Q Consensus 424 l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~Dlk 500 (688)
+.. -++.+++++ ...+|||||+.+..+..... ....++..+...+..+++.+|..| |..+ |||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 964 466677764 56789999998764422211 111244455667889999999999 7777 9999999
Q ss_pred CCceEECCCCCceecccccceecC
Q 005599 501 ASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 501 p~NILl~~~~~~kl~DFGla~~~~ 524 (688)
+.|||++ ++.+.|+|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4679999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-09 Score=100.78 Aligned_cols=131 Identities=23% Similarity=0.308 Sum_probs=104.4
Q ss_pred CccccCCcEeEEEEEeCCCcEEEEEEccCCCc--c------cHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEec
Q 005599 377 NKLGQGGFGPVYKGKLANGQEIAVKRLSTTSG--Q------GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 448 (688)
..|++|+-+.+|.+.+. |..+++|.-.+... . ..+.-.+|+.++.+++--.|.-..=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999774 44466665433211 1 123456799999999877777777777888899999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
+++..|.+.+... +..++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888433 3568888889999999998 99999999999999876 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.6e-09 Score=96.91 Aligned_cols=143 Identities=24% Similarity=0.316 Sum_probs=108.3
Q ss_pred CCCccccCCcEeEEEEEeCCCcEEEEEEccCCC--------cccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEE
Q 005599 375 TSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTS--------GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 375 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 446 (688)
....|-+|+-+.|+++.+. |+...||.-.... ....+.-.+|+++|.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 3578899999999999985 6776676432221 112345678999999998777777777788888889999
Q ss_pred eccCC-CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCC---ceeccccccee
Q 005599 447 EFMPN-KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMN---PRISDFGTARV 522 (688)
Q Consensus 447 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFGla~~ 522 (688)
||+++ .++.+++.........+ .....++..|-+.+.-||.++ |||+||..+||+|..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 47788876543332222 233678899999999999998 999999999999976553 57999999854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.6e-10 Score=130.60 Aligned_cols=250 Identities=19% Similarity=0.261 Sum_probs=168.2
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEeC-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCcee
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKM 443 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 443 (688)
...+.+.+.+-+-+|+++.++.+.-. .|...++|..... .....+....+-.++-..+||-+++...-+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567788888999999999987633 2333344433221 1112223333333444445666666665556677889
Q ss_pred EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
||++|+.+++|...|+... ..+..-....+..+..+++|||... ++|+|++|.|+|...+++.+++|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999988886543 2333333446667888999999976 899999999999999999999999854332
Q ss_pred CCC-------------------------ccc----cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCC
Q 005599 524 GGE-------------------------EIS----TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKN 574 (688)
Q Consensus 524 ~~~-------------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p 574 (688)
... ... .......+|+.|.+||.+.+......+|+|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 110 000 112236789999999999999999999999999999999999999
Q ss_pred CCCCCCCCccHHHHHHHHhcccccccccccccc-CCCCHHHHHHHHHHHhhcccCCCCCCCCHH
Q 005599 575 TGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA-DSCPAPEALRCIQVGLLCVQDRTTDRPSMS 637 (688)
Q Consensus 575 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~ 637 (688)
|....... + ...++...+. ...+......+.+++...+..+|.+|-.|.
T Consensus 1035 ~na~tpq~------~--------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQ------I--------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhh------h--------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 85321110 0 0111111111 112334455677888888889999998776
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.3e-08 Score=105.58 Aligned_cols=168 Identities=23% Similarity=0.332 Sum_probs=128.9
Q ss_pred EeEEEEEe-CCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEe----CCceeEEEeccCC-CChhhHh
Q 005599 385 GPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLE----KDEKMLIYEFMPN-KSLDYFI 458 (688)
Q Consensus 385 g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~~-gsL~~~l 458 (688)
.+.||+.. .||..+++|+++....+....-..-+++.+++.|+|||++..++.. +..++|||+|.|+ ++|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 57899974 4899999999954443443344566888999999999999998873 3457999999986 5666554
Q ss_pred hcc------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC
Q 005599 459 FDE------------SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 459 ~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 526 (688)
+.. ......++...+.++.|+..||.++|+.| +..+-|.|.+||++.+.+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 432 12234677899999999999999999998 888999999999999999999988887766544
Q ss_pred ccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCC
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKN 574 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p 574 (688)
.... +. --.+-|.=-||.+++.|.||...
T Consensus 447 ~~~~----------------le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PTEP----------------LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCcc----------------hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 3111 11 12356888999999999999754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=5e-08 Score=99.24 Aligned_cols=140 Identities=18% Similarity=0.122 Sum_probs=100.6
Q ss_pred ccccCCcEeEEEEEeCCCcEEEEEEccCCCcc-----------cHHHHHHHHHHHhhcCCCC--ccceEEEEEeC-----
Q 005599 378 KLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQ-----------GIEEFKNEVLLIAKLQHRN--LVKLLGCCLEK----- 439 (688)
Q Consensus 378 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~----- 439 (688)
.+-.-....|++..+ +|+.+.||+....... ....+.+|...+.++...+ .++++++....
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333344667766 5788999977433211 1114789999999986444 45556666542
Q ss_pred CceeEEEeccCCC-ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECC-------CCC
Q 005599 440 DEKMLIYEFMPNK-SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-------EMN 511 (688)
Q Consensus 440 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-------~~~ 511 (688)
...+||+|++++. +|.+++..-. ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3468999999986 7888874321 233456677789999999999999998 999999999999985 467
Q ss_pred ceeccccccee
Q 005599 512 PRISDFGTARV 522 (688)
Q Consensus 512 ~kl~DFGla~~ 522 (688)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.6e-08 Score=93.84 Aligned_cols=126 Identities=26% Similarity=0.333 Sum_probs=82.4
Q ss_pred eEEEEEeCCCcEEEEEEccCCC--------------c-------c-----cHHHHHHHHHHHhhcCCC--CccceEEEEE
Q 005599 386 PVYKGKLANGQEIAVKRLSTTS--------------G-------Q-----GIEEFKNEVLLIAKLQHR--NLVKLLGCCL 437 (688)
Q Consensus 386 ~Vy~~~~~~~~~vavK~l~~~~--------------~-------~-----~~~~~~~E~~~l~~l~H~--niv~l~g~~~ 437 (688)
.||.|...+|..+|||..+... . . ......+|.+.|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999899999999765321 0 0 112356799999999866 56666644
Q ss_pred eCCceeEEEeccC--CCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCCCeEecCCCCCceEECCCCCcee
Q 005599 438 EKDEKMLIYEFMP--NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY-LHQDSRLRIIHRDLKASNILLDEEMNPRI 514 (688)
Q Consensus 438 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 514 (688)
...+|||||++ +..+..+. +.. ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 25679999998 54554332 111 1123445677788886666 46777 9999999999999988 9999
Q ss_pred cccccceecC
Q 005599 515 SDFGTARVFG 524 (688)
Q Consensus 515 ~DFGla~~~~ 524 (688)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.7e-07 Score=88.71 Aligned_cols=136 Identities=20% Similarity=0.212 Sum_probs=95.2
Q ss_pred CCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCC----------------------cccHHHHHHHHHHHhhcCCC--C
Q 005599 373 FSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTS----------------------GQGIEEFKNEVLLIAKLQHR--N 428 (688)
Q Consensus 373 f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------------------~~~~~~~~~E~~~l~~l~H~--n 428 (688)
..+.++||.|--+.||.|..+.|.++|||.-+... ........+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 35678999999999999999999999999533210 01123456799999999654 6
Q ss_pred ccceEEEEEeCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECC
Q 005599 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE 508 (688)
Q Consensus 429 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~ 508 (688)
+.+.+++ +...+||||+++-.|...-. ..-+... ++..|+.-+..+-..+ |||+|+.+-|||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~---il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDE---ILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC-----cccCHHH---HHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7776654 55679999998876643321 1122233 3333333333333445 999999999999999
Q ss_pred CCCceecccccceec
Q 005599 509 EMNPRISDFGTARVF 523 (688)
Q Consensus 509 ~~~~kl~DFGla~~~ 523 (688)
+|.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999766543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=8.4e-07 Score=87.21 Aligned_cols=107 Identities=24% Similarity=0.283 Sum_probs=85.4
Q ss_pred HHHHHHHHHHHhhcCC--CCccceEEEEEeCC----ceeEEEeccCCC-ChhhHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 005599 411 IEEFKNEVLLIAKLQH--RNLVKLLGCCLEKD----EKMLIYEFMPNK-SLDYFIFDESRKQLLDWKKRFDIILGIARGV 483 (688)
Q Consensus 411 ~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L 483 (688)
.....+|...+..|.. -..++.+++..... ..+||+|++++. +|.+++..... ++...+..++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 3467888888888853 44567777776643 358999999874 79888854222 55667788999999999
Q ss_pred HHhhcCCCCCeEecCCCCCceEECCCC---Cceecccccceec
Q 005599 484 LYLHQDSRLRIIHRDLKASNILLDEEM---NPRISDFGTARVF 523 (688)
Q Consensus 484 ~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFGla~~~ 523 (688)
+-||..+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999998 99999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.6e-07 Score=74.45 Aligned_cols=72 Identities=35% Similarity=0.727 Sum_probs=57.4
Q ss_pred CceEEeeecccCCCCcceeeccccCHHHHHHHHhc-cCCceeecccccccCCceeeEEee-CCccccccccCCCCceEEe
Q 005599 188 EGFIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLG-NCSCVAYASAYAETNGGIGCLIYH-GDLNDTRTYTNAGQDLFVR 265 (688)
Q Consensus 188 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nC~C~a~~~~~~~~~~~~~C~~~~-~~l~~~~~~~~~~~~~yvr 265 (688)
..|..++++.+++... ......++++|++.|++ +|+|.||.|.. ++.+|.+|. +.+.+....++.+.++|.+
T Consensus 4 ~~f~~~~~~~l~~~~~--~~~~~~s~~~C~~~C~~~~~~C~s~~y~~----~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSR--IVISVASLEECASKCLNSNCSCRSFTYNN----GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCcc--eeEcCCCHHHHHHHhCCCCCceEEEEEcC----CCCEEEEeeCCccccceecccCCceeEEe
Confidence 5699999999996654 22456799999999999 99999999862 467999999 8887777556666677765
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.6e-06 Score=82.25 Aligned_cols=139 Identities=19% Similarity=0.156 Sum_probs=103.2
Q ss_pred cccCCcEeEEEEEeCCCcEEEEEEccCC---C---cccHHHHHHHHHHHhhcCCC--CccceEEEEEeC----CceeEEE
Q 005599 379 LGQGGFGPVYKGKLANGQEIAVKRLSTT---S---GQGIEEFKNEVLLIAKLQHR--NLVKLLGCCLEK----DEKMLIY 446 (688)
Q Consensus 379 LG~G~fg~Vy~~~~~~~~~vavK~l~~~---~---~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~----~~~~lV~ 446 (688)
-|+||-+.|++-.+. |+.+-+|+-... + +.....|.+|+..|..|... .+.+.+...... ...+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 367888899998875 447889986522 1 34567899999999999643 345555222222 2368999
Q ss_pred eccCC-CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCC--ceeccccccee
Q 005599 447 EFMPN-KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMN--PRISDFGTARV 522 (688)
Q Consensus 447 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DFGla~~ 522 (688)
|-+++ -+|.+++.+.. ....+...+..++.++++.+.-||..+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97654 67888874432 224567778899999999999999998 999999999999986666 99999987654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=8.5e-08 Score=105.14 Aligned_cols=152 Identities=19% Similarity=0.350 Sum_probs=101.2
Q ss_pred HHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCC-cccc-----cc-ccccccCCccCceeec
Q 005599 476 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE-EIST-----NT-NRVVGTYGYMSPEYAL 548 (688)
Q Consensus 476 ~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~-~~~~-----~~-~~~~gt~~y~aPE~~~ 548 (688)
+.+++.||.|+|... .+||++|.|++|.++..+..||+.|+.+...... ++.. .. .-......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999875 6999999999999999999999999987654431 1111 10 0123456799999999
Q ss_pred CCCCCCcccchhHHHHHHHHHhCCCC-CCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhccc
Q 005599 549 GGLFSTKSDVFSFGVLLLEIITGKKN-TGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQ 627 (688)
Q Consensus 549 ~~~~s~k~DvwSlGvll~elltG~~p-~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~ 627 (688)
+...+.++|+||+|+++|-+..|..+ +...+. ...+.... ...+... ...+...+.++.+=+.+.+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~----~~~~~~~~-------~~~~~~~-~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG----LLSYSFSR-------NLLNAGA-FGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCC----cchhhhhh-------ccccccc-ccccccCcHHHHHHHHHHhc
Confidence 98899999999999999999965544 221110 00000000 0111111 11122334467777777889
Q ss_pred CCCCCCCCHHHHHH
Q 005599 628 DRTTDRPSMSTVVF 641 (688)
Q Consensus 628 ~~P~~RPt~~evl~ 641 (688)
.++..||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998877653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.2e-06 Score=96.56 Aligned_cols=141 Identities=19% Similarity=0.271 Sum_probs=93.4
Q ss_pred CccccCCcEeEEEEEeCCCcEEEEEEccCCCccc------------------------------HHH----------HHH
Q 005599 377 NKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQG------------------------------IEE----------FKN 416 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~------------------------------~~~----------~~~ 416 (688)
+.|+.++-|.||+|++++|+.||||+.++.-... .++ +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 7899999999999999999999999886542110 111 234
Q ss_pred HHHHHhhcC----CCCccceEEEEEe-CCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHH-HHHhhcCC
Q 005599 417 EVLLIAKLQ----HRNLVKLLGCCLE-KDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG-VLYLHQDS 490 (688)
Q Consensus 417 E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~-L~yLH~~~ 490 (688)
|..-+.+++ +..-+++=.++.+ ....+|+|||++|-.+.++..-.. ...+-+. ++..++++ +..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 444444442 2222333334433 467899999999999988853222 2244222 33333332 22222234
Q ss_pred CCCeEecCCCCCceEECCCCCceecccccceecCC
Q 005599 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 491 ~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 525 (688)
++|.|..|.||+++.++.+.+.|||+...+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999877654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.1e-06 Score=86.07 Aligned_cols=258 Identities=15% Similarity=0.140 Sum_probs=151.0
Q ss_pred CCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCCccceEEEE------EeCCc-eeEEE
Q 005599 375 TSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLVKLLGCC------LEKDE-KMLIY 446 (688)
Q Consensus 375 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~------~~~~~-~~lV~ 446 (688)
....||+|+-+.+|-.-- -..-+.|+..........+ .+..|... .||-+-.-+.+= -++.. .-++|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 357899999999985421 1223456665543332222 22333333 465443312111 11222 45677
Q ss_pred eccCCCC-hhhHhhc---cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 447 EFMPNKS-LDYFIFD---ESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 447 e~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
+.+++.- +..++.. ...-...+|.-.++++..+|.+.+-||..+ .+-+|+.++|+|+++++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 7765542 2233221 122345789999999999999999999998 89999999999999999999987544332
Q ss_pred cCCCccccccccccccCCccCceeec-----CCCCCCcccchhHHHHHHHHHhC-CCCCCCCCCC--CccHHHHHHHHhc
Q 005599 523 FGGEEISTNTNRVVGTYGYMSPEYAL-----GGLFSTKSDVFSFGVLLLEIITG-KKNTGIFNDD--SSNLIRYVWELWS 594 (688)
Q Consensus 523 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvll~elltG-~~p~~~~~~~--~~~l~~~~~~~~~ 594 (688)
.... ....-.+|...|.+||.-. +-.-+...|-|.||+++++|+.| ++|+...... .....+- .+.
T Consensus 167 ~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---~Ia 240 (637)
T COG4248 167 NANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---DIA 240 (637)
T ss_pred ccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---hhh
Confidence 2111 1112257888999999654 33456789999999999999996 8898543211 1111110 000
Q ss_pred cccccccccccc-----cCCCCHH-HHHHHHHHHhhcccCC--CCCCCCHHHHHHHhcCC
Q 005599 595 DDKALEIVDSSM-----ADSCPAP-EALRCIQVGLLCVQDR--TTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 595 ~~~~~~~~d~~l-----~~~~~~~-~~~~~~~l~~~Cl~~~--P~~RPt~~evl~~L~~~ 646 (688)
.+.....-|... ....|.. ....+..|..+|+... +.-|||++..+..|...
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 111111111110 0111221 2334566777787643 67899999988777543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.31 E-value=9.8e-06 Score=80.76 Aligned_cols=138 Identities=16% Similarity=0.185 Sum_probs=85.9
Q ss_pred CccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCC--ccceEEEEEeCCceeEEEeccCCCC-
Q 005599 377 NKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN--LVKLLGCCLEKDEKMLIYEFMPNKS- 453 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gs- 453 (688)
.+||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||++++..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 25567888875432 3455788999999987544 4677888777777889999999863
Q ss_pred hhhHh---------------------hccCCCCCCCHHHHHH-HHH----------HHHH-HHHHhhcC-CCCCeEecCC
Q 005599 454 LDYFI---------------------FDESRKQLLDWKKRFD-IIL----------GIAR-GVLYLHQD-SRLRIIHRDL 499 (688)
Q Consensus 454 L~~~l---------------------~~~~~~~~l~~~~~~~-i~~----------~ia~-~L~yLH~~-~~~~iiH~Dl 499 (688)
+...+ +.... .......+.. +.. .+.. ...+|... ....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 11000 0111111110 000 0001 11222211 2235789999
Q ss_pred CCCceEECCCCCceecccccce
Q 005599 500 KASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 500 kp~NILl~~~~~~kl~DFGla~ 521 (688)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999988 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.18 E-value=6.2e-06 Score=79.47 Aligned_cols=105 Identities=23% Similarity=0.257 Sum_probs=83.9
Q ss_pred HHHHHHHhhcCC-CCccceEEEEEeCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 005599 415 KNEVLLIAKLQH-RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493 (688)
Q Consensus 415 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 493 (688)
.+|.-++..+++ +++++++|+| ..++|.||.+.+++...-.....--..+|..|.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 6999999999 45789999998766422100011123689999999999999999999976566
Q ss_pred eEecCCCCCceEECCCCCceecccccceec
Q 005599 494 IIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 494 iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
+...|++|+|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.9e-07 Score=98.75 Aligned_cols=185 Identities=17% Similarity=0.126 Sum_probs=133.8
Q ss_pred CCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCC-ccceEEEEEeCCceeEEEeccC
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN-LVKLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~ 450 (688)
.+...+.+++|++++++|.+-.-.+...++.+... ....-++++|.+++||| .++.++-+..++...++++++.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 34444678999999999987544455556665433 45567899999999999 7777777777778889999988
Q ss_pred CC-ChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccc
Q 005599 451 NK-SLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 451 ~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 529 (688)
.+ +-..-. ......+...+...+...-++++++||+.. =+|+| |||..+ ...+..||+....+....
T Consensus 318 ~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 318 TGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred CCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--
Confidence 77 211110 001111233334445666778999999864 48998 777766 678999999987665433
Q ss_pred cccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHhCCCC
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKN 574 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~elltG~~p 574 (688)
..+...+|+.++|||......+..+.|+|++|+---++--|-+|
T Consensus 386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 33447889999999999999999999999999877777777665
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.6e-05 Score=74.71 Aligned_cols=139 Identities=16% Similarity=0.183 Sum_probs=93.1
Q ss_pred HHhcCCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHH---------HHHHHHHhhcCCC---CccceEEE
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEF---------KNEVLLIAKLQHR---NLVKLLGC 435 (688)
Q Consensus 368 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~H~---niv~l~g~ 435 (688)
....+|.+.+++-......|.+-.. +|..+++|..+.......+.| .+++..+.+++.. ..+.++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3456788778888777777777766 578999998766543322222 2344444444332 23333333
Q ss_pred EEe-----CCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCC
Q 005599 436 CLE-----KDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM 510 (688)
Q Consensus 436 ~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 510 (688)
... ....+|||||+++..|.++.. ++. .++..++.++.-||..| +.|+|..|.|+++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence 322 234568999999988755531 121 25566778899999998 99999999999999655
Q ss_pred Cceeccccccee
Q 005599 511 NPRISDFGTARV 522 (688)
Q Consensus 511 ~~kl~DFGla~~ 522 (688)
++++||+..+.
T Consensus 173 -i~iID~~~k~~ 183 (229)
T PF06176_consen 173 -IRIIDTQGKRM 183 (229)
T ss_pred -EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.1e-05 Score=77.38 Aligned_cols=140 Identities=14% Similarity=0.141 Sum_probs=86.5
Q ss_pred ccccCCc-EeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCCccceEEEEEeCCceeEEEeccCCCChh
Q 005599 378 KLGQGGF-GPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEKMLIYEFMPNKSLD 455 (688)
Q Consensus 378 ~LG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 455 (688)
.|..|.. ..||+.... +..++||+..... ..++.+|++++..+. +--+.+++++....+..++|||++++.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4556666 689999765 4788888875443 345678999988884 444667788777666789999999988775
Q ss_pred hHh-------------------hccCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHhhc----C
Q 005599 456 YFI-------------------FDESR-KQLLD--WKKRFDIIL--------------------GIARGVLYLHQ----D 489 (688)
Q Consensus 456 ~~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~~L~yLH~----~ 489 (688)
... +.... ..... ...++.... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 11000 00111 001110000 01111222211 1
Q ss_pred CCCCeEecCCCCCceEECCCCCceecccccce
Q 005599 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 490 ~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 521 (688)
....++|+|+.|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23458999999999999998778899999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.05 E-value=2.1e-05 Score=78.58 Aligned_cols=143 Identities=19% Similarity=0.206 Sum_probs=85.2
Q ss_pred CccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCC--CccceEEEEEeC---CceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHR--NLVKLLGCCLEK---DEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lV~e~~~~ 451 (688)
+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.+.... ...+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999877 69999987543 4556788899999888533 356677655433 236899999999
Q ss_pred CChhh----------------Hh---hcc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHhhc-
Q 005599 452 KSLDY----------------FI---FDE-SRKQLLDWKK---------RFDI------------ILGIAR-GVLYLHQ- 488 (688)
Q Consensus 452 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH~- 488 (688)
..+.. .+ +.. .....+.+.. .... ...+.+ .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 11 111 0111111111 0000 111222 2333332
Q ss_pred ---CCCCCeEecCCCCCceEEC-CCCCceeccccccee
Q 005599 489 ---DSRLRIIHRDLKASNILLD-EEMNPRISDFGTARV 522 (688)
Q Consensus 489 ---~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFGla~~ 522 (688)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 556667999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=4.2e-05 Score=84.16 Aligned_cols=141 Identities=16% Similarity=0.246 Sum_probs=88.5
Q ss_pred CccccCCcEeEEEEEeCCCcEEEEEEccCCCccc---------------------------HH----------HHHHHHH
Q 005599 377 NKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQG---------------------------IE----------EFKNEVL 419 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---------------------------~~----------~~~~E~~ 419 (688)
+.||.-+.|.||+|++++|+.||||+-++.-... .+ .|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 7899999999999999999999999876542110 00 1333443
Q ss_pred HHh----hcCCCCc---cceEEEEEe-CCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 005599 420 LIA----KLQHRNL---VKLLGCCLE-KDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 491 (688)
Q Consensus 420 ~l~----~l~H~ni---v~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 491 (688)
-.. .++|-++ |.+=.++.+ ...++|+||||+|..+.+...-. +..++-.....-+.++..-+-+- .
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~~l~~~~~~qIf~--~-- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID--KRGISPHDILNKLVEAYLEQIFK--T-- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH--HcCCCHHHHHHHHHHHHHHHHHh--c--
Confidence 332 2345551 122233333 35789999999998886664221 12233333333333322222222 2
Q ss_pred CCeEecCCCCCceEECC----CCCceecccccceecC
Q 005599 492 LRIIHRDLKASNILLDE----EMNPRISDFGTARVFG 524 (688)
Q Consensus 492 ~~iiH~Dlkp~NILl~~----~~~~kl~DFGla~~~~ 524 (688)
+++|+|=.|.||+++. ++.+.+-|||+...+.
T Consensus 321 -GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 -GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred -CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3999999999999994 6789999999987654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.95 E-value=8.5e-05 Score=72.92 Aligned_cols=153 Identities=18% Similarity=0.237 Sum_probs=98.6
Q ss_pred eehHHHHHHhcCCCCCCc---cccCCcEeEEEEEeCCCcEEEEEEccCCCcc-------------------cHHH-----
Q 005599 361 FELSTVLAATDNFSTSNK---LGQGGFGPVYKGKLANGQEIAVKRLSTTSGQ-------------------GIEE----- 413 (688)
Q Consensus 361 ~~~~~~~~~~~~f~~~~~---LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-------------------~~~~----- 413 (688)
.++..+....++..+... |++|--+.||+|.-.++..+|||+.+..... ..++
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 344555555555555554 4566667899999888999999987643211 1111
Q ss_pred HHHHHHHHhhcC--CCCccceEEEEEeCCceeEEEeccCCCChh-hHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 005599 414 FKNEVLLIAKLQ--HRNLVKLLGCCLEKDEKMLIYEFMPNKSLD-YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490 (688)
Q Consensus 414 ~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~gsL~-~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~ 490 (688)
...|+.-|.++. +-.+.+.+++. +-.|||||++...+. -.| ..-.+...+...+..++++.+.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 134666666663 44555555553 457999999765221 111 1111222245566777888888777633
Q ss_pred CCCeEecCCCCCceEECCCCCceecccccceecC
Q 005599 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 491 ~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 524 (688)
.+||+||+.-|||+. ++.+.|+|||-|....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 399999999999999 8899999999886543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00015 Score=86.23 Aligned_cols=79 Identities=16% Similarity=0.377 Sum_probs=58.7
Q ss_pred CCccccCCcEeEEEEEeCCC---cEEEEEEccCCC-cccHHHHHHHHHHHhhcC-CCCc--cceEEEEEeC---CceeEE
Q 005599 376 SNKLGQGGFGPVYKGKLANG---QEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQ-HRNL--VKLLGCCLEK---DEKMLI 445 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 445 (688)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|++++..+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999887654 467888764432 223457889999999995 6665 7788888764 357899
Q ss_pred EeccCCCCh
Q 005599 446 YEFMPNKSL 454 (688)
Q Consensus 446 ~e~~~~gsL 454 (688)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00028 Score=68.30 Aligned_cols=128 Identities=17% Similarity=0.240 Sum_probs=89.0
Q ss_pred CCccccCCcEeEEEEEeCCCcEEEEEEccCCC----------------cccHHHHHHHHHHHhhcC------CCCccceE
Q 005599 376 SNKLGQGGFGPVYKGKLANGQEIAVKRLSTTS----------------GQGIEEFKNEVLLIAKLQ------HRNLVKLL 433 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l~ 433 (688)
...||+|+.-.||. +++.....||+..... ....+++.+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999999996 4456677888876554 123466777777666665 78899999
Q ss_pred EEEEeCCceeEEEeccCC------CChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEEC
Q 005599 434 GCCLEKDEKMLIYEFMPN------KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 507 (688)
Q Consensus 434 g~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 507 (688)
|+.+.+...-+|+|.+.+ -+|.+++. ...++. ...+.+. +-..||-... |+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998743 24666663 233444 3333333 4445565555 99999999999996
Q ss_pred CCC----Cceecc
Q 005599 508 EEM----NPRISD 516 (688)
Q Consensus 508 ~~~----~~kl~D 516 (688)
... .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 433 355665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00039 Score=72.43 Aligned_cols=76 Identities=9% Similarity=0.093 Sum_probs=57.3
Q ss_pred CCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCC---CCccceEEEEEeC---CceeEEEecc
Q 005599 376 SNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQH---RNLVKLLGCCLEK---DEKMLIYEFM 449 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~e~~ 449 (688)
.+.||.|..+.||+....++ .+++|..+.. .....|..|...|+.|.. -.+.++++++... +..+||||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 46899999999999987656 4666764321 123578999999999853 3688889887653 5689999999
Q ss_pred CCCCh
Q 005599 450 PNKSL 454 (688)
Q Consensus 450 ~~gsL 454 (688)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00021 Score=71.87 Aligned_cols=73 Identities=14% Similarity=0.258 Sum_probs=46.7
Q ss_pred CccccCCcE-eEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCC---CccceEEEEEeCC---ceeEEEecc
Q 005599 377 NKLGQGGFG-PVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHR---NLVKLLGCCLEKD---EKMLIYEFM 449 (688)
Q Consensus 377 ~~LG~G~fg-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~---~~~lV~e~~ 449 (688)
+.|+.|+.. .||+. +..+++|.... ......+.+|.+++..+... .+.+.++.....+ ..++||+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777776 58875 23577776543 22345788999999888632 3444444433322 347899999
Q ss_pred CCCChh
Q 005599 450 PNKSLD 455 (688)
Q Consensus 450 ~~gsL~ 455 (688)
++.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00042 Score=69.57 Aligned_cols=73 Identities=22% Similarity=0.303 Sum_probs=48.6
Q ss_pred CccccCCcEeEEEEEeCC--CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCc-cceEEEEEeCCceeEEEeccCCCC
Q 005599 377 NKLGQGGFGPVYKGKLAN--GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL-VKLLGCCLEKDEKMLIYEFMPNKS 453 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gs 453 (688)
+.|..|-...+|+....+ +..+++|........ .-...+|+.++..+...++ +++++... ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567788888999998764 678889976543221 1233578888888854444 44444322 248999999876
Q ss_pred h
Q 005599 454 L 454 (688)
Q Consensus 454 L 454 (688)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00039 Score=70.83 Aligned_cols=139 Identities=17% Similarity=0.151 Sum_probs=79.8
Q ss_pred ccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCc-cceEEEEEeCCceeEEEeccCCCChhh
Q 005599 378 KLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL-VKLLGCCLEKDEKMLIYEFMPNKSLDY 456 (688)
Q Consensus 378 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~ 456 (688)
.+..|-...+|+... +++.+++|..........-...+|..++..+....+ .++++.. ...+|+||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 456677889999874 577888887644322211135789999998865444 3444443 2368999999876532
Q ss_pred H-----------------hhccCC-CCCCCHHHHH-HHHHH---------HHHHHHHhhcC-----CCCCeEecCCCCCc
Q 005599 457 F-----------------IFDESR-KQLLDWKKRF-DIILG---------IARGVLYLHQD-----SRLRIIHRDLKASN 503 (688)
Q Consensus 457 ~-----------------l~~~~~-~~~l~~~~~~-~i~~~---------ia~~L~yLH~~-----~~~~iiH~Dlkp~N 503 (688)
. |+.... ...++...++ ....+ +...+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 111111 1112222111 11111 11112222111 12358999999999
Q ss_pred eEECCCCCceeccccccee
Q 005599 504 ILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 504 ILl~~~~~~kl~DFGla~~ 522 (688)
||+++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0003 Score=82.03 Aligned_cols=196 Identities=19% Similarity=0.175 Sum_probs=135.0
Q ss_pred HHHHHHHHhhcCCCCccceEEEEEeCCcee----EEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 005599 414 FKNEVLLIAKLQHRNLVKLLGCCLEKDEKM----LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489 (688)
Q Consensus 414 ~~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~ 489 (688)
..-|+..+.++.|+|++.++.|..++...- +..|++..-++...+.. -..++....+.+..++.+||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 345777888889999999999987765433 34577777777777643 34567778888899999999999998
Q ss_pred CCCCeEecCCCCC---ceEECCCCCceec--ccccceecCCCccccccccccccCCccCceeecCCCCCC--cccchhHH
Q 005599 490 SRLRIIHRDLKAS---NILLDEEMNPRIS--DFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFST--KSDVFSFG 562 (688)
Q Consensus 490 ~~~~iiH~Dlkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--k~DvwSlG 562 (688)
. ..|.-+..+ +...+.++...++ ||+..+.+........ ..-+..+.+||......+.. ..|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHH
Confidence 5 555555554 5555666777766 8888876654332211 23355678888776665544 47999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCccHHHHHHHHhccccccccccccccCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 005599 563 VLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 563 vll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 642 (688)
.++..+..|..+..... ....+++... ...+.+....|+..++++|++..+++..
T Consensus 380 ll~~~~~~~~~i~~~~~-----------------~~~~~l~~~~--------~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSA-----------------VPVSLLDVLS--------TSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHHhhhhhcCccccccc-----------------chhhhhcccc--------chhhhhhhhhhcchhhhhccchhhhhhc
Confidence 99999999887632100 0111111111 1145677788999999999999999875
Q ss_pred h
Q 005599 643 L 643 (688)
Q Consensus 643 L 643 (688)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 4
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00092 Score=71.80 Aligned_cols=75 Identities=12% Similarity=0.207 Sum_probs=55.1
Q ss_pred CccccCCcEeEEEEEeCCC-cEEEEEEccCC-----C--cccHHHHHHHHHHHhhcC---CCCccceEEEEEeCCceeEE
Q 005599 377 NKLGQGGFGPVYKGKLANG-QEIAVKRLSTT-----S--GQGIEEFKNEVLLIAKLQ---HRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~-----~--~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 445 (688)
+.||.|.+..||++...+| +.|+||.-... . ....+.+..|.+.|..+. -.++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6799999999999998877 48999985321 1 234567788888888863 2356667766 44667899
Q ss_pred EeccCCCC
Q 005599 446 YEFMPNKS 453 (688)
Q Consensus 446 ~e~~~~gs 453 (688)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.57 E-value=8.6e-05 Score=53.35 Aligned_cols=43 Identities=40% Similarity=0.552 Sum_probs=37.3
Q ss_pred CCCCCCCCCCCccccceecccCCCCCC---cccCCCeeeEEeecCC
Q 005599 646 ETSVPSPKQPTFSVRKIEIDTDYSSTG---TKSSANEVTLTTFIGR 688 (688)
Q Consensus 646 ~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 688 (688)
...+|.|++|.|...+...+.++|++. ..+|+|++|+|.++||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 457899999999999998777776554 5789999999999999
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00088 Score=64.42 Aligned_cols=125 Identities=26% Similarity=0.413 Sum_probs=89.3
Q ss_pred cCCCCCCccccCCc-EeEEEEEeCCCcEEEEEEccC---CCc------------------ccHHHHHHHHHHHhhcC---
Q 005599 371 DNFSTSNKLGQGGF-GPVYKGKLANGQEIAVKRLST---TSG------------------QGIEEFKNEVLLIAKLQ--- 425 (688)
Q Consensus 371 ~~f~~~~~LG~G~f-g~Vy~~~~~~~~~vavK~l~~---~~~------------------~~~~~~~~E~~~l~~l~--- 425 (688)
.+++.++.||.|.- |.||++++ +|+.+|+|.+.. ... .-..-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999999 478999999321 100 11234778888888775
Q ss_pred CCCc--cceEEEEEeCC------------------ceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 005599 426 HRNL--VKLLGCCLEKD------------------EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485 (688)
Q Consensus 426 H~ni--v~l~g~~~~~~------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y 485 (688)
+.++ |+.+||..-.. ...+|.||++... ....+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 4566 89999875331 1246777765432 1123345677888899
Q ss_pred hhcCCCCCeEecCCCCCceEECCCCCceecccccc
Q 005599 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA 520 (688)
Q Consensus 486 LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 520 (688)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99988 999999999976 3478999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00051 Score=63.93 Aligned_cols=130 Identities=20% Similarity=0.272 Sum_probs=86.4
Q ss_pred CCCCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005599 374 STSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKS 453 (688)
Q Consensus 374 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 453 (688)
...+.|++|.+|.||+|.+. |..+|+|+-+..+ ....+..|+++|..++-.++-+=+-++ ++-++.|||+.+-.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcc
Confidence 44588999999999999986 5588888765443 346788999999999876665433222 22345599998888
Q ss_pred hhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCC-CCceEECCCCCceeccccccee
Q 005599 454 LDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLK-ASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 454 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk-p~NILl~~~~~~kl~DFGla~~ 522 (688)
|...-... + .+-+..+++.---|...+ |-|+.|. |...+|-.+..+.|+||.-|..
T Consensus 99 L~~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 75553211 1 122334444434444444 8888886 4445555555999999998873
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00064 Score=70.84 Aligned_cols=142 Identities=17% Similarity=0.166 Sum_probs=87.1
Q ss_pred CCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCC--ccceEEE------EEeCCceeEEEe
Q 005599 376 SNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN--LVKLLGC------CLEKDEKMLIYE 447 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~e 447 (688)
.+.|..|....+|+....+ ..+++|+... ...+....|+.++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4677788888999987654 4788898754 23456677888888885433 4444432 223445689999
Q ss_pred ccCCCChhh----H----------hhccC--------CCCCCCHHHHHH----------HHHHHHHHHHHhhc----CCC
Q 005599 448 FMPNKSLDY----F----------IFDES--------RKQLLDWKKRFD----------IILGIARGVLYLHQ----DSR 491 (688)
Q Consensus 448 ~~~~gsL~~----~----------l~~~~--------~~~~l~~~~~~~----------i~~~ia~~L~yLH~----~~~ 491 (688)
|+++..+.. . ++... ......|..... ....+...+.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 0 11100 001123322210 11123344455543 123
Q ss_pred CCeEecCCCCCceEECCCCCceecccccce
Q 005599 492 LRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 492 ~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 521 (688)
..++|+|+.|.|||++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 459999999999999998777899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.00029 Score=56.48 Aligned_cols=53 Identities=15% Similarity=0.404 Sum_probs=39.6
Q ss_pred eEEeeecccCCCCcceeeccccCHHHHHHHHhccCCceeecccccccCCceeeEEeeCC
Q 005599 190 FIKLTLVKVPDTSVAAHVDMNLGLKACEEKCLGNCSCVAYASAYAETNGGIGCLIYHGD 248 (688)
Q Consensus 190 f~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nC~C~a~~~~~~~~~~~~~C~~~~~~ 248 (688)
|..+.++.++.++.. .+ ...+.++|+..|+.+|+|.||.|. .+.+.|+++...
T Consensus 6 ~~~~~~~~~~g~d~~-~~-~~~s~~~Cq~~C~~~~~C~afT~~----~~~~~C~lk~~~ 58 (73)
T cd01100 6 FRQGSNVDFRGGDLS-TV-FASSAEQCQAACTADPGCLAFTYN----TKSKKCFLKSSE 58 (73)
T ss_pred ccccCCCccccCCcc-ee-ecCCHHHHHHHcCCCCCceEEEEE----CCCCeEEcccCC
Confidence 333456667766552 22 366999999999999999999986 346789999875
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0019 Score=67.54 Aligned_cols=140 Identities=26% Similarity=0.343 Sum_probs=83.2
Q ss_pred CccccCCcEeEEEEEeCC-------CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCc-cceEEEEEeCCceeEEEec
Q 005599 377 NKLGQGGFGPVYKGKLAN-------GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL-VKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~ 448 (688)
+.|..|-...+|+....+ ++.+++|+..... .......+|.+++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456666677899988765 5789999865433 222355788888888854333 445555432 368999
Q ss_pred cCCCChhhH-----------------hhccCCCC------CCC--HHHHHH--------------------------HHH
Q 005599 449 MPNKSLDYF-----------------IFDESRKQ------LLD--WKKRFD--------------------------IIL 477 (688)
Q Consensus 449 ~~~gsL~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~ 477 (688)
+++..+... ++...... ..+ |..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766431 11111110 010 111100 111
Q ss_pred HHHHHHHHhhc------CCCCCeEecCCCCCceEECCC----CCceecccccce
Q 005599 478 GIARGVLYLHQ------DSRLRIIHRDLKASNILLDEE----MNPRISDFGTAR 521 (688)
Q Consensus 478 ~ia~~L~yLH~------~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFGla~ 521 (688)
.+.+.+..|.. ..+..++|+|+.|.|||++++ +.+.|+||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 234569999999999999985 889999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0088 Score=63.03 Aligned_cols=142 Identities=17% Similarity=0.168 Sum_probs=79.2
Q ss_pred CCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCC--ccceEE------EEEeCCceeEEEe
Q 005599 376 SNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN--LVKLLG------CCLEKDEKMLIYE 447 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g------~~~~~~~~~lV~e 447 (688)
.+.|+.|....+|+....+| .+++|+... ...+....|+.++..|...+ +.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35677788889999987655 688898752 12334445666666663222 334332 1223456789999
Q ss_pred ccCCCChhh-----------Hh---hccCC--------CCCCCH-HHHHHH------------H-HHHHHHHHHhhcC--
Q 005599 448 FMPNKSLDY-----------FI---FDESR--------KQLLDW-KKRFDI------------I-LGIARGVLYLHQD-- 489 (688)
Q Consensus 448 ~~~~gsL~~-----------~l---~~~~~--------~~~l~~-~~~~~i------------~-~~ia~~L~yLH~~-- 489 (688)
|+++..+.. .| +.... ...+.| .....- + ..+...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 998875421 11 11110 011112 221111 1 1111222333211
Q ss_pred --CCCCeEecCCCCCceEECCCCCceecccccce
Q 005599 490 --SRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 490 --~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 521 (688)
-+..+||+|+.|.|||++.+...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999976556899999874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0081 Score=61.77 Aligned_cols=31 Identities=32% Similarity=0.602 Sum_probs=25.7
Q ss_pred CCeEecCCCCCceEECCCCC-ceeccccccee
Q 005599 492 LRIIHRDLKASNILLDEEMN-PRISDFGTARV 522 (688)
Q Consensus 492 ~~iiH~Dlkp~NILl~~~~~-~kl~DFGla~~ 522 (688)
..++|+|+.|.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997555 46999998854
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.018 Score=60.32 Aligned_cols=143 Identities=19% Similarity=0.205 Sum_probs=83.7
Q ss_pred CCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCC--ccceEEEE------EeCCceeEEEe
Q 005599 376 SNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN--LVKLLGCC------LEKDEKMLIYE 447 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~e 447 (688)
.+.++.|....+|+....++ .+++|+..... ..++...|++++..|.... +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 46677787789999876555 57788764421 2345566777777774322 34444321 12345689999
Q ss_pred ccCCCChhh-----------H---hhccCCC---------CCCCHHHHHH------------HHHHHHHHHHHhhc----
Q 005599 448 FMPNKSLDY-----------F---IFDESRK---------QLLDWKKRFD------------IILGIARGVLYLHQ---- 488 (688)
Q Consensus 448 ~~~~gsL~~-----------~---l~~~~~~---------~~l~~~~~~~------------i~~~ia~~L~yLH~---- 488 (688)
|+++..+.. . ++..... ....|..... ....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998865421 0 1110000 0112221110 11123344555543
Q ss_pred CCCCCeEecCCCCCceEECCCCCceecccccce
Q 005599 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 489 ~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 521 (688)
..+..++|+|+.+.||++++++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999998777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0078 Score=64.05 Aligned_cols=141 Identities=19% Similarity=0.247 Sum_probs=81.8
Q ss_pred CccccCCcEeEEEEEeCC-----CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCcc-ceEEEEEeCCceeEEEeccC
Q 005599 377 NKLGQGGFGPVYKGKLAN-----GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV-KLLGCCLEKDEKMLIYEFMP 450 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~ 450 (688)
+.|-.|-.-.+|+....+ ++.|++|........... ..+|..++..+...++. ++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345557777899987543 367889987654433222 36788888888654443 556665332 5899998
Q ss_pred CCChhhH-----------------hhccC--C-CCCCCHHHHHHHHHHH-----------------HHHHHHh----hc-
Q 005599 451 NKSLDYF-----------------IFDES--R-KQLLDWKKRFDIILGI-----------------ARGVLYL----HQ- 488 (688)
Q Consensus 451 ~gsL~~~-----------------l~~~~--~-~~~l~~~~~~~i~~~i-----------------a~~L~yL----H~- 488 (688)
+.+|... +|... . .....|.+..++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7666321 11111 0 1111233322222111 1112222 21
Q ss_pred CCCCCeEecCCCCCceEECC-CCCceeccccccee
Q 005599 489 DSRLRIIHRDLKASNILLDE-EMNPRISDFGTARV 522 (688)
Q Consensus 489 ~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~ 522 (688)
..+..++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346899999999999986 46899999988753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0028 Score=64.49 Aligned_cols=134 Identities=17% Similarity=0.222 Sum_probs=91.2
Q ss_pred CCCCCCccccCCcEeEEEEEeCCCcEEEEEEccCCC------------------cc----cHHHHHHHHHHHhhcCC--C
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTS------------------GQ----GIEEFKNEVLLIAKLQH--R 427 (688)
Q Consensus 372 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~------------------~~----~~~~~~~E~~~l~~l~H--~ 427 (688)
-+.+.++||-|--+.||.+...+|++.++|.-+... .. +.-...+|+..|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 357789999999999999999999999998432110 00 11124568888888853 2
Q ss_pred CccceEEEEEeCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEEC
Q 005599 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 507 (688)
Q Consensus 428 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 507 (688)
-+.+.+++ ...++|||++.+-.|...- +..+..+... .+..-+--|...+ +||+|..--||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~---~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYD---DLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHH---HHHHHHHHHHHcC---ceecccchheeEEe
Confidence 34444443 4568899999887764332 1223333333 3333344555566 99999999999999
Q ss_pred CCCCceecccccce
Q 005599 508 EEMNPRISDFGTAR 521 (688)
Q Consensus 508 ~~~~~kl~DFGla~ 521 (688)
+++.++++||--..
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999997543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.016 Score=59.64 Aligned_cols=139 Identities=20% Similarity=0.282 Sum_probs=74.4
Q ss_pred CCccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC---CCCccceEEEEEeCCceeEEEeccCCC
Q 005599 376 SNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ---HRNLVKLLGCCLEKDEKMLIYEFMPNK 452 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~g 452 (688)
.+.|+-|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4678889999999988 578889999875 233356888988888884 445788999988888889999999877
Q ss_pred Ch--------hh---Hhhc-cCC--------------CC----CCCHHH-----HHHHHHHH--------------HHHH
Q 005599 453 SL--------DY---FIFD-ESR--------------KQ----LLDWKK-----RFDIILGI--------------ARGV 483 (688)
Q Consensus 453 sL--------~~---~l~~-~~~--------------~~----~l~~~~-----~~~i~~~i--------------a~~L 483 (688)
.. -. .|+. ... .+ .-+|.+ |+....+. .+.+
T Consensus 98 ~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~~ 177 (288)
T PF03881_consen 98 SPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVERL 177 (288)
T ss_dssp ---CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHHH
Confidence 11 01 1222 100 00 123332 12212211 1111
Q ss_pred -HHhhcC-CCCCeEecCCCCCceEECCCCCceecccc
Q 005599 484 -LYLHQD-SRLRIIHRDLKASNILLDEEMNPRISDFG 518 (688)
Q Consensus 484 -~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 518 (688)
..|+.. ..+.++|+||.+.|++.+.++.+.|.|-.
T Consensus 178 ~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 178 PSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 223322 23569999999999999999989998854
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.039 Score=57.37 Aligned_cols=145 Identities=17% Similarity=0.254 Sum_probs=82.7
Q ss_pred CccccCCcEeEEEEEeCCCcEEEEEEccC--CCcccHHHHHHHHHHHhhcCC--CCccceEEEEEeCC--ceeEEEeccC
Q 005599 377 NKLGQGGFGPVYKGKLANGQEIAVKRLST--TSGQGIEEFKNEVLLIAKLQH--RNLVKLLGCCLEKD--EKMLIYEFMP 450 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~e~~~ 450 (688)
+.+..|-.-.+|..... ++.+++. ... ..........+|..+++.+.- --+.+.++.|.++. ..+.||+|++
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 44433433345555443 7788888 331 223344566778888887753 23455667777666 5689999998
Q ss_pred CCChhhHhhccC-----------------------------------CCCCCCHHHHHHHH--------HHHHHHHHHhh
Q 005599 451 NKSLDYFIFDES-----------------------------------RKQLLDWKKRFDII--------LGIARGVLYLH 487 (688)
Q Consensus 451 ~gsL~~~l~~~~-----------------------------------~~~~l~~~~~~~i~--------~~ia~~L~yLH 487 (688)
+..+.+.+.... ..+.-.|...+..+ -....-..+|+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 743322211000 00111122222111 01222334444
Q ss_pred cC-----CCCCeEecCCCCCceEECCCCCceecccccceec
Q 005599 488 QD-----SRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 488 ~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 523 (688)
.+ ++..++|+|+.+.||+++.+.-+-|.||+++..-
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 33 2346999999999999999888999999998753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.1 Score=54.55 Aligned_cols=64 Identities=17% Similarity=0.243 Sum_probs=40.2
Q ss_pred eEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCC--CccceEEE------EEeCCceeEEEeccCCCCh
Q 005599 386 PVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHR--NLVKLLGC------CLEKDEKMLIYEFMPNKSL 454 (688)
Q Consensus 386 ~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~------~~~~~~~~lV~e~~~~gsL 454 (688)
.||+....+| .+++|+.... .+.+..|+.++..|... .+++++.. ...++..++|+||+++..+
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 3888876555 6889987422 24456677777777433 34444432 2234567899999988654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.13 Score=55.44 Aligned_cols=73 Identities=10% Similarity=0.064 Sum_probs=50.5
Q ss_pred CCccccCCcEeEEEEEeCCCcEEEEEEccCCCc-------ccHHHHHHHHHHHhhcC---CCCccceEEEEEeCCceeEE
Q 005599 376 SNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSG-------QGIEEFKNEVLLIAKLQ---HRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 445 (688)
.+.||-|....||+.... ++.++||+-..... .....-..|...|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 468899999999998864 56799997642111 23344455566666653 247788888876 557889
Q ss_pred EeccCC
Q 005599 446 YEFMPN 451 (688)
Q Consensus 446 ~e~~~~ 451 (688)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.11 Score=54.87 Aligned_cols=73 Identities=11% Similarity=0.192 Sum_probs=47.9
Q ss_pred ccccCCcEeEEEEEeCCC-cEEEEEEccCC-------CcccHHHHHHHHHHHhhcC--CCC-ccceEEEEEeCCceeEEE
Q 005599 378 KLGQGGFGPVYKGKLANG-QEIAVKRLSTT-------SGQGIEEFKNEVLLIAKLQ--HRN-LVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 378 ~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~--H~n-iv~l~g~~~~~~~~~lV~ 446 (688)
.||.|....||++...+| +.|+||.-... -+...++-.-|...|.... -|. +++++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 579999999999998755 58999964321 1333455566777776653 343 333433 3556667999
Q ss_pred eccCCC
Q 005599 447 EFMPNK 452 (688)
Q Consensus 447 e~~~~g 452 (688)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.08 Score=56.04 Aligned_cols=140 Identities=18% Similarity=0.252 Sum_probs=79.2
Q ss_pred CccccCCcEeEEEEEeCC----CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCCc-cceEEEEEeCCceeEEEeccCC
Q 005599 377 NKLGQGGFGPVYKGKLAN----GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL-VKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~ 451 (688)
+.|..|-...+|+....+ +..|++|......... -...+|..++..+..-++ .++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 445556667889887543 2378888875543322 223678889888875555 4566665322 58999977
Q ss_pred CChhhH-----------------hhccC---CCCCCCHHHHHHHHHHH----------------------HHHHH----H
Q 005599 452 KSLDYF-----------------IFDES---RKQLLDWKKRFDIILGI----------------------ARGVL----Y 485 (688)
Q Consensus 452 gsL~~~-----------------l~~~~---~~~~l~~~~~~~i~~~i----------------------a~~L~----y 485 (688)
..|..- +|... .....-|....++..++ .+-+. .
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 655221 11111 01111233322222111 11111 1
Q ss_pred hhc-CCCCCeEecCCCCCceEECC-CCCceecccccce
Q 005599 486 LHQ-DSRLRIIHRDLKASNILLDE-EMNPRISDFGTAR 521 (688)
Q Consensus 486 LH~-~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~ 521 (688)
+.. ..+.-++|.|+.+.|||+++ ++.++++||..|.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 111 12234789999999999975 5789999999874
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.0041 Score=74.56 Aligned_cols=158 Identities=11% Similarity=-0.072 Sum_probs=110.5
Q ss_pred HHHHHHhhcCCCCccceEEEEEe--CCceeEEEeccCCCChhhHhhccCCCC-CCCHHHHHHHHHHHHHHHHHhhcC--C
Q 005599 416 NEVLLIAKLQHRNLVKLLGCCLE--KDEKMLIYEFMPNKSLDYFIFDESRKQ-LLDWKKRFDIILGIARGVLYLHQD--S 490 (688)
Q Consensus 416 ~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~~ia~~L~yLH~~--~ 490 (688)
.|...++...|+++.....-... ..+.+.+++|+..|.+.+.+.....+. .++..-......+...+..-+|+. .
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 34445556688887766554433 335688999999999999887654332 233222222222224444444433 2
Q ss_pred CCCeEecCCCCCceEECCCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCcccchhHHHHHHHHHh
Q 005599 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570 (688)
Q Consensus 491 ~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvll~ellt 570 (688)
..-.+|++||+-|.+|..+..+|+.++|+.+..... ........+++.|++|++...-.++.++|+|..|+.+|++--
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 345799999999999999999999999999843222 222233677888999999988899999999999999999988
Q ss_pred CCCCC
Q 005599 571 GKKNT 575 (688)
Q Consensus 571 G~~p~ 575 (688)
|..++
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 88765
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.034 Score=54.74 Aligned_cols=30 Identities=30% Similarity=0.486 Sum_probs=21.4
Q ss_pred CeEecCCCCCceEE-CCCCCceeccccccee
Q 005599 493 RIIHRDLKASNILL-DEEMNPRISDFGTARV 522 (688)
Q Consensus 493 ~iiH~Dlkp~NILl-~~~~~~kl~DFGla~~ 522 (688)
.+.|+||.|.|||+ +.++.++|+||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48899999999999 8899999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.09 Score=56.22 Aligned_cols=74 Identities=12% Similarity=0.133 Sum_probs=50.0
Q ss_pred CCccccCCcEeEEEEEeCC-CcEEEEEEccCC------CcccHHHHHHHHHHHhhcC--CCC-ccceEEEEEeCCceeEE
Q 005599 376 SNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTT------SGQGIEEFKNEVLLIAKLQ--HRN-LVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~------~~~~~~~~~~E~~~l~~l~--H~n-iv~l~g~~~~~~~~~lV 445 (688)
.+.||.|.-.-||++...+ ++.|+||.-... -+...++..-|.+.|.... -|. +++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4688999999999999743 568999964321 1334566677888887663 344 4444443 55566788
Q ss_pred EeccCC
Q 005599 446 YEFMPN 451 (688)
Q Consensus 446 ~e~~~~ 451 (688)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998864
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.22 Score=52.32 Aligned_cols=141 Identities=21% Similarity=0.277 Sum_probs=83.5
Q ss_pred CccccCCcEeEEEEEeCCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCC------ccceEEE----EEeCCceeEEE
Q 005599 377 NKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN------LVKLLGC----CLEKDEKMLIY 446 (688)
Q Consensus 377 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~----~~~~~~~~lV~ 446 (688)
+.|.+ .-..||+.+..+|+. ++|..... ....+...|+..+..|.-.. +..+-|- ...+...+-|+
T Consensus 32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred ccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 34444 556789998887777 88887654 44566777888887774222 1222121 11113667899
Q ss_pred eccCCCChhh-Hh--------------hc---------cCCCCCCCHHH-------------HHHHHHHHHHHHHHhhcC
Q 005599 447 EFMPNKSLDY-FI--------------FD---------ESRKQLLDWKK-------------RFDIILGIARGVLYLHQD 489 (688)
Q Consensus 447 e~~~~gsL~~-~l--------------~~---------~~~~~~l~~~~-------------~~~i~~~ia~~L~yLH~~ 489 (688)
+|++|..+.. .. +. ........|.. ......++...+..+++.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999988762 10 10 00111233431 011233444444444433
Q ss_pred ----CC---CCeEecCCCCCceEECCCCC-ceecccccce
Q 005599 490 ----SR---LRIIHRDLKASNILLDEEMN-PRISDFGTAR 521 (688)
Q Consensus 490 ----~~---~~iiH~Dlkp~NILl~~~~~-~kl~DFGla~ 521 (688)
-+ ..+||+|+.|.|||++.+.. +.+.||+-+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11 23999999999999999885 8899999874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.091 Score=54.77 Aligned_cols=139 Identities=20% Similarity=0.230 Sum_probs=90.5
Q ss_pred CCccccCCcEeEEEEEeCCCcEEEEEEccCCC-----c----ccHHH-----------------HHHHHHHHhhcCCCCc
Q 005599 376 SNKLGQGGFGPVYKGKLANGQEIAVKRLSTTS-----G----QGIEE-----------------FKNEVLLIAKLQHRNL 429 (688)
Q Consensus 376 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----~----~~~~~-----------------~~~E~~~l~~l~H~ni 429 (688)
.-.|..|--+.||.+.-.+|..+|||+.+... . .+... ...|++-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 35678888999999999999999999875321 0 00001 1346777777765443
Q ss_pred cceEEEEEeCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCceEECCC
Q 005599 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE 509 (688)
Q Consensus 430 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 509 (688)
.-..-... ...+|||+|+...... ....+.-.++......+-.+++.-|.-|...+ ++||.||.--|+|+-+
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd- 300 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD- 300 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-
Confidence 22111111 2347999998643221 11112334555667777788888888888776 5999999999998865
Q ss_pred CCceeccccccee
Q 005599 510 MNPRISDFGTARV 522 (688)
Q Consensus 510 ~~~kl~DFGla~~ 522 (688)
|.+.|+|-+-+..
T Consensus 301 G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 GKLYIIDVSQSVE 313 (520)
T ss_pred CEEEEEEcccccc
Confidence 5788889876643
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.13 Score=49.94 Aligned_cols=139 Identities=13% Similarity=0.134 Sum_probs=85.6
Q ss_pred EEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCCccceEEEEEeCCceeEEEeccCCCChhhHhhccCCCCCCCHHHHHHH
Q 005599 397 EIAVKRLSTTSGQ-GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDI 475 (688)
Q Consensus 397 ~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i 475 (688)
+..+|++....-. ...-|.++..++++++ .|++|..- +.-..-++.|+|-.... .. ..+
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~----~N~ 146 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NF----SNF 146 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------ch----hHH
Confidence 3455655443322 3456788888888875 46676632 33345688898743221 11 112
Q ss_pred HHHHHHHHHHhhcCCCCCeEecCCCCCceEECCCCCceecccccceecCCCccccccccccccCCccCceeecCCCCCCc
Q 005599 476 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTK 555 (688)
Q Consensus 476 ~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k 555 (688)
+..=+++|.-.|+.. ...+|+|-.|+||+-|+.|.+||.|-+.... .+..|.--| ....+.+
T Consensus 147 i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~---Y~~lT~~ 208 (308)
T PF07387_consen 147 ITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIE---YESLTQE 208 (308)
T ss_pred HHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeee---ccccChH
Confidence 222247788889654 3599999999999999999999999875421 011122211 1234667
Q ss_pred ccchhHHHHHHHHHhCCC
Q 005599 556 SDVFSFGVLLLEIITGKK 573 (688)
Q Consensus 556 ~DvwSlGvll~elltG~~ 573 (688)
+.+-+|=.-++++....+
T Consensus 209 aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 209 AEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred HHHHHHHHHHHHHHHHHh
Confidence 777777777777776544
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.23 Score=52.06 Aligned_cols=32 Identities=28% Similarity=0.393 Sum_probs=28.2
Q ss_pred CCCeEecCCCCCceEECCCCCceeccccccee
Q 005599 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 491 ~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 522 (688)
+..++|+|+.+.|||+++++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34699999999999999999999999988753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 688 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-57 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-55 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-36 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-23 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-23 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-22 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-21 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-21 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-20 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-20 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-20 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-20 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-20 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-20 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-20 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-20 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-20 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-20 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-20 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-20 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-20 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-20 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-20 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-19 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-19 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 688 | |||
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-145 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-144 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-125 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 7e-94 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-79 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-68 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 6e-68 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-64 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-64 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 8e-62 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-61 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 7e-61 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 5e-60 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-57 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 9e-53 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-51 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-51 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 5e-50 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-45 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-45 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 8e-45 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-44 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 3e-44 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-44 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-43 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 5e-43 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 9e-43 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-42 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-42 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-42 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-42 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-42 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-42 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-42 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-42 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 6e-42 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 6e-42 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 6e-42 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 7e-42 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 8e-42 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 8e-42 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-41 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-41 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-41 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-41 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-41 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-41 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-41 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 5e-41 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 5e-41 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 5e-41 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 7e-41 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 9e-41 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 9e-41 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-40 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-40 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-40 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-40 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-40 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-40 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-40 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 4e-40 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 7e-40 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 9e-40 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-39 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-39 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-39 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-39 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-39 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-39 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 5e-39 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 6e-39 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-38 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-38 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-38 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-38 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-37 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 8e-37 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 5e-36 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 6e-36 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 7e-36 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-35 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-35 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-35 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-34 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 7e-34 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 9e-34 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 9e-34 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-33 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-33 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-32 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-32 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-32 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-32 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-32 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-32 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 9e-32 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 9e-32 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-31 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-31 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-31 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-31 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 5e-31 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 5e-31 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 8e-31 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 9e-31 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-30 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-30 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-30 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-30 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-30 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 4e-30 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-30 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 7e-30 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 8e-30 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-29 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-29 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-29 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-29 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-29 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-29 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 4e-29 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-29 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-29 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 6e-29 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 8e-29 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 9e-29 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-28 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-28 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-28 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-28 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-28 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-28 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-28 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-28 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 6e-28 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 8e-28 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 8e-28 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 8e-28 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-27 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-27 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-27 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-27 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-27 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 6e-27 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 7e-27 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-26 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-26 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 4e-26 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-26 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 7e-26 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 8e-26 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 8e-26 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 8e-26 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-25 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-25 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-25 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 3e-25 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-25 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 4e-25 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-25 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 9e-25 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 9e-25 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-24 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-24 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-24 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 4e-24 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-23 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-23 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 4e-23 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-23 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 4e-23 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 5e-23 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-22 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-22 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-22 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-22 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-22 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-22 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-21 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 9e-21 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-20 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-20 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-20 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-20 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-20 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-19 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-19 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-19 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-19 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-18 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-18 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-18 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-11 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-17 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-17 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-17 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-17 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-17 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-17 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 4e-17 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-16 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-16 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-16 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 4e-16 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-16 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-15 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-15 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-15 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-15 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 4e-15 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 5e-15 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 6e-15 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 8e-15 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-14 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-14 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-14 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-14 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-14 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-14 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-14 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 5e-14 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 9e-14 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-13 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-13 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-13 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-11 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-11 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 8e-11 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-10 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-10 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 3e-10 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 5e-10 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 5e-10 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 6e-10 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-09 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-08 | |
| 1n1i_A | 105 | Merozoite surface protein-1; MSP1, malaria, surfac | 2e-04 |
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 425 bits (1095), Expect = e-145
Identities = 109/301 (36%), Positives = 162/301 (53%), Gaps = 21/301 (6%)
Query: 359 TFFELSTVLAATDNFS------TSNKLGQGGFGPVYKGKLANGQEIAVKRLST----TSG 408
+F+EL T+NF NK+G+GGFG VYKG + N +AVK+L+ T+
Sbjct: 16 SFYELK---NVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 409 QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLD 468
+ ++F E+ ++AK QH NLV+LLG + D+ L+Y +MPN SL + L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 469 WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528
W R I G A G+ +LH++ IHRD+K++NILLDE +ISDFG AR
Sbjct: 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRY 588
+ T+R+VGT YM+PE L G + KSD++SFGV+LLEIITG + + L+
Sbjct: 189 TVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD-EHREPQLLLDI 246
Query: 589 VWELWSDDKALE-IVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647
E+ ++K +E +D M D + V C+ ++ RP + V +L T
Sbjct: 247 KEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
Query: 648 S 648
+
Sbjct: 306 A 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 421 bits (1086), Expect = e-144
Identities = 126/298 (42%), Positives = 176/298 (59%), Gaps = 13/298 (4%)
Query: 359 TFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIE-EFKNE 417
+ EL A+DNFS N LG+GGFG VYKG+LA+G +AVKRL QG E +F+ E
Sbjct: 21 SLRELQ---VASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 418 VLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQL-LDWKKRFDII 476
V +I+ HRNL++L G C+ E++L+Y +M N S+ + + Q LDW KR I
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE--ISTNTNR 534
LG ARG+ YLH +IIHRD+KA+NILLDEE + DFG A++ ++ ++T
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT---A 194
Query: 535 VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNT---GIFNDDSSNLIRYVWE 591
V GT G+++PEY G S K+DVF +GV+LLE+ITG++ + NDD L+ +V
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 592 LWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSV 649
L + K +VD + + E + IQV LLC Q +RP MS VV ML +
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 373 bits (961), Expect = e-125
Identities = 106/315 (33%), Positives = 170/315 (53%), Gaps = 11/315 (3%)
Query: 334 SSTRLSDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLA 393
S + A + + L + AT+NF +G G FG VYKG L
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 394 NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKS 453
+G ++A+KR + S QGIEEF+ E+ ++ +H +LV L+G C E++E +LIY++M N +
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 454 LDYFIFDESRKQL-LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP 512
L ++ + + W++R +I +G ARG+ YLH + IIHRD+K+ NILLDE P
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178
Query: 513 RISDFGTARVFGGEE---ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEII 569
+I+DFG ++ + +ST V GT GY+ PEY + G + KSDV+SFGV+L E++
Sbjct: 179 KITDFGISKKGTELDQTHLST---VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 570 TGKKNT-GIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQD 628
+ + NL + E ++ + +IVD ++AD + + C+
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295
Query: 629 RTTDRPSMSTVVFML 643
+ DRPSM V++ L
Sbjct: 296 SSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 7e-94
Identities = 64/310 (20%), Positives = 123/310 (39%), Gaps = 33/310 (10%)
Query: 361 FELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLL 420
+ + +G FG V+K +L + +AVK Q + + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 421 IAKLQHRNLVKLLGCCLEKD----EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDII 476
+ ++H N+++ +G + LI F SL F+ + ++ W + I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 477 LGIARGVLYLHQD-------SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529
+ARG+ YLH+D + I HRD+K+ N+LL + I+DFG A F + +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 530 TNTNRVVGTYGYMSPEYALGGL-----FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSN 584
+T+ VGT YM+PE G + + D+++ G++L E+ + D+
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE--Y 245
Query: 585 LIRYVWELWSDDKALEIVDS--------SMADSCPAPEALRCI-QVGLLCVQDRTTDRPS 635
++ + E+ ++ + + D + + + C R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 636 MSTVVFMLSN 645
V ++
Sbjct: 306 AGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 3e-79
Identities = 65/333 (19%), Positives = 117/333 (35%), Gaps = 45/333 (13%)
Query: 361 FELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNE--V 418
S DN +G+G +G VYKG L + + +AVK S + Q F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 419 LLIAKLQHRNLVKLLGCCLE-----KDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF 473
+ ++H N+ + + + E +L+ E+ PN SL ++ DW
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114
Query: 474 DIILGIARGVLYLHQD------SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG-- 525
+ + RG+ YLH + + I HRDL + N+L+ + ISDFG + G
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 526 ----EEISTNTNRVVGTYGYMSPEYALGGL-------FSTKSDVFSFGVLLLEIITGKKN 574
E VGT YM+PE G + + D+++ G++ EI +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 575 TGIFNDDSSNLIRYVWELWSDDKALEIVDS--------SMADSCPAPEALRCIQVGLL-- 624
+ + E+ + ++ ++ +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 625 CVQDRTTDRPSMSTVVFMLSN-ETSVPSPKQPT 656
C R + ++ K +
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 4e-68
Identities = 79/282 (28%), Positives = 129/282 (45%), Gaps = 27/282 (9%)
Query: 377 NKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCC 436
+G+G FG V K K +++A+K++ S + F E+ ++++ H N+VKL G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 437 LEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIH 496
L L+ E+ SL + L ++GV YLH +IH
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 497 RDLKASNILLDEEMN-PRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTK 555
RDLK N+LL +I DFGTA +I T+ G+ +M+PE G +S K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 556 SDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAP-E 614
DVFS+G++L E+IT +K F++ R +W + + + + P P E
Sbjct: 184 CDVFSWGIILWEVITRRKP---FDEIGGPAFRIMWAV-HNGTRPPL-----IKNLPKPIE 234
Query: 615 ALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN-ETSVPSPKQP 655
+L + C + RPSM +V ++++ P +P
Sbjct: 235 SL--MT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 6e-68
Identities = 77/281 (27%), Positives = 142/281 (50%), Gaps = 24/281 (8%)
Query: 377 NKLGQGGFGPVYKGKLANGQEIAVKRL--STTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
K+G G FG V++ + +G ++AVK L + + EF EV ++ +L+H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 494
+ ++ E++ SL + ++ LD ++R + +A+G+ YLH I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 495 IHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFST 554
+HR+LK+ N+L+D++ ++ DFG +R+ +S+ + GT +M+PE +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNE 218
Query: 555 KSDVFSFGVLLLEIITGKK-NTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAP 613
KSDV+SFGV+L E+ T ++ + N + V + K LEI + P
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNL------NPAQVVAAVGFKCKRLEI-----PRNLN-P 266
Query: 614 EALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN--ETSVPSP 652
+ I+ C + RPS +T++ +L +++VP P
Sbjct: 267 QVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-64
Identities = 73/282 (25%), Positives = 137/282 (48%), Gaps = 37/282 (13%)
Query: 377 NKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQG-------IEEFKNEVLLIAKLQHRN 428
++G+GGFG V+KG+ + + +A+K L +G +EF+ EV +++ L H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
+VKL G ++ EF+P L + + D++ + W + ++L IA G+ Y+
Sbjct: 85 IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQN 140
Query: 489 DSRLRIIHRDLKASNILLDE-----EMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMS 543
I+HRDL++ NI L + +++DFG ++ + + + ++G + +M+
Sbjct: 141 -QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMA 194
Query: 544 PE--YALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601
PE A ++ K+D +SF ++L I+TG+ F++ S I+++ + + I
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGP---FDEYSYGKIKFINMIREEGLRPTI 251
Query: 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643
+ CP P I+ LC RP S +V L
Sbjct: 252 -----PEDCP-PRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-64
Identities = 71/208 (34%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 377 NKLGQGGFGPVYKGKLANGQEIAVKRL----STTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
+G GGFG VY+ G E+AVK Q IE + E L A L+H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 492
G CL++ L+ EF L+ + + + + + IARG+ YLH ++ +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 493 RIIHRDLKASNILLDEEMNPR--------ISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
IIHRDLK+SNIL+ +++ I+DFG AR + + G Y +M+P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAP 183
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITGK 572
E +FS SDV+S+GVLL E++TG+
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 8e-62
Identities = 76/304 (25%), Positives = 113/304 (37%), Gaps = 52/304 (17%)
Query: 377 NKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGC 435
LG+G FG K G+ + +K L + F EV ++ L+H N++K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 436 CLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 495
+ I E++ +L I + W +R IA G+ YLH + II
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNII 130
Query: 496 HRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR------------VVGTYGYMS 543
HRDL + N L+ E N ++DFG AR+ E+ R VVG +M+
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 544 PEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603
PE G + K DVFSFG++L EII + ++
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN---------------ADPDYLPRTMDFGLN 235
Query: 604 SS------MADSCPAPEA---LRCIQVGLLCVQDRTTDRPSMSTVVFML---SNETSVPS 651
+CP +RC C D RPS + L +
Sbjct: 236 VRGFLDRYCPPNCPPSFFPITVRC------CDLDP-EKRPSFVKLEHWLETLRMHLAGHL 288
Query: 652 PKQP 655
P P
Sbjct: 289 PLGP 292
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 7e-61
Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 377 NKLGQGGFGPVYKGKLANGQEIAVKRL--STTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
KL + G ++KG+ G +I VK L S + +F E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 435 CCLEKDEK--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRL 492
C LI +MP SL + + + + D + L +ARG+ +LH L
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFLHTLEPL 133
Query: 493 RIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG-- 550
I L + ++++DE+M RIS F + + +++PE AL
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE-ALQKKP 184
Query: 551 --LFSTKSDVFSFGVLLLEIITGK 572
+D++SF VLL E++T +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 5e-60
Identities = 77/272 (28%), Positives = 138/272 (50%), Gaps = 23/272 (8%)
Query: 377 NKLGQGGFGPVYKGKLANGQEIAVKRL--STTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
++G G FG VYKGK +G ++AVK L + + Q ++ FKNEV ++ K +H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 494
+ ++ ++ SL + + K + KK DI ARG+ YLH I
Sbjct: 88 YST-APQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 495 IHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE---YALGGL 551
IHRDLK++NI L E+ +I DFG A S ++ G+ +M+PE
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 552 FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCP 611
+S +SDV++FG++L E++TG+ + + +N + + + + ++ S + +CP
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ----LPYSNINNRDQIIEMVGRGSLSPDL--SKVRSNCP 255
Query: 612 APEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643
R + C++ + +RPS ++ +
Sbjct: 256 -KRMKRLMA---ECLKKKRDERPSFPRILAEI 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 3e-57
Identities = 64/306 (20%), Positives = 120/306 (39%), Gaps = 43/306 (14%)
Query: 377 NKLGQGGFGPVYKGKLANGQEIAVKRL--STTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
+G+G FG VY G+ +G E+A++ + + ++ FK EV+ + +H N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRI 494
C+ +I ++L + K +LD K I I +G+ YLH I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 495 IHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR---VVGTYGYMSPE------ 545
+H+DLK+ N+ D I+DFG + G + ++ G +++PE
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 546 ---YALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602
FS SDVF+ G + E+ + ++ + + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWP---------------FKTQPAEAIIWQM 255
Query: 603 DSSMADSCP---APEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN-ETSVPSPKQPTFS 658
+ M + + + I L C +RP+ + ++ ML P
Sbjct: 256 GTGMKPNLSQIGMGKEISDIL--LFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHF 313
Query: 659 VRKIEI 664
+ E+
Sbjct: 314 WKSAEL 319
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 9e-53
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 377 NKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNE--VLLIAKLQHRNLVKLLG 434
+G+G +G V++G G+ +AVK S+ + + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 435 CCLEKDEK----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
+ LI + SL ++ + LD I+L IA G+ +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 491 RLR-----IIHRDLKASNILLDEEMNPRISDFGTARVF--GGEEISTNTNRVVGTYGYMS 543
I HRDLK+ NIL+ + I+D G A + ++ N VGT YM+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 544 PE------YALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFND 580
PE + D+++FG++L E+ + GI D
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-51
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 377 NKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNE--VLLIAKLQHRNLVKLLG 434
++G+G +G V+ GK G+++AVK T + E + ++H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 435 CCLEKDEK----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
++ LI ++ N SL ++ + LD K + G+ +LH +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 491 RLR-----IIHRDLKASNILLDEEMNPRISDFGTARVF--GGEEISTNTNRVVGTYGYMS 543
I HRDLK+ NIL+ + I+D G A F E+ N VGT YM
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 544 PEYALGGL------FSTKSDVFSFGVLLLEIITGKKNTGIFND 580
PE L +D++SFG++L E+ + GI +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 5e-50
Identities = 65/301 (21%), Positives = 118/301 (39%), Gaps = 47/301 (15%)
Query: 377 NKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNE--VLLIAKLQHRNLVKLLG 434
+G+G FG V++GK G+E+AVK S+ + + E + L+H N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 435 CCLEKDEK----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD- 489
+ + L+ ++ + SL ++ + + + + L A G+ +LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 490 ----SRLRIIHRDLKASNILLDEEMNPRISDFGTARVF--GGEEISTNTNRVVGTYGYMS 543
+ I HRDLK+ NIL+ + I+D G A + I N VGT YM+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 544 PEYALGGL------FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK 597
PE + ++D+++ G++ EI GI D + Y + SD
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED---YQLPYYDLVPSDPS 276
Query: 598 ALEIVDS-----------SMADSCPAPEALRCIQVGLL--CVQDRTTDRPSMSTVVFMLS 644
E+ + SC A + ++ C R + + LS
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMA----KIMRECWYANGAARLTALRIKKTLS 332
Query: 645 N 645
Sbjct: 333 Q 333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-45
Identities = 71/282 (25%), Positives = 120/282 (42%), Gaps = 31/282 (10%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRL-STTSGQGIEEFKNEVLLIAKLQHRN 428
++ ++G+G FG V+ G+L A+ +AVK T +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
+V+L+G C +K ++ E + F+ + L K ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL 548
IHRDL A N L+ E+ +ISDFG +R + + + +PE
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 549 GGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS--- 604
G +S++SDV+SFG+LL E + G + S+ + E V+
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGAS---------------PYPNLSNQQTREFVEKGGR 333
Query: 605 -SMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
+ C P+A+ + C RPS ST+ L +
Sbjct: 334 LPCPELC--PDAVFRLM--EQCWAYEPGQRPSFSTIYQELQS 371
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-45
Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 26/284 (9%)
Query: 377 NKLGQGGFGPVYKGKL-----ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVK 431
+LG+G FG V + G+ +AVK+L ++ + + +F+ E+ ++ LQH N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 432 LLGCCLEKDEK--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
G C + LI E++P SL ++ + K+ +D K I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG-----YMSP 544
R IHRDL NIL++ E +I DFG +V ++ V G + +P
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYAP 186
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603
E FS SDV+SFGV+L E+ T +K+ + + +E++
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 604 SSMADSCPA--PEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
++ P P+ + I C + RPS + +
Sbjct: 247 NNGRLPRPDGCPDEIYMIM--TECWNNNVNQRPSFRDLALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 8e-45
Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 26/284 (9%)
Query: 377 NKLGQGGFGPVYKGKL-----ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVK 431
+LG+G FG V + G+ +AVK+L ++ + + +F+ E+ ++ LQH N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 432 LLGCCLEKDEK--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
G C + LI E++P SL ++ + K+ +D K I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 161
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG-----YMSP 544
R IHRDL NIL++ E +I DFG +V ++ V G + +P
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAP 217
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603
E FS SDV+SFGV+L E+ T +K+ + + +E++
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 604 SSMADSCPA--PEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
++ P P+ + I C + RPS + +
Sbjct: 278 NNGRLPRPDGCPDEIYMIM--TECWNNNVNQRPSFRDLALRVDQ 319
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 69/285 (24%), Positives = 122/285 (42%), Gaps = 30/285 (10%)
Query: 377 NKLGQGGFGPVYKGKLA-----NGQEIAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLV 430
LG+G FG V + G+++AVK L + G I + K E+ ++ L H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 431 KLLGCCLEKDEK--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
K G C E LI EF+P+ SL ++ K ++ K++ + I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL-- 142
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG------YM 542
+ +HRDL A N+L++ E +I DFG + I T+ +
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-----IETDKEYYTVKDDRDSPVFWY 196
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601
+PE + F SDV+SFGV L E++T ++ + + + + +
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ-MTVTRLVNT 255
Query: 602 VDSSMADSCPA--PEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644
+ CP P+ + + C + + ++R S ++
Sbjct: 256 LKEGKRLPCPPNCPDEVYQLM--RKCWEFQPSNRTSFQNLIEGFE 298
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-44
Identities = 70/295 (23%), Positives = 117/295 (39%), Gaps = 28/295 (9%)
Query: 377 NKLGQGGFGPVYKGKLAN-----GQEIAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLV 430
LG+G FG V G+ +AVK L + Q +K E+ ++ L H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 431 KLLGCCLEKDEK--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
K GCC + L+ E++P SL ++ + + + I G+ YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG-----YMS 543
IHRDL A N+LLD + +I DFG A+ V G + +
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYA 205
Query: 544 PEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603
PE F SDV+SFGV L E++T ++ LI + + E+++
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 604 SSMADSCPA--PEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSPKQPT 656
P P + + C + + RP+ ++ +L + P+
Sbjct: 266 RGERLPRPDKCPAEVYHLM--KNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-44
Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 31/219 (14%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQE-----IAVKRL-STTSGQGIEEFKNEVLLIAKL 424
F LG G FG VYKG E +A+K L TS + +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 425 QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIILGIA 480
+ ++ +LLG CL LI + MP L ++ + + LL+W + IA
Sbjct: 75 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
+G+ YL R++HRDL A N+L+ + +I+DFG A++ G EE + G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179
Query: 541 -----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKK 573
+M+ E L +++ +SDV+S+GV + E++T G K
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-43
Identities = 65/202 (32%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 377 NKLGQGGFGPVYKGKLANGQE----IAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVK 431
+G+G FG VY G+ + + A+K L T Q +E F E LL+ L H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 432 LLGCCLEKDE-KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
L+G L + ++ +M + L FI R K L +ARG+ YL +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL---A 141
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY--GYMSPEYAL 548
+ +HRDL A N +LDE +++DFG AR E + + + E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 549 GGLFSTKSDVFSFGVLLLEIIT 570
F+TKSDV+SFGVLL E++T
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLT 223
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-43
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 377 NKLGQGGFGPVYKGKL-----ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVK 431
++LG+G FG V + G +AVK+L + +F+ E+ ++ L +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 432 LLGCCLEKDEK--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
G + L+ E++P+ L F+ + + LD + I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 145
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG-----YMSP 544
R +HRDL A NIL++ E + +I+DFG A++ ++ VV G + +P
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 199
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIIT 570
E +FS +SDV+SFGV+L E+ T
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 9e-43
Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRL--STTSGQGIEEFKNEVLLIAKLQHRN 428
+ ++G G FG V+ G N ++A+K + S E+F E ++ KL H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPK 64
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
LV+L G CLE+ L+ EFM + L ++ +++ L + + L + G+ YL
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL-- 120
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT---YGYMSPE 545
+IHRDL A N L+ E ++SDFG R ++ +++T GT + SPE
Sbjct: 121 -EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPE 175
Query: 546 YALGGLFSTKSDVFSFGVLLLEIIT 570
+S+KSDV+SFGVL+ E+ +
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 377 NKLGQGGFGPVYKGKLANG----QEIAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVK 431
+G+G FG VY G L + AVK L T + +F E +++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 432 LLGCCLEKDEK-MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
LLG CL + +++ +M + L FI + K L +A+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG------YMSP 544
+ +HRDL A N +LDE+ +++DFG AR V G +M+
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAKLPVKWMAL 201
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIIT 570
E F+TKSDV+SFGVLL E++T
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-42
Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRL--STTSGQGIEEFKNEVLLIAKLQHRN 428
+ + +LG G FG V GK ++A+K + + S +EF E ++ L H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEK 80
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
LV+L G C ++ +I E+M N L ++ + ++ ++ + + YL
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL-- 136
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT---YGYMSPE 545
+ +HRDL A N L++++ ++SDFG +R +E VG+ + PE
Sbjct: 137 -ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPE 191
Query: 546 YALGGLFSTKSDVFSFGVLLLEIIT 570
+ FS+KSD+++FGVL+ EI +
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 17/205 (8%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRL--STTSGQGIEEFKNEVLLIAKLQHRN 428
+ + +LG G FG V GK ++AVK + + S +EF E + KL H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPK 64
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
LVK G C ++ ++ E++ N L ++ S + L+ + ++ + G+ +L
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL-- 120
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT---YGYMSPE 545
+ IHRDL A N L+D ++ ++SDFG R ++ VGT + +PE
Sbjct: 121 -ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPE 175
Query: 546 YALGGLFSTKSDVFSFGVLLLEIIT 570
+S+KSDV++FG+L+ E+ +
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 377 NKLGQGGFGPVYKGKLANGQE------IAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
+LG+G FG V+ + N +AVK L S ++F+ E L+ LQH+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYF------------IFDESRKQLLDWKKRFDIILG 478
+ G C E ++++E+M + L+ F ++ L + +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT 538
+A G++YL + L +HRDL N L+ + + +I DFG +R +I + VG
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYRVGG 218
Query: 539 YG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M PE L F+T+SDV+SFGV+L EI T
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-42
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEI--AVKRL--STTSGQGIEEFKNEVLLIAKLQH 426
+ + +KLG G +G VY+G + AVK L T +EEF E ++ +++H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVW-KKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKH 68
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
NLV+LLG C + +I EFM +L ++ E +Q + + I+ + YL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTN-----RVVGTYGY 541
+ IHRDL A N L+ E +++DFG +R+ G+ + + + +
Sbjct: 128 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------W 178
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+PE FS KSDV++FGVLL EI T
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-42
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 377 NKLGQGGFGPVYKGKLANG------QEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
+LG+G FG V+ + N +AVK L + ++F+ E L+ LQH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYF-------------IFDESRKQLLDWKKRFDIIL 477
K G C + D ++++E+M + L+ F K L + I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVG 537
IA G++YL + +HRDL N L+ + +I DFG +R ++ + VG
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVG 192
Query: 538 TYG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+ +M PE + F+T+SDV+SFGV+L EI T
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 33/219 (15%)
Query: 377 NKLGQGGFGPVYKGKLANG------QEIAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNL 429
+LG+ FG VYKG L Q +A+K L G EEF++E +L A+LQH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYF-------------IFDESRKQLLDWKKRFDII 476
V LLG + +I+ + + L F D + K L+ ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
IA G+ YL S ++H+DL N+L+ +++N +ISD G R + +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK-----L 186
Query: 537 GTYG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M+PE + G FS SD++S+GV+L E+ +
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-42
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 431 KLLGCCLEKDEK-MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
+LLG +E+ ++ E+M SL ++ + +L L + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG------YMS 543
+HRDL A N+L+ E+ ++SDFG + E S+ + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQ------DTGKLPVKWTA 182
Query: 544 PEYALGGLFSTKSDVFSFGVLLLEIIT 570
PE FSTKSDV+SFG+LL EI +
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 6e-42
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQE------IAVKRL-STTSGQGIEEFKNEVLLIAK 423
+ + S +LGQG FG VY+G + +A+K + S + EF NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYF-------IFDESRKQLLDWKKRFDII 476
++V+LLG + ++I E M L + + + K +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
IA G+ YL + + +HRDL A N ++ E+ +I DFG R +I
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRK 196
Query: 537 GTYGY-----MSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
G G MSPE G+F+T SDV+SFGV+L EI T
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-42
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 431 KLLGCCLEKDEK-MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
+LLG +E+ ++ E+M SL ++ R +L L + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG-----YMSP 544
+HRDL A N+L+ E+ ++SDFG + E S+ G + +P
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQ-----DTGKLPVKWTAP 355
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIIT 570
E FSTKSDV+SFG+LL EI +
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYS 381
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-42
Identities = 72/294 (24%), Positives = 131/294 (44%), Gaps = 36/294 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQE-----IAVKRL-STTSGQGIEEFKNEVLLIAKL 424
+ +G G FG VYKG L +A+K L + + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 425 QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL 484
H N+++L G + M+I E+M N +LD F+ + + ++ GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT---YGY 541
YL + + +HRDL A NIL++ + ++SDFG +RV E+ T G +
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSGGKIPIRW 216
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALE 600
+PE F++ SDV+SFG+++ E++T G++ + S+ + ++
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNHEVMK 261
Query: 601 IVDSSMADSCP--APEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSP 652
++ P P A+ + + C Q RP + +V +L P
Sbjct: 262 AINDGFRLPTPMDCPSAIYQLM--MQCWQQERARRPKFADIVSILDKLIRAPDS 313
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQE----IAVKRL--STTSGQGIEEFKNEVLLIAKL 424
+ LG+G FG V +G L +AVK + +S + IEEF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 425 QHRNLVKLLGCCLEKD-----EKMLIYEFMPNKSLDYFI---FDESRKQLLDWKKRFDII 476
H N+++LLG C+E + M+I FM L ++ E+ + + + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
+ IA G+ YL S +HRDL A N +L ++M ++DFG ++ +
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR-----Q 205
Query: 537 GTYG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
G +++ E ++++KSDV++FGV + EI T
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-42
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANG----QEIAVKRL--STTSGQGIEEFKNEVLLIAKL 424
F+ LG+G FG V + +L ++AVK L + IEEF E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 425 QHRNLVKLLGCCLEKDEK------MLIYEFMPNKSLDYFIFD---ESRKQLLDWKKRFDI 475
H ++ KL+G L K M+I FM + L F+ L +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 476 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV 535
++ IA G+ YL S IHRDL A N +L E+M ++DFG +R +I +
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYR 194
Query: 536 VGTYG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
G +++ E L++ SDV++FGV + EI+T
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-42
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 377 NKLGQGGFGPVYKGKL----ANGQEIAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVK 431
+G G G V G+L +A+K L + + + +F +E ++ + H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 491
L G M++ E+M N SLD F+ + + ++ G+ G+ YL S
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---SD 169
Query: 492 LRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG------YMSPE 545
L +HRDL A N+L+D + ++SDFG +RV + + T T G + +PE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAPE 224
Query: 546 YALGGLFSTKSDVFSFGVLLLEIIT 570
FS+ SDV+SFGV++ E++
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 377 NKLGQGGFGPVYKGKLANGQE-----IAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLV 430
LG G FG V+KG E + +K + SG Q + + +L I L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIILGIARGVLYL 486
+LLG C L+ +++P SL + + LL+W + IA+G+ YL
Sbjct: 79 RLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYL 131
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG-----Y 541
++HR+L A N+LL +++DFG A + ++ + +
Sbjct: 132 ---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKW 183
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
M+ E G ++ +SDV+S+GV + E++T
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 30/215 (13%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQE-----IAVKRL-STTSGQGIEEFKNEVLLIAKL 424
F LG G FG VYKG E +A+K L TS + +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 425 QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE----SRKQLLDWKKRFDIILGIA 480
+ ++ +LLG CL LI + MP L ++ + + LL+W + IA
Sbjct: 75 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
+G+ YL R++HRDL A N+L+ + +I+DFG A++ G EE + G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179
Query: 541 -----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M+ E L +++ +SDV+S+GV + E++T
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANG------QEIAVKRL-STTSGQGIEEFKNEVLLIAK 423
N + LG G FG VY+G+++ ++AVK L S Q +F E L+I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI----FDESRKQLLDWKKRFDIILGI 479
H+N+V+ +G L+ + ++ E M L F+ S+ L + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLD---EEMNPRISDFGTARVFGGEEISTNTNRVV 536
A G YL IHRD+ A N LL +I DFG AR +I +
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRK 201
Query: 537 GTYGY-----MSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
G M PE + G+F++K+D +SFGVLL EI +
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 29/210 (13%)
Query: 377 NKLGQGGFGPVYKGKLANG----QEIAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVK 431
+G+G FG VY G L + AVK L T + +F E +++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 432 LLGCCLEKDEK-MLIYEFMPNKSLDYFIFDESR----KQLLDWKKRFDIILGIARGVLYL 486
LLG CL + +++ +M + L FI +E+ K L+ L +A+G+ +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQVAKGMKFL 208
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG------ 540
+ + +HRDL A N +LDE+ +++DFG AR + V G
Sbjct: 209 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEFDSVHNKTGAKLPVK 261
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M+ E F+TKSDV+SFGVLL E++T
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 61/218 (27%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKG--KLANGQEI--AVKRL---STTSGQGIEEFKNEVLLIAK 423
+ KLG G FG V +G +G+ + AVK L + + +++F EV +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRK----QLLDWKKRFDIILGI 479
L HRNL++L G L ++ E P SL + L + + +
Sbjct: 78 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQV 130
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT- 538
A G+ YL R IHRDL A N+LL +I DFG R +
Sbjct: 131 AEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRK 185
Query: 539 --YGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKK 573
+ + +PE FS SD + FGV L E+ T G++
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-41
Identities = 63/195 (32%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 377 NKLGQGGFGPVYKGKLAN-GQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGC 435
+KLG G +G VY+G +AVK L + + +EEF E ++ +++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 436 CLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRII 495
C + +I EFM +L ++ E +Q + + I+ + YL + I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340
Query: 496 HRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTK 555
HR+L A N L+ E +++DFG +R+ G+ + + + +PE FS K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399
Query: 556 SDVFSFGVLLLEIIT 570
SDV++FGVLL EI T
Sbjct: 400 SDVWAFGVLLWEIAT 414
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-41
Identities = 68/202 (33%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
+ +LG G FG V+ G ++AVK L S + F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
+L ++ +I E+M N SL F+ L K D+ IA G+ ++
Sbjct: 72 RLYAVVT-QEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGY--MSPEYAL 548
IHRDL+A+NIL+ + ++ +I+DFG AR+ E T R + +PE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAIN 183
Query: 549 GGLFSTKSDVFSFGVLLLEIIT 570
G F+ KSDV+SFG+LL EI+T
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-41
Identities = 68/203 (33%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
++ KLG G FG V+ ++AVK + S E F E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLV 246
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
KL K+ +I EFM SL F+ K D IA G+ ++
Sbjct: 247 KLHAVVT-KEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT---YGYMSPEYA 547
+ IHRDL+A+NIL+ + +I+DFG ARV E + G + +PE
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAI 357
Query: 548 LGGLFSTKSDVFSFGVLLLEIIT 570
G F+ KSDV+SFG+LL+EI+T
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVT 380
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 67/293 (22%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL--ANGQEI--AVKRL-STTSGQGIEEFKNEVLLIAKLQ 425
++ + LG+G FG VY+G G++I AVK + E+F +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRK----QLLDWKKRFDIILGIAR 481
H ++VKL+G ++ +I E P L +++ L+ + L I +
Sbjct: 72 HPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY------SLQICK 124
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG- 540
+ YL + +HRD+ NIL+ ++ DFG +R E+ +
Sbjct: 125 AMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS-------VT 174
Query: 541 -----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWS 594
+MSPE F+T SDV+ F V + EI++ GK+ +
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ---------------PFFWLE 219
Query: 595 DDKALEIVDSSMADSCPA--PEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
+ + +++ P P L + C +DRP + +V LS+
Sbjct: 220 NKDVIGVLEKGDRLPKPDLCPPVLY--TLMTRCWDYDPSDRPRFTELVCSLSD 270
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 38/222 (17%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL--------ANGQEIAVKRLSTTSGQGIEEFKNEVLLIA 422
++ + LGQG F ++KG + E+ +K L E F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 423 KLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 482
KL H++LV G C+ DE +L+ EF+ SLD ++ + K ++ + ++ +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPR--------ISDFGTARVFGGEEISTNTNR 534
+ +L +IH ++ A NILL E + + +SD G + ++
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 535 VVGTYGY-----MSPEYAL-GGLFSTKSDVFSFGVLLLEIIT 570
+ PE + +D +SFG L EI +
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-41
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 371 DNFSTSNKLGQGGFGPVYKG--KLANGQEI--AVKRL-STTSGQGIEEFKNEVLLIAKLQ 425
+ +G+G FG V++G + A+K + TS E+F E L + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
H ++VKL+G ++ +I E L F+ + RK LD ++ + Y
Sbjct: 75 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTN-----RVVGTYG 540
L R +HRD+ A N+L+ ++ DFG +R + +
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------ 182
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M+PE F++ SDV+ FGV + EI+
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-41
Identities = 67/219 (30%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANG------QEIAVKRL-STTSGQGIEEFKNEVLLIAK 423
N + LG G FG VY+G+++ ++AVK L S Q +F E L+I+K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI----FDESRKQLLDWKKRFDIILGI 479
H+N+V+ +G L+ + ++ E M L F+ S+ L + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLD---EEMNPRISDFGTARVFGGEEISTNTNRVV 536
A G YL IHRD+ A N LL +I DFG AR +I
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRK 242
Query: 537 GTYGY-----MSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
G M PE + G+F++K+D +SFGVLL EI +
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-41
Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 28/220 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
+F +G GGFG V+K K +G+ +KR+ + E+ + EV +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 430 VKLLGCCLEKDEKM----------------LIYEFMPNKSLDYFIFDESRKQLLDWKKRF 473
V GC D + EF +L+ +I ++ R + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 474 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTN 533
++ I +GV Y+H ++I+RDLK SNI L + +I DFG +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 534 RVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKK 573
R GT YMSPE + + D+++ G++L E++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVK--RLSTTSGQGIEEFKNEVLLIAKLQHR 427
+ + K+G+G FG K +G++ +K +S S + EE + EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 487
N+V+ E ++ ++ L I + + L + D + I + ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 488 QDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYA 547
+I+HRD+K+ NI L ++ ++ DFG ARV +GT Y+SPE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 548 LGGLFSTKSDVFSFGVLLLEIITGK 572
++ KSD+++ G +L E+ T K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK 222
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 15/208 (7%)
Query: 371 DNFSTSNKLGQGGFGPVYKG--KLANGQEI--AVKRL-STTSGQGIEEFKNEVLLIAKLQ 425
N S +G G FG V G KL + +EI A+K L + + +F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
H N+++L G + M++ E+M N SLD F+ + ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT---YGYM 542
L S + +HRDL A NIL++ + ++SDFG RV + + T R G +
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWT 217
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIIT 570
SPE F++ SDV+S+G++L E+++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 378 KLGQGGFGPVYKGKLANG---QEIAVKRL--STTSGQGIEEFKNEVLLIAKLQHRNLVKL 432
+LG G FG V KG + +AVK L +E E ++ +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFIFDESR---KQLLDWKKRFDIILGIARGVLYLHQD 489
+G C + ML+ E L+ ++ K +++ + ++ G+ YL
Sbjct: 84 IGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYL--- 133
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG------YMS 543
+HRDL A N+LL + +ISDFG ++ +E N + +
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKWPVKWYA 188
Query: 544 PEYALGGLFSTKSDVFSFGVLLLEIIT 570
PE FS+KSDV+SFGVL+ E +
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 378 KLGQGGFGPVYKGKLANGQE---IAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
+LG G FG V +G ++ +A+K L T EE E ++ +L + +V+L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493
G C + ML+ E L F+ +++ + +++ ++ G+ YL
Sbjct: 77 GVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG----------YMS 543
+HRDL A N+LL +ISDFG ++ G ++ Y + +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD---------SYYTARSAGKWPLKWYA 181
Query: 544 PEYALGGLFSTKSDVFSFGVLLLEIIT 570
PE FS++SDV+S+GV + E ++
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 377 NKLGQGGFGPVYKGKLANGQE---IAVKRL-STTSGQGIEEFKNEVLLIAKL-QHRNLVK 431
+ +G+G FG V K ++ A+KR+ S +F E+ ++ KL H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYF-------------IFDESRKQLLDWKKRFDIILG 478
LLG C + L E+ P+ +L F S L ++
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTN----- 533
+ARG+ YL S+ + IHRDL A NIL+ E +I+DFG +R G E T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 205
Query: 534 RVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
R +M+ E +++T SDV+S+GVLL EI++
Sbjct: 206 R------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 66/291 (22%), Positives = 122/291 (41%), Gaps = 44/291 (15%)
Query: 316 TRIGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVTFFELSTVLAATD---- 371
++ +R RR+ + SS+ ++ + +S D
Sbjct: 18 HKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWE 77
Query: 372 ----NFSTSNKLGQGGFGPVYKGKL--------ANGQEIAVKRL-STTSGQGIEEFKNEV 418
+ LG+G FG V + +AVK L + + + + +E+
Sbjct: 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137
Query: 419 LLIAKL-QHRNLVKLLGCCLEKDEKMLIYEFMPNKSL-DY------------FIFDESRK 464
++ + +H+N++ LLG C + +I E+ +L +Y + + +
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 465 QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524
+ + +K +ARG+ YL + + IHRDL A N+L+ E +I+DFG AR
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--- 251
Query: 525 GEEISTNTNRVVGTYG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+I+ T G +M+PE +++ +SDV+SFGVL+ EI T
Sbjct: 252 --DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL--------ANGQEIAVKRL-STTSGQGIEEFKNEVLLI 421
D + LG+G FG V + +AVK L + + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 422 AKL-QHRNLVKLLGCCLEKDEKMLIYEFMPNKSL-DY------------FIFDESRKQLL 467
+ +H+N++ LLG C + +I E+ +L +Y + + ++ +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 468 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527
+K +ARG+ YL + + IHRDL A N+L+ E +I+DFG AR +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----D 206
Query: 528 ISTNTNRVVGTYG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
I+ T G +M+PE +++ +SDV+SFGVL+ EI T
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 377 NKLGQGGFGPVYKGKLAN------GQEIAVKRL-STTSGQGIEEFKNEVLLIAKL-QHRN 428
LG+G FG V + + +AVK L + +E+ ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 429 LVKLLGCCLEKDE-KMLIYEFMPNKSL-DY------------FIFDESRKQLLDWKKRFD 474
+V LLG C + M+I EF +L Y ++ K L +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 475 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR 534
+A+G+ +L + + IHRDL A NILL E+ +I DFG AR +I + +
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDY 204
Query: 535 VVGTYG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
V +M+PE +++ +SDV+SFGVLL EI +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-40
Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 29/227 (12%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN 428
+F LGQG FG V K + + + A+K++ T + + +EV+L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFI---------FD--ESRKQLLDWKKRFDIIL 477
+V+ LE+ + + KS + +D S + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF------------GG 525
I + Y+H IIHRDLK NI +DE N +I DFG A+
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 526 EEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITG 571
S N +GT Y++ E G G ++ K D++S G++ E+I
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-40
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 41/233 (17%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANG------QEIAVKRL-STTSGQGIEEFKNEVLLIAK 423
N LG+G FG V K + +AVK L S + + +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL---------------------DYFIFDES 462
+ H +++KL G C + +LI E+ SL + D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 463 RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522
++ L I++G+ YL + ++++HRDL A NIL+ E +ISDFG +R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 523 FGGEEISTNTNRVVGTYG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
++ + V + G +M+ E +++T+SDV+SFGVLL EI+T
Sbjct: 199 ----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-39
Identities = 76/286 (26%), Positives = 124/286 (43%), Gaps = 29/286 (10%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
++ KLGQG FG V+ G +A+K L + E F E ++ KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 325
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
+L E + ++ E+M SL F + L + D+ IA G+ Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG 550
R+ +HRDL+A+NIL+ E + +++DFG AR+ E + + +PE AL G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 551 LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS----SM 606
F+ KSDV+SFG+LL E+ T R + + + L+ V+
Sbjct: 440 RFTIKSDVWSFGILLTELTT--------------KGRVPYPGMVNREVLDQVERGYRMPC 485
Query: 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSP 652
CP + C + +RP+ + L + + P
Sbjct: 486 PPECPES----LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 27/224 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLS-TTSGQGIEEFKNEVLLIAKLQHRN 428
+F LG+GGFG V++ K + A+KR+ E+ EV +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 429 LVKLLGCCLEKDE---------KMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRFDII 476
+V+ LEK+ K+ +Y + ++L ++ + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV- 535
L IA V +LH ++HRDLK SNI + ++ DFG +E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 536 ---------VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
VGT YMSPE G +S K D+FS G++L E++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-39
Identities = 75/286 (26%), Positives = 124/286 (43%), Gaps = 29/286 (10%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
++ KLGQG FG V+ G +A+K L + E F E ++ KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 242
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
+L ++ ++ E+M SL F + L + D+ IA G+ Y+
Sbjct: 243 QLYAVVS-EEPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG 550
R+ +HRDL+A+NIL+ E + +++DFG AR+ E + + +PE AL G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 551 LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS----SM 606
F+ KSDV+SFG+LL E+ T R + + + L+ V+
Sbjct: 357 RFTIKSDVWSFGILLTELTT--------------KGRVPYPGMVNREVLDQVERGYRMPC 402
Query: 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSP 652
CP + C + +RP+ + L + + P
Sbjct: 403 PPECPES----LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 36/228 (15%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQE------IAVKRL-STTSGQGIEEFKNEVLLIAK 423
+ S LG G FG V + + +AVK L + E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 424 L-QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYF---------------IFDESRKQLL 467
L H N+V LLG C ++I E+ L F E + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 468 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527
D + +A+G+ +L + IHRDL A NILL +I DFG AR
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD----- 194
Query: 528 ISTNTNRVVGTYG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
I ++N VV +M+PE +++ +SDV+S+G+ L E+ +
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 41/227 (18%)
Query: 377 NKLGQGGFGPVYKGKLANG------QEIAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNL 429
+G+G FG V++ + +AVK L S +F+ E L+A+ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYF---------------------IFDESRKQLLD 468
VKLLG C L++E+M L+ F L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 469 WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528
++ I +A G+ YL S + +HRDL N L+ E M +I+DFG +R I
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NI 224
Query: 529 STNTNRVVGTYGY-----MSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+ M PE ++T+SDV+++GV+L EI +
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 32/224 (14%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQE------IAVKRL-STTSGQGIEEFKNEVLLIAK 423
+N LG G FG V + + +AVK L ST E +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 424 L-QHRNLVKLLGCCLEKDEKMLIYEFMPNKSL-----------DYFIFDESRKQLLDWKK 471
L QH N+V LLG C ++I E+ L + +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 472 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531
+A+G+ +L + IHRD+ A N+LL +I DFG AR +I +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMND 217
Query: 532 TNRVVGTYG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+N +V +M+PE +++ +SDV+S+G+LL EI +
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-39
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 36/222 (16%)
Query: 377 NKLGQGGFGPVYKGKL--------ANGQEIAVKRL-STTSGQGIEEFKNEVLLIAKL-QH 426
LG+G FG V + ++AVK L S + + + + +E+ ++ + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSL-DY------------FIFDESRKQLLDWKKRF 473
+N++ LLG C + +I E+ +L +Y + + ++ L K
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 474 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTN 533
+ARG+ YL + + IHRDL A N+L+ E+ +I+DFG AR +I
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 246
Query: 534 RVVGTYG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
T G +M+PE +++ +SDV+SFGVLL EI T
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 56/225 (24%), Positives = 100/225 (44%), Gaps = 23/225 (10%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRL---STTSGQGIEEFKNEVLLIAKLQH 426
NF K+G+G F VY+ L +G +A+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF--DIILG----IA 480
N++K +E +E ++ E L I K K+ + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMI-----KHFKKQKRLIPERTVWKYFVQLC 146
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
+ ++H R++HRD+K +N+ + ++ D G R F + + ++ +VGT
Sbjct: 147 SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 201
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNL 585
YMSPE ++ KSD++S G LL E+ + F D NL
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL 243
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 10/210 (4%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVK--RLSTTSGQGIEEFKNEVLLIAKLQHR 427
+++ +G G +G K + ++G+ + K + + + +EV L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 428 NLVKLLGCCLEKDEKML--IYEFMPNKSLDYFIFDESRK-QLLDWKKRFDIILGIARGVL 484
N+V+ +++ L + E+ L I +++ Q LD + ++ + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 485 YLHQ--DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
H+ D ++HRDLK +N+ LD + N ++ DFG AR+ + T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
SPE ++ KSD++S G LL E+
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-38
Identities = 62/296 (20%), Positives = 112/296 (37%), Gaps = 29/296 (9%)
Query: 292 IIVAIVLGVLLLGLC-------YFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREAS 344
+ +A + L+ G C F+ R + L ++ + R +
Sbjct: 304 LTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPK-----LANNEKQGVRSHT 358
Query: 345 TSAKRNKDTGNVDVTFFELSTVLAAT-----DNFSTSNKLGQGGFGPVYKG--KLANGQE 397
S D + + + +G+G FG V++G
Sbjct: 359 VSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPA 418
Query: 398 I--AVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL 454
+ A+K + TS E+F E L + + H ++VKL+G ++ +I E L
Sbjct: 419 MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGEL 477
Query: 455 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRI 514
F+ + RK LD ++ + YL R +HRD+ A N+L+ ++
Sbjct: 478 RSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKL 532
Query: 515 SDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
DFG +R + + +M+PE F++ SDV+ FGV + EI+
Sbjct: 533 GDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-38
Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 378 KLGQGGFGPVYKGKLANGQE---IAVKRL-STTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
+LG G FG V +G ++ +A+K L T EE E ++ +L + +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493
G C + ML+ E L F+ +++ + +++ ++ G+ YL
Sbjct: 403 GVCQ-AEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 456
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGY--MSPEYALGGL 551
+HR+L A N+LL +ISDFG ++ G ++ S T R G + +PE
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRK 515
Query: 552 FSTKSDVFSFGVLLLEIIT 570
FS++SDV+S+GV + E ++
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 59/250 (23%), Positives = 103/250 (41%), Gaps = 29/250 (11%)
Query: 344 STSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKR 402
+S + + + +F+ V+ ++ KLG+GGF V + L +G A+KR
Sbjct: 2 GSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR 61
Query: 403 LSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKM----LIYEFMPNKSLDYFI 458
+ Q EE + E + H N+++L+ CL + L+ F +L I
Sbjct: 62 ILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI 121
Query: 459 FDESRKQLLDWKKRFD------IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP 512
++L D ++LGI RG+ +H HRDLK +NILL +E P
Sbjct: 122 -----ERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQP 173
Query: 513 RISDFGTARVFGGEEISTNTNRVV-------GTYGYMSPE---YALGGLFSTKSDVFSFG 562
+ D G+ + + T Y +PE + ++DV+S G
Sbjct: 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG 233
Query: 563 VLLLEIITGK 572
+L ++ G+
Sbjct: 234 CVLYAMMFGE 243
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 41/227 (18%)
Query: 377 NKLGQGGFGPVYKGKLANGQE------IAVKRL-STTSGQGIEEFKNEVLLIAKL-QHRN 428
LG G FG V + +AVK L E +E+ ++ +L H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSL-DY-------------------FIFDESRKQLLD 468
+V LLG C LI+E+ L +Y + +E +L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 469 WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528
++ +A+G+ +L +HRDL A N+L+ +I DFG AR +I
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DI 222
Query: 529 STNTNRVVGTYG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+++N VV +M+PE G+++ KSDV+S+G+LL EI +
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 372 NFSTSNKLGQGGFGPVYKGKLANGQEIAVKR--LSTTSGQGIEEFKNEVLLIAKLQHRNL 429
+S ++G GG V++ Q A+K L Q ++ ++NE+ + KLQ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 430 --VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 487
++L + ++ E N L+ ++ +K+ +D +R + V +H
Sbjct: 89 KIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 488 QDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE-- 545
Q I+H DLK +N L+ + ++ DFG A + S + VGT YM PE
Sbjct: 145 Q---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 546 ---------YALGGLFSTKSDVFSFGVLLLEIITGK 572
S KSDV+S G +L + GK
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 372 NFSTSNKLGQGGFGPVYKGKLANGQEIAVKR--LSTTSGQGIEEFKNEVLLIAKLQHRNL 429
+S ++G GG V++ Q A+K L Q ++ ++NE+ + KLQ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 430 --VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 487
++L + ++ E N L+ ++ +K+ +D +R + V +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 488 QDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE-- 545
Q I+H DLK +N L+ + ++ DFG A + S + VGT YM PE
Sbjct: 126 Q---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 546 ---------YALGGLFSTKSDVFSFGVLLLEIITGK 572
S KSDV+S G +L + GK
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 37/212 (17%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCL 437
LG+G +G VY G+ L+N IA+K + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF- 88
Query: 438 EKDEKMLIY-EFMPNKSLD--------YFIFDESR-----KQLLDWKKRFDIILGIARGV 483
++ + I+ E +P SL +E KQ+L G+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-------------EGL 135
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEM-NPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
YLH + +I+HRD+K N+L++ +ISDFGT++ G I+ T GT YM
Sbjct: 136 KYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYM 190
Query: 543 SPEYALGGL--FSTKSDVFSFGVLLLEIITGK 572
+PE G + +D++S G ++E+ TGK
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 56/249 (22%), Positives = 95/249 (38%), Gaps = 18/249 (7%)
Query: 330 LFLNSSTRLSDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYK 389
L+ S +L R S + ++ + +F ++LG G +G V+K
Sbjct: 18 LYFQSMHQLQPRRVSFRGEASETL--QSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFK 75
Query: 390 G-KLANGQEIAVK--RLSTTSGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLI 445
+G+ AVK + EV K+ QH V+L E+ + +
Sbjct: 76 VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-WEEGGILYL 134
Query: 446 Y-EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNI 504
E SL E+ L + + + + +LH ++H D+K +NI
Sbjct: 135 QTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANI 188
Query: 505 LLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVL 564
L ++ DFG G + G YM+PE L G + T +DVFS G+
Sbjct: 189 FLGPRGRCKLGDFGLLVELGT---AGAGEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLT 244
Query: 565 LLEIITGKK 573
+LE+ +
Sbjct: 245 ILEVACNME 253
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 57/255 (22%), Positives = 97/255 (38%), Gaps = 38/255 (14%)
Query: 334 SSTRLSDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGK-L 392
SS + + N+ + + ++G+G FG V++ K
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80
Query: 393 ANGQEIAVKRLSTTSGQGIEEFK-NEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451
G + AVK++ +E F+ E++ A L +V L G E + E +
Sbjct: 81 QTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 452 KSL-----DYFIFDESR-----KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKA 501
SL E R Q L G+ YLH RI+H D+KA
Sbjct: 135 GSLGQLIKQMGCLPEDRALYYLGQAL-------------EGLEYLHTR---RILHGDVKA 178
Query: 502 SNILLDEEMNP-RISDFGTARVFGGEEISTNTNR---VVGTYGYMSPEYALGGLFSTKSD 557
N+LL + + + DFG A + + + + GT +M+PE +G K D
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 238
Query: 558 VFSFGVLLLEIITGK 572
++S ++L ++ G
Sbjct: 239 IWSSCCMMLHMLNGC 253
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVK--RLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
++G+G F VYKG E+A + + + FK E ++ LQH N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 435 CCL--EKDEKML--IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
K +K + + E M + +L ++ R +++ K I +G+ +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 491 RLRIIHRDLKASNILLDEEM-NPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG 549
IIHRDLK NI + + +I D G A + V+GT +M+PE
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYEE 204
Query: 550 GLFSTKSDVFSFGVLLLEIITGK 572
+ DV++FG+ +LE+ T +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 372 NFSTSNKLGQGGFGPVYKGKLANGQEIAVKR--LSTTSGQGIEEFKNEVLLIAKLQHRNL 429
+S ++G GG V++ Q A+K L Q ++ ++NE+ + KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 430 --VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 487
++L + ++ E N L+ ++ +K+ +D +R + V +H
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 488 QDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE-- 545
Q I+H DLK +N L+ + ++ DFG A + S + VG YM PE
Sbjct: 173 Q---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 546 ---------YALGGLFSTKSDVFSFGVLLLEIITGK 572
S KSDV+S G +L + GK
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRN 428
+ S+ LGQG V++G+ G A+K + S + ++ E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 429 LVKLLGCCLEKDEKMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
+VKL E+ EF P SL + + S L + ++ + G+ +
Sbjct: 69 IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 486 LHQDSRLRIIHRDLKASNILL----DEEMNPRISDFGTARVFG-GEEISTNTNRVVGTYG 540
L + I+HR++K NI+ D + +++DFG AR E+ + + GT
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS----LYGTEE 180
Query: 541 YMSPE--------YALGGLFSTKSDVFSFGVLLLEIITGK 572
Y+ P+ + D++S GV TG
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-34
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 23/222 (10%)
Query: 362 ELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEV-LL 420
E S V+ +F + LG G G + + + +++AVKR+ + EV LL
Sbjct: 15 ETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLL 71
Query: 421 IAKLQHRNLVKLLGCCLEKDEKM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG 478
+H N+++ C EKD + + E +Y E + + ++
Sbjct: 72 RESDEHPNVIRYF--CTEKDRQFQYIAIELCAATLQEYV---EQKDFAHLGLEPITLLQQ 126
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDE-----EMNPRISDFGTARVFGGEEIS-TNT 532
G+ +LH L I+HRDLK NIL+ ++ ISDFG + S +
Sbjct: 127 TTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 533 NRVVGTYGYMSPEYALGGLF---STKSDVFSFGVLLLEIITG 571
+ V GT G+++PE + D+FS G + +I+
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLS---TTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
KLG GG VY + ++A+K + + ++ F+ EV ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493
E D L+ E++ +L +I L + I G+ + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFS 553
I+HRD+K NIL+D +I DFG A+ + T TN V+GT Y SPE A G
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATD 190
Query: 554 TKSDVFSFGVLLLEIITGK 572
+D++S G++L E++ G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 30/214 (14%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN 428
++ K+GQG G VY +A GQE+A+++++ E NE+L++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFI----FDESRKQLLDWKKRFDIILGIARGVL 484
+V L L DE ++ E++ SL + DE I + R L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE------------GQIAAVCRECL 126
Query: 485 ----YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR--VVGT 538
+LH + ++IHRD+K+ NILL + + +++DFG F + + R +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 179
Query: 539 YGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+M+PE + K D++S G++ +E+I G+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 60/244 (24%), Positives = 111/244 (45%), Gaps = 33/244 (13%)
Query: 343 ASTSAKRNKDTGNVDVTFFELSTVLAATD---NFSTSNKLGQGGFGPVYKGK-LANGQEI 398
+ + + L V+ D + K+G+G G V + +G+++
Sbjct: 14 GTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQV 73
Query: 399 AVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI 458
AVK + Q E NEV+++ QH N+V++ L +E ++ EF+ +L +
Sbjct: 74 AVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV 133
Query: 459 ----FDESRKQLLDWKKRFDIILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEEM 510
+E + I + VL YLH +IHRD+K+ +ILL +
Sbjct: 134 SQVRLNE------------EQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDG 178
Query: 511 NPRISDFGTARVFGGEEISTNTNR--VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEI 568
++SDFG F + R +VGT +M+PE L++T+ D++S G++++E+
Sbjct: 179 RVKLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234
Query: 569 ITGK 572
+ G+
Sbjct: 235 VDGE 238
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRN 428
+ S+ LGQG V++G+ G A+K + S + ++ E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 429 LVKLLGCCLEKDEKMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
+VKL E+ EF P SL + + S L + ++ + G+ +
Sbjct: 69 IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 486 LHQDSRLRIIHRDLKASNILL----DEEMNPRISDFGTARVFG-GEEISTNTNRVVGTYG 540
L + I+HR++K NI+ D + +++DFG AR E+ + + GT
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS----LYGTEE 180
Query: 541 YMSPE--------YALGGLFSTKSDVFSFGVLLLEIITGK 572
Y+ P+ + D++S GV TG
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN 428
+ F KLG+G +G VYK GQ +A+K++ ++E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
+VK G + + ++ E+ S+ I R + L + I+ +G+ YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR--VVGTYGYMSPEY 546
R IHRD+KA NILL+ E + +++DFG G+ T R V+GT +M+PE
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVIGTPFWMAPEV 196
Query: 547 ALGGLFSTKSDVFSFGVLLLEIITGK 572
++ +D++S G+ +E+ GK
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 32/219 (14%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN-----EVLLIAKL 424
D+ +LG+G +G V K + + +GQ +AVKR+ T +E K ++ + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDISM-RTV 63
Query: 425 QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF--DIILGIARG 482
V G + + + E M + SLD F KQ++D + DI+ IA
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVS 117
Query: 483 VL----YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT-NRVVG 537
++ +LH S+L +IHRD+K SN+L++ ++ DFG + G + + G
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS----GYLVDDVAKDIDAG 171
Query: 538 TYGYMSPE----YALGGLFSTKSDVFSFGVLLLEIITGK 572
YM+PE +S KSD++S G+ ++E+ +
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQG-IEEFKNEVLLIAKLQHRN 428
D+F ++LG G G V+K +G +A K + + E+ ++ +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF--DIILGIARGVL-- 484
+V G E + E M SLD Q+L R I+ ++ V+
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLD---------QVLKKAGRIPEQILGKVSIAVIKG 143
Query: 485 --YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
YL + +I+HRD+K SNIL++ ++ DFG + G+ I + N VGT YM
Sbjct: 144 LTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYM 197
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
SPE G +S +SD++S G+ L+E+ G+
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN 428
+ + +LG G FG VYK K G A K + T S + +E++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL---- 484
+VKLLG + ++ EF P ++D I E + L + I + R +L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTE-----PQIQVVCRQMLEALN 131
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR--VVGTYGYM 542
+LH RIIHRDLKA N+L+ E + R++DFG + + T R +GT +M
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTPYWM 184
Query: 543 SPEYALGGLFS-----TKSDVFSFGVLLLEIITGK 572
+PE + K+D++S G+ L+E+ +
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 15/204 (7%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLS---TTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
LG GG V+ + L + +++AVK L F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 434 GCCLEKDEKMLIY----EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
+ + E++ +L + E + K+ ++I + + + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH-- 133
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS-TNTNRVVGTYGYMSPEYAL 548
+ IIHRD+K +NI++ ++ DFG AR S T T V+GT Y+SPE A
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 549 GGLFSTKSDVFSFGVLLLEIITGK 572
G +SDV+S G +L E++TG+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQG-IEEFKNEVLLIAKLQHR 427
+ F+ K+G+G FG V+KG + +A+K + + IE+ + E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 487
+ K G L+ + +I E++ S D LD + I+ I +G+ YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 488 QDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR--VVGTYGYMSPE 545
+ + IHRD+KA+N+LL E +++DFG A G+ T R VGT +M+PE
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPE 189
Query: 546 YALGGLFSTKSDVFSFGVLLLEIITGK 572
+ +K+D++S G+ +E+ G+
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 9e-32
Identities = 44/274 (16%), Positives = 86/274 (31%), Gaps = 32/274 (11%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK------LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAK 423
+ + LG+G F VY+ N Q+ +K + + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI--FDESRKQLLDWKKRFDIILGIAR 481
+K L ++ +L+ E +L I + + ++++ + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 482 GVLYLHQDSRLRIIHRDLKASNILL-----------DEEMNPRISDFGTARVFGGEEIST 530
+ +H IIH D+K N +L D + D G + T
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK----KNTGIFNDDSSNLI 586
T G+ E ++ + D F + ++ G KN G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
Query: 587 RYV-WELWSD--DKALEIVDSSMADSCPAPEALR 617
R ++W++ L I D P+ + LR
Sbjct: 301 RLPHLDMWNEFFHVMLNIPDC---HHLPSLDLLR 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 62/272 (22%), Positives = 92/272 (33%), Gaps = 72/272 (26%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLS-TTSGQGIEEFKNEVLLIAKLQHRN 428
+F +G+GGFG V++ K + A+KR+ E+ EV +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE--------------------------- 461
+V+ LE + E D
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 462 ------------------SRKQLLDWKKR------------FDIILGIARGVLYLHQDSR 491
++ L DW R I + IA V +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 492 LRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTN----------RVVGTYGY 541
++HRDLK SNI + ++ DFG +E VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEIITGKK 573
MSPE G +S K D+FS G++L E++
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVK---RLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
LG+GGF ++ + A K + E+ E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 435 CCLEKDEKM-LIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYLHQDSR 491
E ++ + ++ E +SL + RK L + + R+ + I G YLH+
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLHR--- 159
Query: 492 LRIIHRDLKASNILLDEEMNPRISDFGTARVF--GGEEISTNTNRVVGTYGYMSPEYALG 549
R+IHRDLK N+ L+E++ +I DFG A GE + GT Y++PE
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV----LCGTPNYIAPEVLSK 215
Query: 550 GLFSTKSDVFSFGVLLLEIITGK 572
S + DV+S G ++ ++ GK
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGK 238
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 49/228 (21%), Positives = 82/228 (35%), Gaps = 34/228 (14%)
Query: 370 TDNFSTSNKLGQGGFGPVYKG-KLANGQEIAVKR--LSTTSGQGIEEFKNEVLLIAKL-Q 425
T F K+G G FG V+K K +G A+KR + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 426 HRNLVKLLGCCLEKDEKMLIY-EFMPNKSLDYFIFDESRKQLLDWKKRFD------IILG 478
H ++V+ E D+ MLI E+ SL I + F ++L
Sbjct: 70 HSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAI-----SENYRIMSYFKEAELKDLLLQ 123
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV-------------FGG 525
+ RG+ Y+H ++H D+K SNI + P + G
Sbjct: 124 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 526 EEISTNTNRVVGTYGYMSPEYALGGL-FSTKSDVFSFGVLLLEIITGK 572
++ G +++ E K+D+F+ + ++ +
Sbjct: 181 VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 66/258 (25%), Positives = 106/258 (41%), Gaps = 19/258 (7%)
Query: 322 QRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQ 381
+ + + D EL FS ++G
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGH 64
Query: 382 GGFGPVYKGK-LANGQEIAVKRLSTTSGQG---IEEFKNEVLLIAKLQHRNLVKLLGCCL 437
G FG VY + + N + +A+K++S + Q ++ EV + KL+H N ++ GC L
Sbjct: 65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124
Query: 438 EKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHR 497
+ L+ E+ + D E K+ L + + G +G+ YLH +IHR
Sbjct: 125 REHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHR 178
Query: 498 DLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG---GLFST 554
D+KA NILL E ++ DFG N+ VGT +M+PE L G +
Sbjct: 179 DVKAGNILLSEPGLVKLGDFG----SASIMAPANS--FVGTPYWMAPEVILAMDEGQYDG 232
Query: 555 KSDVFSFGVLLLEIITGK 572
K DV+S G+ +E+ K
Sbjct: 233 KVDVWSLGITCIELAERK 250
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVK---RLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
LG+GGF ++ + A K + E+ E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 435 CCLEKDEKM-LIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYLHQDSR 491
E ++ + ++ E +SL + RK L + + R+ + I G YLH R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLH---R 133
Query: 492 LRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGL 551
R+IHRDLK N+ L+E++ +I DFG A + + GT Y++PE
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 191
Query: 552 FSTKSDVFSFGVLLLEIITGK 572
S + DV+S G ++ ++ GK
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVL-----LIAKL 424
++ ++G+G +G V K +GQ +AVKR+ +T E+ + ++L ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSS 78
Query: 425 QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF--DIILGIARG 482
+V+ G + + + E M + S D F + +I+ I
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLA 133
Query: 483 VL----YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV-VG 537
+ +L L+IIHRD+K SNILLD N ++ DFG + G+ + + G
Sbjct: 134 TVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAG 187
Query: 538 TYGYMSPE----YALGGLFSTKSDVFSFGVLLLEIITGK 572
YM+PE A + +SDV+S G+ L E+ TG+
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-31
Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQH 426
++ + KLG G +G V + E A+K + T S + EV ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIA 480
N++KL +K L+ E L FDE + +F II +
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIH-----RMKFNEVDAAVIIKQVL 146
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEEISTNTNRVVG 537
GV YLH+ I+HRDLK N+LL +++ +I DFG + VF ++ +G
Sbjct: 147 SGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLG 200
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITG------KKNTGIFN 579
T Y++PE L + K DV+S GV+L ++ G + + I
Sbjct: 201 TAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR 247
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 16/214 (7%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQ-GIEEFKNEVLLIAKLQHRN 428
D++ +G G V +++A+KR++ Q ++E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD--IILGIARGVL-- 484
+V + KDE L+ + + S+ I + D I I R VL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 485 --YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG-TARVFGGEEISTNTNR--VVGTY 539
YLH++ IHRD+KA NILL E+ + +I+DFG +A + G +I+ N R VGT
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 540 GYMSPE-YALGGLFSTKSDVFSFGVLLLEIITGK 572
+M+PE + K+D++SFG+ +E+ TG
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-30
Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 19/215 (8%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEE-FKNEVLLIAKLQHR 427
+ +LG GGFG V + G+++A+K+ E + E+ ++ KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 428 NLVKLL------GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 481
N+V D +L E+ L ++ L ++ I+
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLD---EEMNPRISDFGTARVFG-GEEISTNTNRVVG 537
+ YLH+ RIIHRDLK NI+L + + +I D G A+ GE + VG
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE----FVG 185
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
T Y++PE ++ D +SFG L E ITG
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-30
Identities = 71/229 (31%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLST---TSGQGIEEFKNEVLLIAKLQ 425
+D + LG+G FG V K GQE AVK +S E EV L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGI 479
H N++KL +K L+ E L FDE +KRF II +
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIIS-----RKRFSEVDAARIIRQV 135
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEEISTNTNRVV 536
G+ Y+H+ +I+HRDLK N+LL ++ N RI DFG + F + +
Sbjct: 136 LSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKI 189
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITG------KKNTGIFN 579
GT Y++PE L G + K DV+S GV+L +++G I
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK 237
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 49/223 (21%), Positives = 89/223 (39%), Gaps = 35/223 (15%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-HRNLVKLLGC 435
L +GGF VY+ + + +G+E A+KRL + + EV + KL H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 436 CLEKDEKMLIYEFMPNKSLDYFIFDE-SRKQLLDW------KKRF------DIILGIARG 482
E+ ++ + E + QL+++ + I R
Sbjct: 95 ASIGKEES------DTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR-------- 534
V ++H+ + IIHRDLK N+LL + ++ DFG+A + + +
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 535 --VVGTYGYMSPE---YALGGLFSTKSDVFSFGVLLLEIITGK 572
T Y +PE K D+++ G +L + +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRL--STTSGQGIEE-FKNEVLLIAKLQH 426
++F LG+G FG VY + + +A+K L + G+E + EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------IILGIA 480
N+++L G + LI E+ P ++ + E +K +FD I +A
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKL-----SKFDEQRTATYITELA 119
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
+ Y H R+IHRD+K N+LL +I+DFG + + + GT
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLD 172
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
Y+ PE G + K D++S GVL E + GK
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-30
Identities = 60/231 (25%), Positives = 93/231 (40%), Gaps = 40/231 (17%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEV-LLIAKLQHRNL 429
+ + LG G G V G+ +AVKR+ + E+ LL H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 430 VKLLGCCLEKDEKM--LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRFDIILGIARG 482
++ C E ++ + E N +L + DE+ K ++ ++ IA G
Sbjct: 72 IRYY--CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASG 127
Query: 483 VLYLHQDSRLRIIHRDLKASNILLD-------------EEMNPRISDFGTARVFGGEEIS 529
V +LH L+IIHRDLK NIL+ E + ISDFG + + S
Sbjct: 128 VAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 530 --TNTNRVVGTYGYMSPEYALGGLF-------STKSDVFSFGVLLLEIITG 571
TN N GT G+ +PE + D+FS G + I++
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 46/202 (22%), Positives = 85/202 (42%), Gaps = 17/202 (8%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLS---TTSGQGIEEFKNEVLLIAKLQHRNLVKL- 432
+G+GG G VY+ + + +A+K +S ++ + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 433 -LGCCLEKDEKM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
G E D ++ + + L + + L + I+ I + H
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA- 153
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG 550
HRD+K NIL+ + + DFG A E++ T VGT YM+PE
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSES 210
Query: 551 LFSTKSDVFSFGVLLLEIITGK 572
+ ++D+++ +L E +TG
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-30
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 28/214 (13%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQH 426
+ ++ LG+G FG V K K QE AVK ++ + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIA 480
N++KL + ++ E L FDE K +KRF II +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIK-----RKRFSEHDAARIIKQVF 131
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEEISTNTNRVVG 537
G+ Y+H+ I+HRDLK NILL +++ + +I DFG + F +G
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIG 185
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITG 571
T Y++PE L G + K DV+S GV+L +++G
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 65/211 (30%), Positives = 110/211 (52%), Gaps = 23/211 (10%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKN--------EVLLIA 422
+ + K+G+G +G VYK K + G+ +A+KR+ ++ E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 423 KLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 482
+L H N+V L+ + L++EFM K L + + K L + + + RG
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLYQLLRG 131
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
V + HQ RI+HRDLK N+L++ + +++DFG AR F G + + T+ VV T Y
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYR 186
Query: 543 SPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
+P+ +G +ST D++S G + E+ITGK
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRL--STTSGQGIEE-FKNEVLLIAKLQH 426
++F N LG+G F VY+ + + G E+A+K + G+ + +NEV + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 427 RNLVKLLGCCLEKDEKM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------IILGI 479
++++L E + L+ E N + + + K F + I
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNR----VKPFSENEARHFMHQI 121
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG--TARVFGGEEISTNTNRVVG 537
G+LYLH I+HRDL SN+LL MN +I+DFG T E+ T + G
Sbjct: 122 ITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT----LCG 174
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
T Y+SPE A +SDV+S G + ++ G+
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 1e-29
Identities = 29/290 (10%), Positives = 63/290 (21%), Gaps = 44/290 (15%)
Query: 318 IGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSN 377
+R EL+ L + A A + S +
Sbjct: 10 FMRDLLKREEELIGYCREEALKEPAAMVEAVTAT-VWPQNAETTVDSLLSQGERKLKLVE 68
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLL 433
L G V+ + + ++ A+K + S +E A+L + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 434 GCC--------------------------LEKDEKMLIYEFMP---NKSLDYFIFDESRK 464
+L+ F +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 465 QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524
+ + R L ++H N+ + + + D G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 525 GEEISTNTNRVVGTYGYMSPEYALGG--LFSTKSDVFSFGVLLLEIITGK 572
T Y E+ F+ + + G+ + +
Sbjct: 246 -----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 42/223 (18%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN--------EVLLI 421
D + KLG+G +G VYK + +A+KR+ +E + EV L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 422 AKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------I 475
+LQHRN+++L LI+E+ + K+ +D
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSF 137
Query: 476 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPR-----ISDFGTARVFGGEEIST 530
+ + GV + H R +HRDLK N+LL I DFG AR F G I
Sbjct: 138 LYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQ 193
Query: 531 NTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
T+ ++ T Y PE LG +ST D++S + E++
Sbjct: 194 FTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQH 426
+ ++ LG+G FG V K K QE AVK ++ + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIA 480
N++KL + ++ E L FDE K +KRF II +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIK-----RKRFSEHDAARIIKQVF 131
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEEISTNTNRVVG 537
G+ Y+H+ I+HRDLK NILL +++ + +I DFG + F +G
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIG 185
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLL 565
T Y++PE L G + K DV+S GV+L
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 37/233 (15%), Positives = 67/233 (28%), Gaps = 43/233 (18%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQH-------- 426
LGQ + G+ V T I++ K EVL + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 427 --------RNLVKLLGCCLEKDEK--------MLIYEFMPNKSLDYFIFDE------SRK 464
+LVK + + + P + F E S
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 465 QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524
+ L R + L + R + LH ++H L+ +I+LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 525 GEEISTNTNRVVGTYGYMSPEYALG-----GLFSTKSDVFSFGVLLLEIITGK 572
G + R + L + D ++ G+ + I
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-29
Identities = 43/203 (21%), Positives = 83/203 (40%), Gaps = 24/203 (11%)
Query: 378 KLGQGGFGPVYKGK--LANGQEIAVKRLSTTSGQG-IEEFKNEVLLIAKLQHRNLVKLL- 433
+ GG G +Y NG+ + +K L + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 434 -GCCLEKDEKMLIY---EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
++ + Y E++ +SL S+ Q L + +L I + YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG 549
+ +++ DLK NI+L EE ++ D G + + GT G+ +PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYLYGTPGFQAPEIVRT 251
Query: 550 GLFSTKSDVFSFGVLLLEIITGK 572
G + +D+++ G L +
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDL 273
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 52/213 (24%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN--------EVLLI 421
+ K+G+G +G V+K K + +A+KR+ +++ E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 422 AKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 481
+L+H+N+V+L + L++EF + L + +S LD + + + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF--DSCNGDLDPEIVKSFLFQLLK 112
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGY 541
G+ + H ++HRDLK N+L++ ++++FG AR F G + + VV T Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWY 167
Query: 542 MSPEYALGG-LFSTKSDVFSFGVLLLEIITGKK 573
P+ G L+ST D++S G + E+ +
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 66/217 (30%), Positives = 115/217 (52%), Gaps = 22/217 (10%)
Query: 367 LAATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN-----EVLL 420
++++ F KLG G + VYKG G +A+K + S +G E+ L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISL 56
Query: 421 IAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN--KSL--DYFIFDESRKQLLDWKKRFDII 476
+ +L+H N+V+L +++ L++EFM N K + + R L+ K F
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF--Q 114
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
+ +G+ + H++ +I+HRDLK N+L+++ ++ DFG AR F G ++T ++ VV
Sbjct: 115 WQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV 170
Query: 537 GTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
T Y +P+ +G +ST D++S G +L E+ITGK
Sbjct: 171 -TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKN--------EVLLIA 422
+ + K+G+G +G VYK + G+ A+K++ +E+ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 423 KLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 482
+L+H N+VKL K +L++E + + L + + + L+ +L + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLL--DVCEGGLESVTAKSFLLQLLNG 112
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
+ Y H R++HRDLK N+L++ E +I+DFG AR F G + T+ +V T Y
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYR 167
Query: 543 SPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
+P+ +G +ST D++S G + E++ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 51/240 (21%), Positives = 91/240 (37%), Gaps = 34/240 (14%)
Query: 350 NKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSG 408
A ++ ++G G G V+K + G IAVK++ +
Sbjct: 4 GSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN 63
Query: 409 QGIEEFKNEVL-----LIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESR 463
+E +L ++ +V+ G + + + E M +
Sbjct: 64 ---KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE-------- 111
Query: 464 KQLLDWKKRF--DIILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEEMNPRISDF 517
K + I+ + ++ YL + +IHRD+K SNILLDE ++ DF
Sbjct: 112 KLKKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDF 169
Query: 518 GTARVFGGEEISTNTNRVVGTYGYMSPE-----YALGGLFSTKSDVFSFGVLLLEIITGK 572
G + G +R G YM+PE + ++DV+S G+ L+E+ TG+
Sbjct: 170 G---ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN-----EVLLIAKL 424
+ + +KLG+G + VYKGK +A+K + +G EV L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57
Query: 425 QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKR-FD------IIL 477
+H N+V L + L++E++ D+ KQ LD + +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL----------DKDLKQYLDDCGNIINMHNVKLFLF 107
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVG 537
+ RG+ Y H+ +++HRDLK N+L++E +++DFG AR T N VV
Sbjct: 108 QLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV- 162
Query: 538 TYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
T Y P+ LG +ST+ D++ G + E+ TG+
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQG-IEEFKNEVLLIAKLQHR 427
D F KLG G FG V+ + ++G E +K ++ Q +E+ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
N++K+ + ++ E L + + ++R + L +++ + + Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 487 HQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMS 543
H ++H+DLK NIL +I DFG A +F +E STN GT YM+
Sbjct: 141 HS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTALYMA 194
Query: 544 PEYALGGLFSTKSDVFSFGVLL 565
PE + K D++S GV++
Sbjct: 195 PE-VFKRDVTFKCDIWSAGVVM 215
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 15/206 (7%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVK-----RLSTTSGQGIEEFKNEVLLIAK 423
D + +G+G F V + GQ+ AVK + +++ G E+ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIARG 482
L+H ++V+LL +++EFM L + + + I
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 483 VLYLHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
+ Y H IIHRD+K +LL + ++ FG A G + VGT
Sbjct: 143 LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTP 197
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLL 565
+M+PE + DV+ GV+L
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 28/207 (13%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN 428
++ N +G+G +G V A K++ + ++ FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIARG 482
+++L + + L+ E L F+ K+ F I+ +
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGEL----FERVVH-----KRVFRESDAARIMKDVLSA 118
Query: 483 VLYLHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFG-GEEISTNTNRVVGT 538
V Y H+ L + HRDLK N L + ++ DFG A F G+ + T VGT
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT----KVGT 171
Query: 539 YGYMSPEYALGGLFSTKSDVFSFGVLL 565
Y+SP+ L GL+ + D +S GV++
Sbjct: 172 PYYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN--------EVLLI 421
+ + K+G+G +G V+K + GQ +A+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 422 AKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 481
+L+H NLV LL K L++E+ + L + ++ + I +
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQ 113
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGY 541
V + H+ IHRD+K NIL+ + ++ DFG AR+ G + V T Y
Sbjct: 114 AVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWY 168
Query: 542 MSPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
SPE +G + DV++ G + E+++G
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 31/226 (13%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLS-----------------TTSGQGIEE 413
+++ L QG F + + + + A+K+ + ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 414 FKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSL-DY----FIFDESRKQLLD 468
FKNE+ +I +++ + G DE +IYE+M N S+ + F+ D++ +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 469 WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528
+ II + Y+H + I HRD+K SNIL+D+ ++SDFG + ++I
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 529 STNTNRVVGTYGYMSPEYALGGLF--STKSDVFSFGVLLLEIITGK 572
GTY +M PE+ K D++S G+ L +
Sbjct: 208 KG----SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN--------EVLLI 421
+ + LG+G F VYK + Q +A+K++ E K+ E+ L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66
Query: 422 AKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 481
+L H N++ LL K L+++FM L+ I D S K + +L +
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAY--MLMTLQ 123
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGY 541
G+ YLHQ I+HRDLK +N+LLDE +++DFG A+ F G T++VV T Y
Sbjct: 124 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWY 178
Query: 542 MSPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
+PE G ++ D+++ G +L E++
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN----EVLLIAKLQ 425
+ + +G+G +G V K + G+ +A+K+ + + K E+ L+ +L+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD--KMVKKIAMREIKLLKQLR 82
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
H NLV LL C +K L++EF+ + LD E LD++ + I G+ +
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE 545
H IIHRD+K NIL+ + ++ DFG AR + V T Y +PE
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWYRAPE 194
Query: 546 YALGG-LFSTKSDVFSFGVLLLEIITGK 572
+G + DV++ G L+ E+ G+
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 15/201 (7%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN 428
D + +LG G FG V++ A G+ K ++T KNE+ ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYL 486
L+ L +K E +LI EF+ L FD + + + + + G+ ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 487 HQDSRLRIIHRDLKASNILL--DEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
H+ I+H D+K NI+ + + +I DFG A +EI T + +P
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAP 219
Query: 545 EYALGGLFSTKSDVFSFGVLL 565
E +D+++ GVL
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 39/225 (17%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLS-------------TTSGQGIEEFK 415
+++ KLG G +G V K E A+K + + EE
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 416 NEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF-- 473
NE+ L+ L H N++KL +K L+ EF L F++ + + +F
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQ-----IINRHKFDE 145
Query: 474 ----DIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGE 526
+I+ I G+ YLH+ I+HRD+K NILL + +N +I DFG + F +
Sbjct: 146 CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITG 571
+ +GT Y++PE L ++ K DV+S GV++ ++ G
Sbjct: 203 YKLRD---RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 26/206 (12%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN 428
F LG G F V+ K G+ A+K + + +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIARG 482
+V L L+ + + L FD + + + +I +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL----FDR-----ILERGVYTEKDASLVIQQVLSA 118
Query: 483 VLYLHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
V YLH+ I+HRDLK N+L +E I+DFG +++ +ST GT
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTP 171
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLL 565
GY++PE +S D +S GV+
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 8e-28
Identities = 47/233 (20%), Positives = 83/233 (35%), Gaps = 38/233 (16%)
Query: 363 LSTVLAATDNFSTSNKLGQG--GFGPVYKGK-LANGQEIAVKR--LSTTSGQGIEEFKNE 417
+S+ L + +G+G V + G+ + V+R L S + + + E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 418 VLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI-------FDESRKQLLDWK 470
+ + H N+V + +E ++ FM S I +E
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE--------- 127
Query: 471 KRFDIILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526
I I +GVL Y+H +HR +KAS+IL+ + +S +
Sbjct: 128 ---LAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181
Query: 527 EISTNT-----NRVVGTYGYMSPEYALGGL--FSTKSDVFSFGVLLLEIITGK 572
V ++SPE L + KSD++S G+ E+ G
Sbjct: 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHR 427
F +G G +G VYKG+ + GQ A+K + T G EE K E+ ++ K HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHR 81
Query: 428 NLVKLLGCCLEKDEKM------LIYEFMPNKSL-DYFIFDESRKQLLDWKKRFDIILGIA 480
N+ G ++K+ L+ EF S+ D + ++ L + I I
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLKEEWIAYICREIL 139
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR--VVGT 538
RG+ +LHQ ++IHRD+K N+LL E ++ DFG + + T R +GT
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGRRNTFIGT 192
Query: 539 YGYMSPE-----YALGGLFSTKSDVFSFGVLLLEIITGK 572
+M+PE + KSD++S G+ +E+ G
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 25/268 (9%)
Query: 312 RRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDV--TFFELSTVLAA 369
+ + + R E + S+ L++R S + + ++ F+ V A
Sbjct: 22 QSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAK 81
Query: 370 TDNFS------TSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIA 422
+ + LG G FG V+K + A G ++A K + T + EE KNE+ ++
Sbjct: 82 QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 423 KLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIA 480
+L H NL++L K++ +L+ E++ L FD L + I
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQIC 197
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILL--DEEMNPRISDFGTARVFG-GEEISTNTNRVVG 537
G+ ++HQ + I+H DLK NIL + +I DFG AR + E++ N G
Sbjct: 198 EGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN----FG 250
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLL 565
T +++PE S +D++S GV+
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 370 TDNFSTSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQH 426
+DN+ +LG+G F V + G E A K ++T S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLY 485
N+V+L E+ L+++ + L F++ ++ I I + Y
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAY 120
Query: 486 LHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFG-GEEISTNTNRVVGTYGY 541
H I+HR+LK N+LL + +++DFG A E GT GY
Sbjct: 121 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG----FAGTPGY 173
Query: 542 MSPEYALGGLFSTKSDVFSFGVLL 565
+SPE +S D+++ GV+L
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVIL 197
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 53/250 (21%), Positives = 103/250 (41%), Gaps = 40/250 (16%)
Query: 342 EASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVK 401
+ + V + T ++ +G G FG V++ KL E+A+K
Sbjct: 11 NGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK 70
Query: 402 RLSTTSGQGIEEFKN-EVLLIAKLQHRNLVKLLGCCLEKDEKM------LIYEFMPNKSL 454
++ + FKN E+ ++ ++H N+V L +K L+ E++P
Sbjct: 71 KVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP---- 121
Query: 455 DYFIFDESRKQLLDWKKRFDIILG----------IARGVLYLHQDSRLRIIHRDLKASNI 504
E+ + + + + R + Y+H + I HRD+K N+
Sbjct: 122 ------ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNL 172
Query: 505 LLDEEMNP-RISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFG 562
LLD ++ DFG+A++ N + + Y Y +PE G ++T D++S G
Sbjct: 173 LLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY-YRAPELIFGATNYTTNIDIWSTG 229
Query: 563 VLLLEIITGK 572
++ E++ G+
Sbjct: 230 CVMAELMQGQ 239
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRL--STTSGQGIEE-FKNEVLLIAKLQH 426
D+F LG+G FG VY + N +A+K L S +G+E + E+ + + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------IILGIA 480
N++++ ++ L+ EF P L + E +K RFD + +A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKH-----GRFDEQRSATFMEELA 124
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
+ Y H ++IHRD+K N+L+ + +I+DFG + T + GT
Sbjct: 125 DALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----MCGTLD 177
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
Y+ PE G K D++ GVL E + G
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 35/239 (14%), Positives = 70/239 (29%), Gaps = 54/239 (22%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQ--------- 425
LGQ + G+ V T I++ K EVL + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 426 ----------------HRNLVKLLGCCLEKDEKM--LIYEFMPNKSLDYF--IFDESRKQ 465
+ ++++ + +Y M + + + S
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 466 -LLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524
L R + L + R + LH ++H L+ +I+LD+ ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 525 GEEISTNTNRVVGTYGYMSPEYAL-----------GGLFSTKSDVFSFGVLLLEIITGK 572
+ G+ PE L + D ++ G+++ I
Sbjct: 258 ------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-27
Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN 428
D++ +LG G FG V++ A G A K + T E + E+ ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYL 486
LV L + +E ++IYEFM L F++ + + + + + +G+ ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRI--SDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
H+ +H DLK NI+ + + + DFG ++ GT + +P
Sbjct: 272 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAP 325
Query: 545 EYALGGLFSTKSDVFSFGVLL 565
E A G +D++S GVL
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLS 346
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 54/233 (23%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN--------EVLLI 421
+ K+GQG FG V+K + GQ++A+K++ +E K E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 422 AKLQHRNLVKLLGCCLEKDEKM--------LIYEFMPN---KSLD--YFIFDESR----- 463
L+H N+V L+ C K L+++F + L F S
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 464 KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523
+ LL G+ Y+H++ +I+HRD+KA+N+L+ + +++DFG AR F
Sbjct: 131 QMLL-------------NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 524 GGEEISTN---TNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
+ S TNRVV T Y PE LG + D++ G ++ E+ T
Sbjct: 175 SLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 370 TDNFSTSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQH 426
+DN+ +LG+G F V + G E A K ++T S + ++ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIARGVLY 485
N+V+L E+ L+++ + L F++ ++ I I + Y
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAY 143
Query: 486 LHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
H I+HR+LK N+LL + +++DFG A E GT GY+
Sbjct: 144 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYL 197
Query: 543 SPEYALGGLFSTKSDVFSFGVLL 565
SPE +S D+++ GV+L
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVIL 220
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 42/202 (20%), Positives = 87/202 (43%), Gaps = 18/202 (8%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN 428
+ + + LG+G FG V++ ++ + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE--SRKQLLDWKKRFDIILGIARGVLYL 486
++ L +E ++I+EF+ + F+ + L+ ++ + + + +L
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNP--RISDFGTARVFG-GEEISTNTNRVVGTYGYMS 543
H I H D++ NI+ + +I +FG AR G+ + Y +
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL----LFTAPEYYA 171
Query: 544 PEYALGGLFSTKSDVFSFGVLL 565
PE + ST +D++S G L+
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLV 193
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 48/252 (19%), Positives = 81/252 (32%), Gaps = 52/252 (20%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVK-----RLSTTSGQGIEEFKNEVLLIAK 423
+ +GQG +G V A+K ++ + + +E K EV L+ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF---------- 473
L H N+ +L ++ L+ E L +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 474 ---------------------------DIILGIARGVLYLHQDSRLRIIHRDLKASNILL 506
+I+ I + YLH I HRD+K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201
Query: 507 --DEEMNPRISDFGTARVFGGEEISTNT--NRVVGTYGYMSPE--YALGGLFSTKSDVFS 560
++ ++ DFG ++ F GT +++PE + K D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 561 FGVLLLEIITGK 572
GVLL ++ G
Sbjct: 262 AGVLLHLLLMGA 273
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 54/218 (24%), Positives = 105/218 (48%), Gaps = 35/218 (16%)
Query: 378 KLGQGGFGPVYKGK---LANGQEIAVKR-----LSTTSGQGIEEFKNEVLLIAKLQHRNL 429
K+G+G +G VYK K + ++ A+K+ +S ++ + E+ L+ +L+H N+
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-------EIALLRELKHPNV 80
Query: 430 VKLLGCCLEKDEK--MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD------IILGIAR 481
+ L L ++ L++++ L + I + + ++ I
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPR----ISDFGTARVFG--GEEISTNTNRV 535
G+ YLH + ++HRDLK +NIL+ E R I+D G AR+F + ++ V
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 536 VGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
V T+ Y +PE LG ++ D+++ G + E++T +
Sbjct: 197 V-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGI---------EEFKNEVL 419
+N+ LG+G V + +E AVK + T G E EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 420 LIAKL-QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIIL 477
++ K+ H N+++L L+++ M L FD + K L K+ I+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMR 131
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVG 537
+ + LH+ L I+HRDLK NILLD++MN +++DFG + E V G
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCG 185
Query: 538 TYGYMSPE------YALGGLFSTKSDVFSFGVLL 565
T Y++PE + + D++S GV++
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLST------TSGQGIEEFKNEVLLIA 422
D + +LG G F V K + + G E A K + G EE + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 423 KLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIAR 481
++ H N++ L + + +LI E + L FD ++K+ L ++ I I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILD 126
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNP----RISDFGTARVFG-GEEISTNTNRVV 536
GV YLH +I H DLK NI+L ++ P ++ DFG A G E +
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN----IF 179
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLL 565
GT +++PE ++D++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-26
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQH 426
T+ + +LG+G F V + + GQE A ++T S + ++ + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIA 480
N+V+L E+ LI++ + L F++ ++ + I I
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVA-----REYYSEADASHCIQQIL 120
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEEISTNTNRVVG 537
VL+ HQ + ++HR+LK N+LL + +++DFG A GE+ + G
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAG 175
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLL 565
T GY+SPE + D+++ GV+L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 369 ATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLST-TSGQGIEEFKN----EVLLIA 422
AT + ++G G +G VYK + +G +A+K + G G EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 423 KLQ---HRNLVKLLGCCLEKDEK-----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD 474
+L+ H N+V+L+ C L++E + ++ L ++ D++ L + D
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 475 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR 534
++ RG+ +LH + I+HRDLK NIL+ +++DFG AR++ + T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPV 179
Query: 535 VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
VV T Y +PE L ++T D++S G + E+ K
Sbjct: 180 VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTS------GQGIEEFKNEVLLIA 422
D + +LG G F V K + + G E A K + G EE + EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 423 KLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIAR 481
++ H N++ L + + +LI E + L FD ++K+ L ++ I I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILD 126
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNP----RISDFGTARVFG-GEEISTNTNRVV 536
GV YLH +I H DLK NI+L ++ P ++ DFG A G E +
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN----IF 179
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLL 565
GT +++PE ++D++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTT------SGQGIEEFKNEVLLIA 422
D++ +LG G F V K + G+E A K + G EE + EV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 423 KLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIAR 481
+++H N++ L K + +LI E + L FD + K+ L + + I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILD 119
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNP----RISDFGTARVFG-GEEISTNTNRVV 536
GV YLH RI H DLK NI+L ++ P ++ DFG A G E +
Sbjct: 120 GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN----IF 172
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLL 565
GT +++PE ++D++S GV+
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 55/221 (24%), Positives = 109/221 (49%), Gaps = 34/221 (15%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK--LANGQEIAVKRL----------STTSGQGIEEFKNEV 418
+ ++G+G +G V+K + G+ +A+KR+ +T I E
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST----IREVA--- 63
Query: 419 LL--IAKLQHRNLVKLL----GCCLEKDEKM-LIYEFMPNKSLDYFIFDESRKQLLDWKK 471
+L + +H N+V+L +++ K+ L++E + ++ L ++ D+ + + +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTET 121
Query: 472 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTN 531
D++ + RG+ +LH R++HRDLK NIL+ +++DFG AR++ +
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MAL 176
Query: 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
T+ VV T Y +PE L ++T D++S G + E+ K
Sbjct: 177 TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 55/228 (24%), Positives = 91/228 (39%), Gaps = 42/228 (18%)
Query: 368 AATDNFSTS---------NKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNE 417
+TD+FS + LG+G V L QE AVK + G E
Sbjct: 1 GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60
Query: 418 VLLIAKLQ-HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF--- 473
V ++ + Q HRN+++L+ E+D L++E M S+ K ++ F
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHK-----RRHFNEL 111
Query: 474 ---DIILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEE 527
++ +A + +LH I HRDLK NIL ++ +I DF
Sbjct: 112 EASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168
Query: 528 ISTNTNR-----VVGTYGYMSPE-----YALGGLFSTKSDVFSFGVLL 565
+ + G+ YM+PE ++ + D++S GV+L
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTT------SGQGIEEFKNEVLLIA 422
D + T +LG G F V K + + G + A K + G E+ + EV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 423 KLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGIAR 481
++QH N++ L K + +LI E + L FD + K+ L ++ + + I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILN 125
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNP----RISDFGTARVFG-GEEISTNTNRVV 536
GV YLH L+I H DLK NI+L + P +I DFG A G E +
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 178
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLL 565
GT +++PE ++D++S GV+
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 39/219 (17%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQG--------IEEFKNEVLL 420
+ + +G+G V + A G E AVK + T+ + E + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 421 IAKL-QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF------ 473
+ ++ H +++ L+ L+++ M L FD + K
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTE-----KVALSEKETR 203
Query: 474 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG-GEEISTNT 532
I+ + V +LH I+HRDLK NILLD+ M R+SDFG + GE++
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-- 258
Query: 533 NRVVGTYGYMSPE------YALGGLFSTKSDVFSFGVLL 565
+ GT GY++PE + + D+++ GV+L
Sbjct: 259 --LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 58/243 (23%), Positives = 102/243 (41%), Gaps = 27/243 (11%)
Query: 333 NSSTRLSDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGK- 391
+ + T++ V + + S A +D F ++LG+G VY+ K
Sbjct: 15 TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQ 74
Query: 392 LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451
+ A+K L T + + E+ ++ +L H N++KL E L+ E +
Sbjct: 75 KGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132
Query: 452 KSLDYFIFDESRKQLLDWKKRF------DIILGIARGVLYLHQDSRLRIIHRDLKASNIL 505
L FD + K + D + I V YLH+ I+HRDLK N+L
Sbjct: 133 GEL----FDRIVE-----KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLL 180
Query: 506 L---DEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFG 562
+ +I+DFG +++ + + V GT GY +PE G + + D++S G
Sbjct: 181 YATPAPDAPLKIADFGLSKIVEHQVLMKT---VCGTPGYCAPEILRGCAYGPEVDMWSVG 237
Query: 563 VLL 565
++
Sbjct: 238 IIT 240
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 69/277 (24%), Positives = 122/277 (44%), Gaps = 55/277 (19%)
Query: 325 RRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVTFFELSTVLAA---------TDNFST 375
R R F S + A S K ++D +++TV+A +++
Sbjct: 4 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDG-----SKVTTVVATPGQGPDRPQEVSYTD 58
Query: 376 SNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKN-EVLLIAKLQHRNLVKLL 433
+ +G G FG VY+ KL +G+ +A+K++ + FKN E+ ++ KL H N+V+L
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLR 113
Query: 434 GCCLEKDEKM------LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILG--------- 478
EK L+ +++P E+ ++ R L
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVP----------ETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 479 -IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP-RISDFGTARVFGGEEISTNTNRVV 536
+ R + Y+H I HRD+K N+LLD + ++ DFG+A+ E N + +
Sbjct: 164 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYIC 218
Query: 537 GTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
Y Y +PE G +++ DV+S G +L E++ G+
Sbjct: 219 SRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 50/257 (19%), Positives = 94/257 (36%), Gaps = 66/257 (25%)
Query: 372 NFSTSNKLGQGGFGPVYKGK-LANGQEIAVK--------RLSTTSGQGIEEFKNEVLLIA 422
+ST + LG G FG V+ +E+ VK + + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 423 KLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI----------FDESRKQLLDWKKR 472
+++H N++K+ + N+ + F +D R
Sbjct: 85 RVEHANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLFA-----FIDRHPR 126
Query: 473 FDIILG------IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF-GG 525
D L + V YL IIHRD+K NI++ E+ ++ DFG+A G
Sbjct: 127 LDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183
Query: 526 EEISTNTNRVVGTYGYMSPEYALGGLFS-TKSDVFSFGVLLLEIITG--------KKNTG 576
+ T GT Y +PE +G + + +++S GV L ++ +
Sbjct: 184 KLFYT----FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA 239
Query: 577 IFN------DDSSNLIR 587
+ + +L+
Sbjct: 240 AIHPPYLVSKELMSLVS 256
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 28/207 (13%)
Query: 370 TDNFSTSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN 428
TD + +G G + + A E AVK + + EE +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIARG 482
++ L + ++ E M L D+ + +K F ++ I +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILR-----QKFFSEREASAVLFTITKT 128
Query: 483 VLYLHQDSRLRIIHRDLKASNILL-DEEMNP---RISDFGTARVFGGEEISTNTNRVVGT 538
V YLH ++HRDLK SNIL DE NP RI DFG A+ E T T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183
Query: 539 YGYMSPEYALGGLFSTKSDVFSFGVLL 565
+++PE + D++S GVLL
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 22/199 (11%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHR-NLVKLL 433
+LG+G F V + + GQE A K L E +E+ ++ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFD---ESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
E +LI E+ + F +++ +I I GV YLHQ
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-- 149
Query: 491 RLRIIHRDLKASNILL---DEEMNPRISDFGTARVFG-GEEISTNTNRVVGTYGYMSPEY 546
I+H DLK NILL + +I DFG +R G E+ ++GT Y++PE
Sbjct: 150 -NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE----IMGTPEYLAPEI 204
Query: 547 ALGGLFSTKSDVFSFGVLL 565
+T +D+++ G++
Sbjct: 205 LNYDPITTATDMWNIGIIA 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLS---TTSGQGIEEFKNEVLLIAKLQH 426
++F LG+G F V + A +E A+K L + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 427 RNLVKLLGCCLEKDEKML--IYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DII 476
VKL +D++ L + N L +I FDE+ RF +I+
Sbjct: 90 PFFVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAEIV 140
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
+ YLH IIHRDLK NILL+E+M+ +I+DFGTA+V E N V
Sbjct: 141 SALE----YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 193
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
GT Y+SPE SD+++ G ++ +++ G
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 27/212 (12%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLST--------TSGQGIEEFKNEVLL 420
D + S LG G G V +++A++ +S + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 421 IAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGI 479
+ KL H ++K+ + ++ ++ E M L FD+ + L +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 248
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEEISTNTNRVV 536
V YLH+ IIHRDLK N+LL +E+ +I+DFG +++ G + +
Sbjct: 249 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 302
Query: 537 GTYGYMSPEYALGGLF---STKSDVFSFGVLL 565
GT Y++PE + + D +S GV+L
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 27/212 (12%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEE--------FKNEVLL 420
D + S LG G G V +++A+K +S + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 421 IAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDE-SRKQLLDWKKRFDIILGI 479
+ KL H ++K+ + ++ ++ E M L FD+ + L +
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 123
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEEISTNTNRVV 536
V YLH IIHRDLK N+LL +E+ +I+DFG +++ G + T +
Sbjct: 124 LLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRT--LC 177
Query: 537 GTYGYMSPEYALGGL---FSTKSDVFSFGVLL 565
GT Y++PE + ++ D +S GV+L
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 35/223 (15%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKR-LSTTSGQGIEEFKN----EVLLIAK 423
D F GQG FG V GK G +A+K+ + F+N + +A
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQIMQDLAV 75
Query: 424 LQHRNLVKLLGCCLEKDEK-------MLIYEFMP---NKSLDYFIFDESRKQLL--DWKK 471
L H N+V+L E+ ++ E++P ++ + R+ K
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY---RRQVAPPPILIK 132
Query: 472 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP-RISDFGTARVFGGEEIST 530
F + + R + LH S + + HRD+K N+L++E ++ DFG+A+ E
Sbjct: 133 VF--LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--P 187
Query: 531 NTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
N + Y Y +PE G ++T D++S G + E++ G+
Sbjct: 188 NVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 28/203 (13%)
Query: 374 STSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-HRNLVK 431
LG+G F K + Q AVK +S + E+ + + H N+VK
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVK 70
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRF------DIILGIARGVLY 485
L ++ L+ E + L F+ +K KK F I+ + V +
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGEL----FERIKK-----KKHFSETEASYIMRKLVSAVSH 121
Query: 486 LHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
+H + ++HRDLK N+L ++ + +I DFG AR+ + T T Y
Sbjct: 122 MHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYA 176
Query: 543 SPEYALGGLFSTKSDVFSFGVLL 565
+PE + D++S GV+L
Sbjct: 177 APELLNQNGYDESCDLWSLGVIL 199
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEE-FKNEVLLIAKLQHRNLVKLLGCC 436
LG+G +G V + +AVK + E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 437 LEKDEKMLIYEFMPNKSL-DYFIF------DESRK---QLLDWKKRFDIILGIARGVLYL 486
E + + L E+ L D ++++ QL+ GV+YL
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------------GVVYL 121
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
H + I HRD+K N+LLDE N +ISDFG A VF N++ GT Y++PE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 547 ALGGLFS-TKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRY 588
F DV+S G++L ++ G+ ++ S + Y
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEY 218
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRL--STTSGQGIEEFKNEVLLIAKLQHRNLVKLLGC 435
+G+G F V + + G+E+A+K + + + +++ EV ++ L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 436 CLEKDEKMLIYEFMPNKSL-DYFIF------DESRK---QLLDWKKRFDIILGIARGVLY 485
+ LI E+ + DY + E+R Q++ V Y
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-------------AVQY 129
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF-GGEEISTNTNRVVGTYGYMSP 544
H + RI+HRDLKA N+LLD +MN +I+DFG + F G ++ G Y +P
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA----FCGAPPYAAP 182
Query: 545 EYALGGLFS-TKSDVFSFGVLLLEIITGK 572
E G + + DV+S GV+L +++G
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 66/219 (30%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLS---TTSGQGIEEFKNEVLLIAKLQH 426
D F LG+GGFG V+ ++ ++ A K+L+ +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 427 RNLVKLLGCCLEKDEKM-LIYEFMPNKSLDYFI---------FDESRKQLLDWKKRF--- 473
R +V L E + L+ M + Y I F E R F
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-------IFYTA 296
Query: 474 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTN 533
I+ G+ +LHQ II+RDLK N+LLD++ N RISD G A + T
Sbjct: 297 QIVSGLE----HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG- 348
Query: 534 RVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
GT G+M+PE LG + D F+ GV L E+I +
Sbjct: 349 -YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 34/218 (15%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLS---TTSGQGIEEFKNE--VL-LIAK 423
++FS +G+GGFG VY + A+ ++ A+K L QG NE +L L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DI 475
+V + D+ I + M L Y + F E+ RF +I
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-------RFYAAEI 301
Query: 476 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV 535
ILG+ ++H +++RDLK +NILLDE + RISD G A + +
Sbjct: 302 ILGLE----HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHAS 350
Query: 536 VGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLEIITGK 572
VGT+GYM+PE G+ S D FS G +L +++ G
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 76/299 (25%), Positives = 119/299 (39%), Gaps = 24/299 (8%)
Query: 285 RKRRLALIIVAIVLGVLLLGLCYFFLWRRLDTRIGERQRQRRRELLF--LNSSTRLSDRE 342
+++ + L L R+L T +R Q + LF L T
Sbjct: 97 KRKACGRNLTQNFLSHTGPDLIPEVP-RQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSV 155
Query: 343 ASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEI-AVK 401
A + + N + + L + F LG+GGFG V ++ ++ A K
Sbjct: 156 APFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACK 215
Query: 402 RLS---TTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI 458
+L +G NE ++ K+ R +V L KD L+ M L + I
Sbjct: 216 KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI 275
Query: 459 FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRIS 515
+ + + + F +I G+ LH R RI++RDLK NILLD+ + RIS
Sbjct: 276 YHMGQAGFPEARAVFYAAEICCGLE----DLH---RERIVYRDLKPENILLDDHGHIRIS 328
Query: 516 DFGTARVFGGEEISTN--TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
D G A + VGT GYM+PE ++ D ++ G LL E+I G+
Sbjct: 329 DLGLAV-----HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEE-FKNEVLLIAKLQHRNLVKLLGCC 436
LG+G +G V + +AVK + E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 437 LEKDEKMLIYEFMPNKSL-DYFIF------DESRK---QLLDWKKRFDIILGIARGVLYL 486
E + + L E+ L D ++++ QL+ GV+YL
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------------GVVYL 121
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
H + I HRD+K N+LLDE N +ISDFG A VF N++ GT Y++PE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 547 ALGGLFS-TKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRY 588
F DV+S G++L ++ G+ ++ S + Y
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEY 218
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 44/212 (20%), Positives = 81/212 (38%), Gaps = 46/212 (21%)
Query: 375 TSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQGIEEFKNEV-LLIAKLQHRNLVKL 432
+ LG G G V + GQ+ A+K L + + + EV ++V +
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87
Query: 433 LGCCLEKDEKMLIYEFMPNKSLDYFI----------FDESRKQLLDWKKRF------DII 476
L +YE M + I F +++ + F +I+
Sbjct: 88 LD----------VYENMHHGKRCLLIIMECMEGGELFSRIQER---GDQAFTEREAAEIM 134
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEEISTNTN 533
I + +LH I HRD+K N+L +++ +++DFG A+ + T
Sbjct: 135 RDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT--- 188
Query: 534 RVVGTYGYMSPEYALGGLFSTKSDVFSFGVLL 565
T Y++PE + D++S GV++
Sbjct: 189 -PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 61/239 (25%), Positives = 98/239 (41%), Gaps = 67/239 (28%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLS--------------------------TTSGQGI 411
+G+G +G V + A+K LS I
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 412 EEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM--PNKSLDYFIFDESRK-QLLD 468
E+ E+ ++ KL H N+VKL E + PN+ Y +F+ + +++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL-------------VEVLDDPNEDHLYMVFELVNQGPVME 127
Query: 469 --WKKRF----------DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISD 516
K D+I GI YLH +IIHRD+K SN+L+ E+ + +I+D
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 517 FGTARVFGGEEISTNTNRVVGTYGYMSPE--YALGGLFS-TKSDVFSFGVLLLEIITGK 572
FG + F G + + VGT +M+PE +FS DV++ GV L + G+
Sbjct: 181 FGVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 49/245 (20%), Positives = 89/245 (36%), Gaps = 56/245 (22%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRL------STTSGQGIEEFKNEVLLIAKLQHR--NL 429
LG GGFG VY G +++ +A+K + EV+L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFD--ESRKQLLDW---KKRFDIILG------ 478
++L ++ I + E + L D+ + L
Sbjct: 111 IRL-------------LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEE-MNPRISDFGTARVFGGEEISTNTNRVVG 537
+ V + H ++HRD+K NIL+D ++ DFG+ + + G
Sbjct: 158 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDG 210
Query: 538 TYGYMSPEYALGGLFS-TKSDVFSFGVLLLEIITG--------KKNTGIFN------DDS 582
T Y PE+ + + V+S G+LL +++ G + G +
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 270
Query: 583 SNLIR 587
+LIR
Sbjct: 271 QHLIR 275
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 43/217 (19%), Positives = 81/217 (37%), Gaps = 44/217 (20%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRL------STTSGQGIEEFKNEV----LLIAKLQHR 427
LG+GGFG V+ G L + ++A+K + + EV + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI--FDESRKQLLDW---KKRFD------II 476
+++L ++ + + + L D+ K
Sbjct: 99 GVIRL-------------LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP-RISDFGTARVFGGEEISTNTNRV 535
+ + + H ++HRD+K NIL+D ++ DFG+ + E +
Sbjct: 146 GQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD----F 198
Query: 536 VGTYGYMSPEYALGGLFS-TKSDVFSFGVLLLEIITG 571
GT Y PE+ + + V+S G+LL +++ G
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 56/215 (26%), Positives = 85/215 (39%), Gaps = 38/215 (17%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLS----TTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
LG+G +G V + AVK L G K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 434 GCCLEKDEKMLIY---EFMPNKSLDYFIF--------DESRK---QLLDWKKRFDIILGI 479
L +EK +Y E+ + ++ QL+D
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID----------- 120
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
G+ YLH I+H+D+K N+LL +IS G A G+
Sbjct: 121 --GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 540 GYMSPEYALGG-LFS-TKSDVFSFGVLLLEIITGK 572
+ PE A G FS K D++S GV L I TG
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 62/223 (27%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVK---RLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
LG G FG V G+ G ++AVK R S + + K E+ + +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFI---------FD-----------ESRK---QLLDWKK 471
Y+ + + + + FD E+R+ Q+L
Sbjct: 77 -----------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS--- 122
Query: 472 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF-GGEEIST 530
V Y H R ++HRDLK N+LLD MN +I+DFG + + GE + T
Sbjct: 123 ----------AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 169
Query: 531 NTNRVVGTYGYMSPEYALGGLFS-TKSDVFSFGVLLLEIITGK 572
G+ Y +PE G L++ + D++S GV+L ++ G
Sbjct: 170 ----SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 45/214 (21%), Positives = 80/214 (37%), Gaps = 49/214 (22%)
Query: 375 TSNKLGQGGFGPVYKG-KLANGQEIAVKRLSTTSGQGIEEFKNEV-LLIAKLQHRNLVKL 432
TS LG G G V + ++ A+K L + + EV L Q ++V++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRI 120
Query: 433 LGCCLEKDEKMLIYE-FMPNKSLDYFIFD-----ESRKQLLD-----WKKRF------DI 475
+ +YE + + + E L + F +I
Sbjct: 121 VD----------VYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEI 166
Query: 476 ILGIARGVLYLHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVF-GGEEISTN 531
+ I + YLH + I HRD+K N+L +++DFG A+ ++T
Sbjct: 167 MKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT- 222
Query: 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLL 565
T Y++PE + D++S GV++
Sbjct: 223 ---PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-HR 427
D++ KLG+G + V++ + N +++ VK L + + K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91
Query: 428 NLVKLLGCCLEKDEKM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
N++ L + + L++E + N + L D+ RF + I + + Y
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYEILKALDY 145
Query: 486 LHQDSRLRIIHRDLKASNILLD-EEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
H S I+HRD+K N+++D E R+ D+G A RV Y + P
Sbjct: 146 CH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGP 199
Query: 545 EYALGGLFSTKS-DVFSFGVLLLEIITGKK 573
E + S D++S G +L +I K+
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 61/222 (27%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVK---RLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
LG+G FG V Q++A+K R + E+ + L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFI--------FD-----------ESRK---QLLDWKKR 472
Y+ + + + FD E R+ Q++
Sbjct: 75 -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIIC---- 119
Query: 473 FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF-GGEEISTN 531
+ Y H R +I+HRDLK N+LLD+ +N +I+DFG + + G + T+
Sbjct: 120 ---------AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167
Query: 532 TNRVVGTYGYMSPEYALGGLFS-TKSDVFSFGVLLLEIITGK 572
G+ Y +PE G L++ + DV+S G++L ++ G+
Sbjct: 168 ----CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 5e-20
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 62/223 (27%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVK---RLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
LG G FG V GK G ++AVK R S + + + E+ + +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 435 CCLEKDEKMLIYEFMPNKSLDYFI---------FD-----------ESRK---QLLDWKK 471
Y+ + S + + FD ESR+ Q+L
Sbjct: 82 -----------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--- 127
Query: 472 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF-GGEEIST 530
GV Y H R ++HRDLK N+LLD MN +I+DFG + + GE + T
Sbjct: 128 ----------GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174
Query: 531 NTNRVVGTYGYMSPEYALGGLFS-TKSDVFSFGVLLLEIITGK 572
+ G+ Y +PE G L++ + D++S GV+L ++ G
Sbjct: 175 S----CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 60/247 (24%), Positives = 108/247 (43%), Gaps = 43/247 (17%)
Query: 344 STSAKRNKDTGNVDV--TFFELSTVLAATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAV 400
+ +KR+ + +V++ + F + + +G G G V + +A+
Sbjct: 2 GSRSKRDNNFYSVEIGDSTFTV------LKRYQNLKPIGSGAQGIVCAAYDAILERNVAI 55
Query: 401 KRLSTTSGQGIEEFKN---------EVLLIAKLQHRNLVKLL------GCCLEKDEKMLI 445
K+LS F+N E++L+ + H+N++ LL E + ++
Sbjct: 56 KKLS-------RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108
Query: 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNIL 505
E M +L I + +L + + ++ + G+ +LH IIHRDLK SNI+
Sbjct: 109 MELMDA-NLCQVI----QMELDHERMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIV 159
Query: 506 LDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLL 565
+ + +I DFG AR G + T V T Y +PE LG + D++S G ++
Sbjct: 160 VKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIM 216
Query: 566 LEIITGK 572
E+I G
Sbjct: 217 GEMIKGG 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 56/248 (22%), Positives = 102/248 (41%), Gaps = 59/248 (23%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN-EVLLIAKLQHR 427
+ +S LG G FG V + + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHV 60
Query: 428 NLVKLLGCCLEKDEKM--------------------------------------LIYEFM 449
N++KL+ ++ +I E++
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 450 P---NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILL 506
P +K L FI S + + I + R V ++H L I HRD+K N+L+
Sbjct: 121 PDTLHKVLKSFI--RSGRSIPMNLISI-YIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174
Query: 507 DEEMNP-RISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVL 564
+ + N ++ DFG+A+ E + + + Y +PE LG ++ D++S G +
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCV 231
Query: 565 LLEIITGK 572
E+I GK
Sbjct: 232 FGELILGK 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 52/245 (21%), Positives = 93/245 (37%), Gaps = 34/245 (13%)
Query: 346 SAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLST 405
AK ++ + ++ + G +G V G + G +A+KR+
Sbjct: 3 QAKGEAAMRDLIAELHAM------QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFN 56
Query: 406 TSGQGIEE--FKN---------EVLLIAKLQHRNLVKLLGCCL-EKDEKM----LIYEFM 449
T G + E+ L+ H N++ L + ++ M L+ E M
Sbjct: 57 TVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM 116
Query: 450 PNKSLD-YFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE 508
D + + R + ++ + I G+ LH+ ++HRDL NILL +
Sbjct: 117 RT---DLAQVIHDQRIVISPQHIQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLAD 169
Query: 509 EMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLE 567
+ I DF AR + T+ V Y +PE + TK D++S G ++ E
Sbjct: 170 NNDITICDFNLAREDTADANKTHY---VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAE 226
Query: 568 IITGK 572
+ K
Sbjct: 227 MFNRK 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 4e-19
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 35/219 (15%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN---------EVL 419
+ +G G G V + +A+K+LS F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 420 LIAKLQHRNLVKLL-----GCCLEKDEKM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRF 473
L+ + H+N++ LL LE+ + + L+ E M L I + +L + +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI----QMELDHERMSY 168
Query: 474 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTN 533
++ + G+ +LH IIHRDLK SNI++ + +I DFG AR G + T
Sbjct: 169 -LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY- 223
Query: 534 RVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
V T Y +PE LG + D++S G ++ E++ K
Sbjct: 224 --VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 44/246 (17%)
Query: 344 STSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKR 402
S K+ +V+ T +EL + + +G G +G V +G+++A+K+
Sbjct: 3 SLIRKKGFYKQDVNKTAWEL------PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKK 56
Query: 403 LSTTSGQGIEEFKN---------EVLLIAKLQHRNLVKLL-----GCCLEKDEKM-LIYE 447
LS F++ E+LL+ +QH N++ LL L L+
Sbjct: 57 LS-------RPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 109
Query: 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD 507
FM L + + + K ++ ++ + +G+ Y+H ++HRDLK N+ ++
Sbjct: 110 FMQ-TDLQKIM----GLKFSEEKIQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVN 160
Query: 508 EEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKS-DVFSFGVLLL 566
E+ +I DFG AR E T VV T Y +PE L + ++ D++S G ++
Sbjct: 161 EDCELKILDFGLARHADAEM----TGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 567 EIITGK 572
E++TGK
Sbjct: 216 EMLTGK 221
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 38/209 (18%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEE-FKNEVLLIAKLQHRNLVKLLGCC 436
+G G FG + + +AVK + G I+E + E++ L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE--RGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 437 LEKDEKMLIYEFMPNKSL-DYFIF------DESRK---QLLDWKKRFDIILGIARGVLYL 486
L +I E+ L + DE+R QLL GV Y
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-------------GVSYC 132
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPR--ISDFGTARVF-GGEEISTNTNRVVGTYGYMS 543
H ++I HRDLK N LLD PR I DFG ++ + + VGT Y++
Sbjct: 133 H---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIA 185
Query: 544 PEYALGGLFS-TKSDVFSFGVLLLEIITG 571
PE L + +DV+S GV L ++ G
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 36/97 (37%), Positives = 55/97 (56%), Gaps = 13/97 (13%)
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT 538
+A+G+ +L + + IHRDL A NILL E+ +I DFG AR +I + + V
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKG 253
Query: 539 YG-----YMSPEYALGGLFSTKSDVFSFGVLLLEIIT 570
+M+PE +++ +SDV+SFGVLL EI +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 34/157 (21%), Positives = 57/157 (36%), Gaps = 19/157 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL------ANGQEIAVKRL-STTSGQGIEEFKNEVLLIAK 423
D LG+G FG V + A + +AVK L + +E+ ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 424 L-QHRNLVKLLGCCLEKDEK-MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 481
+ H N+V LLG C + M+I EF +L ++ KR + + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG 518
G + + I DLK + + S F
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 40/244 (16%), Positives = 91/244 (37%), Gaps = 29/244 (11%)
Query: 319 GERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNK 378
G + + +S + ++ + + + D + +
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60
Query: 379 LGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN---------EVLLIAKLQHRN 428
+G G +G V + + +A+K++ F++ E+ ++ +L H +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDH 113
Query: 429 LVKLLGCCLEKDEKM-----LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 483
+VK+L + KD + ++ E + L + + ++ + GV
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTELHIKT-LLYNLLVGV 169
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMS 543
Y+H S I+HRDLK +N L++++ + ++ DFG AR E + + M+
Sbjct: 170 KYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 544 PEYA 547
Sbjct: 227 LVTF 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 53/241 (21%), Positives = 102/241 (42%), Gaps = 44/241 (18%)
Query: 356 VDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEF 414
+++ F+L + LG GG G V+ + +A+K++
Sbjct: 2 MNIHGFDL------GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------L 46
Query: 415 KN---------EVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLD-YFIFD--ES 462
+ E+ +I +L H N+VK+ ++ + Y + + E+
Sbjct: 47 TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET 106
Query: 463 -------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EEMNPRI 514
+ LL+ R + + RG+ Y+H + ++HRDLK +N+ ++ E++ +I
Sbjct: 107 DLANVLEQGPLLEEHARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162
Query: 515 SDFGTARVFGGEEISTN--TNRVVGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLEIITG 571
DFG AR+ + +V T Y SP L TK+ D+++ G + E++TG
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
Query: 572 K 572
K
Sbjct: 222 K 222
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 36/219 (16%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLS----TTSGQGIEEFKNEVLLIAKLQ 425
D+F +G+G FG V + + +++ A+K ++ + + E+ ++ L+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-VRNVFKELQIMQGLE 73
Query: 426 HRNLVKLLGCCLEKDEKM-LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DII 476
H LV L + +E M ++ + + L Y + F E + +++
Sbjct: 74 HPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV-------KLFICELV 125
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
+ + YL RIIHRD+K NILLDE + I+DF A + E T +
Sbjct: 126 MALD----YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-QITT--MA 175
Query: 537 GTYGYMSPE--YALGGLFSTKS-DVFSFGVLLLEIITGK 572
GT YM+PE + G + + D +S GV E++ G+
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 56/233 (24%), Positives = 106/233 (45%), Gaps = 43/233 (18%)
Query: 359 TFFELSTVLAATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN- 416
F++ ++ + +G+G +G V N +A+K+ I F++
Sbjct: 21 QVFDV------GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--------ISPFEHQ 66
Query: 417 --------EVLLIAKLQHRNLVKLLGC----CLEKDEKM-LIYEFMPNKSLDYFIFDESR 463
E+ ++ + +H N++ + +E+ + + ++ + M L + +
Sbjct: 67 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----K 121
Query: 464 KQLL-DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522
Q L + + + I RG+ Y+H S ++HRDLK SN+LL+ + +I DFG ARV
Sbjct: 122 TQHLSNDHICY-FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 523 FGGEEISTN--TNRVVGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLEIITGK 572
+ T T V T Y +PE L TKS D++S G +L E+++ +
Sbjct: 178 ADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 60/280 (21%), Positives = 119/280 (42%), Gaps = 37/280 (13%)
Query: 312 RRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGN----VDVTFFELSTVL 367
++D + + + + + L L+ L + ++NK+ N T ++ +
Sbjct: 7 EKMDNLLRDPKSEVNSDCL-LDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLR 65
Query: 368 AATDNFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLS---TTSGQGIEEFKNEVLLIAK 423
+++ +G+G FG V + + +++ A+K LS F E ++A
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFMPN----KSLDYFIFDESRKQLLDWKKRF---DII 476
+V+L + ++ E+MP + + E RF +++
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-------RFYTAEVV 178
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA-RVFGGEEISTNTNRV 535
L + +H + IHRD+K N+LLD+ + +++DFGT ++ + +T
Sbjct: 179 LALD----AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--A 229
Query: 536 VGTYGYMSPE--YALGGLFS-TKS-DVFSFGVLLLEIITG 571
VGT Y+SPE + GG + D +S GV L E++ G
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 48/222 (21%), Positives = 89/222 (40%), Gaps = 37/222 (16%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLS---TTSGQGIEEFKNEVLLIAKLQH 426
D+F +G+G F V K+ ++ A+K ++ + F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 427 RNLVKLLGCCLEKDEKM-LIYEFMPNKSLDYFI------FDESRKQLLDWKKRF---DII 476
R + +L + + + L+ E+ L + RF +I+
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-------RFYLAEIV 172
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
+ I +H+ L +HRD+K NILLD + R++DFG+ + + + V
Sbjct: 173 MAID----SVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAV 224
Query: 537 GTYGYMSPE-------YALGGLFSTKSDVFSFGVLLLEIITG 571
GT Y+SPE G + + D ++ GV E+ G
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 49/220 (22%), Positives = 90/220 (40%), Gaps = 35/220 (15%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLS---TTSGQGIEEFKNEVLLIAKLQH 426
++F +G+G FG V KL N ++ A+K L+ F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI------FDESRKQLLDWKKRF---DIIL 477
+ + L + + L+ ++ L + E RF ++++
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-------RFYLAEMVI 186
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA-RVFGGEEISTNTNRVV 536
I +HQ L +HRD+K NIL+D + R++DFG+ ++ + ++ V
Sbjct: 187 AID----SVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AV 237
Query: 537 GTYGYMSPEYALGGLFSTKS-----DVFSFGVLLLEIITG 571
GT Y+SPE D +S GV + E++ G
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 62/252 (24%), Positives = 99/252 (39%), Gaps = 35/252 (13%)
Query: 334 SSTRLSDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLA 393
++ + + S K + + S A D F LG G FG V K
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 394 NGQEI-AVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML--IYE 447
A+K L + IE NE ++ + LVKL KD L + E
Sbjct: 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF--KDNSNLYMVME 121
Query: 448 FMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDL 499
++ + + F E RF I+L YLH L +I+RDL
Sbjct: 122 YVAGGEMFSHLRRIGRFSEPHA-------RFYAAQIVLTFE----YLHS---LDLIYRDL 167
Query: 500 KASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVF 559
K N+L+D++ +++DFG A+ + T + GT ++PE L ++ D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWW 222
Query: 560 SFGVLLLEIITG 571
+ GVL+ E+ G
Sbjct: 223 ALGVLIYEMAAG 234
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 54/230 (23%), Positives = 88/230 (38%), Gaps = 58/230 (25%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRL---STTSGQGIEEFKNEVLLIAKLQHRNLVKLL 433
KLG G F V+ K + N +A+K + + +E +KLL
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----------------IKLL 69
Query: 434 GCCLEKDEKMLIYEFMPN--KSLDYFIFDESRKQ------------LLDWKKRF------ 473
+ D + K LD+F LL K++
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 474 -DIILGIAR----GVLYLHQDSRLRIIHRDLKASNILLDEEMNP------RISDFGTARV 522
+ I++ G+ Y+H R IIH D+K N+L++ +P +I+D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC- 186
Query: 523 FGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+ E + + T Y SPE LG + +D++S L+ E+ITG
Sbjct: 187 WYDEHYTN----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 29/215 (13%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLS---TTSGQGIEEFKNEVLLIAKLQH 426
+ F LG+G FG V K A+K L + + E ++ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 427 RNLVKLLGCCLEKDEKM-LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIIL 477
L L + +++ + E+ L + + F E R RF +I+
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RFYGAEIVS 259
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVG 537
+ YLH S +++RDLK N++LD++ + +I+DFG + + + T G
Sbjct: 260 ALD----YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCG 311
Query: 538 TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
T Y++PE + D + GV++ E++ G+
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 61/243 (25%), Positives = 108/243 (44%), Gaps = 43/243 (17%)
Query: 347 AKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLST 405
A+ V T +E+ + +G G +G V G ++A+K+L
Sbjct: 7 ARSGFYRQEVTKTAWEV------RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY- 59
Query: 406 TSGQGIEEFKN---------EVLLIAKLQHRNLVKLL------GCCLEKDEKMLIYEFMP 450
F++ E+ L+ ++H N++ LL + + L+ FM
Sbjct: 60 ------RPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM- 112
Query: 451 NKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM 510
L + ++L + + +F ++ + +G+ Y+H IIHRDLK N+ ++E+
Sbjct: 113 GTDLGKLM---KHEKLGEDRIQF-LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDC 165
Query: 511 NPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLEII 569
+I DFG AR E T VV T Y +PE L + T++ D++S G ++ E+I
Sbjct: 166 ELKILDFGLARQADSEM----TGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220
Query: 570 TGK 572
TGK
Sbjct: 221 TGK 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 40/227 (17%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN---------EVL 419
+ +F + LG+G +G V G+ +A+K+ IE F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 420 LIAKLQHRNLVKLL-----GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFD 474
++ +H N++ + +E +I E M L I S + L D ++
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI---STQMLSDDHIQY- 116
Query: 475 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR 534
I R V LH + +IHRDLK SN+L++ + ++ DFG AR+ +
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 535 V--------VGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLEIITGK 572
V T Y +PE L +++ DV+S G +L E+ +
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 62/246 (25%), Positives = 107/246 (43%), Gaps = 46/246 (18%)
Query: 344 STSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVY---KGKLANGQEI-A 399
S+ N+ + FEL VL G+GG+G V+ K AN +I A
Sbjct: 2 SSETSVNRGPEKIRPECFELLRVL------------GKGGYGKVFQVRKVTGANTGKIFA 49
Query: 400 VKRLS----TTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKM-LIYEFMPNKSL 454
+K L + + K E ++ +++H +V L+ + K+ LI E++ L
Sbjct: 50 MKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL 108
Query: 455 DYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASNILL 506
+ F E F +I + + +LHQ II+RDLK NI+L
Sbjct: 109 FMQLEREGIFMEDTA-------CFYLAEISMALG----HLHQ---KGIIYRDLKPENIML 154
Query: 507 DEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLL 566
+ + + +++DFG + + T+T GT YM+PE + + D +S G L+
Sbjct: 155 NHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMRSGHNRAVDWWSLGALMY 212
Query: 567 EIITGK 572
+++TG
Sbjct: 213 DMLTGA 218
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 37/216 (17%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEI-AVKRLSTTS----GQGIEEFKNEVLLIAKLQ 425
+F LG G FG V+ + + A+K L Q +E +E L+++ +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVT 64
Query: 426 HRNLVKLLGCCLEKDEKML--IYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DI 475
H ++++ G +D + + I +++ L + F +F ++
Sbjct: 65 HPFIIRMWGTF--QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-------KFYAAEV 115
Query: 476 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRV 535
L + YLH II+RDLK NILLD+ + +I+DFG A+ + T +
Sbjct: 116 CLALE----YLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTL 163
Query: 536 VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITG 571
GT Y++PE ++ D +SFG+L+ E++ G
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 43/235 (18%)
Query: 355 NVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEE 413
++ T +E+ + + + +G G +G V G +AVK+LS
Sbjct: 19 ELNKTIWEV------PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP------- 65
Query: 414 FKN---------EVLLIAKLQHRNLVKLL-----GCCLEKDEKM-LIYEFMPNKSLDYFI 458
F++ E+ L+ ++H N++ LL LE+ + L+ M L+ +
Sbjct: 66 FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV 124
Query: 459 FDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG 518
++L D +F +I I RG+ Y+H IIHRDLK SN+ ++E+ +I DFG
Sbjct: 125 ---KCQKLTDDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 177
Query: 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKS-DVFSFGVLLLEIITGK 572
AR E T V T Y +PE L + ++ D++S G ++ E++TG+
Sbjct: 178 LARHTADEM----TGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 69/249 (27%), Positives = 113/249 (45%), Gaps = 44/249 (17%)
Query: 339 SDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVY---KGKLANG 395
S +E + + + D + FEL VL GQG FG V+ K ++
Sbjct: 4 SIKEIAITHHVKEGHEKADPSQFELLKVL------------GQGSFGKVFLVKKISGSDA 51
Query: 396 QEI-AVKRLS--TTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKM-LIYEFMPN 451
+++ A+K L T + K E ++ ++ H +VKL + + K+ LI +F+
Sbjct: 52 RQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRG 110
Query: 452 KSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASN 503
L + F E +F ++ L + +LH L II+RDLK N
Sbjct: 111 GDLFTRLSKEVMFTEEDV-------KFYLAELALALD----HLHS---LGIIYRDLKPEN 156
Query: 504 ILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGV 563
ILLDEE + +++DFG ++ E + GT YM+PE + +D +SFGV
Sbjct: 157 ILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGV 214
Query: 564 LLLEIITGK 572
L+ E++TG
Sbjct: 215 LMFEMLTGT 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 45/248 (18%)
Query: 340 DREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEI- 398
++EA + + K + ++ + F+L V+ G+G + V +L I
Sbjct: 33 EKEAMNTRESGKASSSLGLQDFDLLRVI------------GRGSYAKVLLVRLKKTDRIY 80
Query: 399 AVKRLS---TTSGQGIEEFKNE--VLLIAKLQHRNLVKLLGCCLEKDEKM-LIYEFMPNK 452
A++ + + I+ + E V A H LV L C + + ++ + E++
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGLH-SCFQTESRLFFVIEYVNGG 138
Query: 453 SLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKASNI 504
L + + E RF +I L + YLH+ II+RDLK N+
Sbjct: 139 DLMFHMQRQRKLPEEHA-------RFYSAEISLALN----YLHE---RGIIYRDLKLDNV 184
Query: 505 LLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVL 564
LLD E + +++D+G + +T+T GT Y++PE G + D ++ GVL
Sbjct: 185 LLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEILRGEDYGFSVDWWALGVL 242
Query: 565 LLEIITGK 572
+ E++ G+
Sbjct: 243 MFEMMAGR 250
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 64/251 (25%), Positives = 102/251 (40%), Gaps = 49/251 (19%)
Query: 339 SDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEI 398
+ + + + + FE VL G+G FG V ++ ++
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVL------------GKGSFGKVMLARVKETGDL 50
Query: 399 -AVKRLSTTSGQGIEEFKNEV--------LLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449
AVK L I + ++V +L H L +L C D + EF+
Sbjct: 51 YAVKVLKK---DVILQ-DDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFV 106
Query: 450 PNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHRDLKA 501
L + I FDE+R RF +II + +LH II+RDLK
Sbjct: 107 NGGDLMFHIQKSRRFDEARA-------RFYAAEIISALM----FLHD---KGIIYRDLKL 152
Query: 502 SNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSF 561
N+LLD E + +++DFG + ++T T GT Y++PE L+ D ++
Sbjct: 153 DNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEILQEMLYGPAVDWWAM 210
Query: 562 GVLLLEIITGK 572
GVLL E++ G
Sbjct: 211 GVLLYEMLCGH 221
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 33/209 (15%)
Query: 379 LGQGGFGPVYKGKLANGQEI-AVKRLS---TTSGQGIEEFKNE--VLLIAKLQHRNLVKL 432
+G+G + V +L I A+K + + I+ + E V A H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 75
Query: 433 LGCCLEKDEKM-LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGV 483
C + + ++ + E++ L + + E RF +I L +
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAEISLALN--- 124
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMS 543
YLH+ II+RDLK N+LLD E + +++D+G + +T+T GT Y++
Sbjct: 125 -YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIA 178
Query: 544 PEYALGGLFSTKSDVFSFGVLLLEIITGK 572
PE G + D ++ GVL+ E++ G+
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 20/199 (10%), Positives = 57/199 (28%), Gaps = 41/199 (20%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTTSG---QGIEEFKNEVLLIAKLQHRNLVKLL 433
G ++ A +++A+ + ++E + L ++++ + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 434 GCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLR 493
+ +++ E++ SL ++ + +A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA--DTS---PSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 494 IIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFS 553
+ S + +S G V+ M +
Sbjct: 150 VALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA-------N 180
Query: 554 TKSDVFSFGVLLLEIITGK 572
+ D+ G L ++ +
Sbjct: 181 PQDDIRGIGASLYALLVNR 199
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 45/207 (21%), Positives = 87/207 (42%), Gaps = 30/207 (14%)
Query: 379 LGQGGFGPVYKGKLANGQEI-AVKRLS---TTSGQGIEEFKNEVLLIAKLQHRNLVKLLG 434
LG+G FG V + A+K L + + E ++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 435 CCLEKDEKM-LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLY 485
+ +++ + E+ L + + F E R RF +I+ + Y
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RFYGAEIVSALE----Y 120
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE 545
LH +++RD+K N++LD++ + +I+DFG + + + T GT Y++PE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 175
Query: 546 YALGGLFSTKSDVFSFGVLLLEIITGK 572
+ D + GV++ E++ G+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 51/267 (19%), Positives = 104/267 (38%), Gaps = 56/267 (20%)
Query: 355 NVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEE 413
+ + DN+ + +G+G +G VY + +A+K+++
Sbjct: 16 FQGIKNVHV------PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM------- 62
Query: 414 FKN---------EVLLIAKLQHRNLVKLLGCCLEKDEKM-----LIYEFMPNKSLDYFIF 459
F++ E+ ++ +L+ +++L + D ++ E L
Sbjct: 63 FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF- 120
Query: 460 DESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGT 519
++ L + + I+ + G ++H IIHRDLK +N LL+++ + ++ DFG
Sbjct: 121 -KTPIFLTEEHIKT-ILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGL 175
Query: 520 ARVFGGEEISTNTNRV--------------------VGTYGYMSPEYALGGLFSTKS-DV 558
AR E+ + N + V T Y +PE L TKS D+
Sbjct: 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI 235
Query: 559 FSFGVLLLEIITGKKNTGIFNDDSSNL 585
+S G + E++ ++ + L
Sbjct: 236 WSTGCIFAELLNMLQSHINDPTNRFPL 262
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 60/255 (23%), Positives = 106/255 (41%), Gaps = 55/255 (21%)
Query: 336 TRLSDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLGQGGFGPVYKGKLANG 395
T + + + R++ + +T F VL G+G FG V +
Sbjct: 1 TTNTVSKFDNNGNRDR----MKLTDFNFLMVL------------GKGSFGKVMLSERKGT 44
Query: 396 QEI-AVKRLSTTSGQGIEEFKNEV--------LLIAKLQHRNLVKLLGCCLEKDEKM-LI 445
E+ AVK L + + ++V +L + L +L C + +++ +
Sbjct: 45 DELYAVKILKKDV---VIQ-DDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFV 99
Query: 446 YEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGVLYLHQDSRLRIIHR 497
E++ L Y I F E F +I +G+ +L II+R
Sbjct: 100 MEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAEIAIGLF----FLQS---KGIIYR 145
Query: 498 DLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSD 557
DLK N++LD E + +I+DFG + + ++T T GT Y++PE + D
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEIIAYQPYGKSVD 203
Query: 558 VFSFGVLLLEIITGK 572
++FGVLL E++ G+
Sbjct: 204 WWAFGVLLYEMLAGQ 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 39/212 (18%)
Query: 379 LGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQGIEEFKNEV--------LLIAKLQHRNL 429
+G+G FG V + + AVK L + I + K E +L+ ++H L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQK---KAILK-KKEEKHIMSERNVLLKNVKHPFL 101
Query: 430 VKLLGCCLEKDEKM-LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIA 480
V L + +K+ + +++ L Y + F E R RF +I +
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-------RFYAAEIASALG 153
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
YLH L I++RDLK NILLD + + ++DFG + +T+T GT
Sbjct: 154 ----YLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPE 204
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
Y++PE + D + G +L E++ G
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 63/269 (23%), Positives = 106/269 (39%), Gaps = 49/269 (18%)
Query: 321 RQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSNKLG 380
RQ+ R ++ + + N + + +T F VL G
Sbjct: 303 RQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVL------------G 350
Query: 381 QGGFGPVYKGKLANGQEI-AVKRLSTTSGQGIEEFKNEV--------LLIAKLQHRNLVK 431
+G FG V + E+ AVK L + + ++V +L + L +
Sbjct: 351 KGSFGKVMLSERKGTDELYAVKILKKDV---VIQ-DDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIARGV 483
L C D + E++ L Y I F E F +I +G+
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAEIAIGLF--- 456
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMS 543
+L II+RDLK N++LD E + +I+DFG + + ++T T GT Y++
Sbjct: 457 -FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIA 510
Query: 544 PEYALGGLFSTKSDVFSFGVLLLEIITGK 572
PE + D ++FGVLL E++ G+
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 39/211 (18%)
Query: 379 LGQGGFGPVYKGKLANGQEI-AVKRLSTTSGQGIEEFKNEV--------LLIAKLQHRNL 429
LG+G FG V+ + + A+K L + ++V +L +H L
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKK---DVVLM-DDDVECTMVEKRVLSLAWEHPFL 80
Query: 430 VKLLGCCLEKDEKM-LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILGIA 480
+ C + E + + E++ L Y I FD SR F +IILG+
Sbjct: 81 THMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-------TFYAAEIILGLQ 132
Query: 481 RGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYG 540
+LH I++RDLK NILLD++ + +I+DFG + + TNT GT
Sbjct: 133 ----FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPD 183
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITG 571
Y++PE LG ++ D +SFGVLL E++ G
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 41/211 (19%), Positives = 69/211 (32%), Gaps = 70/211 (33%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEV-LLIAKLQHRNLVKLLGC 435
LG G G V + ++ A+K L + + EV L Q ++V+++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVD- 78
Query: 436 CLEKDEKMLIYEFMPNKSLDYFI----------FDE--SRKQLLDWKKRF------DIIL 477
+YE + I F R + F +I+
Sbjct: 79 ---------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-----QAFTEREASEIMK 124
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEEISTNTNR 534
I + YLH + I HRD+K N+L +++DFG A
Sbjct: 125 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA-------------- 167
Query: 535 VVGTYGYMSPEYALGGLFSTKSDVFSFGVLL 565
E G + D++S GV++
Sbjct: 168 ---------KE-TTGEKYDKSCDMWSLGVIM 188
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 63/276 (22%), Positives = 105/276 (38%), Gaps = 38/276 (13%)
Query: 318 IGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVTFFELSTVLAATDNFSTSN 377
+ E + S + + +NF
Sbjct: 1 MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK 60
Query: 378 KLGQGGFGPVY---KGKLANGQEI-AVKRLS----TTSGQGIEEFKNE--VLLIAKLQHR 427
LG G +G V+ K + ++ A+K L + E + E VL + Q
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSP 119
Query: 428 NLVKLLGCCLEKDEKM-LIYEFMPNKSLDYFI-----FDESRKQLLDWKKRF---DIILG 478
LV L + + K+ LI +++ L + F E + +I+L
Sbjct: 120 FLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-------QIYVGEIVLA 171
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT 538
+ +LH+ L II+RD+K NILLD + ++DFG ++ F +E GT
Sbjct: 172 LE----HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
Query: 539 YGYMSPEYALGGLFS-TKS-DVFSFGVLLLEIITGK 572
YM+P+ GG K+ D +S GVL+ E++TG
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-14
Identities = 52/221 (23%), Positives = 84/221 (38%), Gaps = 56/221 (25%)
Query: 379 LGQGGFGPVYKGK-LANGQEIAVK--R---------------LSTTSGQGIEEFKNEVLL 420
+G+G FG V K Q +A+K R L Q + N + +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 421 IAKLQHRN---LV-KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESR---KQLLDWKKRF 473
+ RN + +LL L YE + F R +L
Sbjct: 165 LENFTFRNHICMTFELLSMNL--------YELIKKNKFQGFSLPLVRKFAHSILQ----- 211
Query: 474 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP--RISDFGTARVFGGEEISTN 531
+ LH + RIIH DLK NILL ++ ++ DFG++ + + + T
Sbjct: 212 --------CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVYT- 258
Query: 532 TNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+ + Y +PE LG + D++S G +L E++TG
Sbjct: 259 ---YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 54/220 (24%), Positives = 86/220 (39%), Gaps = 48/220 (21%)
Query: 377 NKLGQGGFGPVYKGK-LANGQEIAVK---RLSTTSGQGIEEFKNEVLLIAKLQHR----- 427
+ +G+G FG V K + +A+K Q + EV L+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115
Query: 428 -NLVKLLGC-------CL--EKDEKMLIYEFMPNKSLDYFIFDESR---KQLLDWKKRFD 474
+V L CL E L Y+ + N + + +R +Q+
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNL-YDLLRNTNFRGVSLNLTRKFAQQMCT------ 168
Query: 475 IILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP--RISDFGTARVFGGEEISTNT 532
+L+L L IIH DLK NILL +I DFG++ G+ I
Sbjct: 169 -------ALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIYQ-- 217
Query: 533 NRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+ + Y SPE LG + D++S G +L+E+ TG+
Sbjct: 218 --YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.5 bits (174), Expect = 2e-13
Identities = 29/201 (14%), Positives = 60/201 (29%), Gaps = 46/201 (22%)
Query: 367 LAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRL--------STTSGQGIEEFKNEV 418
T+ K+G+G FG V++ A+ +A+K + + + + EE E+
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 419 LLIAKLQ---------HRNLVKLLGCCL-------------------EKDEKMLIYEFMP 450
++ +L + L + F
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 451 NKSLDYFIF-------DESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASN 503
++ F ++ R +L I+ + + LR HRDL N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 504 ILLDEEMNPRISDFGTARVFG 524
+LL + ++ +
Sbjct: 193 VLLKKTSLKKLHYTLNGKSST 213
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 64/249 (25%), Positives = 107/249 (42%), Gaps = 74/249 (29%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKN---------EVL 419
+ KLG+G +G V+K G+ +AVK++ F+N E++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 420 LIAKLQ-HRNLVKLLGCCLEKDEK--MLIYEFMP--------NKSLD-----YFIFDESR 463
++ +L H N+V LL +++ L++++M L+ Y ++
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY---- 116
Query: 464 KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523
QL+ + + YLH S ++HRD+K SNILL+ E + +++DFG +R F
Sbjct: 117 -QLI-------------KVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159
Query: 524 GGEEISTNTNRV-------------------VGTYGYMSPEYALGGLFSTKS-DVFSFGV 563
TN + V T Y +PE LG TK D++S G
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGC 219
Query: 564 LLLEIITGK 572
+L EI+ GK
Sbjct: 220 ILGEILCGK 228
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 51/240 (21%), Positives = 77/240 (32%), Gaps = 74/240 (30%)
Query: 378 KLGQGGFGPVYKG--KLANGQEIAVK--R---------------LSTTSGQGIEEFKNEV 418
LG+G FG V + ++A+K R L + E V
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85
Query: 419 LLIAKLQHRN---LV-KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESR---KQLLDWKK 471
L+ + +LLG +EF+ + + R QL
Sbjct: 86 LMSDWFNFHGHMCIAFELLGKNT--------FEFLKENNFQPYPLPHVRHMAYQLC---- 133
Query: 472 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP------------------- 512
+ +LH ++ H DLK NIL
Sbjct: 134 ---------HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 513 RISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
R++DFG+A F E +T +V T Y PE L ++ DV+S G +L E G
Sbjct: 182 RVADFGSA-TFDHEHHTT----IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 55/240 (22%), Positives = 84/240 (35%), Gaps = 74/240 (30%)
Query: 378 KLGQGGFGPVYKGK--LANGQEIAVK--R---------------LSTTSGQGIEEFKNEV 418
LG+G FG V + A G+ +AVK + L + V
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 419 LLIAKLQHRN---LV-KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESR---KQLLDWKK 471
++ +H +V +LLG Y+F+ F D R Q+
Sbjct: 81 QMLEWFEHHGHICIVFELLGLST--------YDFIKENGFLPFRLDHIRKMAYQIC---- 128
Query: 472 RFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP------------------- 512
+ V +LH ++ H DLK NIL +
Sbjct: 129 ---------KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 513 RISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
++ DFG+A + E ST +V T Y +PE L +S DV+S G +L+E G
Sbjct: 177 KVVDFGSA-TYDDEHHST----LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 57/244 (23%), Positives = 95/244 (38%), Gaps = 78/244 (31%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVK--RLSTTSGQGIEEFKN----EVLLIAKLQHR--- 427
K+G G FG V + + N + AVK R I+++ E ++ K+Q+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILKKIQNDDIN 94
Query: 428 --NLVKLLGC-------CL--EKDEKMLIYEFMPNKSLDYFIFDESR---KQLLDWKKRF 473
N+VK G CL E L YE + + + F ++ + ++L
Sbjct: 95 NNNIVKYHGKFMYYDHMCLIFEPLGPSL-YEIITRNNYNGFHIEDIKLYCIEIL------ 147
Query: 474 DIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP--------------------- 512
+ + YL ++ + H DLK NILLD+
Sbjct: 148 -------KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 513 ----RISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEI 568
++ DFG A F + + ++ T Y +PE L + SD++SFG +L E+
Sbjct: 198 STGIKLIDFGCA-TFKSDYHGS----IINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252
Query: 569 ITGK 572
TG
Sbjct: 253 YTGS 256
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 32/219 (14%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQH-RN 428
+ + K+G G FG +Y G +A G+E+A+K + E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDW-KKRFDI--ILGIARGVL- 484
+ + C E D +++ E + SL+ L ++ ++F + +L +A ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE---------DLFNFCSRKFSLKTVLLLADQMIS 116
Query: 485 ---YLHQDSRLRIIHRDLKASNILLDEEMNP---RISDFGTARVF----GGEEISTNTNR 534
Y+H + IHRD+K N L+ I DFG A+ + + I N+
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173
Query: 535 -VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+ GT Y S LG S + D+ S G +L+ G
Sbjct: 174 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 51/228 (22%), Positives = 90/228 (39%), Gaps = 44/228 (19%)
Query: 378 KLGQGGFGPVYKG------KLANGQEIAVKRLSTTSGQGIEEFK-----NEVLLIAKLQH 426
+GQGGFG +Y + + VK + +G E K + I K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 427 RNLVKLLG-----CCLEKDEKMLIYEFMPNKSLDYFIFD---ESRKQLLDW-KKRFDI-- 475
+K LG D+ Y FM I D +++ + KRF
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFM--------IMDRFGSDLQKIYEANAKRFSRKT 153
Query: 476 ILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEEMNPRI--SDFGTARVF----GG 525
+L ++ +L Y+H+ +H D+KASN+LL+ + ++ D+G A +
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 526 EEISTNTNRV-VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+ + + R GT + S + G S + D+ G +++ +TG
Sbjct: 211 KAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 49/219 (22%), Positives = 92/219 (42%), Gaps = 32/219 (14%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
+ F K+G G FG +Y G + +E+A+K + + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64
Query: 430 V-KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDW-KKRFDI--ILGIARGVL- 484
+ + +E D +L+ + + SL+ L ++ ++ + +L +A ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLE---------DLFNFCSRKLSLKTVLMLADQMIN 114
Query: 485 ---YLHQDSRLRIIHRDLKASNILLDEEMNPR---ISDFGTARVF----GGEEISTNTNR 534
++H S +HRD+K N L+ I DFG A+ + + I N+
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
Query: 535 -VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+ GT Y S LG S + D+ S G +L+ + G
Sbjct: 172 NLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 45/223 (20%), Positives = 87/223 (39%), Gaps = 37/223 (16%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCC 436
K+G GGFG +Y ++ A + +E +N L ++ + K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK------VEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 437 LEKDEKMLIYEFMPN---------KSLDY--FIFD---ESRKQLLDWKKRFDI--ILGIA 480
+ K L Y +P K Y + + +++ F +L +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157
Query: 481 RGVL----YLHQDSRLRIIHRDLKASNILLDEEMNPRI--SDFGTARVF----GGEEIST 530
+L Y+H++ +H D+KA+N+LL + ++ +D+G + + ++
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214
Query: 531 NTNRV-VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
N + GT + S + G S +SDV G +L + GK
Sbjct: 215 NPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 47/219 (21%), Positives = 83/219 (37%), Gaps = 32/219 (14%)
Query: 372 NFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
NF K+G G FG + GK L + +A+K S + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDW-KKRFDI--ILGIARGVL--- 484
++ ++ E + SL+ L D + F + +L IA ++
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLE---------DLFDLCDRTFSLKTVLMIAIQLISRM 118
Query: 485 -YLHQDSRLRIIHRDLKASNILLDEEMNPR-----ISDFGTARVF----GGEEISTNTNR 534
Y+H + +I+RD+K N L+ N I DF A+ + + I ++
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 535 -VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+ GT YMS LG S + D+ + G + + + G
Sbjct: 176 SLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 43/220 (19%), Positives = 89/220 (40%), Gaps = 32/220 (14%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
++ ++G+G FG +++G L N Q++A+K S + + +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA-GCTGI 68
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDW-KKRFDI--ILGIARGVL-- 484
+ E +L+ + + SL+ LLD ++F + + A+ +L
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLG-PSLE---------DLLDLCGRKFSVKTVAMAAKQMLAR 118
Query: 485 --YLHQDSRLRIIHRDLKASNILLDEEMNPR-----ISDFGTARVF----GGEEISTNTN 533
+H+ S +++RD+K N L+ + + DFG + + + I
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 534 R-VVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+ + GT YMS LG S + D+ + G + + + G
Sbjct: 176 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 53/268 (19%), Positives = 92/268 (34%), Gaps = 94/268 (35%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCC 436
KLG G F V+ + + +A+K + ++ E +E+ +LL
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEI------------RLLKSV 90
Query: 437 LEKDEKMLIYEFMPNKSLDYF------------IFDESRKQLLDWKKRFD---------- 474
D E + + LD F +F+ LL W + +
Sbjct: 91 RNSDPNDPNREMVV-QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 475 -IILGIARGVLYLHQDSRLRIIHRDLKASNILL--------------------------- 506
II + +G+ YLH ++ RIIH D+K NILL
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 507 ----------------------DEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
E++ +I+D G A + + + + T Y S
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC-WVHKHFTE----DIQTRQYRSL 262
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITGK 572
E +G ++T +D++S + E+ TG
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 42/233 (18%), Positives = 84/233 (36%), Gaps = 42/233 (18%)
Query: 372 NFSTSNKLGQGGFGPVYKGK---------LANGQEIAVKRLSTTSGQGIEEFKNEVLLIA 422
+ + + G +Y+ Q+ ++K L G+ E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101
Query: 423 KLQHRNLVKLLGC------------CLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWK 470
LQ KL + + L+ + +SL D S K +L +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSER 159
Query: 471 KRFDIILGIARGVL----YLHQDSRLRIIHRDLKASNILLDEEMNPRI--SDFGTARVF- 523
+L +A +L +LH++ +H ++ A NI +D E ++ + +G A +
Sbjct: 160 ----SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 524 -GGEEISTNTNRV---VGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
G+ ++ G ++S + G S +SD+ S G +L+ + G
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 3e-08
Identities = 73/488 (14%), Positives = 137/488 (28%), Gaps = 129/488 (26%)
Query: 248 DLNDTRTYTNAGQDLFVRADAAELAAEAQKNSKSNRARKRRLALI-------IVAIVLGV 300
D D + + + + + + SK + RL +V +
Sbjct: 34 DCKDVQDMP---KSILSKEEIDHII-----MSKDAVSGTLRLFWTLLSKQEEMVQKFVEE 85
Query: 301 LLLGLCYFFLWRRLDTRIGERQRQRRRELLFLNSSTRLSDREASTSAKRNKDTGNVDVTF 360
+L + Y FL + T +RQ + ++ RL + AK N V+
Sbjct: 86 VL-RINYKFLMSPIKTE--QRQPSMMTRM-YIEQRDRLY-NDNQVFAKYN-------VSR 133
Query: 361 FELSTVL-AATDNFSTSNKL---GQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEE-FK 415
+ L A + + G G G K +A L ++
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWVA---------LDVCLSYKVQCKMD 181
Query: 416 NEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDI 475
++ + L C + + + + L + D + D +
Sbjct: 182 FKIFWLN----------LKNCNSPETVLEMLQ-----KL-LYQIDPNWTSRSDHSSNIKL 225
Query: 476 ILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRIS---DFG-----TARVFGGEE 527
+ + L RL + + + ++L N + + T R
Sbjct: 226 RIHSIQAEL-----RRL-LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRF----- 274
Query: 528 ISTNTNRVVG-TYGYMSPEYALGGLFSTKS-DVFS--FGV--------------LLLEII 569
T+ + T ++S ++ L + + L II
Sbjct: 275 -KQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII 333
Query: 570 TGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPA------------PEALR 617
D W+ + DK I++SS+ PA P +
Sbjct: 334 ------AESIRDGLATWDN-WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH 386
Query: 618 CIQVGLLCV--QDRTTDRPSMSTVVFMLSNETSVP-SPKQPTFSVRKIEIDTDYSSTGTK 674
I LL + D + VV L + V PK+ T S+ I ++
Sbjct: 387 -IPTILLSLIWFDVIKSDVMV--VVNKLHKYSLVEKQPKESTISIPSIYLEL------KV 437
Query: 675 SSANEVTL 682
NE L
Sbjct: 438 KLENEYAL 445
|
| >1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4 Length = 105 | Back alignment and structure |
|---|
Score = 40.5 bits (94), Expect = 2e-04
Identities = 13/55 (23%), Positives = 21/55 (38%), Gaps = 5/55 (9%)
Query: 125 APKEQCDYYGHCGPNSNCSPYHADEFECTCLPGFEPK----YPKEWSLRDGSGGC 175
+ +C + N+ C Y E CL GF+ P + + +GGC
Sbjct: 8 SSAHKCID-TNVPENAACYRYLDGTEEWRCLLGFKEVGGKCVPASITCEENNGGC 61
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 688 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-72 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-69 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-68 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-63 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-62 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-62 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-60 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-24 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 3e-72
Identities = 72/286 (25%), Positives = 140/286 (48%), Gaps = 24/286 (8%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
+ ++G G FG VYKGK + + ++ + Q ++ FKNEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
+G + ++ ++ SL + + K + K DI A+G+ YLH S
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG- 549
IIHRDLK++NI L E++ +I DFG A V S ++ G+ +M+PE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 550 --GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSN--LIRYVWELWSDDKALEIVDSS 605
+S +SDV++FG++L E++TG+ +++ ++ +I V + ++ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKVRSN- 237
Query: 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN-ETSVP 650
P+A++ ++ C++ + +RP ++ + S+P
Sbjct: 238 ------CPKAMK--RLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 4e-69
Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 21/274 (7%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
+ ++G G FG V+ G N ++A+K + E+F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
+L G CLE+ L++EFM + L ++ +++ L + + L + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG 550
+IHRDL A N L+ E ++SDFG R ++ T++ + SPE
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 177
Query: 551 LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSC 610
+S+KSDV+SFGVL+ E+ + K +E S+ + +E + +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK--------------IPYENRSNSEVVEDISTGFRLYK 223
Query: 611 PAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644
P + Q+ C ++R DRP+ S ++ L+
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 3e-68
Identities = 77/275 (28%), Positives = 130/275 (47%), Gaps = 21/275 (7%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
+ +LG G FG V+ G ++AVK L S + F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
+L ++ +I E+M N SL F+ S +L K D+ IA G+ ++ + +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG 550
IHRDL+A+NIL+ + ++ +I+DFG AR+ E + + +PE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 551 LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSC 610
F+ KSDV+SFG+LL EI+T R + ++ + ++ ++
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHG--------------RIPYPGMTNPEVIQNLERGYRMVR 231
Query: 611 PAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
P Q+ LC ++R DRP+ + +L +
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 2e-67
Identities = 79/286 (27%), Positives = 129/286 (45%), Gaps = 22/286 (7%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
++ KLGQG FG V+ G +A+K L + E F E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
+L ++ ++ E+M SL F+ E+ K L + D+ IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER-- 131
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG 550
+ +HRDL+A+NIL+ E + +++DFG AR+ E + + +PE AL G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 551 LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSC 610
F+ KSDV+SFG+LL E+ T R + + + L+ V+ C
Sbjct: 190 RFTIKSDVWSFGILLTELTTKG--------------RVPYPGMVNREVLDQVERGYRMPC 235
Query: 611 PAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE-TSVPSPKQP 655
P + C + +RP+ + L + TS QP
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 3e-67
Identities = 65/291 (22%), Positives = 122/291 (41%), Gaps = 29/291 (9%)
Query: 378 KLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCL 437
+G+G FG V++GK G+E+AVK S+ + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 438 EKDEK----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD---- 489
+ + L+ ++ + SL ++ + + + + L A G+ +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 490 -SRLRIIHRDLKASNILLDEEMNPRISDFGTARVF--GGEEISTNTNRVVGTYGYMSPEY 546
+ I HRDLK+ NIL+ + I+D G A + I N VGT YM+PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 547 ALGGL------FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALE 600
+ ++D+++ G++ EI GI D V S ++ +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 601 IV-----DSSMADSCPAPEALRCI-QVGLLCVQDRTTDRPSMSTVVFMLSN 645
+V ++ + + EALR + ++ C R + + LS
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 8e-67
Identities = 60/275 (21%), Positives = 125/275 (45%), Gaps = 21/275 (7%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
+ + +LG G FG V GK ++A+K + S +EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
+L G C ++ +I E+M N L ++ + + ++ ++ + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGG 550
+ +HRDL A N L++++ ++SDFG +R +E +++ + PE +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYS 176
Query: 551 LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSC 610
FS+KSD+++FGVL+ EI + + +E +++ + E + +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLG--------------KMPYERFTNSETAEHIAQGLRLYR 222
Query: 611 PAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
P + + + C ++ +RP+ ++ + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 214 bits (547), Expect = 4e-65
Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
+ + +KLG G +G VY+G +AVK L + + +EEF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
V+LLG C + +I EFM +L ++ E +Q + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE-- 132
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG 549
+ IHRDL A N L+ E +++DFG +R+ G+ + + + +PE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190
Query: 550 GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609
FS KSDV++FGVLL EI T + + + E+++
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS--------------PYPGIDLSQVYELLEKDYRME 236
Query: 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
P + ++ C Q +DRPS + +
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 4e-65
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 369 ATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGI-EEFKNEVLLIAKLQH 426
D+F ++LG G G V+K +G +A K + I + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
+V G E + E M SLD + R + + + + + +G+ YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
+ +I+HRD+K SNIL++ ++ DFG + I + N VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 547 ALGGLFSTKSDVFSFGVLLLEIITGK 572
G +S +SD++S G+ L+E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 212 bits (540), Expect = 6e-64
Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 45/301 (14%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLAN------GQEIAVKRLS-TTSGQGIEEFKNEVLLIAK 423
+N +G+G FG V++ + +AVK L S +F+ E L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQL----------------- 466
+ N+VKLLG C L++E+M L+ F+ S +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 467 ----LDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522
L ++ I +A G+ YL + + +HRDL N L+ E M +I+DFG +R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 523 FGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDS 582
+ +M PE ++T+SDV+++GV+L EI +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP------- 242
Query: 583 SNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642
+ + ++ + V +CP L + LC DRPS ++ +
Sbjct: 243 -------YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 643 L 643
L
Sbjct: 296 L 296
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 1e-63
Identities = 69/276 (25%), Positives = 112/276 (40%), Gaps = 27/276 (9%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLV 430
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 431 KLLGCCLEKDEKM-LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
+LLG +E+ + ++ E+M SL ++ R +L L + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 490 SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG 549
+HRDL A N+L+ E+ ++SDFG + E S+ + + +PE
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174
Query: 550 GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609
FSTKSDV+SFG+LL EI + R + + V+
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFG--------------RVPYPRIPLKDVVPRVEKGYKMD 220
Query: 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
P +V C RPS + L +
Sbjct: 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-63
Identities = 62/281 (22%), Positives = 120/281 (42%), Gaps = 26/281 (9%)
Query: 369 ATDNFSTSN-KLGQGGFGPVYKGKLA---NGQEIAVKRLSTTSGQG-IEEFKNEVLLIAK 423
DN ++ +LG G FG V +G ++A+K L + + EE E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 483
L + +V+L+G C + + ML+ E L F+ +++ + +++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI-STNTNRVVGTYGYM 542
YL + +HRDL A N+LL +ISDFG ++ G ++ T + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602
+PE FS++SDV+S+GV + E ++ + ++ + + +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYG--------------QKPYKKMKGPEVMAFI 225
Query: 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643
+ CP + C + DRP TV +
Sbjct: 226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (532), Expect = 8e-63
Identities = 70/310 (22%), Positives = 125/310 (40%), Gaps = 39/310 (12%)
Query: 359 TFFELSTVLAATDNFSTS---------NKLGQGGFGPVYKGKLA----NGQEIAVKRL-S 404
TF + + A F+ +G G FG V G L +A+K L S
Sbjct: 8 TFEDPN---EAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS 64
Query: 405 TTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRK 464
+ + +F +E ++ + H N++ L G + M+I EFM N SLD F+ +
Sbjct: 65 GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ 124
Query: 465 QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524
+ ++ GIA G+ YL + +HRDL A NIL++ + ++SDFG +R
Sbjct: 125 F--TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 525 GEEISTNTNRVVG---TYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDD 581
+ +G + +PE F++ SDV+S+G+++ E+++ +
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-------- 231
Query: 582 SSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641
+ ++ + ++ P Q+ L C Q RP +V
Sbjct: 232 ------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 642 MLSNETSVPS 651
L P+
Sbjct: 286 TLDKMIRNPN 295
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-62
Identities = 65/304 (21%), Positives = 111/304 (36%), Gaps = 39/304 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTSGQG-IEEFKNEVLLIAK 423
+ S LG G FG V + +AVK L ++ E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 424 L-QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFD---------------ESRKQLL 467
L H N+V LLG C ++I E+ L F+ E + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 468 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527
D + +A+G+ +L IHRDL A NILL +I DFG AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIR 587
+M+PE +++ +SDV+S+G+ L E+ + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 588 YVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647
+ D K +++ P + C RP+ +V ++ +
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
Query: 648 SVPS 651
S +
Sbjct: 307 SEST 310
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 3e-62
Identities = 72/327 (22%), Positives = 138/327 (42%), Gaps = 27/327 (8%)
Query: 366 VLAATDNFSTSNKLGQGGFGPVYKGK-LANGQE----IAVKRLS-TTSGQGIEEFKNEVL 419
+L T+ F LG G FG VYKG + G++ +A+K L TS + +E +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 420 LIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 479
++A + + ++ +LLG CL LI + MP L ++ + + + + I
Sbjct: 64 VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQI 120
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
A+G+ YL R++HRDL A N+L+ + +I+DFG A++ G EE +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL 599
+M+ E L +++ +SDV+S+GV + E++T ++ +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFG--------------SKPYDGIPASEIS 223
Query: 600 EIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSPKQPTFSV 659
I++ P + + + C RP ++ S P
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGD 283
Query: 660 RKIEIDTDYSSTGTKSSANEVTLTTFI 686
++ + + S ++ +E + +
Sbjct: 284 ERMHLPSPTDSNFYRALMDEEDMDDVV 310
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-61
Identities = 66/304 (21%), Positives = 111/304 (36%), Gaps = 44/304 (14%)
Query: 371 DNFSTSNKLGQGGFGPVYKG------KLANGQEIAVKRLSTTSGQG-IEEFKNEVLLIAK 423
+N LG G FG V K ++AVK L + E +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 424 L-QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRK------------------ 464
L H N+V LLG C LI+E+ L ++ + K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 465 --QLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522
+L ++ +A+G+ +L +HRDL A N+L+ +I DFG AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 523 FGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDS 582
+ +M+PE G+++ KSDV+S+G+LL EI + N +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN--PYPGIP 271
Query: 583 SNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642
D +++ + P + C + RPS +
Sbjct: 272 -----------VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 643 LSNE 646
L +
Sbjct: 321 LGCQ 324
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-61
Identities = 64/275 (23%), Positives = 112/275 (40%), Gaps = 27/275 (9%)
Query: 377 NKLGQGGFGPVYKGKLAN---GQEIAVKRLSTTSGQG--IEEFKNEVLLIAKLQHRNLVK 431
+LG G FG V KG + +AVK L + +E E ++ +L + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 432 LLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSR 491
++G C E + ML+ E L+ ++ + K +++ ++ G+ YL +
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES-- 126
Query: 492 LRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE-EISTNTNRVVGTYGYMSPEYALGG 550
+HRDL A N+LL + +ISDFG ++ + + +PE
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 551 LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADSC 610
FS+KSDV+SFGVL+ E + + + + +++ C
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYG--------------QKPYRGMKGSEVTAMLEKGERMGC 231
Query: 611 PAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
PA + LC +RP + V L N
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-60
Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 29/281 (10%)
Query: 372 NFSTSNKLGQGGFGPVYKGKLAN----GQEIAVKRLSTTSGQG-IEEFKNEVLLIAKLQH 426
+F+ +G+G FG VY G L + AVK L+ + G + +F E +++ H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 427 RNLVKLLGCCLEKDEK-MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
N++ LLG CL + +++ +M + L FI +E+ + F + +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR--VVGTYGYMS 543
+ + + +HRDL A N +LDE+ +++DFG AR +E + N+ +M+
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 544 PEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603
E F+TKSDV+SFGVLL E++T N L + L+
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGRRLLQ--- 255
Query: 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644
+ CP P +V L C + RPS S +V +S
Sbjct: 256 ---PEYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-60
Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 26/288 (9%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQE-----IAVKRLSTTSGQG-IEEFKNEVLLIAKL 424
+ +G G FG VYKG L +A+K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 425 QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVL 484
H N+++L G + M+I E+M N +LD F+ + + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 485 YLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT-NRVVGTYGYMS 543
YL + +HRDL A NIL++ + ++SDFG +RV + +T T + + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 544 PEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603
PE F++ SDV+SFG+++ E++T + R WE S+ + ++ ++
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE-------------RPYWE-LSNHEVMKAIN 227
Query: 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPS 651
P Q+ + C Q RP + +V +L P
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (516), Expect = 2e-60
Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 33/278 (11%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQG---IEEFKNEVLLIAKLQ 425
FS ++G G FG VY + + N + +A+K++S + Q ++ EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
H N ++ GC L + L+ E+ + D K+ L + + G +G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE 545
LH +IHRD+KA NILL E ++ DFG+A + N VGT +M+PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 546 YALG---GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602
L G + K DV+S G+ +E+ K +FN ++ + + ++ +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSALYHI---------AQNE 230
Query: 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV 640
++ + + C+Q DRP+ ++
Sbjct: 231 SPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLL 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-59
Identities = 73/302 (24%), Positives = 126/302 (41%), Gaps = 32/302 (10%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL------ANGQEIAVKRLS-TTSGQGIEEFKNEVLLIAK 423
+ + S +LGQG FG VY+G +A+K ++ S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIF-------DESRKQLLDWKKRFDII 476
++V+LLG + ++I E M L ++ + K +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 477 LGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVV 536
IA G+ YL+ + + +HRDL A N ++ E+ +I DFG R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD 596
+MSPE G+F+T SDV+SFGV+L EI T ++ S++
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA--------------EQPYQGLSNE 242
Query: 597 KALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSPKQPT 656
+ L V P ++ +C Q RPS ++ + E P ++ +
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME-PGFREVS 301
Query: 657 FS 658
F
Sbjct: 302 FY 303
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-59
Identities = 73/311 (23%), Positives = 130/311 (41%), Gaps = 43/311 (13%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANG---QEIAVKRLS-TTSGQGIEEFKNEVLLIAKL-Q 425
++ + +G+G FG V K ++ + A+KR+ S +F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFI-------------FDESRKQLLDWKKR 472
H N++ LLG C + L E+ P+ +L F+ S L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 473 FDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT 532
+ARG+ YL Q + IHRDL A NIL+ E +I+DFG +R G+E+
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 533 NRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWEL 592
+M+ E +++T SDV+S+GVLL EI++ +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--------------YCG 229
Query: 593 WSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN-----ET 647
+ + E + P + C +++ +RPS + ++ L+ +T
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
Query: 648 SVPSPKQPTFS 658
V + F+
Sbjct: 290 YVNTTLYEKFT 300
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 3e-59
Identities = 58/278 (20%), Positives = 117/278 (42%), Gaps = 25/278 (8%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRL--STTSGQGIEEFKNEVLLIAKLQHR 427
+++ +G G +G K + ++G+ + K L + + + +EV L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 428 NLVKLLGCCLEKDEKML--IYEFMPNKSLDYFIFDESR-KQLLDWKKRFDIILGIARGVL 484
N+V+ +++ L + E+ L I ++ +Q LD + ++ + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 485 YLHQ--DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
H+ D ++HRDLK +N+ LD + N ++ DFG AR+ + VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYM 181
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602
SPE ++ KSD++S G LL E+ + +S + +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCAL---------------MPPFTAFSQKELAGKI 226
Query: 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV 640
P + ++ + + RPS+ ++
Sbjct: 227 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-58
Identities = 63/272 (23%), Positives = 106/272 (38%), Gaps = 22/272 (8%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGI-EEFKNEVLLIAKLQHRN 428
+++ LG+G +G V + +AVK + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
+VK G E + + L E+ L I + + GV+YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL 548
+ I HRD+K N+LLDE N +ISDFG A VF N++ GT Y++PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 549 GGLFST-KSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607
F DV+S G++L ++ G+ +D + + + +I
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI------ 232
Query: 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTV 639
L + + + + R ++ +
Sbjct: 233 ----DSAPLALLH---KILVENPSARITIPDI 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-58
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN 428
D + +LG G FG VYK + A K + T S + +E++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
+VKLL ++ ++ EF ++D + + ++ L + + + YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL 548
+IIHRDLKA NIL + + +++DFG + ++ +GT +M+PE +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 549 G-----GLFSTKSDVFSFGVLLLEIITGK 572
+ K+DV+S G+ L+E+ +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-57
Identities = 76/287 (26%), Positives = 113/287 (39%), Gaps = 27/287 (9%)
Query: 365 TVLAATDNFSTSNKLGQGGFGPVYKGKL----ANGQEIAVKRLS---TTSGQGIEEFKNE 417
T L + KLG G FG V +G+ +AVK L + + +++F E
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 418 VLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIIL 477
V + L HRNL++L G L KM + E P SL + LL R +
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR--YAV 118
Query: 478 GIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG-GEEISTNTNRVV 536
+A G+ YL R IHRDL A N+LL +I DFG R ++
Sbjct: 119 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 537 GTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD 596
+ + +PE FS SD + FGV L E+ T G N + + ++ +
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY----GQEPWIGLNGSQILHKIDKEG 231
Query: 597 KALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFML 643
+ L + CP V + C + DRP+ + L
Sbjct: 232 ERLPRP-----EDCPQ----DIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-57
Identities = 63/272 (23%), Positives = 117/272 (43%), Gaps = 30/272 (11%)
Query: 377 NKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLL 433
++G+G F VYKG E+A L + + FK E ++ LQH N+V+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 434 GCCLE----KDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
K +L+ E M + +L ++ R +++ K I +G+ +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 490 SRLRIIHRDLKASNILL-DEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL 548
+ IIHRDLK NI + + +I D G A + + V+GT +M+PE
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYE 186
Query: 549 GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608
+ DV++FG+ +LE+ T + +++ + +++ + V + D
Sbjct: 187 EK-YDESVDVYAFGMCMLEMATSEYP---YSEC-----QNAAQIY--RRVTSGVKPASFD 235
Query: 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV 640
PE I+ C++ +R S+ ++
Sbjct: 236 KVAIPEVKEIIE---GCIRQNKDERYSIKDLL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 5e-57
Identities = 67/282 (23%), Positives = 118/282 (41%), Gaps = 33/282 (11%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLS---TTSGQGIEEFKNEVLLIAKLQH 426
++F LG+G FG VY + + +A+K L + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
N+++L G + LI E+ P ++ + S+ D ++ I +A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
H R+IHRD+K N+LL +I+DFG + S+ + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 175
Query: 547 ALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606
G + K D++S GVL E + GK F ++ K + V+ +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP---PFEANTYQETY---------KRISRVEFTF 223
Query: 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV---FMLSN 645
D A I ++ + RP + V+ ++ +N
Sbjct: 224 PDFVT-EGARDLIS---RLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-55
Identities = 67/290 (23%), Positives = 129/290 (44%), Gaps = 31/290 (10%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRN 428
++ K+GQG G VY +A GQE+A+++++ E NE+L++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
+V L L DE ++ E++ SL + + D + + + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL 548
++IHRD+K+ NILL + + +++DFG E+ +T +VGT +M+PE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 549 GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608
+ K D++S G++ +E+I G + + +AL ++ ++
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEG---------------EPPYLNENPLRALYLIATNGTP 234
Query: 609 SCPAPEALRCIQVGLL--CVQDRTTDRPSMSTVV----FMLSNETSVPSP 652
PE L I L C+ R S ++ ++ S +P
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 4e-55
Identities = 74/297 (24%), Positives = 116/297 (39%), Gaps = 38/297 (12%)
Query: 371 DNFSTSNKLGQGGFGPVYKG------KLANGQEIAVKRLSTTSGQG-IEEFKNEV-LLIA 422
D LG+G FG V + K A + +AVK L + +E+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 423 KLQHRNLVKLLGCCLEKDEK-MLIYEFMPNKSLDYFIF-------------DESRKQLLD 468
H N+V LLG C + M+I EF +L ++ ++ K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 469 WKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528
+ +A+G+ +L + IHRDL A NILL E+ +I DFG AR +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 529 STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRY 588
+M+PE +++ +SDV+SFGVLL EI + + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS----PYPGVKIDEE 245
Query: 589 VWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
+ + D + + Q L C + RP+ S +V L N
Sbjct: 246 FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-52
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 10/206 (4%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLS---TTSGQGIEEFKNEVLLIAKLQH 426
++F LG+G F V + LA +E A+K L + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
VKL + ++ + N L +I D I + YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
H IIHRDLK NILL+E+M+ +I+DFGTA+V E N VGT Y+SPE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 547 ALGGLFSTKSDVFSFGVLLLEIITGK 572
SD+++ G ++ +++ G
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-52
Identities = 67/298 (22%), Positives = 117/298 (39%), Gaps = 40/298 (13%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL--------ANGQEIAVKRL-STTSGQGIEEFKNEVLLI 421
D LG+G FG V + ++AVK L S + + + + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 422 AKL-QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQL-------------L 467
+ +H+N++ LLG C + +I E+ +L ++ L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 468 DWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527
K +ARG+ YL + IHRDL A N+L+ E+ +I+DFG AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIR 587
T +M+PE +++ +SDV+SFGVLL EI T
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG--------------G 235
Query: 588 YVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
+ ++ +++ P+ + C + RP+ +V L
Sbjct: 236 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 5e-52
Identities = 55/280 (19%), Positives = 107/280 (38%), Gaps = 26/280 (9%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLAN----GQEIAVKRLSTTSGQGI-EEFKNEVLLIAKLQ 425
+ +G+G FG V++G + +A+K + + E+F E L + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
H ++VKL+G E + +I E L F+ LD ++ + Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE 545
L R +HRD+ A N+L+ ++ DFG +R + + ++ +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPE 179
Query: 546 YALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605
F++ SDV+ FGV + EI+ ++ ++ + +++
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKP--------------FQGVKNNDVIGRIENG 225
Query: 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
P + C + RP + + LS
Sbjct: 226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 180 bits (457), Expect = 2e-51
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
D++ +LG G FG V++ A G A K + T E + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
V L + +E ++IYEFM L + DE K + + + + + +G+ ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 490 SRLRIIHRDLKASNILLDEEMNPRI--SDFGTARVFGGEEISTNTNRVVGTYGYMSPEYA 547
+H DLK NI+ + + + DFG + + GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVA 197
Query: 548 LGGLFSTKSDVFSFGVLLLEIITGK 572
G +D++S GVL +++G
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (446), Expect = 6e-50
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 11/205 (5%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
D + +LG G FG V++ A G+ K ++T KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
+ L +K E +LI EF+ L I + + + + + G+ ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 490 SRLRIIHRDLKASNILLDEEMNPRI--SDFGTARVFGGEEISTNTNRVVGTYGYMSPEYA 547
I+H D+K NI+ + + + DFG A +EI T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 548 LGGLFSTKSDVFSFGVLLLEIITGK 572
+D+++ GVL +++G
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (428), Expect = 2e-47
Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 21/235 (8%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLS---TTSGQGIEEFKNEVLLIAKLQ- 425
++FS +G+GGFG VY + G+ A+K L QG NE ++++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 426 --HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 483
+V + D+ I + M L Y + S+ + I G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMS 543
++H +++RDLK +NILLDE + RISD G A F + VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 544 PEYALGGL-FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK 597
PE G+ + + +D FS G +L +++ G F + + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEIDRMTLTMA 225
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-47
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 7/212 (3%)
Query: 365 TVLAATDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQG-IEEFKNEVLLIA 422
V ++ + +G+G +G V N +A+K++S Q + E+ ++
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 423 KLQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARG 482
+ +H N++ + + + ++ + ++ + Q L + I RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 483 VLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNT-NRVVGTYGY 541
+ Y+H ++HRDLK SN+LL+ + +I DFG ARV + T V T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 542 MSPEYALGGLFSTKS-DVFSFGVLLLEIITGK 572
+PE L TKS D++S G +L E+++ +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (420), Expect = 4e-47
Identities = 62/275 (22%), Positives = 111/275 (40%), Gaps = 27/275 (9%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQG---IEEFKNEVLLIAKLQ 425
+D + LG GG V+ + L +++AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 426 HRNLVKLLGCCLEKDEK----MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 481
H +V + + ++ E++ +L + E + K+ ++I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG-GEEISTNTNRVVGTYG 540
+ + H + IIHRD+K +NI++ ++ DFG AR T T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALE 600
Y+SPE A G +SDV+S G +L E++TG+ F DS + + +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSV-----AYQHVREDP 231
Query: 601 IVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPS 635
I S+ + + + + +R
Sbjct: 232 IPPSARHEGLS-ADLDAVVL---KALAKNPENRYQ 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 166 bits (421), Expect = 8e-47
Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 18/216 (8%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLS---TTSGQGIEEFKNEVLLIAKLQH 426
+F LG G FG V+ + NG+ A+K L + +E +E L+++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
++++ G + + +I +++ L + R K + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
II+RDLK NILLD+ + +I+DFG A+ + T + GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172
Query: 547 ALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDS 582
++ D +SFG+L+ E++ G F D +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT---PFYDSN 205
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-45
Identities = 43/205 (20%), Positives = 89/205 (43%), Gaps = 12/205 (5%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
+ + + LG+G FG V++ ++ + K + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNI 63
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
+ L +E ++I+EF+ + I + L+ ++ + + + +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 490 SRLRIIHRDLKASNILLDEEMNPR--ISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYA 547
I H D++ NI+ + I +FG AR + N + Y +PE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVH 175
Query: 548 LGGLFSTKSDVFSFGVLLLEIITGK 572
+ ST +D++S G L+ +++G
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGI 200
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 4e-45
Identities = 65/297 (21%), Positives = 120/297 (40%), Gaps = 30/297 (10%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEE-FKNEVLLIAKLQHR 427
D + + LG G F V + + +A+K ++ + +G E +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 487
N+V L LI + + L I K + +I + V YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 488 QDSRLRIIHRDLKASNILL---DEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSP 544
I+HRDLK N+L DE+ ISDFG +++ + + GT GY++P
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPGYVAP 178
Query: 545 EYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDS 604
E +S D +S GV+ ++ G ++++ + L + KA DS
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGY--PPFYDENDAKLFEQIL------KAEYEFDS 230
Query: 605 SMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV---FMLSNETSVPSPKQPTFS 658
D A I+ ++ R + + + ++ +T++ + S
Sbjct: 231 PYWDDIS-DSAKDFIR---HLMEKDPEKRFTCEQALQHPW-IAGDTALDKNIHQSVS 282
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 7e-45
Identities = 59/284 (20%), Positives = 103/284 (36%), Gaps = 24/284 (8%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
+ + K+G G FG +Y G +A G+E+A+K + + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
+ + C + + ++ + SL+ SRK K + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120
Query: 490 SRLRIIHRDLKASNIL---LDEEMNPRISDFGTARVFGGEEISTN-----TNRVVGTYGY 541
IHRD+K N L + I DFG A+ + + + GT Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601
S LG S + D+ S G +L+ G + + R +E S+ K +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP---WQGLKAATKRQKYERISEKK-MST 235
Query: 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
+ P E + C R D+P S + + N
Sbjct: 236 PIEVLCKGYP-SEFATYLN---FCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (398), Expect = 4e-44
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGI---------EEFKNEVLL 420
+N+ LG+G V + +E AVK + T G E EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 421 IAKLQ-HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 479
+ K+ H N+++L L+++ M L ++ + K L K+ I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTY 539
+ LH +L I+HRDLK NILLD++MN +++DFG + E V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTP 173
Query: 540 GYMSPEYALGGL------FSTKSDVFSFGVLLLEIITGK 572
Y++PE + + + D++S GV++ ++ G
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-44
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLS---TTSGQGIEEFKNEV-LLIAKLQ 425
++F LG+G FG V+ + Q A+K L +E E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 426 HRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
H L + K+ + E++ L Y I D + I G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE 545
LH I++RDLK NILLD++ + +I+DFG + + TN GT Y++PE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPE 173
Query: 546 YALGGLFSTKSDVFSFGVLLLEIITGK 572
LG ++ D +SFGVLL E++ G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVK--RLSTTSGQGIEEFKNEVLLIAKLQHR 427
+NF K+G+G +G VYK + G+ +A+K RL T + E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 487
N+VKLL +++ L++EF+ + D S + + + +G+ + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 488 QDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYA 547
R++HRDLK N+L++ E +++DFG AR F G + T T+ VV +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILL 175
Query: 548 LGGLFSTKSDVFSFGVLLLEIITGK 572
+ST D++S G + E++T +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 377 NKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEE-----FKNEVLLIAKLQHRNLV 430
+ LG+G F VYK + Q +A+K++ ++ E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 431 KLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS 490
LL K L+++FM +L +L +G+ YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALG- 549
I+HRDLK +N+LLDE +++DFG A+ FG V T Y +PE G
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGA 175
Query: 550 GLFSTKSDVFSFGVLLLEIITGK 572
++ D+++ G +L E++
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 63/292 (21%), Positives = 115/292 (39%), Gaps = 27/292 (9%)
Query: 369 ATDNFSTSNKLGQGGFGPVYKGK--LANGQEIAVKRLSTTSGQG--IEEFKNEVLLIAKL 424
A + ++G+G +G V+K + G+ +A+KR+ +G+ EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 425 ---QHRNLVKLLGCCLEKDEKMLIYEFMPNKSLD---YFIFDESRKQLLDWKKRFDIILG 478
+H N+V+L C + + +D D+ + + + D++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 479 IARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGT 538
+ RG+ +LH R++HRDLK NIL+ +++DFG AR++ VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 539 YGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK------KNTGIFNDDSSNLIRYVWEL 592
Y +PE L ++T D++S G + E+ K + + E
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 593 WSDDKALEIVDSSMADSCPAPEALRCIQVGLL-----CVQDRTTDRPSMSTV 639
W D AL + P + + I C+ R S +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-42
Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
+++ + +G G FG VY+ KL +G+ +A+K++ Q E+ ++ KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNI 75
Query: 430 VKLLGCCLEKDEKM------LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 483
V+L EK L+ +++P KQ L + + R +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEE-MNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
Y+H I HRD+K N+LLD + ++ DFG+A+ E + + + + Y
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 189
Query: 543 SPEYALGGL-FSTKSDVFSFGVLLLEIITGKKNTGIFNDDS 582
+PE G +++ DV+S G +L E++ G+ IF DS
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDS 227
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (380), Expect = 1e-41
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVK--RLSTTSGQGIEEFKNEVLLIAKLQHRN 428
+ + K+G+G +G VYK + G+ A+K RL E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
+VKL K +L++E + E L+ +L + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 489 DSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYAL 548
R++HRDLK N+L++ E +I+DFG AR FG + T Y +P+ +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
Query: 549 G-GLFSTKSDVFSFGVLLLEIITGK 572
G +ST D++S G + E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 150 bits (380), Expect = 2e-41
Identities = 44/286 (15%), Positives = 99/286 (34%), Gaps = 26/286 (9%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL 429
++ ++G+G FG +++G L N Q++A+K S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 430 VKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD 489
+ + ++ ++ + SL+ + + + K + V +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 490 SRLRIIHRDLKASNILLDEEMNP-----RISDFGTARVFGGEEISTN-----TNRVVGTY 539
+++RD+K N L+ + + DFG + + + + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL 599
YMS LG S + D+ + G + + + G + + + +E + K
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP---WQGLKAATNKQKYERIGEKKQS 234
Query: 600 EIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645
+ A P E + + P + + S
Sbjct: 235 TPLRELCAG-FP-EEFYKYMH---YARNLAFDATPDYDYLQGLFSK 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 62/280 (22%), Positives = 114/280 (40%), Gaps = 32/280 (11%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRL------STTSGQGIEEFKNEVLLIAK 423
D + T +LG G F V K + + G + A K + S+ G E+ + EV ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 424 LQHRNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 483
+QH N++ L K + +LI E + L F+ K+ L ++ + + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNG- 125
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNPR----ISDFGTARVFGGEEISTNTNRVVGTY 539
++ L+I H DLK NI+L + P+ I DFG A + + GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTP 180
Query: 540 GYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL 599
+++PE ++D++S GV+ +++G F D+ E ++ A+
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTK------QETLANVSAV 231
Query: 600 EIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTV 639
S + A I+ + R ++
Sbjct: 232 NYEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 7e-40
Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 20/206 (9%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEE------FKNEVLLIAKLQ--HRN 428
LG GGFG VY G +++ +A+K + E EV+L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 429 LVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ 488
+++LL D +LI E + + + L + + V + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 489 DSRLRIIHRDLKASNILLDEE-MNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYA 547
++HRD+K NIL+D ++ DFG+ + T GT Y PE+
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWI 181
Query: 548 LGGLFSTKS-DVFSFGVLLLEIITGK 572
+ +S V+S G+LL +++ G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 43/206 (20%), Positives = 85/206 (41%), Gaps = 12/206 (5%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLS---TTSGQGIEEFKNEVLLIAKLQH 426
++F LG+G FG V + A G+ A+K L + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
L L D + E+ L + + SR+++ ++ I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA---L 118
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
+++RD+K N++LD++ + +I+DFG + + GT Y++PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEV 176
Query: 547 ALGGLFSTKSDVFSFGVLLLEIITGK 572
+ D + GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 6e-39
Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 20/216 (9%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQG--IEEFKNEVLLIAKLQHR 427
+ K+GQG FG V+K + GQ++A+K++ + + E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 428 NLVKLLGCCLEKDEKM--------LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGI 479
N+V L+ C K L+++F + + L + K+ ++L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL-- 127
Query: 480 ARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR--VVG 537
L+ R +I+HRD+KA+N+L+ + +++DFG AR F + S V
Sbjct: 128 ----NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 538 TYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGK 572
T Y PE LG + D++ G ++ E+ T
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-38
Identities = 55/310 (17%), Positives = 123/310 (39%), Gaps = 36/310 (11%)
Query: 371 DNFSTSNK-LGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHR 427
D++ +++ LG G G V + ++ A+K L Q + + EV L + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 65
Query: 428 NLVKLLGCC----LEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGV 483
++V+++ + +++ E + L I + Q ++ +I+ I +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAI 124
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEEMNP---RISDFGTARVFGGEEISTNTNRVVGTYG 540
YLH + I HRD+K N+L + +++DFG A+ + T
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPY 178
Query: 541 YMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALE 600
Y++PE + D++S GV++ ++ G F + I + E
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYE 235
Query: 601 IVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV---FMLSNETSVPSPKQPTF 657
+ ++ + E I+ ++ T R +++ + +++ + P+ P
Sbjct: 236 FPNPEWSEV--SEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQST---KVPQTPLH 287
Query: 658 SVRKIEIDTD 667
+ R ++ D +
Sbjct: 288 TSRVLKEDKE 297
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 7e-38
Identities = 55/247 (22%), Positives = 101/247 (40%), Gaps = 10/247 (4%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVK--RLSTTSGQGIEEFKNEVLLIAKLQHR 427
+ K+G+G +G V+K K + +A+K RL E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 428 NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLH 487
N+V+L + L++EF YF + + + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH 118
Query: 488 QDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYA 547
++HRDLK N+L++ ++++FG AR F G + + VV +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 548 LGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607
L+ST D++S G + E+ + ND L R L + + + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 608 DSCPAPE 614
D P P
Sbjct: 235 DYKPYPM 241
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (353), Expect = 3e-37
Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 15/206 (7%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLS---TTSGQGIEEFKNEVLLIAKLQH 426
D F LG G FG V K +G A+K L + IE NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
LVKL + ++ E++ + + R I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
H L +I+RDLK N+L+D++ +++DFG A+ G + + GT ++PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 547 ALGGLFSTKSDVFSFGVLLLEIITGK 572
L ++ D ++ GVL+ E+ G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-35
Identities = 49/207 (23%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHR 427
+ +G G +G V G ++A+K+L S + E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 428 NLVKLLGCCLEKDEKMLIYEF-MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
N++ LL + +F + + + + + L + ++ + +G+ Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEY 546
H IIHRDLK N+ ++E+ +I DFG AR + + V T Y +PE
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189
Query: 547 ALGGL-FSTKSDVFSFGVLLLEIITGK 572
L + ++ D++S G ++ E+ITGK
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-34
Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 18/213 (8%)
Query: 371 DNFSTSNKLGQGGFGPVYKGKLA----NGQEIAVKRLS----TTSGQGIEEFKNEVLLIA 422
+NF LG G +G V+ + G+ A+K L + E + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 423 KLQHR-NLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 481
++ LV L + + LI +++ L + R + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGY 541
VL L +L II+RD+K NILLD + ++DFG ++ F +E + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEY 196
Query: 542 MSPEYALGGL--FSTKSDVFSFGVLLLEIITGK 572
M+P+ GG D +S GVL+ E++TG
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (320), Expect = 5e-33
Identities = 45/208 (21%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-HRN 428
D++ KLG+G + V++ + N +++ VK L ++ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 429 LVKLLGCCLEKDEKM--LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
++ L + + L++E + N Q L + I + + Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 487 HQDSRLRIIHRDLKASNILLDEE-MNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE 545
H + I+HRD+K N+++D E R+ D+G A + + N V + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPE 199
Query: 546 YALG-GLFSTKSDVFSFGVLLLEIITGK 572
+ ++ D++S G +L +I K
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-31
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 371 DNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLS--TTSGQGIEEFKNEVLLIAKLQHR 427
+ +G G G V + +A+K+LS + + E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 428 NLVKLLGCCL------EKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIAR 481
N++ LL E + L+ E M + LD ++ ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 130
Query: 482 GVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGY 541
G+ +LH IIHRDLK SNI++ + +I DFG AR G + T V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYY 184
Query: 542 MSPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
+PE LG + D++S G ++ E++ K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-30
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 13/208 (6%)
Query: 370 TDNFSTSNKLGQGGFGPVYKGK-LANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQH 426
+ + + +G G +G V G +AVK+LS S + E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 427 RNLVKLLGCCLEKDEKMLI-YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLY 485
N++ LL ++ + + + + Q L +I I RG+ Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 486 LHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPE 545
+H IIHRDLK SN+ ++E+ +I DFG AR E T Y +PE
Sbjct: 137 IHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPE 188
Query: 546 YALGGL-FSTKSDVFSFGVLLLEIITGK 572
L + ++ D++S G ++ E++TG+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (295), Expect = 2e-29
Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 18/210 (8%)
Query: 378 KLGQGGFGPVYKGK-LANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCC 436
KLG G F V+ K + N +A+K + E ++E+ L+ ++ + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 437 LEKDEKMLIY--EFMPNKSLDYFIFDESRKQLLDWKKRFD-----------IILGIARGV 483
K+L + PN +F+ + LL K+++ I + G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 484 LYLHQDSRLRIIHRDLKASNILLDEE-MNPRISDFGTARVFGGEEISTNTNRVVGTYGYM 542
Y+H+ R IIH D+K N+L++ + A + + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 543 SPEYALGGLFSTKSDVFSFGVLLLEIITGK 572
SPE LG + +D++S L+ E+ITG
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.2 bits (241), Expect = 9e-24
Identities = 44/202 (21%), Positives = 70/202 (34%), Gaps = 27/202 (13%)
Query: 377 NKLGQGGFGPVYKGKLANGQEIAVK--RLSTTSGQ--------GIEEFKNEVLLIAKLQH 426
+G+G V+ E VK ++ TS + G F + A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 427 RNLVKLLGCCLEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYL 486
R L KL G + K Y + N L I + ++ +++ I V
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 487 HQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNR-VVGTYGYMSPE 545
+ I+H DL N+L+ E I DF + G E R V Y S
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175
Query: 546 YALGGLFSTKSDVFSFGVLLLE 567
Y T+ D+ S +L+
Sbjct: 176 Y------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 688 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.92 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.29 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.16 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 97.72 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.6 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.58 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 97.31 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 97.19 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 97.02 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.72 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 96.53 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 96.34 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 93.26 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.13 Aligned_cols=256 Identities=28% Similarity=0.447 Sum_probs=208.9
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEECC
Q ss_conf 23999788103378383999995799689999804789206899999999986047998111578998489326999616
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 449 (688)
.++|++.+.||+|+||.||+|++.+++.||||++... ....++|.+|+.++.+++|||||+++|++...+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEEC
T ss_conf 6995888898208882999999889999999998788-676899999999999668997565352431599337999836
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCCCCC
Q ss_conf 99995567330388788998889999999999989844089997575578999458779998100131121002797531
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 529 (688)
++|+|.+++... ...+++..++.++.|+|.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE
T ss_conf 999189975201--347889999999999999877653164---310443153266668877686553210023688733
Q ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCC-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 122343455773371011389889746524489999998819999-9888889831789999982466432113432469
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKN-TGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 608 (688)
. .....||+.|+|||++.+..++.++||||||+++|||+++..| +... ........+.. . ...
T Consensus 158 ~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~---~----------~~~ 221 (263)
T d1sm2a_ 158 S-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDIST---G----------FRL 221 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHH---T----------CCC
T ss_pred E-ECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHH---C----------CCC
T ss_conf 5-043001766678578607999840332105999999987898887789--99999999980---6----------888
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 999899999999984153599889999789999822899
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 609 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 647 (688)
..|...+.++.+|+.+||+.||++||||.+|++.|+.+.
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 995436799999999976579768919999999999998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.38 Aligned_cols=261 Identities=28% Similarity=0.442 Sum_probs=207.4
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCC--CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEE
Q ss_conf 72399978810337838399999579968999980478--9206899999999986047998111578998489326999
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 369 ~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 446 (688)
..++|++.+.||+|+||+||+|+.+ ..||||+++.. .....+.|.+|+.++.+++|||||++++++.+ +..++|+
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred CCCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEE
T ss_conf 5451899889830788589999999--989999997346998999999999999984799878645679715-5899999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCC
Q ss_conf 61699995567330388788998889999999999989844089997575578999458779998100131121002797
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~ 526 (688)
||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ECCCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCC
T ss_conf 658998889998523--578999999999999999988875099---951614789979818997887500221333556
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCC---CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 531122343455773371011389---88974652448999999881999998888898317899999824664321134
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGG---LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 603 (688)
..........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ......+......+..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-~~~~~~~~~~~~~p~~----- 231 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGYLSPDL----- 231 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHHHHTSCCCCG-----
T ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHCCCCCCCC-----
T ss_conf 7763125665574317999995056899995315163599999999788998998969-9999999658889860-----
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 32469999899999999984153599889999789999822899
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 604 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 647 (688)
..+ +...+..+.+|+.+||+.+|++|||+.+|++.|+.+.
T Consensus 232 ~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 232 SKV----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp GGS----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHC----CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 003----6555499999999975889768929999999999999
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.72 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=209.3
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEECC-C-----CEEEEEECCCC-CCCCHHHHHHHHHHHHHC-CCCCCCCEEEEEEECC
Q ss_conf 72399978810337838399999579-9-----68999980478-920689999999998604-7998111578998489
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLAN-G-----QEIAVKRLSTT-SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKD 440 (688)
Q Consensus 369 ~~~~f~~~~~lg~G~fg~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 440 (688)
..++|++.++||+|+||+||+|+... + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 78993970198307881999999857885542049999996633587899999999999997158996868778886299
Q ss_pred CEEEEEECCCCCCHHHHHHCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCC
Q ss_conf 32699961699995567330388--------------------7889988899999999999898440899975755789
Q 005599 441 EKMLIYEFMPNKSLDYFIFDESR--------------------KQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLK 500 (688)
Q Consensus 441 ~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlk 500 (688)
..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCC
T ss_conf 5899997279995999998625777510221000012220012577899999999999999999997399---0505270
Q ss_pred CCCEEECCCCCCEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 9945877999810013112100279753112234345577337101138988974652448999999881-999998888
Q 005599 501 ASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFN 579 (688)
Q Consensus 501 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~ 579 (688)
|+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred HHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 32144345982898514222204577861562343578765783887279999633030003999999838999999989
Q ss_pred CCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 89831789999982466432113432469999899999999984153599889999789999822
Q 005599 580 DDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLS 644 (688)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 644 (688)
.. ..+... .. ...+...+...+.++.+|+.+||+.+|++|||+.||++.|.
T Consensus 272 ~~-~~~~~~----~~---------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VD-ANFYKL----IQ---------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CS-HHHHHH----HH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH-HHHHHH----HH---------CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 89-999999----85---------69989988767899999999975889668939999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=368.32 Aligned_cols=259 Identities=29% Similarity=0.413 Sum_probs=210.8
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 7239997881033783839999957-996899998047892068999999999860479981115789984893269996
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 369 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 447 (688)
..++|++.+.||+|+||+||+|+.. +++.||||++... ....++|.+|+.++.+++|||||++++++.+.+..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEE
T ss_conf 579939865982088808999999999969999997776-1039999999999986799988267752745785478763
Q ss_pred CCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCCC
Q ss_conf 16999955673303887889988899999999999898440899975755789994587799981001311210027975
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~ 527 (688)
|+++|+|..++... ....+++..++.++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++......
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred CCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC
T ss_conf 14676067775303-5541579999999999999788898789---3057604576899899928983244546537887
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 31122343455773371011389889746524489999998819999988888983178999998246643211343246
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 607 (688)
... .....|++.|+|||++.+..++.++||||||+++|||++|+.|+....+ ... +.... .....
T Consensus 170 ~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----~~~-~~~~i---------~~~~~ 234 (287)
T d1opja_ 170 YTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQ-VYELL---------EKDYR 234 (287)
T ss_dssp SEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHH-HHHHH---------HTTCC
T ss_pred CEE-ECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH----HHH-HHHHH---------HCCCC
T ss_conf 221-0355665466692787279998104302178999999867998877425----999-99998---------55888
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 9999899999999984153599889999789999822899
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 608 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 647 (688)
...+...+..+.+|+.+||+.||++||||.+|++.|+...
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 8887433099999999975779768939999999999998
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.31 Aligned_cols=255 Identities=30% Similarity=0.430 Sum_probs=205.3
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEECC
Q ss_conf 23999788103378383999995799689999804789206899999999986047998111578998489326999616
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 449 (688)
.++|++.+.||+|+||.||+|.++++..||||++... ....++|.+|+.++.+++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf 8993886798107982899999999999999998647-6888999999999986799988578731045-9769999957
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCCCCC
Q ss_conf 99995567330388788998889999999999989844089997575578999458779998100131121002797531
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 529 (688)
++|+|.+++.... ...+++..+++++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+|+........
T Consensus 90 ~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCC
T ss_conf 8982888875147-898878899999999999999997489---546756422515620244042341014773588644
Q ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 12234345577337101138988974652448999999881999998888898317899999824664321134324699
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 609 (688)
. .....|++.|+|||++.+..++.++||||||+++|||+||+.|+..... ......... .+ ....
T Consensus 166 ~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~~~~~~~i~-~~---------~~~~ 230 (272)
T d1qpca_ 166 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVIQNLE-RG---------YRMV 230 (272)
T ss_dssp C-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHH-TT---------CCCC
T ss_pred C-CCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC----HHHHHHHHH-HC---------CCCC
T ss_conf 2-0356774444582898379998245645257999999968988888889----999999997-06---------8888
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 998999999999841535998899997899998228
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 610 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 645 (688)
.+...+..+.+|+.+||+.+|++||||.+|+++|+.
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 965571999999999758897689399999998611
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=365.15 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=206.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECC-C---CEEEEEECCCC-CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEE
Q ss_conf 399978810337838399999579-9---68999980478-920689999999998604799811157899848932699
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN-G---QEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 445 (688)
++|++.++||+|+||+||+|.... + ..||||.+... .....+.|.+|+.++.+++|||||+++|++...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCC
Q ss_conf 96169999556733038878899888999999999998984408999757557899945877999810013112100279
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~ 525 (688)
|||+++|+|..++... ...+++..++.++.|||.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCEEEECCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf 9722798530021045--679999999999999999889885279---83576150448988999199888443157567
Q ss_pred CCCCC---CCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 75311---2234345577337101138988974652448999999881-9999988888983178999998246643211
Q 005599 526 EEIST---NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 526 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (688)
..... ......||+.|+|||.+.+..++.++|||||||++|||+| |++||.... ..+.......
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-----~~~~~~~i~~------- 248 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-----NQDVINAIEQ------- 248 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHT-------
T ss_pred CCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHC-------
T ss_conf 7776536502566688300387888369978612144535789999867999999999-----9999999973-------
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 3432469999899999999984153599889999789999822899
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 602 id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 647 (688)
..+...+...+..+.+|+.+||+.+|++||||.+|++.|+.+.
T Consensus 249 ---~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 249 ---DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf ---7889997422699999999975879768929999999999984
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.81 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=206.1
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEECC
Q ss_conf 3999788103378383999995-799689999804789206899999999986047998111578998489326999616
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 449 (688)
++|++.+.||+|+||+||+|+. .+++.||+|++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCCCCC
Q ss_conf 99995567330388788998889999999999989844089997575578999458779998100131121002797531
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 529 (688)
++|+|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC-
T ss_conf 79808988641----59999999999999999999999879---72267768886887899686425156413213666-
Q ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 12234345577337101138988974652448999999881999998888898317899999824664321134324699
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 609 (688)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .............. ...
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~~~~~~~~--------~~~ 237 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-----PLRALYLIATNGTP--------ELQ 237 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHHCSC--------CCS
T ss_pred -CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHCCCC--------CCC
T ss_conf -4444444777368266447998801203137299999804889989979-----99999999857999--------888
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 99899999999984153599889999789999
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 610 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 641 (688)
.+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 85537999999999986699668909999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.42 Aligned_cols=253 Identities=25% Similarity=0.313 Sum_probs=205.8
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC-CCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 239997881033783839999957-99689999804789-2068999999999860479981115789984893269996
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 447 (688)
.++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++.+++|||||++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred CCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCCC
Q ss_conf 16999955673303887889988899999999999898440899975755789994587799981001311210027975
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~ 527 (688)
|+++|+|.+++. ....+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 458980899975---3799999999999999999999999759---8357546899788789987983231422404688
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 3112234345577337101138988-974652448999999881999998888898317899999824664321134324
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLF-STKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 606 (688)
........+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....+........ .......
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~----~~~~~~~------- 226 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----KEKKTYL------- 226 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH----HTTCTTS-------
T ss_pred CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----HCCCCCC-------
T ss_conf 65311132557474287286189999971016173799999982997888898599999998----6388878-------
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 69999899999999984153599889999789999
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 607 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 641 (688)
......+.++.+|+.+||+.||++|||+.|+++
T Consensus 227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 --NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf --864469999999999976799668909999961
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.49 Aligned_cols=255 Identities=24% Similarity=0.421 Sum_probs=211.1
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEECC
Q ss_conf 23999788103378383999995799689999804789206899999999986047998111578998489326999616
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 449 (688)
.++|++.++||+|+||+||+|+.++++.||||+++... ...++|.+|+.++.+++||||++++|++.+.+..++|+||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECC
T ss_conf 69979968982078839999998899899999987475-77899999999999668986015889985078169999704
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCCCCC
Q ss_conf 99995567330388788998889999999999989844089997575578999458779998100131121002797531
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 529 (688)
++|+|..++... ...+++..+++++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE
T ss_conf 899388864102--467768999999999999999875468---434665413588769984798861442023578722
Q ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 12234345577337101138988974652448999999881-99999888889831789999982466432113432469
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 608 (688)
......+|+.|+|||++.+..++.++||||||+++|||+| |+.||..... .... .... .+ .+.
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~~~~---~~i~-~~---------~~~ 220 (258)
T d1k2pa_ 157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETA---EHIA-QG---------LRL 220 (258)
T ss_dssp -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHH---HHHH-TT---------CCC
T ss_pred -EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCH--HHHH---HHHH-HC---------CCC
T ss_conf -524657887757807863799885210336432467397559999889999--9999---9998-07---------978
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 99989999999998415359988999978999982289
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 609 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 646 (688)
..|...+..+.+|+.+||+.+|++|||+.+|++.|..+
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf 99654659999999997668976893999999874188
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.46 Aligned_cols=256 Identities=25% Similarity=0.437 Sum_probs=204.7
Q ss_pred HCCCCCCC-CCCCCCCEEEEEEEEC---CCCEEEEEECCCCC-CCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEE
Q ss_conf 23999788-1033783839999957---99689999804789-2068999999999860479981115789984893269
Q 005599 370 TDNFSTSN-KLGQGGFGPVYKGKLA---NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 370 ~~~f~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 444 (688)
.++|.+.+ +||+|+||.||+|... ++..||||++.... ....++|.+|+.++.+++|||||+++|++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEE
T ss_conf 44718878487306080999999960897689999998820397899999999999986799888068656036-80799
Q ss_pred EEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECC
Q ss_conf 99616999955673303887889988899999999999898440899975755789994587799981001311210027
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~ 524 (688)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 vmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEECCCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCC
T ss_conf 99807899689975212--569999999999999999878998688---1057676466045468854203313421155
Q ss_pred CCCCC-CCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 97531-12234345577337101138988974652448999999881-99999888889831789999982466432113
Q 005599 525 GEEIS-TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 525 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 602 (688)
..... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||.... ....... ...+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~~~~~~----i~~~~----- 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAF----IEQGK----- 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHH----HHTTC-----
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCC--HHHHHHH----HHCCC-----
T ss_conf 434321135621137433586887279999541232201789999938999999979--9999999----98189-----
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 43246999989999999998415359988999978999982289
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 603 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 646 (688)
+...|...+.++.+|+.+||+.+|++||||.+|++.|+..
T Consensus 230 ----~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 230 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ----9999976789999999997577976890999999999999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.03 Aligned_cols=263 Identities=28% Similarity=0.428 Sum_probs=211.5
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEECC
Q ss_conf 23999788103378383999995799689999804789206899999999986047998111578998489326999616
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 449 (688)
.++|++.+.||+|+||.||+|+.++++.||||++... ....+.|.+|+.++.+++|+|||+++|++. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCCEEEEEEEC
T ss_conf 7997984699307980999999999999999998804-488899999999998666678868999982-39759999944
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCCCCC
Q ss_conf 99995567330388788998889999999999989844089997575578999458779998100131121002797531
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 529 (688)
++|+|..++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 94 ~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCE
T ss_conf 7994354200003-553059999999999999999875411---433531230799989992998442555425688733
Q ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 12234345577337101138988974652448999999881999998888898317899999824664321134324699
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 609 (688)
......||+.|+|||++.+..++.++||||||+++|||++|+.|+..... .......+. . .....
T Consensus 170 -~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~~~~i~----~---------~~~~~ 234 (285)
T d1fmka3 170 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVE----R---------GYRMP 234 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHH----T---------TCCCC
T ss_pred -EECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCC-HHHHHHHHH----H---------CCCCC
T ss_conf -52454556654580898379989177413235899999868999998888-999999998----2---------68999
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCC
Q ss_conf 99899999999984153599889999789999822899999999
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETSVPSPK 653 (688)
Q Consensus 610 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~p~ 653 (688)
.+...+.++.+++.+||+.+|++||+|.+|+++|+.......|+
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~ 278 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCCCC
T ss_conf 98323799999999975669758919999999876662389999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.62 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=207.4
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECCC-----CEEEEEECCCC-CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEE
Q ss_conf 23999788103378383999995799-----68999980478-9206899999999986047998111578998489326
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLANG-----QEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKM 443 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 443 (688)
.+.|+..++||+|+||.||+|.+... ..||||++... ......+|.+|+.++.+++|||||+++|++.+....+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 89968615981177909999999689987879999999884459689999999999998568987832367783388038
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEEC
Q ss_conf 99961699995567330388788998889999999999989844089997575578999458779998100131121002
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~ 523 (688)
+|+||+.++++..++... ...+++..++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEECCCCCCHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCC
T ss_conf 999721357402221023--454208999999999998541212123---425765644278889984998455103003
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 797531-1223434557733710113898897465244899999988199999888889831789999982466432113
Q 005599 524 GGEEIS-TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 524 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 602 (688)
...... .......||+.|+|||++.+..++.++||||||+++|||+++..|+..... ...... . +
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-~~~~~~---~----------i 226 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMK---A----------I 226 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHH---H----------H
T ss_pred CCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC-HHHHHH---H----------H
T ss_conf 5787652674267777343488887049999735563448989999967988655689-999999---9----------8
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 4324699998999999999841535998899997899998228999
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETS 648 (688)
Q Consensus 603 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 648 (688)
....+...+...+..+.+|+.+||+.+|++||||.+|+++|+.+..
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 6357899850457999999999776797689399999999999866
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=349.36 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=206.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEECC
Q ss_conf 3999788103378383999995-799689999804789206899999999986047998111578998489326999616
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFM 449 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 449 (688)
++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.++.+++|||||++++++.+.+..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECC
T ss_conf 57589889840768199999988999899999984524316999999999998679979992999999899999999857
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC--CCCCEECCCCCCEECCCCC
Q ss_conf 99995567330388788998889999999999989844089997575578999458779--9981001311210027975
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE--EMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~--~~~~kl~Dfgla~~~~~~~ 527 (688)
++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCCC
T ss_conf 998899999762--378999999999999999999997569---760001546736416889869995452104425654
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 31122343455773371011389889746524489999998819999988888983178999998246643211343246
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 607 (688)
.. ....||+.|+|||++.+..++.++||||+||++|||++|+.||.... . .+........... +...
T Consensus 181 ~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~---~~~~~~i~~~~~~---~~~~-- 247 (350)
T d1koaa2 181 SV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--D---DETLRNVKSCDWN---MDDS-- 247 (350)
T ss_dssp CE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--H---HHHHHHHHHTCCC---SCCG--
T ss_pred CC---CEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC--H---HHHHHHHHHCCCC---CCCC--
T ss_conf 32---00068624218899758998726765546599999985989989979--9---9999999847889---8942--
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 99998999999999841535998899997899998
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 608 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 642 (688)
.....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 248 --~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 --AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --235899999999999756896679089998629
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=346.67 Aligned_cols=257 Identities=21% Similarity=0.269 Sum_probs=207.8
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEC
Q ss_conf 23999788103378383999995-79968999980478920689999999998604799811157899848932699961
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 448 (688)
.++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++.+++|||||++++++.+.+..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC--CCCCCEECCCCCCEECCCC
Q ss_conf 69999556733038878899888999999999998984408999757557899945877--9998100131121002797
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD--EEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~--~~~~~kl~Dfgla~~~~~~ 526 (688)
+++|+|.+++... ...+++.....++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+|..+...
T Consensus 108 ~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 8998088889863--899899999999999999999999779---26513144553113467884899525630343788
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 53112234345577337101138988974652448999999881999998888898317899999824664321134324
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 606 (688)
... ....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ............ ...
T Consensus 183 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~i~~~~-------~~~ 247 (352)
T d1koba_ 183 EIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----DLETLQNVKRCD-------WEF 247 (352)
T ss_dssp SCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHHCC-------CCC
T ss_pred CCE---EECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHCC-------CCC
T ss_conf 720---10047645348999747998976333898999999996889989979-----999999998478-------898
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HCCC
Q ss_conf 699998999999999841535998899997899998--2289
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LSNE 646 (688)
Q Consensus 607 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~ 646 (688)
........+.++.+|+.+||+.||++|||+.|+++. +++.
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 930024799999999999756996689189999609734888
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.11 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=205.1
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEC
Q ss_conf 239997881033783839999957-9968999980478920689999999998604799811157899848932699961
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 448 (688)
.+.|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++.+++|||||++++++.+.+..++||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 03759847993077819999999999939999998728999999999999999867999988498898009958999962
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCCCC
Q ss_conf 69999556733038878899888999999999998984408999757557899945877999810013112100279753
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~ 528 (688)
+++|+|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|.......
T Consensus 91 ~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 91 CAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC-
T ss_conf 7998188999862--899999999999999999999999889---8871407003148789998997161230357786-
Q ss_pred CCCCCCCCCCCCCCCCEEEC-----CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 11223434557733710113-----8988974652448999999881999998888898317899999824664321134
Q 005599 529 STNTNRVVGTYGYMSPEYAL-----GGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 603 (688)
.......||+.|+|||++. +..++.++||||+||++|||++|+.||..... ..... .......
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--~~~~~---~i~~~~~------ 232 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVLL---KIAKSEP------ 232 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--GGHHH---HHHHSCC------
T ss_pred -CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHH---HHHCCCC------
T ss_conf -41001025626479999832025788888066578789999998208899999899--99999---9970799------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 32469999899999999984153599889999789999
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 604 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 641 (688)
+ ....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 233 ~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 P--TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp C--CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C--CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8--77765669999999999976699668919999962
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.57 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=204.8
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCC-CCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEE
Q ss_conf 723999788103378383999995-799689999804789-206899999999986047998111578998489326999
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 369 ~~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 446 (688)
..++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.++.+++|||||++++++.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCC
Q ss_conf 6169999556733038878899888999999999998984408-999757557899945877999810013112100279
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQD-SRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~ 525 (688)
||+++|+|..++... ..+++..+..++.|++.||.|||+. + |+||||||+|||+++++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 767998689987424---999999999999999999999998599---97144577994687899899954877625678
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH----------H--
Q ss_conf 7531122343455773371011389889746524489999998819999988888983178999998----------2--
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWEL----------W-- 593 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~----------~-- 593 (688)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||................. .
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred ----CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf ----8621113771411946875899894888998999999999888998998878999999887517754577421233
Q ss_pred ------------CCCCCCCCCCCCCCC----CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf ------------466432113432469----999899999999984153599889999789999
Q 005599 594 ------------SDDKALEIVDSSMAD----SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 594 ------------~~~~~~~~id~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 641 (688)
......+.++..... ......+.++.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 3221111222354134778876650268766764448999999999986899467908999960
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=355.98 Aligned_cols=264 Identities=26% Similarity=0.415 Sum_probs=212.6
Q ss_pred HHHHHCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEECCCCCC-CCHHHHHHHHHHHHHCCCCCCCCEEEEEEE
Q ss_conf 9987239997881033783839999957------996899998047892-068999999999860479981115789984
Q 005599 366 VLAATDNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTSG-QGIEEFKNEVLLIAKLQHRNLVKLLGCCLE 438 (688)
Q Consensus 366 ~~~~~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 438 (688)
++...++|++.+.||+|+||+||+|+.. ++..||||++..... ...++|.+|+.++.+++|+||+++++++..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECC
T ss_conf 13898893886798207883999999888765778829999998821085799999999999996689976552466605
Q ss_pred CCCEEEEEECCCCCCHHHHHHCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEC
Q ss_conf 893269996169999556733038---------------------87889988899999999999898440899975755
Q 005599 439 KDEKMLIYEFMPNKSLDYFIFDES---------------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHR 497 (688)
Q Consensus 439 ~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~ 497 (688)
....++++||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EEEE
T ss_conf 9803899981589929999985275542100001110012103467889899999999999999855413578---6854
Q ss_pred CCCCCCEEECCCCCCEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCC-CCCC
Q ss_conf 789994587799981001311210027975311223434557733710113898897465244899999988199-9998
Q 005599 498 DLKASNILLDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK-KNTG 576 (688)
Q Consensus 498 Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~-~p~~ 576 (688)
||||+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCC
T ss_conf 88401168989992898331442113677641115777767676798997268898056302523629999806899999
Q ss_pred CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 88889831789999982466432113432469999899999999984153599889999789999822899
Q 005599 577 IFNDDSSNLIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 647 (688)
... ..+.... ...+.. ...+...+.++.+|+.+||+.+|++||||.||+++|+.+.
T Consensus 245 ~~~-----~~e~~~~-v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMA-----HEEVIYY-VRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSC-----HHHHHHH-HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCC-----HHHHHHH-HHCCCC---------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 989-----9999999-973997---------8887325299999999974889657939999999999842
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.17 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=206.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCC----EEEEEECCCC-CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEE
Q ss_conf 39997881033783839999957-996----8999980478-92068999999999860479981115789984893269
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQ----EIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 444 (688)
++|++.++||+|+||+||+|... +++ .||+|++... .....++|.+|+.++.+++|||||+++|++.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEE
T ss_conf 99978319820899299999995899889899999996513497999999999999986799888158999961-98369
Q ss_pred EEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECC
Q ss_conf 99616999955673303887889988899999999999898440899975755789994587799981001311210027
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~ 524 (688)
++|++.+++|.+++... ...+++..+++++.|||.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEECCCCCCCCCCCCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECC
T ss_conf 99842687401011133--457999999999999999999998769---5047621203116799875860255222335
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 9753112234345577337101138988974652448999999881-999998888898317899999824664321134
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 603 (688)
............||+.|+|||++.+..++.++||||||+++|||+| |.+||.... ...+...+..
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~--~~~~~~~i~~------------ 228 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEK------------ 228 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--GGGHHHHHHH------------
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHC------------
T ss_conf 44453223651058644670887469998356544079999999977999999999--8999999975------------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 3246999989999999998415359988999978999982289
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 604 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 646 (688)
..+...+...+..+.+|+.+||+.+|++|||+.+|++.|+..
T Consensus 229 -~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 229 -GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf -998999855689999999984789934691999999999998
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.71 Aligned_cols=247 Identities=27% Similarity=0.399 Sum_probs=199.4
Q ss_pred CCCCCCCCEEEEEEEECC---CCEEEEEECCCC--CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEECCCC
Q ss_conf 810337838399999579---968999980478--920689999999998604799811157899848932699961699
Q 005599 377 NKLGQGGFGPVYKGKLAN---GQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEFMPN 451 (688)
Q Consensus 377 ~~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 451 (688)
++||+|+||.||+|.+.. ++.||||+++.. .....++|.+|+.++.+++|||||+++|++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCCCCC-C
Q ss_conf 995567330388788998889999999999989844089997575578999458779998100131121002797531-1
Q 005599 452 KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS-T 530 (688)
Q Consensus 452 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~-~ 530 (688)
|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ .
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCC
T ss_conf 968999752---257899999999999999976687479---55677761131023567512341345331343234432
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 2234345577337101138988974652448999999881-999998888898317899999824664321134324699
Q 005599 531 NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMADS 609 (688)
Q Consensus 531 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 609 (688)
......||+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+.... ...+ .+..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-----~~~~~~~-i~~~---------~~~~ 230 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GSEVTAM-LEKG---------ERMG 230 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHH-HHTT---------CCCC
T ss_pred CCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCC-----HHHHHHH-HHCC---------CCCC
T ss_conf 24456778420391665379998434430340313289658999999989-----9999999-9828---------9999
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 998999999999841535998899997899998228
Q 005599 610 CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSN 645 (688)
Q Consensus 610 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 645 (688)
.+...+.++.+|+.+||+.||++|||+.+|+++|+.
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 986567999999999758897689098999998528
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.40 Aligned_cols=255 Identities=23% Similarity=0.353 Sum_probs=204.2
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCC--CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEEC--CCEEE
Q ss_conf 239997881033783839999957-9968999980478--920689999999998604799811157899848--93269
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK--DEKML 444 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 444 (688)
.++|++.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.++.+++|||||++++++.+. ...++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEECCCCCCHHHHHHCCC-CCCCCCHHHHHHHHHHHHHHHHHHHCCC--CCCEEECCCCCCCEEECCCCCCEECCCCCCE
Q ss_conf 996169999556733038-8788998889999999999989844089--9975755789994587799981001311210
Q 005599 445 IYEFMPNKSLDYFIFDES-RKQLLDWKKRFDIILGIARGVLYLHQDS--RLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 445 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~ 521 (688)
||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 02797531122343455773371011389889746524489999998819999988888983178999998246643211
Q 005599 522 VFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEI 601 (688)
Q Consensus 522 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (688)
.+..... ......||+.|+|||++.+..++.++|||||||++|||++|++||.... ...+. ... ......
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--~~~~~---~~i-~~~~~~-- 232 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QKELA---GKI-REGKFR-- 232 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHH---HHH-HHTCCC--
T ss_pred ECCCCCC--CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCC--HHHHH---HHH-HCCCCC--
T ss_conf 2245777--5566778823279999839999938988752789999801889989989--99999---999-718998--
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 3432469999899999999984153599889999789999
Q 005599 602 VDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 602 id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 641 (688)
. .+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 233 ---~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 ---R----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---C----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf ---8----97435999999999976799557918999972
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.73 Aligned_cols=248 Identities=25% Similarity=0.310 Sum_probs=205.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC---CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEE
Q ss_conf 3999788103378383999995-79968999980478---9206899999999986047998111578998489326999
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 446 (688)
++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCC
Q ss_conf 61699995567330388788998889999999999989844089997575578999458779998100131121002797
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~ 526 (688)
||+++|+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ECCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 704898777765315---99999999999999999997621650---884767741236688853886032102422567
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 53112234345577337101138988974652448999999881999998888898317899999824664321134324
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 606 (688)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||.... ........... . ..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~-~------~~- 228 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EYLIFQKIIKL-E------YD- 228 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHTT-C------CC-
T ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHCC-C------CC-
T ss_conf 76433355567755258440026898966623045699999803889989959-----99999999718-9------99-
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHH
Q ss_conf 6999989999999998415359988999978999
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVV 640 (688)
Q Consensus 607 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 640 (688)
.+...+..+.+|+.+||+.||++|||+.|++
T Consensus 229 ---~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 229 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp ---CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHC
T ss_conf ---9854799999999998557976891978973
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.46 Aligned_cols=245 Identities=24% Similarity=0.352 Sum_probs=203.2
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCC---CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEE
Q ss_conf 39997881033783839999957-9968999980478---9206899999999986047998111578998489326999
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 446 (688)
++|++.+.||+|+||.||+|+.+ +++.||+|++... .....+.+.+|+.++.+++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCC
Q ss_conf 61699995567330388788998889999999999989844089997575578999458779998100131121002797
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~ 526 (688)
||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EECCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf 504798589887504---89999999999999999999999889---465220234414668998711555633544888
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 53112234345577337101138988974652448999999881999998888898317899999824664321134324
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 606 (688)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ........... . .
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~-~------~-- 221 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRV-E------F-- 221 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTT-C------C--
T ss_pred C----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHCC-C------C--
T ss_conf 5----235578876349999758998931440467599999832999988899-----99999999718-9------9--
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 69999899999999984153599889999789999
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 607 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 641 (688)
..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 222 --~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf --998668999999999976479768909999971
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=344.83 Aligned_cols=258 Identities=21% Similarity=0.266 Sum_probs=206.5
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCC-CCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEE
Q ss_conf 7239997881033783839999957-99689999804789-206899999999986047998111578998489326999
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 369 ~~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 446 (688)
..+.|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++.+++|||||++++++.+.+..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC---CCCCCEECCCCCCEEC
Q ss_conf 6169999556733038878899888999999999998984408999757557899945877---9998100131121002
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD---EEMNPRISDFGTARVF 523 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfgla~~~ 523 (688)
||+++|+|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ECCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf 52689848886530---367887899999999999987524130---556870463001104688824998315435872
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 79753112234345577337101138988974652448999999881999998888898317899999824664321134
Q 005599 524 GGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 524 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 603 (688)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .............
T Consensus 161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~~~------ 226 (307)
T d1a06a_ 161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-----DAKLFEQILKAEY------ 226 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHTTCC------
T ss_pred CCCC---EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHCCCC------
T ss_conf 5897---0440032842259188737999807873451599999985979999989-----9999999861687------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HCCCC
Q ss_conf 324699998999999999841535998899997899998--22899
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LSNET 647 (688)
Q Consensus 604 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~ 647 (688)
......+...+.++.+|+.+||+.||++|||+.|+++. +.+..
T Consensus 227 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 227 -EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred -CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf -778766667899999999997608975791899986298447997
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.48 Aligned_cols=248 Identities=19% Similarity=0.274 Sum_probs=203.6
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC---CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEE
Q ss_conf 23999788103378383999995-79968999980478---920689999999998604799811157899848932699
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 445 (688)
-++|++.+.||+|+||.||+++. .+++.||+|++... .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCC
Q ss_conf 96169999556733038878899888999999999998984408999757557899945877999810013112100279
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~ 525 (688)
|||+++|+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EECCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 0035798605555325---67759999999999965211343159---62246477784765899888820565200356
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 75311223434557733710113898897465244899999988199999888889831789999982466432113432
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 605 (688)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|++||.... ...+.. ..... . .
T Consensus 158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--~~~~~~---~i~~~-~------~- 222 (337)
T d1o6la_ 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFE---LILME-E------I- 222 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHH---HHHHC-C------C-
T ss_pred CC--CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCC--HHHHHH---HHHCC-C------C-
T ss_conf 78--62055100889966665048988833310223067889987899999969--999999---98528-9------9-
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 469999899999999984153599889999-----789999
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 641 (688)
Q Consensus 606 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 641 (688)
..|...+.++.+|+.+||++||++||+ +.++++
T Consensus 223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf ---89866899999999866638934422565234999972
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=349.14 Aligned_cols=245 Identities=28% Similarity=0.457 Sum_probs=198.1
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCC---CCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEE
Q ss_conf 3999788103378383999995-7996899998047892---06899999999986047998111578998489326999
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSG---QGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 446 (688)
+.|+..+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.+++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCC
Q ss_conf 61699995567330388788998889999999999989844089997575578999458779998100131121002797
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~ 526 (688)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCC-
T ss_conf 80699945789973---799999999999999999999998689---76667884217987999789844365334677-
Q ss_pred CCCCCCCCCCCCCCCCCCEEECC---CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 53112234345577337101138---988974652448999999881999998888898317899999824664321134
Q 005599 527 EISTNTNRVVGTYGYMSPEYALG---GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 603 (688)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.... .............
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-----~~~~~~~i~~~~~------ 231 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNES------ 231 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCC------
T ss_pred -----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHCCC------
T ss_conf -----873134766368899834678886721454558999999987889999979-----9999999982899------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 32469999899999999984153599889999789999
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 604 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 641 (688)
+.+ .+...+..+.+|+.+||+.||++|||+.++++
T Consensus 232 ~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 988---87888999999999977379657918999971
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.63 Aligned_cols=252 Identities=22% Similarity=0.291 Sum_probs=203.3
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCC------CCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC
Q ss_conf 723999788103378383999995-799689999804789------2068999999999860479981115789984893
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS------GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE 441 (688)
Q Consensus 369 ~~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 441 (688)
..++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.++.+++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 55677982798117895999999999998999999875663213406899999999999986799899938899997998
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC----CCEECCC
Q ss_conf 269996169999556733038878899888999999999998984408999757557899945877999----8100131
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM----NPRISDF 517 (688)
Q Consensus 442 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Df 517 (688)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEECCCCCCCCCHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCH
T ss_conf 99999867786431001035---64215578999999999987666254---2211333012798258986664696433
Q ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 12100279753112234345577337101138988974652448999999881999998888898317899999824664
Q 005599 518 GTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK 597 (688)
Q Consensus 518 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 597 (688)
|++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... .............
T Consensus 162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQETLANVSAVNY 233 (293)
T ss_dssp TTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHTTCC
T ss_pred HHHHHCCCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHHCCC
T ss_conf 44210577763---122477774309999818999976652214099999970889988999-----9999999981688
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 32113432469999899999999984153599889999789999
Q 005599 598 ALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 598 ~~~~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 641 (688)
. ...... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 234 ~---~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 E---FEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C---CCHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C---CCCHHC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8---870104----788999999999986389668919999961
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.62 Aligned_cols=262 Identities=24% Similarity=0.372 Sum_probs=210.7
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEECCCCC-CCCHHHHHHHHHHHHHC-CCCCCCCEEEEEEECC
Q ss_conf 7239997881033783839999957------99689999804789-20689999999998604-7998111578998489
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKD 440 (688)
Q Consensus 369 ~~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 440 (688)
..++|++.++||+|+||.||+|+.. .+..||||+++... .....++.+|+.++.++ +|||||++++++.+..
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf 78996985498206882999999806644778869999998742487799999999999876269998878998983199
Q ss_pred CEEEEEECCCCCCHHHHHHCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEE
Q ss_conf 3269996169999556733038---------------8788998889999999999989844089997575578999458
Q 005599 441 EKMLIYEFMPNKSLDYFIFDES---------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNIL 505 (688)
Q Consensus 441 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nil 505 (688)
..++||||+++|+|..++.... ....+++..+..++.||+.||.|||+++ ++||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCC
T ss_conf 78999973799879999985356654444453322233458899999999999999999887579---266624102100
Q ss_pred ECCCCCCEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCH
Q ss_conf 77999810013112100279753112234345577337101138988974652448999999881999998888898317
Q 005599 506 LDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNL 585 (688)
Q Consensus 506 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~ 585 (688)
++.++.+|++|||+++...............||+.|+|||.+.+..++.++||||||+++|||++++.|+.........+
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred CCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf 00257521023401023367886158620135968767788617999974001025899999985899887789989999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 8999998246643211343246999989999999998415359988999978999982289
Q 005599 586 IRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 586 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 646 (688)
...+ +...+...+...+..+.+|+.+||+.||++||||.+|+++|+..
T Consensus 258 ~~~i-------------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 258 YKMI-------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHH-------------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH-------------HCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 9998-------------66898898543659999999997577965792999999999876
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.77 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=192.7
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCC--CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEEC----CCEEEEE
Q ss_conf 97881033783839999957-9968999980478--920689999999998604799811157899848----9326999
Q 005599 374 STSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK----DEKMLIY 446 (688)
Q Consensus 374 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~lv~ 446 (688)
++.++||+|+||+||+|+.. +++.||+|++... .....+.+.+|+.++.+++|||||++++++... ...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC-CCCCCEECCCCCCEECCC
Q ss_conf 6169999556733038878899888999999999998984408999757557899945877-999810013112100279
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLD-EEMNPRISDFGTARVFGG 525 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfgla~~~~~ 525 (688)
||+++|+|.+++... ..+++..+..++.||+.||.|||+++ ++|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred ECCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC
T ss_conf 578989489997513---55469999999999999999999789-97996876743511667999889800576542368
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 75311223434557733710113898897465244899999988199999888889831789999982466432113432
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 605 (688)
. ......||+.|+|||++.+ .++.++||||+||++|||++|+.||..... .... ......+.. ...
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----~~~~-~~~i~~~~~----~~~ 233 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQI-YRRVTSGVK----PAS 233 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHH-HHHHTTTCC----CGG
T ss_pred C----CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCC----HHHH-HHHHHCCCC----CCC
T ss_conf 7----6677553813008988478-999867110079999999878899987655----9999-999973899----865
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 469999899999999984153599889999789999
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 606 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 641 (688)
+.. ..+.++.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~----~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 FDK----VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC----CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 675----57899999999976379758929999967
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.01 Aligned_cols=262 Identities=26% Similarity=0.403 Sum_probs=211.5
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEECC--------CCEEEEEECCCCC-CCCHHHHHHHHHHHHHC-CCCCCCCEEEEEEE
Q ss_conf 72399978810337838399999579--------9689999804789-20689999999998604-79981115789984
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLAN--------GQEIAVKRLSTTS-GQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLE 438 (688)
Q Consensus 369 ~~~~f~~~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 438 (688)
..++|++.+.||+|+||.||+|+... +..||||++.... .....++.+|...+.++ +|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf 58996970098516782899999857875556675499999988112868899999999999981399969734652201
Q ss_pred CCCEEEEEECCCCCCHHHHHHCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEE
Q ss_conf 893269996169999556733038-------------8788998889999999999989844089997575578999458
Q 005599 439 KDEKMLIYEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNIL 505 (688)
Q Consensus 439 ~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nil 505 (688)
....++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEE
T ss_conf 88689999736999099999860677643222334574346799999999999999998766379---786302210224
Q ss_pred ECCCCCCEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCC
Q ss_conf 77999810013112100279753112234345577337101138988974652448999999881-99999888889831
Q 005599 506 LDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSN 584 (688)
Q Consensus 506 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~ 584 (688)
++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |.+||.... ..
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~--~~- 244 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VE- 244 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HH-
T ss_pred ECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC--HH-
T ss_conf 547897676221110113555554314667888466326675179888255547758888874017989899999--99-
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 7899999824664321134324699998999999999841535998899997899998228999
Q 005599 585 LIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETS 648 (688)
Q Consensus 585 ~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 648 (688)
.+......+. ....+...+.++.+|+.+||+.+|++|||+.||++.|+++.+
T Consensus 245 ---~~~~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 ---ELFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ---HHHHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHCCC---------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ---9999997288---------889874352999999999766797679399999999988860
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.09 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=205.7
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECC-CC--EEEEEECCCC-CCCCHHHHHHHHHHHHHC-CCCCCCCEEEEEEECCCEEEE
Q ss_conf 399978810337838399999579-96--8999980478-920689999999998604-799811157899848932699
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLAN-GQ--EIAVKRLSTT-SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 445 (688)
++|++.++||+|+||.||+|++.+ +. .||||++... .....+.|.+|+.++.++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EECCCCCCHHHHHHCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCC
Q ss_conf 9616999955673303-------------887889988899999999999898440899975755789994587799981
Q 005599 446 YEFMPNKSLDYFIFDE-------------SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNP 512 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 512 (688)
+||+++|+|.+++... .....+++..+++++.|||.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EECCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCCCCCCCHHHHHHH
Q ss_conf 0013112100279753112234345577337101138988974652448999999881999-998888898317899999
Q 005599 513 RISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKK-NTGIFNDDSSNLIRYVWE 591 (688)
Q Consensus 513 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~-p~~~~~~~~~~~~~~~~~ 591 (688)
||+|||+++..... .......||..|+|||.+.+..++.++||||||+++|||++|.. ||... ...+....
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-----~~~~~~~~ 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCAELYEK 238 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHH
T ss_pred EECCCCCCCCCCCC---CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
T ss_conf 87434432244422---34553013775555387526999962215313889999983689999999-----99999999
Q ss_pred HHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 82466432113432469999899999999984153599889999789999822899
Q 005599 592 LWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 592 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 647 (688)
. ..+ .+...+...+.++.+|+.+||+.||++||||.+|++.|+.+.
T Consensus 239 i-~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 239 L-PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp G-GGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-HHC---------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 9-826---------888887667899999999976789668949999999999998
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.10 Aligned_cols=262 Identities=27% Similarity=0.387 Sum_probs=206.5
Q ss_pred HHHCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEECCCC-CCCCHHHHHHHHHHHHHC-CCCCCCCEEEEEEEC
Q ss_conf 87239997881033783839999957------9968999980478-920689999999998604-799811157899848
Q 005599 368 AATDNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTT-SGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLEK 439 (688)
Q Consensus 368 ~~~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 439 (688)
...++|++.++||+|+||.||+|+.. +++.||||++... .....+.+..|...+.++ +|+||+.+++++...
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCC
T ss_conf 16799798449841678399999986777555783999999860017178999999999988614998499741154047
Q ss_pred C-CEEEEEECCCCCCHHHHHHCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEE
Q ss_conf 9-3269996169999556733038-------------8788998889999999999989844089997575578999458
Q 005599 440 D-EKMLIYEFMPNKSLDYFIFDES-------------RKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNIL 505 (688)
Q Consensus 440 ~-~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nil 505 (688)
+ ..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEE
T ss_conf 97579999845899299999853666665322202332146899999999999999999887379---717867731065
Q ss_pred ECCCCCCEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCCCCCC
Q ss_conf 7799981001311210027975311223434557733710113898897465244899999988199-999888889831
Q 005599 506 LDEEMNPRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK-KNTGIFNDDSSN 584 (688)
Q Consensus 506 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~-~p~~~~~~~~~~ 584 (688)
|++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+++. +||..... ...
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-~~~ 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEE 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-SHH
T ss_pred ECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCH-HHH
T ss_conf 7799828984575200113566522247516672102036864688996632213678999998688999989998-999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 78999998246643211343246999989999999998415359988999978999982289
Q 005599 585 LIRYVWELWSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 585 ~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 646 (688)
+...+. .+. ....+...+.++.+|+.+||+.||++|||+.+|++.|+++
T Consensus 246 ~~~~~~----~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 246 FCRRLK----EGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHHH----HTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHH----CCC---------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 999996----389---------8888865789999999997677966791999999999799
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.88 Aligned_cols=262 Identities=26% Similarity=0.374 Sum_probs=211.1
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEECCCC-CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC
Q ss_conf 7239997881033783839999957------9968999980478-92068999999999860479981115789984893
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKLA------NGQEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE 441 (688)
Q Consensus 369 ~~~~f~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 441 (688)
..++|++.++||+|+||.||+|.+. ++..||||++... .......|.+|+.++.+++||||+++++++...+.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf 68991883598207881899999878644778968999998701286899999999999997699988412547842881
Q ss_pred EEEEEECCCCCCHHHHHHCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEE
Q ss_conf 26999616999955673303-------88788998889999999999989844089997575578999458779998100
Q 005599 442 KMLIYEFMPNKSLDYFIFDE-------SRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRI 514 (688)
Q Consensus 442 ~~lv~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 514 (688)
.++|+||+++|+|..++... .....+++..+.+++.|+|.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEE
T ss_conf 06777604899889998750332113444688799999999999999999876479---654328677540359964999
Q ss_pred CCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCCCCCCHHHHHHHHH
Q ss_conf 1311210027975311223434557733710113898897465244899999988199-999888889831789999982
Q 005599 515 SDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGK-KNTGIFNDDSSNLIRYVWELW 593 (688)
Q Consensus 515 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~ 593 (688)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++|. +|+... ...+......
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~~~~~~~~i~ 249 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVLRFVM 249 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHHHHHH
T ss_pred EECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHH
T ss_conf 42454202357763031340231632378888736998833344437899999996899999998-----9999999998
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 4664321134324699998999999999841535998899997899998228999
Q 005599 594 SDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETS 648 (688)
Q Consensus 594 ~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 648 (688)
+ +.. ...+...+..+.+|+.+||+.+|++||||.+|+++|+....
T Consensus 250 ~-~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 E-GGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp T-TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H-CCC---------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 0-888---------88863353999999999757796589399999999787617
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=334.60 Aligned_cols=248 Identities=25% Similarity=0.302 Sum_probs=196.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCC---CCCCHHHHHH---HHHHHHHCCCCCCCCEEEEEEECCCEE
Q ss_conf 39997881033783839999957-9968999980478---9206899999---999986047998111578998489326
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKN---EVLLIAKLQHRNLVKLLGCCLEKDEKM 443 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~ 443 (688)
++|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+ ++.++..++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEEC
Q ss_conf 99961699995567330388788998889999999999989844089997575578999458779998100131121002
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~ 523 (688)
+||||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEECCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf 999914898389998732---55327899999999999999999779---622044422167858896798220102333
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 79753112234345577337101138-98897465244899999988199999888889831789999982466432113
Q 005599 524 GGEEISTNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIV 602 (688)
Q Consensus 524 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 602 (688)
.... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||...... ............
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~~~~------- 224 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTM------- 224 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHHHHSSSC-------
T ss_pred CCCC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHCCCC-------
T ss_conf 7886----433113455421687603899984410467789999998599988889989--999999860468-------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 432469999899999999984153599889999-----789999
Q 005599 603 DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 641 (688)
Q Consensus 603 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 641 (688)
.. ..+...+.++.+|+.+||+.||++||| +.++++
T Consensus 225 ~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CC----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CC----CCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf 88----78877899999999998566988808874357999974
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.95 Aligned_cols=254 Identities=30% Similarity=0.431 Sum_probs=202.3
Q ss_pred CCCCCCCCCEEEEEEEECCC----CEEEEEECCCC-CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEEC-CCEEEEEECC
Q ss_conf 88103378383999995799----68999980478-920689999999998604799811157899848-9326999616
Q 005599 376 SNKLGQGGFGPVYKGKLANG----QEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK-DEKMLIYEFM 449 (688)
Q Consensus 376 ~~~lg~G~fg~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 449 (688)
.++||+|+||+||+|++.+. ..||||++... .....++|.+|+.++.+++||||++++|++... ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCCCCC
Q ss_conf 99995567330388788998889999999999989844089997575578999458779998100131121002797531
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 529 (688)
++++|.+++... ...+++..+++++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ECCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 067414421013--454048999999999887652003367---625776687576779998899106523225566555
Q ss_pred C--CCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 1--22343455773371011389889746524489999998819999988888983178999998246643211343246
Q 005599 530 T--NTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMA 607 (688)
Q Consensus 530 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 607 (688)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... .+....+ ... . +
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i---~~g-~---------~ 252 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYL---LQG-R---------R 252 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH---HTT-C---------C
T ss_pred CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHH---HCC-C---------C
T ss_conf 310025655564556768874379997457466199999999789999888999-9999999---808-9---------8
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 99998999999999841535998899997899998228999
Q 005599 608 DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNETS 648 (688)
Q Consensus 608 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 648 (688)
...+...+..+.+|+.+||+.||++||+|.||++.|+.+..
T Consensus 253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 89964475999999999768897689399999999999997
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=336.55 Aligned_cols=244 Identities=23% Similarity=0.313 Sum_probs=201.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC---CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEE
Q ss_conf 3999788103378383999995-79968999980478---9206899999999986047998111578998489326999
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 446 (688)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.++..++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCC
Q ss_conf 61699995567330388788998889999999999989844089997575578999458779998100131121002797
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~ 526 (688)
||+++|+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EECCCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf 503786322343222---21110079999999987655412476---770556810503868998898317521671245
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 53112234345577337101138988974652448999999881999998888898317899999824664321134324
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 606 (688)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ............ .
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~~~~-------~-- 218 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKILNAE-------L-- 218 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHCC-------C--
T ss_pred -----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCC-----HHHHHHHHHCCC-------C--
T ss_conf -----643457634359999838999804304653336899975989999969-----999999997089-------8--
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 6999989999999998415359988999-----9789999
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 641 (688)
Q Consensus 607 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 641 (688)
..+...+.++.+++.+||+.+|++|| |+.++++
T Consensus 219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf --89977899999999999544997666431021999981
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.34 Aligned_cols=255 Identities=23% Similarity=0.334 Sum_probs=204.7
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECC----CCEEEEEECCCC-CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEE
Q ss_conf 2399978810337838399999579----968999980478-92068999999999860479981115789984893269
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLAN----GQEIAVKRLSTT-SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 444 (688)
.++|++.+.||+|+||.||+|+... +..||+|.+... .....+.|.+|+.++.+++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf 8996987799307882999999936996449999999365668799999999999998689999856988995-374799
Q ss_pred EEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECC
Q ss_conf 99616999955673303887889988899999999999898440899975755789994587799981001311210027
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFG 524 (688)
Q Consensus 445 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~ 524 (688)
|+||+++|+|..++... ...+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEECCCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECC
T ss_conf 99840698077654224--789999999999999987752302267---4414102655320678967876503421336
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 9753112234345577337101138988974652448999999881-999998888898317899999824664321134
Q 005599 525 GEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVD 603 (688)
Q Consensus 525 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 603 (688)
..... ......||+.|+|||++.+..++.++||||||+++|||++ |.+|+..... ..+...+. . +..
T Consensus 160 ~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~i~---~-~~~----- 227 (273)
T d1mp8a_ 160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIE---N-GER----- 227 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHH---T-TCC-----
T ss_pred CCCCE-ECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH--HHHHHHHH---C-CCC-----
T ss_conf 77623-305400583103266751699887452444247899998269999888999--99999998---1-899-----
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 3246999989999999998415359988999978999982289
Q 005599 604 SSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 604 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 646 (688)
...+...+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 228 ----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 228 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ----989877799999999997687976892999999999999
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=335.76 Aligned_cols=244 Identities=23% Similarity=0.248 Sum_probs=202.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCC---CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEE
Q ss_conf 39997881033783839999957-9968999980478---9206899999999986047998111578998489326999
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 446 (688)
++|++++.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++..++|||||++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCC
Q ss_conf 61699995567330388788998889999999999989844089997575578999458779998100131121002797
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGE 526 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~ 526 (688)
||+.+|+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 233466226667515---89899999999999999899998599---861767999936077897886101033322566
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 53112234345577337101138988974652448999999881999998888898317899999824664321134324
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 606 (688)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||... ............. ..
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~i~~~~-------~~- 256 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QPIQIYEKIVSGK-------VR- 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCC-------CC-
T ss_pred -----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHCCC-------CC-
T ss_conf -----64336763567889971799885331145007899997588998995-----9999999986179-------88-
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 6999989999999998415359988999-----9789999
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRP-----SMSTVVF 641 (688)
Q Consensus 607 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 641 (688)
.+...+.++.+|+.+||+.||.+|+ |+.++++
T Consensus 257 ---~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 ---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf ---9766899999999998340998606553454999971
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.98 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=202.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEEC-CCEEEEEECC
Q ss_conf 399978810337838399999579968999980478920689999999998604799811157899848-9326999616
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK-DEKMLIYEFM 449 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 449 (688)
++|++.+.||+|+||.||+|+.+ +..||||+++.. ...+.+.+|+.++.+++||||++++|++.+. +..++|+||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
T ss_conf 99488579820798089999999-909999998857--779999999999986789898549878872389289999636
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCCCCC
Q ss_conf 99995567330388788998889999999999989844089997575578999458779998100131121002797531
Q 005599 450 PNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEIS 529 (688)
Q Consensus 450 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~ 529 (688)
++|+|.+++.... ...+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCC---
T ss_conf 9998999987457-888899999999999985232113376---553666567601468997763245600344787---
Q ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 12234345577337101138988974652448999999881-99999888889831789999982466432113432469
Q 005599 530 TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSMAD 608 (688)
Q Consensus 530 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 608 (688)
.....++..|+|||++.+..++.++||||||+++|||++ |++|+... ...+....+. . ..+.
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~----~---------~~~~ 219 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVE----K---------GYKM 219 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHT----T---------TCCC
T ss_pred --CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHH----C---------CCCC
T ss_conf --765566646778178727988858877757999999997899999999--9999999998----0---------8999
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 99989999999998415359988999978999982289
Q 005599 609 SCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 609 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 646 (688)
..+...+.++.+|+.+||+.||++||||.+|+++|+.+
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 99765799999999997566976893999999999999
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.34 Aligned_cols=251 Identities=18% Similarity=0.255 Sum_probs=202.0
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEC
Q ss_conf 239997881033783839999957-9968999980478920689999999998604799811157899848932699961
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 448 (688)
.++|++.+.||+|+||+||+|... +++.||+|.+.... .....+.+|+.++..++|||||++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 010588789831778399999998999699999975786-6599999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCC--CCCEECCCCCCEECCCC
Q ss_conf 6999955673303887889988899999999999898440899975755789994587799--98100131121002797
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEE--MNPRISDFGTARVFGGE 526 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~--~~~kl~Dfgla~~~~~~ 526 (688)
+++|+|.+++... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.+ ..+||+|||++......
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf 8998088998753--899999999999999999999998769---97513554443443788518997644111003467
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 53112234345577337101138988974652448999999881999998888898317899999824664321134324
Q 005599 527 EISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSSM 606 (688)
Q Consensus 527 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 606 (688)
.. .....+++.|+|||.+.+..++.++||||+||++|+|++|+.||.... .............. ++...
T Consensus 158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-----~~~~~~~i~~~~~~---~~~~~ 226 (321)
T d1tkia_ 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----NQQIIENIMNAEYT---FDEEA 226 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHTCCC---CCHHH
T ss_pred CC---CCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHCCCC---CCHHH
T ss_conf 75---321223322234021048777840113027999999982899999989-----99999999838999---88022
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 69999899999999984153599889999789999
Q 005599 607 ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 607 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 641 (688)
.. ..+.++.+|+.+||+.||++|||+.|+++
T Consensus 227 ~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 FK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC----CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 36----78999999999986699668909999963
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.14 Aligned_cols=257 Identities=26% Similarity=0.367 Sum_probs=205.2
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEECC--C--CEEEEEECCCC---CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCE
Q ss_conf 2399978810337838399999579--9--68999980478---920689999999998604799811157899848932
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLAN--G--QEIAVKRLSTT---SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEK 442 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 442 (688)
.++|++.+.||+|+||.||+|+... + ..||||++... .....++|.+|+.++.+++||||++++|++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCH
T ss_conf 4891997898038883999999988999079999999983555798999999999999986899998789877740-100
Q ss_pred EEEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEE
Q ss_conf 69996169999556733038878899888999999999998984408999757557899945877999810013112100
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 443 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~ 522 (688)
++|+||++++++.+.+... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred HEEEEEECCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHH
T ss_conf 1146542386125444212--689999999999999999998752178---75205668881565565433256115553
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 2797531-12234345577337101138988974652448999999881-999998888898317899999824664321
Q 005599 523 FGGEEIS-TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIIT-GKKNTGIFNDDSSNLIRYVWELWSDDKALE 600 (688)
Q Consensus 523 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (688)
....... .......|+..|+|||.+.+..++.++||||||+++|||++ |+.||... ...+........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-----~~~~~~~~i~~~~~--- 232 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQILHKIDKEGE--- 232 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTSCC---
T ss_pred CCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHHCCC---
T ss_conf 0358875265476325731079999837999942156614899999996899999996-----99999999984799---
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 1343246999989999999998415359988999978999982289
Q 005599 601 IVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 601 ~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 646 (688)
....+...+..+.+|+.+||+.||++||||.+|++.|++.
T Consensus 233 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf ------9998544539999999997688966792999999999964
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.03 Aligned_cols=267 Identities=21% Similarity=0.304 Sum_probs=199.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECC----CEEEEE
Q ss_conf 3999788103378383999995799689999804789206899999999986047998111578998489----326999
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD----EKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 446 (688)
++|.+.++||+|+||.||+|++ +|+.||||++..... .......|+..+.+++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCCH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf 6899988982078819999999-998999999872004-67999999999962799868326889983798604899999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-----CCCEEECCCCCCCEEECCCCCCEECCCCCCE
Q ss_conf 61699995567330388788998889999999999989844089-----9975755789994587799981001311210
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS-----RLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~ 521 (688)
||+++|+|..++.. ..++|..+++++.++|.||+|||+.. .++|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ECCCCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
T ss_conf 64669898999865----89998999999999999999988766520468986615317313578688776887638662
Q ss_pred ECCCCCCC--CCCCCCCCCCCCCCCEEECCCC------CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC---------C
Q ss_conf 02797531--1223434557733710113898------89746524489999998819999988888983---------1
Q 005599 522 VFGGEEIS--TNTNRVVGTYGYMSPEYALGGL------FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSS---------N 584 (688)
Q Consensus 522 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~elltg~~p~~~~~~~~~---------~ 584 (688)
........ .......||+.|+|||++.+.. ++.++|||||||++|||++|..|+........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred CCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCC
T ss_conf 34677762001355250354767822105654546777675012201599999996289988766311241012255643
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 7899999824664321134324699-99899999999984153599889999789999822899
Q 005599 585 LIRYVWELWSDDKALEIVDSSMADS-CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNET 647 (688)
Q Consensus 585 ~~~~~~~~~~~~~~~~~id~~l~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 647 (688)
...........+ .+++.+... .+......+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 237 ~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 237 SVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHCC----CCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 099999987502----468887765577689999999999976069858959999999999888
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.74 Aligned_cols=261 Identities=23% Similarity=0.312 Sum_probs=197.6
Q ss_pred CCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCC-----CHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEC
Q ss_conf 7881033783839999957-9968999980478920-----689999999998604799811157899848932699961
Q 005599 375 TSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQ-----GIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 375 ~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 448 (688)
.+++||+|+||+||+|+.. +++.||||++...... ..+.+.+|+.++.+++|||||++++++...+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCCCC
Q ss_conf 69999556733038878899888999999999998984408999757557899945877999810013112100279753
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~ 528 (688)
+.++++..+. .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred HCCHHHHHHH---HCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC
T ss_conf 3450776554---12667789999999999999998863163---55035776258853778411465761000578755
Q ss_pred CCCCCCCCCCCCCCCCEEECCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC------C
Q ss_conf 1122343455773371011389-88974652448999999881999998888898317899999824664321------1
Q 005599 529 STNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALE------I 601 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 601 (688)
......||+.|+|||++.+. .++.++||||+||++|||++|.+||.... ..+....+........... .
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred --CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCC--HHHHHHHHHHHCCCCCHHHCCCHHCC
T ss_conf --43302047333639997267788805643630428999985969999999--99999999985189972545210002
Q ss_pred CCCCC---CCCCCH-----HHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHCC
Q ss_conf 34324---699998-----99999999984153599889999789999--8228
Q 005599 602 VDSSM---ADSCPA-----PEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSN 645 (688)
Q Consensus 602 id~~l---~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~evl~--~L~~ 645 (688)
..... ....+. ..+.++.+|+.+||+.||++|||+.|+++ -+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred CHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 134430347898867856568999999999976389456908999967996578
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.44 Aligned_cols=251 Identities=19% Similarity=0.210 Sum_probs=196.4
Q ss_pred HCCCCCCC-CCCCCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHC-CCCCCCCEEEEEEE----CCCE
Q ss_conf 23999788-103378383999995-79968999980478920689999999998604-79981115789984----8932
Q 005599 370 TDNFSTSN-KLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKL-QHRNLVKLLGCCLE----KDEK 442 (688)
Q Consensus 370 ~~~f~~~~-~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 442 (688)
.++|.+.. .||+|+||.||+|+. .+++.||||++.. ...+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 14879810796545486999999889998999999897-----4779999999998669999782989995034689789
Q ss_pred EEEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC---CCCCEECCCCC
Q ss_conf 699961699995567330388788998889999999999989844089997575578999458779---99810013112
Q 005599 443 MLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---EMNPRISDFGT 519 (688)
Q Consensus 443 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfgl 519 (688)
++||||+++|+|.+++... ....+++.....++.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 9999778998499999862-7877579999999999999999999769---86444100220113555566311354551
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 10027975311223434557733710113898897465244899999988199999888889831789999982466432
Q 005599 520 ARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL 599 (688)
Q Consensus 520 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (688)
++....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||....... .......
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~~~~-------- 227 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKT-------- 227 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred EEECCCCCC---CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH--HHHHHHH--------
T ss_conf 233368886---432267756379277748988888888764516778865889988988778--8999999--------
Q ss_pred CCCCCCCC--CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 11343246--99998999999999841535998899997899998
Q 005599 600 EIVDSSMA--DSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 600 ~~id~~l~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 642 (688)
.+...... .......+.++.+|+.+||+.||++|||+.|+++.
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 985388888985434699999999999756996579099999709
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=328.75 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=205.8
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCC---CCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC----
Q ss_conf 23999788103378383999995-799689999804789---2068999999999860479981115789984893----
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS---GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDE---- 441 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 441 (688)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++..++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCE
Q ss_conf 26999616999955673303887889988899999999999898440899975755789994587799981001311210
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 442 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~ 521 (688)
.++||||+++++|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++..+++|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEEHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 99999778898710112035---89999999999999999999998579---5276346755665754320100344432
Q ss_pred ECCCCCC-CCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 0279753-112234345577337101138988974652448999999881999998888898317899999824664321
Q 005599 522 VFGGEEI-STNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALE 600 (688)
Q Consensus 522 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (688)
....... ........||+.|+|||++.+..++.++||||+|+++|||++|++||.... ...............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~~~~~~~~~- 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----PVSVAYQHVREDPIP- 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHCCCCC-
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHCCCCC-
T ss_conf 21235443333464257624369999839999966320265289999976979989969-----999999998469999-
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHCC
Q ss_conf 1343246999989999999998415359988999-97899998228
Q 005599 601 IVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRP-SMSTVVFMLSN 645 (688)
Q Consensus 601 ~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~ 645 (688)
...... ..+..+.+++.+||++||++|| |+++++..|..
T Consensus 234 --~~~~~~----~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 --PSARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp --GGGTSS----SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --CCHHCC----CCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf --710034----7899999999998667976777399999999999
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=324.32 Aligned_cols=252 Identities=22% Similarity=0.279 Sum_probs=201.6
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCCC---------CHHHHHHHHHHHHHCC-CCCCCCEEEEEEE
Q ss_conf 23999788103378383999995-79968999980478920---------6899999999986047-9981115789984
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQ---------GIEEFKNEVLLIAKLQ-HRNLVKLLGCCLE 438 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 438 (688)
.++|++.+.||+|+||+||+++. .+++.||||++...... ..+.+.+|+.++.+++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCEEEEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCC
Q ss_conf 89326999616999955673303887889988899999999999898440899975755789994587799981001311
Q 005599 439 KDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG 518 (688)
Q Consensus 439 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 518 (688)
.+..++||||+++|+|.+++... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCCEEEEEECCCCCHHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCH
T ss_conf 76059999768986689999865---99999999999999999999998759---9432346254898689983871240
Q ss_pred CCEECCCCCCCCCCCCCCCCCCCCCCEEECC------CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 2100279753112234345577337101138------9889746524489999998819999988888983178999998
Q 005599 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALG------GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWEL 592 (688)
Q Consensus 519 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 592 (688)
+++....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ........
T Consensus 156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-----~~~~~~~i 227 (277)
T d1phka_ 156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-----QMLMLRMI 227 (277)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHH
T ss_pred HEEECCCCCC---EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCC-----HHHHHHHH
T ss_conf 3167268872---134524678889888605344567889923318565602310322888988999-----99999999
Q ss_pred HCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 24664321134324699998999999999841535998899997899998
Q 005599 593 WSDDKALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 593 ~~~~~~~~~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 642 (688)
... .. . .........+.++.+|+.+||+.+|++|||+.||++.
T Consensus 228 ~~~-~~-~-----~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSG-NY-Q-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHT-CC-C-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHC-CC-C-----CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 818-98-8-----8985434689999999999765896689199999739
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.52 Aligned_cols=247 Identities=25% Similarity=0.368 Sum_probs=199.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCC---CCCCHHHHHHHHHHHH-HCCCCCCCCEEEEEEECCCEEEE
Q ss_conf 39997881033783839999957-9968999980478---9206899999999986-04799811157899848932699
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT---SGQGIEEFKNEVLLIA-KLQHRNLVKLLGCCLEKDEKMLI 445 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 445 (688)
++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+..|..++. .++|||||++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCC
Q ss_conf 96169999556733038878899888999999999998984408999757557899945877999810013112100279
Q 005599 446 YEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGG 525 (688)
Q Consensus 446 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~ 525 (688)
|||+++|+|..++... ..+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEECCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 7503798089986404---78999999999999999999998689---34034765404444899630155530232356
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 75311223434557733710113898897465244899999988199999888889831789999982466432113432
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKALEIVDSS 605 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 605 (688)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...+. ...... .+.
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~---~~i~~~-------~~~ 221 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--EEELF---HSIRMD-------NPF 221 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHH---HHHHHC-------CCC
T ss_pred CC--CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC--HHHHH---HHHHCC-------CCC
T ss_conf 65--33454578777689999827998832320112278989873889999989--99999---999718-------998
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 46999989999999998415359988999978-9999
Q 005599 606 MADSCPAPEALRCIQVGLLCVQDRTTDRPSMS-TVVF 641 (688)
Q Consensus 606 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl~ 641 (688)
.+...+.++.+|+.+||+.||++||++. ++++
T Consensus 222 ----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf ----975679999999999654489878388999980
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.51 Aligned_cols=272 Identities=24% Similarity=0.369 Sum_probs=203.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCC--CCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 3999788103378383999995-799689999804789--2068999999999860479981115789984893269996
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 447 (688)
++|++.++||+|+||+||+|+. .+++.||+|++.... ....+.+.+|+.++.+++|||||++++++.+....++|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred CCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCCC
Q ss_conf 16999955673303887889988899999999999898440899975755789994587799981001311210027975
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~ 527 (688)
|+.++.+. ++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~~~-~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKK-FMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHH-HHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ECCCCHHH-HHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 23774455-54420-2568888999999999999999865288---9921357114011346762103578613436886
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH-CCCC-CCC----
Q ss_conf 311223434557733710113898-897465244899999988199999888889831789999982-4664-321----
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGL-FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELW-SDDK-ALE---- 600 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~-~~~---- 600 (688)
. ......||+.|+|||.+.... ++.++||||+|+++|+|++|+.||..... ........... .... ...
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred C--CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCH--HHHHHHHHHHCCCCCHHHCCCCCC
T ss_conf 4--100103652154112213665777422103333134279668799898899--999999998328983331444222
Q ss_pred CCCC--CCC--CCC-----CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HCCCCCCCCC
Q ss_conf 1343--246--999-----98999999999841535998899997899998--2289999999
Q 005599 601 IVDS--SMA--DSC-----PAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LSNETSVPSP 652 (688)
Q Consensus 601 ~id~--~l~--~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~~~~~p 652 (688)
..+. ... ... ....+..+.+|+.+||+.||++|||+.|+++. ++++ ..|.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~-~~p~p 294 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV-TKPVP 294 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC-CCCCC
T ss_pred CCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC-CCCCC
T ss_conf 421243454322220444166789999999999763995579189999678701469-99999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=319.61 Aligned_cols=261 Identities=22% Similarity=0.357 Sum_probs=202.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCCC--CCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEC
Q ss_conf 3999788103378383999995799689999804789--20689999999998604799811157899848932699961
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYEF 448 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 448 (688)
++|++.++||+|+||+||+|+.++++.||||++.... ....+.+.+|+.++.+++||||+++++.+...+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCCCC
Q ss_conf 69999556733038878899888999999999998984408999757557899945877999810013112100279753
Q 005599 449 MPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEEI 528 (688)
Q Consensus 449 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~ 528 (688)
+.++.+..+. .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||.+........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EHHHHHHHHH---HHCCCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC
T ss_conf 0045678998---60477514456899999999999860574---88267877505686899787323664301146765
Q ss_pred CCCCCCCCCCCCCCCCEEECCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCC------CC
Q ss_conf 1122343455773371011389-8897465244899999988199999888889831789999982466432------11
Q 005599 529 STNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL------EI 601 (688)
Q Consensus 529 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 601 (688)
......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||..... .+....+.......... ..
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--ADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCH--HHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf --410102431101378871788888410021117589999779799898898--9999999986389971104212333
Q ss_pred --CCCCC-------CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf --34324-------69999899999999984153599889999789999
Q 005599 602 --VDSSM-------ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 602 --id~~l-------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 641 (688)
..... ........+..+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 2214333335676466651258999999999986689668909999856
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.11 Aligned_cols=264 Identities=22% Similarity=0.333 Sum_probs=194.8
Q ss_pred HHCCCCCCCCCCCCCCEEEEEEEE-CC-CCEEEEEECCCC--CCCCHHHHHHHHHHHHHC---CCCCCCCEEEEEEEC--
Q ss_conf 723999788103378383999995-79-968999980478--920689999999998604---799811157899848--
Q 005599 369 ATDNFSTSNKLGQGGFGPVYKGKL-AN-GQEIAVKRLSTT--SGQGIEEFKNEVLLIAKL---QHRNLVKLLGCCLEK-- 439 (688)
Q Consensus 369 ~~~~f~~~~~lg~G~fg~Vy~~~~-~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-- 439 (688)
..++|++.++||+|+||+||+|+. .+ ++.||||++... .......+.+|+.++..+ +||||+++++++...
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 75897988899215586999999988899899999980232451679999999999998742589880236632214666
Q ss_pred ---CCEEEEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECC
Q ss_conf ---93269996169999556733038878899888999999999998984408999757557899945877999810013
Q 005599 440 ---DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISD 516 (688)
Q Consensus 440 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 516 (688)
...++++|+++++.+..... .....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCCEEEEEEEECCCCCHHHHHH--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECC
T ss_conf 66746999997405871444443--03789998999999999999999997588---98357986278985899754210
Q ss_pred CCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 11210027975311223434557733710113898897465244899999988199999888889831789999982466
Q 005599 517 FGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD 596 (688)
Q Consensus 517 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 596 (688)
||++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...............
T Consensus 160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIGLP 234 (305)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCC
T ss_pred HHHHHHHCCC---CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCC--HHHHHHHHHHHHCCC
T ss_conf 0010110023---45777654851148310017988811100032899999987879989989--899999999840799
Q ss_pred CCC------CCCCCCC-------CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 432------1134324-------699998999999999841535998899997899998
Q 005599 597 KAL------EIVDSSM-------ADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 597 ~~~------~~id~~l-------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 642 (688)
... ....... ........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 61105321111033302234564544044589999999999874896679189999669
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=317.75 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=190.9
Q ss_pred CCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECC------CEEE
Q ss_conf 9997881033783839999957-99689999804789206899999999986047998111578998489------3269
Q 005599 372 NFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD------EKML 444 (688)
Q Consensus 372 ~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 444 (688)
+|...++||+|+||+||+|+.. +++.||||++...... ..+|+.++.+++|+||+++++++.... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 767516982176839999999999979999998816068----9999999986689898738789974476577318999
Q ss_pred EEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC-CCEECCCCCCEEC
Q ss_conf 996169999556733038878899888999999999998984408999757557899945877999-8100131121002
Q 005599 445 IYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM-NPRISDFGTARVF 523 (688)
Q Consensus 445 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgla~~~ 523 (688)
||||++++.+..+.........+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 9841688607888863103689999999999999999999998668---7645788603787358971167336605440
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH----------HH
Q ss_conf 797531122343455773371011389-8897465244899999988199999888889831789999----------98
Q 005599 524 GGEEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVW----------EL 592 (688)
Q Consensus 524 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~----------~~ 592 (688)
...... ....|++.|+|||.+.+. .++.++||||+||++|||++|++||...... ..+..... ..
T Consensus 174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHH
T ss_pred CCCCCC---CCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHH-HHHHHHHHHHCCCHHHHHHH
T ss_conf 477653---20025555568277640468882100024652778550287998987999-99999999748981776543
Q ss_pred HCCC----CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 2466----432113432469999899999999984153599889999789999
Q 005599 593 WSDD----KALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 593 ~~~~----~~~~~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 641 (688)
.... ..................+.++.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 06210110355445674444315689999999999976589557929999966
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=309.43 Aligned_cols=268 Identities=18% Similarity=0.272 Sum_probs=199.6
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCC-CCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECC----CEE
Q ss_conf 23999788103378383999995-799689999804789-206899999999986047998111578998489----326
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS-GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD----EKM 443 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 443 (688)
+++|++.+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.+|.+++|||++++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEEC
Q ss_conf 99961699995567330388788998889999999999989844089997575578999458779998100131121002
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVF 523 (688)
Q Consensus 444 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~ 523 (688)
++++++.+++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||++...
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 99996259865664405----89999999999999999999999789---867778764378879997787545705650
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCEEECC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCC--
Q ss_conf 797531-12234345577337101138-98897465244899999988199999888889831789999982466432--
Q 005599 524 GGEEIS-TNTNRVVGTYGYMSPEYALG-GLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL-- 599 (688)
Q Consensus 524 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 599 (688)
...... .......|++.|+|||++.. ..++.++||||+|+++|||++|+.||..... .................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHHH
T ss_pred CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCH--HHHHHHHHHHCCCCCHHHH
T ss_conf 47776410101102652000387860478887410100467013377669799788888--9999987652069975664
Q ss_pred ---------CCC-CCCCCCCCCH-----HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HCCC
Q ss_conf ---------113-4324699998-----999999999841535998899997899998--2289
Q 005599 600 ---------EIV-DSSMADSCPA-----PEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LSNE 646 (688)
Q Consensus 600 ---------~~i-d~~l~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~ 646 (688)
... ........+. ..+..+.+|+.+||+.||++|||+.++++. |+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 2343322220244677557787778378999999999999764895679089998619865558
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=311.12 Aligned_cols=262 Identities=22% Similarity=0.320 Sum_probs=198.6
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC--CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECC------
Q ss_conf 23999788103378383999995-79968999980478--9206899999999986047998111578998489------
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKD------ 440 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 440 (688)
.++|++.++||+|+||+||+|.. .+++.||||++... .....+.+.+|+.+|.+++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred CEEEEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCC
Q ss_conf 32699961699995567330388788998889999999999989844089997575578999458779998100131121
Q 005599 441 EKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTA 520 (688)
Q Consensus 441 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla 520 (688)
..++||||+ +.+|..+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEECC-CCCHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 599998405-521899987----402269999999999999999987378---764566851111210012211343102
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCEEECCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCC---
Q ss_conf 002797531122343455773371011389-8897465244899999988199999888889831789999982466---
Q 005599 521 RVFGGEEISTNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDD--- 596 (688)
Q Consensus 521 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 596 (688)
...... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ..............
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--LDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHH
T ss_pred ECCCCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCH--HHHHHHHHHCCCCCCHH
T ss_conf 206876-----31024553335889981787899650103003899999978699888976--89999998503788488
Q ss_pred --------C-------CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HCCCC
Q ss_conf --------4-------321134324699998999999999841535998899997899998--22899
Q 005599 597 --------K-------ALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM--LSNET 647 (688)
Q Consensus 597 --------~-------~~~~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~ 647 (688)
. ........+. ......+..+.+|+.+||+.||++|||+.|+++. ++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHCCHHHHHHHCCCCCCCCCCHH-HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 88653000344331157866655667-75568999999999997729955792999996396237587
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=309.91 Aligned_cols=265 Identities=20% Similarity=0.311 Sum_probs=198.9
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCC--CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEEC-------
Q ss_conf 23999788103378383999995-79968999980478--920689999999998604799811157899848-------
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK------- 439 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 439 (688)
.++|++.++||+|+||+||+|+. .+++.||||++... .......+.+|+.++.+++|+|++++++.+...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred -CCEEEEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCC
Q ss_conf -9326999616999955673303887889988899999999999898440899975755789994587799981001311
Q 005599 440 -DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFG 518 (688)
Q Consensus 440 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 518 (688)
...++|+||+.++.+.... .....++......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEECCCCCCCCHHH---HCCCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECC
T ss_conf 76389998535787410122---20344330899999999999998852299---8856767222036689968763135
Q ss_pred CCEECCCCCCC--CCCCCCCCCCCCCCCEEECCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 21002797531--122343455773371011389-889746524489999998819999988888983178999998246
Q 005599 519 TARVFGGEEIS--TNTNRVVGTYGYMSPEYALGG-LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSD 595 (688)
Q Consensus 519 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 595 (688)
++......... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||....+ .............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--~~~~~~i~~~~~~ 240 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLCGS 240 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCC
T ss_pred EEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCH--HHHHHHHHHHCCC
T ss_conf 00223554443211356602497874289970799989178700678646617448799899899--9999999984189
Q ss_pred --CCCC-C--------CCCCCCCCCCCHH-------HHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --6432-1--------1343246999989-------99999999841535998899997899998
Q 005599 596 --DKAL-E--------IVDSSMADSCPAP-------EALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 596 --~~~~-~--------~id~~l~~~~~~~-------~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 642 (688)
+... . .+........+.. ....+.+|+.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 98255344320344433201334455503340444599899999999873896589099999749
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=307.79 Aligned_cols=256 Identities=20% Similarity=0.285 Sum_probs=196.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCC-CCCCCCEEEEEEEC--CCEEEEE
Q ss_conf 3999788103378383999995-799689999804789206899999999986047-99811157899848--9326999
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEK--DEKMLIY 446 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 446 (688)
++|++.++||+|+||+||+|+. .+++.||+|+++.. ..+++.+|+.++.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 6718978983174819999998899979999998889---9999999999998515799876799999816877126888
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC-CCEECCCCCCEECCC
Q ss_conf 6169999556733038878899888999999999998984408999757557899945877999-810013112100279
Q 005599 447 EFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEM-NPRISDFGTARVFGG 525 (688)
Q Consensus 447 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgla~~~~~ 525 (688)
||+++++|..+. +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+|.....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 631798589974------68999999999999999998876433---443456441237748998366415654266468
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH-----------HHH
Q ss_conf 75311223434557733710113898-897465244899999988199999888889831789999-----------982
Q 005599 526 EEISTNTNRVVGTYGYMSPEYALGGL-FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVW-----------ELW 593 (688)
Q Consensus 526 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~-----------~~~ 593 (688)
... .....+|+.|+|||.+.+.. ++.++||||+|++++||++|+.||....+.......... ...
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHC
T ss_conf 874---44322486424761026888888452323354555876048899988760189999999987884155555422
Q ss_pred CCCC---CCCCC--------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 4664---32113--------432469999899999999984153599889999789999
Q 005599 594 SDDK---ALEIV--------DSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 594 ~~~~---~~~~i--------d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 641 (688)
.... ..... ............+.++.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 54447430000033343311211552112448999999999986699568908999964
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.91 Aligned_cols=241 Identities=23% Similarity=0.367 Sum_probs=192.2
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCC------CCHHHHHHHHHHHHHCC--CCCCCCEEEEEEECC
Q ss_conf 23999788103378383999995-7996899998047892------06899999999986047--998111578998489
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSG------QGIEEFKNEVLLIAKLQ--HRNLVKLLGCCLEKD 440 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 440 (688)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.++.+++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred CEEEEEECCCC-CCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC-CCCCEECCCC
Q ss_conf 32699961699-995567330388788998889999999999989844089997575578999458779-9981001311
Q 005599 441 EKMLIYEFMPN-KSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-EMNPRISDFG 518 (688)
Q Consensus 441 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg 518 (688)
..++|+||+.+ +++..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEEECCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf 689999833686228999861---589999999999999999999998779---75566761114774478848977546
Q ss_pred CCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 2100279753112234345577337101138988-974652448999999881999998888898317899999824664
Q 005599 519 TARVFGGEEISTNTNRVVGTYGYMSPEYALGGLF-STKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK 597 (688)
Q Consensus 519 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 597 (688)
++....... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... ......
T Consensus 157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------~i~~~~- 220 (273)
T d1xwsa_ 157 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------EIIRGQ- 220 (273)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HHHHCC-
T ss_pred CCEECCCCC----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH-----------HHHHCC-
T ss_conf 535324445----5665658774799998489978865332554034536756889988736-----------776154-
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 321134324699998999999999841535998899997899998
Q 005599 598 ALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 598 ~~~~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 642 (688)
..+.... +.++.+|+.+||+.||++|||+.|+++.
T Consensus 221 ------~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 ------VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------CCCCCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ------4778779----9999999999760897589399998539
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=306.08 Aligned_cols=262 Identities=21% Similarity=0.327 Sum_probs=202.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCC--CCCHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 3999788103378383999995-799689999804789--2068999999999860479981115789984893269996
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 447 (688)
++|++.++||+|+||+||+|+. .+++.||||+++... ......+.+|+.++..++|+||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred CCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCEECCCCC
Q ss_conf 16999955673303887889988899999999999898440899975755789994587799981001311210027975
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTARVFGGEE 527 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~ 527 (688)
++.+++|..++. ..+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ECCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 023322211212---3565403678999999999987743399---8600146761211337826652046011046887
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCC------CC
Q ss_conf 311223434557733710113898-89746524489999998819999988888983178999998246643------21
Q 005599 528 ISTNTNRVVGTYGYMSPEYALGGL-FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKA------LE 600 (688)
Q Consensus 528 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~ 600 (688)
.. .....++..|+|||.+.+.. ++.++||||+||++|||++|+.||....+ .......+......... ..
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-HHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CC--CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCC-HHHHHHHHHHHCCCCCHHHHHHHHH
T ss_conf 51--00103443101466750698888044402654188998518999988999-9999999986118997355134432
Q ss_pred CCC--------CC-CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 134--------32-469999899999999984153599889999789999
Q 005599 601 IVD--------SS-MADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVF 641 (688)
Q Consensus 601 ~id--------~~-l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 641 (688)
..+ .. -........+..+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 22113344454431043306568999999999986499668909999964
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=303.81 Aligned_cols=259 Identities=22% Similarity=0.275 Sum_probs=195.4
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCCCCE-EEEEEECCCEEEEEE
Q ss_conf 23999788103378383999995-7996899998047892068999999999860479981115-789984893269996
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNLVKL-LGCCLEKDEKMLIYE 447 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e 447 (688)
.++|++.+.||+|+||.||+|+. .+++.||||++...... .++..|+.++..++|++++.. ..+..+.+..++|+|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC--HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf 88899968985078809999999889989999997210058--8899999999970389960179999951987789998
Q ss_pred CCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC---CCCCEECCCCCCEECC
Q ss_conf 1699995567330388788998889999999999989844089997575578999458779---9981001311210027
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE---EMNPRISDFGTARVFG 524 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfgla~~~~ 524 (688)
|++ ++|...+... ...+++..+..++.|++.||.|||+++ |+||||||+|||++. +..+||+|||+|+.+.
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLG-PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCC-CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred ECC-CCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECC
T ss_conf 738-7133324430--688768999999999999999999799---4426678766064335777615650467513425
Q ss_pred CCCCC-----CCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC-HH-HHHHHHHCCCC
Q ss_conf 97531-----1223434557733710113898897465244899999988199999888889831-78-99999824664
Q 005599 525 GEEIS-----TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSN-LI-RYVWELWSDDK 597 (688)
Q Consensus 525 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~-~~-~~~~~~~~~~~ 597 (688)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .. .........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-- 235 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-- 235 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--
T ss_pred CCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCC--
T ss_conf 544554100013577678735329999918998983218861778999984987665530577999999852356789--
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 3211343246999989999999998415359988999978999982289
Q 005599 598 ALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 598 ~~~~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 646 (688)
..+.+....+ .++.+++..|++.+|++||++.++.+.|+..
T Consensus 236 ----~~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 236 ----PIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ----CHHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ----CHHHHCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ----8357534788----9999999998439955791999999999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=305.52 Aligned_cols=252 Identities=22% Similarity=0.302 Sum_probs=199.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC----CCCEEEEEECCCC----CCCCHHHHHHHHHHHHHCCC-CCCCCEEEEEEECCC
Q ss_conf 39997881033783839999957----9968999980478----92068999999999860479-981115789984893
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA----NGQEIAVKRLSTT----SGQGIEEFKNEVLLIAKLQH-RNLVKLLGCCLEKDE 441 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 441 (688)
++|++.+.||+|+||+||+|+.. +|+.||+|.+... .....+.+.+|+.++.+++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCE
Q ss_conf 26999616999955673303887889988899999999999898440899975755789994587799981001311210
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 442 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~ 521 (688)
.++++||+.+++|..++... ..++......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEEECCCCCHHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 00123123411799998730---45437888888999999998851499---8965477320124699988874132022
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCEEECCC--CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 02797531122343455773371011389--8897465244899999988199999888889831789999982466432
Q 005599 522 VFGGEEISTNTNRVVGTYGYMSPEYALGG--LFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDKAL 599 (688)
Q Consensus 522 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (688)
.+...... ......|++.|+|||.+.+. .++.++||||+||+||||++|+.||........ ............
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~~~~--- 252 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE--- 252 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCC---
T ss_pred HHCCCCCC-CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHCCCCC---
T ss_conf 20344443-2212223333310687605776887132517777999999768999888877779-999998335689---
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 113432469999899999999984153599889999-----789999
Q 005599 600 EIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPS-----MSTVVF 641 (688)
Q Consensus 600 ~~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 641 (688)
...+...+.++.+++.+||++||++||| ++|+++
T Consensus 253 --------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --------CCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf --------988654799999999997445898819997450999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=303.14 Aligned_cols=258 Identities=23% Similarity=0.280 Sum_probs=197.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCC--CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEEEC------CC
Q ss_conf 39997881033783839999957-9968999980478--920689999999998604799811157899848------93
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTT--SGQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK------DE 441 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 441 (688)
++|++.++||+|+||+||+|... +++.||||++... .......+.+|+.++.+++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCE
Q ss_conf 26999616999955673303887889988899999999999898440899975755789994587799981001311210
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 442 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~ 521 (688)
.++|+||+.++.+. .+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEECCCHHHHH-HHH-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHHH
T ss_conf 69998414467787-650-----38999999999999999998865221---1245677632113654431320102321
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH----------
Q ss_conf 0279753112234345577337101138988974652448999999881999998888898317899999----------
Q 005599 522 VFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWE---------- 591 (688)
Q Consensus 522 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~---------- 591 (688)
...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||..... ......+..
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~--~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHH
T ss_pred CCCCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCH--HHHHHHHHHHCCCCCHHHH
T ss_conf 146665---53322146555581331477778774333566257898659899888977--8899999972058987999
Q ss_pred ---------HHCCC-CC-----CCCCCCCCCCC---CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ---------82466-43-----21134324699---998999999999841535998899997899998
Q 005599 592 ---------LWSDD-KA-----LEIVDSSMADS---CPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFM 642 (688)
Q Consensus 592 ---------~~~~~-~~-----~~~id~~l~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 642 (688)
..... .. ........... .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 876566777764175435666421264333543210133379999999999876994579089999669
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-45 Score=296.87 Aligned_cols=260 Identities=17% Similarity=0.213 Sum_probs=201.8
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCC-CCCCCEEEEEEECCCEEEEEE
Q ss_conf 239997881033783839999957-996899998047892068999999999860479-981115789984893269996
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKLA-NGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQH-RNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 447 (688)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ...+..|++.+..++| +|++.+++++......++|+|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 9806997998417882999999988997999999750258--29999999999996489998779999601881179999
Q ss_pred CCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC-----CCCCEECCCCCCEE
Q ss_conf 1699995567330388788998889999999999989844089997575578999458779-----99810013112100
Q 005599 448 FMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDE-----EMNPRISDFGTARV 522 (688)
Q Consensus 448 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~-----~~~~kl~Dfgla~~ 522 (688)
|+ +++|..++... ...++......++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EC-CCCHHHHHHHH--CCCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 64-88879999752--031106899999999999999999779---6626677131523475434479568723660577
Q ss_pred CCCCCCC-----CCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC-HHHHHHHHHCCC
Q ss_conf 2797531-----1223434557733710113898897465244899999988199999888889831-789999982466
Q 005599 523 FGGEEIS-----TNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSN-LIRYVWELWSDD 596 (688)
Q Consensus 523 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~ 596 (688)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ....+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 14676654111024676277510267989648888869998983199999986987678853021999999997056799
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 43211343246999989999999998415359988999978999982289
Q 005599 597 KALEIVDSSMADSCPAPEALRCIQVGLLCVQDRTTDRPSMSTVVFMLSNE 646 (688)
Q Consensus 597 ~~~~~id~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 646 (688)
. -..+....| .++.+++..|+..+|++||+++.+.+.|+..
T Consensus 236 ~-----~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 236 P-----LRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp C-----HHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred C-----HHHHCCCCC----HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
T ss_conf 9-----589657998----9999999998439930085999999999999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=297.53 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=198.2
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCC--CCCHHHHHHHHHHHHHCCCCCCCCEEEEEEEC-----CC
Q ss_conf 23999788103378383999995-799689999804789--20689999999998604799811157899848-----93
Q 005599 370 TDNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTS--GQGIEEFKNEVLLIAKLQHRNLVKLLGCCLEK-----DE 441 (688)
Q Consensus 370 ~~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 441 (688)
.++|++.++||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.++.+++|+|+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECCCCCCE
Q ss_conf 26999616999955673303887889988899999999999898440899975755789994587799981001311210
Q 005599 442 KMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISDFGTAR 521 (688)
Q Consensus 442 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~ 521 (688)
.+++++++.+|+|.+++. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEEECCCCHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 499999625886232002----245309999999999999999997388---7651667763345543220013210001
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCC---
Q ss_conf 027975311223434557733710113898-8974652448999999881999998888898317899999824664---
Q 005599 522 VFGGEEISTNTNRVVGTYGYMSPEYALGGL-FSTKSDVFSFGVLLLEIITGKKNTGIFNDDSSNLIRYVWELWSDDK--- 597 (688)
Q Consensus 522 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 597 (688)
.... ......|++.|+|||...+.. ++.++||||+|+++|+|++|+.||..... ......+........
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~--~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCHHH
T ss_pred CCCC-----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHCCCCCHHH
T ss_conf 2575-----444434543555835533775678551243205899999768899788988--999999997307997577
Q ss_pred --------CCCCCCCCCC-CCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHCCCC
Q ss_conf --------3211343246-9999-----899999999984153599889999789999--822899
Q 005599 598 --------ALEIVDSSMA-DSCP-----APEALRCIQVGLLCVQDRTTDRPSMSTVVF--MLSNET 647 (688)
Q Consensus 598 --------~~~~id~~l~-~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~--~L~~~~ 647 (688)
.......... ...+ ...+..+.+|+.+||+.||++|||+.|+++ -+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 320010244544430355787555662678999999999997758834593899985599548799
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-41 Score=271.36 Aligned_cols=278 Identities=21% Similarity=0.257 Sum_probs=198.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCC-----------CCCCCCEEEEEEE
Q ss_conf 3999788103378383999995-799689999804789206899999999986047-----------9981115789984
Q 005599 371 DNFSTSNKLGQGGFGPVYKGKL-ANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-----------HRNLVKLLGCCLE 438 (688)
Q Consensus 371 ~~f~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 438 (688)
.+|++.++||+|+||+||+|+. .+++.||||+++... ...+.+.+|+.++..++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 85799899750778189999999999799999983431-33689999999999840145555542276764789987631
Q ss_pred C--CCEEEEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCCEEECCCCCCCEEECCCCC----
Q ss_conf 8--9326999616999955673303887889988899999999999898440-89997575578999458779998----
Q 005599 439 K--DEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQ-DSRLRIIHRDLKASNILLDEEMN---- 511 (688)
Q Consensus 439 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiH~Dlkp~Nill~~~~~---- 511 (688)
. ...+++++++..+..............+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCC
T ss_conf 2565202343200035420000012234678689999999999999888764058---6465677057056305765644
Q ss_pred --CEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC-CC----
Q ss_conf --10013112100279753112234345577337101138988974652448999999881999998888898-31----
Q 005599 512 --PRISDFGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLLEIITGKKNTGIFNDDS-SN---- 584 (688)
Q Consensus 512 --~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~-~~---- 584 (688)
++++|||.+..... ......|++.|+|||++.+..++.++|+||+|+++++|++|+.||....... ..
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred CEEEEEECCCCCCCCC-----CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHH
T ss_conf 3056753144212344-----54223665210571321466777643201237899999878899898755432102689
Q ss_pred HHHHHHHH-----------------HCCCCCCCCCCCC----------CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf 78999998-----------------2466432113432----------46999989999999998415359988999978
Q 005599 585 LIRYVWEL-----------------WSDDKALEIVDSS----------MADSCPAPEALRCIQVGLLCVQDRTTDRPSMS 637 (688)
Q Consensus 585 ~~~~~~~~-----------------~~~~~~~~~id~~----------l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 637 (688)
+....... .........+... .....+...+..+.+|+.+||+.||++|||+.
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 99999983799878862453220001320122024323577644421000156743589999999998779945790899
Q ss_pred HHHHH--HCCCC---CCCCCCCCCC
Q ss_conf 99998--22899---9999999984
Q 005599 638 TVVFM--LSNET---SVPSPKQPTF 657 (688)
Q Consensus 638 evl~~--L~~~~---~~~~p~~p~~ 657 (688)
|+++. +++.. .+..|+.+..
T Consensus 324 e~L~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 324 GLVNHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp HHHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred HHHCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 9966934078987444779986667
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.3e-23 Score=158.85 Aligned_cols=169 Identities=22% Similarity=0.214 Sum_probs=119.2
Q ss_pred CCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCC------------------CCHHHHHHHHHHHHHCCCCCCCCEEEEE
Q ss_conf 7881033783839999957996899998047892------------------0689999999998604799811157899
Q 005599 375 TSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSG------------------QGIEEFKNEVLLIAKLQHRNLVKLLGCC 436 (688)
Q Consensus 375 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~~ 436 (688)
+.++||+|+||+||+|+..+|+.||||+++.... ........|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred HCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEC
T ss_conf 27780248565999999799999999998604434666556563000888999999778999999981699914499862
Q ss_pred EECCCEEEEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCCEECC
Q ss_conf 84893269996169999556733038878899888999999999998984408999757557899945877999810013
Q 005599 437 LEKDEKMLIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDSRLRIIHRDLKASNILLDEEMNPRISD 516 (688)
Q Consensus 437 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 516 (688)
..+++||++++..+.. ++......++.|++.+|.|||+.+ |+||||||+|||++++ .++|+|
T Consensus 84 ----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred ----CCEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEEEE
T ss_conf ----8889999504565420----------015789999999999999982688---8983689036114289-899987
Q ss_pred CCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHHH
Q ss_conf 11210027975311223434557733710113898897465244899999
Q 005599 517 FGTARVFGGEEISTNTNRVVGTYGYMSPEYALGGLFSTKSDVFSFGVLLL 566 (688)
Q Consensus 517 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ 566 (688)
||+|.............+.+. .-.+. ....|+.++|+||..--++
T Consensus 146 FG~a~~~~~~~~~~~l~rd~~----~~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWREILERDVR----NIITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHHHHHHHHHH----HHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHHHHHH----HHHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 788430899870999987799----99999-7578998446899999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.92 E-value=1.1e-08 Score=68.12 Aligned_cols=149 Identities=16% Similarity=0.083 Sum_probs=97.2
Q ss_pred HHHHHHCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCC-CCCCCCEEEEEEECCCEE
Q ss_conf 8998723999788103378383999995799689999804789206899999999986047-998111578998489326
Q 005599 365 TVLAATDNFSTSNKLGQGGFGPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEKM 443 (688)
Q Consensus 365 ~~~~~~~~f~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 443 (688)
++...-+.|...+..+.++...||+... +++.+++|+...........+..|...+..+. +-.+.+++.+....+..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf 9997513527997678998771899990-898699998488765325569999999998760699872899975089649
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---------------------------------
Q ss_conf 99961699995567330388788998889999999999989844089---------------------------------
Q 005599 444 LIYEFMPNKSLDYFIFDESRKQLLDWKKRFDIILGIARGVLYLHQDS--------------------------------- 490 (688)
Q Consensus 444 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------- 490 (688)
+|++++++..+....... .....++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEECCCCCCCCCCCCC--------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 999860433435433440--------269999998999999985568421435764465655577899877655554303
Q ss_pred -----------------------CCCEEECCCCCCCEEECCCCCCEECCCCCCEE
Q ss_conf -----------------------99757557899945877999810013112100
Q 005599 491 -----------------------RLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 491 -----------------------~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~ 522 (688)
...++|+|+.|.|||++++...-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 3232005799999999844986781789860047642364996599960231441
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.29 E-value=5e-06 Score=51.76 Aligned_cols=131 Identities=18% Similarity=0.152 Sum_probs=82.2
Q ss_pred CCCCCCC-EEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCC--CCCCCCEEEEEEECCCEEEEEECCCCCCH
Q ss_conf 1033783-83999995799689999804789206899999999986047--99811157899848932699961699995
Q 005599 378 KLGQGGF-GPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ--HRNLVKLLGCCLEKDEKMLIYEFMPNKSL 454 (688)
Q Consensus 378 ~lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL 454 (688)
.+..|.. ..||+....++..+++|........ .+..|...+..+. ...+.+++.+..+.+..++|++++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCHH---HHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 767865477589999389878999958966776---89999999999986599988613222456615999874413554
Q ss_pred HHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q ss_conf 567330388788998889999999999989844-----------------------------------------------
Q 005599 455 DYFIFDESRKQLLDWKKRFDIILGIARGVLYLH----------------------------------------------- 487 (688)
Q Consensus 455 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH----------------------------------------------- 487 (688)
.... ... ...+.+++..|..||
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred CCCC--------CCH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 3221--------268---99999999999987368854488755412468899999987541101134011213799999
Q ss_pred ----C----CCCCCEEECCCCCCCEEECCCCCCEECCCCCCEE
Q ss_conf ----0----8999757557899945877999810013112100
Q 005599 488 ----Q----DSRLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 488 ----~----~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~ 522 (688)
. .....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 9998718765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.16 E-value=4.1e-05 Score=46.09 Aligned_cols=77 Identities=10% Similarity=0.177 Sum_probs=49.3
Q ss_pred CCCCCCCCCEEEEEEEECC-CCEEEEEECCCC-------CCCCHHHHHHHHHHHHHCC-C--CCCCCEEEEEEECCCEEE
Q ss_conf 8810337838399999579-968999980478-------9206899999999986047-9--981115789984893269
Q 005599 376 SNKLGQGGFGPVYKGKLAN-GQEIAVKRLSTT-------SGQGIEEFKNEVLLIAKLQ-H--RNLVKLLGCCLEKDEKML 444 (688)
Q Consensus 376 ~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 444 (688)
.+.||.|....||+....+ ++.+++|.-... ......+...|...+..+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEECCCCCCH
Q ss_conf 9961699995
Q 005599 445 IYEFMPNKSL 454 (688)
Q Consensus 445 v~e~~~~gsL 454 (688)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=97.72 E-value=0.00016 Score=42.44 Aligned_cols=94 Identities=11% Similarity=0.057 Sum_probs=58.2
Q ss_pred EEEEEECCCCCC--------------CCCCCEEEEECCCCCEEEEEECCEEEEEECCCCCCCCCCCCCCCEEEEEEEEEE
Q ss_conf 379970899999--------------985407975418983689982996899823579831357656520123479984
Q 005599 13 RYLTAWKSPDDP--------------GSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQRLSGVPEMTRNFIFNITYM 78 (688)
Q Consensus 13 ~~L~Sw~s~~Dp--------------s~G~f~~~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~~~~p~~~~~~~~~~~~~ 78 (688)
..|.||-+.+++ +.|.|+|.|+.+|+ ++++.+..++|.++..... .+ ..+.....-++...
T Consensus 2 ~~~~s~~~~~~~~~~l~~~q~l~~~~~~~~y~l~mQ~DGN--LVLy~~~~~vWssnt~~~~--~~-~~l~l~~dGnLvL~ 76 (119)
T d1b2pa_ 2 NIIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN--LVLYDNNNPIWATNTGGLG--NG-CRAVLQPDGVLVVI 76 (119)
T ss_dssp CEEECSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC--EEEEETTEEEEECCCTTSC--SS-CEEEECTTSCEEEE
T ss_pred CEEEEEECCCCCCCEEECCCEEEEECCCCEEEEEECCCCC--EEEEECCEEEEEECCCCCC--CC-EEEEEEECCCEEEE
T ss_conf 7888610177998888289758870478538999889982--9999799679994678877--41-69999837779998
Q ss_pred ECCCEEEEEEEECCCCCEEEEEECCCCCEEEEE
Q ss_conf 088618999980389830148982268457985
Q 005599 79 DNQDEVFVYYSLNNPSILSRMVVNETGFEQRFT 111 (688)
Q Consensus 79 ~n~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~ 111 (688)
+..+...............+++|..||++.+|.
T Consensus 77 d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg 109 (119)
T d1b2pa_ 77 TNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG 109 (119)
T ss_dssp CTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE
T ss_pred CCCCCEEEECCCCCCCCCEEEEECCCCCEEEEC
T ss_conf 999857997887699886599996998899979
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.60 E-value=0.00038 Score=40.12 Aligned_cols=135 Identities=13% Similarity=0.148 Sum_probs=72.6
Q ss_pred EEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHCCCCCC--CCEE-----EEEEECCCEEEEEECCCCCCHHH-
Q ss_conf 839999957996899998047892068999999999860479981--1157-----89984893269996169999556-
Q 005599 385 GPVYKGKLANGQEIAVKRLSTTSGQGIEEFKNEVLLIAKLQHRNL--VKLL-----GCCLEKDEKMLIYEFMPNKSLDY- 456 (688)
Q Consensus 385 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~gsL~~- 456 (688)
-.||+++..+|+.+++|..+... ...+++..|+..+..|....+ +..+ .........+.+++++++..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred CEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCCC
T ss_conf 02699983899979999847877-88999999999999998559987875206898056653479999865277688999
Q ss_pred ----H------H---HC------CCCCCCCCH-------------------H---HHHHHHHHHHHHHHHH-HCCCCCCE
Q ss_conf ----7------3---30------388788998-------------------8---8999999999998984-40899975
Q 005599 457 ----F------I---FD------ESRKQLLDW-------------------K---KRFDIILGIARGVLYL-HQDSRLRI 494 (688)
Q Consensus 457 ----~------l---~~------~~~~~~l~~-------------------~---~~~~i~~~ia~~L~~L-H~~~~~~i 494 (688)
+ + +. .......++ . .....+..+...+..+ .......+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCEE
T ss_conf 99999998999999886303578655677897887665689998747699889899999999999999984545687120
Q ss_pred EECCCCCCCEEECCCCCCEECCCCCCEE
Q ss_conf 7557899945877999810013112100
Q 005599 495 IHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 495 iH~Dlkp~Nill~~~~~~kl~Dfgla~~ 522 (688)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.58 E-value=0.00032 Score=40.60 Aligned_cols=72 Identities=14% Similarity=0.218 Sum_probs=47.0
Q ss_pred CCCCCCCCEEEEEEEECCC--------CEEEEEECCCCCCCCHHHHHHHHHHHHHCC-CCCCCCEEEEEEECCCEEEEEE
Q ss_conf 8103378383999995799--------689999804789206899999999986047-9981115789984893269996
Q 005599 377 NKLGQGGFGPVYKGKLANG--------QEIAVKRLSTTSGQGIEEFKNEVLLIAKLQ-HRNLVKLLGCCLEKDEKMLIYE 447 (688)
Q Consensus 377 ~~lg~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 447 (688)
+.|+.|-.-.+|+....++ ..|++++.. .. .......+|..++..+. +.-.+++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-CC-CHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEE
T ss_conf 991785334348999688775445789817999659-96-1165899999999999757999808998189----56999
Q ss_pred CCCCCCH
Q ss_conf 1699995
Q 005599 448 FMPNKSL 454 (688)
Q Consensus 448 ~~~~gsL 454 (688)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EECCCCC
T ss_conf 7345548
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=97.31 E-value=0.0014 Score=36.61 Aligned_cols=95 Identities=12% Similarity=0.104 Sum_probs=56.6
Q ss_pred CCCCEEEEECCCCCEEEEEECCEEEEEECCCCCCCCCCCCCCCEEEEEEEEEEECCCEEEEEEEECCCCCEEEEEECCCC
Q ss_conf 85407975418983689982996899823579831357656520123479984088618999980389830148982268
Q 005599 26 SGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQRLSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNETG 105 (688)
Q Consensus 26 ~G~f~~~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~~~~p~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~r~~l~~~G 105 (688)
.|.|.|.|+.+|. ++++....++|.++..+.. .+ +.......-++.... .............+...+++|..||
T Consensus 18 ~g~~~l~~q~DGN--Lvly~~~~~vW~s~~~~~~--~~-~~l~l~~dGnLvl~~-~~~~~w~s~t~~~~~~~~l~L~ddG 91 (112)
T d1xd5a_ 18 EGGYLFIIQNDCN--LVLYDNNRAVWASGTNGKA--SG-CVLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDR 91 (112)
T ss_dssp ETTEEEEECTTSC--EEEEETTEEEEECCCTTSC--SS-EEEEECTTSCEEEEE-TTEEEEECCCCCSCCCCEEEECTTS
T ss_pred ECCEEEEECCCCC--EEEECCCCEEEECCCCCCC--CC-CEEEEECCCCEEEEE-CCCEEEEEEECCCCCCEEEEECCCC
T ss_conf 7879999817998--8987398389984673478--88-579996153499993-4874999830368872599996789
Q ss_pred CEEEEEEECCCCCEEEEEECCCCCCC
Q ss_conf 45798530578633798626787876
Q 005599 106 FEQRFTWSSQDRRWIGFWTAPKEQCD 131 (688)
Q Consensus 106 ~l~~~~w~~~~~~w~~~~~~~~~~C~ 131 (688)
+|.+|.- .....|+...+.|+
T Consensus 92 Nlvly~~-----~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 92 NVVIYDN-----SNNAIWATHTNVGN 112 (112)
T ss_dssp CEEEECT-----TSCEEEECCCCCCC
T ss_pred CEEEECC-----CCCEEECCCCCCCC
T ss_conf 9999989-----99679618885698
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=97.19 E-value=0.00059 Score=38.98 Aligned_cols=82 Identities=10% Similarity=0.055 Sum_probs=50.5
Q ss_pred CCCCCEEEEECCCCCEEEEEECCEEEEEECCCCCCCCCCCCCCCEEEEEEEEEEECCCEEEEEEEECCCCCEEEEEECCC
Q ss_conf 98540797541898368998299689982357983135765652012347998408861899998038983014898226
Q 005599 25 GSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQRLSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNET 104 (688)
Q Consensus 25 s~G~f~~~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~~~~p~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~r~~l~~~ 104 (688)
+.|.|+|.|+.+|. ++++....++|.++.- +........+.. .-++...+..++..............+++|+.|
T Consensus 33 ~~g~y~L~~q~DGN--LvL~~~~~~vW~s~t~-~~~~~~~~~l~~--~GnLvl~d~~~~~lW~S~t~~~~~~~~l~Lq~D 107 (120)
T d1dlpa2 33 QLSPYRLSMETDCN--LVLFDRDDRVWSTNTA-GKGTGCRAVLQP--NGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPD 107 (120)
T ss_dssp BCSSCEEEEETTTE--EEEEBTTBCCSCCCCC-SSCSSCEEEEET--TTEEEEEETTTEEEEECCCCCSSSCCEEEECSS
T ss_pred ECCCEEEEECCCCC--EEEECCCCEEEEECCC-CCCCCEEEEEEC--CEEEEEECCCCCEEEEECCCCCCCCEEEEECCC
T ss_conf 74887999968983--8996499689997522-477747999907--764999929998899819999998489998889
Q ss_pred CCEEEEE
Q ss_conf 8457985
Q 005599 105 GFEQRFT 111 (688)
Q Consensus 105 G~l~~~~ 111 (688)
|++++|.
T Consensus 108 GnlvlY~ 114 (120)
T d1dlpa2 108 RNLAIYG 114 (120)
T ss_dssp SCEEEEC
T ss_pred CCEEEEC
T ss_conf 8699968
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=97.02 E-value=0.0023 Score=35.29 Aligned_cols=82 Identities=10% Similarity=0.007 Sum_probs=50.9
Q ss_pred CCCCCEEEEECCCCCEEEEEECCEEEEEECCCCCCCCCCCCCCCEEEEEEEEEEECCCEEEEEEEECCCCCEEEEEECCC
Q ss_conf 98540797541898368998299689982357983135765652012347998408861899998038983014898226
Q 005599 25 GSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQRLSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNET 104 (688)
Q Consensus 25 s~G~f~~~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~~~~p~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~r~~l~~~ 104 (688)
..|.|+|.|+.+|. +++|++..++|.++...-. ..+.+.-...-++......+...............+++|..|
T Consensus 17 ~ng~~~l~~q~DGN--Lvly~~~~~vW~s~~~~~~---~~~~l~l~~~Gnlvl~~~~g~~vWsS~t~~~~~~~~l~L~dd 91 (108)
T d1jpca_ 17 NYGSFVFIMQEDCN--LVLYDVDKPIWATNTGGLS---RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKD 91 (108)
T ss_dssp EETTEEEEECTTSC--EEEEETTEEEEECCCTTSC---SSCEEEECTTSCEEEECTTCCEEEECCCCCSCSCEEEEECTT
T ss_pred ECCCEEEEECCCCE--EEEEECCCEEEEECCCCCC---CCCEEEEECCCEEEEECCCCCCEEECCCCCCCCCEEEEECCC
T ss_conf 72888999878980--9997099021570788998---754799812603999779855127704558887679999688
Q ss_pred CCEEEEE
Q ss_conf 8457985
Q 005599 105 GFEQRFT 111 (688)
Q Consensus 105 G~l~~~~ 111 (688)
|+|.+|.
T Consensus 92 GNlVly~ 98 (108)
T d1jpca_ 92 RNVVIYG 98 (108)
T ss_dssp SCEEEEE
T ss_pred CCEEEEC
T ss_conf 8999969
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.72 E-value=0.012 Score=30.82 Aligned_cols=32 Identities=25% Similarity=0.239 Sum_probs=27.4
Q ss_pred CCCEEECCCCCCCEEECCCCCCEECCCCCCEE
Q ss_conf 99757557899945877999810013112100
Q 005599 491 RLRIIHRDLKASNILLDEEMNPRISDFGTARV 522 (688)
Q Consensus 491 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfgla~~ 522 (688)
+.++||+|+.+.||+++.+...-+.||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 45033378636564020454126742221236
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=96.53 E-value=0.012 Score=30.82 Aligned_cols=83 Identities=12% Similarity=-0.008 Sum_probs=48.0
Q ss_pred CCCCCEEEEECCCCCEEEEEECCEEEEEECCCCCCCCCCCCCCCEEEEEEEEEEECCCEEEEEEEECCCCCEEEEEECCC
Q ss_conf 98540797541898368998299689982357983135765652012347998408861899998038983014898226
Q 005599 25 GSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQRLSGVPEMTRNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNET 104 (688)
Q Consensus 25 s~G~f~~~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~~~~p~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~r~~l~~~ 104 (688)
+.|.|+|.|+.+|. ++++.+..++|.+.+=+ . ......+.-...-++...+..+.....-....+..-.+++|..|
T Consensus 17 ~~g~~~l~~q~dgn--Lvl~~~~~~vW~ant~~-~-~~~~~~l~l~~dGnLvl~~~~g~~vW~s~t~~~~~~~~l~L~dd 92 (109)
T d1kj1a_ 17 DVEPYHFIMQEDCN--LVLYDHSTSVWASNTGI-L-GKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQED 92 (109)
T ss_dssp EETTEEEEECTTSC--EEEEETTEEEEECCCCC-T-TCCCCEEEECTTSCEEEECSSSCEEEECCCCCCSSCCEEEECTT
T ss_pred EECCEEEEECCCCE--EEEEECCEEEEEECCCC-C-CCEEEEEEECCCCEEEEEECCCCEEEEEEEECCCCCEEEEEECC
T ss_conf 83788999448986--99986998999837899-8-75107999937960999908986799973088999779999479
Q ss_pred CCEEEEE
Q ss_conf 8457985
Q 005599 105 GFEQRFT 111 (688)
Q Consensus 105 G~l~~~~ 111 (688)
|++.+|.
T Consensus 93 GNlvly~ 99 (109)
T d1kj1a_ 93 GNVVIYG 99 (109)
T ss_dssp SCEEEEC
T ss_pred CCEEEEC
T ss_conf 7599979
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=96.34 E-value=0.0028 Score=34.80 Aligned_cols=79 Identities=13% Similarity=0.163 Sum_probs=47.0
Q ss_pred CCCCCEEEEECCCCCEEEEEECCEEEEEECCCCCCCCCCCCCCC-EEEEEEEEEEECCCEEEEEEEECCCCCEEEEEECC
Q ss_conf 98540797541898368998299689982357983135765652-01234799840886189999803898301489822
Q 005599 25 GSGNCSFKMDLAGFSQVSLYKSDVKWWRAGSWTGQRLSGVPEMT-RNFIFNITYMDNQDEVFVYYSLNNPSILSRMVVNE 103 (688)
Q Consensus 25 s~G~f~~~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~~~~p~~~-~~~~~~~~~~~n~~~~~~~~~~~~~~~~~r~~l~~ 103 (688)
..|.|+|.|+.+|. ++|+++..+||.++.= +.. .....+. .+.+ .+.+..+...............+++|..
T Consensus 24 ~~g~~~l~~q~DGN--LvL~~~~~~vW~s~t~-~~~-~~~l~l~~dGNL---vl~d~~~~~vWsS~t~~~~g~y~l~Lq~ 96 (115)
T d1dlpa1 24 ELSSFRFTMQSDCN--LVLFDSDVRVWASNTA-GAT-GCRAVLQSDGLL---VILTAQNTIRWSSGTKGSIGNYVLVLQP 96 (115)
T ss_dssp CSTTEEEEECTTSC--EEEEESSSEEECCCCC-SCS-CCBCCBCSSSCB---CCBCTTTCCSCCCCCCCCSSCCEEEECS
T ss_pred ECCCEEEEECCCCE--EEEECCCEEEEECCCC-CCC-CEEEEEECCCCE---EEECCCCCEEEECCCCCCCCCEEEEECC
T ss_conf 75988999979983--9998199068971168-997-568999446789---9990589789981888999978999989
Q ss_pred CCCEEEE
Q ss_conf 6845798
Q 005599 104 TGFEQRF 110 (688)
Q Consensus 104 ~G~l~~~ 110 (688)
||++..|
T Consensus 97 DGNlvlY 103 (115)
T d1dlpa1 97 DRTVTIY 103 (115)
T ss_dssp SSCEEEE
T ss_pred CCCEEEE
T ss_conf 9869996
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=93.26 E-value=0.058 Score=26.67 Aligned_cols=15 Identities=13% Similarity=0.034 Sum_probs=12.2
Q ss_pred EEEEECCCCCEEEEE
Q ss_conf 148982268457985
Q 005599 97 SRMVVNETGFEQRFT 111 (688)
Q Consensus 97 ~r~~l~~~G~l~~~~ 111 (688)
.++.|..||+|.+|.
T Consensus 28 ~~l~~q~DGNLvL~~ 42 (115)
T d1dlpa1 28 FRFTMQSDCNLVLFD 42 (115)
T ss_dssp EEEEECTTSCEEEEE
T ss_pred EEEEECCCCEEEEEC
T ss_conf 899997998399981
|